
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-12901-13200*
  '("(BC)" "4EBP1and" "53-nullizygosity" "A-172" "A-C" "A-CDK2" "A-SIRT6" "A-T"
    "A-loop" "A1" "A1062T" "A146T" "A188T" "A248T" "A279T-HeLa" "A2A2" "A391E"
    "A431and" "A498" "A498-RAD001-resistant" "A549-1C" "A877S" "A9" "AAAAA"
    "AAACA" "AATC" "ABC-subtype" "ABCSG" "ABPs" "ACFs" "ACHP" "ACS" "ADAD1"
    "ADAM-12" "ADAM-8" "ADP-ribosyltransferases" "AFs" "AG014361" "AGTGA"
    "AH-2348" "AIEOP" "AIEOP-BFM" "AIF-V5" "AIFmit" "AIS" "AJR" "AKK"
    "AKT-dependent" "AKT-inactivating" "AKT-mediated" "AKTeven" "ALL2000"
    "ALL2000-ALLR2006" "ALLR2006" "AMAPR" "AMPAR" "AMPK-α" "AMPK-α2" "AMPKR"
    "AMPKa1" "AMPKα2" "ANCOVA" "ANI" "ANKMY2" "ANKRD13C" "AOA" "APIs" "APRO"
    "AR+" "AR-DBD-LBD" "AR-DBD-LBD-related" "AR-FL" "AR-FL-specific" "AR-FQNLF"
    "AR-FxxxY" "AR-LBD-BUD31" "AR-NTD" "AR-V" "AR-cofactor" "AR-coregulator"
    "AR-reporter" "ARG1" "ARQ197" "ARTDs" "AR + " "ASC-J9" "ASK00420" "ASSGL"
    "ATCAATCAA" "ATFS-1" "ATG5-non-expressing" "ATGGTGAGGA" "ATM-null"
    "ATM-pS1981" "ATM-pSer1981" "ATM-phosphorylated" "ATO+ATRA" "ATO-ATRA"
    "ATO-promoted" "ATR-NE" "ATR-defective" "ATR-inhibited" "ATRA-ATO" "ATS"
    "ATTCCCAAA" "AUG" "AWS" "AZD2014" "Aantagonists" "Ab1620" "Ab240" "Abcam"
    "Abmurine" "Abruidis" "Ac-ENPE" "Ac-ENPEpY" "AcLDL" "AcOH" "Acetylation"
    "Achr" "Actos" "Acylthiourea" "Ad" "Ad-GFP" "Ad-GFP-transfected" "Ad-PTB"
    "Ad-PTB-U-box" "Ad-PTB-U-box-treated" "Ad-PTB-treated" "Ad-SIRT1" "Ad-TM"
    "Ad-TM-FOXO3a" "Ad-U6" "Ad-shRNA-FOXO3a" "Adamo" "Advexin" "Affymetrix"
    "Africa" "African" "African-American" "African-Americans" "Africans"
    "Afro-Caribbean" "Ai" "Aim" "Aims" "Aires" "Aisner" "Akt-dependent"
    "Akyurek" "Alani" "Albany" "Alexa" "Alexa568" "Alexander" "Alhazzazi"
    "Allegrini" "Alomari" "Alterations" "Alzheimer" "Alzheimer's" "Alzheimer’s"
    "Amadeus" "America" "American" "Americans" "Amoy" "Ampliseq" "Amsterdam"
    "Anderson" "Andes" "Andover" "Andrea" "Angle1" "Angle1 " "Angle2" "Angle2 "
    "Angulo" "Anisomycin" "Ankara" "Arab" "Arabia" "Aramaki" "Arg-1" "Arg-I"
    "Arg-II" "Arg-II-deficient" "Arg-II-induced" "Arg-II-mediated" "Arg399Gln"
    "ArgPro" "ArgPro " "Argentina" "Argentinean" "Aromasin" "Arun" "Aruna"
    "Arvealo" "Arévalo" "AsPC-1" "AsPC-1cells" "Ashkenazi" "Asian" "Asians"
    "Asn1193" "Associazione" "AstraZeneca" "Atadja" "Ataxiatelangiectasia"
    "AuNP" "AuNPs" "Aurora-1" "Australia" "Austria" "Avandia" "Avanti" "AvgP"
    "AxxAA" "Azzopardi" "A–C" "A–D" "B&C" "B-DNA" "B-II" "B-RafV600E" "B-boxes"
    "B-cell-like" "B-lymphoid" "B-lymphoma" "B-other" "B-subunit" "B-targeted"
    "B1" "B1-6" "B2" "B2264-19" "B5" "B6" "BACa6-Cre" "BALB" "BART-RNAs"
    "BCL6-rearrangements" "BCR-ABL1" "BCRA2" "BD" "BELLE" "BELLE-2" "BFM" "BGJ"
    "BGJ-398" "BH3-only" "BHQ" "BIO" "BIRADS" "BJ-K-Ras" "BLBCL" "BLCA"
    "BLM-BRCA1-telomere" "BLS" "BLS-211" "BMB7" "BMOE" "BMs" "BNLF-1" "BOLERO"
    "BOLERO-2" "BOLERO-3" "BRAC2" "BRCA-null" "BRCA-proficient" "BRCA1-MRN"
    "BRCA1-P002-C2" "BRCA1-defective" "BRCA1-nullizigous" "BRCA1-proficient"
    "BRCA1GFP" "BRCA2-P045-B3" "BRCA2-defective" "BRCAness" "BRST" "BRST-2"
    "BSC-1" "BSCs" "BSE" "BT474-P" "BTG-Box" "BUD31-wt-FxxFY" "Babinski"
    "Background" "Baeyer" "Baeyer-Villiger" "Bai" "Balouch" "Band-4.1"
    "Bangladesh" "Bao" "Bao-di" "Barmherzige" "Barr" "Barrett" "Barrett's"
    "Barrett’s" "Barth" "Bartolomeo" "Bas-Congo" "Basal-specific" "Basel"
    "Basro" "Bassi" "Bayes" "Bayview" "Bcl" "Bcl-2" "Bcl-2-selective" "Bcl-xl"
    "BeadChip" "Begg" "Begg’s" "Bellini" "Benedetti" "Benjamini" "Benke" "Benn"
    "Bera" "Berkeley" "Bethesda" "Bethyl" "Biacore" "BigDye" "Billah"
    "Binder-1" "Binswanger" "Binswanger’s" "Bio-Rad" "Bio-Tek" "BioCare"
    "BioID" "BioID-EWS-Fli-1" "Bioinformatics-based" "Biomatik" "Biosystems"
    "Biotek" "Biotin-labeled" "Bis" "Bismaleimidoethane" "Blackford" "Blc2"
    "Blood-brain" "Blood-flow" "Blume" "Blume-Jensen" "Bmal" "Boch" "Bolos"
    "Boma" "Bonferroni" "Borges" "Bouwman" "Box-like" "Boyden" "Brassica"
    "Bratislava" "Brazil" "Brazilians" "Brca1-null" "Breslow" "Brg" "Bristol"
    "Bristol-Myers" "British" "Britton" "Brodsky" "Browser" "Bruker" "Brunet"
    "Bruton" "Bruton's" "Brüstle" "BstU1" "Buache" "Buenos" "Bukhari"
    "Bulge-Loop" "Burkitt" "Burkitt’s" "Burleson" "B–D" "B–S4D" "C-09T" "C-11T"
    "C-A" "C-Cdh1" "C-Cdh1-mediated" "C-E" "C-alpha" "C-labeled" "C-lobe"
    "C-loop" "C-terminally" "C13-Glass" "C1–C3" "C2" "C2V5" "C2orf44" "C2–C4"
    "C3" "C4" "C4orf7" "C51" "C5–C6" "C7" "C8" "CAAG" "CAAX" "CAGG" "CAL-148"
    "CALGB" "CALGB40603" "CAMK2N1" "CATTCCAAAA" "CC-10"
    "CCAAT-enhancer-binding" "CCD-16" "CCDC117" "CCLE" "CCNO" "CCRCCs" "CCRT"
    "CCX771" "CD133-knockout" "CD3ζ-chain" "CD5-positive-subgroup" "CDC25s"
    "CDK-A-Plk1-A" "CDMs" "CDRs" "CDX-W741L-AR" "CDX-W741L-AR-LBD" "CE-IVD"
    "CELF3-6" "CEN17" "CENP-C-Mis18α-expressing" "CEP7" "CEP701" "CEP8" "CES"
    "CEU" "CFM" "CGATG" "CGC" "CGCGAAAACCCCGG" "CGCggaccGGT" "CGG" "CGGs"
    "CH-TOG" "CH5164840" "CHEK" "CHEK2-P190-B1" "CHORD" "CICs" "CINAHL" "CJUN"
    "CL" "CL-6B" "CLEOPATA" "CLIA" "CM-H2DCFDA" "CM2-DCFHDA" "CNV" "CNVs"
    "COADREAD" "COLsi" "CP66" "CPAI" "CPAI-Q123K" "CPBA" "CPG" "CQ-treatment"
    "CR+PR" "CRAPome" "CRC-CRCLM" "CRIB-like" "CRISPR"
    "CRLRSPPKKGLGSPTVHKISRFPLKRC" "CRM197" "CRP-transgenic" "CRi" "CRs"
    "CS-1008" "CSFV" "CT-I" "CTAR" "CTAR1" "CTAR2" "CTAR2-double" "CTC1"
    "CTC_EMT" "CTCs" "CTG" "CTGTTTA" "CTL4A" "CTONG" "CTT" "CTTCCTAAA" "CUB1"
    "CUG" "CUI" "CVs" "CXC771" "CXCL11-induced" "CXCL11-mediated"
    "CXCL12+RAD001" "CXCL12-secretion" "CXCR12" "CXCR4-12G5"
    "CXCR4–CXCR7-unrelated" "CXCR7-12G8" "CXCR7-mediated" "CXXC" "CYCL16" "CZ"
    "Cajal–Retzius" "Calbiochem" "Calgranulin" "Cambridge" "Canada" "Canetta"
    "Canman" "Cappuzzo" "Cardarella" "Cardone" "Caribbean" "Carlo" "Carlsbad"
    "Carney" "Carpinteria" "Cas-mediated" "Castellana" "Castleman" "Catherine"
    "Caucasians" "Cav1-RFP-caveolae–enriched" "Caveolin-1–null" "Cdc7"
    "Ceccaldi" "Cech" "Cellitti" "Cep120" "Ceppi" "Cesari" "ChIP-PCR"
    "ChIP-qPCR" "ChIP-re-IP" "Cha" "Chakravarty" "Chang" "Chaos3" "Chatelier"
    "Chatelier's" "Chattopadhyay" "Chaudhuri" "ChemAxon" "Chemicon" "Cheng"
    "Cheng-Prusoff" "Cheung" "Chi-Square" "Chi-square" "Chianti" "Chk" "Chk-1"
    "Chou" "Chou-Talalay" "Chua" "Chun" "Cierna" "Cip" "Cis-eQTLs"
    "ClinicalTrials" "Clinico-pathologic" "Clontech" "Cnidium" "CoMFA" "CoMSIA"
    "CoMSIA-NCM-SHD" "Cochin" "Cochrane" "Coffalyser" "Cohen" "Cohesinopathies"
    "Col2a1BAC" "Colao" "Colman" "Colo699" "Comi" "ConSig" "Congo" "Connell"
    "Conover" "Consite" "Contreras" "Control" "Cornelia" "Cost-effectiveness"
    "Cox-model" "CpG-DNA" "CpG-DNA-induced" "CpG-DNA-mediated"
    "CpG-DNA-treated" "CpG-OND" "CpG-dinucleotides" "Craen" "Cre" "Creighton"
    "Crohn" "Crohn's" "Crohn’s" "Crouzon" "Cruz" "Ct" "Ctr" "CuPP" "Cul"
    "Custodio" "Cy" "Cy1" "Cy2" "CyQUANT" "Cyan" "CyberT" "Cybulski"
    "Cys-X21-Cys-X3-Cys" "Cys112-X21-Cys134-X3-Cys138" "Cys8092Ala"
    "Cysteine-to-serine" "Cys→Ala" "Czech" "Cα" "Cα-RMSD" "Cα-RMSF" "Cα-RMSFs"
    "C–E" "D&E" "D-M" "D-P" "D-SIRT6" "D-loops" "D-score" "D15–D50" "D1–D2"
    "D2" "D2-like" "D2R" "D2–40" "D3" "D32H" "D4" "D4R" "D53±6" "D55-R63"
    "D58A" "D74A" "D80A" "D9" "DAF-2DA" "DAKO" "DCEG" "DCFHDA" "DCIS-like"
    "DDN" "DEAGSVYAGILSYGVGFFLFILVVAAVTL"
    "DEAGSVYAGILSYGVGFFLFILVVAAVTL-CRLRSPPKKGLGSPTVHKISRFPLKRC" "DEPDC1"
    "DER-11" "DETA" "DExD" "DFG-motif" "DHMEQ" "DHO" "DHSs" "DHT-T877A-AR"
    "DHT-wt-AR-DBD-LBD" "DHT-wt-AR-LBD" "DIL" "DJB" "DKO" "DMAG" "DMKG" "DMPC"
    "DMPG" "DN-Clim" "DN-Rac1–expressing" "DNA+AGT" "DNA-damage-responsive"
    "DNA-methyltransferase" "DNA-protein" "DNA-seq" "DNR" "DNaseI" "DO-1"
    "DOBS" "DOK-R" "DPOC" "DQ8" "DQSPAGS" "DRC" "DSBs" "DSGFCLDS" "DSGRGDS"
    "DSRCT" "DU145" "DXH9" "Dameshek" "Danio" "Danish" "Danvers" "Dasatinib"
    "Database@Taiwan" "Davies" "DeCyder" "Deiry" "Dela" "Demethylase-1"
    "Denmark" "Detroit" "Dhh" "Diakos" "Diaminofluorescein"
    "Diaphanous-related" "Dictyostelium" "Diego" "Dihydroethidium" "Dil-AcLDL"
    "Dimethyl-α-ketoglutarate" "Diouf" "Dixit" "Dlx" "Dlx5" "Dlx6-Cre" "Dmitry"
    "DnaK-SBD" "Dominant-negative" "Dong" "Donnell" "Dorsopmorphin" "Dotor"
    "Double-Hit" "Double-strand" "Douillard" "Down-modulation" "Dox"
    "Drosopoulos" "Dual-color" "Dubois" "Duckett" "Dulbecco" "Dulbecco's"
    "Dulbecco’s" "Dunn" "Durant" "Durocher" "Dutch" "DyeCycle" "E-Box" "E-CMF"
    "E-MEXP-3271" "E-T-CMF" "E-box" "E-boxes" "E-domain" "E-plates" "E2-E10"
    "E2-E6" "E2-E7" "E2-E8" "E2A" "E2F1-Δ3" "E2F1protein" "E2F1–DNA"
    "E3-ligase" "E3L" "E5" "E543G" "E545K" "E6E7" "E6E7-immortalized" "E7"
    "E8.5" "E9.5" "EAW" "EBER" "EBER-and" "EBIC" "EBUS" "EBUS-TBNA" "ECAR"
    "ECFP" "ECMs" "ECOG" "ED" "ED75" "ED90" "EDCF" "EDCFs" "EEDB" "EEEEE"
    "EFG-like" "EFGR" "EGAPP" "EGF-like" "EGF-treatment" "EGF104535" "EGFR-3"
    "EGFR-L858R" "EGFR-containing" "EGFR1" "EGFR2" "EGFR3" "EGFR4" "EGFRvIII"
    "EJ5-GFP" "ELISA" "ELISAs" "EMILIA" "EML" "EMT-like" "ENERGI" "ENERGI-F704"
    "ENPE" "ENPEpY" "ENSG00000262904" "EOC" "EOL1" "EPSCs" "ER+BC"
    "ER-beta+-positive" "ER-responsive" "ERBB-1" "ERBB-3" "ERBB-4" "ERBB1-4"
    "ERBBs" "ERCC18092" "ERGneg" "ERGpos" "ERK-dependent" "ERRB" "ER + "
    "ESC2-A279T" "ESS" "ETP-ALL" "EURTAC" "EWS-Fli-1-Interacting"
    "EWS-Fli-1-containing" "EWS894" "EXPERT-C" "EYFP-BAG4" "EYFPBAG4"
    "Early-passage" "Early-stage" "East-Asian" "East-Asians" "Eberhard"
    "Ectopic-expression" "EdgeExpress" "Egf" "Egger" "Egger's" "Eitzman" "El"
    "El-Deiry" "Ellis" "Elmer" "Elsevier" "EmGFP" "EmGFP-miR-29b" "Ematologia"
    "End-Binding" "English" "Enhancer-of-zeste" "Ensembl" "EpCAM-only"
    "Epac-Rap1-dependent" "Epithelial-mesenchymal" "Epithelial-to-mesenchymal"
    "Epithelial–mesenchymal" "Epstein" "Eq" "ErPC" "ErbB1-3" "Erufosine"
    "EsC-1" "EsC1-A279T" "EsC1-TERT" "EsC2-A279T" "EsC2-TERT" "Essen" "EtOAc"
    "Ethyl-isopropyl" "Euclidean" "Eugene" "Europe" "European"
    "European-American" "Europeans" "Exome" "Exon14" "Extra-pulmonary"
    "F-2-fluro-2-deoxy-d-glucose" "F-FDG" "F-ara-A" "F1" "F2" "F2,6BP" "F26BP"
    "F4" "F537-I546dup10" "F547L" "F6P" "F901A-C" "FA-A" "FA-J" "FA-J-null"
    "FA-like" "FAB-M1" "FAB-M4" "FAIRE" "FAIRE-seq" "FANCJ-null" "FANCM-null"
    "FAST-ACT" "FB1329" "FBE1" "FBE3" "FBE4" "FBX11" "FBXL11" "FBXO24" "FDLFY"
    "FERM" "FEVR" "FGFR-2-shRNA-transfected" "FGFR1-4" "FGFR1-Y653" "FGFR1–3"
    "FGFR2–4" "FITC-Albumin" "FITC-Dextran" "FITC-PL" "FITC-albumin"
    "FITC-avidin" "FKBP36" "FKBPs" "FLAG" "FLAG-His-EWS-Fli-1"
    "FLAG-His-macroH2A" "FLAG-His-p21" "FLAG-His-tagged" "FLAG-hp53" "FLT3-ITD"
    "FLT3-ITD-associated" "FLT3-ITD-bearing" "FLT3-ITD-dependent"
    "FLT3-ITD-expressing" "FLT3-ITD-induced" "FLT3-ITD-mediated"
    "FLT3-ITD-mutant" "FLT3-TKD" "FLT3-TKD-MUT" "FN-fragmentation" "FNU4H1"
    "FOXO3aTM" "FOXO3aWT" "FOXOA1" "FP-1039" "FQ" "FQNLF" "FRET-FLIM" "FRMD4B"
    "FRS1" "FSC" "FSCN-1" "FSK" "FT-730" "FVC" "FWVS" "Fa-bao" "Factor-1"
    "Fancd" "Fancd2-null" "Fas" "Fas-ESSs" "Fast" "Fat-cell" "Fc" "Fcγ" "Feliu"
    "Fernandez" "Fernandez-L" "Fifty-four" "Fig.
S1A"
    "Fig.
S8C"
    "Fig.
S9F"
    "Fig.
S9J"
    "Fine-tuning" "Fink" "Finkel" "Finland" "Finley" "Finnish" "Firehose"
    "First-SIGNAL" "Fischer" "Flag" "FluR" "FluR-Nalm-6" "FluS" "Fluor-de-Lys"
    "Flurkey" "Fo" "Fo-Fc" "Follow-up" "Forty-eight" "Forty-six"
    "Forward-side-scatter" "Fourier" "Foxp1" "Framingham" "France" "Fraumeni"
    "Fraumeni-fibroblasts" "Fregene" "French"
    "French-American-British-classification" "French-Canadian" "Friboulet"
    "Friedman" "Fru-2,6-BP" "Fu" "Fujifilm" "Fukai" "Full-text" "Fxx" "FxxA"
    "FxxFF" "FxxFY" "FxxHY" "FxxLF" "FxxLF-like" "FxxWY" "FxxYY" "FxxxY"
    "Förster" "G-M" "G-T" "G-loop" "G-phase" "G-quadruplex" "G-quadruplexes"
    "G-quadruplexs" "G-quartet" "G-quartets" "G-rich" "G0" "G0-G1" "G1" "G1-G0"
    "G1-S-G2-M" "G1-fraction" "G1-like" "G1-to" "G12A" "G12mut" "G13Dmut"
    "G15A" "G1–G6" "G2" "G2-M" "G2P0" "G5-methyl" "G5x" "G6" "G719S" "G9a-like"
    "G9s" "GABA-A" "GABA-Aantagonists" "GADD45α" "GAR" "GB-1" "GCB-subgroup"
    "GCCCTGACGTGTCCCC" "GCCcttGCA" "GCFS" "GCLS" "GCN≥4" "GDLTIANLGTSEGR"
    "GEF-catalyzed" "GEF-mediated" "GEMMs" "GFP-M18BP1-NT" "GFP-MRCKα_CAT"
    "GFP-Mis18α" "GFP-PDK1_K465E" "GFP-PDK1_KD" "GFP-PDK1_L155E" "GFP-fusion"
    "GFP-paxillinΔPro" "GFP-tag" "GFPBRCA1" "GFP–Coro1C-tail" "GFP–RCC2-K439E"
    "GFP–α-tubulinK40R" "GG" "GG-A" "GGAAAGGAA" "GGAAAGTCC" "GGAGTCC" "GGCC"
    "GGGAAAGTCC" "GGGCACC" "GGGCAGAGCCC" "GGs" "GKW" "GMB" "GNR" "GNRs"
    "GO-terms" "GOT" "GSE21257" "GSE29354" "GSE46581" "GSK-3beta(WT)"
    "GSK3--are" "GSKIII" "GSSG-to-GSH" "GST-BF4" "GST-MRCKα" "GST-N"
    "GST-PDK1_WT" "GST-protein" "GST-pull" "GST-ΔNp73" "GST–Coro1C-tail"
    "GST–GDP-Rac1" "GSs" "GTCTGCTGACTCCGTGATGA" "GZ" "Gaal" "Gadd45α" "Gahr"
    "Gain-of-function" "Gal4-VP16" "Gallen" "Ganesan" "Garcia" "García"
    "García-Cao" "GenBank" "GeneBank" "GeneCard" "GeneDireX" "Genechip"
    "Genentech" "Genes" "Genomatix" "Genome-wide" "GeparSixto" "German"
    "Germany" "Gibco" "Gil1" "GlaxoSmithKline" "Gleason" "Gleevac" "Glickman"
    "Glide-score" "Globo" "Glu1192" "Glu22-His49-Cys69" "Glu775X" "Glu797fs"
    "Go" "Goltz" "Gonzalez" "Gonzalez-Angulo" "Gonzalez-Moles" "Goosecoid"
    "Gorenne" "Gould" "Gram-negative" "Gram-positive" "Graphpad" "Grasso"
    "Greece" "Greek" "Greenberg" "Grivas" "Gromacs" "Grompe" "Grp78" "Gsdmc2–4"
    "Gu" "Guangzhou" "Guarani" "Guarente" "Guillemette" "Gujrathi" "Gukas"
    "GxxxG" "Gy" "Gyorffy" "Götschel" "Gαi" "Gαi-protein" "Gβγ" "G→A" "G→C"
    "G→T" "H&E" "H-FY" "H-NMR" "H-TY" "H-bond" "H-bonding" "H-bonds"
    "H-glucose" "H-rasV12" "H-score" "H-scores" "H-thymidine" "H1047L" "H1047R"
    "H1975" "H1993" "H2" "H3" "H334R" "H3K27" "H3K36" "H3K4m3" "H3K9Ac"
    "H3K9m3" "H3lysine" "H4" "H4K16" "H4K16Ac" "H4K4" "H5" "H538K539delinsL"
    "H538Y" "HA-PML4" "HA-tag" "HADC2" "HAREDD1" "HARM" "HCAECs" "HCC-2998"
    "HCT116p53KO" "HCZ" "HD-75" "HDAC8-SAHA" "HDAC8-substrate"
    "HDAC8-substrate-activator" "HDAC8s" "HDLECs" "HEC-1-B" "HEC59+chr2" "HEIH"
    "HER-family" "HER2-Resistance" "HER2-Y" "HER2-amplicon-related" "HER2-gene"
    "HER2-genes" "HER2-related" "HER2-resistance" "HER2E" "HF-26" "HF-T877A-AR"
    "HF-T877A-AR-DBD-LBD" "HF-T877A-AR-LBD" "HFE-145" "HFF" "HFFs" "HG-U133"
    "HGMD" "HGVS" "HHV-4" "HIF-1αhas" "HIF-1αis" "HIF-alpha" "HIF1-α"
    "HIF1-α-dependent" "HJ" "HLCZ02" "HMBG1" "HMGB1-deficience"
    "HMGB1-proficient" "HMGD" "HMLE" "HMVII" "HNRNPA3" "HNSC" "HNSCCs"
    "HOMA-IR" "HPAI-RR" "HPDE4" "HPDE6" "HPLC-ESI-MS" "HPMCs" "HPRD" "HPTLC"
    "HPV16E5" "HRASV" "HRASV12-induced" "HRD" "HRMAS" "HRs" "HSP70-NRLLLTG"
    "HSP70-SBDα" "HSP70-clients" "HSP70-substrate" "HSP70s" "HSV-1" "HS "
    "HT29-M6" "HXRXXS" "HZ" "HZS" "Haigis" "Hanauske" "Hans" "Hap550" "HapMap"
    "HaploReg" "Hardwick" "Hardy-Weinberg" "Hardy–Weinberg" "Hayflick"
    "Hayward" "HdaI" "Heah" "Heike" "Helicos" "Heliscope" "Helsinki"
    "Hematoxyllin" "HepG2-pCDH-control" "HepG2-pCDH-miR-100" "HiSeq"
    "Higashimoto" "High-Risk" "High-grade" "High-penetrance" "High-quality"
    "High-resolution" "Hilden" "Hippo-YAP" "Hippo-independent" "Hiramatsu"
    "Hiroshima" "Hirsch" "Hirschsprung" "Hirschsprung's" "Hisaoka" "Hispanic"
    "HistoBioTec" "Hitachi" "Hiwi" "Hochberg" "Hodgkin" "Hodgkin’s" "Hoechest"
    "Hoechst" "Hoesel" "Hoffman" "Holland" "Holzenberger" "Hopkins"
    "Hp-DNA-induced" "Hristova" "HscC" "Hsp70-8" "Hsp90" "Hsp90α" "HspB"
    "Huang" "Hultman" "HumDiv" "Human-miR-200" "Human660W-Quad" "HumanHap550"
    "HumanMethylation450" "Huntington" "Huntington's" "Hupki" "Huzarski"
    "Hyper-IgE" "Hyperinsulinemia" "I)xF" "I-HA" "I-II" "I-III" "I-IV"
    "I-coated" "I-hypersensitive" "I-induced" "I-rich" "I243N" "IASLC" "ICP47"
    "ICP8" "IDH-1" "IEBP3" "IEGs" "IFTEM" "IGBP" "IGBP-2" "IGF-1-induced"
    "IGF-1-mediated" "IGF-1-null" "IGF-1-targeted" "IGF-1-treated"
    "IGF-1R-targeted" "IGF-2-null" "IGF1-mediated" "IHA" "IHC4" "II-1" "II-11"
    "II-3" "II-5" "II-7" "II-9" "II-B08" "II-IV" "II-IVA-B" "II-V" "III-4"
    "III-5" "III-IV" "III-V" "III1" "IIIB" "IIIB–IV" "IIIa" "IIIc" "IIa" "IIx"
    "IL-1R-like" "IL-8R" "INO" "INO-1001" "INV-HG" "INV-LG" "IPed" "IPython"
    "IQ" "IQR" "IQR " "IR+SR" "IR-A" "IR-B" "IR-overexpressing" "IR-β" "IRB"
    "IRDye" "IRES-EGFP" "IRS-2-4" "IRST" "ISEL" "ISG12a" "ISG12a3" "ISGs"
    "ISGylation-mediated" "ISH-analysis" "ISI" "ISLA" "ISOs" "ITC" "ITG" "IUPs"
    "IV-1" "IV-independent" "IVA" "IVA–B" "IVC" "IVCs" "IVS2 + " "IZKF3"
    "Iceland" "Ig-NRG1" "Ig-like" "Illumina" "Immunodominant" "In-silico"
    "InCHIANTI" "Inc" "Indians" "Indovina" "Infinity-plus" "Infinium" "Inotek"
    "Invecchiare" "Invitrogen" "Isg" "Isg15-dependent" "Israel" "Israeli"
    "Italiana" "Italiano" "Italians" "Ivanova" "I·C" "I–II" "I–III" "J-B" "J-M"
    "J-R" "J-S" "JA3" "JAK2V617F" "JF" "JIMT" "JMEN" "JML" "JMa" "JNK1-3"
    "JNKi" "JPC" "JQ1" "JTC" "JVH" "JW" "JWT" "JXP" "JZ" "Jackson" "Japanese"
    "Jeghers" "Jewish" "Jeyapalan" "Jiang" "Jiont" "Jiricny" "JmjC-domain"
    "Johansson" "Johnson" "Jolla" "K)(V" "K-phosphate" "K141" "K160" "K191"
    "K21" "K21R" "K487" "K487Q" "K549I" "K63R" "K64" "K64R" "K65" "K76"
    "K898E-C" "KALP" "KASUMI" "KASUMI-2" "KChIP" "KChIPs" "KD1" "KD2" "KDM5"
    "KEEG" "KEGG" "KIRC" "KMM" "KOS" "KP4×1.1" "KRASV" "KRASV12"
    "KRASV12-expressing" "KRT" "KSP" "KTH" "KU-812" "KVTA" "KVTF" "KYAA"
    "Kabsch" "Kaikita" "Kang" "Kannouche" "Kaplan-Meier" "Kaplan–Meier"
    "Kaposi" "Kaposi's" "Kaposin" "Kaposi’s" "Karapetis" "Karim" "Karnofsky"
    "Kashiwagi" "Kasper" "Kato" "Katori" "Kawakami" "Kelch" "Kenny" "Kenyon"
    "Khanna" "Ki-67" "Ki-67-positive" "Ki67" "Ki67-positeve" "Kilic" "Kim"
    "Kima" "Kimmelman" "Kimpese" "Kinshasa" "Kip" "Kirsten" "Kit-8" "Klein"
    "Knock-In" "Knock-down" "Knosp" "Koelsche" "Kolodner" "Komuro" "Koon"
    "Kordi" "Kordi-Tamandani" "Korea" "Korean" "Kortlever" "Kosynkin" "Koyama"
    "Kozlvosky" "Krankenhaus" "Kratz" "Krawczyk" "Krebs" "Kreitman" "Kruppel"
    "Kruppel-like" "Kruskal-Wallis" "Krynetskaia" "Krämer" "Ku" "Kuilman"
    "Kumar" "Kumaraswamy" "Kuo" "Kuriyan" "Kyoto" "K→Q" "K→R"
    "L-NAME-inhibitable" "L-NG-Nitroarginine" "L-citrulline" "L-lysine"
    "L-shaped" "L1" "L1197" "L2" "L3" "L4" "L7" "L858R" "LAML" "LBY135"
    "LC3B-I" "LC3B-II" "LC3BII" "LCCA" "LCL" "LCL-3" "LCL-4" "LCL-721" "LCL-B"
    "LCLs" "LCS6" "LD540" "LEF-responsive" "LELLSDS" "LF2000" "LGLD"
    "LIM-homeodomain" "LIM-only" "LINC00977" "LINE-1" "LINE-1s" "LIS_TUB"
    "LIS_TUB012_foetus22" "LIS_TUB_005_foetus01" "LIS_TUB_009" "LIS_TUB_013"
    "LIS_TUB_021" "LIS_TUB_022" "LIS_TUB_025" "LKB1-null" "LKB1-pCMV"
    "LKB1-proficient" "LMICs" "LMM" "LMMs" "LMO" "LMS-R" "LMS14" "LMS24"
    "LN-COLsi" "LN2B" "LN3" "LNBTG2si" "LNCaP" "LNGFR" "LNM" "LOD" "LOO"
    "LP-BER" "LR" "LSD-1" "LSKs" "LTPQ" "LTR" "LUAD" "LUMIER" "LUSC" "LUX-Lung"
    "LXSN" "LY209002" "LY294003" "LZRS" "LZRS-mp120" "La-GFP" "Lakatta" "Lange"
    "Langley" "Lanka" "Lapatinib-Resistance" "Large-T" "Large-scale" "Larson"
    "Late-passage" "Latinos" "Le" "Leary" "Lehmann" "Lehnmann" "Leigh"
    "Lengyel" "Lentiviral-mediated" "Leonardo" "Leptomycin-B" "Lesort" "Let-7c"
    "Leu+4" "Leu126-Tyr133" "Leu31-Pro35" "Leung" "Levine" "Lhx" "Li"
    "Li-Fraumeni" "Li-hong" "Libya" "Lieb" "Life-long" "LifeAct"
    "LifeAct-mTurquoise" "LigandFit" "Lindberg" "Linz" "Lipinski"
    "Lipofectamine" "Liquid-Tissue-SRM" "Liquid-Tissue-Selected" "Litman" "Liu"
    "Live-cell" "Loewe" "Lohrum" "Loi" "London" "Loss-of-function" "Louis"
    "Low-doses" "Low-grade" "LoxP" "Lu" "Lukas" "Lundgaard" "LungCarta" "Luo"
    "Lup" "Lup-20" "Luschka" "Lutterbach" "LxxLL" "LxxLL-mimetic" "Lymphochip"
    "Lyz1" "M-K" "M-M" "M-W" "M-arrest" "M2a" "M5-7" "M532V" "M535I" "M7" "M8"
    "M8a" "MAH" "MAI-11" "MALI" "MALI1-V1" "MALT-V1" "MALT1-V1" "MALT1-V2"
    "MAPK-PARP-1-poly" "MARIANNE" "MATL" "MATL1-V2" "MBCs" "MCF7cells" "MCM2-7"
    "MCMs" "MD-AMB-453" "MDA-MD-231" "MDA-MD-453" "MDACC" "MDBio" "MDM2-A"
    "MDM2-ALT1-mediated" "MDM2-ALT3" "MDM2-B" "MDM2-C" "MDM2-interactive"
    "MDMX-S" "MDSCs" "MELAS" "MEM" "MES-Parkin" "MET-induced" "MET-mediated"
    "MG15" "MG15-Luc" "MHCII" "MHH" "MHH-ES-1" "MHz" "MIR1208" "MIX"
    "MIX-treated" "MJH" "MK-4827" "MLV-HA-RASSF1C" "MMP-1promoter" "MMTV-NeuT"
    "MMTV-Polyoma" "MMTV-PyMT" "MMTVneu" "MNC" "MNCs" "MOI " "MPECs" "MPFS"
    "MPFSI" "MRCKβ" "MRFT" "MRFT-A" "MRM" "MRTF" "MRTF-B" "MRU" "MS-PCR" "MSDC"
    "MSH2-proficient" "MSH2–SLX4–FANCD2–FAN1-dependent" "MSI-H" "MSI-L"
    "MST-FOXO" "MSX" "MT-APC" "MTGreen" "MTS" "MTS-PstI-HA" "MUNC13-4" "MV4"
    "MYCi" "MYCp" "MYND" "MZ" "MaCFC" "MaCFCs" "Mad1" "Mad2" "Magendie" "Maier"
    "Maki" "Malay" "MammaPrint" "Manassas" "Mandola" "Mantel-Cox" "Marchetti"
    "Marinus" "Marsden" "Marshall" "Marsischky" "Martinez" "Maruzuru"
    "MassARRAY" "Massachusetts" "Masson" "Masuda" "Matadi" "Matrigel-coated"
    "Mattagajasingh" "MbI" "Mbp" "McDonald" "McDonald-Kreitman" "McLaughlin"
    "Mcpt" "Mcpt5-Cre" "MeOPh" "Meacham" "Mec-1" "Mec-2" "Meckel"
    "Mediterranean" "Mego" "Meier" "Melton" "Mendrysa" "Menghini" "Menon"
    "Menton" "Merck" "Merkel" "Merkel-cell" "Met40-Ser47" "Meta-analytical"
    "MetaCore" "Mexican" "Mexico" "MiR-124" "MiR-17" "MiR-184" "MiR-221"
    "MiR-375" "MiR-375-regulated" "MiR-494" "MiR-506" "MiR-9" "MiR-942"
    "MiRNA-155" "MiaPaca-2" "Miami" "Michigan" "Michishita" "Micro-angiography"
    "MicroRNA-200c" "MicroRNA-942" "Microwell" "Midi" "Millipore" "Minamino"
    "Mis18β" "Miseq" "MitoTracker" "Mlak" "Moiseeva" "MolA" "MolB" "Moldovan"
    "Moloney" "Monophosphate" "Monte" "Montgomery" "Moreland" "Morikawa" "Moro"
    "Moro-Sibilot" "Moshkin" "Mougiakakos" "Mougiakakos’s" "Mozdy" "Mr" "MscI"
    "MsigDB" "Mu" "Muanda" "Mumbuc" "Muniandy" "Murai" "Mure" "Murray" "MutSα"
    "MutSβ" "Mutations" "Mutdb" "Mu " "My09" "My11" "Myc-as" "Myc-tag" "Myers"
    "Myr-Akt" "Mζ" "Mφ" "N+" "N-Arginine" "N-SH2" "N-acetyl"
    "N-acétylaspartate" "N-linked" "N-lobe" "N-methyl-N" "N-oxide"
    "N-phosphonacetyl-L-aspartate" "N-stage" "N0" "N0P10" "N194" "N4"
    "N542-E543del" "N=9" "NAM+TSA" "NB4-R2" "NBDs" "NBR4-R2" "NCBI" "NCEP"
    "NCEP-ATP" "NCI" "NCI-H1838" "NCI-H322" "NCI-H716" "NCI-HCC827" "NCI60"
    "NCR" "NCT00468715" "NCT00620594" "NCT00876109" "NCT01004224" "NCTs"
    "NCsiRNA" "NDKGRL" "NEBD " "NEEC" "NEIL" "NEJ002" "NENs" "NEOSPHERE" "NEs"
    "NF-κB-pathway" "NF-κBs" "NF-κΒ" "NF-кB" "NG2DsRed" "NG2DsRed-vascular"
    "NGF-R" "NH" "NHBE" "NHLBI" "NHW" "NKI295" "NKI947" "NL" "NLNSVSVPR"
    "NLS-HA-K65" "NLS-K487R" "NLS-K65" "NLS-PstI-HA" "NNK" "NO" "NO-cGMP"
    "NO-sGC-cGMP" "NRCTs" "NRG1α" "NRG2-6" "NRG6" "NRLILTG" "NSAID" "NTF2-like"
    "NTSR" "NVC" "NVP" "NVP-BEZ-235" "NVP-BKM-120" "Nacalai" "Nadri"
    "Nagelkerke" "Namp" "Nanfang" "NarI" "Nariño" "Nehme" "Nestin8-Cre"
    "Netherlands" "NeuT" "Nevada" "Newbern" "Next-Generation" "Next-generation"
    "Nextera" "Nielsen" "Nigeria" "Ninety-six" "Ningxia" "Nli" "Norgen"
    "Norway" "Notch-regulated" "Nottingham" "Novartis" "Novex" "Nowosielska"
    "Nox" "Npro" "Nrf2-ARE" "Nrf2-null" "Nrg" "Nrg1" "Nrg1-Erbb" "Nu" "NuPAGE"
    "NuRD" "Nussenzweig" "Nε" "N = 2" "O-GNR" "O-GNR-PEG-DSPE"
    "O-GNR-PEG-DSPEs" "O-GNRs" "OARSI" "OCCAR" "OCCAR-8" "OCI-LY19" "OCl"
    "ODNs" "OH" "OLP" "OMIM" "OND" "OPTI" "OPTI-MEM" "OPUS" "OR=3.50" "ORF-K9"
    "ORPphilin" "ORPphilins" "ORR" "ORRs" "ORs" "OSW-1" "Ob" "Oct3"
    "Octyl-β-glucoside" "Olympus" "Omni" "OmniExpress" "Oncel" "OncoMap"
    "Oncologia" "Oncology" "Oncomine" "One-third" "Orbitrap" "OregAnno"
    "Oregon" "Osaka" "Ostrovich" "Otsu" "Otx" "Over-activation" "Ovt" "OxPt"
    "Oxford" "Oxytrichia" "Oδ2" "O–stained" "P1" "P151T" "P278" "P278A"
    "P38MAPK" "P53–promoter" "P815-KD1" "P815-KD2" "P=0.001" "P=0.002"
    "P=0.003" "P=0.004" "P=0.009" "P=0.035" "P=0.037" "P=0.038" "PABP-1"
    "PAGFP–Rac1" "PAGs" "PAI-1–675" "PAI-1–844A" "PAI-L" "PAK1-3" "PAK1–3"
    "PAK4-6" "PAM50" "PAML" "PANDoRA" "PANGEA" "PAPRi" "PARP-1binds"
    "PARP-1–knockout" "PARP-DNA" "PARPi" "PARR" "PAb1801" "PAb1801-induced"
    "PAb246" "PAb421" "PBS+DMSO" "PBS-T" "PBST" "PC-3" "PC3-120" "PC3-NT" "PCA"
    "PCC" "PCNA-POGO" "PCNA-Peptide" "PCNA-T3" "PCNA-ligand" "PCNA-peptide"
    "PCOL" "PCR-RFLP" "PCR–RFLP" "PCT" "PDACs" "PDFGRA" "PDFGRβ" "PDFRA"
    "PDK1_L155EK465E" "PDK1_Δ50" "PDK1_ΔPH" "PDL-1" "PDL41-44" "PDL6-8"
    "PEG-DSPE" "PEG-DSPE-coated" "PELP1-shRNA" "PESS" "PEST-PTP" "PEST-family"
    "PETT" "PF-04691502" "PGC-1a" "PGFRA" "PI-staining" "PI3K-H1047R-mediated"
    "PI3K-Tiam1-dependent" "PI3KCA" "PI3KR3" "PI3Kp85" "PI3 K" "PICCOLO"
    "PIF-binding" "PIK3CA-GS" "PIKCA" "PIVUS" "PIWILI" "PJ" "PKCiota" "PKCzeta"
    "PKCζ" "PKMζ" "PLQRpY" "PML6" "PMN" "PMN-MDSCs" "PNS" "POGO" "POGO-ligase"
    "POPS" "PP1-non-binding" "PP1αmyc" "PP2AA" "PP2AB" "PP2AC" "PPARγ1"
    "PPARγ2" "PPXY" "PR-positive" "PRCKZ" "PRF5" "PRHER" "PRHER-2" "PRIDE"
    "PRKMZ" "PRL-and" "PRR15L" "PSA-fowlpox" "PTB-RING" "PTB-U-box"
    "PTB-U-box-carrying" "PTB-U-box-caused" "PTB-U-box-driven"
    "PTB-U-box-expressing" "PTB-U-box-transfected" "PTB-U-box-trigged"
    "PTB1B-CASA" "PTEN-L" "PTEN-Long" "PTEN-L–specific" "PTEN-null" "PTENα"
    "PTGS" "PTP1B-C215S-BPPM" "PTP1B-reactive" "PTPD" "PTPD1-containing"
    "PTPD1-mCitrine" "PTPα" "PTT5" "PV-9000" "PVT1-RNA" "PVT1-RNA-dependent"
    "PWV" "PZ5001" "PZ5009" "PZ5010" "PZ5018" "PZ5024" "PZ5056" "PZ5074"
    "PZ5086" "PZ5091" "Paik" "Pallister" "Pallister-Killian" "Palo"
    "Pan-cancer" "PanIN" "PanScan" "Panc-1and" "Papillary-predominant"
    "Parkinson" "Partek" "Partitioning-defective" "Pavlicek" "Paz-Ares"
    "Pearson's" "Pediatrica" "Peng" "Perkin" "Perkin-Elmer" "Pernambuco"
    "Perrin" "Petrelli" "Peutz" "Peutz-Jeghers" "Peyton" "Pfam" "Pfirrmann"
    "Pfizer" "PgR-negative" "Ph" "Pharmingen" "Phe+1" "Phe+5" "Philadelphia"
    "Phospho" "Phosphorylated-YAP" "Phyllostachys" "Pichler" "Picrasma"
    "Pittsburgh" "Piwil" "Piwil-Argonaute-Zwille" "Platz" "Plk-D" "Plk1-A"
    "Polo-Box" "PolyPhen" "PolyPhen-2" "Polyendocrinopathy"
    "Polymicrogyria-like" "Polyphen-2" "Post-operative" "Post-operatively"
    "Potente" "Pratilas" "Prenen" "Pro-inflammatory" "Pro72" "Probst"
    "Progenetix" "Proia" "Promega" "Prusoff" "Pten" "Pull-down" "Purkinje"
    "PvuII" "Pvull" "Pyr-PP" "P = 0.002" "P = 0.004" "P = 0.008" "P = 0.028"
    "P = 0.03" "P = 0.04" "P = 0.05" "Q-HY" "Q-deprivation" "Q-deprived"
    "Q-induced" "Q-mediated" "Q-sensitive" "QALYS" "QD" "QIAamp" "QP"
    "QXXφXXΩΩ" "QZ" "Qiagen" "Quant" "R-5-P" "R-CHOP" "R-CHOP-treated" "R-SOH"
    "R-X-R-X-X-pS" "R1" "R107" "R110P" "R2" "R2TP" "RASF1C" "RASSF1-6"
    "RASSF1A-RASSF1C" "RASSF1C-SP-CD133" "RASSF7∼10" "RBCV" "RD-ES-1" "RECA-1"
    "REDD1-knockout" "REDD1–V5" "REMARK" "RET-kinase-inhibitors" "RFLP"
    "RITA-unique" "RKR" "RMM" "RMSDs" "RMSFs" "RNA-seq" "RNA22" "RNAPII"
    "RNAhybrid" "RNAi-like" "RNhybrid" "RO5" "ROS-scavenging" "ROSA"
    "ROSA-mTmG" "RP11-144N1.1" "RPA-ssDNA" "RPA-ssDNA-mediated" "RQ-PCR"
    "RRAGSVYAGILSYG" "RRL" "RRLs" "RRRCWWGYYY" "RRRCWWGYYYN" "RS012895"
    "RS102895" "RSAs" "RSSG" "RSSR" "RT-qPCR" "RTOG" "RT–qPCR" "RVM" "Ra"
    "Rac-GTP" "Rac1" "Rac1-GDP" "Rac1-GDP–RCC2" "Rac1-sequestration" "RacN17"
    "RacV12" "Racine" "Rad3" "RagBC" "Raichu-Rac-transfected" "Rando" "Ranvier"
    "Rapamycine" "Ras-association" "Ras-dependent" "Ras-like" "RasG" "RasG37"
    "RasG37-transformed" "RasGAP2" "Rat6" "Razis" "Rb-E2F" "Rb-dependant"
    "Rb-knockout" "Rb-levels" "Rb-loss" "Rb-null" "Rb-pathway" "Rb-proficient"
    "RcCMVp120" "Re-interpretation" "Recife" "Reddel" "Redox-sensitivity"
    "Reed-Sternberg" "RefSeq" "Reg" "Remak" "Rembrandt" "Renilla"
    "Retro-orbital" "Retzius" "Rev-erbα" "RevMan" "Revesz" "Revesz-like"
    "Rheb-GDP" "Rheb-GTP" "Rho-GTPase–associated" "Rho-family" "RhoGDIα" "Rhoc"
    "Richter" "Risk-reducing" "Risques" "Ro-41-5153" "Ro-41-52-53" "Ro-41-5253"
    "Roche" "Rockford" "Rodina" "Roh" "Romberg" "Rosell" "RosettaBackrub"
    "RossetteSep" "Rous" "Rp" "Rp-v" "Ru-5-P" "Russ" "Russo" "Rux" "S-6-kinase"
    "S-C" "S-HL" "S-HZ" "S-S" "S-fraction" "S-labeled" "S-methionine"
    "S-protein-agarose" "S-score" "S1" "S100-immunopositive" "S117A" "S117E"
    "S19" "S193" "S1B-C" "S1C–E" "S1D" "S1D-G" "S1E" "S1F" "S1c" "S21" "S217"
    "S221" "S235" "S240" "S2A" "S2A-C" "S2B" "S2C" "S2D" "S2E" "S2F" "S3" "S32"
    "S33L" "S378-G382" "S378-G382-L385" "S3C" "S3D" "S3E" "S3F" "S3G" "S3H"
    "S3J–K" "S419A" "S423A" "S473D" "S4A" "S4A-D" "S4B" "S4C" "S4E" "S4F" "S4G"
    "S5A-C" "S5A–D" "S5B-C" "S5B–G" "S5C" "S5D" "S5D-E" "S5E" "S5F" "S5a" "S5c"
    "S6" "S69-phosphoarylation" "S6A" "S6C" "S6F" "S6G" "S6RP" "S7" "S8" "S807"
    "S8A" "S8B" "S8D" "S8D–G" "S8G" "S9" "S9A" "S9H" "SA-β-gal-positive" "SABC"
    "SAR" "SARs" "SATURN" "SB-218078" "SBDβ" "SCEs" "SCI" "SCNECs" "SDS-Page"
    "SEDFIT" "SEDNTERP" "SEDP" "SF-767" "SFFV" "SHDA" "SIFT" "SILAC" "SIRT"
    "SIRT1-Tg" "SIRT2-null" "SIRT5-mediated" "SISH" "SK-ES" "SKBR" "SKBR-TzbR"
    "SKBR3-P" "SKBR3-TzbR" "SKBR3-TzbS" "SKP-cullin-F-box" "SLNs" "SLUG"
    "SMC1-pS957" "SMU" "SNAIL2-negative" "SNEC" "SNP8NRG221132" "SNP8NRG221533"
    "SNP8NRG243177" "SNP8NRG433E1006" "SNPs" "SOH" "SOSC2" "SOX2-levels"
    "SP-BER" "SP141-MDM2" "SP141’s" "SPAC1" "SPSS" "SRCC" "SRCCs" "SRS"
    "SS18-SSX-regulated" "SS18-SSX2-dependent" "SS18-SSX2-harboring"
    "SS18-SSX2-regulated" "SSC" "SSCP" "SSCloAldebr" "SSSGL" "STAT3C" "STAT3β"
    "STATTIC" "STE20-like" "STRING" "SU3" "SUM-185" "SUM159-P0" "SUMO-2ΔGG"
    "SUMO-4" "SUNE-1" "SW-1710" "SW-620" "SY" "SYII" "SYTOX" "SaO" "Saal"
    "Saharan" "Saint-Louis" "Sakaguchi" "Sakurai" "Saleh" "Sander" "Sanger"
    "Sansom" "Saridaki" "Sarkies" "Sarno" "Saudi" "Sc-4" "Sc-5" "Scagliotti"
    "Scandinavia" "Scbg3a1" "SceGFP" "Scgb1a" "Scgb1a1" "Schaffer"
    "Schizosaccharomyces" "Schlacher" "Schlecht" "Schliephake" "Schmitt"
    "Schneiderman" "Schwab" "Schwestern" "Sclafani" "Scruggs" "Sculier" "Sebio"
    "Seckel" "Seckel " "Segni" "Seidel" "Self-sufficiency" "Sequenom"
    "Sequestome-1" "Ser-Foxo3a" "Ser-MDM2" "Ser1177" "Ser176" "Ser177" "Ser592"
    "Serine-235" "Serrano" "Seventy-nine" "Seventy-three" "Seventy-two" "Sh-16"
    "Sh-21" "Shan" "Shandong" "Shankavaram" "Sharma" "Shen" "Shereda"
    "Short-term" "Sibilot" "Side-population" "Sigma-Aldrich" "Signa" "Sinclair"
    "Sindbis" "Singh" "Sirtuins" "Sjögren" "Sjögren's" "Skp-Cullin-F-box"
    "Sloan" "Slovak" "Slug-mediated" "Small-cell" "Smeenk" "Smogorzewska"
    "Smouse" "Snail" "Snail-1" "Soane" "Sohn" "Solano" "Solid-State"
    "Solid-predominant" "Solid-state" "Soncini" "Soudan" "Sp1" "Sp1-1" "Sp1-2"
    "Sp1-depdent" "Sp3-dependent" "Spain" "Spanish" "Spearman" "Spearman's"
    "Spoel" "SpringerLink" "SqCC" "Squibb" "Src" "Src-family" "Stein"
    "Stem-cell" "Sternberg" "Stewart" "Stewart-Treves" "Stoehlmacher"
    "Stress-responsive" "Structure" "Structure–Function" "Sub-Saharan"
    "Suhasini" "Sulfides" "Sunlight-induced" "SuperBlock" "SureBlue" "Svendsen"
    "Sweden" "Swedish" "Swiss" "SxxxA" "SxxxS" "Sylla" "SynICre" "Syto60"
    "T)(T" "T-786C" "T-DM1" "T-S" "T-SCE" "T-SCEs" "T-TW" "T-complex"
    "T-lymphotropic" "T-stage" "T-status" "T-to-A" "T1" "T1-weighted" "T18"
    "T1D" "T1N0" "T1N0M0" "T202" "T226" "T2AA" "T2DM" "T2–3" "T2–T4" "T3"
    "T3-PCNA" "T308D" "T37" "T3N0M0" "T4" "T410" "T47DR" "T59" "T702" "T790M"
    "T877A-AR-FQNLF" "TAATGARAT" "TACC3-ch-TOG" "TACE1" "TAMRAD" "TAPI"
    "TAPI-0" "TAPI-1" "TATA" "TATacaagctAAA" "TAp73" "TBCRC011" "TBNA" "TBST"
    "TCF3-PBX1" "TCF3-PBX1-positive" "TCF3-rearranged" "TCF3-rearrangement"
    "TCGA-C8-A12L" "TCP" "TCTAAG" "TCTT" "TEADs" "TEA–HCl" "TEBPβ" "TEBs"
    "TECAN" "TEFTTALQR" "TEGAFOX" "TEGAFOX-E" "TERC-deficient" "TERCdel"
    "TERT-HeLa" "TERT-immortalized" "TERT-over-expressers" "TFAP"
    "TFEB-lysosome" "TFF" "TGCCTTGCCTGGACTTGCCTGGCCTTGCCTTT" "TGF-β1R"
    "TGFβRII" "TGGGGTTACAGTGGGGATTA" "TH3RESA" "TI09485" "TI10124" "TI13831"
    "TI17313" "TI18318" "TI18382" "TI21327" "TI22687" "TIMP2-3" "TIPM-1"
    "TITAN" "TKIs-resistance" "TKT-like" "TKT-null" "TLE" "TMN" "TMPS" "TM–JM"
    "TNBCtype" "TO" "TP53alu" "TRANSFAC" "TRASH" "TRBCV" "TRIAIL" "TRYPAHENA"
    "TSC1•TSC2" "TSN3" "TTGTTTT" "TTTGCA" "TUBB3B" "TWHF" "TWS" "TY" "TZD"
    "TZD-based" "TZDs" "Table1" "Taipei" "Taiwan" "Taiwanese" "Tajima" "Takai"
    "Takara" "Takeda" "Talalay" "Tamandani" "Tanzania" "Tapia" "Taq" "Taqman"
    "TargetPrint" "Targetscan" "Tax-1" "Tek" "Teperino" "Tesque" "Tet-On"
    "Tet-off" "Tet-on" "Texas" "TheraScreen" "Thermo" "Thirty-five"
    "Thirty-two" "Thisse" "Thomas" "Thr-X-Tyr" "Thr180" "Three-dimensional"
    "Time-course" "Tiseo" "TissueScan" "Titer" "Tjarnlund" "Tjarnlund-Wolf"
    "Tobp1" "Togashi" "Tokyo" "Toll-like" "Toluidine" "Tongji" "Tongshu"
    "Top1-DNA" "Top1-cc" "Tra-1-81" "Transducer" "Travis" "Trepel" "Treves"
    "Trichostatin-A" "TrioD1" "Triple-Hit" "Triple-negative" "Tripterygium"
    "Trithorax" "Trock" "Trynka" "TtzmR" "Tucson" "Tumaco" "Tumorscape"
    "Turkish" "Tween" "Tween-20" "Twenty-eight" "Twenty-five" "Twenty-four"
    "Twenty-nine" "Twenty-six" "Twenty-three" "Twenty-two"
    "Two-Related-samples" "Tyner" "TypeIII" "Tyr+5" "Tyr126" "Tyr182" "Tyr279"
    "TzbR" "TzbS" "Túquerres" "TβRI" "U133" "U20S" "U251" "U6" "UAP1L1" "UAS"
    "UB-48" "UB-63" "UCA" "UCA1-BRG" "UCA1-shRNA-infected"
    "UCA1-shRNA-transfected" "UCAs" "UCC" "UCCs" "UCEC" "UCSC" "UDM" "UEV1B"
    "UEV1C" "UGT3A1" "UNK" "UNK-51-like" "UNS " "UPMC" "UPS8" "UQL" "URI1"
    "UTRs" "UV-Vis" "UVC-irradiated" "Ub" "Ubc" "Uchida" "Uev1B" "Uev1C"
    "Uev1s" "Uganda" "Ulp1in" "Umar" "UniProtKB" "Uppsala" "V+I10" "V+III15"
    "V+III15+I10" "V225" "V5" "V5-directed" "V5-tagged" "V600E" "V600K" "VC-C"
    "VC-IR" "VCX" "VCX3A" "VE1" "VER" "VER-155008" "VFCS" "VGFFL" "VM"
    "VM-CUB1" "VNTR" "VRAA" "VTA" "VVA" "VWCS" "VWR" "VYQP" "VZ" "Vanhoutte"
    "Vantaa" "Varmus" "Vasquez" "Vaughn" "Vectibix" "Vegas" "Venn" "Ventana"
    "Venus-Cables1" "VenusMVA" "Verhoog" "Villiger" "Vogelstein" "Vrugt"
    "Vulliamy" "VxF" "Vybrant" "W453X" "W515L" "W741L-AR-FQNLF" "WALP" "WBC"
    "WBRT" "WC" "WDL" "WFCS" "WG" "WHR" "WJTOG" "WJTOG3405" "WMD" "WMG"
    "WNT-pathway" "WPD" "WQ" "WST-1" "WT-C" "WT-EGFR" "WT-EGFR-expressing"
    "WT-IR" "WT-YAP" "WW3" "WY" "WZ" "Waals" "Wald" "Wallis" "Warburg"
    "Warburg-like" "Warburg’s" "Warchoł" "Warsaw" "Warthin" "Wastanabe"
    "Web-based" "WebArrayDB" "Weinberg" "Weisenberger" "Weiss" "Werner"
    "Western" "Western-blot" "Whitby" "Whitney" "Whole-Cell" "Whole-genome"
    "Williams" "Wilmington" "Wilson" "Winooski" "Wnt5a" "Wojas"
    "Wojas-Krawczyk" "Written" "Wu" "X-4" "X-FM" "X-inactivation" "X-ray"
    "X-rays" "X-score" "XC" "XF-24" "XFY" "XIIIa" "XTT" "XTZ" "XW" "XY" "XZ"
    "XbaI" "Xbal" "Xeloda" "Xi" "Xiamen" "Xiao" "Xiao-dong" "Xie" "Xq11-12"
    "Xq27.3" "Xu" "Y-YB" "Y-box" "Y-related" "Y126F+Y220F" "Y204" "Y306F"
    "Y397" "YAZ" "YE" "YK5" "YLX" "YMN" "YPL" "YQL" "YSL" "YTAATGR" "YW" "YWFS"
    "YXXM" "YYY" "YZ" "Yale" "Yamada" "Yamamoto" "Yang" "Yao" "Yat" "Yat-sen"
    "Yes-Associated" "Yes-associated" "Yi" "Yohannes" "Yoona" "York"
    "Yoshikawa" "Yoshikiyo" "Yosunkaya" "Youden" "Yue" "Yun" "Yunnan" "ZC"
    "ZDOCK" "ZEB1-dependent" "ZJ" "ZL" "ZMP" "ZODIAC" "ZORBAX" "ZTZ" "ZX" "ZY"
    "Zack" "Zaug" "Zeocin" "Zhang" "Zheng" "Zhou" "Zhu" "Zhuo" "Zn" "ZnPP"
    "Zoom" "Zu" "Zyxin-null" "a-SMA"
    "a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic" "a-subunit" "aCGH"
    "aCGH-A" "aK" "ab32020" "abozantinib" "absorbance" "ac" "ac-K382"
    "accountQ" "acetyl-K294" "acetyl-K76" "acetyl-lysine" "acetyl-mimetic"
    "acetylation-mimetic" "acetylcholine" "acetylome" "acinar-predominant"
    "acral" "acridine" "acteylglucosamine" "actin-remodeling"
    "activation-competent" "activators" "active-site" "activeBRAF"
    "activity-defective" "acute-phase" "acyl" "acétylaspartate" "adenoid"
    "adenoma-carcinoma" "adenosyl" "adenylate" "adherens"
    "adhesion-receptor-associated" "adhesome" "adipose-derived"
    "ado-trastuzumab" "adult-onset" "advanced-for-age" "advanced-stage" "ae"
    "affecteds" "agar" "agyria" "air-liquid" "akaline" "akt" "aldose" "alelle"
    "algorithm" "algorithms" "alkyl" "alkyl-glycerophosphate" "alkylguanine"
    "alkylguanines" "alkyltransfer" "all-atom" "all-atoms" "allosterism"
    "alpha-methylacyl-CoA" "alveolar-like" "amenorrhoea" "amianthoid"
    "amianthoid-like" "amino-acid" "amino-terminal" "amino-terminally"
    "amino-terminus" "aminoacid" "aminobenzamide" "aminooxyacetate" "amoeboid"
    "amoeboid-like" "ampL" "amplicon" "amplicons" "amplifications" "amplifiy"
    "amygdala" "anIC" "analogue-sensitive" "analyte" "analytes" "anaphase-like"
    "anchorage-independence" "andDbf4" "andTsc2" "andp27" "androgen-mt-AR"
    "aneuploidy" "aneurysm" "angiogenesis-associated" "angiography"
    "anisotropy" "anterior-dominant" "anterior-predominant" "anterograde"
    "anthracyclins" "antiFLAG" "antibiofilm" "antibody-drug" "antibody-p53-DNA"
    "antidepressivelike" "antihormone" "antiparallel" "antiseizure"
    "antitumour" "antracyclines" "antrum" "apFRET" "aphidicoline"
    "apical-basal" "apocrine" "apoptogen" "apoptosis-like" "approximateK"
    "arabinofuranoside" "arachidonoylglycerol" "arachnoid" "archaebacteria"
    "arginase-II" "arisen" "aromatic-rich" "arterio" "arterio-venous"
    "as-yet-undetermined" "ascidians" "ascities" "astroglia" "at-risk" "ation"
    "atypia" "aureus" "autoantigens" "autoradiograph" "axial" "axon-glia"
    "axon-glial" "b-c" "bZIPDB" "back-end" "bacterially-produced"
    "basal-derived" "basal-expressed" "basal-like" "basal-specific"
    "basal-to-luminal" "basal-type" "basaloid" "base-excision" "base-pair"
    "basement-membrane" "begun" "bench-to-bedside" "benzofuran-3-yl" "benzyl"
    "beta-sheets" "beween" "bi" "bi-allelic" "bi-annual" "bi-directional"
    "bifronto" "bifronto-parietal" "big-data" "bilayer" "bilayers" "biliverdin"
    "bilobe" "binucleate" "bioGRID" "biomass" "biomolecules" "biopsy-proven"
    "biotargets" "biotin" "biphenyl" "bis-chloroethylnitrosourea"
    "bismaleimidohexane" "bisphosphate" "blocker" "blockers" "blood-borne"
    "blood-brain" "blood-derived" "blood-flow" "blood–brain" "blown"
    "blue-shift" "blue-shifted" "blue-staining" "blue–positive" "body-specific"
    "body-weight" "bolus" "bonobo" "bonobos" "bootstrap" "borderline-atypia"
    "botulinum" "bp" "brain-like" "brain-resident" "brainstem" "branch-like"
    "break-apart" "break-fusion-bridge" "break-producing" "breakpoint"
    "breakpoints" "breast-like" "breviscapus" "broad-acting" "broad-range"
    "broader" "bronchio" "bronchio-alveolar" "brushings" "brussel" "bucca"
    "butanone" "butathionine" "by-products" "c-IAPs" "c-Jun-N-terminal"
    "c-MYCp" "cGMP-analogue" "cIMT" "caAkt" "caRags" "caRheb" "cadaver-derived"
    "caecum" "callosum" "calorimetry" "cancer-relevant" "cancers–e.g." "caner"
    "cap-independent" "capillary-like" "capsid" "carbonyl" "carboxyfluorescein"
    "carboxyhaemoglobin" "carboxyl" "carboxyl-terminal" "carcinomaswas"
    "cardia" "cardio" "cardio-toxic" "cardiomyoblasts" "carotid" "carriers"
    "case-by-case" "castration-recurrent" "castration-resistant" "catheter"
    "caudate" "cause-and-effect" "caveolae-deficient" "cavernosum" "cavin-GFP"
    "cavin-to-caveolin" "cbio" "celiac" "cell-adhesion-like" "cell-autonomous"
    "cell-cycle-regulators" "cell-death-induced" "cell-extrinsic"
    "cell-intrinsic" "cell-permeable" "cell-protective" "cell-sparse"
    "cell-to-cell" "cell-type-specific" "cells" "cellular-catabolic" "cellulin"
    "centile" "centioles" "centriole" "centromere" "centrum" "cerebellum"
    "cerebrovasculature" "cerebrum" "cerevesiae" "cesarean" "cg16922167"
    "cg26930596" "ch-TOG" "chaperonin" "charcoal-stripped" "charge-charge"
    "chemical-and" "chemo" "chemo-radioresistance" "chemo-radiotherapy"
    "chemo-sensitivity" "chemoattractant" "chemoendocrine" "chemoradiotherapy"
    "chemoresistance" "chemoresistant" "chewers" "chi-squared" "chiasm"
    "chlormadinone" "chloroethylnitrosourea" "chlorophenylhydrazone"
    "cholesterol-binding" "chosen" "chr" "chr16q23.1" "chr17" "chr17p" "chr17q"
    "chr22q12.1" "chromatid" "chromatids" "chromatin-remodeling" "chromophobe"
    "chromosome-breakage" "chymotrypsinogen" "chymotrypsinogens"
    "ciliated-secretory" "ciliome" "cingulate" "circadian-controlled"
    "circuitry" "cis-regulatory" "cistrome" "clade" "clara" "class-I"
    "classifier" "clearer" "cleavage-susceptibility" "client-driven"
    "client-interaction" "clinic-pathological" "clinical-pathologic"
    "clinical-pathological" "clinicians" "clinico" "clinico-pathological"
    "cloroquine" "coactivator-1" "coarse-texture" "cobas" "cobblestone-like"
    "cochaperone" "codon" "codon12" "codon13" "codons" "coeliac" "cofactor-AR"
    "coli" "colitides" "colitis-induced" "colloid" "colloid-predominant" "colo"
    "colo-rectal" "colon-peritoneal" "colonies-forming" "colonoscopy"
    "colonospheres" "colony-formation" "colony-forming" "colony-stimulating"
    "colorectum" "combination-treated" "combined-type" "comedo"
    "commercially-available" "commonalities" "compactly-folded" "complex--APC"
    "complex-2" "compound-specific" "compressive-load" "concensus"
    "concomitance" "condensate" "condyle" "configuration-specific" "congeners"
    "congenita" "congeries" "conjunctiva" "consensus-binding"
    "constitutively-activated" "context-specific" "continuum"
    "contraction-induced" "control-Fc" "control-design" "copGFP" "copy-number"
    "cor-relate" "coregulator-mediated" "coronin-1C" "cortical-amygdala"
    "cortical–amygdala" "cortico" "cortico-spinal" "corticosteroids"
    "cost-effectiveness" "cost-efficient" "counter-evolve" "counter-intuitive"
    "counter-productive" "coupler" "covariance" "covariate" "covariates"
    "coworkers" "cribriform" "cribriform-predominant" "cribrosa"
    "cross-complementation" "cross-complementing" "cross-contamination"
    "cross-linker" "cross-platform" "cross-react" "cross-reacting"
    "cross-reactivity" "cross-reacts" "cross-regulation" "cross-regulations"
    "cross-resistance" "cross-sectional" "cross-sections" "cross-species"
    "cross-validation" "crossover" "crystal-packing" "crystals" "crytochrome"
    "cut-off" "cut-offs" "cut-point" "cyclohexamine" "cyclopropylmethoxy"
    "cyclotherapy" "cylcin" "cystectomies" "cystectomy" "cysteine-to-serine"
    "cysteinglycine" "cysteinyl" "cytoarchitecture" "cytokoines"
    "cytologicatypia" "cytology" "cytometer" "cytopenias"
    "cytoplasmic-positive" "cytoplasmic-to-nuclear" "cytoreductions"
    "cytosine-phosphate-guanine" "cytospin" "dN" "dS" "dS " "damage-associated"
    "damage-induced" "damage-inducing" "damage-mediated" "damage-tolerant"
    "damager" "damage–inducible" "dasatinb" "dasatininb" "databank" "dataset"
    "datasets" "day16" "dbGaP" "dbSNP" "dbSNP131" "ddPCR" "de-acetylases"
    "de-phosphatase" "de-regulated" "de-regulation" "deacelylate" "decile"
    "deciles" "deeper" "deepest" "defined-stiffness" "degraded-stimulus"
    "degron" "dehydrogenases" "delGA" "delavay" "delete16" "deletions"
    "delta-retroviridae" "dendrite" "densitometer" "dependnt" "depicture"
    "depolarization-induced" "deprivation-induced" "der" "derivate" "derivates"
    "dermomucus" "descriptors" "desmoglein" "desmoid" "desmoplasia"
    "destabilizers" "detectedin" "detennine" "detergent-insoluble"
    "detergent-soluble" "deuterium-observe" "df" "di-Ub" "di-methylates"
    "di-methylating" "di-methylation" "diaminobenzidine" "diaminobutyl"
    "diammonium" "diaphanous-related" "dichlorodihydrofluorescein" "dichroism"
    "dideoxy" "diet–induced" "dihedrals" "diiodophenyl" "dilations" "dimain"
    "dimethylenastron" "dimethyloxaloylglycine" "dimmer" "diphosphate"
    "diploid" "diplopia" "dipole" "disaggregate" "discoideum" "discrepant"
    "discriminant" "discriminators" "disomy" "disordered-to-ordered"
    "disruptors" "dissecta" "distant-relapse-free" "distantly-related"
    "distill" "dithiol-disulfide" "diyl" "dk5" "dmin" "docking-CoMSIA"
    "documentedEGFR" "doi" "dominant-negative" "donor-derived" "dormancy"
    "dorsum" "dose-additivity" "dose-dependently" "dose-response"
    "double-blind" "double-hit" "double-knockout" "double-membrane"
    "double-mutant" "double-strand" "doublings" "down-expressed"
    "down-modulated" "down-modulation" "down-regulatory" "down-stream"
    "downgrowth" "dpYAP" "dpf" "drawn" "droplets" "drug-DNA" "drug-like"
    "drug-resistance" "drug-selection" "drug-sensitivity" "dry-to-wet" "dsDNA"
    "dual-color" "dulanermin" "duplexes" "dura" "dural" "dwarfism" "dyad"
    "dysgeneses" "dyslipidemia" "dysplasia" "dyspnea" "eGFP-KRAS" "eNOS-S1177"
    "eQTL" "earlier-stage" "early-onset" "early-passage" "early-phase"
    "early-response" "early-stage" "early-to-mid-life" "ectoderm" "ectodomain"
    "ectopias" "edema" "edulis" "effector-memory" "eightfold" "eighty-five"
    "electron-density" "element-1" "element-binding" "ellipsoid" "elrotinib"
    "embolus" "embryo-lethality" "embryoid" "emphasise" "emphasises" "enabler"
    "encephalomyelitis" "end-binding" "end-products" "end-replication"
    "end-resection" "end-stage" "end-to-end" "endarterectomy"
    "endocrine-sensitivity" "endoderm" "endodermally-derived"
    "endometrial-specific" "endometriod" "endometrioid" "endometrium"
    "endometroid" "endoscopy" "endosome-like" "endothelial-derived"
    "endothelial-mediated" "endplates" "endpoint" "endpoints" "enhancer"
    "enhancer-promoter" "ensemble-average" "ensheath" "enteropathy"
    "enzyme-substrate" "enzyme–substrate" "enzymology" "eosin" "eosinophil"
    "eosinophilia" "eosinophils" "epidermis-like" "epidermoid" "epigenome"
    "epigenome-wide" "epigenomes" "epithelia" "epithelial-derived"
    "epithelial-like" "epithelial-mesenchymal" "epithelial-to-mesenchymal"
    "epithelial-type" "epithelial–mesenchymal" "epithelioid" "epithelium"
    "erigeron" "erlotinb" "erlotinib-quinacrine" "erltoinib" "eru" "eru-fosine"
    "erucylphospho" "erucylphospho-N" "erufosine’s" "erythematosus"
    "erythremia" "erythrocytes" "esophagectomy" "esotropia"
    "esthesioneuroblastomas" "estimateK" "estimatedK" "estrogen-dependence"
    "estrogen-independence" "et" "etal" "ethmoid" "ethylacetate" "ethylguanine"
    "ethynyldeoxyuridine" "et " "euroendocrine" "events" "eventuate"
    "ever-changing" "ever-escalating" "ever-expanding" "ever-smokers" "ex"
    "excision-repair" "exocrine" "exomes" "exon-11" "exon-by-exon" "exon12"
    "exon20" "exons" "expressers" "expressingKRAS" "expression-only"
    "extra-hepatic" "extra-nuclear" "extra-telomeric" "extrauterine" "exudate"
    "factor-1" "factor-α" "farnesylation-and" "fascicles" "fast-growing"
    "feed-back" "feedback-activation" "feedforward" "females" "festooned-like"
    "fibroadipose" "fibroblast-like" "fibromatosis-like" "fies" "figures"
    "fine-mapping" "fine-needle" "fine-texture" "fine-textures" "fine-tune"
    "fine-tunes" "fine-tuning" "first-degree" "first-in-human" "fish-to-fish"
    "five-year" "flavoenzymes" "flow-mediated" "flowchart" "fluid-attenuating"
    "fluid-like" "fluorescense" "fluorescent-labelled" "fluorophore"
    "focal-adhesion" "foeto" "foeto-maternal" "fold-specific" "follicle"
    "follow-up" "for1-year" "foramina" "force-induced" "forced-suspension"
    "forebrain" "forebrains" "foresaw" "forestomach" "foretenib" "formazan"
    "formin-1" "formtumours" "forptf1a" "fosine" "fossa" "four-layered"
    "four-point-one" "four-stranded" "four-to-six-tiered" "four-to-sixtiered"
    "fowlpox" "frame-shift" "frame-shifts" "frameshift" "free-R" "free-ratio"
    "fresh-frozen" "freshly-infected" "fromrb" "front-end" "fronto"
    "fronto-central" "fronto-centrally" "fructose-2,6-bisphosphatases"
    "fructose-2,6-bisphosphate" "fructus" "ftorafur-UFT" "full-text"
    "fully-understand" "fumarate" "fusiform" "fusion-driven"
    "fusion-expression" "fusion-mediated" "fusion-negative" "fusion-positive"
    "fusion-specific" "fœtus06" "fœtus07" "fœtus14" "g-ratio"
    "gain-of-function" "gallbladder" "gamma-H2AX-marked" "gamma-H2AX-positive"
    "gardeniae" "gastro" "gastro-esophageal" "gastrostomy" "gatekeeper"
    "gavage" "gefitinib-resistance" "gel-filtration" "gene-dosage" "gene-dose"
    "gene-environment" "gene-gene" "gene-sunlight" "genetic-acquired"
    "genetically-engineered" "gene–environment" "gene–gene" "genome"
    "genome-wide" "genomes" "genotoxicity-induced" "genotype" "genotypes"
    "genotype–phenotype" "germanium" "germline" "gigabases" "glia-end"
    "glial-end" "glial-neuronal" "global-scale" "glomeruloid" "glucopharanin"
    "glucose-deprivation" "glucose-poor" "glucose-uptake" "glutamyl"
    "glutathione-S-transferases" "gluten-sensitive" "glycerophosphate"
    "glycinamide" "go-no" "gold-particle" "gone" "goodQ" "goodness-of-fit"
    "grainy" "gram-negative" "greater" "greatest" "growth-stimulatory"
    "growth-suppressive" "guanine-nucleotide-dissociation" "guanylyl" "gyral"
    "gyri" "hDIXDC1" "hG10" "hMNC" "hMNCs" "hMSC" "hMSCs" "hNPC" "hNPCs"
    "hNSCs" "hPer" "hTEC" "hTERT+mutant" "hTERT-HM" "hTERT-immortalized" "hUCB"
    "hUCB-MNC" "hUCB-MNCs" "haem-oxygenase-1" "half-life" "half-maximal"
    "half-maximum" "half-rings" "half-time" "handoff" "haplo"
    "haplo-insufficient" "haplotype" "haplotype-association" "haplotypes"
    "hard-to-treat" "has-miR-124" "has-miR-1303" "has-miR-135b" "has-mir-203a"
    "health-care" "healthspan" "healthy-volunteer" "heat-inactivated"
    "heat-shock" "heatmap" "heavier" "heavily-treated" "helices" "helix"
    "helix-loop-helix" "hemiplegia" "hemisplenectomy" "hemosiderin"
    "heparin-binding" "hepta" "hepta-peptide" "heptapeptides"
    "herceptin-resistance" "herpesvirus-4" "herpesvirus-5" "herpesvirus-8"
    "herpetiformis" "het-norm" "heterdimer" "hetero" "hetero-oligomerization"
    "heteroatoms" "heterocycles" "heterohexamer" "heteromider" "heterotopia"
    "heterotopias" "heterotrimer" "heterozygote" "heterozygous +" "hexokinases"
    "hiPSC" "hiPSCs" "hidden" "high-8q24.21" "high-DRC" "high-accuracy"
    "high-affinity" "high-amplitude" "high-confidence" "high-copy"
    "high-density" "high-dose" "high-energy" "high-frequency" "high-gastric"
    "high-grade" "high-level" "high-mobility" "high-quality" "high-resolution"
    "high-risk" "high-signal" "high-to-low" "high-yield" "highKi" "highKi-67"
    "highNPI" "higher-dose" "higher-grade" "higher-order" "highly-available"
    "highly-conserved" "highly-expressed" "highly-penetrant" "highly-related"
    "hilar" "hilum" "hindbrain" "hirsutism" "histologic-molecular"
    "histologies" "histology" "histone-lysine" "histopathology" "histoscore"
    "hnRNPs" "holo" "holo-enzyme" "holocomplex" "holocord" "holoenzymes" "hom"
    "hom-high" "hom-low" "homo-complexes" "homolog" "homologs" "homozygote"
    "homozygotes" "hong" "hormone-like" "hormone-nonresponsive"
    "hospital-funded" "host-virus" "hot-spot" "hotspot" "hotspots" "hour-1"
    "hours" "hour–1" "hp53-null" "hr" "hsa-miR-718" "hyclate"
    "hydrodynamically-equivalent" "hydrogels" "hydrogen-bonds"
    "hydrophobic-K-X-E" "hydroxy" "hydroxybutyrate" "hydroxycamptothecin"
    "hydroxydeoxyguanine" "hydroxyglutarate" "hydroxyl" "hydroxylases"
    "hydroxymethyl" "hygromycin-selectable" "hyper-activity" "hyper-resistance"
    "hyper-stability" "hyper-tetraploid" "hyperchromasia" "hyperdiploid"
    "hypereosinophilia" "hypergrowth" "hyperintensities" "hypermyelinate"
    "hypo-methylated" "hypo-phosphorylated" "hypo-phosphorylation"
    "hypo-tetraploid" "hypochlorite" "hypoglycemia" "hypoinsulinaemia"
    "hypomnesia" "hypopharynx" "hypotriploid" "hypo–phosphorylated" "iCpG"
    "iGFP" "iKRas" "iPLEX" "ictal" "identi" "ie" "ii" "iii" "ill-defined"
    "imidazole" "immediate-early" "immonoblot" "immune-competent"
    "immune-inhibitory" "immune-reactive" "immune-staining" "immuno"
    "immuno-colocalization" "immuno-electron" "immuno-precipitated"
    "immunochemotherapy" "immunocytochemistry" "immunoglobulin" "immunogold"
    "immunohistochemestry" "immunohistochemistry" "immunomarkers"
    "immunomicroarray" "immunophenotype" "immunophenotypes"
    "immunoprecipitation-on-chip" "immunosurveillance" "immunotherapies"
    "immunotherapy" "impedance" "imtinib" "in-depth" "in-frame" "in-group"
    "in-silico" "in-situ" "in-vitro" "inBRAF" "inLkb1" "includingTsc2" "indel"
    "independent-samples" "indol" "indol-3-yl" "induced-nephrotoxicity"
    "induced-toxicity" "infancd2" "inflammation-mediated" "inframe" "inhibiors"
    "inner-quartet" "inpairs" "instability-induced" "instability–induced"
    "insulin-like" "integrant" "integrants" "inter-ictal" "inter-laboratory"
    "inter-metastatic" "inter-observer" "inter-species" "inter-tumour"
    "interacting-domain" "interactome" "interactomes" "interdomain"
    "interferon-regulatory" "intermediate-risk" "internodes" "interquartile"
    "interstrand" "interventions" "intestinal-type" "intima" "intra"
    "intra-cardiac" "intra-epithelial" "intra-group" "intra-laboratory"
    "intra-motif" "intra-patient" "intra-peritoneal" "intra-site"
    "intra-strand" "intra-tumoral" "intra-uterine" "intravasate" "intron"
    "introns" "inute" "invaginations" "invariant" "invasive-metastatic"
    "inverse-weighted" "inverted-phase" "invitro" "involucrum" "ionic"
    "ionization-time" "irradiation-induced" "ischemia-reperfusion" "isintegrin"
    "iso" "iso-enzyme" "isobolograms" "isochromosome" "isoenzyme" "isoenzymes"
    "isofom" "isolation-associated" "isopleth" "isopleths" "isopropyl"
    "isotope-coded" "isotype" "isotypes" "isozymes" "issubject" "iv" "jBid"
    "just-below" "juvenile-onset" "kHz" "kPa" "kalirin-7" "kappa-B"
    "karyocytes" "karyoplasm" "karyotype" "karyotypes" "kcal" "kd"
    "keloid-like" "ketol" "ketose" "kg" "kg " "ki-67" "kinses" "knock-down"
    "knock-in" "knocked-down" "knocking-down" "knowlege" "knowlwedge" "lac"
    "laevis" "lamella" "lamellae" "lamellopodia" "lamina" "large-caliber"
    "large-cell" "large-scale" "large-sized" "larger-scale" "laryngectomies"
    "laryngectomy" "laser-capture" "last-but-one" "late-differentiated"
    "late-hMSCs" "late-passage" "late-phase" "late-stage" "latency-associated"
    "lateral-predominant" "lead-time" "learnt" "lectin-UEA-1" "left-hand"
    "leiomyoblastomas" "lepidic-pattern" "lepidic-predominant" "leptomeninges"
    "lesion-search" "lesion-specific" "lesions" "less-not" "lethality-based"
    "letrozole-resistance" "letrozole–have" "leukoencephalopathy" "leverages"
    "liability-threshold" "libitum" "life-long" "lifecycle" "lifespan"
    "ligand-AR-peptide" "limbus" "lineage-specific" "lipid–peptide"
    "lipopolysaccharide" "lipopolysaccharides" "lithium-treated" "littermate"
    "littermates" "live-cell" "lncRNA-EBIC" "lncRNA-HEIH" "lncRNA-TI17313"
    "lobectomies" "lobopodia" "localizations" "loco-regional" "long-chain"
    "long-fragment" "long-lasting" "long-lived" "long-range" "long-standing"
    "longer-lived" "loop-sheet-helix" "loss-of" "loss-of-fuction"
    "loss-of-function" "losses" "low-affinity" "low-amplitude"
    "low-cellularity" "low-density" "low-dose" "low-energy" "low-frequency"
    "low-gastric" "low-grade" "low-intensity" "low-level" "low-penetrance"
    "low-resolution" "low-risk" "low-temperature" "low-throughput"
    "lower-affinity" "lower-grade" "lower-risk" "luminal-B" "luminal-like"
    "luminal-to-myoepithelial" "lupeol" "lupeol's" "lymph-vascular"
    "lymphadenopathy" "lympho" "lympho-vascular" "lymphoblastoid"
    "lymphoblasts" "lymphoid-enhancing" "lymphopenia" "lysine-null"
    "lysine-to-arginine" "lysine-to-glutamine" "lysis" "m-cherry" "m7GTP"
    "mAB1936" "mApple-EB3" "mCRPC" "mCherry-expressing" "mCitrine" "mEPSC"
    "mEmerald" "mJ" "mPFC" "mRNA" "mRNA-IL-8" "mRNA-base" "mS100A8" "mSin3A"
    "mTOR-independent" "mTmG" "mTurquoise" "macro-metastases" "macrophage-like"
    "macrophain" "macropinocytosis-like" "main-chain" "make-up"
    "mal-attachments" "malar" "male-lethal" "male-to-female"
    "malformation-associated" "maligna" "malignances" "malignant-IPMNs"
    "malignomas" "mammography" "mammosphere" "mammospheres" "mamospheres"
    "mangoes" "mant" "mant-GTP" "marinopyrrole" "marinopyrroles" "mark-up"
    "markers-typically" "masala" "mass-to-length" "mast-cell" "mastectomy"
    "matched-therapy" "mate-choice" "materials" "maternal-fetal" "max1"
    "maxillectomy" "mean=0.49" "mechano" "mechanosensors" "median-drug"
    "median=0.49" "median=0.75" "mediastinoscopy" "medulla" "megabases"
    "mellitus" "men" "meniscus" "mesenchymal-associated" "mesenchymal-like"
    "mesenchymal-type" "mesenteries" "mesentery" "meshwork" "meshwork-like"
    "mesoderm" "mesothelium" "messager" "meta-static" "metabolome"
    "metal-binding" "metallofullerenes" "metallopeptidase-2"
    "metalloproteinase-1" "metalloproteinase-9" "metastais"
    "metastasis-suppressor" "methanone" "methicillin" "methods" "methoxy"
    "methoxybenzylsulfonyl" "methoxybenzylthio" "methoxymethyl" "methoxyphenyl"
    "methylQTL" "methylTHF" "methyladenine" "methylcytosine" "methylcytosines"
    "methyleneTHF" "methylisobutylxantine" "methylnitrosamino" "methylomes"
    "methylsulfinylbutyl" "methylthiazolyldiphenyl"
    "methylthiazolyldiphenyl-tetrazolium" "miR-100" "miR-100-induced"
    "miR-100-promoted" "miR-100-transfectants" "miR-100-transfected" "miR-101"
    "miR-122" "miR-124" "miR-124-induced" "miR-124-transfected" "miR-1245"
    "miR-124–mediated" "miR-124–overexpression" "miR-125" "miR-127" "miR-128"
    "miR-130a" "miR-132" "miR-135b" "miR-135b-binding"
    "miR-135b-down-regulated" "miR-135b-induced" "miR-137" "miR-137-induced"
    "miR-137-mediated" "miR-139" "miR-143" "miR-145" "miR-146a" "miR-146b-3p"
    "miR-150" "miR-17" "miR-17-5p" "miR-17-92" "miR-17-overexpresion"
    "miR-17-overexpressing" "miR-17-producing" "miR-17-reagent"
    "miR-17-regulated" "miR-17–92" "miR-18" "miR-181" "miR-181-recognition"
    "miR-184" "miR-18a" "miR-19" "miR-193a" "miR-194" "miR-194-induced"
    "miR-194-targeting" "miR-194-up" "miR-195" "miR-19a" "miR-19b-1" "miR-200"
    "miR-200b" "miR-200s" "miR-203" "miR-203-dependent" "miR-203-mediated"
    "miR-203-regulated" "miR-205" "miR-206" "miR-20a" "miR-21" "miR-21-Pten"
    "miR-21-mediated" "miR-214" "miR-217" "miR-218" "miR-221"
    "miR-221-targeted" "miR-221expression" "miR-26a" "miR-29" "miR-296"
    "miR-29a" "miR-30a" "miR-31" "miR-34" "miR-34b" "miR-375" "miR-375+JAK2"
    "miR-375+Vec" "miR-376b" "miR-486" "miR-486-5p" "miR-493" "miR-493-induced"
    "miR-493-treated" "miR-502" "miR-503" "miR-504" "miR-506"
    "miR-506-enhanced" "miR-519d" "miR-520e" "miR-612" "miR-708" "miR-718"
    "miR-718-binding" "miR-8" "miR-9" "miR-92" "miR-92a-1" "miR-942" "miR-99a"
    "miR-NC" "miR125b" "miR15b-induced" "miR200c" "miR203" "miR21" "miRNA-155"
    "miRNA-194" "miRNA-200c" "miRNA-218" "miRNA-221" "miRNA-29b" "miRNA-493"
    "miRNA-depandent" "miRNAs" "miRZip" "miRZip-155" "miRanda" "miRtarget"
    "miRwalk" "micelles" "micro-dissected" "micro-environment"
    "micro-environmental" "micro-metastases" "microRNA-200c" "microRNA-34a"
    "microcapillaries" "microdomain" "microdomains" "micrographs"
    "micropapillary-predominant" "microplate" "micropolygyria-like"
    "microsatellite" "microsatellites" "microvessel" "microvessels" "mid-S"
    "mid-epithelium" "mid-gestation" "mid-level" "mid-point" "midbrain"
    "midpoint" "midterm" "midzone" "migration-relevant" "millisecond"
    "mimic-miR-221" "mini-array" "mini-mental" "minichromosome" "minimise"
    "ministacks" "minus-end" "minus-ends" "mir" "mir-181b" "mir-200s" "mir-21"
    "mir-548k" "mis-segregation" "misincorporations" "mismatch-repair"
    "misrepair" "missense" "mitochondrially-produced" "mitoses" "mobilizer"
    "mock-infected" "mock-stimulated" "moderately-sized" "mole-fraction"
    "molecules" "mol·s" "monnieri" "mono-molecule" "mono-ribosyltransferase"
    "monocyte-derived" "monocyte-enhanced" "monodisperse" "monolayer"
    "monosomy" "monotherapies" "monotherapy" "mono–ADP" "months"
    "mood-stabilizing" "morbidities" "morphant" "morphants" "morpholino"
    "morpholinos" "morula" "most-commonly" "motif-like" "motif-negative"
    "motile" "motogen" "msh" "mt-ARs" "mucin-rich" "mucin–rich"
    "mucoepidermoid" "mucosa" "mulatta" "multi-cancer" "multi-cellular"
    "multi-centric" "multi-component" "multi-drug" "multi-functional"
    "multi-gene" "multi-institutional" "multi-kinase" "multi-kinase-inhibitors"
    "multi-modality" "multi-plex" "multi-stage" "multi-step" "multi-subunit"
    "multicenter" "multicentre" "multienzyme" "multigene"
    "multikinase-inhibitor" "multilevel" "multilineage" "multimers"
    "multiorgan" "multiprotein" "multistage" "multitarget" "multivariant"
    "multivariate" "muscle-specific" "mutantions" "mutated-disease"
    "mutation-susceptive" "mutations" "myeloid-lineage" "myoepithelium"
    "myofibroblasts" "myoid" "myoinositol" "myometrium" "myosin-II" "myotonin"
    "myristate" "myxoid" "n=1" "n=10" "n=11" "n=12" "n=13" "n=15" "n=16" "n=17"
    "n=2" "n=21" "n=3" "n=4" "n=40" "n=5" "n=6" "n=63" "n=66" "n=7" "n=8" "n=9"
    "nBM" "nGpG" "nSNPs" "nailfold" "nano" "nano-particles" "nanogold"
    "nanohybrid" "nanomaterials" "nanometric-scale" "nanoplatelets"
    "nanoribbon" "nanoribbons" "nanoscale" "naphthalen-1-yl" "nasal-type"
    "nasopharynx" "naturally-formed" "naturally-occurring" "naïve"
    "near-complete" "near-holocord" "near-identical" "near-normal" "near-term"
    "near-ultraviolet" "necropsy" "neg" "neo-adjuvant" "neoadjuvant"
    "neocortex" "neoepitope" "neoepitopes" "neointima" "neonatologists"
    "neoplasias" "neovasculature" "neu-negative" "neuregulin-2beta" "neurite"
    "neuro" "neuro-astro-vascular" "neuro-vascular" "neuroendocrine"
    "neuroepithelium" "neuron-to-glia" "neuron-to-neuron" "neuronal-like"
    "neuropathology" "neuropil" "neurosurgeons" "neutralise" "never-smoker"
    "never-smokers" "new-developed" "newer" "newly-developed" "next-generation"
    "nicotinc" "nigricans" "ninety-four" "nitrophenyl" "noPAG" "node-negative"
    "node-positive" "nodular-like" "nonMet" "nonacute" "nonbrainstem"
    "noncavin" "nonendocrine" "nonfat" "nonhistone" "nonhotspot" "nonimmune"
    "nonlepidic-predominant" "nonmalignant" "nonmitochondria" "nonmotile"
    "nonmuscle-myosin" "nonobese" "nonpromoter" "nonprotein" "nonraft"
    "nonrandom" "nonredundant" "nonresponder" "nonresponders"
    "nonresponsiveness" "nonsense-mediated" "nonsignificant" "nonsmall"
    "nonsmall-cell" "nonsteroid" "normal-range" "notochord" "notoginseng"
    "nucleases" "nucleates" "nucleic-sensing" "nucleofilaments" "nzyme"
    "n = 13" "n = 2" "n = 3" "n = 4" "n = 44" "n = 5" "n = 6" "n = 7" "n = 9"
    "n = 10" "n = 11" "n = 13" "n = 15" "n = 16" "n = 17" "n = 3" "n = 5"
    "n = 6" "n = 7" "n = 9" "occlude" "odorant" "odors" "oestrogen" "ofKras"
    "ofR" "off-axial" "off-label" "off-rate" "off-target" "offs" "ofp27"
    "ofβ-actin" "ofτ" "oligo" "oligo-lesions" "oligodeoxynucleotides"
    "oligomycin" "oligos" "omentum" "on-target" "once-daily" "oncogene-like"
    "oncogenec" "oncologists" "oncomir" "one-cell-thick" "one-fifth"
    "one-fourth" "one-half" "one-quarter" "one-ratio" "one-sixth" "one-tailed"
    "one-third" "one-time" "one-year" "ones" "open-label" "oral-cancer"
    "orally-available" "organelle" "organelles" "ori" "oropharynx" "ortholog"
    "orthologues" "osteoblasts" "osteoid" "osteopenia" "ouble" "ought" "ouse"
    "out-competed" "out-of-frame" "out-performed" "over-accumulation"
    "over-activation" "over-estimated" "over-proliferation" "overdoses"
    "overexpressors" "overreliance" "overview" "oxidases" "oxoG" "oxoglutarate"
    "oxoguanine" "oxygen-consumption" "oxygenase-1" "p127YAP" "p16sh"
    "p16shRNA" "p21-like" "p21-null" "p38-MAPK-mediated" "p38-MAPK-specific"
    "p38MAPK" "p38mapk" "p38β" "p4E-BP" "p4E-BP1" "p501s" "p52-specific"
    "p53-MDM2-based" "p53-RE-S" "p53-checkpoint" "p53-competent"
    "p53-defective" "p53-deficient" "p53-dependence" "p53-dependent"
    "p53-dependnt" "p53-immune" "p53-immunreactivity" "p53-indendent"
    "p53-indirectly" "p53-knockout" "p53-nonfunctional" "p53-null"
    "p53-reactive" "p53-reactivity" "p53-status" "p53-transcriptional"
    "p53-wild" "p53C" "p53RE" "p53RE-L" "p53RE-S" "p53mutations"
    "p70S6K-dependent" "p73ΔOD" "p73α" "p73β" "p85α" "p89TAZ" "p=0.001"
    "p=0.002" "p=0.003" "p=0.004" "p=0.005" "p=0.007" "p=0.008" "p=0.01"
    "p=0.011" "p=0.019" "p=0.02" "p=0.023" "p=0.028" "p=0.03" "p=0.037"
    "p=0.039" "p=0.04" "p=0.041" "p=0.044" "p=0.047" "p=0.05" "p=0.053"
    "p=0.06" "pA" "pACCA" "pATPCL" "pBABE" "pBSMC" "pBSMCs" "pBh" "pBn" "pCMV"
    "pChk1" "pEGFP-C2" "pEGFP-N1-IGFBP-2" "pEGFP-N2" "pEGFR" "pERK2-catalyzed"
    "pFLAG-CMV-4" "pGIPZ" "pGL3-375pro" "pGL3-ISG12aUTR" "pGL3-PPRE-acyl-CoA"
    "pGL3-YAP-MUT" "pGL3-basic" "pGL3-promoter" "pGL3basic" "pGSK-3beta-ser-9"
    "pGSK-3β-ser-9" "pGSK-3β-tyr-216" "pHER" "pHER1" "pHER2" "pHER3" "pHage"
    "pIRES-S-SBP-FLAG-AMPK" "pIκBα-DN" "pL" "pLATS1" "pLENTI" "pLENTI6.3-CMV"
    "pLKO" "pLL3.7-ISL1-siRNA" "pLenti" "pLenti6-PRDX2-V5" "pLentilox3.7"
    "pLucMCS" "pMET" "pMIR" "pMIR-REPORT" "pNPP" "pPI3K" "pPIK3" "pPRAS"
    "pPTEN" "pSTAT3" "pSTAT3-Luc" "pSilence-ISG12a" "pT" "pT202" "pT702" "pTAZ"
    "pTRG" "pTRIPZ" "pTRIPZ-shG9a" "pThr202" "pTyr204-MAPK" "pY+1" "pY+2"
    "pY+3" "pY+4" "pY106" "pY204" "pY507" "pYAP" "pY–2" "pY–3" "pY–4"
    "pachygyria" "pack-years" "paclitaxol" "pairwise" "pallidum" "pan-cancer"
    "pan-phosphoinositol-3-kinase" "pan-proliferation" "pan-wildtype"
    "panacismajoris" "pancreata" "pancreatitis" "pancytopenia" "paniscus"
    "panitumumab-FOLFOX4" "papillary-predominant" "para-articular"
    "para-nitrophenyl" "paracrine" "paraformalin" "paralog" "paralogues"
    "parenchyma" "parent-proband" "paresthesias" "parieto" "parieto-occipital"
    "parotid" "patch-clamp-automatized" "patch-clamp-induced" "patho"
    "pathobiology" "pathogen-associated" "pathophysiology" "paths-to-stemness"
    "pathwaymay" "pattern-like" "pattern-recognition" "patternless"
    "paxillin-null" "pcDNA-GW" "pcDNA3-HIF1α" "pcDNA3-Tiam1" "pcDNA3.0-Rac1"
    "pcDNA3.1-AIF" "pcDNA3.1-AIF-V5" "pcDNA3.1-ISG12a" "pcDNA3.1-c-Myc"
    "pcDNA3.1-miR-942" "pcDNA4.0" "pcDNA6.2-ctrl" "pcDNA6.2-miR-155" "pcTax"
    "pearson" "penetrance" "penetrant" "pentamer" "pentaspan" "pepducin"
    "peptidases" "peptide-HSP70-SBD" "peptide-PTPN18-C229S" "peptide-sequence"
    "peptides" "peptidoglycan" "per-allele" "perhaps" "perhapsdue"
    "peri-nuclear" "peri-operative" "periarthritis" "pericardium"
    "pericyte-endothelial" "pericyte-like" "peritoneum"
    "permeability-and-retention" "peroxide-induced" "pers" "persulphide"
    "perturbations" "pestivirus" "pestiviruses" "petechiae" "phTERTp"
    "phTERTp-289" "phTERTp-289EM" "pharmacologically-induced" "pharmacophore"
    "phase-I" "phase-contrast" "phase-nonspecific" "phase-specific"
    "phenanthrolene" "phenyl" "phenyl-ring" "phenylcarbamothioyl"
    "phenylhydrazone" "phenylmethanethiol" "phiC" "phiC31-mediated" "phopho"
    "phopho-peptide" "phophorylates" "phorsphorylate" "phosopho"
    "phosopho-peptides" "phosphatidylinositol-4,5-biphosphate" "phospho-4EBP1"
    "phospho-ATF-2" "phosphoATF-2" "phosphoSer-1177-modified" "phosphoacetyl"
    "phosphodegron" "phosphodiester" "phosphogluconate" "phosphoinositides"
    "phosphoisoforms" "phosphomutants" "phosphonacetyl" "phosphopeptide"
    "phosphorylation-dephosphorylation" "phosphorylation-mimic"
    "photomicrographs" "photoreceptors" "physio" "physio-pathological" "pi-pi"
    "pial" "picrasidine" "pictilisib" "piperidinyl" "pipet" "pipette-induced"
    "pipette-mediated" "pixels" "placebo-controlled" "placode" "placodes"
    "plantaris" "planus" "plasmacytoid" "plasmodesmata" "plasmon" "platins"
    "pleiotropy" "plekstrin" "pleomorphism" "plethysmograhy" "plexi" "plug-in"
    "plus-end" "plus-ends" "plusTipTracker" "pmiRZip" "pmiRZip-155"
    "point-mutant" "poly-Ub" "poly-lysine" "polyautoimmune" "polycistron"
    "polycomb-group" "polydendrocytes" "polyethyleneglycol" "polyhydramnios"
    "polymerase-1" "polymicrogyria-like" "polymorphism" "polymorphisms"
    "polymorphismsm" "polymorphyme" "polyphylla" "polysomy" "pombe" "pons"
    "pontine" "pontis" "ponto" "ponto-cerebellar" "poolings" "poor-prognosis"
    "poorer" "poorly-differentiated" "poorly-studied" "pos" "positeve"
    "positive-sense" "post-SE" "post-TMZ" "post-conceptional"
    "post-differentiation" "post-hoc" "post-immunization" "post-implantation"
    "post-infection" "post-injury" "post-inoculation" "post-integration"
    "post-irradiation" "post-menopausal" "post-migrational" "post-mitotic"
    "post-natal" "post-operative" "post-remission" "post-replication"
    "post-shMTH1-transduction" "post-shear" "post-study" "post-surgery"
    "post-transcriptional" "post-transcriptionally" "post-transfect"
    "post-transfection" "post-translational" "post-translationally"
    "post-transplant" "post-transplantation" "post-treatment" "post-vaccine"
    "postdoc" "posthoc" "postmortem" "post–translational" "precancer"
    "precursor-negative" "predilects" "predilute" "predomiant" "prefoldin-like"
    "prelamin" "premalignancies" "premorbid" "premortem" "prepulse"
    "present-day" "presert" "pri-miR-375" "primary-culture"
    "primary-metastatic" "primary-site" "prion-like" "priori" "pro-ILβ"
    "pro-Nrgs" "pro-aging" "pro-angiogenic" "pro-apoptosis" "pro-arrest"
    "pro-autophagy" "pro-cancer" "pro-death" "pro-drug" "pro-inflammatory"
    "pro-invasion" "pro-invasive" "pro-malignant" "pro-metastasis"
    "pro-metastatic" "pro-migratory" "pro-mitotic" "pro-proliferative"
    "pro-senescence" "pro-survival" "pro-thrombotic" "pro-viruses" "proband"
    "procaspase-3" "procoagulant" "prodomain" "product-moment"
    "proerythroblasts" "progenitor-like" "progeny" "progeroid" "progestin"
    "prognosis-associated" "programd" "prokaryotes" "prolate"
    "proliferator-activated" "proliferator-activator" "promoter-reporter"
    "pronouncedatypia" "proof-of-concept" "proof-of-principle" "propanol"
    "propeller-like" "prostaglandins" "prostatectomies" "prostatectomy"
    "prostatomy" "proteasom" "protein-2" "protein-DNA" "protein-RNA"
    "protein-coding" "protein-ligand" "protein-solvent" "protein-tyrosine"
    "proteins" "proteinsp27" "protein–DNA" "proteome" "proteome-level"
    "proteomes" "proteomics-based" "proteosome" "protomer" "protooncogene"
    "protooncogenes" "proven" "pro–arrest" "pseudo-affinity" "pseudocapsule"
    "pseudogene" "pseudogenes" "pseudosubstrate" "psiCHECK" "pull-down"
    "pulldown" "pulposus" "pulse-chase" "puromycin-selectable" "purpura"
    "putamen" "pyridine" "pyridinophane" "pyridinophanes" "pyridinyl" "pyrido"
    "p = 0.007" "p = 0.01" "p = 0.03" "p = 0.04" "p = 0.001" "p = 0.002"
    "p = 0.004" "p = 0.005" "p = 0.007" "p = 0.01" "p = 0.011" "p = 0.02"
    "q-value" "qMSP" "qRT-PCT" "quadri" "quadri-radial" "quadruplex"
    "quadruplexes" "quadruplexs" "quasi" "quassioides" "quench-pulse"
    "quiescent-like" "rACAT2" "rG3BP1" "rRNA" "radiation-associated"
    "radiation-induced" "radio-therapy" "radiochemotherapy" "radioresistance"
    "radioresistant" "radioresponse" "radiosurgery" "radiotherapy-induced"
    "random-effects" "randomly-distributed" "rapalog" "rapalog-feedback"
    "rapalogs" "rapalogues" "rapamycin-resistance" "rapaplog" "rapid-phase"
    "rarer" "ratio=3.56" "re-adding" "re-analyzed" "re-assessment"
    "re-consider" "re-designed" "re-distributed" "re-enter" "re-entering"
    "re-entry" "re-establish" "re-established" "re-establishment" "re-evaluate"
    "re-evaluation" "re-examine" "re-exposed" "re-expressed" "re-expression"
    "re-folding" "re-graded" "re-grew" "re-induced" "re-introduced"
    "re-introduction" "re-isolated" "re-localization" "re-measured"
    "re-organization" "re-punched" "re-replication" "re-reviewed"
    "re-sensitize" "re-sensitized" "re-sequencing" "re-start" "re-starting"
    "re-stimulation" "re-targeting" "reactant" "reaction-restriction" "readout"
    "readouts" "rear-delimited" "reboot" "recPP1α" "recQ-like" "receptor-2"
    "receptor-DNA" "receptor-ligand" "receptor-like" "receptor-α" "recognise"
    "recognises" "recombinant-human" "recombination-associated"
    "recombination-based" "recombination-directed" "reconfirm" "recuit"
    "redirects" "redox-protective" "redox-regulatory" "reemerges" "refFlat"
    "region-1" "region-leucine" "regmins" "regrowth" "regulatd" "regulators"
    "related-molecules" "relatedness" "relative-risk" "remodeling" "repellants"
    "replication-competent" "reportedptf1a" "reporterassay" "repressors"
    "rerio" "research-based" "residuals" "residue-wise" "residueT790M"
    "responder" "responders" "restorede" "restriction-induced" "retro"
    "retro-orbital" "retrognathia" "retromer" "retroperitoneum" "retrovirus"
    "reverse-phase" "reverse-transcribed" "rexinoids" "rhabdoid"
    "ribonucleoparticles" "ribose" "ribose-5-phosphate" "ribulose-5-phosphate"
    "rictor-knockout" "right-sided" "ring-like" "ring-ring" "risk=17.36"
    "risk=3.81" "risk=6.14" "roos" "rosette-like" "rotein" "rs10088218"
    "rs1026916" "rs1042522" "rs10503929" "rs1053005" "rs1060915" "rs10796045"
    "rs10798176" "rs10919791" "rs10974944" "rs1143627" "rs11540654" "rs1159782"
    "rs11685878" "rs11887698" "rs1205" "rs12340895" "rs12343867" "rs13192841"
    "rs1536800" "rs1561927" "rs16940" "rs16941" "rs16986825" "rs1738074"
    "rs17849781" "rs1799782" "rs1799889" "rs1799949" "rs1799966" "rs1799983"
    "rs193779" "rs2030171" "rs2070744" "rs2157453" "rs2227203" "rs2227631"
    "rs2230926" "rs2234358" "rs2234693" "rs223493" "rs2254002" "rs2293152"
    "rs2293941" "rs25484" "rs25487" "rs25489" "rs2736098" "rs2736100"
    "rs2780890" "rs280519" "rs285640" "rs28934571" "rs28934874" "rs3024974"
    "rs3024979" "rs3091244" "rs3093077" "rs310245" "rs31490" "rs334558"
    "rs3755557" "rs3780367" "rs3816997" "rs3924999" "rs401681" "rs402710"
    "rs4073" "rs4075188" "rs4405858" "rs4558075" "rs4574216" "rs4796793"
    "rs4962153" "rs531930" "rs61748181" "rs6503691" "rs6584400" "rs6806528"
    "rs687289" "rs6920220" "rs6922466" "rs6927127" "rs6933404" "rs6971499"
    "rs7014762" "rs707284" "rs7190458" "rs7202877" "rs7218653" "rs744166"
    "rs74942016" "rs7553007" "rs7598440" "rs799917" "rs8069645" "rs8081391"
    "rs839523" "rs859637" "rs859665" "rs9286879" "rs9340799" "rs9543325"
    "rs957970" "rs9581943" "rs9900213" "rtTA" "s-s" "s10549-014-3056-x"
    "s11523-014-0329-6" "s13058-014-0406-x" "sEPSCs" "sIPSCs" "sacrum"
    "salt-and-pepper" "sanitizes" "sarcomatoid" "scaRNPs" "schefflera"
    "scissile" "sclerotherapy" "scratch-wound" "screenings" "scylloinositol"
    "second-generation" "second-order" "second-site" "segregation-analysis"
    "seizure-like" "selenomethionine" "self-DNA" "self-competition"
    "self-examination" "self-priming" "self-regulated" "self-regulation"
    "self-renewal" "self-sufficiency" "self-sufficient" "self-sustaining"
    "semi" "semi-quantify" "semi-quantitative" "semi-solid"
    "semiconductor-based" "semiovale" "sen" "senescence-like"
    "senescent-associated" "sensistivy" "sensitise" "sensitizer" "sensitizers"
    "seq" "sequence-identity" "sequence-independent" "sequence-randomised"
    "sequence-specific" "sequnens" "serine-359" "serine–arginine-rich" "serosa"
    "sessile" "set-up" "seven-bladed" "seventy-five" "sh-1" "shAR" "shAR-1"
    "shAR-2" "shCTRL" "shCon" "shFOXO3a-1" "shFOXO3a-2" "shFOXO4" "shFascin4"
    "shFascin5" "shG9a" "shGFP" "shGSK3A" "shLacZ" "shLuc" "shMSH2" "shMTH"
    "shMTH1" "shNonsense" "shNrf2" "shPAK1" "shPDK1" "shRNA-1" "shRNA-3"
    "shRNA-constructs" "shRNA-lentiviral" "shRNA3" "shRNAi" "shSIRT3" "shScr"
    "shUEV1" "shUEV1-1" "shUEV1-2" "shake-off" "sheer-stress" "sheet-like"
    "short-hairpin" "short-lasting" "short-term" "showingK" "shutoff" "si-Ctr"
    "si4EBP1" "si4EBP1-treated" "siBak" "siCTRL" "siClim1" "siCont" "siERBB3"
    "siFOXO4" "siGFP" "siMTA" "siMTA1-transfected" "siMyc" "siPARP-1"
    "siPTEN#1" "siPTEN#2" "siPvt1" "siRNA-Brachyury" "siRNA-Nrf2" "siSCR"
    "siYAP" "side-by-side" "side-chain" "side-chains" "side-effect"
    "side-effects" "sidebands" "sidewall" "signal-cascades" "signiﬁcant"
    "silico" "simpler" "simplest" "single-cell" "single-center" "single-copy"
    "single-cycle" "single-gene" "single-molecule" "single-nucleotide"
    "single-phase" "single-point" "single-stand" "single-strand" "sirtuin"
    "sirtuin-2" "sist" "sister-chromatid" "situ" "six-stranded" "skewness"
    "slow-growing" "slower-proliferating" "slowly-repaired" "small-cell"
    "small-molecule" "small-scale" "small-secreted" "smokers" "smooth-muscle"
    "snap-frozen" "soft-tissue" "solid-elastic" "solid-phase"
    "solid-predominant" "solid-state" "somatoplasm" "sorafenib–FLAG–Amsa"
    "sorbitol" "sorted-cell" "south-east" "spacer" "spacers" "spatio"
    "spatio-temporal" "spatio-temporally" "spearman’s" "speciﬁc" "spectrometer"
    "spectrometers" "sphere-forming" "sphingosine-1" "spindle-cell"
    "spindle-like" "splice-acceptor" "splittings" "squamous-cell" "ssGSEA"
    "stainings" "standard-of-care" "steady-state" "stellate" "stem-like"
    "stem-loop" "stemness" "stepof" "stepwise" "stereo-chemical"
    "stereochemistry" "stereoisomer" "stiffness-induced"
    "stiffness-sensitivity" "stonger" "straight-forward" "strain-specific"
    "strepavidin" "streptavidin-biotin-peroxidase" "streptavidin-sepharose"
    "stress-activating" "stress-induced" "stress-inducible" "stress-mediated"
    "stress-response" "stressful" "stretch-relaxation" "stromal-like"
    "structural-rearrangement" "structure-activity" "structure-based"
    "structure-function" "structure-specific" "structure–activity"
    "studies–though" "studyl" "sub-G1" "sub-Saharan" "sub-angstrom"
    "sub-cellular" "sub-cohort" "sub-cohorts" "sub-cortical" "sub-divided"
    "sub-endothelial" "sub-family" "sub-genotypes" "sub-groups"
    "sub-lethally-irradiated" "sub-module" "sub-nanomolar" "sub-networks"
    "sub-phenotypes" "sub-placode" "sub-population" "sub-populations"
    "sub-proteome" "sub-structure" "sub-type" "sub-types" "sub-ungual" "subG"
    "subG1" "subG1-fraction" "subG1-phase" "subarachnoid" "subclass"
    "subclasses" "subcohorts" "subcomplexes" "subdiploid" "subdomain"
    "subfamilies" "sublines" "submembrane" "submucosa" "subnetwork" "subplate"
    "subset" "subsets" "subspecialists" "subspecies" "substituents"
    "substrate-bound-HSP70-SBD" "subthreshold" "subunit-1" "successful–only"
    "succinate" "succinimidyl" "sulfahydryl" "sulfhydryl" "sulfide"
    "sulfonylphenyl" "sulphenyl" "sulphoximine" "sulphydryl" "sumoylaiton"
    "sun-exposure" "super-repressor" "supercluster" "superclusters"
    "supernatant" "supernatants" "suppressant" "surgically-obtained" "sw"
    "synapse" "synapses" "synapsinI" "syndecan-4-knockout" "synergism"
    "synthesizer" "system-wide" "t-scores" "t-statistic" "tAkt" "tagSNPs"
    "taget" "tail-retraction" "tail-vein" "talin-GFP–positive" "taxane-based"
    "tellurium" "telomerase-negative" "tendu" "tenovins" "teratoid" "tertiles"
    "tetra-peptide" "tetra-peptides" "tetrachloride" "tetrad" "tetrads"
    "tetraploid" "tetrasomy" "tetrazolium" "tetrodotoxin" "thalami" "thatthe"
    "theK" "theUDP" "thefancd2" "therapy-based" "therapy-induced" "theta"
    "theta-burst" "thiamine" "thiazolidine" "thick-walled" "thinner"
    "thiol-disulfide" "thiol-reductive" "third-generation" "three-day"
    "three-dimensional" "three-dimensions" "three-helix" "three-layered"
    "three-tiered" "three-year" "threonine-protein" "threonine-specific"
    "thrombi" "thrombocythemia" "thrombus" "thymidilate" "thymidyne"
    "thymocytes" "time-dependence" "time-lapse" "time-of-flight" "time-point"
    "time-points" "time-release" "time-to-event" "time-to-onset"
    "time-to-relapse" "timecourse" "timepoint" "timepoints" "tissue-economic"
    "to-upregulate" "to71" "toBRAF" "toll-like" "tomacula" "top-most"
    "topoisomerases" "topologies" "topology" "trade-off" "trans-activational"
    "trans-membrane" "trans-regulators" "trans-synaptic" "trans-well"
    "transcript-level" "transcription-quantitative" "transcription–PCR"
    "transcriptome" "transcriptomes" "transfectancts" "transfectans"
    "transfectant" "transfections" "transfer-fluorescence" "transition-dipole"
    "transporter-1" "transposons" "transversions" "transwell-matrigel"
    "trapping-mutant" "trastuzumab-DM1" "treatmen" "tri-peptide" "trichrome"
    "triepoxide" "triethanolamine" "triflate" "trimester" "trimethyl"
    "trinucleotide-repeat-containing" "triose" "triphosphate" "triple-epitope"
    "triple-hit" "triple-negative" "triploidy" "trisomies" "trisomy"
    "trisphosphate" "truhydroxystilbene" "tube-like" "tubule" "tubules"
    "tubulinopathies" "tubulinopathy" "tumor-proliferative" "tumor-stromal"
    "tumor-suppressive" "tumour-relevant" "tumour-to-liver" "turn-over"
    "twenty-five" "twenty-four" "twenty-nine" "twenty-one" "twenty-seven"
    "twenty-two" "two-carbon" "two-hybrid" "two-layered" "two-phase"
    "two-ratio" "two-sided" "two-tailed" "two-thirds" "two-three" "two-tiered"
    "two-year" "type-18" "type-I" "type-II" "tyrosyl" "ubiqinone"
    "ubiquitin-proteasom" "ubiquitously-expressed" "ubstrate" "ug"
    "ultra-conserved" "ultrasonography" "ultrastructure" "ultrastructures"
    "ultraviolet-related" "uman" "umor" "un" "unclose" "under-appreciated"
    "under-expression" "undergoes" "undergone" "underpinnings" "undertaken"
    "univariant" "univariate" "unmet" "up-and" "up-front" "up-regulatory"
    "up-stream" "up-to-date" "upto" "uracil-N-glycosylase" "urea" "ureter"
    "urethra" "usual-type" "usual-types" "uteri" "utero" "v-Ki-ras2" "v-akt"
    "vGAT" "vMCF" "vMCF-7DNp53" "vRNA" "vacuoles" "var" "variants"
    "vascular-parenchymal" "vascular-specific" "vasculatures" "vasospasm"
    "vehicle-treated" "vermis" "vi" "videocapillaroscopy" "villi" "villus"
    "virally-encoded" "viremia" "viremias" "vis-à-vis" "viscera" "vitreo"
    "vitreo-retinopathy" "vitro" "vivo" "viz" "water-soluble" "website"
    "week-long" "weeks" "well-annotated" "well-bounded" "well-characterised"
    "well-circumscribed" "well-conducted" "well-conserved" "well-defined"
    "well-designed" "well-differentiated" "well-documented" "well-educated"
    "well-formed" "well-identified" "well-kept" "well-kept-up" "well-ordered"
    "well-recognized" "well-studied" "well-tolerated" "well-used" "whenR"
    "whereinsertions" "whole-brain" "whole-cell" "whole-exome" "whole-genome"
    "whole-section" "wide-spread" "wilfordii" "wingless-style" "witchdoctors"
    "witha" "within-error" "without-radiotherapy" "wk" "wks" "women" "workers"
    "workflow" "workup" "world-wide" "wound-edge" "wt-AR-FQNLF" "wt-FOXO4"
    "wt-p53-expressing" "wtEGFR" "wtTERC" "wtTERT" "x1" "xF" "xQxT" "xantphos"
    "xenograte" "xl" "year-old" "yl" "yr" "z-scores" "zeste" "µL" "×
10"
    "×1.1" "×10" "×100" "×His-PTEN-3" "×UAS" "× 10" "× 10" "× 100" "ØK" "˜4"
    "˜9" "Δ1058-1064" "Δ244–248" "Δ3" "Δ30" "Δ50" "Δ9" "ΔCCDC170" "ΔFERM" "ΔGG"
    "ΔN" "ΔNp73-mediated" "ΔNp73-p-1" "ΔNp73-p-2" "ΔNp73α" "ΔNter1" "ΔOD" "ΔPH"
    "ΔPro" "ΔRaf-1" "ΔSASA" "ΔSASA " "ΔΝp73" "ΔΨm" "α-1" "α-KG"
    "α-KG-dependent" "α-PD-1" "α-PDL-1" "α-Per2" "α-TAT1" "α-helical"
    "α-helices" "α-helix" "α-p53" "α-subunits" "α-tubulinK40R" "α1β2" "α2β1"
    "α3β1" "α4β1" "α5" "α5β1-integrin-binding" "α6" "α6-integrin" "α6β1" "α7"
    "αA" "αA–αE" "αB" "αC" "αC-helix" "αD" "αE" "αERKO" "αKG" "αN" "αPD-1"
    "αvβ1" "β-MD" "β-acetic" "β-catenin-nuclear" "β-ethylacetate"
    "β-hydroxybutyrate" "β-methyl-aspartate" "β-oxidation" "β-pancreatic"
    "β-propeller" "β-propellers" "β-sandwich" "β-secretase" "β-sheet"
    "β-sheets" "β-strands" "β-structure" "β-subunit" "β-subunits" "β-turn" "β3"
    "β4" "β6" "β7" "β8" "βARK" "β±SE" "γ-IR" "γ-ionizing" "γ-irradiation"
    "γ-rays" "γ2" "κB" "μg" "μl" "μmol" "μs" "π-stacking" "χ3" "‘BRCAness’"
    "‘Sanger’" "”-tranformed" "”-transformed" "€31" "€35" "€554" "↑CD24"
    "ﬁrst"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-12901-13200*
  '("CFM" "-3-pyridine-carbonitrile" "-4-" "-6-hydroxyphenyl" "piperidinyl"
    "cyclopropylmethoxy" "T-lymphotropic" "EBV-transformed LCLs"
    "LMP1-transformed LCLs" "Sternberg" "Hodgkin’s" "shFascin 4" "shFascin 5"
    "shFascin4" "shFascin5" "LNGFR" "shNonsense" "non-attached"
    "the NF-κB-dependent LMP1-target gene 4-1BB" "FSC" "ACHP"
    "HA-LMP1-Δ371-386" "pcTax" "Δ371-386" "NGF-R:LMP1" "B2264-19/3" "LCL-3"
    "LCL-721" "Kaposi’s" "LCL" "CTAR1" "CTAR2" "LCLs" "Lymphoblastoid" "and 2A"
    "EBER-and" "EBER" "Hsp90α" "18D" "pIκBα" "p38MAPK" "RMSFs"
    "which employs H-bonding" "H-bonding" "Sander" "Kabsch"
    "the respective Cα RMSDs" "RMSDs" "only 15 SNPs" "Polyphen-2" "HumDiv"
    "synonymous SNPs" "mutated apo and holo p53C" "p53C" "Mutdb" "nSNPs"
    "rs17849781" "rs28934874" "computational tools SIFT" "rs11540654"
    "Polyphen" "2 ns" "occlude" "ALT3" "34a" "14-3-3σ" "cytoreductions"
    "relapsed/refractory" "pg/ml" "19+" "14+" "CR/CRi" "CRi" "N-oxide" "#5"
    "mg/m 2" "E2F1 protein" "Rhoc" "E2F1-Δ3" "Δ3" "Bruker" "40 ug" "= 0.000"
    "non-protein-coding" "Alhazzazi" "CM-H2DCFDA" "= 0.0015" "μ L" "= 0.016"
    "aspirin/NSAIDS" "SOSC2" "aspirin/NSAID" "aspirin/NSAIDs" "rs9900213"
    "DOBS" "rs310245" "rs2254002" "rs2780890" "rs11685878" "rs1026916"
    "rs3024979" "rs7218653" "rs1536800" "rs3024974" "NHW" "/signal" "1 of"
    "rs11887698" "rs193779" "rs280519" "=0.71" "95 %CI" "AG/GG" "PR−" "=0.8"
    "≥30" "race/ethnicity" "non-steroidal" "non-receptor" "Chun" "ﬁrst" "d"
    "SVG" "×His-PTEN-3" "pPTEN" "Kaposin" "multicentric Castleman's"
    "multicentric Castleman" "Castleman"
    "an acquired immunodeficiency syndrome-related Kaposi's" "Kaposi's"
    "Kaposi" "Anti-Flag" "GeneCard" "μl" "NED" "gain-of-function"
    "co-immunostained" "AR +" "BELLE" "Masuda" "apocrine" "co-selected" "NVP"
    "cytospin" "SUM-185" "S21/S9" "TCGA-C8-A12L" "AR+/PIK3CA" "RPKM" "UNS "
    "TNBCtype" "a mesenchymal stem-like (MSL)"
    "numerous world-wide gene expression (GE) datasets" "P  = 0.041"
    "P  = 0.003" "P  = 0.004" "P  = 0.047" "S8B" "2 N" "S8A" "P  = 0.01"
    "= 0.0001" "P  = 0.007" "= 8" "= 22" "AR + " "deletion/suppression"
    "SMAD2/3" "anti-miRNAs" "miR-181a/b" "psiCHECK" "sporadic TNBCs" "ANI"
    "co-suppression" "expressers" "‘BRCAness’" "the hypoxia-inducible factor-1"
    "Finley" "ABPs" "chemoradiotherapy" "mg/kg " "GADD45α" "∼60%"
    "Supplemental Figure S2C" "Δ30" "-hp53" "Bmal" "hPer" "screenings"
    "the circadian factor crytochrome" "rotein (TCTP)" "crytochrome" "rotein"
    "umor" "pTRG" "mM 3-amino-1,2" "ouse" "multilevel"
    "hp53 that acts by modifying the hp53’s" "inute-" "inute" "ouble" "uman"
    "hp53" "SYTO 60" "non–small" "S-labeled" "Egf" "CCNO" "centioles" "Lyz1"
    "Scbg3a1" "ciliome" "KRT" "the healthy airway epithelium" "Ki67 +" "Myb +"
    "wk" "wks" "the tracheal epithelium" "mTmG" "ROSA" "hTEC"
    "the well-annotated cilia transcriptome" "Myb+" "Scgb1a1" "Scgb1a" "Cep120"
    "non-proliferating" "centrioles" "the multilayered tracheal epithelium"
    "intestinal epithelia" "Clara" "non-proliferative" "=12" "f/f"
    "progenitor-like" "polymerization/depolymerization" "dissecta"
    "lamellopodia" "submembrane"
    "microtubule-associated protein adenomatous polyposis coli (APC)" "taget"
    "Fresh EC monolayers" "plekstrin" "#17" "Non-specific" "periarthritis"
    "polyphylla" "gardeniae" "fructus" "panacismajoris" "roos" "delavay"
    "breviscapus" "erigeron" "schefflera" "notoginseng" "Yunnan" "Yi" "Tongshu"
    "non-carriers" "12-year" "lupeol's" "Wnt/" "PLC/PRF5" "lupeol-" "∼48 h" "ɛ"
    "recognise" "epidermoid" "antihormone" "mangoes" "-en-3H-ol" "Lup" "∼3%"
    "Lupeol" "lupeol" "μ g" "∼70%" "TITAN" "SATURN" "CTONG" "bootstrap"
    "crossover" "5.8-month" "this important patient subset" "rarer" "dideoxy"
    "‘Sanger’" "bronchial brushings" "brushings" "bronchial biopsy" "WJTOG/802"
    "exon 20" "= 0.0004" "= 0.012" "= 127" "NEJ002" "Non-small" "= 0.000"
    "HPV-associated HNSCCs" "HNSCCs" "overreliance" "Detroit" "hypopharynx"
    "200mm 3" "# 10" "recurrent unbalanced breakpoints" "ConSig"
    "a more aggressive subset" "pathobiology" "ΔCCDC170" "gain-of-" "∼15%"
    "non-genomic" "Multigene" "= 0.11" "= 0.18" "P = 0.04" "XW" "KMM" "XC"
    "E1a/Ras" "non-epithelial" "≥ 2" "non-HER2" "specificity/sensitivity"
    "underwent MRM" "MRM" "Wald" "IHC4" "Non-HER2" "normal/losses"
    "non-HER2-related" "Chr17" "chr17q" "maximally 500 bp"
    "an otherwise stable chr17" "CEN17" "17q12" "chr" "Non-HER2-gene"
    "non-HER2-gene" "non-HER2-genes" "chr17" "non-luminal" "= 0.0354"
    "= 0.0003" "= 0.030" "p = 0.008" "= 0.038" "17q21" "p = 0.001" "= 0.017"
    "p = 0.011" "p = 0.007" "RTOG" "MPFS" "EURTAC" "Hirsch"
    "a previous prospective randomized study undertaken" "S/SRS" "≤1"
    "underwent S/SRS" "MPFSE" "MPFSI" "55/109" "non-TKI" "PFSE" "PFSI" "Xiamen"
    "Amoy" "ng/µL" "sen" "Yat" "WBRT/SRS/surgery"
    "stereotactic radiosurgery (SRS)" "BMs" "underwent WBRT/SRS/surgery"
    "/surgery" "SRS" "radiosurgery" "WBRT" "NEJ 002" "WJTOG 3405" "95 %CI"
    "95 % CI" "= 1" "/µL" "= 0.032" "−94" "exudate" "dominant-negative STAT3β"
    "TATA" "−178" "CpG-DNA-induced" "Rux" "CpG-DNA-" "∼53%" "∼2-fold" "nGpG"
    "OND" "co-incubated" "iCpG" "the immune-reactive ODNs" "ODNs"
    "highly methylated CpG dinucleotides" "subthreshold" "hypochlorite"
    "corticosteroids" "Subsets" "Calgranulin" "plasmacytoid" "phosphodiester"
    "oligodeoxynucleotides" "non-methylated" "Non-adherent" "Toll-like" "HMGD"
    "nearly all the EGF-like" "MscI" "GTC" "hemiplegia" "gastrostomy"
    "hyperintensities" "Romberg" "Babinski" "hypomnesia" "Binswanger’s"
    "Binswanger" "Cerebral magnetic resonance angiography (MRA)"
    "angiography (MRA)" "aneurysm" "severe diffuse leukoencephalopathy" "Signa"
    "FLAIR" "MMSE" "HGMD" "C-loop" "semiovale" "centrum"
    "epidermal growth factor-like" "leukoencephalopathy" "Alexander" "indel"
    "exophytic UCAs" "UCAs" "IUPs" "CNV" "papillary UCA" "Chromogenic ISH"
    "pleomorphism" "pronouncedatypia" "cytologicatypia" "amplifiy"
    "both noninvasive low-grade and high-grade papillary UCA" "AmpliSeq" "UCA"
    "IUP" "= 0.38" "200 bp" "osteoid" "pMIR"
    "an independent prognostic covariate" "covariate" "p=0.037" "= 1/2"
    "Olympus" "HNF" "microRNA-34a" "paraformalin" "p=0.023" "=0.044" "=0.039"
    "=0.041" "=66" "SCI" "A/CDK2" "AcLDL" "Dil" "n  = 6" "emphasises" "IGBP"
    "radiochemotherapy" "Karnofsky" "∼1-fold" "minimise" "SU3" "and 1p/19q"
    "μ g " "48 h" "β 1" "NRCTs" "Elsevier" "Begg’s" "Begg" "T1/T2" "T3/T4"
    "0.54–1.00" "three-year" "one-year" "Oxford" "concensus" "grade/stage"
    "TMN" "WMD" "= 0.55" "= 16" "P = 0.04" "P = 0.03" "= 0.76" "P = 0.008"
    "n = 5" "P = 0.02" "P = 0.05" "5- year" "= 0.0001" "n = 11" "n = 13"
    "lobopodia" "invasive cells/spheroid" "impedance" "PDK1_Δ50" "lamella"
    "mTurquoise" "LifeAct" "pixels" "TIRF" "T18/S19" "nonimmune"
    "efficiently pull-down GFP-MRCKα_CAT" "GFP-MRCKα_CAT" "_CAT" "PDK1_K465E"
    "MRCKβ" "PDK1_ΔPH" "_Δ50" "PDK1_L155E" "_ΔPH" "PDK1_KD" "PDK1_L155EK465E"
    "_L155EK465E" "_K465E" "ΔPH" "_L155E" "Δ50" "_KD" "#79" "shPDK1" "PDK1_WT"
    "shScr" "myotonin" "discoideum" "Dictyostelium" "MRCKα" "S4 B" "S3 C"
    "1–3 µ" "Connell" "pmiRZip" "miRZip" "-UTR-MUT" "-UTR-WT" "myristate"
    "LSKs" "1*6" "*6" "CEP701" "TKD" "MV4" "FLT3-ITD-associated MV4" "oncomiR"
    "~ 72%" "Balb/C" "DEPDC1" "non-adhesion" "Rat6" "antiFLAG" "photoreceptors"
    "AxxAA" "FDLFY" "FxxxY" "Nε" "FQNLF" "Oδ2" "W741L-AR-FQNLF"
    "T877A-AR-FQNLF" "FxxYY" "FxxWY" "FxxHY" "FxxFY" "HF-T877A-AR-DBD-LBD"
    "wt-AR-DBD-LBD" "CDX-W741L-AR-LBD" "HF-T877A-AR-LBD" "DHT-wt-AR-LBD"
    "AR-LBD co-crystals" "Tyr+5" "sidewall" "Leu+4" "Phe+5" "FxxLF-like"
    "FxxFF" "FxxLF" "LxxLL" "C/L" "chlormadinone" "AWS" "W/Y" "+5" "Fxx"
    "co-crystals" "L-shaped" "/L" "residueT790M" "KSP" "Spoel" "co-linearity"
    "covariance" "DSSP" "pharmacophore" "Gromacs" "RosettaBackrub" "Yoshikawa"
    "G719S/T790M" "Yun" "2 ps" "pHER" "pMET" "G12 mutated genotype" "G12mut"
    "pPI3K/pHER3" "pPI3K/pHER" "immunomicroarray" "non-response"
    "the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog ( KRAS )"
    "v-Ki-ras2" "akt" "CEER"
    "v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog ( KRAS )"
    "homolog ( KRAS )" "Kirsten" "= 120" "immunosenescent hMSCs" "Gu"
    "encephalomyelitis" "Scruggs" "hMNCs" "hMNC" "COX-2/PGE 2"
    "immunocytochemistry" "submucosal edema" "caecum" "submucosa" "MNC" "MNCs"
    "hUCB" "doublings" "Replicatively senescent hMSCs" "Toluidine"
    "multilineage" "prelamin" "immune/inflammatory response" "hMSCs" "hMSC"
    "n = 3" "n = 16" "= 12" "&D" "n = 15" "Akyurek" "BLBCL" "≥70%" "non-DHL"
    "1/140" "Non-GCB" "classifier" "Hans" "non-GCB" "Stainings"
    "/immunohistochemical" "Heike" "immunochemotherapy" "non-germinal" "DHSs"
    "BCL2-" "BCL" "3-year" "P  = 0.047" "= 0.019" "P  = 0.001" "= 0.089"
    "= 0.044" "P  = 0.035" "= 0.015" "P  = 0.011" "P  = 0.005" "= 0.006"
    "P  = 0.009" "P  = 0.008" "P  = 0.038" "P  = 0.007" "= 0.014" "= 0.043"
    "ictal" "NG2 +" "vascular RECA-1" "PDGFRβ +" "the Racine's" "IV/V" "Racine"
    "parenchymal microcapillaries" "temporal lobectomies" "lobectomies" "neuro"
    "polydendrocytes" "microcapillaries" "leaky microvessels" "TLE"
    "seizure-like" "RECA-1" "Cerebrovascular NG2DsRed" "re-distributed"
    "cerebrovasculature" "OHC" "NG2DsRed" "BBB" "non-treated" "n = 7"
    "a third smaller supercluster" "_3" "_1" "_Mitotic" "_2" "_Magnoid"
    "_Proliferative" "Supercluster" "_MSI/CIMP" "_secretory" "_Mesenchymal"
    "_Immunoreactive" "_4" "_5" "posthoc" "MSigDB" "ssGSEA" "Algorithm"
    "A tumor-associated normal cell supercluster" "supercluster"
    "pairwise Pearson’s" "COADREAD" "the squamous histology" "heatmap" "UCEC"
    "LUSC" "LUAD" "KIRC" "HNSC" "BLCA" "LAML"
    "French-American-British-classification" "the largest superclusters"
    "superclusters" "=51" "=26" "P = 0.06" "= 0.10" "= 71"
    "ethynyldeoxyuridine" "methylthiazolyldiphenyl" "LIU" "bao" "Bao" "CUI"
    "Yue" "ZHANG" "dong" "Xiao" "YE" "hong" "hydroxycamptothecin" "DRFS"
    "miR-520e" "e" "Allegrini" "Smouse" "Billah" "Krawczyk" "Wojas" "Togashi"
    "Leary" "Tapia" "Hiramatsu" "immunomarkers" "LCC" "Spain"
    "endobronchial ultrasonography-guided transbronchial needle aspiration biopsy"
    "transthoracic biopsies" "TBNA" "EBUS" "ultrasonography" "ng/μl"
    "mediastinoscopy" "Gahr" "Boch" "Rosell" "lepidic non-mucinous" "Eberhard"
    "Marshall" "Aisner" "ADSQ" "Travis" "Petrelli"
    "Cytological and small biopsy" "Cytological or small biopsy" "p  = 0.001"
    "≥20 " "= 0.043" "p  = 0.04" "Cul1-" "Cul" "non-irradiated" "S/T-Q" "iGFP"
    "SceGFP" "HMLE" "Radioresistant" "×
10"
    "Nu/Nu" "P = 0.02" "1
× 10"
    "Co-immunoprecipitation" "MCF7 cells" "chr16q23.1" "chr22q12.1" "HaploReg"
    "MIR1208" "MIR" "rs4962153" "LR" "inc" "exocrine" "13q12.2" "rs7202877"
    "CEU" "chymotrypsinogens" "chymotrypsinogen" "Kruppel-like"
    "a p53-induced long intergenic non-protein" "rs1561927" "rs687289"
    "16q23.1" "rs7190458" "rs6971499" "HumanHap550" "CALGB" "PANDoRA" "9q34.2"
    "13q22.1" "1q32.1" "missing genotypes" "DCEG" "Omni" "Beadchip"
    "OmniExpress" "PanScan" "7q32.3" "multistage" "n=21" "= 0.75" "= 0.76"
    "22q12.1" "= 0.74" "Mir-548k" "mir-548k" "HPV+" "UPMC" "Pittsburgh"
    "Hochberg" "Benjamini" "genome-wide dataset" "distill" "IPython" "Firehose"
    "k" "3p" "non-linear" "11q13" "P = 0.004" "± 2" "P = 0.002" "JTC" "JWT"
    "WQ" "CDC25s" "active CDK1/2" "Overactive CDK1/2" "Chaudhuri" "D&E" "B&C"
    "isobolograms" "&C" "#10" "HL60/Ara-C" "being approximately 600-times"
    "DNR" "anti-leukemic" "non-t" "p = 0.007" "= 24" "n = 5" "= 29" "CDK1/2"
    "non-telomeric" "≤30%" "CCCTAA" "Cy3-" "Cy" "recQ-like" "affecteds" "SCEs"
    "Werner" "quadri" "nonmalignant-" "positeve" "andp27" "condensate"
    "condensation/decondensation" "NEs" "NEBD " "Seckel " "nanogold"
    "karyoplasm" "sorbitol" "aphidicoline-" "aphidicoline" "NEBD"
    "topoisomerases"
    "replication protein A (RPA)-coated single-stranded DNA (ssDNA) nucleofilaments"
    "nucleofilaments" "patho" "dwarfism" "Seckel" "0.0%±0.0%" "16.7%±6.2%" "/l"
    "NBM" "P =0.005" "UCs" "DSRCT" "Gaal" "2F+3−4F" "2p" "EML4–" "EML" "87/96"
    "3–4F" "≥5F" "8p" "10q" "11p" "17p" "5p" "19q" "ECOG" "IIx" "Oncomap"
    "Five-year" "CRM197" "Zn" "ectodomain" "prodomain" "βARK" "Gαi/" "Gαi"
    "TAPI" "phenanthrolene" "TMPS" "Gβγ" "Non-significant" "24- hour" "~70%"
    "highNPI" "highKi" "NPI+" "PRHER" "issubject" "three-tiered NPI"
    "moderate and poor NPI" "NPI" "≤3" "procoagulant" "IIIa"
    "the sub-endothelial neointima" "Wilson" "thrombi" "re-exposed"
    "an occlusive thrombus" "thrombus" "the subendothelial VG neointima"
    "Anti-CD31" "/WT" "IVC" "IVCs" "p44/42" "n=6" "KIM" "enzymology" "RKR"
    "S419A/S423A" "DQSPAGS" "DSGLPS" "DSGRGDS" "DSGFCLDS" "mutantions" "UB"
    "202/204" "χ3" "pY+4" "pY+1 S" "C-terminally" "PTP1B-C215S-BPPM" "pY–3"
    "SEDP" "PLQRpY" "phopho" "pY+3" "pY+2" "/E1192" "ENPE" "pY+1"
    "the small artificial substrate pNPP" "P-loop" "Fo" "Ac" "LTPQ" "LGLD"
    "ENPEpY" "invariant" "WPD" "pNPP" "nitrophenyl" "phosopho" "scissile"
    "1221/1222" "The precise HER2 C-terminal phosphorylation barcode" "PEST"
    "barcodes" "barcode" "6-diamidino-2-phenylindole" "β6" "+1 S" "/ K"
    "abozantinib" "PDFRA"
    "the most frequently mutated gene, and MLH1 and MET SNPS" "SNPS"
    "epigenomes" "Heliscope" "Helicos" "HiSeq" "177/189" "183/189" "Mbp"
    "gigabases" "Carney" "PGFRA" "PDFGRA" "leiomyoblastomas" "mesentery"
    "Swiss" "Swedish" "Ampliseq" "CD34 +"
    "transcriptomic and proteomic datasets" "HJ" "SY" "WY"
    "Upstream regulatory factor 1/2" "USF1/2" "MRFT" "EdgeExpress" "Datasets"
    "caveolar lipid raft microdomains" "MRTF" "Yohannes" "JNKi" "MYCi"
    "clearer" "PDGF-treated pBSMCs" "pBSMCs" "OregAnno" "bZIPDB" "Amadeus"
    "EEDB" "mSigDB" "pBSMC" "motogen" "Oxygenase-1" "μg" "non-redundant" "NEIL"
    "TEBPβ" "Oxytrichia" "larger substituents" "-ethylguanine" "ethylguanine"
    "G-quartet" "1/10" "NarI" "oligo" "mol·s" "·s" "triethanolamine" "tetrad"
    "alkyltransfer" "homologous quadruplexes" "quadruplexs" "AGT/G5x"
    "AGT/22wtx" "randomly-distributed residuals" "residuals" "°K" "G5x" "22wtx"
    "dichroism" "ellipsoid" "TEA" "hydrodynamically-equivalent prolate"
    "Perrin relation" "prolate" "SEDNTERP" "Perrin" "SEDFIT" "∼1.4" "22wt"
    "∼2.0" "Quadruplex" "-alkylguanines" "alkylguanines" "tetrads" "6mG"
    "AGT:DNA" "G-rich" "= 0.23" "= 21 " "G-quadruplexes" "G-quadruplex"
    "gastric cells co-cultured" "neutralise" "derivate" "Kato" "MG15"
    "a bacterial chaperonin" "HspB" "the superficial gastric epithelium"
    "Tumaco" "Andes" "Túquerres" "underwent GI tract endoscopy" "Nariño"
    "endoscopy" "eventuate" "Rat Sarcoma Viral Oncogene Homolog (RAS)"
    "Homolog (RAS)" "Homolog" "co-evolution" "gastric biopsies"
    "gastric epithelium" "The developmental transcriptome" "regenerative BSCs"
    "LHX" "Clims partially rescues mammosphere" "siClim1/2"
    "smaller mammospheres" "MaCFCs" "MaCFC" "MRU" "Dataset" "°CD24 +" "CyberT"
    "BETR" "smaller TEBs" "a dominant-negative Clim" "Nli" "Otx" "LMO" "BSCs"
    "TEBs" "multipotent stem cell-enriched placodes" "mesenchyme" "BSC"
    "basal-expressed Clims" "Clim" "Clims" "Co-factor" "non-cell" "CD24 +"
    "α4β1" "adherens" "TIMP2-3" "non-adherent" "Bayes"
    "The apical actin meshwork" "a cross-linking filamentous meshwork"
    "E-plates" "Basel" "Roche" "Louis" "ZFN" "CDH1 -/-"
    "The multifocal gastric SRCCs" "pers" "antrum" "SRCC" "penetrant" "SRCCs"
    "lines/models" "CDH1-/-" "αvβ1" "α3β1" "α2β1" "= 0.12" "p = 0.03"
    "p = 0.04" "p = 0.01" "= 0.74" "= 0.015" "p = 0.004" "= 15" "48 h"
    "Anti-rabbit" "commonalities" "exam S69pTAZ's" "reagents/methods" "pYAP"
    "pLATS1" "dpYAP" "YAZ" "dimethyloxaloylglycine (DMOG)"
    "dimethyloxaloylglycine"
    "17-dimethylaminoethylamino-17-demethoxygeldanamycin" "DMAG" "HXRXXS"
    "paralog" "pTAZ" "HOSE" "EOC" "non-white" "EDCFs" "EDCF" "Vanhoutte"
    "type 2 diabetic patients ESR1 XbaI genotypes" "alelle" "aminoacid"
    "non-classical" "nigricans" "progestin" "German" "Malay" "PIVUS" "Uppsala"
    "intima" "microvessels" "polymorphismsm" "Framingham" "healthy ones" "max1"
    "plethysmograhy" "the wild-type homozygous ones" "mm/s" "RBCV" "TRBCV"
    "Videocapillaroscopy" "ischemia/reperfusion" "videocapillaroscopy (NVC)"
    "NVC" "approximately 50 bp" "6p25.1" "EDHF" "vasospasm"
    "important anti-atherogenic" "healthy early postmenopausal ones" "dyad"
    "Pvull" "videocapillaroscopy" "nailfold" "p = 0.004" "= 0.10" "n = 17"
    "n = 10" "= 30" "rs2234693" "p = 0.02" "CJUN"
    "an investigational HSP90 inhibitor compound CH5164840" "CH5164840"
    "E746_A750" "_A750" "times/week" "Proia" "ganetespib/erlotinib" "= 0.0003"
    "n  = 4" "200 mm 3" "5 × 10" "72 h" "1-methyl-1" "doi:10.1007" "CK1/2"
    "G-loop" "HRD" "kcal" "apoptogen" "jBid" "non-phosphorylated" "LC-MS/MS"
    "≥1.5" "mg/ml" "72 h" "JNK1-3" "Co-expression" "JNK 1–3" "ADME"
    "novel symmetrical and nonsymmetrical marinopyrroles"
    "nonsymmetrical marinopyrrole" "the symmetrical marinopyrrole"
    "symmetrical marinopyrroles" "symmetrical marinopyrrole" "vi" "MeOPh"
    "Winooski" "Tek" "Quant" "VWR" "Microwell" "SureBlue" "Montgomery" "Bethyl"
    "Rockford" "SuperBlock" "Wilmington" "Biomatik" "ELISAs" "Jolla" "Graphpad"
    "TECAN" "AcOH" "O/THF" "methoxybenzylsulfonyl" "sulfonylphenyl"
    "methoxybenzylthio" "MeOH:H" "300SB-C8" "EtOAc/petroleum" "Xantphos"
    "-bipyrrole-2,2" "-Tetrachloro-1" "ZORBAX" "EtOAc" "xantphos"
    "2-hydroxy-4-" "methanone" "ethylacetate" "-diyl" "diyl" "bis" "Fukai"
    "Elmer" "Perkin" "MHz" "another nonsymmetrical marinopyrrole" "–S–"
    "Symmetrical marinopyrroles" "Both nonsymmetrical marinopyrroles"
    "Lipinski" "ChemAxon" "Villiger" "Baeyer" "-CPBA" "CPBA" "Sulfides"
    "methoxyphenyl" "phenylmethanethiol" "triflate"
    "the nonsymmetrical marinopyrroles" "iv" "SARs" "SAR" "aureus (MRSA)"
    "aureus" "methicillin" "Marinopyrroles" "programd"
    "a nonsymmetrical marinopyrrole" "marinopyrrole"
    "highly potent dual Mcl-1/Bim and Bcl-xL/Bim disruptors" "disruptors"
    "methoxy" "benzyl" "FQ" "sulfide" "marinopyrroles" "spacers" "= 0.6 µ"
    "M +" "= 30" "12H" "= 8" "48 h" "drug-like" "Singh" "-acylthiourea"
    "acylthiourea" "-Acylthiourea" "Acylthiourea" "HDAC8s" "H334R/Y306F"
    "imidazole" "I243N/Y306F" "A188T/Y306F" "A188T" "Warsaw" "cohesinopathies"
    "Cohesinopathies" "phenylcarbamothioyl" "Lange" "Cornelia" "= 0.50"
    "ring-like" "-methylQTL" "non-replication" "non-Hispanic" "PRCKZ" "β ±SE"
    "β±SE" "rs4574216" "InCHIANTI" "Chianti" "Invecchiare" "GOLDN"
    "Mediterranean" "two intergenic single nucleotide polymorphisms"
    "MethylQTL" "cg26930596" "methylQTL" "nmol/L" "=0.84" "=0.49" "=0.75"
    "≥ 10" "≥ 1%" "= 0.85" "AKTeven" "TtzmR" "severe hypoglycemia"
    "phosphomutants" "19p13.3" "-diphosphate" "diphosphate" "hypoglycemia"
    "osteopenia" "lymphopenia" "de-acetylases" "/F" "the respective morpholino"
    "morpholino" "morphant" "the Meckel's" "Meckel" "morphants" "Thisse"
    "lamellae" "co-traffic" "PAGFP" "microdomains" "SILAC" "co-precipitate"
    "TrioD1" "mant" "GEF-mediated" "rerio" "Danio" "morpholinos"
    "non-protrusive" "coronin-1C" "non-dividing" "transcription/translation"
    "neural plexi" "plexi" "Necropsy" "hemisplenectomy" "shLacZ" "pictilisib"
    "KP4×1.1" "×1.1" "cellulin (BTC)" "cellulin" "re-established" "Essen"
    "botulinum" "pancreatitis" "retroperitoneum" "PAK1–3" "p73/ΔNp73"
    "arrest/apoptosis" "ΔOD" "PPXY" "ΔNp73α" "p73α" "Isg" "1 × 10"
    "stem/progenitor" "ISOs" "Rapamycine" "libitum" "Morikawa" "nonobese"
    "HER2E" "PETT" "immunohistochemestry" "co-interventions" "=0.053"
    "tertiles" "mg/dl" "12/19" "insulin-like" "= 0.046" "= 0.034" "speciﬁc"
    "ΔNp73-p-1" "Biosystems" "somatoplasm" "48h" "20 μmol/L" "CPG" "20μmol/L"
    "signiﬁcant" "ΔNp73" "NCTs" "TAp73" "ΔΝp73" "** P" "* P" "g/kg" "=0.047"
    "P =0.001" "= 0.047" "amoeboid" "cytosol/membrane" "nonredundant"
    "RNAi-like" "ΔPro" "the characteristic motile" "to 2D"
    "a cohesive interconnected organelle" "HFFs" "nonmotile" "CDMs" "apFRET"
    "anterograde" "a cohesive organelle" "ministacks" "adhesome" "14 d"
    "anti–Rabbit" "anti–Mouse" "Anti–mouse" "6-kb" "a 2D" "and 3D"
    "non-medical" "Koon" "Glu797fs" "_2390" "Tanzania" "Nigeria" "Libya"
    "Gukas" "Basro" "Fregene" "Soudan" "Abruidis" "witchdoctors"
    "around Kinshasa" "delGA" "cytology" "BIRADS" "Muanda" "Bas-Congo" "Boma"
    "Matadi" "Kimpese" "the capital Kinshasa" "CBE" "BSE" "BHGI" "LMICs"
    "British" "Sylla" "Uganda" "Congo (DRC)" "Africa" "Clinicians" "Congo"
    "Kinshasa" "= 12" "= 2" "Johnson" "Friedman" "healthspan" "progeroid"
    "Flurkey" "Dunn" "Conover" "Mendrysa" "García" "Maier" "Segni"
    "Holzenberger" "Moiseeva" "Lu" "Schmitt" "Leonardo" "Murray" "Luo" "ac"
    "Sakaguchi" "Levine" "IGF-1-mediated" "IGF-1-treated" "Serrano" "Tyner"
    "Lohrum" "Smeenk" "Kuilman" "Atadja" "Langley" "Kenyon" "Michishita" "Chua"
    "Jeyapalan" "Ostrovich" "Blume" "Maki" "IGF-1-induced" "± 1"
    "senescence-like" "CL" "CZ" "QZ" "kinase/signal" "ChIP-re-IP"
    "IL-6/STATTIC" "Anisomycin/SP600125" "TAAT" "YTAATGR" "refFlat" "heavier"
    "Bio" "NENs" "enhancer binding protein-1" "homeodomain" "pCDNA3.1-c-Myc"
    "24 hr" "1 × 10" "~ 75%" "leukemia/lymphoma" "co-localizations" "Ct"
    "transducers" "= 9" "PR -" "Revesz" "structure/function" "PolyPhen"
    "platelets/μl" "monosomy" "angiography" "9-year" "esotropia" "purpura"
    "petechiae" "FEVR" "vitreo" "cytopenias" "congenita (DC)" "phiC"
    "unique subcellular localization/compartmentalization" "non-tumorigenic"
    "Dissected abdominal viscera" "viscera" "dpf" "hindbrain" "ptf1a:Gal4-VP16"
    "22/106" "2/79" "A146T" "Gal4/UAS" "UAS" "Ai" "mutation/variants"
    "neoplasias" "mutation/variant" "Basal-like" "n = 8" "≥ 2" "n = 11"
    "Dmitry" "Thomas" "the other cytokines-treated MDSCs" "IL-6-treated MDSCs"
    "treated MDSCs" "supernatants" "65.8±7.5%" "karyocytes"
    "6 putative noncanonical NF-κB binding sequnens" "sequnens" "Ser176/180"
    "Ser177/181" "JSI-124-treated MDSCs" "NCsiRNA" "CATTCCAAAA" "CTTCCTAAA"
    "ATTCCCAAA" "TRANSFAC" "developing more efficient immunotherapy"
    "Mougiakakos’s" "Mougiakakos" "Reg" "polymorphonuclear MDSCs" "PMN" "MDSCs"
    "Immunotherapy" "IFN-α/β" "co-cultured" "Millipore" "guanylyl"
    "co-incubation" "-3β" "Calbiochem" "factor/lymphocyte" "MPECs" "C57BL/6"
    "Cardone" "co-diffusion" "bisphosphate" "around 1 µm 2 /s" "TCSPC"
    "Förster" "an anomalous exponent ofτ" "ACFs" "co-localised" "ΔFERM"
    "phosphoinositides" "half-time" "mCitrine" "PTPD" "FCCS" "co-localisation"
    "= 29" "n = 9" "1.02–1.31" "1.02–1.28" "flowchart" "rs9340799" "A/G"
    "rs223493" "XbaI" "SpringerLink" "Alzheimer’s" "Xbal" "PvuII" "=0.47"
    "=0.23" "=0.12" "P =0.02" "DHO" "ubiqinone" "Krebs" "phosphonacetyl"
    "Oligomycin" "phenylhydrazone" "oligomycin" "Bd" "XF" "ECAR" "Ev"
    "phophorylates" "/acutely" "indolent non-Hodgkin’s" "indolent non-Hodgkin"
    "Rapalogs" "FluS" "FluR" "1.0 × 10" "phospho-p70S6K" "anti-metabolite"
    "aberrant directions abnormal whirling heterotopic fascicles"
    "neuroepithelium" "most tubulin related cortical dysgeneses"
    "tubulin related cortical dysgeneses" "dysgeneses" "Retzius" "quasi" "BFPP"
    "bifronto" "pial" "neuroglial ectopias" "focal neuroglial ectopias"
    "ectopias" "either focal heterotopia" "radial columnar heterotopia"
    "about foetal tubulinopathies" "pachygyria" "Barth" "Norman" "pons"
    "the retrospective re-evaluation" "ponto"
    "tubulin related polymicrogyria-like cortical dysplasia" "3/6" "Brainstem"
    "large bilateral olivary heterotopias"
    "multiple and short axonal fascicles" "foetal tubulinopathies" "parieto"
    "generalized polymicrogyria-like cortical dysplasia" "fronto"
    "diffuse (4/6) polymicrogyria-like cortical dysplasia"
    "asymmetrical abnormal coarse perisylvian gyri" "polymicrogyria-like"
    "Polymicrogyria-like cortical dysplasia" "Polymicrogyria-like" "_013" "4/7"
    "_025" "_022" "voluminous olivary heterotopias" "cortico" "medulla"
    "deepest" "LIS_TUB_021" "_021" "cortical cytoarchitecture"
    "cytoarchitecture" "_009" "massive neuroglial heterotopia" "heterotopia"
    "_005" "LIS_TUB" "thalami" "putamen" "caudate" "pallidum" "trimester"
    "Probst" "_009_foetus" "cortical dysplasia" "_foetus"
    "Nodular or radial heterotopias" "_TUB" "arachnoid" "heterotopic fascicles"
    "subplate" "6/13" "5/13" "retrognathia" "WG"
    "micropolygyria-like cortical dysplasia" "Cochin"
    "foetal brain tubulinopathies" "tubulinopathy" "agyria" "gyral" "isotypes"
    "gyri" "subarachnoid" "2/6" "Foetal TUBA1A tubulinopathies"
    "tubulinopathies" "neuronal heterotopias" "heterotopias"
    "polymicrogyria-like cortical dysplasia" "re-analyzed" "10/13" "n = 6"
    "6/7" "n = 7" "n = 13" "stem/tumor" "miR-200s"
    "a nodular growth pattern-like" "pattern-like" "NL" "Genechip"
    "discriminant" "Partek" "neuropil" "-Namp" "Namp" "-ampL" "ampL" "dmin"
    "microRNA-200c" "/tumor" "Only REDD1 ΔNter1" "ΔNter1"
    "transcribed/translated" "anti-clonogenic" "Cellitti" "Schlecht" "4IO8"
    "S-score" "Rodina" "SBD/peptide" "NRLILTG" "HSP70s" "αC"
    "the following eukaryotic HSP70 SBDα" "3LOF" "αE" "Waals" "der" "αD" "αA"
    "NDKGRL" "SSSGL" "ASSGL" "αB" "Cα" "MolB" "MolA"
    "the characteristic SBDβ and SBDα subdomains" "excellent stereochemistry"
    "stereochemistry" "selenomethionine" "hepta" "VER-155008" "VER" "NBDs"
    "an α-helical subdomain" "NRLLLTG" "cerevesiae" "HscC" "archaebacteria"
    "SBDβ" "the substrate-bound DnaK" "the bacterial ortholog" "DnaK" "SBDα"
    "subdomains" "= 0.77" "mir" "Zhu" "ISEL" "tween" "GR/anti-Ctr" "siPTEN#1"
    "siPTEN#2" "siSCR" "AKK" "this invasive ability **p" "**p" "*p" "mol/L"
    "PC-9/GR" "Tongji" "and+++" "34/47" "37/47" "pc-9/GR" "n = 6" "72 h" "AJR"
    "JVH" "IPASS" "ORRs" "squamous histology" "0.14–1.57" "0.25–1.06" "MT+"
    "FISH+" "ZODIAC" "= 0.058" "= 0.023" "•TSC2" "holocomplex" "Menon"
    "B-subunit" "PP2AB" "a regulatory B-subunit" "HAREDD1" "KYAA" "caAkt"
    "FOXO1/3" "RagBC" "caRags" "caRheb" "•GDP" "RagA/B" "ORR" "E545K/D"
    "EGF104535" "= 0.095" "= 0.71" "0/1" "3 + " "= 0.039" "P  = 0.001"
    "Genbank" "KVTA" "Solano" "Pavlicek" "SIFT" "PP1αmyc" "GFPBRCA1" "recPP1α"
    "BF4" "VxF" "a PP1-binding consensus motif (R/K)(V/I)xF" "xF" "holoenzymes"
    "Argentinean" "protein phosphatase 1α" "KVTF" "24 h" "P = 0.011"
    "non-Ashkenazi" "phospho-MEK1/2 S217" "Yale" "misrepair" "exomes" "=not"
    "=64%" "=55%" "NCR" "T202/Y204" "72h" "pLENTI" "HMVII" "_1799GT" "DNV"
    "co-occurring" "re-sequencing" "sequenom" "SNV" "13/15" "mg / kg" "12h"
    "non-additive" "125 autosomal SNPs" "Denmark" "decile" "deciles" "Sweden"
    "Danish" "Nagelkerke" "CNVs" "at least one eQTL" "eQTL" "eQTLs"
    "Independently associated SNPs" "= 1×10" "1×10" "Genotypes"
    "the biological underpinnings" "P -values" "P =0.035" "≤ 5" "≥ 20"
    "pGL3-375pro" "Promega" "Consite" "non-metastasis" "5×10" "non-malignant"
    "Korea" "CES" "1.040–1.979" "embolus" "22q11.2" "1/3" "= 0.012" "= 0.039"
    "P-value" "P-values" "3q26.3" "P = 0.028" "P = 0.002" "= 10"
    "β-catenin-nuclear/cytoplasmic-positive" "p=0.028" "the corneal limbus"
    "limbus" "miR-221expression" "p=0.004" "p=0.007" "p=0.003" "conjunctiva"
    "OMIM" "p=0.001" "PECs" "=0.028" "=0.007" "p=0.002" "sh-1" "shRNAi" "Jiont"
    "Sp1-1" "5 ×10" "12 h" "beween" "Blc2" "the Spearman's" "trisomy" "≥2-fold"
    "Richter" "8q23.3-q24.3" "13q14" "Berkeley" "mamospheres" "TzbR" "TzbS"
    "SKBR" "JIMT" "non-CIC" "biotargets" "antracyclines" "anti-diabetes"
    "receptor+" "Aromasin" "rexinoids" "HER2/EGFR1" "EGFR2" "Xeloda" "EMILIA"
    "HER+" "TRYPAHENA" "NEOSPHERE" "MARIANNE" "cardio" "CLEOPATA" "blockers"
    "vMCF" "mammospheres" "ΔRaf-1" "chemoendocrine" "TFAP" "MSX" "msh"
    "MCF-7/GSK-3beta(WT)" "MCF-7/GSK-3beta" "studyl" "p4E-BP1" "Endometrioid"
    "endometriod" "ER+/PR+" "ERalpha+" "NSABP" "MCF-7/(BC)" "MCF-7/"
    "activated/suppressed" "Britton" "theUDP" "UGT3A1" "flavoenzymes"
    "acteylglucosamine" "UAP1L1" "tyrosyl" "mammary epithelium" "YXXM"
    "the possible co-targeting" "MCF-10A/" "PR-" "MBCs" "region-1" "Moloney"
    "-adenosyl" "adenosyl" "Bis" "Ras-like" "colo" "Mutations/Alterations"
    "neuregulin-2beta" "biological situations EGFR4" "whereinsertions"
    "mammosphere" "4HT" "/RT-PCR" "BT474/"
    "mitogen-activated protein kinase kinase1/2" "pan-phosphoinositol-3-kinase"
    "Gatekeeper" "hydroxy" "TP53+" "EGFR1+" "comedo" "EGFR4" "EGFR3"
    "ER-alpha+" "A2A2" "regmins" "+16" "Greek" "biphenyl" "Chk/2" "EGFR1"
    "CICs" "S235/236" "one-half" "4/11" "Platz" "the secondary endpoint" "LMMs"
    "TaqMan" "antitumour" "multicentre" "Cobas" "=79" "4/6" "8/79"
    "a novel organotypic 3D coculture model mimicking human omentum" "HPMCs"
    "coculture" "Lengyel" "Kenny" "ascities" "disaggregate" "Burleson"
    "mesothelium" "Shen" "motility/directionality" "motile/less" "I-coated"
    "Euclidean" "mesenteries" "PAK1-3" "COLL" "DSBS" "co-fractionated"
    "I-induced" "SMC1-pS957" "Kruppel" "dihydroethidium (DHE)"
    "dihydroethidium" "IHA" "3.9/4.0"
    "selectively cause mitochondrial DNA DSBs" "Retroviruses"
    "the rare autosomal recessive disorder Ataxiatelangiectasia"
    "Ataxiatelangiectasia" "MELAS" "ATFS-1" "MTS-" "ATM-pS1981" "P = 0.009"
    "n = 6" "n = 4" "P -value" "31/127" "UV index ≤5" "Breslow" "acral" "LMM"
    "maligna" "around codon" "≤5" "n=9" "=40" "≥3" "P =0.03" "GeparSixto"
    "Angulo" "Gonzalez" "Arun" "Huzarski" "6p22.3" "3q29" "2q32.2" "0/14"
    "= 0.004" "= 0.008" "PAM50" "non-mutated" "kd" "heterotrimer" "6-month-old"
    "12-month-old" "24-month-old" "OARSI" "OA" "5 × 10" "AMPK α 2"
    "re-establish" "co-immuno-precipitated" "simplest" "PARP-1 binds"
    "-quadruplexes" "concomitance" "phosphoacetyl" "DNAseI" "DNaseI" "FB1329"
    "re-entry" "PARP-1binds" "/ME1a1" "quadruplex" "siGFP" "IEGs" "IEG"
    "polymerase-1" "ARTDs" "ation" "co-regulators" "YQL" "GZ" "Minichromosome"
    "xenograte" "A:MCM2" "andDbf4/Cdc7" "heterohexamer" "Rembrandt"
    "Four independent external microarray datasets" "minichromosome"
    "WebArrayDB" "n = 3" "n = 2" "n = 4" "n = 9" "= 27" "H-bonds" "LigandFit"
    "UniProtKB" "Benn" "quassioides" "Picrasma" "picrasidine" "poses"
    "Database@Taiwan" "TCM" "Leigh" "finally increased cIMT" "the former ones"
    "the most significant ones" "RMR/FFM" "HOMA" "severe IMTG" "RMR" "cIMT"
    "IMTG" "NAFLD" "Sirtuin (SIRT)" "Sirtuin" "P = 0.038" "P = 0.001"
    "P = 0.03" "= 0.07" "P = 0.035" "P = 0.01" "= 0.007" "P = 0.003" "= 0.0001"
    "= 0.05" "mg/L" "AMP/adenosine triphosphate" "monophosphate"
    "Background/Aims" "only non-affected villi" "chorionic villus" "villi"
    "villus" "12p" "isochromosome" "Pallister" "tetrasomy" "Goltz"
    "sclerotherapy" "centile" "cutaneous edema" "cesarean"
    "other pediatric subspecialists" "subspecialists" "neonatologists"
    "polyhydramnios" "G2P0" "Alomari" "fibroadipose" "CLOVES" "#24"
    "heavily treated mCRPC" "highly treated lethal ERGpos mCRPC" "PCC"
    "euroendocrine" "#22" "ERGneg" "Michigan" "ERGpos"
    "heavily-treated lethal mCRPC" "pos" "neg" "mCRPC" "supernumerary 8q24"
    "formtumours" "Progenetix" "co-gain" "8q24" "siMYC" "siPVT1" "siPvt1"
    "siMyc" "gain(Myc, Pvt1, Ccdc26, Gsdmc) mammary epithelium"
    "phospho-ERK1/2" "The mammary epithelium" "MMTVneu"
    "approximately 2 megabases" "megabases" "8q24.21" "n = 3" "+ 2" "= 7"
    "n = 10" "fromTsc2 +/+" "SynICre" "synapsinI" "NuPage" "+4" "2 +" "Hoffman"
    "the exact tumor subsets" "MARK1/4" "Gyorffy" "algorithm (CONEXIC)"
    "11q23.1" "hDIXDC1" "nonMet" "ofKras" "Wnt5a/b" "to 14-3-3" "oligos" "Pfam"
    "other eukaryotic proteomes" "AMPKR" "intravasate" "ortholog" "Contreras"
    "endometrium" "non-phosphorylatable" "1  +" "~25%" "multienzyme" "212LN"
    "EOL1" "HFF" "NADPH/NADP +" "Shan" "NADPH/NADP+" "non-distinguishable"
    "K→R" "rACAT2" "dehydrogenases" "CL-6B" "IEF" "K76/294Q" "NAM+TSA"
    "phosphogluconate" "n=4" "n=15" "XY" "JZ" "MZ" "JF" "XZ" "usual UC"
    "nonrandom" "perhapsdue" "non-SCC" "Azzopardi" "patternless" "prostatomy"
    "cystectomies" "TURBT" "cystectomy" "gallbladder" "bi-directional Sanger"
    "NEEC" "Deiry" "El" "−164" "C/EBP" "transducer" "Browser" "UCSC"
    "HumanMethylation450" "BeadChip" "Infinium" "pCMV" "Jeghers" "Peutz"
    "=0.038" "=16" "=21" "P=0.005" "P=0.01" "pGL3 Basic" "Melton"
    "pGSK-3beta-ser-9" "ANCOVA" "Nadri" "Lesort" "Kozlvosky" "Gould" "Sarno"
    "Roh" "Menton" "Klein" "pGSK-3β-ser-9" "cingulate" "= 0.006" "= 0.003"
    "Chang" "Rando" "Yao" "Guarani" "Khanna" "Menghini"
    "senescent HUVECs almost completely removed H4K16Ac" "H4K16Ac" "H3K9Ac"
    "H4K16" "-844G" "-844A" "Hultman" "CPAI" "LCCA" "PWV" "vascular dilations"
    "dilations" "Lieb" "Brodsky" "Tg" "SIRT" "3-month-old" "22-month-old"
    "Hoechest" "underwent carotid endarterectomy" "endarterectomy" "Zu"
    "Gorenne" "Stein" "Mattagajasingh" "Potente" "Sinclair" "Haigis" "Finkel"
    "sirtuins" "Guarente" "Colman" "Kortlever" "Tjarnlund" "Kaikita" "Eitzman"
    "Comi" "Cesari" "Yamamoto" "Schneiderman" "Craen" "Bai" "Komuro" "Minamino"
    "Lakatta" "Crohn’s" "Germline" "Transducer" "5/5" "4/5" "utero"
    "non-stimulated" "arisen" "3 yrs" "coeliac" "yrs" "Polyendocrinopathy"
    "Enteropathy" "T1D" "polyautoimmune" "emphasise" "Hyper" "n=63"
    "methylomes" "non-NF1" "qMSP" "17q"
    "MPNSTs commonly display complex karyotypes" "karyotypes" "ought" "= 28"
    "= 16" "= 12" "n = 15" "= 27" "= 21" "n = 44" "9p" "= 0.014"
    "chaperone/co-chaperone/client" "Eukaryotic proteomes" "proteomes"
    "co-evolve" "antiparallel" "continuum" "much larger multiprotein"
    "co-chaperone/client" "Genomes" "fold-specific co-chaperones" "FBXO24"
    "Kelch" "R2TP" "Virtually all eukaryotic genomes"
    "The quantitative readout" "even some co-chaperones" "cochaperones"
    "Hsp90/client" "handoff" "homologous co-chaperones" "OSBP/FKBP36" "OSW-1"
    "ORPphilin" "ORPphilins" "drug/target"
    "the highly homologous co-chaperone FKBP36" "FKBP36" "interactomes" "MYND"
    "FKBPs" "co-purifying" "chaperone/client"
    "the best computational algorithm" "≥0.85" "≥0.5" "AvgP" "≥7"
    "Co-chaperones" "CHORD" "Trepel" "co-chaperone" "LUMIER" "co-chaperones"
    "S5C" "S4E" "S3D" "S3C" "S2E" "S2D" "S1E" "S1C" "centriole" "anaphase/G1"
    "phosphopeptide" "anaphase-like" "laevis" "co-purification" "midzone"
    "co-purified" "Mis18β" "Mis18α" "non-functional" "= 10" "Italians" "21/65"
    "2/15" "BRCA1 /2-" "15/80" "endometroid" "hom" "and 1b" "CGGs" "POA/OPOI"
    "Israeli" "Verhoog" "Dutch" "some homozygous BRCA1 /2 mouse homologs"
    "OPOI" "CGG" "= 0.21" "= 0.65" "9/80" "= 26" "BRCA1/2" "non-cancer"
    "BRCA1 /2" "hetero-" "hetero" "proteome" "leverages" "-hydroxyl"
    "estimateK" "congeners" "diiodophenyl" "unique interaction site topologies"
    "ΔSASA " "ΔSASA" "topology" "−3.4±0.5" "showingK" "p85α" "Box-like" "Eq"
    "approximateK" "fluorophore" "theK" "Prusoff" "Cheng" "estimatedK" "anIC"
    "aK" "POGO" "ITC" "calorimetry" "IDCL" "interdomain" "allosterism"
    "topological and molecular descriptors" "descriptors" "= 130" "co-crystal"
    "N  = 4" "and 2HG" "hrs" "3hr" "chemo/radiosensitivity" "2HG"
    "hydroxyglutarate" "hydroxylases" "methylcytosine" "αKG" "KG" "co-deletion"
    "E6/E7" "immunotherapies" "bronchio" "SqCC" "CC-10" "clara"
    "esthesioneuroblastomas" "15 mg/kg" "littermate" "dyspnea"
    "three publically available NSCLC datasets" "GEMMs" "GEMM" "C57BL/6J"
    "postdoc" "ZY" "cardiomyoblasts" "human diabetic corpus cavernosum"
    "DAF-2DA" "expression/activity" "cavernosum" "p38 mapk" "acetylcholine"
    "Diaminofluorescein" "Dihydroethidium" "p38mapk" "C57BL/6 J"
    "lymphoblastoid" "heterochromatic DSBs" "hNSCs" "KChip"
    "6-diamidin-2-fenilindolo" "RADAR" "hNPC" "MACA" "subdiploid"
    "their respective proliferating hNPCs" "Hz" "sIPSCs" "sEPSCs" "=13" "pA/pF"
    "tetrodotoxin" "KChIP" "KChIPs" "hNPCs" "embryoid" "mesoderm" "endoderm"
    "ectoderm" "Tra-1-81" "Oct3/4" "only Ctrl and A-T hiPSC" "neuropathology"
    "hiPSC" "hiPSCs" "Purkinje" "cc" "III+/microtubule-associated protein 2+"
    "non-essential" "±2" "n =10" "nonmitochondria" "K487Q" "K65/160R"
    "NLS-HA-K65/160R" "NLS-HA-K65" "PML6" "K487/515R" "PML4" "nonhistone"
    "deacelylate" "Sirtuins" "pcDNA3" "pcDNA 3" "anti-acetyl-lysine"
    "expression/activation" "upregulation/activation" "8/10" "extrauterine"
    "shAR" "shCTRL" "myometrium" "midterm"
    "a model whereby nuclear PFKFB3-synthesized F2,6BP"
    "a pharmacodynamic endpoint"
    "3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one" "pyridinyl" "3PO" "APC/C"
    "K/R" "kinase:phosphatase" "F6P" "an essential coupler" "coupler"
    "The homodimeric bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFB)"
    "fructose-2,6-bisphosphatases" "co-siRNA" "F2,6BP"
    "6-phosphofructo-1-kinase" "2 N" "2n" "G 0 /G 1" "/R" "metastais"
    "chaperonin" "T-complex" "microvessel" "cell cycle/death" "DeCyder"
    "unclose" "SW480/miR-29b" "EmGFP" "non-cancerous" "EGAPP" "Let-7c"
    "Cappuzzo" "Pichler" "Sebio" "internalization/degradation" "Razis"
    "nonresponsiveness" "Karapetis" "Prenen" "MHRA" "Sclafani" "TEGAFOX"
    "Bartolomeo" "Russo" "Saridaki" "PICCOLO" "OPUS" "events/molecules" "Feliu"
    "Custodio" "A-loop" "Vectibix" "ZJ" "cardia" "=0.046" "TCP"
    "adenomatous polyposis coli (APC)" "coli (APC)" "coli" "TEADs" "1/2"
    "protein kinase 1/2" "EGJ" "AEG" "= 0.033" "P = 0.004" "± 2" "± 1" "=0.037"
    "= 16" "P = 0.002" "=0.008" "= 0.019" "feedforward" "iKRas" "three/five"
    "Subsequent necropsy" "p16sh" "o" "S807/811"
    "the functional status/activity" "p16shRNA" "p16 shRNA" "Bera" "E6E7"
    "G12D" "Leung" "PanIN" "HPNE" "NOD/SCID" "12D" "=180" "5A4"
    "either pure mucinous or mixed mucinous/nonmucinous" "=0.85" "=0.089"
    "non-mucinous" "=0.019" "=0.032" "predominant subtypes/mucinous"
    "Nonmucinous AIS/MIA" "nonmucinous AIS" "=0.011" "predomiant"
    "2 nonmucinous AIS" "No mucinous or mixed mucinous/nonmucinous AIS" "AIS"
    "mucinous/nonmucinous" "colloid" "ERS" "ATS" "IASLC" "G→A" "G→C" "G→T"
    "≥50%" "=0.18" "=130" "=0.055" "=0.012" "=0.001" "P =0.009" "P =0.002"
    "co-regulator" "Brg" "myoepithelium" "FBXL11"
    "a strong co-localization 6 hr" "and 1.7±0.9-fold" "pipet" "x" "LNM"
    "especially E2Fs 1- 3" "Demethylase-1" "re-assessment" "G-phase" "MEPCs"
    "MEPC" "methylation/demethylation" "H3K27" "co-repressors" "anti-Rabbit"
    "= 28" "normal/benign" "24 hr" "1- 3" "stemness" "chemo-" "shRNA3"
    "shRNA-3" "shRNA-1" "5-8F" "SUNE-1" "Italiano" "negative/weak" "LMS14"
    "SHCL" "topologies" "UHCL" "sirtuin" "P  = 0.004" "N  = 10" "N  = 44"
    "Sakurai" "Cha" "neovasculature" "nonsteroid" "Egger's" "Egger" "~20.08"
    "SABC" "prostaglandins" "CINAHL" "Cochrane" "= 0.78" "= 11"
    "documentedEGFR" "L858R/T790M" "intercalates" "erlotinb" "I/II" "Garcia"
    "erltoinib" "elrotinib" "ED" "Ty" "diaminobutyl" "acridine" "erythematosus"
    "sub-IC 50" "H1975" "H1993" "Talalay" "Chou" "wtEGFR" "n = 5" "JMEN"
    "Friboulet" "heterozygous +/+ 6 bp" "showing 3R/3R genotype" "and 3R"
    "Arévalo" "Arvealo" "Hu" "3RC/3R" "/3R" "2R/2R" "Bukhari" "and 2R/3R"
    "to 2R/2R" "2R/3R" "heterozygotes" "3R/3R" "multicenter" "Mlak" "Sohn"
    "Kumar" "Dotor" "Stoehlmacher" "Uchida" "Kawakami" "Mandola" "TSER"
    "1494del6" "Tiseo" "methylTHF" "methyleneTHF" "Ceppi" "Hanauske"
    "Chattopadhyay" "GARFT" "glycinamide" "thymidyne" "multitarget" "Saleh"
    "Zheng" "Scagliotti" "Sibilot" "Moro" "Sculier" "Dela" "non-squamous"
    "VNTR" "homozygotes" "non-randomized" "YSL" "KTH" "NHBE" "zeste" "shG9a"
    "pTRIPZ" "de-phosphatase" "an autophagic sequestration blocker" "blocker"
    "methyladenine" "obvious vacuoles" "Fu" "affymetrix" "U133"
    "Biotin-labeled" "≥ 1.5-fold" "non-apoptotic" "Arab" "Arg / Pro72"
    "Indians" "Europeans" "Southern Brazil" "Brazil" "Greece"
    "status/polymorphism" "Arg / Pro 72" "Arg/Pro72" "ae" "139pb"
    "Polymorphisms (SNP)" "Pernambuco" "Recife" "BRCAness"
    "present heterozygous genotype" "rs1042522" "CAG / GGN" "Caribbean" "foeto"
    "≤ 22.5" "≤ 22" "≤23" "≤22.5" "Aruna"
    "two functionally polymorphic microsatellites" "Xq11-12" "microsatellites"
    "hirsutism" "amenorrhoea" "≤22" "RSAs" "Ningxia" "CAG/GGN" "ZL"
    "Non-functioning" "Follicle" "a progressive regrowth" "regrowth" "Moshkin"
    "spearman’s" "spearman" "Colao" "Knosp" "non-functioning" "Spearman's"
    "D2R" "= 0.021" "= 44" "non-small" "ALL2000-" "immunophenotypes" "MsigDB"
    "yr" "4-year" "Youden" "ALLR2006" "ALL2000" "BFM" "Pediatrica" "Oncologia"
    "Ematologia" "Italiana" "Associazione" "WBC" "MRD" "AIEOP"
    "immunophenotype" "P=0.035" "N=10" "N=9" "=0.003" "=0.004" "P=0.002"
    "antibody/inhibitor" "copGFP" "MTGreen" "MitoTracker" "ΔΨm" "1~4" "CQ"
    "co-transfecting" "Mcpt" "retro" "DBA/2" "-KD2" "KD2" "KD1" "ITD" "pY507"
    "leukemic proerythroblasts" "proerythroblasts" "aggressive SM" "SM"
    "CD45 +" "microdomain" "CAAX" "Drosopoulos" "duplexes" "Shankavaram"
    "a modest growth inhibition ~20-80%" "~20-80%" "OCCAR" "NCI60" "dulanermin"
    "24-hour" "& E" "100 ng/mL" "co-existence" "71/80" "pcDNA3.1-c-Myc"
    "miR-135b" "co-occur" "stressful" "pentamer" "co-occurrence" "tumor/normal"
    "rs3093077" "rs1205" "rs7553007" "rs3091244"
    "a major human acute phase reactant" "reactant" "p  = 0.04" "predilects"
    "IPMs" "Hisaoka" "Weiss" "etal" "hilar" "perinuclear vacuoles" "Codon"
    "n=5" "n=11" "desmoid" "trichrome" "Masson" "congeries" "hemosiderin" "=11"
    "mild nuclear atypia" "hyperchromasia" "Perinuclear vacuoles" "vacuoles"
    "hilum" "a thin fibrous pseudocapsule" "pseudocapsule"
    "matted lymph nodes underwent core needle biopsy" "catheter"
    "inguinal lymphadenopathy" "lymphadenopathy" "present-day" "XIIIa"
    "characteristic stellate" "myoid" "amianthoid" "IPM"
    "8 (mean,2; median, 1) mitotic figures/50" "=15" "fascicles" "n=1"
    "Possible trauma/injury" "=6" "n=8" "=5" "n=3" "n=10"
    "the unfavorable genotypes" "an unfavorable genotype" "399Arg/Arg"
    "a favorable genotype" "8092Ala/Ala" "Cys8092Ala" "8092 Cys" "8092Cys"
    "8092Ala" "≥20" "hydroxydeoxyguanine" "399Gln/Gln"
    "nitrosamine 4-(methylnitrosamino)-1-(3-pyri-dyl)-1- butanone (NNK)"
    "butanone (NNK)" "NNK" "butanone" "methylnitrosamino" "more proficient DRC"
    "399Arg" "399 Gln/Gln" "399 Gln" "1.031–3.438" "399 Arg/Arg" "399 Arg"
    "Arg399Gln" "IVA" "polymorphyme" "inducing inefficient DRC" "399Gln"
    "a well-studied single nucleotide polymorphism (SNP)" "polymorphism (SNP)"
    "DRC" "Polymorphisms" "treatmen" "non-smokers" "2–3" "P  = 0.002" "= 0.047"
    "pack-years" "non-metastatic" "Johansson" "Kashiwagi" "Nielsen" "HRs"
    "TNBCs" "CK5/6" "NHG" "Nottingham" "BLBC" "Lehnmann" "PR+" "≥10" "≥25%"
    "= 0.04" "P  = 0.03" "= 0.007" "= 0.008" "= 0.07" "non-TNBC"
    "-D-ribofuranoside (AICAR)" "XTT" "edulis" "Phyllostachys" "ribose (AICAR)"
    "Huntington's" "Huntington" "iNOS" "ENERGI" "Anti-inflammatory" "mg/mL"
    "anti-inflammation" "YW" "EAW" "HU" "DDN" "proper re-starting"
    "di-methylation" "MRN" "Ku" "H3K36" "PEC" "Trithorax" "var" "Enhancer"
    "re-start" "ZX" "exon 12" "insertion/deletion" "1234_1235insTTGTC"
    "the previously reported c" "_1223del" "1179_1230del"
    "the bi-directional Sanger" "bi" "poolings" "12/Exon14" "T/c" "K549I" "C/c"
    "M532V/E543G" "erythremia" "akaline" "carboxyhaemoglobin" "Dameshek"
    "_1230del" "_1223del/c" "_1235insTTGTC" "Ph" "Philadelphia" "JAK2 V617F"
    "tumor microenvironment/vasculature" "Karim" "ClinicalTrials" "dasatinb"
    "ER+BC" "NeuT" "CRs" "PyMT" "dasatininb" "rapaplog" "24hr" "HR+" "rapalog"
    "co-activation" "= 2" "rtTA" "holo" "RNAPII" "Kasper" "heptapeptides"
    "paclitaxol" "trimethyl" "enhancers" "non–specific" "anti–rabbit"
    "anti–mouse" "B5/589" "quadruplexes" "8-oxo-dGTP" "18d" "shGFP/shMTH1"
    "KRASV12/MTH1" "KRASV12/pBh" "pBh" "oxoG" "KRASV12" "a retroviral
KRASV"
    "KRASV" "pBn" "pBABE" "tAkt" "shLuc" "hyclate" "plko" "shMTH1-" "shMTH"
    "shGFP-" "shMTH1" "shGFP" "oxoguanine" "HRASV" "transversions" "Nox"
    "sanitizes" "200X" "~ 50%" "vis-à-vis" "2 vs" "n=7" "S1D" "Q-mediated"
    "Kimmelman" "DMKG" "GOT" "AOA" "aminooxyacetate" "BJ" "Q-deprived"
    "Q-induced" "non-G1" "hr" "re-enter" "heterdimer" "di-Ub" "regulatd"
    "phorsphorylate" "heteromider" "UEV1B" "-Luc" "shUEV1-1" "shUEV1" "BALB/c"
    "TissueScan" "PCT" "UEV1C" "LN2B" "Uev1s" "Uev1C" "Uev1B"
    "polyubiquitinate NF-κB essential modulator/inhibitor" "a unique Ubc/E2"
    "bacterial lipopolysaccharides (LPS)" "lipopolysaccharides" "20q13.2" "Ub"
    "κB" "кB" "S6A" "S5E" "S5D" "S5A" "10/10" "LN3" "100 ng/ml" "/E"
    "hypoinsulinaemia" "plantaris" "Forkhead box O3a" "∼30%" "hoc"
    "non-phospho-4EBP1" "UNK" "∼40%" "arterio" "non-insulin" "72-hour-fast"
    "of β-actin" "= 0.048" "p = 0.005" "∼25%" "∼100%" "∼10%" "∼50%" "Teperino"
    "Warburg-like" "knowlwedge" "Dhh" "#2" "PLKO" "knowlege" "±1" "+++" "#1"
    "2N" "colorectum" "the human rectal mucosa" "normoglycemic littermates"
    "littermates" "their normal rectal mucosa" "normal appearing rectal mucosa"
    "rectal mucosal biopsies" "p=0.005" "Ovt/Ob" "WHR" "hyperinsulinemia"
    "TUNEL" "IR-A:IR-B" "colonoscopy" "normal rectal mucosa" "Hyperinsulinemia"
    "p=0.06" "=0.005" "p=0.01" "necropsy" "mg/kg/d" "anti-pancreatic"
    "AsPC-1 cells" "SP141’s" "-9H-pyrido" "6-methoxy-1-" "Biacore" "pyrido"
    "SP141" "AsPC-1cells" "pancreata" "pediatric GGs"
    "four nonmetastatic adult GGs" "nonmetastatic GG" "Koelsche" "strong VE1"
    "nonsupratentorial GG" "10 nonbrainstem pediatric GGs"
    "12 pediatric brainstem GGs"
    "the additional four adult non–cerebral hemispheric GGs" "22 pediatric GGs"
    "nonbrainstem" "four adult non–cerebral hemispheric GGs" "non–cerebral"
    "adult nonsupratentorial GGs" "holocord" "Postmortem" "BRST" "cribriform"
    "pontis" "paresthesias" "mastectomy" "BioCare"
    "cervicothoracic spinal cord GG" "brainstem" "anaplastic GG" "binucleate"
    "dural" "parenchyma" "leptomeninges" "Magendie" "Luschka" "foramina"
    "chiasm" "dorsum" "dura" "serosa" "pericardium" "omentum" "premortem"
    "pontine" "fossa" "begun" "diplopia" "IDH-1" "Miami" "HistoBioTec"
    "Carpinteria" "DAKO" "Tucson" "predilute" "glomeruloid" "Biopsy"
    "nonsupratentorial GGs"
    "an additional four nonmetastatic adult nonsupratentorial GGs" "VE1"
    "The 27-year-old underwent two biopsies" "immunohistochemistry (IHC)" "GGs"
    "Merkel" "#4" "mature and immature eosinophils" "4q12" "IHES"
    "eosinophilia" "eosinophil" "eosinophils" "hypereosinophilia" "TFF1-" "TFF"
    "PTT5" "the mammary epithelium" "Buache" "gastric dysplasia" "rs2293152"
    "kg/m 2" "mmol/L" "NCEP" "WC" "dyslipidemia" "Guangzhou" "Nanfang"
    "rs8069645" "GG" "French" "Catherine" "Argentina" "Aires" "Buenos"
    "Genomatix" "rs4796793" "the online microRNA target prediction tool RNA22"
    "RNA22" "the homozygous CC genotype" "heterozygote"
    "sterol regulatory element binding protein 1c" "rs957970" "rs1053005"
    "tagSNPs" "year-old" "p = 0.04" "= 0.17" "p = 0.002" "= 0.51" "= 0.001"
    "= 0.47" "= 0.40" "p = 0.02" "antibiofilm" "Mumbuc" "Oncel" "Gujrathi"
    "Katori" "severe dysplasia" "dihedrals" "RMSF" "ZDOCK" "multivariant"
    "univariant" "urethra" "ureter" "procaspase-3" "Finland" "Vantaa" "Thermo"
    "microplate" "formazan" "Nevada" "Vegas" "GeneDireX" "-AGTGA" "AGTGA"
    "MDBio" "using Costar Transwell" "Albany" "Bethesda" "densitometer" "Tokyo"
    "Fujifilm" "PBST" "-dichlorodihydrofluorescein"
    "dichlorodihydrofluorescein" "Manassas" "Pharmingen" "/Tyr 185" "Danvers"
    "Cruz" "Dulbecco's" "Gibco" "Lipofectamine" "MEM" "OPTI" "Aldrich"
    "antiseizure" "7-methoxy-8-" "monnieri" "Cnidium" "AGP-treated HCAECs"
    "transcription factor-κB" "carotid" "neointima" "HCAECs" "glycerophosphate"
    "alkyl" "Kit-8" "cervical squamous intraepithelial dysplasia/neoplasms"
    "HPV-positive Warthin's" "Warthin" "Hodgkin" "Africans" "adenoid"
    "mucoepidermoid" "7/51" "30/51" "14/51" "parotid" "uteri" "n =2" "=45"
    "and 3+" "2–3 µ" "=4" "n =3" "=17" "Co-IP" "supernatant" "S117A/S117E"
    "multimers" "dimmer" "Bismaleimidoethane" "BMOE" "bismaleimidohexane"
    "sulfahydryl" "SB-218078" "GKW" "ACS" "UQL" "RMM" "DIL" "Polymorphism"
    "antagonistic pleiotropy" "pleiotropy" "viral progeny" "lifecycle"
    "viral genomes" "odorant" "FxxA" "the simian primate dataset" "hidden"
    "Tajima" "Kreitman" "McDonald" "subspecies" "all synonymous SNPs"
    "Australia" "Disease-associated SNPs" "simpler" "clade" "dN/dS" "PAML"
    "dN/dS " "dS " "dS" "available genome" "several unique polymorphisms"
    "examining BRCA1 polymorphisms" "mulatta" "bonobo" "paniscus" "bonobos"
    "n = 44" "SMU" "MJH" "UC" "isoenzyme" "iso"
    "the mesenchymal cell line SW-1710" "malignomas" "CUB1"
    "the urothelial carcinoma cell lines SW-1710" "VM" "SW-1710" "UCCs" "UCC"
    "multiprotein" "acetylome" "transcriptional co-repressors" "HdaI"
    "orthologues" "non-muscle" "WMG" "JPC" "DJB" "DPOC" "JXP" "PCOL" "Tween"
    "Dulbecco’s" "MDACC" "Dulbecco" "DMEM" "diammonium" "an aggressive subset"
    "S2C" "ERE" "S2A" "non-targeting" "change (FC) = 1" "Univariate"
    "subcohorts" "BCSS" "diaminobenzidine" "REMARK" "PRDX1/2" "= 0.009" "= 1"
    "= 0.003" "P  = 0.002" "= 0.59" "= 0.005" "= 0.05" "= 0.001" "= 0.004"
    "= 0.61" "95% CI " "= 0.40" "= 0.62" "viremias"
    "lethally hypermutated viral genomes" "the proviral genome" "nonacute"
    "misincorporations" "C2env-nef -3" "the entire C2env-nef -3" "LTR" "C2V5"
    "the viral genomes" "the viral genome" "ISLA"
    "the persisting viral genomes" "reemerges" "= 45" "2V" "depicture"
    "expressingKRAS" "activeBRAF" "inBRAF" "toBRAF" "= 0.004" "n = 7"
    "Micelles" "Sansom" "SxxxS" "GxxxG" "SxxxA" "Hristova" "sidebands" "drawn"
    "Alexa" "KALP" "WALP" "acyl" "DMPC/DMPG" "Helix" "POPC/POPS" "a 10:3"
    "kcal/mol" "McLaughlin" "dipole" "germanium" "μs" "kHz"
    "Varian Infinity-plus 500, 600, and 700 spectrometers" "Palo"
    "spectrometers" "fluorescense" "Alexa568" "micelles" "peptide/lipid"
    "Hitachi" "DMPC" "Bilayers" "synthesizer" "-octyl-β-" "thiazolidine"
    "CRLRSPPKKGLGSPTVHKISRFPLKRC" "DEAGSVYAGILSYGVGFFLFILVVAAVTL"
    "formic acid/water" "propanol" "VVA" "VGFFL" "RRAGSVYAGILSYG" "Eugene"
    "Avanti" "DMPG" "Kyoto" "Tesque" "Nacalai" "Hiroshima" "Wastanabe" "Osaka"
    "Andover" "Cambridge" "bilayer" "Crouzon" "A391E" "bilayers" "Kuriyan"
    "subdomain" "subfamilies" "Fourier" "CoMFA" "and 2i" "cyan" "Cyan"
    "-indol-3-yl" "2aa" "2ab" "non-active" "2v" "the less active compound 2ad"
    "2ad" "the indol-3-yl substituent, and compound 2ah" "2av" "hydroxymethyl"
    "2ah" "isopleth" "methoxymethyl" "isopleths"
    "The highly active compound 2aw" "2aw" "ofR" "whenR" "Fischer" "splittings"
    "accountQ" "LOO" "2ap" "bulky substituents" "ionic" "2az" "and 2aa"
    "Angle2 " "Angle1 " "Angle2" "Angle1" "-C3-C4" "″-C4-C5" "benzofuran-3-yl"
    "propeller-like" "pyridinophane" "macrocyclic pyridinophanes"
    "pyridinophanes" "/IC 50" "heteroatoms" "heterocycles" "indol-3-yl"
    "the heterocyclic substituents" "heterocyclic substituents" "yl" "indol"
    "2OW3" "RMSD" "MCMs" "non-cyclic" "goodQ" "CoMSIA" "QSAR" "substituents"
    "derivates" "= 2" "= 6" "= 40" "= 52" "= 44" "vital HSV-1"
    "the viral p53RE" "Factor-1" "TAATGARAT" "pLucMCS" "a viral genome"
    "Abmurine" "GCCCTGACGTGTCCCC" "human immunodeficiency virus-1"
    "only three other conserved p53RE" "TGCCTTGCCTGGACTTGCCTGGCCTTGCCTTT"
    "AATC" "TTTGCA" "CAGG" "TATacaagctAAA"
    "subsequently recruiting diverse transcriptional co-regulators" "Renilla"
    "non-p53RE" "the homologous p53RE-L" "protomer" "PAb1801-induced" "DO-1"
    "CTG" "TCTAAG" "ICP47" "Barr" "Epstein" "CTT" "CGATG" "CGCggaccGGT"
    "GCCcttGCA" "CAAG" "T/A" "RRR C(A/T)(T/A)G YYY" "spacer" "YYY" "Maruzuru"
    "the essential viral DNA replication protein ICP8" "ICP8" "oncogenec"
    "~152-kbp" "p53RE" "KOS" "HSV-1" "p53RE-S" "p53RE-L"
    "herpes simplex virus-1" "ori" "non-denaturing" "co-transfections"
    "co-localizes" "co-associate" "follicle" "Anti-CD133" "Immunogold"
    "anti-CD133 treated placodes" "IFTEM" "co-stained" "more mature placodes"
    "Venn" "Bolos" "pentaspan" "downgrowth" "placodes" "placode" "20s" "Zack"
    "the femoral condyle" "condyle" "Pfirrmann" "AFs" "anti-rabbit"
    "anti-mouse" "IRDye" "VYQP" "neoepitopes" "a fibrillar meshwork" "meshwork"
    "meniscus" "V+I10" "pulposus" "VRAA" "neoepitope" "isintegrin" "=10" "n=2"
    "=8" "GCLS" "oxphos" "Succinate" "Warburg’s" "HRMAS" "OXPHOS"
    "oxoglutarate" "fumarate" "fructose-2,6-bisphosphate" "hexokinases"
    "myoinositol" "stereoisomer" "cysteinglycine" "scylloinositol"
    "hydroxybutyrate" "acétylaspartate" "HPTLC" "GCFS" "co-varied" "LXSN"
    "metabolome" "sdha/c" "idh1/2" "succinate" "pACCA" "Warburg" "= 0.005"
    "p = 0.01" "= 0.001" "LBD/hinge" "simultaneous activation/expression" "DOX"
    "22Rv-1" "AR-V7/pHage" "AR-V7/pLenti" "co-regulated" "protein A1"
    "carboxyl" "RP11-144N1.1" "16q" "1201bp" "Ensembl" "pseudogene" "Canada"
    "Biotek" "Norgen" "ASK00420" "TI09485" "TI22687" "TI18318" "TI21327"
    "TI18382" "TI10124" "TI13831" "TI17313" "subnetwork"
    "inducing genome-wide re-targeting" "RVM" "Affymetrix" "Transcriptome"
    "HEIH" "EBIC" "H3 lysine" "Saharan" "lifespan" "invitro" "at 5p15.33"
    "Rs401681" "= 0.59–0.93" "5p15" "5p15.33" "CT/TT" "rs2736098" "homozygote"
    "CC" "rs401681" "LDR" "= 0.05" "= 0.61" "95% CIs" "= 0.009" "= 0.59"
    "95% CI  " "SSCloAldebr" "expression/function" "Dorsopmorphin"
    "RASSF1C/IGFBP-5" "RASSF1C/ IGFBP-5" "BA anti-proliferative" "PIWILI"
    "progeny" "RASSF1C/" "PIWIL" "Hiwi" "Piwil" "BA" "RASSF1C" "stem cell-like"
    "MAH" "Dual synergism" "synergism" "Weisenberger" "Newer"
    "all the available biopsies" "region/country" "Israel" "codon 13"
    "codon 12" "AJCC" "216/755" "unremarkable colorectal mucosa" "reconfirm"
    "19/757" "Clinico" "workup" "Davies" "Vaughn" "sessile" "caner"
    "benign (adenoma) neoplastic epithelium" "blown" "Vogelstein"
    "familial hereditary colorectal cancers especially Hereditary non polyposis colorectal cancer (HNPCC) syndrome /Lynch Syndrome (LS)"
    "/Lynch Syndrome (LS)" "Arabia" "Saudi" "CIMP" "non-KRAS" "offs" "ie"
    "Douillard" "G12A" "exome" "the less frequently mutated codon"
    "TheraScreen" "cobas" "12A" "has-mir-203a" "caspase-3/7"
    "a public human prostate cancer dataset" "Taiwan" "Taipei" "RasG37" "WB"
    "Sloan" "RasG" "SNAI1/2" "C/activator protein 1" "miR-203-" "cyclotherapy"
    "covariates" "the latter study p53 mutations" "= 63" "= 44" "non-matched"
    "56/142" "88/258" "59/142" "81/258" "codons" "p53 Mutations" "=52" "=49"
    "Marsden" "108/273" "122/418" "Texas" "non-matched-therapy" "P53 mutations"
    "p53 mutations" "p53mutations" "≤40" "= 0.15" "= 1" "=9" "ABCSG"
    "preoperative biopsies" "foresaw" "QALYs" "QALYS" "preoperative biopsy"
    "Linz" "Schwestern" "Barmherzige" "Krankenhaus" "priori" "Austria"
    "MammaPrint (MP)" "Gallen" "TargetPrint" "MammaPrint" "MDT" "multigene"
    "=14" "++" "PgR +" "ER +" "reboot" "LBD" "hypothesise" "E-domain"
    "biliverdin" "sulphydryl" "SFFV" "apoptosis-like" "CuPP" "ZnPP"
    "sensitises" "overdoses" "shNrf2" "-BHQ" "BHQ" "glutamyl" "recognises"
    "-arabinofuranoside" "arabinofuranoside" "anthracyclins"
    "Nuclear/cytoplasmic" "oxygenase-1" "co-administration" "ascidians"
    "notochord" "Kilic" "cylcin" "monolayers" "Brachyury-" "ELDA"
    "colonospheres" "quiescent-like" "Brachyury" "Table 1" "MetaCore" "ZMP"
    "-Monophosphate" "Monophosphate" "AMPKα2" "Luc" "peptidases" "Grasso"
    "CRPC" "destabilizers" "pT288" "soft polyacrylamide ECMs" "EEEEE" "AAAAA"
    "pT288–Aurora A" "Em" "mEmerald" "plusTipTracker" "mApple" "chromatids"
    "neurites" "X1" "Massachusetts" "Titer" "Novartis"
    "an LSR II flow cytometer" "cytometer" "Invitrogen" "Midi" "Novex"
    "RSK 3/4" "Cyclin D/" "Loewe" "pPRAS" "pATPCL" "-triphosphate"
    "sensitizers" "T47DR" "naïve" "non-overlapping" "non-significant"
    "anti-aging" "E-Box" "UDM" "MYCp" "c" "CTGTTTA" "TTGTTTT" "E-box" "phTERTp"
    "E-boxes" "FOXO3aTM" "Brunet" "anti-senescence" "RGD" "FERM" "soft ECMs"
    "pEGFR" "ECMs" "hydrogels" "phosphoisoforms" "one-quarter" "brain-like"
    "kPa" "nonmuscle" "non-HLA" "colitides" "rs2234358" "mellitus" "Bonferroni"
    "dbGaP" "herpetiformis (DH)" "only SNP rs6806528" "rs6806528" "3p14.1"
    "17q21.32" "rs859665" "rs2157453" "rs859637" "6p15" "Trynka" "4q27"
    "Dubois" "gluten-sensitive enteropathy" "enteropathy" "Celiac" "10p11.23"
    "6q25" "6q15" "3p21.31" "herpetiformis" "6q22.31" "10p15.1" "1q24.3"
    "FRMD4B" "a further seven SNPs" "1.0×10" "celiac" "mSin3A"
    "non-selectively" "biomolecules" "redirects" "retromer" "only three 15-cm"
    "15-cm" "LELLSDS" "CRAPome" "bilobe" "FLAG-His-EWS-Fli-1" "BioID" "24
h"
    "m / z" "Schliephake" "Spanish" "γ2" "Lindberg" "Scandinavia" "bucca"
    "a Pearson's" "Spearman" "T1N0" "basaloid" "T-stage" "N-stage" "N+/unknown"
    "Norway" "= 1" "N = 2" "= 0.003" "p = 0.002" "= 0.033" "= 5" "= 0.021"
    "phenocopies" "the major mutational hotspot" "precisely phenocopy"
    "phosphodegron" "this region precisely phenocopy" "phenocopy" "MbI"
    "Burkitt’s" "degron" "~50%" "dependnt" "NTF2-like" "Soncini"
    "-truhydroxystilbene" "truhydroxystilbene" "RSVL" "anti-Flag"
    "coprecipitates" "isoform 1A" "RcCMVp120" "LZRS" "14-day" "7-day" "1-day"
    "4-day" "desmoplasia" "forestomach" "Lipopolysaccharide"
    "lipopolysaccharide" "cyclin dependent kinase 4/6" "Xi" "nonprotein"
    "G1/G0" "Pearson's" "Three bioinformatic algorithms" "Globo" "tetrazolium"
    "μ g/mL" "LC3BII" "RD-ES-1" "non-tumor" "technical constraints co-staining"
    "triploidy" "PTEN/centromeric" "EWS894" "MHH" "FAIRE-seq" "seq" "FAIRE"
    "co-staining" "WST-1" "Balb/c" "stellate" "T308D/S473D" "AAACA"
    "nonmalignant" "AMPK α1β1γ2" "= 6" "anti-oncogenic" "=0.009" "NuPAGE"
    "biotin" "oncogene-like" "BLS" "transcriptome" "UCA1" "μg/ml"
    "prostatectomies" "our study underwent 12 core biopsy" "CLIA" "Perhaps"
    "Trock" "= 0.035" "13/16" "65/67" "the evaluable non-upgraded" "1/6"
    "Biopsies" "non-upgraded" "Bayview" "Hopkins" "7/103" "13/71" "vs"
    "patients underwent radical prostatectomy" "apparently indolent Gleason"
    "=7" "indolent Gleason" "Gleason" "~10%" "7/7" "p = 0.01" "=0.06" "3 +"
    "Bellini" "methylcytosines" "non-CpG" "pcDNA3.1-AIF" "+303" "+306" "CCRCCs"
    "chromophobe" "Clontech" "BD" "CCRCC" "Ras" "AIFmit" "anti-FLAG" "Korean"
    "Kima" "Yoona" "Parkinson" "C/C" "Benedetti" "=1" "=2" "HapMap" "df"
    "nonresponder" "responder" "rs3755557" "rs334558" "Pairwise" "=0.03443"
    "=0.03477" "=0.07074" "antidepressivelike" "A/T" "Russ"
    "glycogen synthase kinase–3β" "Haplotype" "−1727A" "nonresponders" "T/T"
    "C/T" "Erbb4+" "release soluble Nrgs" "overexpressors"
    "hippocampal inhibitory synapses" "arachidonoylglycerol" "Yang" "mPFC"
    "Lhx6-" "Lhx" "GABAergic circuitry" "learning/memory" "Pathophysiology"
    "Hirschsprung's" "Hirschsprung" "the original Icelandic haplotype" "ACHR"
    "NRG6" "rs7598440" "DLPFC" "JMa" "three intronic SNPs" "10q22" "Jewish"
    "Ashkenazi" "SZ-associated SNPs" "rs10503929" "Four NRG1 exonic SNPs"
    "postmortem" "the Icelandic haplotype" "decreased fractional anisotropy"
    "anisotropy" "SNP8NRG221533" "SNP8NRG243177" "intronic SNPs" "IQ"
    "premorbid" "PPI" "prepulse" "PGAS" "GWAS"
    "additional SZ-associated single nucleotide polymorphisms" "8p21-p22"
    "Iceland" "Nrgs" "AChR" "nicotinc" "amygdala" "Postsynaptic D4R" "D4R"
    "Nrg1/Erbb4" "Aantagonists" "mouse cortical layers 2-3" "2-3" "VTA"
    "midbrain" "TBS" "theta" "EPSCs" "AMAPR" "AMPAR-" "AMPAR" "Schaffer"
    "Lundgaard" "OPC" "neocortex" "callosum" "forebrain" "dimain" "β1" "TACE1"
    "EGF-like" "an easily quantifiable readout" "tomacula" "hypergrowth"
    "-trisphosphate" "Newbern" "Grb2-Associated Binder-1"
    "Nrg1 Type III null mutants even large-caliber axons" "ensheath"
    "sympathetic C-fiber axons" "Remak" "axonal Nrg1 TypeIII" "TypeIII"
    "hypermyelinate" "transgenes" "sensory neuron axons" "Canetta"
    "millisecond" "Ranvier" "internodes" "PNS" "neuronal Achr"
    "mature endplates" "endplates" "Achr" "the peripheral synapse" "dendrites"
    "Nrg1/Erbb" "forebrains" "astroglia" "radial glia" "glia" "neurite"
    "Gad65+" "vGAT" "GABAergic synapses" "glutamatergic synapses" "PV+"
    "excitatory synapses" "mEPSC" "repellants"
    "excitatory and inhibitory synapses" "synapses" "Dlx" "MGE"
    "the GABAergic circuitry" "synapse" "dendrite" "Erbb"
    "an increasingly complex circuitry" "axons" "neuronal circuitry" "axon"
    "Nrg/Erbb" "neural circuitry" "circuitry" "Soane" "Hardwick" "K21/K64" "ØK"
    "K21R/K64R" "W453X" "sw" "xl" "Bcl" "SHDA" "chlorophenylhydrazone" "1–3"
    "× 10 " "/K" "mobilizer" "neuroendocrine" "p-4EBP1 and" "Table1"
    "CXCL12+RAD001" "A498/RAD 10 " "SN12C/RAD" "succinimidyl"
    "carboxyfluorescein" "CXC771" "p-4EBP1and" "11G8" "12G5" "CXCL11-" "CXCL"
    "CCX771" "rapalogs" "P38 MAPK" "non-Hodgkin" "μ g/ml" "P38MAPK" "p-P70S6K"
    "100 ng/ml" "nonpromoter" "epigenome" "chewers" "nonsmall" "Indovina"
    "amplicons" "precancerous epithelial dysplasia" "Tamandani" "Kordi"
    "histologically proven biopsies" "RFLP" "masala" "oncology"
    "healthy oral mucosa" "-alkylguanine" "alkylguanine"
    "-methyguanine-DNA-methyltransferase" "eukaryotic genome" "planus (OLP)"
    "OLP" "planus" "oropharynx" "tendu" "premalignancies" "precancer"
    "-methyguanine-DNA-methyltransferase ( MGMT )" "Krynetskaia" "Diouf"
    "non-TCF3-rearranged" "Diakos" "ATCAATCAA" "hyperdiploid"
    "the PKCζ-inhibiting PKCζ pseudosubstrate" "KASUMI" "pseudosubstrate"
    "PKCζ/λ" "nBM" "PRKMZ" "E2A" "cerebellum" "PKCiota" "PKCzeta"
    "at least 12 isozymes" "isozymes" "PKC/Mζ"
    "its constitutively active form PKMζ" "PKMζ" "only ∼65 nt"
    "HEK 293T/HeLa cells" "Chatelier's" "Chatelier" "scaRNPs" "non-abundant"
    "RRL" "∼90%" "S5a" "M/G1 phase" "S1c" "S4b" "rRNA" "S4a" "RRLs" "Reddel"
    "Cohen" "ab32020" "Abcam" "hypotriploid" "Cech" "Mozdy" "subcomplexes"
    "ssDNA" "Takai" "nt" "= 3" "ANTI-FLAG" "∼80%" "the PicTar algorithm"
    "algorithm" "SDPEEDDE" "polycistron" "Miranda" "SYII" "OncomiR" "p38 MAPK"
    "sulfhydryl" "co-treated" "Histopathology" "isoenzymes" "brussel"
    "Brassica" "methylsulfinylbutyl" "glucopharanin" "tetrachloride"
    "Chinese medicinal herb TWHF" "BALB/C" "TWHF" "triepoxide" "wilfordii"
    "Tripterygium" "anti-inflammatory" "fromrb" "Borges" "impaired erufosine’s"
    "co-exist" "S-fraction" "gone" "Rb/E2F" "Schwann" "Jackson" "thymidilate"
    "erufosine’s" "the lentiviral transduction system pLentilox3.7"
    "pLentilox3.7" "ErPC" "erucylphospho" "fosine" "eru" "erufosine"
    "Erufosine" "G 1 /S" "= 3" "Cip/Kip" "bacterial lysis" "cloroquine"
    "chemoattractant" "DHMEQ" "Mφ" "the gastric epithelium" "peptidoglycan"
    "workflow" "oncologists" "presence/occurrence" "shorter DFS"
    "significantly inferior DFS" "Carlo" "Monte" "IIA" "non-contrast"
    "non-invasive" "grainy" "Non-invasive" "DFS" "skewness" "LungCarta"
    "tumoral QTA" "QTA" "nanoscale" "ultrastructures" "Ra" "v" "Rp"
    "considerable cellular plasmodesmata" "thinner" "plasmodesmata" "fusiform"
    "the CAM arterial endpoint" "AuNP" "tubules" "tube-like" "tubule"
    "monolayer" "Transwell" "monodisperse" "ultrastructure" "AuNPs" "24 h"
    "PDL-1" "PD-1/PDL-1" "immunodominant" "Immunodominant" "MHCII"
    "re-stimulation" "relatedness" "MSDC" "p=0.02" "Greater" "Monocytic MDSC"
    "MDSC" "Subset" "anti-MVA" "VenusMVA" "p=0.03" "isotype" "broader" "ISR"
    "immunological endpoints" "endpoints" "York" "Squibb" "Myers" "Bristol"
    "fowlpox" "4TI" "Hupki" "Advexin" "immunotherapy" "GI" "Ankara" "=0.002"
    "co-cultures" "100 ng/ml" "WZ" "VZ" "written" "mammography" "pseudogenes"
    "Nextera" "Diego" "Miseq" "-TGGGGTTACAGTGGGGATTA" "TGGGGTTACAGTGGGGATTA"
    "-GTCTGCTGACTCCGTGATGA" "GTCTGCTGACTCCGTGATGA" "II-3" "CHEK" "Coffalyser"
    "Netherlands" "Holland" "BigDye" "Carlsbad" "Sanger" "Otsu" "Takara" "Taq"
    "Ex" "Germany" "Hilden" "Qiagen" "QIAamp" "CE" "IRST" "Helsinki" "France"
    "Slovak" "Czech" "IVS2 + " "Cybulski" "Dong" "northern Europe" "Europe"
    "Finnish" "1100delC" "pombe" "Schizosaccharomyces" "penetrance"
    "co-workers" "2 + " "JW" "QP" "Written" "transcriptomes" "Götschel" "4/8"
    "3+" "cerebellar vermis" "vermis" "neurosurgeons" "histopathology" "IDH1/2"
    "astrocytoma/GBM" "cerebrum" "America" "ERBB-3" "Shandong" "G0/G1" "YPL"
    "HZS" "ZTZ" "JML" "SZ" "YLX" "XFY" "YZ" "HCZ" "transfectancts"
    "transfectans" "G protein/GTPase" "Goosecoid" "stem-like" "TGF-β1R"
    "small G protein/GTPase" "damager" "hydroxyl" "mJ/cm 2" "ATGGTGAGGA"
    "CGCGAAAACCCCGG" "UVC" "UVB" "clinicians" "codon (CUG)" "HGVS" "AUG" "CUG"
    "frameshift" "10q23" "trisphosphate" "re-sensitized" "re-replication"
    "BIO-" "TWS" "BIO" "readout" "OxPt" "HCT116p53KO" "retroviruses"
    "re-sensitize" "growth/survival" "Alzheimer's" "Alzheimer" "isofom"
    "re-localization" "silencing/inhibition" "g/mL" "/B" "cistrome" "TTGTTTAC"
    "CAMK2N1-" "VCX" "≥1.5-fold" "shFOXO4" "Oregon" "siFOXO4" "website" "cbio"
    "databank" "BLAST" "transwells" "MOI " "pGIPZ" "CAMK2N1" "platins" "co-IP"
    "co-precipitation" "0/16" "PANGEA"
    "multi-plex additional important analytes" "analytes" "MET+" "biopsy"
    "≥1500" "interpretation/scoring" "weeks/months" "Simultaneous IHC"
    "Ventana" "°C" "semi" "stonger" "≥150" "GCN≥4" "≥2"
    "sensistivy/specificity" "≥1+" "an alternate IHC" "20/23" "≥LOD" "Met+"
    "amol/" "0.92–1" "0.69–1"
    "this molecularly heterogeneous primary tumor sample 23a" "23a" "23c" "H&E"
    "polysomy/disomy" "polysomy" "MET:CEP7" "≥4" "16/22" "almost 5000 amol/µ"
    "45/130" "endoscopic primary tumor biopsies, and core needle biopsies"
    "hour–1" "fmol/ug" "the subsequent microdissection/analysis"
    "microdissection/analysis" "CVs" "598.35 (19V)/699.39 (20V)/846.47"
    "/699.39" "m/z 588.35 (19V)/689.39 (20V)/836.42" "/689.39" "m/z" "CV"
    "GDLTIANLGTSEGR" "NLNSVSVPR" "analyte" "foretenib" "IIa" "Barrett’s"
    "dysplasia" "∼5%" "MET/CEP7" "amol/µ" "LOQ" "LOD" "TEFTTALQR" "GCN" "GEC"
    "non-specificity" "H-Score" "= 0.51" "non-amplified" "nearly non-toxic"
    "erythrocytes" "carbonyl" "urea" "p38β" "phenyl" "absorbance" "3.41×10"
    "lac" "FWVS" "VFCS" "YWFS" "WFCS" "Gleevac" "VWCS"
    "unique structural properties viz" "viz" "cytokoines" "learnt" "plasmon"
    "FWCS" "non-toxic" "anti-phospho" "anti-Phospho" "Exome" "NHLBI" "Latinos"
    "Risques" "the squamous epithelia" "gastro" "epithelia" "transposons"
    "Zaug" "Vulliamy" "RMRP" "vitro" "apoptosis/senescence"
    "corresponding normal esophageal mucosa" "Rb" "tetraploid" "centromeres"
    "discrepant" "proteosome" "non-canonical" "Non-canonical" "wtTERC"
    "TERCdel" "respective TERT-over-expressers" "EsC2" "EsC1" "congenita"
    "matched normal esophageal mucosa" "A1062T" "non-synonymous"
    "the proband's" "proband" "T3N0M0" "The patient underwent esophagectomy"
    "esophagectomy" "pancytopenia" "Barrett's" "Barrett" "GAR" "Hayflick"
    "TTAGGG" "Zeocin" "Fraumeni" "Li" "A279T" "situ" "wtTERT" "MTS"
    "non-transformed" "1/4" "=0.51" "proven" "Microsatellite" "PTGS" "=0.05"
    "=0.04" "=0.03" "resectable CRCLM" "CRCLM" "95% CI" "=0.01" "The Pearson's"
    "Immunohistochemical stainings" "stainings" "NTSR" "discriminators"
    "Treves" "Stewart" "=0.33" "=3" "22q" "myxoid" "rhabdoid" "aCGH" "1p"
    "A877S" "the mass spectrometric readouts" "readouts" "Genotype" "FFPE"
    "10q23.3" "9p21" "Le" "and 3p" "Karyotype" "chemoresistant" "sacrum"
    "axial" "OncoMap" "desorption/ionization-time" "iPLEX" "spectrometer"
    "desorption/ionization" "Kuo" "miR-200b" "b" "Xu" "germline"
    "immunoglobulin" "tellurium" "ITG" "dormancy" "Ivanova" "IDC" "Castellana"
    "C4orf7" "GSE46581" "European" "Caucasians" "African" "Americans" "SEER"
    "approximate 15%~20%" "non-Asian" "TNBC" "~20%" "19q13.1" "clinico" "PCA"
    "de-regulation" "homolog" "mucosa (HARM)" "HARM" "=0.02" "HFD" "enhancer"
    "TZD" "GlaxoSmithKline" "Avandia" "Takeda" "Actos" "T2DM" "sensitizer"
    "Hayward" "Inc" "immonoblot" "500ug" "Fluor-de-Lys" "PPARγ2" "PPARγ1"
    "TZDs" "spatio" "lymphatic vasculatures" "vasculatures" "Fc"
    "capillary-like" "HDLECs" "imtinib" "edema" "PDGFRβ/Fc" "= 3" "= 4"
    "Hotspot" "Oestrogen" "TAMRAD" "BOLERO" "IQR" "Mu"
    "previously published GSs" "overview" "2-week" "Ellis" "and 2-week"
    "-noPAG-GS" "responders" "noPAG" "PAGs" "nonsignificant" "non-HS/WT"
    "non-HS " "H-score" "PgR+" "H-scores" "Mu " "IQR " "ddPCR" "endpoint"
    "hotspots" "/regulated" "non-HS" "Non-HS" "nonhotspot" "hotspot" "-loss-GS"
    "Saal" "Creighton" "Loi" "-GS" "GS" "GSs" "oestrogen" "MassARRAY"
    "Sequenom" "= 40" "HER2+" "= 9" "× 100" "ER + " "RRRCWWGYYY" "RRRCWWGYYYN"
    "AR+" "proteasom" "unique DNA adducts" "adducts" "GGAGTCC" "GGGAAAGTCC"
    "COLsi" "CyQUANT" "PC-3" "APRO" "adduct" "GGAAAGGAA" "GGAAAGTCC" "GGGCACC"
    "GGGCAGAGCCC" "anti-proliferative" "morula" "+2" "helix" "β8" "helices"
    "Pyr" "24 h—" "+1" "autoradiograph" "thiamine" "pyridine" "pL"
    "Non-oxidative" "TSC1/2" "de-regulated" "aldose" "ketose" "ketol"
    "nucleic acid ribose" "triose" "ribose" "lymphoblasts" "non-oxidative"
    "~80%" "Biomass" "Non-smoking" "Higashimoto" "Kang" "Mexico" "FVC" "SaO"
    "pack/year" "hours/year" "BMI" "non-smoking" "Mexican" "biomass" "TY" "HZ"
    "Hypoxia-inducible factor 1α" "transporter-1" "F-2-fluro-2-deoxy-d-glucose"
    "pulmonary NEC" "non-SCLC" "NECs" "Meacham" "the present laryngeal SCNECs"
    "SCNECs" "SNEC" "three patients underwent total laryngectomy"
    "four patients underwent partial laryngectomies" "male/female" "to 71"
    "sinonasal NEC" "ethmoid" "univariate" "carcinomaswas" "two-year"
    "Three patients underwent total laryngectomies" "laryngectomies"
    "postoperative CCRT"
    "four patients underwent horizontal supraglottic laryngectomy"
    "laryngectomy" "maxillectomy" "CCRT" "/s" "DWI"
    "further evidence thatthe phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathwaymay"
    "pathwaymay" "thatthe" "NEC" "mitoses" "cribrosa" "lamina"
    "males around 50-years-old" "Primary sinonasal and laryngeal SCNEC"
    "sinonasal and laryngeal SCNEC"
    "histologically demonstrated nasal and laryngeal SCNEC"
    "nasal and laryngeal SCNEC" "SCNEC" "= 4" "× 10" "five-year" "= 3" "upto"
    "HPV16E5" "~99.8%" "~62%"
    "Dox-loaded PEG-DSPE-coated multi-walled carbon nanotubes and graphene nanoplatelets"
    "~65%" "non-inhibited" "~72%" "genome/s" "genome/genomes" "U251" "g/ml"
    "Dox" "co-localize" "CDRs" "isopropyl" "macropinocytosis-like"
    "O-GNR-PEG-DSPEs" "nanoplatelets" "Kosynkin" "GNRs" "GNR" "nanoribbon"
    "APIs" "metallofullerenes" "nano" "EFGR" "O-GNR-PEG-DSPE"
    "-glycero-3-phosphoethanolamine-N" "polyethyleneglycol" "DSPE"
    "nanoribbons" "non-HPV" "Paik" "0.57–1.10" "Marchetti" "170/5599" "95%CI"
    "non-ADCs" "SSCP" "Cardarella" "Pratilas" "Seidel"
    "clinically relevant molecular subsets" "95%CI " "ISI" "= 4" "oncomir" "mt"
    "wt" "miRwalk" "SPAC1" "Multivariate" "15q25.1" "_012337.2" "GeneBank"
    "NCBI" "nasopharynx" "non-specific" "= 5" "= 4" "trisomies" "aneuploidy"
    "re-isolated" "soft agar" "restorede" "dimethylenastron" "karyotype"
    "chromatid" "G1/S phase" "G1/S" "non-covalently" "coprecipitate"
    "persulphide" "sulphoximine" "butathionine" "Mr" "PTPα" "strepavidin"
    "bolus" "CXXC" "midpoint" "Grx/GSH" "sulphenyl" "RSSG" "RSSR" "intra-"
    "cysteinyl" "SOH" "oxidases" "non-covalent" "Cy1" "Cy2" "co-transfection"
    "cyclohexamine (CHX)" "cyclohexamine" "co-localized" "co-transfected"
    "pLKO" "Venus" "alpha type3" "macrophain" "co-localization" "ubstrate"
    "nzyme" "cyclin-dependent kinase inhibitor 1A" "1 +" "PDACs" "3/7"
    "-amplified-PDAC" "25/48" "IIIc" "Kaplan–Meier" "100 ng/mL" "24 h" "× 10"
    "2+" "1+" "N-acetyl" "both the distal and proximal MMP-1 promoter"
    "the distal and proximal MMP-1 promoter" "MMP-1 promoter" "SiRNA" "Krämer"
    "pGL3 basic" "Mego" "Cierna" "PJ" "ZC" "&E" "eosin" "Hematoxyllin"
    "Bratislava" "ones" "myofibroblasts" "invasive ductal histology"
    "histoscore" "MMP1 expression at least 1+" "CTC_EMT" "_EMT" "RossetteSep"
    "CTCs" "= 0.02" "missense" "pathophysiology"
    "a premature termination codon" "inframe" "the associated haplotype"
    "or/and" "PESS" "ESS" "silico" "TCTT" "rs10974944"
    "the JAK2-associated haplotypes" "rs12343867" "C/G" "T/G" "T/C" "GGCC"
    "46/1" "SNPs" "JAK2V617F" "essential thrombocythemia (ET)"
    "thrombocythemia" "global genome" "radioresistant" "et" "Fernandez"
    "Oncology" "EV" "migrated/invaded" "agar" "siCont" "siYAP" "HEC-1-B"
    "nuclear/cytoplasmic" "recurrence/metastasis"
    "postoperative metastasis/recurrence" "Representative micrographs"
    "micrographs" "radioresistance" "co-activators" "11q22"
    "sensitivity/resistance" "LVSI" "poorer" "endometrioid" "American"
    "co-activator" "migration/invasion" "G0/G1 phase" "multivariate"
    "postoperative recurrence/metastasis" "lympho"
    "a transcriptional co-activator" "= 0.002" "re-introduction" "60/70"
    "suppressant" "inpairs" "transwell" "G0/G1-phase" "inhibiors" "Taqman"
    "algorithms" "sumoylaiton" "protein 4E-BP1" "SUMO-2ΔGG" "witha" "m7GTP"
    "4EGI-1" "ΔGG" "reporterassay" "non-conjugatable" "congjugate" "ECFP"
    "EYFP" "paralogues" "SUMO-2/3" "stepof" "Eukaryotic Initiation Factor 4G"
    "Factor 4G" "factor 4F" "normal mammary epithelium" "Amsterdam"
    "microsatellite" "partially methylated LINE-1s" "LINE-1s" "dinucleotides"
    "pT" "Hoesel" "Whitney" "Pearson" "interquartile" "stepwise" "Wallis"
    "CD44+" "basal-like" "non-coding" "ADH/FEA"
    "atypical ductal hyperplasia/flat epithelial atypia" "atypia" "LINE-1"
    "element-1" "Kaplan-Meier" "RITA/nutlin" "STRING" "DAVID" "KEEG"
    "the biological replicates" "SLNs" "replicates" "USA" "iii" "TP53−/−"
    "Genome" "/Apr-246" "tenovins" "co-binding" "coworkers" "Brüstle"
    "Sjögren's" "Sjögren" "MALI" "bp" "GenBank" "MATL" "mature thymocytes"
    "thymocytes" "Crohn's" "Crohn" "Dixit" "mucosa" "× 100" "Japanese" "Koyama"
    "Turkish" "Yosunkaya" "Warchoł" "Brazilians" "Bassi" "Taiwanese" "Benke"
    "haplotype" "Balouch" "rs25484" "genotypes" "rs1799782" "dermomucus"
    "300 valid single nucleotide polymorphisms" "dbSNP" "19q13.2-13.3" "dsDNA"
    "UV" "autoantigens" "XRCC1 399 Arg/Gln heterozygous genotype" "haplotypes"
    "malar" "= 0.02" "anti-tumorigenesis" "co-treatment"
    "a more severe anti-proliferation" "anti-proliferation" "siBak" "siCTRL"
    "DKO" "membrane/organelle" "anti-apoptotic" "siERBB3" "anti-tumorigenic"
    "Aramaki" "siMTA" "SPSS" "pEGFP" "immunogold" "immuno" "NuRD" "malignances"
    "selectivity/specificity" "nanomaterials" "anti-cancer" "ErbB1-3" "μg/mL"
    "transfectants" "transfectant" "CHX" "HQ" "undertaken" "chemo" "Anti-tumor"
    "×100" "anti-tumor" "TargetScan" "p-p70S6K" "miR-26a" "miR-17-5p"
    "subclass" "RNAhybrid" "miRtarget" "miRanda" "re-expression" "Meier"
    "Involucrum" "sensitise" "anti-tumour" "p" "involucrum" "×10" "5-year"
    "&222" "TRIAIL" "pearson" "RNhybrid" "Targetscan" "pcDNA3.1-ISG12a" "pcDNA"
    "ISGs" "HLCZ02" "ISG12a" "12a" "anti-V5" "previously investigated PARPi"
    "an occasional DSB" "S/G2" "newer" "PAPRi" "Murai" "PARPi"
    "Representative photomicrographs" "photomicrographs"
    "radiation-induced DSBs" "Gy" "μmol/L" "AG014361" "INO-1001" "Merck"
    "Pfizer" "Inotek" "INO" "AstraZeneca" "aminobenzamide" "radioresponse"
    "24 h" "non-homologous" "co-inhibition" "si" "JQ1" "ibrutinib/AZD2014"
    "pSTAT3" "Lymphochip" "24h" "pairwise" "mTORC1/2" "ER+" "rapalogues"
    "Bruton's" "Bruton" "B Cell-like (ABC)" "Germinal Center B cell-like (GCB)"
    "B cell-like (GCB)" "subtype" "= 9" "greatest" "co-targeting" "co-culture"
    "co-ordinated" "immunosurveillance" "proliferation/viability" "x1/2pal-i3"
    "enabler" "2pal-i3" "x1" "a peptide-based receptor-targeting pepducin"
    "pepducin" "RS102895" "100ng/ml" "timecourse" "Boyden" "co-dependent"
    "fibroblast-like" "macrophage-like" "un" "prostatectomy" "intra" "haplo"
    "underpinnings" "deeper" "ii" "nonraft" "multiorgan" "physio"
    "fluorescent cavins" "FSK/MIX" "noncavin" "8Br-cAMP–"
    "markedly smaller lipid droplets" "8Br-cAMP" "methylisobutylxantine (MIX)"
    "methylisobutylxantine" "adenylate" "FSK" "Cavin" "nonfat" "kg" "8-week"
    "biopsies" "frozen" "retrovirus" "Droplets" "mechano-active organelles"
    "mechano" "eightfold" "organelle" "homologs" "cavin" "cavins"
    "mechanosensors" "invaginations" "× 10" "WDL" "YMN" "XTZ" "Weinberg"
    "English" "genotype" "polymorphisms" "Heah" "Zhou" "0.34–1.23" "0.53–1.34"
    "0.97–1.35" "0.31–1.43" "0.48–1.22" "HWE" "Jiang" "Zhuo" "CGC" "Lanka"
    "Bangladesh" "Asians" "ArgPro " "ArgPro" "ORs" "RevMan" "Asian"
    "polymorphism" "codon" "undergone" "viremia" "vivo" "ex" "Burkitt" "exons"
    "CD34+" "introns" "intron" "sist" "integrants" "integrant" "breakpoint"
    "pre" "presert" "fies" "identi" "breakpoints" "detennine" "Illumina"
    "viral/host" "TCGA" "oncomine" "the uncommon histological subsets"
    "Lutterbach" "IHC" "QD" "timepoints" "timepoint" "GSKIII" "S6RP" "kinses"
    "the highly focal amplicon" "amplicon" "centromere" "messager"
    "Immunohistochemistry" "wildtype" "unmet" "NCI" "S4B" "S4A" "strongest"
    "motile" "Hoechst" "DETA" "PI3KCA-" "GB-1" "GMB" "Mure" "subG1" "SYTOX"
    "DyeCycle" "Vybrant" "adequate 1 nM siRNA" "PIKCA" "chloroethylnitrosourea"
    "chosen" "triphosphate" "subclasses" "OH" "CNS" "subG" "PI3KCA" "OC"
    "osteoblasts" "DCFHDA" "PARR" "sublines" "dataset" "nonendocrine"
    "neoadjuvant" "acquired chemoresistance" "chemoresistance" "NH2-" "NH"
    "Chakravarty" "Varmus" "Rous" "Peyton" "SW-620"
    "cancerous colorectal epithelium" "Grivas" "immunohistochemistry" "#3"
    "Oncomine" "the immortalized colorectal epithelium" "NMAR"
    "normal colorectal epithelium" "the normal colorectal epithelium"
    "colorectal epithelium" "epithelium" "protooncogenes"
    "a potential protooncogene" "protooncogene" "Glickman" "monotherapy"
    "monotherapies" "gatekeeper" "SISH" "BGJ-398" "BGJ" "NCT01004224" "mg/kg"
    "gavage" "two independent FGFR1-targeting shRNAs" "anti-phosphotyrosine"
    "multi" "biphasic histologies" "22/53" "DataSets" "histologies" "ISH"
    "ELISA" "datasets" "FGFR1:CEP8" "diploid" "histology" "CCLE" "paracrine"
    "sarcomatoid" "epithelioid" "peritoneum" "HNSCC" "subsets" "Whitby"
    "FANCJ-" "FANCJ" "subset" "undergoes" "opportunistic nucleases" "London"
    "Cheung" "S2B" "Schwab" "Sarkies" "Larson" "Marsischky" "Kolodner" "Alani"
    "Martinez" "Moreland" "Durant" "DSB" "S8D" "Blackford" "Lukas" "thefancd2"
    "greater" "Vrugt" "Kumaraswamy" "Greenberg" "co-deficient" "shRNAs"
    "Lehmann" "Kannouche" "˜4" "shCon" "Grompe" "perhaps" "Litman" "Ceccaldi"
    "K141/142A" "Anderson" "re-introduced" "Umar" "HEC59+chr2" "shRNA"
    "co-depletion" "hyper" "Jiricny" "Nehme" "Fink" "Marinus" "Nowosielska"
    "MutSα" "MutSβ" "lesions/perturbations" "Vasquez" "Wu" "Zhang" "Yamada"
    "Duckett" "Guillemette" "Suhasini" "Xie" "Peng" "Williams" "Huang"
    "Yoshikiyo" "Smogorzewska" "Shereda" "Durocher" "Donnell" "Liu" "Kratz"
    "Svendsen" "Kim" "Schlacher" "nucleases" "Bouwman" "Adamo" "Ganesan"
    "Nussenzweig" "DSBs" "Canman" "Sharma" "crosslink" "et " "Muniandy"
    "Andrea" "Moldovan" "Fancd" "survive toxic DNA interstrand crosslinks"
    "crosslinks" "interstrand" "recuit" "VSS" "exogenous siRNA" "genomes"
    "UTRs" "vRNA" "interactome" "endosome-like vesicular organelles"
    "organelles" "Sindbis" "droplets" "shutoff" "I·C" "hnRNPs" "siRNAs" "siRNA"
    "E3L" "ribonucleoparticles" "Pestivirus" "Npro" "nucleates" "desmoglein"
    "detectedin" "PRIDE" "Cys112-X21-Cys134-X3-Cys138" "pulldown" "PABP-1"
    "IEBP3" "Y-box" "lysis" "·C" "Orbitrap" "disassemble" "prokaryotes" "IRES"
    "replicate" "capsid" "genome" "BDV" "CSFV" "Pestiviruses" "pestivirus"
    "TRASH" "BVDV" "pestiviruses"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-12901-13200*
  '(("AK and BF" . SPARSER::COLLECTION)
    ("CG, MCM, and KRS" . SPARSER::COLLECTION)
    ("KRS" . SPARSER::PROTEIN-FAMILY)
    ("Tumor necrosis factor receptor-associated factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tetramethylrhodamine" . SPARSER::MOLECULE) ("TAMRA" . SPARSER::MOLECULE)
    ("Dithiothreitol" . SPARSER::PROTEIN)
    ("different viral oncoproteins" . SPARSER::PROTEIN)
    ("other viral oncoproteins" . SPARSER::PROTEIN)
    ("the viral oncoprotein Tax" . SPARSER::PROTEIN)
    ("a weak activator" . SPARSER::ACTIVATOR)
    ("junctional plakoglobin" . SPARSER::PROTEIN)
    ("both LMP1 and the phosphorylated transcription factor signal transducer and activator of transcription 3 (STAT3)"
     . SPARSER::COLLECTION)
    ("receptor (TNFR)" . SPARSER::RECEPTOR) ("TNFR" . SPARSER::PROTEIN)
    ("the viral oncoprotein LMP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neither LMP1 nor Fascin" . SPARSER::COLLECTION)
    ("Fascin (shFascin4; shFascin5) or unspecific control shRNAs (shNonsense)"
     . SPARSER::COLLECTION)
    ("unspecific control shRNAs" . SPARSER::PROTEIN)
    ("NF-κB and JNK" . SPARSER::COLLECTION)
    ("cytometry and RNA" . SPARSER::COLLECTION)
    ("LMP1 and Fascin" . SPARSER::COLLECTION)
    ("the costimulatory tumor necrosis factor superfamily receptor 4-1BB"
     . SPARSER::PROTEIN)
    ("IκBα-DN" . SPARSER::COLLECTION) ("pIκBα" . SPARSER::PROTEIN)
    ("canonical NF-κB" . SPARSER::PROTEIN) ("pIκBα-DN" . SPARSER::COLLECTION)
    ("Δ371-386" . SPARSER::PROTEIN) ("HA-LMP1-" . SPARSER::PROTEIN)
    ("LMP1 and Tax-1" . SPARSER::COLLECTION)
    ("LMP1 and the respective mutants" . SPARSER::COLLECTION)
    ("the respective mutants" . SPARSER::MUTANT)
    ("HA-LMP1-Δ371-386" . SPARSER::PROTEIN)
    ("HA-LMP1(AAA)" . SPARSER::COLLECTION) ("wt-LMP1" . SPARSER::COLLECTION)
    ("p38/MAPKK" . SPARSER::COLLECTION)
    ("secondary anti-mouse antibodies" . SPARSER::ANTIBODY)
    ("NF-κB, p38MAPK, JNK1/2 and STAT1" . SPARSER::COLLECTION)
    ("an immediate-early cellular target gene" . SPARSER::PROTEIN)
    ("NGF" . SPARSER::PROTEIN) ("Fascin and actin" . SPARSER::COLLECTION)
    ("HA-LMP1" . SPARSER::COLLECTION) ("FSCN" . SPARSER::PROTEIN)
    ("cytoskeletal proteins and adhesion molecules" . SPARSER::COLLECTION)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("TRAF6 and the tumor necrosis factor-receptor-associated factor 2 (TRAF2)"
     . SPARSER::COLLECTION)
    ("the tumor necrosis factor-receptor-associated factor 2"
     . SPARSER::PROTEIN)
    ("TNIK" . SPARSER::PROTEIN) ("TNF-receptor" . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN)
    ("TNF receptor-associated factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAFs" . SPARSER::PROTEIN)
    ("a costimulatory receptor" . SPARSER::PROTEIN)
    ("LMP1 and a variety" . SPARSER::COLLECTION)
    ("other latency-associated viral genes" . SPARSER::GENE)
    ("BART" . SPARSER::PROTEIN)
    ("NF-κB and both NF-κB and Fascin" . SPARSER::COLLECTION)
    ("NF-κB and Fascin" . SPARSER::COLLECTION)
    ("IκBα (NFKBIA)" . SPARSER::PROTEIN)
    ("a classical target" . SPARSER::TARGET-PROTEIN)
    ("a dominant-negative inhibitor" . SPARSER::INHIBITOR)
    ("NFKBIA" . SPARSER::PROTEIN)
    ("both the inducers and the mechanisms" . SPARSER::COLLECTION)
    ("Fascin" . SPARSER::PROTEIN)
    ("Tumor necrosis factor receptor" . SPARSER::PROTEIN)
    ("Nerve growth factor receptor" . SPARSER::PROTEIN)
    ("Low-affinity nerve growth factor receptor" . SPARSER::PROTEIN)
    ("Latent membrane protein 1" . SPARSER::PROTEIN) ("4-1" . SPARSER::PROTEIN)
    ("IKK-β" . SPARSER::PROTEIN) ("B17" . SPARSER::PROTEIN)
    ("IκB-α" . SPARSER::PROTEIN) ("K-2" . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("g-3" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("3 B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nerve growth factor receptor" . SPARSER::PROTEIN)
    ("TNFR superfamily" . SPARSER::PROTEIN)
    ("decoy receptor 3" . SPARSER::PROTEIN) ("CD30" . SPARSER::PROTEIN)
    ("gene 4" . SPARSER::PROTEIN) ("TNFRSF 9" . SPARSER::PROTEIN)
    ("4-1BB" . SPARSER::PROTEIN)
    ("low-affinity nerve growth factor receptor" . SPARSER::PROTEIN)
    ("LMP-1" . SPARSER::PROTEIN) ("MT-2" . SPARSER::PROTEIN)
    ("I-κB" . SPARSER::PROTEIN) ("CD40" . SPARSER::PROTEIN)
    ("LMP-2A" . SPARSER::PROTEIN) ("EBNA-1" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("FSCN1" . SPARSER::PROTEIN)
    ("Threonine and Proline" . SPARSER::COLLECTION)
    ("PC1 and PC2" . SPARSER::COLLECTION)
    ("the first two principal components" . SPARSER::COMPONENT)
    ("PC2" . SPARSER::PROTEIN) ("PC1" . SPARSER::PROTEIN)
    ("a more flexible conformation" . SPARSER::BIO-CONFORMATION)
    ("L12 and H2 helix" . SPARSER::COLLECTION) ("DSSP" . SPARSER::PROTEIN)
    ("Methionine" . SPARSER::AMINO-ACID) ("Glycine" . SPARSER::AMINO-ACID)
    ("polar amino acids" . SPARSER::AMINO-ACID)
    ("apo and holo" . SPARSER::COLLECTION) ("MDS" . SPARSER::PROTEIN)
    ("L12" . SPARSER::PROTEIN) ("L11" . SPARSER::PROTEIN)
    ("Glutamic Acid" . SPARSER::AMINO-ACID)
    ("both the formidable negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("at least miRNAs" . SPARSER::MICRO-RNA)
    ("Noxa and PCNA" . SPARSER::COLLECTION)
    ("MDM2-ALT1/MDMX-ALT2" . SPARSER::COLLECTION)
    ("Fas1 and cell-cycle control genes GADD45A and p21" . SPARSER::COLLECTION)
    ("GADD45A and p21" . SPARSER::COLLECTION)
    ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("type and extent" . SPARSER::COLLECTION)
    ("genotoxic stress p53" . SPARSER::PROTEIN) ("ALT3" . SPARSER::PROTEIN)
    ("MDM2-ALT3" . SPARSER::COLLECTION)
    ("another common cancer-associated MDM2" . SPARSER::PROTEIN)
    ("p21 or p53" . SPARSER::COLLECTION)
    ("p53, MDM2, and MDMX" . SPARSER::COLLECTION)
    ("MDM2/MDMX" . SPARSER::COLLECTION) ("Cisplatinum" . SPARSER::DRUG)
    ("Bax , Fas1 and p21" . SPARSER::COLLECTION)
    ("DMSO or Nutlin-3" . SPARSER::COLLECTION)
    ("p53-MDM2" . SPARSER::COLLECTION)
    ("Bax , Cyclin D1 , and Fas1" . SPARSER::COLLECTION)
    ("p21 , GADD45A , WIP1 , PCNA , Cyclin D1 and 14-3-3σ"
     . SPARSER::COLLECTION)
    ("Fas1" . SPARSER::PROTEIN) ("Propidium" . SPARSER::MOLECULE)
    ("a strong inhibitor" . SPARSER::INHIBITOR)
    ("full-length MDM2 ( xref and xref ) and MDMX ( xref and xref )"
     . SPARSER::COLLECTION)
    ("myc-MDMX-ALT2" . SPARSER::COLLECTION)
    ("a damage-induced isoform" . SPARSER::PROTEIN)
    ("LacZ or GFP" . SPARSER::COLLECTION) ("myc-LacZ" . SPARSER::COLLECTION)
    ("MDM2 or MDMX" . SPARSER::COLLECTION) ("myc-GFP" . SPARSER::COLLECTION)
    ("myc-MDM2-ALT1" . SPARSER::COLLECTION) ("cisplatinum" . SPARSER::DRUG)
    ("MDM2-ALT2" . SPARSER::COLLECTION)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("MDMX and MDM2" . SPARSER::COLLECTION)
    ("binding full-length MDMX as well as full-length MDM2"
     . SPARSER::COLLECTION)
    ("MDM2-MDMX-p53" . SPARSER::COLLECTION) ("MDMX-ALT2" . SPARSER::COLLECTION)
    ("MDM2-ALT1" . SPARSER::COLLECTION)
    ("the chief negative regulators of the tumor-suppressor protein p53 and are"
     . SPARSER::COLLECTION)
    ("MDM2 and MDMX" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("miR29b" . SPARSER::RNA) ("WIP1" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("ALT2" . SPARSER::PROTEIN) ("ALT1" . SPARSER::PROTEIN)
    ("CR or CR" . SPARSER::COLLECTION) ("amsacrine" . SPARSER::DRUG)
    ("relapsed or refractory FLT3-ITD AML" . SPARSER::PROTEIN)
    ("CYP3A4" . SPARSER::PROTEIN) ("G-CSF" . SPARSER::PROTEIN)
    ("FLT3 ligand" . SPARSER::PROTEIN)
    ("a potential tumor suppressive miRNA" . SPARSER::MICRO-RNA)
    ("the suppressive complex" . SPARSER::BIO-COMPLEX)
    ("FZD4, Rhoc, MKK7 and IGF1R" . SPARSER::COLLECTION)
    ("relevant miRNAs as well as the specific mechanisms"
     . SPARSER::COLLECTION)
    ("relevant miRNAs" . SPARSER::MICRO-RNA)
    ("AKT, GSK3b and ERK" . SPARSER::COLLECTION) ("GSK3b" . SPARSER::PROTEIN)
    ("AKT and its downstream target GSK3β ( xref )" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION) ("Ras/Raf" . SPARSER::COLLECTION)
    ("E2F1-" . SPARSER::PROTEIN) ("haematoxylin" . SPARSER::MOLECULE)
    ("HBE" . SPARSER::PROTEIN) ("pLP2" . SPARSER::PROTEIN)
    ("MKK7" . SPARSER::PROTEIN) ("FZD4" . SPARSER::PROTEIN)
    ("Myc or Ras" . SPARSER::COLLECTION)
    ("tumor suppressor protein and mitochondrial" . SPARSER::COLLECTION)
    ("Ku70-Bax" . SPARSER::COLLECTION)
    ("SIRT2 and SIRT7" . SPARSER::COLLECTION) ("DCFDA" . SPARSER::DRUG)
    ("NAD-" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide-" . SPARSER::MOLECULE)
    ("homologues" . SPARSER::PROTEIN) ("SIRT 1" . SPARSER::PROTEIN)
    ("CM-H" . SPARSER::MOLECULE) ("HIF1 α" . SPARSER::PROTEIN)
    ("factor 1 alpha" . SPARSER::PROTEIN) ("Sirtuin 3" . SPARSER::PROTEIN)
    ("JAK1, JAK2, and STAT3" . SPARSER::COLLECTION)
    ("JAK2 , SOCS2 , STAT3 and STAT5 and cigarette" . SPARSER::COLLECTION)
    ("STAT5 and cigarette" . SPARSER::COLLECTION)
    ("IL6-STAT3" . SPARSER::COLLECTION) ("Nicotine" . SPARSER::DRUG)
    ("JAK2 , STAT3 , STAT5a , and STAT5b" . SPARSER::COLLECTION)
    ("JAK and STATs" . SPARSER::COLLECTION)
    ("JAK1 , JAK2 , and STAT3" . SPARSER::COLLECTION)
    ("JAK1 (3 out of 10 SNPs) and JAK2 (4 out of 11 SNPs)"
     . SPARSER::COLLECTION)
    ("NSAID" . SPARSER::PROTEIN) ("IL6 and its receptor" . SPARSER::COLLECTION)
    ("JAK/STAT/SOC" . SPARSER::COLLECTION) ("SOC" . SPARSER::PROTEIN)
    ("STAT1 (2 SNPs) and STAT4 (1 SNP)" . SPARSER::COLLECTION)
    ("JAK1 (3 SNPs) and JAK2 (4 SNPs)" . SPARSER::COLLECTION)
    ("STAT3 (4 SNPs) and STAT5A (2 SNPs) and STAT5B (1 SNP)"
     . SPARSER::COLLECTION)
    ("STAT5A (2 SNPs) and STAT5B (1 SNP)" . SPARSER::COLLECTION)
    ("IL6 and other cytokine SNPs" . SPARSER::COLLECTION)
    ("Pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("JAKs and STATs" . SPARSER::COLLECTION)
    ("unique breast cancer subtypes" . SPARSER::PROTEIN)
    ("STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6"
     . SPARSER::COLLECTION)
    ("STATS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT1 and STAT2" . SPARSER::COLLECTION)
    ("JAK1, JAK2, and TYK2" . SPARSER::COLLECTION)
    ("kinases, JAK1, JAK2, JAK3, and TYK2" . SPARSER::COLLECTION)
    ("JAK/STAT/SOCS" . SPARSER::COLLECTION)
    ("SOCS2 (1 of 3 SNPs) and all STAT3 , STAT5A , and STAT5B SNPs"
     . SPARSER::COLLECTION)
    ("STAT3 , STAT5A , and STAT5B" . SPARSER::COLLECTION)
    ("JAK1 (3 of 10 SNPs) and JAK2 (4 of 11 SNPs)" . SPARSER::COLLECTION)
    ("SOCS" . SPARSER::PROTEIN) ("pro-oxidants" . SPARSER::MOLECULE)
    ("vitamin C" . SPARSER::MOLECULE) ("anti-oxidants" . SPARSER::DRUG)
    ("STAT5b" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN) ("SOCS2" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN)
    ("other K1 and Nef-regulated miRNAs" . SPARSER::COLLECTION)
    ("the attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("directly targets PTEN" . SPARSER::PROTEIN)
    ("viral miRNAs" . SPARSER::MICRO-RNA)
    ("b, miR-217, miR-486, miR-193a and miR-519d" . SPARSER::COLLECTION)
    ("Recombinant soluble Nef protein" . SPARSER::PROTEIN)
    ("PTEN/PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("mTOR/p70 S6K1" . SPARSER::COLLECTION)
    ("KS, PEL and MCD" . SPARSER::COLLECTION)
    ("miR-718 directly target PTEN" . SPARSER::PROTEIN)
    ("pEGFP-N2" . SPARSER::PROTEIN-PAIR)
    ("miR-718 directly targets PTEN" . SPARSER::PROTEIN)
    ("the K1- and Nef-expressing EA" . SPARSER::COLLECTION)
    ("hemorrhagic necrotic foci" . SPARSER::PROTEIN)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("PTEN/AKT/mTOR" . SPARSER::COLLECTION)
    ("Hematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("the K1- or Nef-expressing EA" . SPARSER::COLLECTION)
    ("K1-" . SPARSER::PROTEIN) ("Hematoxylin" . SPARSER::MOLECULE)
    ("K1 and Nef protein" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("soluble Nef protein" . SPARSER::PROTEIN)
    ("PI3K, AKT and mTOR" . SPARSER::COLLECTION) ("hy" . SPARSER::MOLECULE)
    ("/mechanistic target of rapamycin" . SPARSER::COLLECTION)
    ("viral genes" . SPARSER::GENE)
    ("soluble Nef protein can" . SPARSER::PROTEIN)
    ("viral mRNAs" . SPARSER::PROTEIN)
    ("vIL-6 and vGPCR" . SPARSER::COLLECTION)
    ("endemic KS and iatrogenic KS" . SPARSER::COLLECTION)
    ("classical KS, endemic KS and iatrogenic KS" . SPARSER::COLLECTION)
    ("iatrogenic KS" . SPARSER::PROTEIN) ("endemic KS" . SPARSER::PROTEIN)
    ("classical KS" . SPARSER::PROTEIN)
    ("transcription factor-" . SPARSER::PROTEIN)
    ("several viral miRNAs" . SPARSER::MICRO-RNA)
    ("ORF-K1" . SPARSER::COLLECTION) ("ORF-K2" . SPARSER::COLLECTION)
    ("vIRF" . SPARSER::PROTEIN) ("vFLIP" . SPARSER::PROTEIN)
    ("vCyclin" . SPARSER::PROTEIN) ("LANA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vGPCR" . SPARSER::PROTEIN)
    ("two dozens viral microRNAs" . SPARSER::MICRO-RNA)
    ("MCD" . SPARSER::PROTEIN) ("PEL" . SPARSER::PROTEIN)
    ("KS" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("p70 S6K1" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("pcDNA3" . SPARSER::PROTEIN) ("negative factor" . SPARSER::PROTEIN)
    ("vIL-6" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("ORF71" . SPARSER::PROTEIN) ("ORF72" . SPARSER::PROTEIN)
    ("ORF73" . SPARSER::PROTEIN)
    ("viral G protein-coupled receptor" . SPARSER::PROTEIN)
    ("ORF74" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("K1" . SPARSER::PROTEIN) ("IL-1β and IL-6" . SPARSER::COLLECTION)
    ("particularly bone metastatic PCa" . SPARSER::PROTEIN)
    ("radiopharmaceuticals, and bisphosphonates" . SPARSER::COLLECTION)
    ("bisphosphonates" . SPARSER::MOLECULE)
    ("radiopharmaceuticals" . SPARSER::DRUG)
    ("at least 30 different proteins" . SPARSER::PROTEIN)
    ("DU145 and PC3" . SPARSER::COLLECTION)
    ("media and IL-1β" . SPARSER::COLLECTION)
    ("the autolysosomal inhibitor" . SPARSER::INHIBITOR)
    ("AR and p62" . SPARSER::COLLECTION)
    ("Interleukin 1-beta" . SPARSER::COLLECTION)
    ("NFκB and NRF2" . SPARSER::COLLECTION)
    ("NFκB [ xref ] and NRF2 [ xref ]" . SPARSER::COLLECTION)
    ("transactive antioxidant response genes" . SPARSER::GENE)
    ("KEAP1-NRF2" . SPARSER::COLLECTION)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("IL-1β and Nerve Growth Factor" . SPARSER::COLLECTION)
    ("the multifunctional adaptor protein" . SPARSER::PROTEIN)
    ("angiogenic proteins" . SPARSER::PROTEIN) ("Monocytes" . SPARSER::PROTEIN)
    ("its heterodimeric IL-1RI/IL-1RAcP receptor" . SPARSER::RECEPTOR)
    ("Mature IL-1β" . SPARSER::PROTEIN)
    ("IL-1RI/IL-1RAcP" . SPARSER::COLLECTION)
    ("AR or p62" . SPARSER::COLLECTION)
    ("the inflammatory cytokine" . SPARSER::PROTEIN)
    ("Interleukin 1" . SPARSER::PROTEIN)
    ("Androgen Receptor" . SPARSER::PROTEIN)
    ("interleukin-1 beta" . SPARSER::PROTEIN) ("KEAP1" . SPARSER::PROTEIN)
    ("Kelch-Like ECH-Associated Protein 1" . SPARSER::PROTEIN)
    ("Nuclear Factor Erythroid 2-Related Factor 2" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor Receptor" . SPARSER::PROTEIN)
    ("IL-1RAcP" . SPARSER::PROTEIN) ("IL-1RI" . SPARSER::PROTEIN)
    ("Interleukin-1 beta" . SPARSER::PROTEIN)
    ("a robust biomarker" . SPARSER::MOLECULE)
    ("BELLE-3" . SPARSER::COLLECTION)
    ("only 10% achieving pCR" . SPARSER::PROTEIN)
    ("anthracycline, cytoxan and taxane" . SPARSER::COLLECTION)
    ("cytoxan" . SPARSER::DRUG) ("PI3K and AR" . SPARSER::COLLECTION)
    ("PHLPP" . SPARSER::PROTEIN) ("approximately 50 mm 3" . SPARSER::PROTEIN)
    ("NVP-BKM120 or NVP-BEZ235" . SPARSER::COLLECTION)
    ("GDC-0941 or GDC0980" . SPARSER::COLLECTION) ("ADR" . SPARSER::PROTEIN)
    ("GDC-0941 (300 nM) and GDC-0980 (100 nM)" . SPARSER::COLLECTION)
    ("GDC-0941 or GDC-0980" . SPARSER::COLLECTION)
    ("shRNA and CDX" . SPARSER::COLLECTION)
    ("GDC-0941 and GDC-0980" . SPARSER::COLLECTION)
    ("NVP-BKM120 and NVP-BEZ235" . SPARSER::COLLECTION)
    ("GDC-0941 (680 nM versus 2044 nM, P  = 0.01) and GDC-0980 (66 nM versus 504 nM, P  = 0.015)"
     . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitors GDC-0980 and NVP-BEZ235"
     . SPARSER::COLLECTION)
    ("GDC-0941 and NVP-BKM120" . SPARSER::COLLECTION)
    ("GDC-0980 and NVP-BEZ235" . SPARSER::COLLECTION)
    ("PI3K and downstream mTOR" . SPARSER::COLLECTION)
    ("CAL" . SPARSER::PROTEIN) ("p-GSK3β" . SPARSER::COLLECTION)
    ("Dihydrotestosterone" . SPARSER::DRUG) ("PI3K/TOR" . SPARSER::COLLECTION)
    ("TNBC" . SPARSER::PROTEIN) ("only 12 genes" . SPARSER::GENE)
    ("TNBCs" . SPARSER::PROTEIN) ("IM " . SPARSER::PROTEIN)
    ("simultaneously target AR and PI3K" . SPARSER::COLLECTION)
    ("AR and PI3K" . SPARSER::COLLECTION)
    ("those expressing ER [ xref ] and AR [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("BL1 and BL2" . SPARSER::COLLECTION) ("LAR" . SPARSER::PROTEIN)
    ("IM" . SPARSER::PROTEIN)
    ("anthracyclines and taxanes" . SPARSER::COLLECTION)
    ("the estrogen receptor (ER) and progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("the pan-PI3K inhibitor GDC-0941 or the dual PI3K/mTOR inhibitor GDC-0980"
     . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor GDC-0980" . SPARSER::DRUG)
    ("pan-PI3K" . SPARSER::COLLECTION)
    ("genetic or pharmacological AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BKM-120" . SPARSER::DRUG)
    ("NVP-BKM120" . SPARSER::DRUG) ("BL2 " . SPARSER::PROTEIN)
    ("BL1 " . SPARSER::PROTEIN) ("GDC0980" . SPARSER::DRUG)
    ("NVP-BEZ235" . SPARSER::DRUG) ("BL2" . SPARSER::PROTEIN)
    ("BL1" . SPARSER::PROTEIN)
    ("these contextual factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA1, MSH2, and ATM" . SPARSER::COLLECTION)
    ("ATM or CHEK2" . SPARSER::COLLECTION) ("the miRNA's" . SPARSER::MICRO-RNA)
    ("the homologous recombination genes ATM and CHEK2" . SPARSER::COLLECTION)
    ("ATM and CHEK2" . SPARSER::COLLECTION)
    ("synthetic lethality-based cancer therapeutics" . SPARSER::THERAPEUTICS)
    ("TGFβ1 and miR-181" . SPARSER::COLLECTION)
    ("TGFβ1 and BRCA1" . SPARSER::COLLECTION) ("Tau-b" . SPARSER::COLLECTION)
    ("Tau" . SPARSER::PROTEIN)
    ("TGFβ1, miR-181, and BRCA1" . SPARSER::COLLECTION)
    ("ATM and BRCA1" . SPARSER::COLLECTION)
    ("miR-181 and miR-21 most effectively abolished TGFβ's"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PBS or doxorubicin" . SPARSER::COLLECTION)
    ("doxorubicin and ABT-888" . SPARSER::COLLECTION)
    ("ABT-888 or PBS" . SPARSER::COLLECTION)
    ("ATM and MSH2" . SPARSER::COLLECTION)
    ("BRCA or ATM" . SPARSER::COLLECTION)
    ("ATM , MSH2 , and BRCA1" . SPARSER::COLLECTION)
    ("HPRT" . SPARSER::PROTEIN) ("ATM , MSH2 , or BRCA1" . SPARSER::COLLECTION)
    ("the genotoxic chemotherapeutic agent doxorubicin" . SPARSER::PROTEIN)
    ("HDR" . SPARSER::PROTEIN) ("TGFB1 and ATM" . SPARSER::COLLECTION)
    ("BRCA1 and MSH2" . SPARSER::COLLECTION)
    ("mediating TGFβ's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ ligand or expression of Alk5 TD in both TNBC lines ( xref and data not shown)"
     . SPARSER::COLLECTION)
    ("ATM, MSH2, and BRCA1" . SPARSER::COLLECTION) ("Alk5" . SPARSER::PROTEIN)
    ("TD" . SPARSER::PROTEIN)
    ("exogenous TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MSH2 , MSH6 , MLH1 , ATM , and BRCA1" . SPARSER::COLLECTION)
    ("MSH2 and ATM" . SPARSER::COLLECTION)
    ("further identified BRCA1" . SPARSER::PROTEIN)
    ("P53, BRCA1, and CHEK2" . SPARSER::COLLECTION)
    ("many chemotherapeutic drugs" . SPARSER::DRUG)
    ("TGFB1 and MSH2" . SPARSER::COLLECTION)
    ("Drosha/p68" . SPARSER::COLLECTION) ("Drosha" . SPARSER::PROTEIN)
    ("TGFβ/SMADs" . SPARSER::COLLECTION)
    ("TGFβ and SMADs" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors and HER2" . SPARSER::COLLECTION)
    ("BRCA1, ATM, and MSH2" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM) and mutS homolog 2 (MSH2)"
     . SPARSER::COLLECTION)
    ("IL2R" . SPARSER::PROTEIN) ("LY2109761" . SPARSER::DRUG)
    ("TβRI" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("TGFβ1" . SPARSER::PROTEIN) ("mutS homolog 2" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GLUT1 and LDHA" . SPARSER::COLLECTION)
    ("sirtuins, SIRT3, SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("sirtuins, SIRT1, SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("factors, cofactors and regulators" . SPARSER::COLLECTION)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("SIRT3, IDH1, and GOT2" . SPARSER::COLLECTION)
    ("Pfn1 and mitochondria" . SPARSER::COLLECTION)
    ("Pfn1-" . SPARSER::PROTEIN)
    ("HIF1α-targeted lactate dehydrogenase A (LDHA) and Glut1 [ xref ]"
     . SPARSER::COLLECTION)
    ("lactate dehydrogenase A (LDHA)" . SPARSER::PROTEIN)
    ("Pfn1 and shSIRT3" . SPARSER::COLLECTION)
    ("Pfn1 or SIRT3" . SPARSER::COLLECTION)
    ("Pfn1 and HIF1α" . SPARSER::COLLECTION) ("Pfn1-KD" . SPARSER::COLLECTION)
    ("pcDNA3-HIF1α, and pcDNA3" . SPARSER::COLLECTION)
    ("pcDNA3-HIF1α" . SPARSER::PROTEIN-PAIR) ("SIRT3-HA" . SPARSER::COLLECTION)
    ("Pfn1-FLAG" . SPARSER::COLLECTION)
    ("Pfn1 and SIRT3" . SPARSER::COLLECTION)
    ("Ki67, PCNA and c-Myc" . SPARSER::COLLECTION)
    ("SIRT3-" . SPARSER::PROTEIN)
    ("polyproline ligands and phosphoinositide [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("investigating Pfn1’s" . SPARSER::PROTEIN)
    ("polyproline" . SPARSER::PROTEIN) ("SIRT3-HIF1α" . SPARSER::COLLECTION)
    ("the Pfn1-associated proteins" . SPARSER::PROTEIN)
    ("an actin-associated protein" . SPARSER::PROTEIN)
    ("Pfn1" . SPARSER::PROTEIN) ("abnormal actin" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("HIF1a" . SPARSER::PROTEIN) ("lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("E-F" . SPARSER::PROTEIN) ("PFN1" . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("Profilin1" . SPARSER::PROTEIN)
    ("Per2-p53" . SPARSER::COLLECTION) ("Clock/Bmal1" . SPARSER::COLLECTION)
    ("a secondary step" . SPARSER::PROTEIN)
    ("the hp53/hPer2 complex and hp53 stabilization" . SPARSER::COLLECTION)
    ("the cardiomyocyte circadian clock" . SPARSER::PROTEIN)
    ("CBP/p300" . SPARSER::COLLECTION)
    ("the ovarian tumor domain-containing ubiquitin aldehyde-binding protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Otub1" . SPARSER::PROTEIN) ("aldehyde" . SPARSER::MOLECULE)
    ("The herpes virus–associated ubiquitin-specific protease (HAUSP)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protease (HAUSP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HAUSP" . SPARSER::PROTEIN) ("hPer2/hp53" . SPARSER::COLLECTION)
    ("long-period" . SPARSER::PROTEIN) ("NCL" . SPARSER::PROTEIN)
    ("the clock's" . SPARSER::PROTEIN) ("p53–clock" . SPARSER::COLLECTION)
    ("the clock factor hPer2 and the tumor suppressor hp53 ( xref and xref )"
     . SPARSER::COLLECTION)
    ("core circadian clock components" . SPARSER::COMPONENT)
    ("hPer2-hp53" . SPARSER::COLLECTION) ("SFN and BAX" . SPARSER::COLLECTION)
    ("SFN , CDKN1a , and GADD45α" . SPARSER::COLLECTION)
    ("hp53 and not vice versa" . SPARSER::COLLECTION)
    ("CDKN1a , GADD45α , or BAX" . SPARSER::COLLECTION)
    ("CDKN1a , SFN , GADD45α , and BAX" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("CDKN1a" . SPARSER::PROTEIN)
    ("erb" . SPARSER::PROTEIN) ("Rev" . SPARSER::PROTEIN)
    ("hp53 ( xref , top) and hPer2 ( xref , bottom)" . SPARSER::COLLECTION)
    ("Bmal1" . SPARSER::PROTEIN) ("hp53 and Mdm2" . SPARSER::COLLECTION)
    ("hp53, Mdm2, and hPer2" . SPARSER::COLLECTION)
    ("the Mdm2/hp53 complex or any" . SPARSER::COLLECTION)
    ("Mdm2/hp53" . SPARSER::COLLECTION) ("hp53/Mdm2" . SPARSER::COLLECTION)
    ("the trimeric complex" . SPARSER::BIO-COMPLEX)
    ("hp53, hPer2, and Mdm2" . SPARSER::COLLECTION)
    ("Mdm2 or hPer2" . SPARSER::COLLECTION)
    ("hPer2 and its E3-ubiquitin ligase β-TrCP" . SPARSER::COLLECTION)
    ("-Mdm2" . SPARSER::COLLECTION) ("FLAG-hPer2" . SPARSER::COLLECTION)
    ("hPer2/Mdm2" . SPARSER::COLLECTION)
    ("hPer2, hp53, and Mdm2 and complexes" . SPARSER::COLLECTION)
    ("Mdm2 and complexes" . SPARSER::COLLECTION)
    ("hp53/hPer2/Mdm2" . SPARSER::COLLECTION)
    ("hp53 and its negative regulator" . SPARSER::COLLECTION)
    ("hPer2 and hp53" . SPARSER::COLLECTION) ("GST-hp53" . SPARSER::COLLECTION)
    ("-hp53" . SPARSER::COLLECTION) ("GST-hPer2" . SPARSER::COLLECTION)
    ("hPer2—GST-hPer2" . SPARSER::COLLECTION)
    ("hp53 and hPer2" . SPARSER::COLLECTION)
    ("antibody or immunoglobulin" . SPARSER::COLLECTION)
    ("hp53/hPer2" . SPARSER::COLLECTION) ("hp53" . SPARSER::PROTEIN)
    ("FLAG-hp53" . SPARSER::COLLECTION) ("-hPer2" . SPARSER::COLLECTION)
    ("p53 and Per2" . SPARSER::COLLECTION)
    ("Clock/NPAS2" . SPARSER::COLLECTION)
    ("neurotransmitters" . SPARSER::MOLECULE) ("Clock" . SPARSER::PROTEIN)
    ("the circadian factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TCTP" . SPARSER::PROTEIN) ("streptomycin" . SPARSER::DRUG)
    ("nonselective media" . SPARSER::PROTEIN) ("triazole" . SPARSER::MOLECULE)
    ("patched" . SPARSER::PROTEIN) ("pBT" . SPARSER::PROTEIN)
    ("full-length hPer2 and two fragments" . SPARSER::COLLECTION)
    ("CCND1 , CCNA2 , and MYC" . SPARSER::COLLECTION)
    ("circadian factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a core circadian component and tumor suppressor protein"
     . SPARSER::COLLECTION)
    ("a core circadian component" . SPARSER::COMPONENT)
    ("iod" . SPARSER::MOLECULE) ("the circadian clock genes" . SPARSER::GENE)
    ("all circadian-controlled genes" . SPARSER::GENE)
    ("the molecular circadian clock" . SPARSER::PROTEIN)
    ("whose protein products are necessary components" . SPARSER::COMPONENT)
    ("core circadian clock genes are genes" . SPARSER::GENE)
    ("a stable trimeric complex" . SPARSER::BIO-COMPLEX)
    ("circadian components" . SPARSER::COMPONENT)
    ("a trimeric complex" . SPARSER::BIO-COMPLEX)
    ("p53 and Mdm2" . SPARSER::COLLECTION) ("SP6" . SPARSER::PROTEIN)
    ("Gal11" . SPARSER::PROTEIN) ("hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK9" . SPARSER::PROTEIN)
    ("growth arrest and DNA-damage-inducible" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN) ("NR1D1" . SPARSER::PROTEIN)
    ("Per1" . SPARSER::PROTEIN) ("NPAS2" . SPARSER::PROTEIN)
    ("CCNA2" . SPARSER::PROTEIN) ("mPer2" . SPARSER::PROTEIN)
    ("Per2" . SPARSER::PROTEIN) ("per2" . SPARSER::PROTEIN)
    ("period 2" . SPARSER::PROTEIN) ("hPer2" . SPARSER::PROTEIN)
    ("Period 2" . SPARSER::PROTEIN)
    ("cancer are cell cycle-associated genes" . SPARSER::GENE)
    ("Foxa2" . SPARSER::PROTEIN) ("Cre-" . SPARSER::PROTEIN)
    ("LYZ" . SPARSER::PROTEIN) ("lysozyme" . SPARSER::PROTEIN)
    ("the well-differentiated P63" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P63, KRT5 and KRT14" . SPARSER::COLLECTION)
    ("severe COPD" . SPARSER::PROTEIN) ("SPARC" . SPARSER::PROTEIN)
    ("distal lung factor Sox9" . SPARSER::PROTEIN)
    ("Wt and Myb" . SPARSER::COLLECTION) ("Wt" . SPARSER::PROTEIN)
    ("Shh-Cre" . SPARSER::COLLECTION)
    ("downstream Notch-regulated genes" . SPARSER::GENE)
    ("NICD" . SPARSER::PROTEIN)
    ("mucous cell-associated genes Muc5ac , Spdef and Foxa3"
     . SPARSER::COLLECTION)
    ("Muc5ac , Spdef and Foxa3" . SPARSER::COLLECTION)
    ("Spdef" . SPARSER::PROTEIN)
    ("several secretory cell-related genes" . SPARSER::GENE)
    ("approximately 2,900 genes" . SPARSER::GENE)
    ("naphthalene" . SPARSER::MOLECULE)
    ("Scgb1a1 or Muc5ac" . SPARSER::COLLECTION)
    ("cells lacked transcription factors Foxj1 and Rfx3" . SPARSER::COLLECTION)
    ("Foxj1 and Rfx3" . SPARSER::COLLECTION)
    ("α-tubulin and γ-tubulin" . SPARSER::COLLECTION)
    ("TEC" . SPARSER::PROTEIN) ("p63 or Krt14" . SPARSER::COLLECTION)
    ("Myb-" . SPARSER::PROTEIN) ("ALI" . SPARSER::PROTEIN)
    ("the secretory type" . TYPE) ("club, or Clara" . SPARSER::COLLECTION)
    ("club" . SPARSER::PROTEIN) ("Muc5ac" . SPARSER::PROTEIN)
    ("Myb" . SPARSER::PROTEIN) ("one-step" . SPARSER::PROTEIN)
    ("Foxp1" . SPARSER::PROTEIN) ("Foxm1" . SPARSER::PROTEIN)
    ("Jagged1" . SPARSER::PROTEIN) ("3a1" . SPARSER::PROTEIN)
    ("FOXJ1" . SPARSER::PROTEIN) ("FC 1" . SPARSER::PROTEIN)
    ("KRT14" . SPARSER::PROTEIN) ("KRT5" . SPARSER::PROTEIN)
    ("SSEA-1" . SPARSER::PROTEIN) ("Sox9" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("Hey1" . SPARSER::PROTEIN)
    ("MUC5AC" . SPARSER::PROTEIN) ("IL-13" . SPARSER::PROTEIN)
    ("Foxa3" . SPARSER::PROTEIN) ("Scgb3a1" . SPARSER::PROTEIN)
    ("P63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rfx3" . SPARSER::PROTEIN)
    ("Krt5" . SPARSER::PROTEIN) ("Krt14" . SPARSER::PROTEIN)
    ("V-myb" . SPARSER::PROTEIN) ("Scgb1a1" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN) ("Foxj1" . SPARSER::PROTEIN)
    ("APC-" . SPARSER::PROTEIN)
    ("polymerized tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac/Cdc42" . SPARSER::COLLECTION)
    ("basal endothelial barrier and re-establishment" . SPARSER::COLLECTION)
    ("barrier and re-establishment" . SPARSER::COLLECTION)
    ("Asef-APC" . SPARSER::COLLECTION) ("EC, and HGF" . SPARSER::COLLECTION)
    ("PAK1 and regulator" . SPARSER::COLLECTION)
    ("Asef, APC and Tiam1" . SPARSER::COLLECTION)
    ("APC and Asef" . SPARSER::COLLECTION)
    ("APC, Asef and Tiam1" . SPARSER::COLLECTION)
    ("EB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TER" . SPARSER::PROTEIN)
    ("ND" . SPARSER::DRUG) ("Nocodazole" . SPARSER::DRUG)
    ("APC-Asef" . SPARSER::COLLECTION) ("pulmonary EC" . SPARSER::PROTEIN)
    ("Asef and APC" . SPARSER::COLLECTION)
    ("c-Met and PI3-kinase" . SPARSER::COLLECTION)
    ("Asef or Tiam1" . SPARSER::COLLECTION)
    ("Asef/IQGAP1" . SPARSER::COLLECTION)
    ("Tiam1 or Asef" . SPARSER::COLLECTION) ("avidin" . SPARSER::PROTEIN)
    ("Bar" . SPARSER::PROTEIN) ("Tiam1 or both proteins" . SPARSER::COLLECTION)
    ("Asef, Tiam1 or both proteins" . SPARSER::COLLECTION)
    ("Asef and Tiam1" . SPARSER::COLLECTION)
    ("Adenomatous Polyposis Coli Protein (APC)" . SPARSER::PROTEIN)
    ("SH3" . SPARSER::PROTEIN) ("APC or Asef" . SPARSER::COLLECTION)
    ("high molecular weight hyaluronan and protective oxidized phospholipids [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("hyaluronan" . SPARSER::MOLECULE) ("Epac" . SPARSER::PROTEIN)
    ("Dbl" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase (PI3-kinase) and its downstream effector GSK-3β [ xref ] and small GTPase Rac [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("its downstream effector GSK-3β [ xref ] and small GTPase Rac [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Src and c-Abl" . SPARSER::COLLECTION)
    ("Erk1/2 and p38" . SPARSER::COLLECTION) ("Barrier" . SPARSER::PROTEIN)
    ("a multifunctional mesenchyme-derived factor" . SPARSER::PROTEIN-PAIR)
    ("mesenchyme-derived factor" . SPARSER::PROTEIN-PAIR)
    ("agonists and growth factors" . SPARSER::COLLECTION)
    ("barrier disruptive bioactive molecules" . SPARSER::MOLECULE)
    ("Rac and its cytoskeletal effectors PAK1 and cortactin"
     . SPARSER::COLLECTION)
    ("its cytoskeletal effectors PAK1 and cortactin" . SPARSER::COLLECTION)
    ("PAK1 and cortactin" . SPARSER::COLLECTION)
    ("HGF receptor and PI3-kinase" . SPARSER::COLLECTION)
    ("Tiam1 and Asef" . SPARSER::COLLECTION) ("Asef" . SPARSER::PROTEIN)
    ("pathologic agonists" . SPARSER::AGONIST) ("IQGAP1" . SPARSER::PROTEIN)
    ("matrix-bound" . SPARSER::PROTEIN) ("G15" . SPARSER::PROTEIN)
    ("Adenomatous Polyposis Coli Protein" . SPARSER::PROTEIN)
    ("γ-catenin" . SPARSER::PROTEIN) ("HGF receptor" . SPARSER::PROTEIN)
    ("Si-RNA" . SPARSER::RNA) ("Tamoxifen" . SPARSER::MOLECULE)
    ("tamoxifen, fulvestrant, and aromatase" . SPARSER::COLLECTION)
    ("CyclinD1 and estrogen-induced CyclinD1 ( xref )" . SPARSER::COLLECTION)
    ("CCND1/Cyclin D1" . SPARSER::COLLECTION)
    ("just inhibiting ERα" . SPARSER::PROTEIN)
    ("ERα and its downstream target genes" . SPARSER::COLLECTION)
    ("CTSD and pS2" . SPARSER::COLLECTION) ("CTSD" . SPARSER::PROTEIN)
    ("ERα and its downstream target gene Cyclin D1" . SPARSER::COLLECTION)
    ("regular media" . SPARSER::PROTEIN)
    ("PARP and caspase-7" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY) ("licorice" . SPARSER::DRUG)
    ("Paris" . SPARSER::PROTEIN) ("A popular form" . SPARSER::FORM)
    ("estrogen and estrogen" . SPARSER::COLLECTION)
    ("ERα and Cyclin D1" . SPARSER::COLLECTION) ("ER-α" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("regular PSA" . SPARSER::PROTEIN)
    ("both the carrier group and the non-carrier comparison group"
     . SPARSER::COLLECTION)
    ("age and PSA" . SPARSER::COLLECTION) ("IMPACT" . SPARSER::PROTEIN)
    ("cis-platinum" . SPARSER::DRUG)
    ("Bcl-2, Bcl-xL and survivin" . SPARSER::COLLECTION)
    ("PTP-BL" . SPARSER::COLLECTION) ("PTPRT" . SPARSER::PROTEIN)
    ("NANOG" . SPARSER::PROTEIN)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("JAKs and Akt" . SPARSER::COLLECTION)
    ("Src and JAKs" . SPARSER::COLLECTION)
    ("Src and JAK" . SPARSER::COLLECTION)
    ("c-Src, JAK1 and JAK2" . SPARSER::COLLECTION)
    ("cyclin D1, Bcl-2, Bcl-xL, survivin, VEGF and MMP-9"
     . SPARSER::COLLECTION)
    ("JAK1, JAK2 and Src" . SPARSER::COLLECTION)
    ("The pivotal aim" . SPARSER::PROTEIN)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION) ("esterase" . SPARSER::PROTEIN)
    ("pro-caspase-3" . SPARSER::COLLECTION)
    ("pro-caspase-9" . SPARSER::COLLECTION)
    ("pro-caspases" . SPARSER::COLLECTION)
    ("pro-apoptotic protein" . SPARSER::PROTEIN)
    ("the pro-apoptotic proteins Bak and Bax" . SPARSER::COLLECTION)
    ("survivin and Mcl-1" . SPARSER::COLLECTION)
    ("the angiogenic gene product VEGF and an important matrix metalloproteinase-9 (MMP-9)"
     . SPARSER::COLLECTION)
    ("the antiapoptotic proteins (Bcl-xL, survivin), the angiogenic gene product VEGF and an important matrix metalloproteinase-9 (MMP-9)"
     . SPARSER::COLLECTION)
    ("the angiogenic gene product VEGF" . SPARSER::PROTEIN)
    ("dominant-negative STAT3" . SPARSER::PROTEIN) ("PRF" . SPARSER::PROTEIN)
    ("STAT3, JAK1 and JAK2" . SPARSER::COLLECTION)
    ("SHP-2 and SHP-1" . SPARSER::COLLECTION)
    ("pervanadate" . SPARSER::PROTEIN) ("PTPase" . SPARSER::PROTEIN)
    ("Tyrosine" . SPARSER::AMINO-ACID)
    ("interleukins and other cytokines ( xref )" . SPARSER::COLLECTION)
    ("interleukins" . SPARSER::PROTEIN) ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("soluble tyrosine kinases" . SPARSER::KINASE)
    ("mutated oligonucleotide" . SPARSER::MOLECULE)
    ("mitochondrial, Akt/PKB and NF- κ B" . SPARSER::COLLECTION)
    ("strong antioxidant" . SPARSER::PROTEIN) ("bark" . SPARSER::PROTEIN)
    ("a naturally occurring dietary pentacyclic triterpene"
     . SPARSER::MOLECULE)
    ("triterpene" . SPARSER::MOLECULE)
    ("STAT3 and NF- κ B" . SPARSER::COLLECTION)
    ("Pervanadate" . SPARSER::PROTEIN) ("JAKs" . SPARSER::PROTEIN)
    ("TC-PTP" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("SHP-1" . SPARSER::PROTEIN)
    ("TC45" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("IL-6R α" . SPARSER::PROTEIN) ("SH-PTP2" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("T-ICs" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN)
    ("gefitinib or carboplatin" . SPARSER::COLLECTION)
    ("LUX" . SPARSER::PROTEIN) ("a longer PFS" . SPARSER::PROTEIN)
    ("all reported significantly longer PFS" . SPARSER::PROTEIN)
    ("only median PFS" . SPARSER::PROTEIN)
    ("erlotinib (13.2 months) and gefitinib (9.8 months)"
     . SPARSER::COLLECTION)
    ("runs" . SPARSER::PROTEIN-FAMILY)
    ("erlotinib (12.4 months) or gefitinib (9.4 months)" . SPARSER::COLLECTION)
    ("PFS/TTP" . SPARSER::COLLECTION) ("TTP" . SPARSER::PROTEIN)
    ("afatinib and icotinib" . SPARSER::COLLECTION)
    ("longer PFS" . SPARSER::PROTEIN)
    ("Afatinib and icotinib" . SPARSER::COLLECTION)
    ("evaluated icotinib and one" . SPARSER::COLLECTION)
    ("gefitinib and other EGFR TKIs" . SPARSER::COLLECTION)
    ("dacomitinib (an irreversible TKI of EGFR, HER2 and HER4) and icotinib (an EGFR TKI)"
     . SPARSER::COLLECTION)
    ("Afatinib (an irreversible HER-family blocker), dacomitinib (an irreversible TKI of EGFR, HER2 and HER4) and icotinib (an EGFR TKI)"
     . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER4" . SPARSER::COLLECTION)
    ("more recent TKIs" . SPARSER::PROTEIN)
    ("afatinib, dacomitinib and icotinib" . SPARSER::COLLECTION)
    ("icotinib" . SPARSER::DRUG) ("dacomitinib" . SPARSER::DRUG)
    ("cetuximab and PI3K or mTOR" . SPARSER::COLLECTION)
    ("PI3K or mTOR" . SPARSER::COLLECTION)
    ("PIK3CA- and RAS-" . SPARSER::COLLECTION)
    ("RAS and PI3KCA" . SPARSER::COLLECTION)
    ("PI3K-α, AKT, and mTOR" . SPARSER::COLLECTION)
    ("TORC1 and TORC2" . SPARSER::COLLECTION)
    ("PI3K/TORC1/TORC2" . SPARSER::COLLECTION)
    ("RAS and PIK3CA" . SPARSER::COLLECTION)
    ("clinically relevant mTOR" . SPARSER::PROTEIN)
    ("cetuximab-" . SPARSER::DRUG)
    ("Rapamycin or cetuximab and rapamycin" . SPARSER::COLLECTION)
    ("CD31 and LYVE1" . SPARSER::COLLECTION)
    ("cetuximab or rapamycin" . SPARSER::COLLECTION)
    ("cetuximab, rapamycin, and cetuximab" . SPARSER::COLLECTION)
    ("Cetuximab and Rapamycin" . SPARSER::COLLECTION)
    ("cetuximab and rapamycin" . SPARSER::COLLECTION)
    ("cetuximab and the mTOR inhibitor rapamycin" . SPARSER::COLLECTION)
    ("EGFR and mTOR" . SPARSER::COLLECTION)
    ("PI3K- and RAS" . SPARSER::COLLECTION)
    ("Cetuximab and mTOR" . SPARSER::COLLECTION)
    ("ERK or mTOR" . SPARSER::COLLECTION)
    ("EGFR and pEGFR" . SPARSER::COLLECTION)
    ("pAKT and pERK" . SPARSER::COLLECTION)
    ("PIK3CA- and RAS" . SPARSER::COLLECTION)
    ("AKT, and ERK" . SPARSER::COLLECTION)
    ("the catalytic PI3K-α subunit and oncogenic mutants"
     . SPARSER::COLLECTION)
    ("cetuximab and rapamycin or Rad001" . SPARSER::COLLECTION)
    ("rapamycin or Rad001" . SPARSER::COLLECTION)
    ("rapamycin and Rad001" . SPARSER::COLLECTION)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("cetuximab and PI3K" . SPARSER::COLLECTION)
    ("EGFR, PIK3CA , and RAS" . SPARSER::COLLECTION)
    ("cetuximab and mTOR" . SPARSER::COLLECTION)
    ("PIK3CA and RAS" . SPARSER::COLLECTION)
    ("a monoclonal blocking antibody" . SPARSER::ANTIBODY)
    ("LYVE1" . SPARSER::PROTEIN) ("TORC1 complex" . SPARSER::BIO-COMPLEX)
    ("PI3K-α" . SPARSER::PROTEIN) ("new light" . SPARSER::PROTEIN)
    ("JAZF1-JJAZ1" . SPARSER::COLLECTION) ("NPM-ALK" . SPARSER::COLLECTION)
    ("twist" . SPARSER::PROTEIN)
    ("the constitutively active promoter" . SPARSER::PROMOTER)
    ("estrogen or tamoxifen" . SPARSER::COLLECTION)
    ("E2, or tamoxifen" . SPARSER::COLLECTION)
    ("AKT, ERK, and p38" . SPARSER::COLLECTION)
    ("a key scaffold protein" . SPARSER::PROTEIN)
    ("c-Met/Gab1/PI3K-AKT" . SPARSER::COLLECTION)
    ("the matched Agilent gene" . SPARSER::GENE)
    ("the available antibody" . SPARSER::ANTIBODY)
    ("fusion-specific siRNA" . SPARSER::PROTEIN)
    ("the ΔCCDC170 variants or vector control" . SPARSER::COLLECTION)
    ("a commercial polyclonal antibody" . SPARSER::ANTIBODY)
    ("14kDa" . SPARSER::PROTEIN) ("30kDa" . SPARSER::PROTEIN)
    ("39kDa" . SPARSER::PROTEIN) ("41kDa" . SPARSER::PROTEIN)
    ("ESR1 or CCDC170" . SPARSER::COLLECTION)
    ("significantly higher Ki67" . SPARSER::PROTEIN)
    ("ESR1 and exon" . SPARSER::COLLECTION)
    ("the luminal A subtype" . SPARSER::PROTEIN)
    ("all possible variant" . SPARSER::VARIANT)
    ("ESR1 and CCDC170" . SPARSER::COLLECTION)
    ("the fallopian tube" . SPARSER::PROTEIN)
    ("P2RY6-ARHGEF17" . SPARSER::COLLECTION) ("TICs" . SPARSER::PROTEIN)
    ("the estrogen receptor gene ESR1 and the adjacent gene CCDC170"
     . SPARSER::COLLECTION)
    ("catalog meaningful fusion genes" . SPARSER::GENE)
    ("MAGI3-AKT3" . SPARSER::COLLECTION) ("FGFR-TACC" . SPARSER::COLLECTION)
    ("BCOR-CCNB3" . SPARSER::COLLECTION) ("VTI1A-TCF7L2" . SPARSER::COLLECTION)
    ("TACC" . SPARSER::PROTEIN-FAMILY) ("BCOR" . SPARSER::PROTEIN)
    ("signalosome" . SPARSER::PROTEIN)
    ("N-terminally truncated CCDC170 proteins" . SPARSER::PROTEIN)
    ("ESR1-CCDC170" . SPARSER::COLLECTION)
    ("estrogen receptor gene ESR1 and its neighbor CCDC170"
     . SPARSER::COLLECTION)
    ("the more aggressive forms" . SPARSER::FORM) ("PUM1" . SPARSER::PROTEIN)
    ("ESR 1" . SPARSER::PROTEIN) ("JJAZ1" . SPARSER::PROTEIN)
    ("JAZF1" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("S-G2" . SPARSER::PROTEIN)
    ("ARHGEF17" . SPARSER::PROTEIN) ("P2RY6" . SPARSER::PROTEIN)
    ("MAGI3" . SPARSER::PROTEIN) ("CCNB3" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("VTI1A" . SPARSER::PROTEIN)
    ("CCDC170" . SPARSER::PROTEIN)
    ("a residual familial component" . SPARSER::COMPONENT)
    ("birth cohort or country" . SPARSER::COLLECTION)
    ("BIRTH COHORT AND COUNTRY" . SPARSER::COLLECTION)
    ("COHORT" . SPARSER::MOLECULE) ("HORMONE-RECEPTOR" . SPARSER::COLLECTION)
    ("RECEPTOR" . SPARSER::PROTEIN) ("HORMONE" . SPARSER::PROTEIN)
    ("Age" . SPARSER::PROTEIN) ("FAMILIES" . SPARSER::PROTEIN-FAMILY)
    ("well-documented genes" . SPARSER::GENE)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY)
    ("estrogen-receptor" . SPARSER::PROTEIN) ("CMK" . SPARSER::PROTEIN)
    ("Ku70 and other DDR-associated proteins" . SPARSER::COLLECTION)
    ("several DDR-associated genes" . SPARSER::GENE)
    ("other DDR-associated proteins" . SPARSER::PROTEIN)
    ("IMR90-RSH and IMR90-hTERT" . SPARSER::COLLECTION)
    ("Cyclooxygenase-2 (COX-2) and Twist1" . SPARSER::COLLECTION)
    ("IL6 and IL8" . SPARSER::COLLECTION)
    ("Interleukin-6 (IL6) and IL8" . SPARSER::COLLECTION)
    ("Ras and hTERT" . SPARSER::COLLECTION)
    ("hTERT and oncogenic-Ras" . SPARSER::COLLECTION)
    ("RSH" . SPARSER::PROTEIN) ("Interleukin-8" . SPARSER::PROTEIN)
    ("Ku 80" . SPARSER::PROTEIN) ("Ku 70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ku80" . SPARSER::PROTEIN)
    ("anthracyclines or taxanes" . SPARSER::COLLECTION)
    ("standard unfavorable characteristics and vice versa" . SPARSER::PROTEIN)
    ("THRA and CDC6" . SPARSER::COLLECTION)
    ("STARD3 and THRA" . SPARSER::COLLECTION)
    ("ERBB2 and STARD3" . SPARSER::COLLECTION)
    ("STARD3, PSMD3 and THRA" . SPARSER::COLLECTION)
    ("FISH and aCGH" . SPARSER::COLLECTION)
    ("genes or regions" . SPARSER::COLLECTION)
    ("the favorable prognosis group" . SPARSER::MOLECULE)
    ("CMF" . SPARSER::PROTEIN)
    ("STARD3, ERBB2, PSMD3 and THRA" . SPARSER::COLLECTION)
    ("ERBB2, PSMD3, THRA, CDC6 and IGFBP4" . SPARSER::COLLECTION)
    ("ERBB2, STARD3, PSMD3 and THRA" . SPARSER::COLLECTION)
    ("ERBB2, PSMD3 and THRA" . SPARSER::COLLECTION)
    ("FISH and ERBB2" . SPARSER::COLLECTION)
    ("THRA and RARA" . SPARSER::COLLECTION)
    ("the four HER2-amplicon-related genes" . SPARSER::GENE)
    ("RARA and IGFBP4" . SPARSER::COLLECTION)
    ("ERBB2 and its neighbor genes ( STARD3, PSMD3, THRA )"
     . SPARSER::COLLECTION)
    ("RARA, TOP2A and IGFBP4" . SPARSER::COLLECTION)
    ("ERBB2 and four additional genes" . SPARSER::COLLECTION)
    ("PSMD3, THRA and CDC6" . SPARSER::COLLECTION) ("THRA" . SPARSER::PROTEIN)
    ("ERBB2 (p = 0.014) and SMARCE1 (p = 0.012)" . SPARSER::COLLECTION)
    ("IGFBP4 (p = 0.030) and STAT3 (p = 0.011)" . SPARSER::COLLECTION)
    ("ERBB2 (p = 0.004) and CDC6 (p = 0.022)" . SPARSER::COLLECTION)
    ("STARD3 and ERBB2" . SPARSER::COLLECTION)
    ("classic FISH" . SPARSER::PROTEIN)
    ("ERBB2 and TOP2A" . SPARSER::COLLECTION)
    ("larger parts" . SPARSER::COMPONENT) ("-genes" . SPARSER::GENE)
    ("Kappa" . SPARSER::PROTEIN-FAMILY)
    ("HER2- and non-HER2-genes" . SPARSER::COLLECTION)
    ("CN" . SPARSER::PROTEIN) ("HER2 and TOP2A" . SPARSER::COLLECTION)
    ("KRT20" . SPARSER::PROTEIN) ("SMARCE1" . SPARSER::PROTEIN)
    ("IGFBP4" . SPARSER::PROTEIN) ("PSMD3" . SPARSER::PROTEIN)
    ("STARD3" . SPARSER::PROTEIN) ("NOS2" . SPARSER::PROTEIN)
    ("TOP2A" . SPARSER::PROTEIN) ("FAST" . SPARSER::PROTEIN)
    ("a much longer MOS, MPFSI and MPFSE" . SPARSER::COLLECTION)
    ("TKI and WBRT" . SPARSER::COLLECTION) ("Hirsch FR’s" . SPARSER::PROTEIN)
    ("Gefinitib or Erlotinib" . SPARSER::COLLECTION)
    ("Gefinitib" . SPARSER::DRUG) ("FR" . SPARSER::PROTEIN)
    ("MOS, MPFSI and PFSE" . SPARSER::COLLECTION)
    ("the TKI group and 54 " . SPARSER::COLLECTION)
    ("Gefitinib or Erlotinib" . SPARSER::COLLECTION)
    ("the remaining common independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("favorable factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MOS, MPFSI and MPFSE" . SPARSER::COLLECTION)
    ("MOS, MPFSI, and MPFSE" . SPARSER::COLLECTION) ("MOS" . SPARSER::PROTEIN)
    ("the dominant pathological subtype" . SPARSER::PROTEIN)
    ("All prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAM and HEX" . SPARSER::COLLECTION) ("HEX" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN) ("mix" . SPARSER::PROTEIN)
    ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("IL-10 and PGE2" . SPARSER::COLLECTION)
    ("hypohalous acid oxidants" . SPARSER::MOLECULE)
    ("TLR3, TLR4 and TLR9" . SPARSER::COLLECTION)
    ("secondary modulators" . SPARSER::PROTEIN)
    ("TGF-β, PGE2, and IL-10" . SPARSER::COLLECTION)
    ("a strong TLR agonist" . SPARSER::AGONIST)
    ("STAT3 and C/EBP" . SPARSER::COLLECTION)
    ("IL-10-JAK-STAT" . SPARSER::COLLECTION)
    ("LPS and glucocorticoids" . SPARSER::COLLECTION)
    ("glucocorticoids" . SPARSER::PROTEIN)
    ("secondary mediators" . SPARSER::PROTEIN)
    ("IL-10 (reviewed in xref ) and S100A8" . SPARSER::COLLECTION)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("cAMP which promotes synergistic PKA- and p38-dependent IL-10 production"
     . SPARSER::COLLECTION)
    ("synergistic PKA-" . SPARSER::PROTEIN) ("PKA-" . SPARSER::PROTEIN)
    ("-PKA" . SPARSER::COLLECTION) ("receptor (EP)" . SPARSER::RECEPTOR)
    ("pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("neither IL-10 nor PGE 2" . SPARSER::COLLECTION)
    ("TGFβ and cAMP" . SPARSER::COLLECTION)
    ("receptors, and cAMP" . SPARSER::COLLECTION)
    ("Macrophage" . SPARSER::PROTEIN) ("Mediators" . SPARSER::PROTEIN)
    ("primary murine peritoneal exudate macrophages and human M-CSF-differentiated macrophages"
     . SPARSER::COLLECTION)
    ("primary murine peritoneal exudate macrophages" . SPARSER::PROTEIN)
    ("bacterial DNA or CpG-containing ODNs" . SPARSER::COLLECTION)
    ("human placental DNA" . SPARSER::DNA) ("pIRES-EGFP" . SPARSER::COLLECTION)
    ("VEGF and Jab1" . SPARSER::COLLECTION) ("AA or TT" . SPARSER::COLLECTION)
    ("exon and intron" . SPARSER::COLLECTION)
    ("IL-10 and COX-2/PGE 2" . SPARSER::COLLECTION)
    ("p38, JNK, PI3K and JAK-STAT" . SPARSER::COLLECTION)
    ("P38, JNK, PI3K, and JAK" . SPARSER::COLLECTION)
    ("MAPK, PI3K, and JAK" . SPARSER::COLLECTION)
    ("Exogenous IL-10 or PGE 2" . SPARSER::COLLECTION)
    ("P38, JNK, PI3K, and JAK2" . SPARSER::COLLECTION)
    ("exogenous IL-10 or PGE 2" . SPARSER::COLLECTION)
    ("IL-10 or PGE 2" . SPARSER::COLLECTION)
    ("PGE 2 and IL-10" . SPARSER::COLLECTION)
    ("S100A8 and IL-10" . SPARSER::COLLECTION) ("Ruxolitinib" . SPARSER::DRUG)
    ("U0126, SB202190, and JNK" . SPARSER::COLLECTION)
    ("particular MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPKs, PI3K and JAK2" . SPARSER::COLLECTION)
    ("IL-10 or COX-2" . SPARSER::COLLECTION)
    ("receptor and EP4" . SPARSER::COLLECTION) ("AH" . SPARSER::MOLECULE)
    ("EP1" . SPARSER::PROTEIN) ("IL-10 and/or PGE 2" . SPARSER::COLLECTION)
    ("Indomethacin" . SPARSER::DRUG)
    ("decreased CpG-DNA-induced S100A8 mRNA" . SPARSER::RNA)
    ("Cycloheximide" . SPARSER::PROTEIN) ("Placental DNA" . SPARSER::DNA)
    ("IL-10 ( xref ) and COX-2 ( xref ) mRNAs" . SPARSER::COLLECTION)
    ("IL-10 and COX-2" . SPARSER::COLLECTION)
    ("CpG-dinucleotides" . SPARSER::PROTEIN-PAIR)
    ("neither human DNA nor DNase-treated E" . SPARSER::COLLECTION)
    ("Neither DNase-treated DNA ( xref ) nor human DNA (not shown)"
     . SPARSER::COLLECTION)
    ("Neither DNase-treated DNA" . SPARSER::DNA)
    ("human monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("DNase ( xref ) or CpG-ODN co-incubated" . SPARSER::COLLECTION)
    ("placental DNA" . SPARSER::DNA) ("the bacterial DNAs" . SPARSER::DNA)
    ("MAPKs, PI3K, and JAK-STAT" . SPARSER::COLLECTION)
    ("myeloperoxidase" . SPARSER::PROTEIN) ("HOCl" . SPARSER::MOLECULE)
    ("IL-6, IL-12 and iNOS" . SPARSER::COLLECTION)
    ("IL-10 and cAMP/PGE 2" . SPARSER::COLLECTION)
    ("LPS, Poly I:C, IFNγ or TNF" . SPARSER::COLLECTION)
    ("fungi" . SPARSER::PROTEIN) ("calprotectin" . SPARSER::PROTEIN)
    ("MRP8 or Calgranulin A" . SPARSER::COLLECTION)
    ("MRP9 or Calgranulin" . SPARSER::COLLECTION)
    ("monocytes, macrophages and neutrophils" . SPARSER::COLLECTION)
    ("CpG-ODN" . SPARSER::COLLECTION) ("-deoxyribose" . SPARSER::MOLECULE)
    ("deoxyribose" . SPARSER::MOLECULE)
    ("Bacterial and viral DNAs" . SPARSER::DNA)
    ("Secondary genes" . SPARSER::GENE)
    ("secondary response genes" . SPARSER::GENE)
    ("chemokines and antimicrobial proteins" . SPARSER::COLLECTION)
    ("proinflammatory cytokines, chemokines and antimicrobial proteins"
     . SPARSER::COLLECTION)
    ("antimicrobial proteins" . SPARSER::PROTEIN)
    ("Macrophages" . SPARSER::PROTEIN) ("receptor (TLR)" . SPARSER::RECEPTOR)
    ("PAMPs" . SPARSER::PROTEIN) ("TLR" . SPARSER::PROTEIN)
    ("MAPKs, PI3K and JAK" . SPARSER::COLLECTION)
    ("IL-10 and PGE 2" . SPARSER::COLLECTION)
    ("prostanoid" . SPARSER::MOLECULE)
    ("IL-10 and Prostaglandin E 2" . SPARSER::COLLECTION)
    ("S100A9, mRNA and protein" . SPARSER::COLLECTION)
    ("bacterial and viral DNA" . SPARSER::DNA)
    ("S100A8 and S100A9" . SPARSER::COLLECTION)
    ("neutrophil gelatinase-associated lipocalin" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("Bay 11–7082" . SPARSER::DRUG) ("poly I:C" . SPARSER::MOLECULE)
    ("IL-1Ra" . SPARSER::PROTEIN) ("Jab1" . SPARSER::PROTEIN)
    ("N5" . SPARSER::PROTEIN) ("JAK-2" . SPARSER::PROTEIN)
    ("Stat-3" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("AH-6809" . SPARSER::DRUG) ("NS398" . SPARSER::DRUG)
    ("AG490" . SPARSER::DRUG) ("SB202190" . SPARSER::DRUG)
    ("TLR3" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("Poly I:C" . SPARSER::MOLECULE) ("S100A8/A9" . SPARSER::PROTEIN)
    ("MRP9" . SPARSER::PROTEIN) ("Calgranulin A" . SPARSER::PROTEIN)
    ("MRP8" . SPARSER::PROTEIN) ("TRAF3" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN) ("IP-10" . SPARSER::PROTEIN)
    ("CXCL-10" . SPARSER::PROTEIN) ("Prostaglandin E 2" . SPARSER::MOLECULE)
    ("almost all the EGF" . SPARSER::PROTEIN) ("hEGF" . SPARSER::PROTEIN)
    ("typical MRI" . SPARSER::PROTEIN) ("MRIs" . SPARSER::PROTEIN)
    ("the heterozygous c" . SPARSER::PROTEIN) ("TGG/CCA" . SPARSER::COLLECTION)
    ("CCA" . SPARSER::PROTEIN) ("MRA" . SPARSER::PROTEIN)
    ("trans-membrane protein" . SPARSER::COLLECTION)
    ("ankyrin" . SPARSER::PROTEIN) ("migraine" . SPARSER::PROTEIN)
    ("cysteine and glycine" . SPARSER::COLLECTION)
    ("the neurogenic locus notch homolog protein 3 ( NOTCH3 ) gene"
     . SPARSER::PROTEIN)
    ("1–C" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("hTERT, TERC , and microsatellite" . SPARSER::COLLECTION)
    ("MLL2, MLL3, ARID1A , and SMARCA2" . SPARSER::COLLECTION)
    ("HRAS and/or FGFR3" . SPARSER::COLLECTION)
    ("other genomic hot" . SPARSER::PROTEIN)
    ("FGFR3-Ras" . SPARSER::COLLECTION)
    ("FBXW7, ERBB2 , and NOTCH1" . SPARSER::COLLECTION)
    ("NOTCH1 (R1594Q) and TP53 (M160I)" . SPARSER::COLLECTION)
    ("FBXW7 and ERBB2" . SPARSER::COLLECTION) ("GP5/GP6" . SPARSER::COLLECTION)
    ("LG, and INV" . SPARSER::COLLECTION) ("LG" . SPARSER::MOLECULE)
    ("INV" . SPARSER::PROTEIN)
    ("the 50 most frequently mutated oncogenes and tumor suppressors"
     . SPARSER::COLLECTION)
    ("genomic hot" . SPARSER::PROTEIN)
    ("HRAS, KRAS , and BRAF" . SPARSER::COLLECTION)
    ("SMARCA2" . SPARSER::PROTEIN) ("ARID1A" . SPARSER::PROTEIN)
    ("MLL3" . SPARSER::PROTEIN) ("kit 2" . SPARSER::PROTEIN)
    ("GP6" . SPARSER::PROTEIN) ("GP5" . SPARSER::PROTEIN)
    ("p16INK4a" . SPARSER::PROTEIN)
    ("QKI , KIAA1239 , EPHA5 , NACC2 , MCTS1 and SAMD4A" . SPARSER::COLLECTION)
    ("QKI" . SPARSER::PROTEIN) ("N-cadherin and IGF-IR" . SPARSER::COLLECTION)
    ("IGFIR" . SPARSER::PROTEIN)
    ("Insulin and insulin-like growth factor receptor" . SPARSER::COLLECTION)
    ("other clinicopathologic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mRNAs and miRNA" . SPARSER::COLLECTION)
    ("IGF1R and N-cadherin" . SPARSER::COLLECTION)
    ("high miR-194 expression group (n=21) and low miR-194 expression group (n=78)"
     . SPARSER::COLLECTION)
    ("high miR-194 expression group (n=41) and low miR-194 expression group (n=66)"
     . SPARSER::COLLECTION)
    ("NATs" . SPARSER::PROTEIN)
    ("an OE group (overexpression of miRNA-194) and a KD group (knocked down miRNA-194)"
     . SPARSER::COLLECTION)
    ("a blank group (untransfected cells), a control group (cells transfected with the control lentivirus), an OE group (overexpression of miRNA-194) and a KD group (knocked down miRNA-194)"
     . SPARSER::COLLECTION)
    ("its possible direct targets" . SPARSER::TARGET-PROTEIN)
    ("IGF1R and CDH2" . SPARSER::COLLECTION)
    ("self-renewal factor BMI-1" . SPARSER::PROTEIN)
    ("CDH2 (N-cadherin) and TLN2 ( xref – xref )" . SPARSER::COLLECTION)
    ("SSH2 , HBEGF , IGF1R , CDH2 (N-cadherin) and TLN2 ( xref – xref )"
     . SPARSER::COLLECTION)
    ("HBEGF" . SPARSER::PROTEIN)
    ("99 formalin- or paraformalin-fixed paraffin-embedded tissues"
     . SPARSER::COLLECTION)
    ("CDH2 and IGF1R" . SPARSER::COLLECTION) ("formalin-" . SPARSER::MOLECULE)
    ("CDH2 (N-cadherin) and IGF1R" . SPARSER::COLLECTION)
    ("SAMD4A" . SPARSER::PROTEIN) ("MCTS1" . SPARSER::PROTEIN)
    ("NACC2" . SPARSER::PROTEIN) ("EPHA5" . SPARSER::PROTEIN)
    ("KIAA1239" . SPARSER::PROTEIN) ("l-glutamine" . SPARSER::MOLECULE)
    ("Hepatocyte nuclear factor" . SPARSER::PROTEIN)
    ("SSH2" . SPARSER::PROTEIN)
    ("p27 kip1 , CDK2, cyclin D1 and PCNA" . SPARSER::COLLECTION)
    ("CDK2-cyclin" . SPARSER::COLLECTION)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE)
    ("cyclin D1-CDK2" . SPARSER::COLLECTION)
    ("cyclin E and CDK2" . SPARSER::COLLECTION)
    ("FOXO3a and p27 kip1" . SPARSER::COLLECTION) ("AFX" . SPARSER::PROTEIN)
    ("Bim and p27 kip1" . SPARSER::COLLECTION)
    ("Akt-FOXO3a-Bim" . SPARSER::COLLECTION)
    ("the triple mutant form" . SPARSER::FORM)
    ("previously constructed recombinant adenovirus vectors Ad-TM (triple mutant)-FOXO3a"
     . SPARSER::COLLECTION)
    ("FOXO1, FOXO3, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("cyclin D1 and CDK2" . SPARSER::COLLECTION)
    ("cyclin E/CDK2" . SPARSER::COLLECTION)
    ("cyclin D1/CDK6" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("cyclin dependent kinases (CDKs) and cyclins" . SPARSER::COLLECTION)
    ("clock" . SPARSER::PROTEIN) ("CDKIs" . SPARSER::DRUG)
    ("Transfected EPCs appeared green" . SPARSER::PROTEIN)
    ("green fluorescent light and ordinary light ( xref )"
     . SPARSER::COLLECTION)
    ("ordinary light" . SPARSER::PROTEIN) ("vWF" . SPARSER::PROTEIN)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hemin" . SPARSER::MOLECULE)
    ("Hcy" . SPARSER::MOLECULE) ("PCNA, p21 and p27" . SPARSER::COLLECTION)
    ("Atorvastatin" . SPARSER::DRUG) ("cyclin/CDK" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO4" . SPARSER::COLLECTION)
    ("CDK2, cyclin D1 and PCNA" . SPARSER::COLLECTION)
    ("cyclin D1 and proliferating cell nuclear antigen" . SPARSER::COLLECTION)
    ("-FOXO3a" . SPARSER::COLLECTION) ("Protein kinase B" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("green fluorescent" . SPARSER::PROTEIN)
    ("six 6" . SPARSER::PROTEIN) ("Ser-315" . SPARSER::PROTEIN)
    ("kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vascular endothelial" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("Forkhead box" . SPARSER::PROTEIN) ("MAPK/ERK1/2" . SPARSER::COLLECTION)
    ("β 1" . SPARSER::PROTEIN) ("β 1-ERK" . SPARSER::COLLECTION)
    ("antibody or non-immune" . SPARSER::COLLECTION)
    ("receptors and ERK" . SPARSER::COLLECTION)
    ("IGFBP-2 and integrin" . SPARSER::COLLECTION)
    ("RGD" . SPARSER::COLLECTION) ("Integrin" . SPARSER::PROTEIN)
    ("U87, SU3, and U251" . SPARSER::COLLECTION)
    ("integrin-ERK" . SPARSER::COLLECTION)
    ("Arg-Gly-Asp" . SPARSER::COLLECTION)
    ("Exogenous IGFBP-2" . SPARSER::PROTEIN)
    ("U87 and U251" . SPARSER::COLLECTION)
    ("exogenous IGFBP-2" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("β 1-integrin" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGFBP-2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("snail and twist1" . SPARSER::COLLECTION) ("Meta" . SPARSER::PROTEIN)
    ("apt" . SPARSER::PROTEIN) ("pathological type" . TYPE)
    ("selectin" . SPARSER::PROTEIN-FAMILY) ("twist1" . SPARSER::PROTEIN)
    ("actin-arc" . SPARSER::COLLECTION) ("arc" . SPARSER::PROTEIN)
    ("MLCK" . SPARSER::PROTEIN) ("RhoA and RhoGDI" . SPARSER::COLLECTION)
    ("an unconventional type" . TYPE) ("PDK1/MRCK" . SPARSER::COLLECTION)
    ("MLC2 or the myosin phosphatase target subunit-1 MyPT1 ( xref )"
     . SPARSER::COLLECTION)
    ("Rho-GTPase–associated kinases" . SPARSER::KINASE)
    ("Akt and RSK" . SPARSER::COLLECTION)
    ("PDK1_WT or PDK1_KD" . SPARSER::COLLECTION)
    ("PDK1_WT and PDK1_KD" . SPARSER::COLLECTION)
    ("PDK1_KD and PDK1_Δ50" . SPARSER::COLLECTION)
    ("PDK1_WT and PDK1" . SPARSER::COLLECTION)
    ("PLA and TIRF" . SPARSER::COLLECTION) ("MRCKα/PDK1" . SPARSER::COLLECTION)
    ("polymerized actin" . SPARSER::PROTEIN) ("PDK1_L155E" . SPARSER::PROTEIN)
    ("PDK1_K465E" . SPARSER::PROTEIN) ("PDK1_KD" . SPARSER::PROTEIN)
    ("GFP-PDK1_K465E" . SPARSER::COLLECTION)
    ("GFP-PDK1_L155E, and GFP-PDK1_KD" . SPARSER::COLLECTION)
    ("GFP-PDK1_KD" . SPARSER::COLLECTION)
    ("GFP-PDK1_L155E" . SPARSER::COLLECTION)
    ("GFP-PDK1_WT" . SPARSER::COLLECTION)
    ("mCherry-MRCKα" . SPARSER::COLLECTION) ("GFP-PDK1" . SPARSER::COLLECTION)
    ("MRCKα" . SPARSER::PROTEIN) ("GST-MRCKα" . SPARSER::COLLECTION)
    ("PDK1_WT and MRCKα" . SPARSER::COLLECTION) ("PDK1_WT" . SPARSER::PROTEIN)
    ("both S19 ( xref and S3B) and T18/S19 ( xref and S3 C)"
     . SPARSER::COLLECTION)
    ("MLC2 and MyPT1" . SPARSER::COLLECTION)
    ("Myc-tagged PDK1 and endogenous MRCKα" . SPARSER::COLLECTION)
    ("their respective antibodies" . SPARSER::ANTIBODY)
    ("GST-PDK1_WT" . SPARSER::COLLECTION) ("GST-PDK1" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("chelerythrine" . SPARSER::DRUG)
    ("EGF ( xref ) and FMI ( xref )" . SPARSER::COLLECTION)
    ("Rho-GTPase–associated kinase" . SPARSER::KINASE)
    ("Blebbistatin" . SPARSER::DRUG)
    ("nonmuscular myosin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("all Rho-GTPase–associated kinases" . SPARSER::KINASE)
    ("the Rho-GTPase–associated kinase family" . SPARSER::PROTEIN-FAMILY)
    ("SGK2, S6K, Akt, and RSK2" . SPARSER::COLLECTION)
    ("In contrast PDK1_ΔPH and PDK1_L155E mutants" . SPARSER::MUTANT)
    ("exogenous mutants" . SPARSER::MUTANT)
    ("membrane-associated PIP3" . SPARSER::PIP3)
    ("PH domain-deleted mutant" . SPARSER::MUTANT) ("EK" . SPARSER::PROTEIN)
    ("PH" . SPARSER::PROTEIN) ("FMI" . SPARSER::PROTEIN)
    ("significantly increase chemotaxis" . SPARSER::PROTEIN)
    ("actin-myosin" . SPARSER::COLLECTION)
    ("GTPase-CDC42" . SPARSER::COLLECTION)
    ("Rho-associated protein kinase (ROCK; xref )—citron Rho-interacting kinase (CRIK; xref ) and myotonin protein kinase (DMPK; xref )—and three isoforms"
     . SPARSER::COLLECTION)
    ("myotonin protein kinase (DMPK; xref )—and three isoforms"
     . SPARSER::COLLECTION)
    ("myotonic dystrophy kinase–related CDC42-binding kinase"
     . SPARSER::KINASE)
    ("Rho-associated protein kinase (ROCK; xref )—citron Rho-interacting kinase"
     . SPARSER::KINASE)
    ("—citron" . SPARSER::COLLECTION) ("DMPK" . SPARSER::PROTEIN)
    ("CRIK" . SPARSER::PROTEIN) ("citron" . SPARSER::PROTEIN)
    ("regulators of cell migration and tumor cell invasion"
     . SPARSER::COLLECTION)
    ("nonmuscle" . SPARSER::PROTEIN) ("nonmuscle-myosin" . SPARSER::COLLECTION)
    ("acto-myosin" . SPARSER::COLLECTION)
    ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("fragment (PIF)" . SPARSER::FRAGMENT) ("PIF" . SPARSER::PROTEIN)
    ("p70S6K, SGK, RSK, and PKC" . SPARSER::COLLECTION)
    ("SGK" . SPARSER::PROTEIN) ("AGC" . SPARSER::PROTEIN)
    ("PDK1 and MRCKα" . SPARSER::COLLECTION) ("MRCK" . SPARSER::PROTEIN)
    ("Phenol red" . SPARSER::DRUG) ("N-Term" . SPARSER::PROTEIN)
    ("CDC42BPB" . SPARSER::PROTEIN) ("CCL-2" . SPARSER::PROTEIN)
    ("myosin phosphatase" . SPARSER::PROTEIN) ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("MCL2" . SPARSER::PROTEIN) ("Y-27632" . SPARSER::MOLECULE)
    ("2 B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RSK2" . SPARSER::PROTEIN)
    ("SGK2" . SPARSER::PROTEIN) ("GSK2334470" . SPARSER::DRUG)
    ("Ral-GEF" . SPARSER::PROTEIN) ("_WT" . SPARSER::PROTEIN)
    ("1 D" . SPARSER::PROTEIN) ("1 C" . SPARSER::PROTEIN)
    ("MRCKγ" . SPARSER::PROTEIN) ("MyPT1" . SPARSER::PROTEIN)
    ("myosin phosphatase target subunit 1" . SPARSER::PROTEIN)
    ("S19" . SPARSER::PROTEIN) ("MLC2" . SPARSER::PROTEIN)
    ("myosin regulatory light chain 2" . SPARSER::PROTEIN)
    ("PLCγ1" . SPARSER::PROTEIN) ("cAMP-dependent" . SPARSER::PROTEIN)
    ("FLT3-ITD-induced miR-155" . SPARSER::PROTEIN)
    ("FLT3-ITD/miR-155/PU.1" . SPARSER::COLLECTION)
    ("pmiRZip-scr" . SPARSER::COLLECTION) ("miRZip-scr" . SPARSER::COLLECTION)
    ("miR-155 directly targets PU.1" . SPARSER::PROTEIN)
    ("pRL-PU.1–3" . SPARSER::COLLECTION) ("pRL" . SPARSER::PROTEIN)
    ("LNA" . SPARSER::PROTEIN) ("LNAs" . SPARSER::PROTEIN)
    ("ctrl" . SPARSER::PROTEIN) ("LSK" . SPARSER::PROTEIN)
    ("MEPs" . SPARSER::PROTEIN) ("GMPs" . SPARSER::PROTEIN)
    ("CMPs" . SPARSER::CMP) ("myeloid and erythroid" . SPARSER::COLLECTION)
    ("neither STAT5 nor STAT5 1*6" . SPARSER::COLLECTION)
    ("pGL3-" . SPARSER::PROTEIN) ("Mx-Cre" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("flox" . SPARSER::PROTEIN)
    ("STAT5 and p65" . SPARSER::COLLECTION)
    ("STAT5 or p65" . SPARSER::COLLECTION) ("p65/STAT5" . SPARSER::COLLECTION)
    ("p65 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("TKD and FLT3" . SPARSER::COLLECTION) ("PKI" . SPARSER::PROTEIN-FAMILY)
    ("PKIs" . SPARSER::PROTEIN-FAMILY) ("TKD" . SPARSER::PROTEIN)
    ("FLT3-TKD" . SPARSER::COLLECTION) ("ITD and FLT3" . SPARSER::COLLECTION)
    ("FLT3-ITD-associated AML" . SPARSER::PROTEIN) ("MV" . SPARSER::PROTEIN)
    ("ITDs" . SPARSER::PROTEIN) ("p65 and STAT5" . SPARSER::COLLECTION)
    ("FLT3-ITD downstream targets nuclear factor-κB (p65) and signal transducer"
     . SPARSER::COLLECTION)
    ("IL3" . SPARSER::PROTEIN) ("SU5614" . SPARSER::MOLECULE)
    ("PKC412" . SPARSER::DRUG) ("IL-3" . SPARSER::PROTEIN)
    ("interleukin-3" . SPARSER::PROTEIN) ("C/EBPα" . SPARSER::PROTEIN)
    ("PU.1" . SPARSER::PROTEIN)
    ("transcription factor PU.1" . SPARSER::PROTEIN)
    ("miR-155" . SPARSER::PROTEIN) ("MiR-155" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN) ("KL" . SPARSER::PROTEIN)
    ("YL" . SPARSER::PROTEIN) ("FS" . SPARSER::PROTEIN)
    ("DEPDC1b" . SPARSER::PROTEIN) ("GDP-GTP" . SPARSER::PROTEIN-PAIR)
    ("EGL-10 and Pleckstrin" . SPARSER::COLLECTION)
    ("dominant-negative Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DEPDC1B and Rac" . SPARSER::COLLECTION)
    ("U0126 or PD98059" . SPARSER::COLLECTION)
    ("p38-MAPK-specific inhibitors" . SPARSER::INHIBITOR)
    ("SB203580, SP600125, U0126, and PD98059" . SPARSER::COLLECTION)
    ("DEPDC1B-Rac1" . SPARSER::COLLECTION)
    ("wild-type Rac1 (Rac), dominant-negative Rac1 (RacN17), and constitutively active Rac1 (RacV12)"
     . SPARSER::COLLECTION)
    ("dominant-negative Rac1" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("membrane-associated Rac1 and GTP" . SPARSER::COLLECTION)
    ("Rac1 and GTP" . SPARSER::COLLECTION)
    ("membrane-associated Rac1" . SPARSER::PROTEIN)
    ("membrane-associated GTPases" . SPARSER::GTPASE)
    ("a detergent-insoluble membrane fraction" . SPARSER::COMPONENT)
    ("RhoGEF" . SPARSER::PROTEIN) ("FLAG-DEPDC1B" . SPARSER::COLLECTION)
    ("Rac1, CDC42, or RhoA" . SPARSER::COLLECTION)
    ("Rac1 and Rho" . SPARSER::COLLECTION)
    ("an active membrane-associated GTP-bound form" . SPARSER::FORM)
    ("Rho GTPase-activating protein (GAP)" . SPARSER::COLLECTION)
    ("ERK, p38 and JNK" . SPARSER::COLLECTION) ("retina" . SPARSER::DRUG)
    ("DEPDC1B-Rac1-ERK1/2" . SPARSER::COLLECTION)
    ("Rac, CDC42, and Rho" . SPARSER::COLLECTION) ("RhoGAP" . SPARSER::PROTEIN)
    ("approximately 90 amino acids" . SPARSER::AMINO-ACID)
    ("Pleckstrin" . SPARSER::PROTEIN) ("CDC 42" . SPARSER::PROTEIN)
    ("DEPDC1B " . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("pp38" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("DEPDC1B" . SPARSER::PROTEIN) ("EGL-10" . SPARSER::PROTEIN)
    ("The above-described peptidomimetic molecules" . SPARSER::MOLECULE)
    ("the LxxLL-mimetic small molecule" . SPARSER::MOLECULE)
    ("a peptidomimetic molecule" . SPARSER::MOLECULE)
    ("AR-LBD BF-3-blocking small molecules" . SPARSER::MOLECULE)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-C and AR-coregulator" . SPARSER::COLLECTION)
    ("peptides and proteins" . SPARSER::COLLECTION)
    ("BUD31 and related peptides" . SPARSER::COLLECTION)
    ("BUD31 and other AR-DBD-LBD-related peptides (see sequences in xref )"
     . SPARSER::COLLECTION)
    ("DHT and HF" . SPARSER::COLLECTION)
    ("the AR and the BUD31 peptide" . SPARSER::COLLECTION)
    ("AR and BUD31" . SPARSER::COLLECTION)
    ("ARs and BUD31" . SPARSER::COLLECTION) ("MMTV-LUC" . SPARSER::COLLECTION)
    ("anti-AR or anti-Flag" . SPARSER::COLLECTION)
    ("GST-AR" . SPARSER::COLLECTION) ("wt-BUD31" . SPARSER::COLLECTION)
    ("×-Flag-BUD31" . SPARSER::COLLECTION) ("AR-BUD31" . SPARSER::COLLECTION)
    ("mt" . SPARSER::PROTEIN) ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("hG" . SPARSER::MOLECULE) ("-HY" . SPARSER::COLLECTION)
    ("−HY" . SPARSER::COLLECTION)
    ("aromatic amino acids" . SPARSER::AMINO-ACID)
    ("Leu and Phe" . SPARSER::COLLECTION) ("Phe and Tyr" . SPARSER::COLLECTION)
    ("the +4 peptide and the protein" . SPARSER::COLLECTION)
    ("Trp and His" . SPARSER::COLLECTION)
    ("T877A-AR and W741L-AR" . SPARSER::COLLECTION)
    ("peptide and protein" . SPARSER::COLLECTION)
    ("the nitrogen atom and the hydroxyl group" . SPARSER::COLLECTION)
    ("HF and CDX" . SPARSER::COLLECTION)
    ("ternary wt-AR" . SPARSER::COLLECTION)
    ("Seventeen ternary complex" . SPARSER::BIO-COMPLEX)
    ("a short α-helical peptide" . SPARSER::PEPTIDE)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("wt-AR" . SPARSER::COLLECTION)
    ("DHT-wt-AR-DBD-LBD and HF-T877A-AR-DBD-LBD" . SPARSER::COLLECTION)
    ("DHT-wt-AR-DBD-LBD" . SPARSER::PROTEIN-PAIR)
    ("the HF-T877A mutant and the CDX-W741L mutant" . SPARSER::COLLECTION)
    ("Three binary complex" . SPARSER::BIO-COMPLEX)
    ("androgen or anti-androgen" . SPARSER::COLLECTION)
    ("liganded" . SPARSER::MOLECULE)
    ("the bulky peptide side" . SPARSER::PROTEIN)
    ("modulating coregulator-mediated AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The AR and other nuclear receptors" . SPARSER::COLLECTION)
    ("also known as NCOA4 (nuclear receptor coactivator 4) and SHP"
     . SPARSER::COLLECTION)
    ("ARA70, also known as NCOA4 (nuclear receptor coactivator 4) and SHP"
     . SPARSER::COLLECTION)
    ("SHP" . SPARSER::PROTEIN)
    ("androgens and anti-androgens" . SPARSER::COLLECTION)
    ("estramustine" . SPARSER::DRUG) ("diethylstilbestrol" . SPARSER::DRUG)
    ("nilutamide" . SPARSER::DRUG) ("wt and mutant" . SPARSER::COLLECTION)
    ("DHT-wt-AR" . SPARSER::COLLECTION)
    ("the peptide and Gln733" . SPARSER::COLLECTION)
    ("mt-ARs" . SPARSER::COLLECTION) ("dihydrotestosterone" . SPARSER::DRUG)
    ("CDX" . SPARSER::PROTEIN) ("HF" . SPARSER::PROTEIN)
    ("hydroxyflutamide" . SPARSER::DRUG) ("BF-3" . SPARSER::PROTEIN)
    ("family A" . SPARSER::PROTEIN) ("MAGE-11" . SPARSER::PROTEIN)
    ("EPI-001" . SPARSER::DRUG) ("N-C" . SPARSER::PROTEIN)
    ("EDG-2" . SPARSER::PROTEIN) ("nitrogen atom" . SPARSER::MOLECULE)
    ("H12" . SPARSER::PROTEIN) ("GAG-3" . SPARSER::PROTEIN)
    ("P20" . SPARSER::PROTEIN) ("BL13" . SPARSER::PROTEIN)
    ("magnesium sulfate" . SPARSER::DRUG) ("c-T" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("TAT-3" . SPARSER::PROTEIN)
    ("nuclear receptor subfamily 0" . SPARSER::PROTEIN)
    ("NR0B2" . SPARSER::PROTEIN)
    ("nuclear receptor coactivator 4" . SPARSER::PROTEIN)
    ("NCOA4" . SPARSER::PROTEIN) ("ARA70" . SPARSER::PROTEIN)
    ("megestrol acetate" . SPARSER::DRUG) ("Anti-androgen" . SPARSER::DRUG)
    ("BUD31" . SPARSER::PROTEIN)
    ("the mitotic kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("first two principal components" . SPARSER::COMPONENT)
    ("Diagonal covariance matrices" . SPARSER::PROTEIN-FAMILY)
    ("the native secondary structural element conformations"
     . SPARSER::BIO-CONFORMATION)
    ("EGFR (Met 793) and gefitinib" . SPARSER::COLLECTION)
    ("-EGFR" . SPARSER::COLLECTION) ("L858R/T790M" . SPARSER::PROTEIN)
    ("both the single T790M mutant and the double-mutant L858R/T790M"
     . SPARSER::COLLECTION)
    ("growth factors or other cognate ligands" . SPARSER::COLLECTION)
    ("Multi" . SPARSER::PROTEIN)
    ("matched primary and metastatic CRCs" . SPARSER::PROTEIN)
    ("the aggressive KRAS WT CRCs" . SPARSER::PROTEIN)
    ("the aggressive KRAS G12mut CRCs" . SPARSER::PROTEIN)
    ("Even KRAS WT CRCs" . SPARSER::PROTEIN)
    ("HER1 and HER3" . SPARSER::COLLECTION)
    ("HER3/c-MET" . SPARSER::COLLECTION)
    ("a differential c-MET-" . SPARSER::PROTEIN) ("c-MET-" . SPARSER::PROTEIN)
    ("The primary-metastatic CRC" . SPARSER::PROTEIN)
    ("pHER/pIGF1R" . SPARSER::COLLECTION) ("pIGF" . SPARSER::PROTEIN)
    ("metastatic CRCs" . SPARSER::PROTEIN)
    ("PI3K-driven aggressive CRCs" . SPARSER::PROTEIN)
    ("each KRAS mutational subtype" . SPARSER::PROTEIN)
    ("snap-frozen" . SPARSER::PROTEIN-PAIR)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the multiplexed immunomicroarray based Collaborative Enzyme"
     . SPARSER::ENZYME)
    ("HER1, HER2, HER3, c-MET, and insulin-like growth factor"
     . SPARSER::COLLECTION)
    ("the key negative predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS-RAF-mitogen-activated protein kinase 1" . SPARSER::COLLECTION)
    ("receptor (HER)" . SPARSER::RECEPTOR)
    ("Monoclonal antibodies" . SPARSER::ANTIBODY)
    ("currently approved therapeutics" . SPARSER::THERAPEUTICS)
    ("aggressive CRCs" . SPARSER::PROTEIN)
    ("c-MET and IGF1R" . SPARSER::COLLECTION)
    ("HER1/c-MET" . SPARSER::COLLECTION)
    ("multiplexed collaborative enzyme" . SPARSER::ENZYME)
    ("human epidermal receptor 1" . SPARSER::PROTEIN)
    ("Shc" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 1" . SPARSER::PROTEIN)
    ("phosphatidylinositide 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ki-ras" . SPARSER::PROTEIN) ("ERK and p38" . SPARSER::COLLECTION)
    ("an inflammatory trigger" . SPARSER::PROTEIN)
    ("MSCs and IL-10" . SPARSER::COLLECTION)
    ("TGF-β or IL-10" . SPARSER::COLLECTION)
    ("a critical soluble factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prominent cytokines" . SPARSER::PROTEIN)
    ("TGF-β1 and PGE 2" . SPARSER::COLLECTION)
    ("old donor-derived MSCs" . SPARSER::PROTEIN)
    ("human adipose-derived MSCs" . SPARSER::PROTEIN)
    ("soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOD1 and NOD2" . SPARSER::COLLECTION) ("NOD2-RIP2" . SPARSER::COLLECTION)
    ("/COX-2" . SPARSER::COLLECTION) ("Celecoxib" . SPARSER::DRUG)
    ("PGE 2 and the expression of the COX-2 protein" . SPARSER::COLLECTION)
    ("PGE 2 and COX-2" . SPARSER::COLLECTION)
    ("immunomodulatory molecules" . SPARSER::MOLECULE)
    ("IFN-γ and TNF-α" . SPARSER::COLLECTION)
    ("relevant mediators" . SPARSER::PROTEIN)
    ("PGE 2 , IDO and TGF-β1" . SPARSER::COLLECTION)
    ("PBS or late-passage hMSCs" . SPARSER::COLLECTION)
    ("PBS-" . SPARSER::PROTEIN) ("dextran" . SPARSER::DEXTRAN)
    ("DSS" . SPARSER::PROTEIN) ("ConA" . SPARSER::PROTEIN)
    ("CD29, CD73, and CD105" . SPARSER::COLLECTION)
    ("CD34, CD45, and HLA-DR" . SPARSER::COLLECTION)
    ("Alizarin" . SPARSER::DRUG) ("consecutive MSC" . SPARSER::PROTEIN)
    ("PcGs" . SPARSER::PROTEIN-FAMILY) ("MSC" . SPARSER::PROTEIN)
    ("Cyclooxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EP2 and EP4" . SPARSER::COLLECTION)
    ("nitric oxide (NO) and indoleamine 2, 3-dioxygenase (IDO)"
     . SPARSER::COLLECTION)
    ("several inducible soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("these proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IFN-γ, TNF-α and IL-1" . SPARSER::COLLECTION)
    ("adipocytes, chondrocytes and osteoblasts" . SPARSER::COLLECTION)
    ("MSCs" . SPARSER::PROTEIN) ("COX-2 and PGE 2" . SPARSER::COLLECTION)
    ("Glyceraldehyde-3-Phosphate Dehydrogenase" . SPARSER::PROTEIN)
    ("IFNGR1" . SPARSER::PROTEIN) ("interleukin-2" . SPARSER::PROTEIN)
    ("Con A" . SPARSER::PROTEIN) ("K 3" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Concanavalin A" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("ZMPSTE24" . SPARSER::PROTEIN)
    ("JMJD3" . SPARSER::PROTEIN) ("jumonji domain" . SPARSER::PROTEIN)
    ("RIP2" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("NOD2" . SPARSER::PROTEIN)
    ("nucleotide-binding oligomerization domain" . SPARSER::PROTEIN)
    ("EP4" . SPARSER::PROTEIN) ("EP2" . SPARSER::PROTEIN)
    ("indoleamine 2, 3-dioxygenase" . SPARSER::PROTEIN)
    ("transforming growth factor-β1" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("MYC , BCL2 and BCL6" . SPARSER::COLLECTION)
    ("the optimal cut" . SPARSER::PROTEIN) ("BCL6 and t" . SPARSER::COLLECTION)
    ("IGH and BCL2" . SPARSER::COLLECTION)
    ("MYC , BCL2 and BCL 6" . SPARSER::COLLECTION)
    ("the geographic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD10, BCL6 and MUM1" . SPARSER::COLLECTION)
    ("MYC , BCL6 and BCL2" . SPARSER::COLLECTION)
    ("MYC or BCL2" . SPARSER::COLLECTION)
    ("IPI, MYC, BCL2, and BCL6" . SPARSER::COLLECTION)
    ("high BCL2/BCL6 DHS and high THS" . SPARSER::COLLECTION)
    ("MYC/BCL2 DHS, high MYC/BCL6 DHS, high BCL2/BCL6 DHS and high THS"
     . SPARSER::COLLECTION)
    ("IPI, MYC protein, and BCL2" . SPARSER::COLLECTION)
    ("high BCL2 protein and low BCL6 protein" . SPARSER::COLLECTION)
    ("the negative prognostic impact" . SPARSER::PROTEIN)
    ("limited prognostic impact" . SPARSER::PROTEIN)
    ("the candidate prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY) ("THS-2/3" . SPARSER::COLLECTION)
    ("MYC and BCL6 , and 4/131" . SPARSER::COLLECTION)
    ("BCL6 , and 4/131" . SPARSER::COLLECTION)
    ("MYC, BCL6 and BCL2" . SPARSER::COLLECTION)
    ("MYC , BCL6 , and BCL2" . SPARSER::COLLECTION)
    ("MYC/BCL2/BCL6" . SPARSER::COLLECTION)
    ("BCL2 and BCL6" . SPARSER::COLLECTION)
    ("DHS and THS" . SPARSER::COLLECTION) ("BCL2/BCL6" . SPARSER::COLLECTION)
    ("GCB and non-GCB" . SPARSER::COLLECTION)
    ("MYC, BCL2, BCL6 and Ki67" . SPARSER::COLLECTION)
    ("MYC, BCL2, and BCL6" . SPARSER::COLLECTION)
    ("MYC , BCL2 , and BCL6" . SPARSER::COLLECTION)
    ("MYC and BCL2" . SPARSER::COLLECTION)
    ("GCB and non-germinal" . SPARSER::COLLECTION)
    ("high MYC/BCL2 DHS, high MYC/BCL6 DHS and high THS" . SPARSER::COLLECTION)
    ("CHOP and R-CHOP" . SPARSER::COLLECTION)
    ("high MYC/BCL6 DHS and high THS" . SPARSER::COLLECTION)
    ("multiple adverse prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYC/BCL6" . SPARSER::COLLECTION) ("MYC/BCL2" . SPARSER::COLLECTION)
    ("IPI" . SPARSER::PROTEIN) ("DHS" . SPARSER::PROTEIN)
    ("MYC, BCL2 and BCL6" . SPARSER::COLLECTION) ("THS" . SPARSER::PROTEIN)
    ("BCL2 (≥70%) and BCL6 (≥50%)" . SPARSER::COLLECTION)
    ("MYC (≥40%), BCL2 (≥70%) and BCL6 (≥50%)" . SPARSER::COLLECTION)
    ("MYC and BCL6" . SPARSER::COLLECTION) ("IGH/BCL2" . SPARSER::COLLECTION)
    ("MYC-, BCL2- and BCL6-rearrangements and protein" . SPARSER::COLLECTION)
    ("CHOP or R-CHOP" . SPARSER::COLLECTION)
    ("proteins and MYC" . SPARSER::COLLECTION)
    ("rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("vincristine" . SPARSER::DRUG) ("BCL 6" . SPARSER::PROTEIN)
    ("MUM1" . SPARSER::PROTEIN) ("DP2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins and connexins" . SPARSER::COLLECTION)
    ("connexins" . SPARSER::PROTEIN) ("cerebral ischemia" . SPARSER::PROTEIN)
    ("the epileptic BBB" . SPARSER::PROTEIN)
    ("NG2/PDGFRβ" . SPARSER::COLLECTION)
    ("NG2 and PDGFRβ" . SPARSER::COLLECTION)
    ("PDGFRβ and RECA-1" . SPARSER::COLLECTION)
    ("the microglial marker IBA-1" . SPARSER::PROTEIN)
    ("PDGFRb" . SPARSER::PROTEIN) ("vascular PDGFRβ" . SPARSER::PROTEIN)
    ("PDGFRβ and NG2DsRed" . SPARSER::COLLECTION)
    ("Pericyte soma and ramifications" . SPARSER::COLLECTION)
    ("soma" . SPARSER::DRUG) ("PDGFRβ and NG2" . SPARSER::COLLECTION)
    ("Albumin" . SPARSER::PROTEIN) ("BBB" . SPARSER::PROTEIN)
    ("CS6" . SPARSER::PROTEIN) ("IBA1" . SPARSER::PROTEIN)
    ("platelet derived growth factor receptor beta" . SPARSER::PROTEIN)
    ("IBA-1" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor beta" . SPARSER::PROTEIN)
    ("CDK4/CDK6" . SPARSER::COLLECTION)
    ("immunomodulatory therapeutics" . SPARSER::THERAPEUTICS)
    ("chemotactic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-PD1 and anti-CTL4A" . SPARSER::COLLECTION)
    ("EGFR and ERBB4" . SPARSER::COLLECTION)
    ("a BRCA and a UCEC subtype" . SPARSER::COLLECTION)
    ("each subtype and each IPA" . SPARSER::COLLECTION)
    ("IPAs" . SPARSER::PROTEIN)
    ("subtype or supercluster" . SPARSER::COLLECTION)
    ("at least two subtypes" . SPARSER::PROTEIN) ("NMF" . SPARSER::DRUG)
    ("Subtype" . SPARSER::PROTEIN) ("OV" . SPARSER::MOLECULE)
    ("COAD" . SPARSER::PROTEIN)
    ("the breast carcinoma basal subtype" . SPARSER::PROTEIN)
    ("the classical subtype" . SPARSER::PROTEIN)
    ("robust expression subtypes" . SPARSER::PROTEIN)
    ("CTL4" . SPARSER::PROTEIN) ("PD1" . SPARSER::PROTEIN)
    ("top 1" . SPARSER::PROTEIN)
    ("new reagents or analytic tools" . SPARSER::COLLECTION)
    ("new reagents" . SPARSER::MOLECULE)
    ("SUN, and Fa-bao" . SPARSER::COLLECTION)
    ("Fa" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SUN" . SPARSER::PROTEIN)
    ("WANG" . SPARSER::PROTEIN) ("ACSL1 and ACSL4" . SPARSER::COLLECTION)
    ("YAP and c-Myc" . SPARSER::COLLECTION) ("AFP" . SPARSER::PROTEIN)
    ("an essential downstream effector" . SPARSER::EFFECTOR)
    ("YAP and its direct target genes (c-Myc and CTGF)" . SPARSER::COLLECTION)
    ("Form" . SPARSER::FORM) ("20-paired clinical HCCs" . SPARSER::PROTEIN)
    ("pGL3-YAP" . SPARSER::COLLECTION) ("c-Myc and CTGF" . SPARSER::COLLECTION)
    ("c-Myc and connective tissue growth factor" . SPARSER::COLLECTION)
    ("onco-protein" . SPARSER::COLLECTION) ("HCCs" . SPARSER::PROTEIN)
    ("HBx" . SPARSER::PROTEIN)
    ("approximately 19–25 nucleotides" . SPARSER::NUCLEOTIDE)
    ("YAP and its target genes c-Myc and the connective tissue growth factor (CTGF)"
     . SPARSER::COLLECTION)
    ("its target genes c-Myc and the connective tissue growth factor (CTGF)"
     . SPARSER::COLLECTION)
    ("connective tissue growth factor (CTGF)" . SPARSER::PROTEIN)
    ("MTT and EdU" . SPARSER::COLLECTION)
    ("YAP and its target genes" . SPARSER::COLLECTION)
    ("ACSL4" . SPARSER::PROTEIN) ("ACSL1" . SPARSER::PROTEIN)
    ("family member 1" . SPARSER::PROTEIN) ("SOX7" . SPARSER::PROTEIN)
    ("ABCC4" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 1" . SPARSER::PROTEIN)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("SOX4" . SPARSER::PROTEIN)
    ("box 4" . SPARSER::PROTEIN) ("YAP 3" . SPARSER::PROTEIN)
    ("peripheral AC" . SPARSER::PROTEIN) ("Stella" . SPARSER::PROTEIN)
    ("AC and LCC" . SPARSER::COLLECTION) ("ACs" . SPARSER::PROTEIN)
    ("CE-IVD" . SPARSER::PROTEIN-PAIR)
    ("invasive mucinous and acinar AC" . SPARSER::PROTEIN)
    ("papillary and solid AC" . SPARSER::PROTEIN)
    ("Erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("6.3 " . SPARSER::PROTEIN) ("TTF1" . SPARSER::PROTEIN)
    ("a ZEB1-associated deubiquitinating enzyme" . SPARSER::PROTEIN)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("EMT and
radioresistance"
     . SPARSER::COLLECTION)
    ("safe and effective tumor radiosensitizers" . SPARSER::DRUG)
    ("CHK1 and ZEB1" . SPARSER::COLLECTION)
    ("wild-type ZEB1 or the S585D mutant ( xref )" . SPARSER::COLLECTION)
    ("phosphomimetic (S585D) mutants" . SPARSER::MUTANT)
    ("ZEB1 and ATM" . SPARSER::COLLECTION)
    ("either alanine (S585A) or aspartic acid
(S585D)"
     . SPARSER::COLLECTION)
    ("ZEB1
and CHK1"
     . SPARSER::COLLECTION)
    ("USP7 (either
overexpressed or endogenous) and CHK1"
     . SPARSER::COLLECTION)
    ("HLTF and p53" . SPARSER::COLLECTION)
    ("CHK1, HLTF,
p53 and Claspin"
     . SPARSER::COLLECTION)
    ("USP7 and its various substrates" . SPARSER::COLLECTION)
    ("USP7 and ZEB1" . SPARSER::COLLECTION)
    ("HLTF, p53 or Claspin" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("ZEB1 and USP7" . SPARSER::COLLECTION) ("GST-USP7" . SPARSER::COLLECTION)
    ("MBP" . SPARSER::PROTEIN) ("USP7 and CHK1" . SPARSER::COLLECTION)
    ("ZEB1 and CHK1" . SPARSER::COLLECTION) ("Claspin" . SPARSER::PROTEIN)
    ("HLTF" . SPARSER::PROTEIN)
    ("CTBP2, CTBP1 and SIRT1" . SPARSER::COLLECTION)
    ("SFB-ZEB1" . SPARSER::COLLECTION) ("SFB" . SPARSER::PROTEIN)
    ("CHK1 and CHK2" . SPARSER::COLLECTION) ("DR-GFP" . SPARSER::COLLECTION)
    ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("Snail and Twist" . SPARSER::COLLECTION) ("intact p53" . SPARSER::PROTEIN)
    ("Snail or Twist" . SPARSER::COLLECTION)
    ("Snail, Twist or ZEB1" . SPARSER::COLLECTION)
    ("DDR and tumor
radioresistance"
     . SPARSER::COLLECTION)
    ("CSC" . SPARSER::PROTEIN)
    ("Twist, Snail, Slug, ZEB1 and
ZEB2"
     . SPARSER::COLLECTION)
    ("MRN" . SPARSER::PROTEIN) ("RAD9-HUS1-RAD1" . SPARSER::COLLECTION)
    ("EMT and radioresistance" . SPARSER::COLLECTION)
    ("ZEB1, and ZEB1" . SPARSER::COLLECTION) ("p-H3" . SPARSER::MOLECULE)
    ("Cyclin A" . SPARSER::PROTEIN) ("p-ATM" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("p-S" . SPARSER::PROTEIN)
    ("Ku55933" . SPARSER::DRUG) ("T-Q" . SPARSER::DRUG)
    ("ETP-46464" . SPARSER::DRUG) ("CTBP1" . SPARSER::PROTEIN)
    ("CTBP2" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("RAD1" . SPARSER::PROTEIN) ("HUS1" . SPARSER::PROTEIN)
    ("RAD9" . SPARSER::PROTEIN) ("USP7" . SPARSER::PROTEIN)
    ("zinc finger E-box binding homeobox 1" . SPARSER::PROTEIN)
    ("plausible candidate genes" . SPARSER::GENE)
    ("Cis-eQTLs" . SPARSER::PROTEIN-PAIR) ("POMP" . SPARSER::PROTEIN)
    ("Cis" . SPARSER::PROTEIN) ("MYC or PVT1" . SPARSER::COLLECTION)
    ("PVT1 and LINC00977" . SPARSER::COLLECTION) ("LINC" . SPARSER::PROTEIN)
    ("the new SNP" . SPARSER::PROTEIN)
    ("This SNP and several correlated SNPs" . SPARSER::COLLECTION)
    ("The new SNP" . SPARSER::PROTEIN)
    ("TERT and CLPTM1L" . SPARSER::COLLECTION)
    ("TERT/CLPTM1L" . SPARSER::COLLECTION)
    ("the newly identified synonymous SNP" . SPARSER::PROTEIN)
    ("ABO/ADAMTS13" . SPARSER::COLLECTION)
    ("CLPTM1L/TERT" . SPARSER::COLLECTION)
    ("p53, BRCA1 and ATM" . SPARSER::COLLECTION)
    ("PDX1-AS1" . SPARSER::COLLECTION) ("AS1" . SPARSER::PROTEIN)
    ("CTRB1 and CTRB2" . SPARSER::COLLECTION)
    ("the related genes PRSS1 ( trypsin 1 ) and CTRC" . SPARSER::COLLECTION)
    ("CTRC" . SPARSER::PROTEIN) ("the last exon" . SPARSER::PROTEIN)
    ("a synonymous SNP" . SPARSER::PROTEIN)
    ("KLF5 and KLF12" . SPARSER::COLLECTION) ("Muskelin" . SPARSER::PROTEIN)
    ("Muskelin 1 (MKLN1) and KLF14 ( xref and xref )" . SPARSER::COLLECTION)
    ("ABO , OR = 1" . SPARSER::COLLECTION)
    ("CLPTM1L , OR = 1" . SPARSER::COLLECTION)
    ("KLF5/KLF12" . SPARSER::COLLECTION) ("ABO" . SPARSER::PROTEIN)
    ("call" . SPARSER::PROTEIN)
    ("PanScan III prospective cohorts" . SPARSER::MOLECULE)
    ("BCAR1/CTRB1/CTRB2" . SPARSER::COLLECTION) ("group C" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("Alpha-Tocopherol" . SPARSER::MOLECULE) ("chr8" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("chr13" . SPARSER::PROTEIN)
    ("CFDP1" . SPARSER::PROTEIN) ("RNA 1" . SPARSER::PROTEIN)
    ("pancreatic and duodenal homeobox1" . SPARSER::PROTEIN)
    ("trypsin 1" . SPARSER::PROTEIN) ("PRSS1" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("KLF14" . SPARSER::PROTEIN)
    ("MKLN1" . SPARSER::PROTEIN) ("Muskelin 1" . SPARSER::PROTEIN)
    ("ADAMTS13" . SPARSER::PROTEIN) ("NR5A2" . SPARSER::PROTEIN)
    ("KLF12" . SPARSER::PROTEIN) ("ZNRF3" . SPARSER::PROTEIN)
    ("PDX1" . SPARSER::PROTEIN) ("CTRB2" . SPARSER::PROTEIN)
    ("CTRB1" . SPARSER::PROTEIN) ("BCAR1" . SPARSER::PROTEIN)
    ("LINC-PINT" . SPARSER::PROTEIN) ("bank" . SPARSER::PROTEIN)
    ("Caspase 8 or Ras" . SPARSER::COLLECTION)
    ("TP53- 3p" . SPARSER::COLLECTION)
    ("Caspase 8 as well as Ras and components" . SPARSER::COLLECTION)
    ("Ras and components" . SPARSER::COLLECTION)
    ("CCND1 and FADD" . SPARSER::COLLECTION)
    ("TP53 and chromosome 3p" . SPARSER::COLLECTION)
    ("mRNA and microRNA" . SPARSER::COLLECTION)
    ("genes and other molecular features for stratifying HNSCC tumors"
     . SPARSER::COLLECTION)
    ("-3p" . SPARSER::COLLECTION) ("Caspase 8" . SPARSER::PROTEIN)
    ("MUC5B" . SPARSER::PROTEIN) ("HE" . SPARSER::PROTEIN)
    ("CX" . SPARSER::PROTEIN-FAMILY) ("CDK1/CDK2" . SPARSER::COLLECTION)
    ("Wee1 and CHK1" . SPARSER::COLLECTION)
    ("CHK1 and H2AX" . SPARSER::COLLECTION) ("relapsed AML" . SPARSER::PROTEIN)
    ("a strong transcriptional repressor" . SPARSER::REPRESSOR)
    ("the promyelocytic leukemia ( PML ) gene and the retinoic acid receptor α ( RARα ) gene"
     . SPARSER::COLLECTION)
    ("PML/RARα" . SPARSER::COLLECTION)
    ("all- trans retinoic acid and/or arsenic trioxide" . SPARSER::COLLECTION)
    ("MK-1775 and LY2603618" . SPARSER::COLLECTION)
    ("MK-1775 and Roscovitine" . SPARSER::COLLECTION)
    ("p-CHK1" . SPARSER::COLLECTION) ("CDK2 and MYT1" . SPARSER::COLLECTION)
    ("p-CDK2" . SPARSER::COLLECTION) ("p-CDK1" . SPARSER::COLLECTION)
    ("overactive CDKs" . SPARSER::PROTEIN)
    ("cytarabine (ara-C) and anthracycline [e.g. daunorubicin (DNR)]"
     . SPARSER::COLLECTION)
    ("CHK1 and Wee1" . SPARSER::COLLECTION) ("Roscovitine" . SPARSER::DRUG)
    ("annexin V/PI" . SPARSER::COLLECTION) ("annexin V " . SPARSER::PROTEIN)
    ("MLF1" . SPARSER::PROTEIN) ("AF1q" . SPARSER::PROTEIN)
    ("MYH11" . SPARSER::PROTEIN) ("1L" . SPARSER::PROTEIN)
    ("AF9" . SPARSER::PROTEIN) ("PLZF-RARα" . SPARSER::PROTEIN)
    ("HOX11" . SPARSER::PROTEIN) ("TAL1" . SPARSER::PROTEIN)
    ("AF17" . SPARSER::PROTEIN) ("AF4" . SPARSER::PROTEIN)
    ("AF10" . SPARSER::PROTEIN) ("MDS1" . SPARSER::PROTEIN)
    ("C-kit" . SPARSER::PROTEIN) ("PF-00477736" . SPARSER::DRUG)
    ("MK-8776" . SPARSER::DRUG) ("RARα" . SPARSER::PROTEIN)
    ("LY2603618" . SPARSER::DRUG) ("F-H" . SPARSER::PROTEIN)
    ("MYT1" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("ara-C" . SPARSER::DRUG) ("MK-1775" . SPARSER::DRUG)
    ("BRCA1-RAD50" . SPARSER::COLLECTION)
    ("the energetic barrier" . SPARSER::PROTEIN)
    ("an internal truncated fragment" . SPARSER::FRAGMENT)
    ("purified full-length BRCA1 and BLM proteins and telomeric substrates"
     . SPARSER::COLLECTION)
    ("BRCA1-MRN" . SPARSER::PROTEIN-PAIR)
    ("BRCA1 or BLM" . SPARSER::COLLECTION)
    ("BRCA1 and RAD50" . SPARSER::COLLECTION)
    ("using anti-RAD50" . SPARSER::ANTIBODY)
    ("MRE11-RAD50-NBS" . SPARSER::COLLECTION)
    ("almost all BRCA1 foci" . SPARSER::PROTEIN)
    ("BRCA1 and a telomeric Cy3-(CCCTAA) 3 PNA" . SPARSER::COLLECTION)
    ("PNA" . SPARSER::PROTEIN)
    ("DNA damage-induced replication/recombination foci" . SPARSER::PROTEIN)
    ("APB" . SPARSER::PROTEIN) ("WRN and BLM" . SPARSER::COLLECTION)
    ("dominant-negative BRCA1" . SPARSER::PROTEIN)
    ("BRCA1-CtIP" . SPARSER::COLLECTION) ("BRCA1-BACH1" . SPARSER::COLLECTION)
    ("BRCA1-Abraxas" . SPARSER::COLLECTION) ("CtIP" . SPARSER::PROTEIN)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION) ("SCE" . SPARSER::PROTEIN)
    ("TRF1 and TRF2" . SPARSER::COLLECTION)
    ("POT1, TRF1 and TRF2" . SPARSER::COLLECTION)
    ("proteins and Fanconi anemia" . SPARSER::COLLECTION)
    ("the recQ-like helicases BLM (defective in Bloom's syndrome) and WRN (defective in Werner's syndrome)"
     . SPARSER::COLLECTION)
    ("WRN" . SPARSER::PROTEIN) ("recQ" . SPARSER::PROTEIN)
    ("tri-" . SPARSER::PROTEIN) ("APBs" . SPARSER::PROTEIN)
    ("repetitive non-coding DNA" . SPARSER::DNA)
    ("RAD50 and BLM" . SPARSER::COLLECTION)
    ("BRCA1 and BLM" . SPARSER::COLLECTION)
    ("BLM and BRCA1" . SPARSER::COLLECTION) ("BLM-BRCA1" . SPARSER::COLLECTION)
    ("BLM or BRCA1" . SPARSER::COLLECTION) ("Rad50" . SPARSER::PROTEIN)
    ("PG-M" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("KRAS and TP53" . SPARSER::COLLECTION)
    ("BMI-1 and Ki-67" . SPARSER::COLLECTION)
    ("EZH2 and Ki-67" . SPARSER::COLLECTION)
    ("EZH2 and p27 Kip1" . SPARSER::COLLECTION)
    ("EZH2 and p27 KIP1" . SPARSER::COLLECTION)
    ("EZH2 and BMI-1" . SPARSER::COLLECTION)
    ("EZH2 and PTEN" . SPARSER::COLLECTION)
    ("WAF1 , and PTEN" . SPARSER::COLLECTION)
    ("this complex’s" . SPARSER::BIO-COMPLEX)
    ("DPC4/SMAD4/MADH4" . SPARSER::COLLECTION)
    ("invasive components" . SPARSER::COMPONENT) ("CIS" . SPARSER::PROTEIN)
    ("homolog)" . SPARSER::PROTEIN) ("BMI-1" . SPARSER::PROTEIN)
    ("MADH4" . SPARSER::PROTEIN) ("chromatin and genome" . SPARSER::COLLECTION)
    ("the perinuclear chromatin" . SPARSER::PROTEIN)
    ("NE and chromatin" . SPARSER::COLLECTION)
    ("chromatin-lamin" . SPARSER::COLLECTION) ("ssDNA" . SPARSER::PROTEIN)
    ("nuclear and nonnuclear targets" . SPARSER::COLLECTION)
    ("nonnuclear targets" . SPARSER::TARGET-PROTEIN)
    ("condensins and DNA topoisomerase II" . SPARSER::COLLECTION)
    ("condensins" . SPARSER::PROTEIN-FAMILY)
    ("condensin" . SPARSER::PROTEIN-FAMILY)
    ("perinuclear chromatin" . SPARSER::PROTEIN)
    ("coordinate chromatin and NE dynamics" . SPARSER::COLLECTION)
    ("ATRIP-ATR" . SPARSER::COLLECTION) ("ATRIP and ATR" . SPARSER::COLLECTION)
    ("RPA and DNA" . SPARSER::COLLECTION) ("aphidicolin-" . SPARSER::PROTEIN)
    ("condensation and chromatin" . SPARSER::COLLECTION)
    ("ATR, ATRIP, and pChk1" . SPARSER::COLLECTION)
    ("chromatin " . SPARSER::BIO-COMPLEX)
    ("condensation and NEBD " . SPARSER::COLLECTION)
    ("the partially condensed chromatin" . SPARSER::BIO-COMPLEX)
    ("a functional ATR" . SPARSER::PROTEIN)
    ("condensation and NEBD" . SPARSER::COLLECTION)
    ("RFP-Lamin" . SPARSER::COLLECTION) ("GFP-H2B" . SPARSER::COLLECTION)
    ("Lamin" . SPARSER::PROTEIN)
    ("Condensation and NEBD" . SPARSER::COLLECTION)
    ("Condensation" . SPARSER::PROTEIN-FAMILY)
    ("m-cherry H2B" . SPARSER::PROTEIN) ("CLS" . SPARSER::PROTEIN)
    ("BAPTA" . SPARSER::MOLECULE) ("Targets" . SPARSER::TARGET-PROTEIN)
    ("Rad17 and TopBP1" . SPARSER::COLLECTION)
    ("RPA32 and ATR" . SPARSER::COLLECTION)
    ("ATR and RPA" . SPARSER::COLLECTION) ("RPA-ssDNA" . SPARSER::PROTEIN-PAIR)
    ("Leptomycin" . SPARSER::DRUG) ("RFP-Nucleophosmin" . SPARSER::COLLECTION)
    ("Nucleophosmin" . SPARSER::PROTEIN) ("GFP-ATR" . SPARSER::COLLECTION)
    ("ATR and chromatin" . SPARSER::COLLECTION)
    ("NE and Chk1" . SPARSER::COLLECTION) ("hydroxyurea- (HU)" . SPARSER::DRUG)
    ("hydroxyurea-" . SPARSER::DRUG) ("HU" . SPARSER::DRUG)
    ("p-Chk1" . SPARSER::COLLECTION) ("ATRIP" . SPARSER::PROTEIN)
    ("ATRi" . SPARSER::MOLECULE) ("NE " . SPARSER::PROTEIN)
    ("Colcemid" . SPARSER::DRUG) ("ATR and Chk1" . SPARSER::COLLECTION)
    ("ATR and α-tubulin" . SPARSER::COLLECTION) ("Gold" . SPARSER::MOLECULE)
    ("ATR/Chk1" . SPARSER::COLLECTION) ("ATR and Nup153" . SPARSER::COLLECTION)
    ("SR-SIM" . SPARSER::COLLECTION) ("SIM" . SPARSER::PROTEIN)
    ("Fraction" . SPARSER::COMPONENT)
    ("the inner and outer nuclear" . SPARSER::PROTEIN)
    ("RPA or DNA" . SPARSER::COLLECTION)
    ("key nucleoporins" . SPARSER::PROTEIN) ("nucleoporins" . SPARSER::PROTEIN)
    ("NE" . SPARSER::PROTEIN) ("lamin-associated chromatin" . SPARSER::PROTEIN)
    ("highly recombinogenic and aberrant DNA" . SPARSER::DNA)
    ("an essential PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mec1/ATR" . SPARSER::COLLECTION) ("ATR 1" . SPARSER::PROTEIN)
    ("Lamin-A" . SPARSER::PROTEIN) ("Leptomycin B" . SPARSER::MOLECULE)
    ("RAD17" . SPARSER::PROTEIN) ("NUP153" . SPARSER::PROTEIN)
    ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("DNA topoisomerase II" . SPARSER::PROTEIN) ("mec1" . SPARSER::PROTEIN)
    ("Rad53" . SPARSER::PROTEIN) ("TORC2" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("Rad17" . SPARSER::PROTEIN)
    ("ATR-interacting protein" . SPARSER::PROTEIN)
    ("leptomycin B" . SPARSER::MOLECULE) ("Nup153" . SPARSER::PROTEIN)
    ("replication protein" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN) ("Mec1" . SPARSER::PROTEIN)
    ("a strong independent predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/FLT3-ITD" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("poor EFS" . SPARSER::PROTEIN)
    ("the favorable karyotypes t(8;21) and inv(16)" . SPARSER::COLLECTION)
    ("the favorable karyotypes t" . SPARSER::PROTEIN)
    ("FAB" . SPARSER::PROTEIN) ("t(15;17) and inv(16)" . SPARSER::COLLECTION)
    ("known prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLT3-ITD" . SPARSER::COLLECTION) ("fms" . SPARSER::PROTEIN)
    ("CEBPA" . SPARSER::PROTEIN) ("inv" . SPARSER::PROTEIN)
    ("paralogue" . SPARSER::PROTEIN) ("EVI1" . SPARSER::PROTEIN)
    ("ecotropic viral integration site 1" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN)
    ("crizotinib and their generation" . SPARSER::COLLECTION)
    ("EML4-" . SPARSER::PROTEIN) ("TFG" . SPARSER::PROTEIN)
    ("nucleophosmin (NPM)" . SPARSER::PROTEIN) ("NPM" . SPARSER::PROTEIN)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("HME" . SPARSER::PROTEIN) ("TGF and KIF5" . SPARSER::COLLECTION)
    ("/mTOR" . SPARSER::COLLECTION) ("CNA" . SPARSER::PROTEIN)
    ("CNAs" . SPARSER::PROTEIN) ("Arm" . SPARSER::PROTEIN)
    ("NPM 1" . SPARSER::PROTEIN) ("KIF 5B" . SPARSER::PROTEIN)
    ("TRK-fused gene" . SPARSER::PROTEIN) ("Kinesin family" . SPARSER::PROTEIN)
    ("CEP2" . SPARSER::PROTEIN) ("KIF5" . SPARSER::PROTEIN)
    ("anaplastic lymphoma Kinase" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("a heterologous receptor" . SPARSER::PROTEIN)
    ("HB-EGF and EGFR" . SPARSER::COLLECTION)
    ("ErbB-1/EGFR" . SPARSER::COLLECTION)
    ("ADAM-9 and ADAM-10" . SPARSER::COLLECTION)
    ("proHB-EGF" . SPARSER::COLLECTION) ("disintegrin" . SPARSER::PROTEIN)
    ("uPA and plasmin" . SPARSER::COLLECTION)
    ("the general inhibitor NAC and the more specific inhibitors DPI and apocynin"
     . SPARSER::COLLECTION)
    ("DPI and apocynin" . SPARSER::COLLECTION) ("apocynin" . SPARSER::MOLECULE)
    ("DPI" . SPARSER::PROTEIN) ("src, PKC and oxygen" . SPARSER::COLLECTION)
    ("ARK" . SPARSER::PROTEIN) ("Gαq and Gβγ" . SPARSER::COLLECTION)
    ("siRNA and siRNA" . SPARSER::COLLECTION)
    ("Disintegrin And Metalloproteinase" . SPARSER::COLLECTION)
    ("MMP and ADAM" . SPARSER::COLLECTION)
    ("EACA and aprotinin" . SPARSER::COLLECTION)
    ("aprotinin" . SPARSER::PROTEIN) ("EACA" . SPARSER::DRUG)
    ("inhibitor and inhibitors" . SPARSER::COLLECTION)
    ("plasmin and metalloproteinases" . SPARSER::COLLECTION)
    ("CTF, EGF and HB-EGF" . SPARSER::COLLECTION)
    ("EGF and HB-EGF" . SPARSER::COLLECTION)
    ("Pyk2 and protein kinase" . SPARSER::COLLECTION)
    ("the tethered ligand heparin binding-EGF [HB-EGF] or other latent ligands"
     . SPARSER::COLLECTION)
    ("a heterologous receptor-linked tyrosine kinase" . SPARSER::PROTEIN)
    ("Plasmin" . SPARSER::PROTEIN) ("GPI" . SPARSER::PROTEIN)
    ("uPA or plasminogen" . SPARSER::COLLECTION)
    ("proteases, integrins and extracellular" . SPARSER::COLLECTION)
    ("src" . SPARSER::PROTEIN) ("plasmin and MMP" . SPARSER::COLLECTION)
    ("both plasmin inhibitors and the EGFR inhibitor" . SPARSER::COLLECTION)
    ("metalloprotease [MMP] and A Disintegrin and Metalloproteinase [ADAM]"
     . SPARSER::COLLECTION)
    ("Disintegrin and Metalloproteinase" . SPARSER::COLLECTION)
    ("EGFR and ADAMs" . SPARSER::COLLECTION) ("ADAMs" . SPARSER::PROTEIN)
    ("Metalloproteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Disintegrin" . SPARSER::PROTEIN) ("CTF" . SPARSER::PROTEIN)
    ("Urokinase" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("heparan sulfate" . SPARSER::MOLECULE) ("ErbB-1" . SPARSER::PROTEIN)
    ("ADAM-17" . SPARSER::PROTEIN) ("ARK1" . SPARSER::PROTEIN)
    ("ADAM -10" . SPARSER::PROTEIN) ("ADAM-9" . SPARSER::PROTEIN)
    ("ADAM12" . SPARSER::PROTEIN) ("ADAM10" . SPARSER::PROTEIN)
    ("ADAM9" . SPARSER::PROTEIN) ("PP3" . SPARSER::PROTEIN)
    ("GF109203X" . SPARSER::DRUG)
    ("beta-adrenergic receptor kinase 1" . SPARSER::PROTEIN)
    ("Gαq" . SPARSER::PROTEIN) ("GM6001" . SPARSER::DRUG)
    ("Pyk2" . SPARSER::PROTEIN) ("ADAM-10" . SPARSER::PROTEIN)
    ("UG" . SPARSER::PROTEIN) ("SHK" . SPARSER::PROTEIN)
    ("FK" . SPARSER::PROTEIN) ("MIB" . SPARSER::PROTEIN)
    ("ER and Bcl-2" . SPARSER::COLLECTION)
    ("antioncogenic protein p53" . SPARSER::PROTEIN) ("GEP" . SPARSER::PROTEIN)
    ("ER, PR, and Bcl-2" . SPARSER::COLLECTION)
    ("no special type (NST)" . TYPE) ("class 4" . SPARSER::PROTEIN)
    ("class 2" . SPARSER::PROTEIN) ("class 1" . SPARSER::PROTEIN-FAMILY)
    ("Factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("arteriosclerotic VGs" . SPARSER::PROTEIN)
    ("Jabs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("canine VGs" . SPARSER::PROTEIN)
    ("PAI-1 and TF" . SPARSER::COLLECTION)
    ("strong human CRP" . SPARSER::PROTEIN)
    ("very weak or undetectable human CRP" . SPARSER::PROTEIN)
    ("/CRP-Tg" . SPARSER::COLLECTION) ("fibrin" . SPARSER::PROTEIN)
    ("Fibrin" . SPARSER::MOLECULE) ("VGs" . SPARSER::PROTEIN)
    ("CRP-Tg" . SPARSER::COLLECTION) ("CRP and TF" . SPARSER::COLLECTION)
    ("TF and PAI-1" . SPARSER::COLLECTION)
    ("glycoprotein VI" . SPARSER::PROTEIN) ("MCP-1" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("Texas-Red" . SPARSER::DRUG) ("tissue factor" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("PTPN12 and PTPN22" . SPARSER::COLLECTION)
    ("CSK and PSTPIP" . SPARSER::COLLECTION) ("PSTPIP" . SPARSER::PROTEIN)
    ("CSK" . SPARSER::PROTEIN) ("Vpu or PTPN18" . SPARSER::COLLECTION)
    ("CD4 or HER2" . SPARSER::COLLECTION) ("Vpu" . SPARSER::PROTEIN)
    ("PTPN12, PTPN18 and PTPN22" . SPARSER::COLLECTION)
    ("STEP or HePTP" . SPARSER::COLLECTION) ("HePTP" . SPARSER::PROTEIN)
    ("STEP" . SPARSER::PROTEIN) ("SHPs" . SPARSER::PROTEIN)
    ("HER2 and c-Cbl" . SPARSER::COLLECTION) ("geldanamycin" . SPARSER::DRUG)
    ("PTPN18:HER2" . SPARSER::BIO-COMPLEX)
    ("HER2 pY 1196 and HER2 pY 1248" . SPARSER::COLLECTION)
    ("HER2:PTPN18" . SPARSER::BIO-COMPLEX)
    ("“HER2-AKT-PTPN18/β-Trcp-HER2" . SPARSER::COLLECTION)
    ("receptor and insulin receptor" . SPARSER::COLLECTION)
    ("adrenergic" . SPARSER::PROTEIN) ("Receptor" . SPARSER::PROTEIN)
    ("HER2 or PTPN18" . SPARSER::COLLECTION)
    ("β-Trcp and c-Cbl" . SPARSER::COLLECTION)
    ("β-Trcp or c-Cbl" . SPARSER::COLLECTION)
    ("PTPN18 or β-Trcp" . SPARSER::COLLECTION)
    ("PTPN18 and β-Trcp" . SPARSER::COLLECTION)
    ("HER2 and PTPN18" . SPARSER::COLLECTION)
    ("PTPN18/β-Trcp" . SPARSER::COLLECTION)
    ("the PTPN18 D197A dominant-negative mutant" . SPARSER::MUTANT)
    ("HER2 and pY" . SPARSER::COLLECTION) ("HER2/c-Cbl" . SPARSER::COLLECTION)
    ("Lamp1" . SPARSER::PROTEIN) ("DLG" . SPARSER::PROTEIN)
    ("HER2-AKT-PTPN18-HER2" . SPARSER::COLLECTION)
    ("AKT or another kinase" . SPARSER::COLLECTION)
    ("ERK or GSK3" . SPARSER::COLLECTION)
    ("PTPN18 and PTPN18" . SPARSER::COLLECTION) ("PEST" . SPARSER::PROTEIN)
    ("ubiquitin mutant K48R or UB-63" . SPARSER::COLLECTION)
    ("Cbl-EGFR" . SPARSER::COLLECTION)
    ("lysosome marker Lamp1" . SPARSER::PROTEIN) ("Lamp" . SPARSER::PROTEIN)
    ("SRC-Paxillin-PAK" . SPARSER::COLLECTION)
    ("PI3K-AKT-WT1" . SPARSER::COLLECTION) ("DOKR-ERK" . SPARSER::COLLECTION)
    ("Leu and pY+4" . SPARSER::COLLECTION)
    ("Ser and pY+2" . SPARSER::COLLECTION) ("Glu/Asp" . SPARSER::COLLECTION)
    ("the extended R198 conformation and the χ3" . SPARSER::COLLECTION)
    ("PTPN18-HER2" . SPARSER::COLLECTION)
    ("the pY+1 Asp of SKAP-HOM" . SPARSER::PROTEIN)
    ("PEST-PTP" . SPARSER::PROTEIN-PAIR)
    ("the pY+1 Leu of the HER2 pY 1248" . SPARSER::PROTEIN)
    ("PTP1B-IRK" . SPARSER::COLLECTION) ("IRK" . SPARSER::PROTEIN-FAMILY)
    ("the aliphatic parts" . SPARSER::COMPONENT)
    ("PTPN18 and pY" . SPARSER::COLLECTION) ("PTPN18-pY" . SPARSER::COLLECTION)
    ("amides" . SPARSER::MOLECULE) ("the central pY" . SPARSER::PROTEIN)
    ("K63 and a water molecule" . SPARSER::COLLECTION)
    ("YopH and several other PTPs" . SPARSER::COLLECTION)
    ("PTP1B, YopH and several other PTPs" . SPARSER::COLLECTION)
    ("the catalytically invariant Asp" . SPARSER::AMINO-ACID)
    ("YopH" . SPARSER::PROTEIN) ("HER2-pY" . SPARSER::COLLECTION)
    ("HER2 and its phosphatase PTPN18" . SPARSER::COLLECTION)
    ("PTPN18 D197A and HER2" . SPARSER::COLLECTION)
    ("PTPN18 and HER2" . SPARSER::COLLECTION)
    ("GST-PTPN18" . SPARSER::COLLECTION)
    ("the wild-type PTPN18 (PTPN18-WT) and an inactive mutant (D197A)"
     . SPARSER::COLLECTION)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("small artificial substrates" . SPARSER::SUBSTRATE)
    ("PTP-PEST/PTPN12" . SPARSER::COLLECTION)
    ("LYP/PTPN22" . SPARSER::COLLECTION)
    ("EGFR or IGF1R" . SPARSER::COLLECTION)
    ("PTPN12, PTPN13 and PTPN18" . SPARSER::COLLECTION)
    ("PTP-MEG2" . SPARSER::COLLECTION) ("CRK" . SPARSER::PROTEIN)
    ("DOK" . SPARSER::PROTEIN) ("SHC1 and PIK3R3" . SPARSER::COLLECTION)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("HER2 or ErbB2" . SPARSER::COLLECTION)
    ("LYP and PTPN12" . SPARSER::COLLECTION) ("LYP" . SPARSER::PROTEIN)
    ("HER2/PTPN18" . SPARSER::COLLECTION) ("diverse HER2" . SPARSER::PROTEIN)
    ("CCP4" . SPARSER::PROTEIN) ("mM 3" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("Cdc25B" . SPARSER::PROTEIN)
    ("β-Trcp" . SPARSER::PROTEIN) ("K29" . SPARSER::PROTEIN)
    ("RPN12" . SPARSER::PROTEIN) ("WT1" . SPARSER::PROTEIN)
    ("SKAP-HOM" . SPARSER::PROTEIN) ("pY–1" . SPARSER::PROTEIN)
    ("PTP-PEST" . SPARSER::PROTEIN) ("PTPN22" . SPARSER::PROTEIN)
    ("BDP1" . SPARSER::PROTEIN) ("PTPN13" . SPARSER::PROTEIN)
    ("MEG2" . SPARSER::PROTEIN) ("c-Cbl" . SPARSER::PROTEIN)
    ("SHC1" . SPARSER::PROTEIN) ("PTPN12" . SPARSER::PROTEIN)
    ("PTPN18" . SPARSER::PROTEIN)
    ("a dual c-Met/VEGFR2 inhibitor" . SPARSER::INHIBITOR)
    ("tyrosine kinase, and abozantinib" . SPARSER::COLLECTION)
    ("c-Met/VEGFR2" . SPARSER::COLLECTION) ("Tivantinib" . SPARSER::DRUG)
    ("ligand or receptor" . SPARSER::COLLECTION)
    ("these latter proteins" . SPARSER::PROTEIN)
    ("MSH2 and MLH1" . SPARSER::COLLECTION)
    ("POLB and POLG" . SPARSER::COLLECTION)
    ("POLG or POLB" . SPARSER::COLLECTION) ("POLG" . SPARSER::PROTEIN)
    ("POLB" . SPARSER::PROTEIN)
    ("Masitinib, Nilotinib, and Dasatinib" . SPARSER::COLLECTION)
    ("FLT3, CSF-1R, and RET" . SPARSER::COLLECTION)
    ("Nilotinib" . SPARSER::DRUG) ("Masitinib" . SPARSER::DRUG)
    ("Sunitinib" . SPARSER::DRUG)
    ("MLH1, MSH2, and PMS2" . SPARSER::COLLECTION)
    ("KIT, PDFRA, and PIK3CA" . SPARSER::COLLECTION)
    ("MET and MLH1" . SPARSER::COLLECTION)
    ("gene, and MLH1 and MET" . SPARSER::COLLECTION)
    ("MLH1 and MET" . SPARSER::COLLECTION) ("Light" . SPARSER::PROTEIN)
    ("faster pace" . SPARSER::PROTEIN) ("pace" . SPARSER::PROTEIN)
    ("Drugs like small-molecule inhibitors or monoclonal antibodies"
     . SPARSER::COLLECTION)
    ("CD34 and CD117" . SPARSER::COLLECTION)
    ("its transmembrane and cytoplasmic domain" . SPARSER::PROTEIN)
    ("KIT or PDGFR" . SPARSER::COLLECTION) ("Jak/Stat" . SPARSER::COLLECTION)
    ("Stat" . SPARSER::PROTEIN) ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRAF, CDH1, EGFR, ERBB4, FLT3, KRAS, PDGFRA, PTEN, TP53, and VHL"
     . SPARSER::COLLECTION)
    ("genes and oncogenes" . SPARSER::COLLECTION) ("PGM" . SPARSER::PROTEIN)
    ("dNTPs" . SPARSER::MOLECULE) ("KIT/PDGFRA" . SPARSER::COLLECTION)
    ("the KIT (exon: 9, 11, 13 and 17) and PGFRA (exon: 12, 14 and 18) genes"
     . SPARSER::COLLECTION)
    ("KIT or mutant" . SPARSER::COLLECTION)
    ("KIT and PDGFRA" . SPARSER::COLLECTION)
    ("KIT and PDFGRA" . SPARSER::COLLECTION)
    ("PDGF-AA and stem cell factor" . SPARSER::COLLECTION)
    ("KIT or PDGFRA" . SPARSER::COLLECTION) ("ICC" . SPARSER::PROTEIN)
    ("clinically developing new drugs" . SPARSER::DRUG)
    ("potential raw base" . SPARSER::PROTEIN)
    ("reliable variant" . SPARSER::VARIANT) ("Ion" . SPARSER::MOLECULE)
    ("KIT or platelet-derived growth factor A (PDGFRA)" . SPARSER::COLLECTION)
    ("KIT or platelet-derived growth factor A" . SPARSER::COLLECTION)
    ("chr3" . SPARSER::PROTEIN) ("XL184" . SPARSER::DRUG)
    ("CSF-1R" . SPARSER::PROTEIN) ("SU11248" . SPARSER::DRUG)
    ("stem cell factor" . SPARSER::PROTEIN)
    ("derived growth factor A" . SPARSER::PROTEIN) ("MRF" . SPARSER::PROTEIN)
    ("JK" . SPARSER::PROTEIN) ("MDM" . SPARSER::PROTEIN)
    ("Myocardin" . SPARSER::PROTEIN)
    ("Genes and Genomes" . SPARSER::COLLECTION) ("Heme" . SPARSER::PROTEIN)
    ("GOBP" . SPARSER::PROTEIN) ("FES" . SPARSER::PROTEIN)
    ("Diaphanous-related formin" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN) ("phenylindole" . SPARSER::MOLECULE)
    ("angiogenic inducer" . SPARSER::PROTEIN) ("Chemokine" . SPARSER::PROTEIN)
    ("Bovine Serum Albumin" . SPARSER::PROTEIN) ("BSA" . SPARSER::PROTEIN)
    ("MYC and JUN/AP-1" . SPARSER::COLLECTION)
    ("the transcriptional co-activator Yes-associated protein (YAP)"
     . SPARSER::PROTEIN)
    ("JUN and MYC" . SPARSER::COLLECTION)
    ("actin regulators and DIAPH3" . SPARSER::COLLECTION)
    ("PDGF-treated SMC" . SPARSER::PROTEIN)
    ("mDia2/DIAPH3" . SPARSER::COLLECTION)
    ("mDia2 and its homolog mDia1" . SPARSER::COLLECTION)
    ("MRTF-A and MRTF-B" . SPARSER::COLLECTION)
    ("mDia1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mDia" . SPARSER::PROTEIN)
    ("the diaphanous-related formin family" . SPARSER::PROTEIN-FAMILY)
    ("GTPases, Rho, Rac and Cdc42" . SPARSER::COLLECTION)
    ("AP-1 and CREB" . SPARSER::COLLECTION)
    ("JUN, MYC and EGR1" . SPARSER::COLLECTION)
    ("EGR1 and the AP-1 subunit c-Fos" . SPARSER::COLLECTION)
    ("streptozotocin" . SPARSER::DRUG) ("USF1 and USF2" . SPARSER::COLLECTION)
    ("the MYC family members upstream regulatory factor 1 (USF1) and USF2"
     . SPARSER::COLLECTION)
    ("the MYC family members upstream regulatory factor 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AP-1, EGR-1 and MYB" . SPARSER::COLLECTION)
    ("hypertrophic smooth muscle" . SPARSER::PROTEIN)
    ("vascular SMC" . SPARSER::PROTEIN)
    ("CXCL12 and CYR61" . SPARSER::COLLECTION)
    ("CYR61, HMOX1 and CXCL12" . SPARSER::COLLECTION)
    ("exogenous ligand" . SPARSER::LIGAND)
    ("thrombomodulin" . SPARSER::PROTEIN)
    ("visceral smooth muscle" . SPARSER::PROTEIN)
    ("visceral SMC" . SPARSER::PROTEIN) ("SMCs" . SPARSER::PROTEIN)
    ("MYC-JUN-DIAPH3" . SPARSER::COLLECTION)
    ("the diaphanous-related formin protein DIAPH3" . SPARSER::PROTEIN)
    ("MYC or JUN" . SPARSER::COLLECTION) ("MYC-" . SPARSER::PROTEIN)
    ("Pdgfrb, Cyr61 and Gdf15" . SPARSER::COLLECTION)
    ("Gdf15" . SPARSER::PROTEIN) ("Pdgfrb" . SPARSER::PROTEIN)
    ("JUN, MYC, and EGR1" . SPARSER::COLLECTION)
    ("JNK or MYC" . SPARSER::COLLECTION) ("JUN or MYC" . SPARSER::COLLECTION)
    ("CXCL12 or CYR61" . SPARSER::COLLECTION)
    ("HMOX1, CXCL12, and CYR61" . SPARSER::COLLECTION)
    ("JUN/AP-1" . SPARSER::COLLECTION)
    ("HMOX1, PDGFRB, CYR61, CXCL12, GDF15 and DIAPH3" . SPARSER::COLLECTION)
    ("FDR " . SPARSER::PROTEIN)
    ("EGR1, JUN, MYB, RUNX1, and MYC" . SPARSER::COLLECTION)
    ("DDIT3, NFAT5, and SOX5" . SPARSER::COLLECTION)
    ("TRED" . SPARSER::PROTEIN)
    ("those representing up-regulated genes (Clusters 1 to 4) and those reflecting down-regulated genes (Clusters 5 to 7)"
     . SPARSER::COLLECTION)
    ("human visceral SMC" . SPARSER::PROTEIN) ("ICAT" . SPARSER::PROTEIN)
    ("proteins or genes" . SPARSER::COLLECTION)
    ("the soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen and motogen" . SPARSER::COLLECTION)
    ("an extensive cohort" . SPARSER::MOLECULE)
    ("the diaphanous-related formin" . SPARSER::PROTEIN)
    ("MYC and JUN" . SPARSER::COLLECTION) ("MYB" . SPARSER::PROTEIN)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("derived factor" . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("Activator Protein 1" . SPARSER::PROTEIN) ("R-250" . SPARSER::PROTEIN)
    ("MRTF-A" . SPARSER::PROTEIN) ("mDia2" . SPARSER::PROTEIN)
    ("HMOX-1" . SPARSER::PROTEIN) ("USF2" . SPARSER::PROTEIN)
    ("USF1" . SPARSER::PROTEIN) ("Cyr61" . SPARSER::PROTEIN)
    ("DIAPH3" . SPARSER::PROTEIN) ("GDF15" . SPARSER::PROTEIN)
    ("CYR61" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("SOX5" . SPARSER::PROTEIN) ("NFAT5" . SPARSER::PROTEIN)
    ("DDIT3" . SPARSER::PROTEIN)
    ("platelet-derived growth factor-BB" . SPARSER::PROTEIN)
    ("duplex DNAs" . SPARSER::DNA) ("a strong case" . SPARSER::PROTEIN)
    ("TEBP" . SPARSER::PROTEIN) ("a unimolecular step" . SPARSER::PROTEIN)
    ("AGT and DNA" . SPARSER::COLLECTION)
    ("protein or DNA" . SPARSER::COLLECTION)
    ("unavailable and available states" . SPARSER::BIO-STATE)
    ("DNA and DNAs" . SPARSER::COLLECTION) ("nt" . SPARSER::PROTEIN)
    ("duplex DNA" . SPARSER::DNA) ("normal guanine" . SPARSER::PROTEIN)
    ("a 3-nt" . SPARSER::COLLECTION) ("a longer G11 DNA" . SPARSER::DNA)
    ("DNA or protein" . SPARSER::COLLECTION)
    ("adequate fits" . SPARSER::PROTEIN-FAMILY)
    ("0.27 AGT/22wtx DNA and 4.38" . SPARSER::COLLECTION)
    ("protein and a protein–DNA complex" . SPARSER::COLLECTION)
    ("frictional ratios 1.95 and 1.86" . SPARSER::PROTEIN)
    ("TE" . SPARSER::PROTEIN) ("-methylguanines" . SPARSER::MOLECULE)
    ("methylguanines" . SPARSER::MOLECULE) ("thymine" . SPARSER::NUCLEOBASE)
    ("monomeric protein" . SPARSER::PROTEIN)
    ("chemotherapeutic DNA-alkylating drugs" . SPARSER::DRUG)
    ("a duplex DNA substrate" . SPARSER::SUBSTRATE) ("DNAs" . SPARSER::DNA)
    ("-methylguanine" . SPARSER::MOLECULE) ("mG" . SPARSER::PROTEIN)
    ("methylguanine" . SPARSER::MOLECULE)
    ("mismatch repair protein" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("A  2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potassium chloride" . SPARSER::MOLECULE) ("n protein" . SPARSER::PROTEIN)
    ("g −1" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("Na +" . SPARSER::MOLECULE) ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("ligases, ARF-BP1 and HDM2" . SPARSER::COLLECTION)
    ("p53 and p14ARF" . SPARSER::COLLECTION)
    ("a bacterial oncogene" . SPARSER::ONCOGENE)
    ("bacterial factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARF-p53" . SPARSER::COLLECTION)
    ("ligases, HDM2 and ARF-BP1" . SPARSER::COLLECTION)
    ("ARF-BP1/Mule" . SPARSER::COLLECTION) ("Mule" . SPARSER::PROTEIN)
    ("p14ARF and co-cultured" . SPARSER::COLLECTION)
    ("cor" . SPARSER::PROTEIN-FAMILY) ("HFE" . SPARSER::PROTEIN)
    ("ARF and p53" . SPARSER::COLLECTION)
    ("significantly weaker inducers" . SPARSER::MOLECULE)
    ("PG13-Luc and MG15-Luc" . SPARSER::COLLECTION)
    ("p21/WAF1" . SPARSER::COLLECTION)
    ("camptothecin or other DNA-damaging drugs (cisplatin and etoposide)"
     . SPARSER::COLLECTION)
    ("cisplatin and etoposide" . SPARSER::COLLECTION)
    ("GroEL" . SPARSER::PROTEIN) ("antiserum" . SPARSER::PROTEIN)
    ("p14ARF and p53" . SPARSER::COLLECTION)
    ("a bacterial oncoprotein" . SPARSER::PROTEIN)
    ("bacterial components" . SPARSER::COMPONENT) ("cag" . SPARSER::PROTEIN)
    ("The best-characterised bacterial virulence factors"
     . SPARSER::PROTEIN-FAMILY)
    ("cagA" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor/phosphoinositide 3-kinase/AKT"
     . SPARSER::COLLECTION)
    ("Rat" . SPARSER::PROTEIN) ("bacterial CagA protein" . SPARSER::PROTEIN)
    ("HDM2 and ARF-BP1" . SPARSER::COLLECTION)
    ("ARF-BP1 and Human Double Minute 2 (HDM2) proteins" . SPARSER::COLLECTION)
    ("CagA" . SPARSER::PROTEIN) ("cytotoxin" . SPARSER::PROTEIN)
    ("Hsp60" . SPARSER::PROTEIN)
    ("Hypoxanthine-Guanine Phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("Heat Shock Protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Monoclonal Antibody" . SPARSER::DRUG)
    ("PMA-induced protein 1" . SPARSER::PROTEIN) ("SRα" . SPARSER::PROTEIN)
    ("T4SS" . SPARSER::PROTEIN-FAMILY)
    ("vacuolating cytotoxin A" . SPARSER::PROTEIN)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("Double Minute 2" . SPARSER::PROTEIN) ("ARF-BP1" . SPARSER::PROTEIN)
    ("novel prognostic and therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("luminal and basal cells" . SPARSER::COLLECTION)
    ("Clim/LMO4" . SPARSER::COLLECTION)
    ("its known mammary gland binding partner LMO4" . SPARSER::PROTEIN)
    ("RLIM" . SPARSER::PROTEIN) ("Lhx2" . SPARSER::PROTEIN)
    ("Clim/LIM" . SPARSER::COLLECTION) ("LMO2 and LHX2" . SPARSER::COLLECTION)
    ("GATA3, Notch1, Elf5, and STAT5a" . SPARSER::COLLECTION)
    ("STAT5a" . SPARSER::PROTEIN) ("7 weeks entire arms" . SPARSER::PROTEIN)
    ("DN-Clim/PyMT" . SPARSER::COLLECTION) ("CLIM" . SPARSER::PROTEIN)
    ("only two DN-Clim" . SPARSER::COLLECTION) ("LSC" . SPARSER::PROTEIN)
    ("mammary gland stem cell genes" . SPARSER::GENE)
    ("Basal-specific DEGs" . SPARSER::PROTEIN)
    ("K5, K14, and smooth muscle" . SPARSER::COLLECTION)
    ("K8, K18, Gata3, estrogen and progesterone" . SPARSER::COLLECTION)
    ("smooth muscle and mammary basal epithelial cell genes"
     . SPARSER::COLLECTION)
    ("mammary basal epithelial cell genes" . SPARSER::GENE)
    ("TCF3 and SOX9" . SPARSER::COLLECTION)
    ("the Clim-regulated TEB and duct gene" . SPARSER::COLLECTION)
    ("DEG" . SPARSER::PROTEIN)
    ("66 TEB and 137 duct genes" . SPARSER::COLLECTION)
    ("DEGs" . SPARSER::PROTEIN)
    ("developmentally associated TEB and duct genes" . SPARSER::COLLECTION)
    ("developmentally associated TEB" . SPARSER::PROTEIN)
    ("the intrinsic subtypes" . SPARSER::PROTEIN)
    ("1,313 TEB and 815 duct genes" . SPARSER::COLLECTION)
    ("lactating" . SPARSER::MOLECULE)
    ("delayed ductal elongation" . SPARSER::PROTEIN)
    ("the K14-positive basal MECs" . SPARSER::PROTEIN)
    ("TEB" . SPARSER::PROTEIN) ("K14-DN-Clim" . SPARSER::COLLECTION)
    ("Clims" . SPARSER::PROTEIN) ("Clim" . SPARSER::PROTEIN)
    ("basal MECs" . SPARSER::PROTEIN) ("Clim1 and Clim2" . SPARSER::COLLECTION)
    ("DN-Clim" . SPARSER::COLLECTION) ("Ldb2" . SPARSER::PROTEIN)
    ("Clim1" . SPARSER::PROTEIN) ("Ldb" . SPARSER::PROTEIN-FAMILY)
    ("GATA, bHLH, and Otx" . SPARSER::COLLECTION) ("bHLH" . SPARSER::PROTEIN)
    ("GATA" . SPARSER::PROTEIN) ("LID" . SPARSER::PROTEIN)
    ("homeodomain" . SPARSER::PROTEIN) ("MEC" . SPARSER::PROTEIN)
    ("LSCs" . SPARSER::PROTEIN)
    ("either committed unipotent luminal and basal epithelial stem cells"
     . SPARSER::COLLECTION)
    ("bipotent MaSCs" . SPARSER::PROTEIN)
    ("either committed unipotent luminal" . SPARSER::DRUG)
    ("luminal and basal cell" . SPARSER::COLLECTION)
    ("MaSCs" . SPARSER::PROTEIN)
    ("These basal-derived cues" . SPARSER::PROTEIN-FAMILY)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION) ("Fgfr2" . SPARSER::PROTEIN)
    ("Clim2" . SPARSER::PROTEIN) ("CLIM/LDB/NLI" . SPARSER::COLLECTION)
    ("NLI" . SPARSER::PROTEIN) ("LDB" . SPARSER::PROTEIN-FAMILY)
    ("LHX3" . SPARSER::PROTEIN) ("LHX2" . SPARSER::PROTEIN)
    ("LMO2" . SPARSER::PROTEIN) ("Elf5" . SPARSER::PROTEIN)
    ("CD61" . SPARSER::PROTEIN) ("Lgr5" . SPARSER::PROTEIN)
    ("Gata3" . SPARSER::PROTEIN) ("K18" . SPARSER::PROTEIN)
    ("K5" . SPARSER::PROTEIN) ("K8" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN) ("serum response factor" . SPARSER::PROTEIN)
    ("metallopeptidase activity" . SPARSER::PROTEIN) ("K14" . SPARSER::PROTEIN)
    ("Keratin 14" . SPARSER::PROTEIN) ("Ldb1" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("CD49f" . SPARSER::PROTEIN)
    ("LMO4" . SPARSER::PROTEIN)
    ("S100A7 , S100A8 and S100A9" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("TGF-β and ERBB2" . SPARSER::COLLECTION)
    ("MMP9 , MMP14 , MMP15 , MMP17 and MMP28" . SPARSER::COLLECTION)
    ("TGF-β or FN" . SPARSER::COLLECTION)
    ("TWIST1 , TWIST2 , SNAI1 , SNAI2 , ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("talin (encoded by TLN1 and TLN2 ) and other genes" . SPARSER::COLLECTION)
    ("TNS1, TSN3 and UTRN" . SPARSER::COLLECTION) ("TSN" . SPARSER::PROTEIN)
    ("scaffold and cytoskeletal proteins" . SPARSER::COLLECTION)
    ("E-cadherin and integrin" . SPARSER::COLLECTION)
    ("ITGA1, ITGA4, ITGA5, ITGAV, ITGB1 and ITGB2" . SPARSER::COLLECTION)
    ("integrin subunits and focal adhesion proteins" . SPARSER::COLLECTION)
    ("ECM proteins [ xref ], integrin subunits and focal adhesion proteins"
     . SPARSER::COLLECTION)
    ("linking integrins" . SPARSER::PROTEIN)
    ("talin, paxillin, tensin and P130Cas" . SPARSER::COLLECTION)
    ("RhoA , RhoB and RhoC" . SPARSER::COLLECTION)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION) ("RhoB" . SPARSER::PROTEIN)
    ("ninein" . SPARSER::PROTEIN) ("NIN" . SPARSER::PROTEIN)
    ("CDH1-" . SPARSER::PROTEIN) ("junctional proteins" . SPARSER::PROTEIN)
    ("zonula" . SPARSER::PROTEIN) ("Par3 and Scribble" . SPARSER::COLLECTION)
    ("Scribble" . SPARSER::PROTEIN)
    ("P-cadherin and desmosomal cadherin" . SPARSER::COLLECTION)
    ("desmosomal cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNAI1, SNAI2, TWIST1, TWIST2, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("S100A8 (4.1 fold) and S100A7 (7.0 fold)" . SPARSER::COLLECTION)
    ("VTN nor ACTA2" . SPARSER::COLLECTION)
    ("the mesenchymal markers CDH2, CDH11, VIM, FN1, S100A4, VTN nor ACTA2"
     . SPARSER::COLLECTION)
    ("the mesenchymal markers CDH2" . SPARSER::PROTEIN)
    ("CLDN1, OCLN, TJP3, and CGN" . SPARSER::COLLECTION)
    ("EMT-associated genes" . SPARSER::GENE)
    ("ECM proteins and their associated integrins" . SPARSER::COLLECTION)
    ("their associated integrins" . SPARSER::PROTEIN)
    ("collagen, fibronectin, vitronectin or laminin" . SPARSER::COLLECTION)
    ("rhoGAP" . SPARSER::PROTEIN) ("RHOA" . SPARSER::PROTEIN)
    ("PXN" . SPARSER::PROTEIN)
    ("the actin and microtubule cytoskeletal proteins ACTB , ACTG1 and TUBB2A mRNA"
     . SPARSER::COLLECTION)
    ("microtubule cytoskeletal proteins ACTB , ACTG1 and TUBB2A mRNA"
     . SPARSER::RNA)
    ("ACTB , ACTG1 and TUBB2A" . SPARSER::COLLECTION)
    ("ACTB" . SPARSER::PROTEIN) ("utrophin" . SPARSER::PROTEIN)
    ("UTRN" . SPARSER::PROTEIN) ("integrin and actin" . SPARSER::COLLECTION)
    ("TNS1 and TNS2" . SPARSER::COLLECTION) ("tensin" . SPARSER::PROTEIN)
    ("vinculin ( VCL ) and α-actinin ( ACTN1 , ACTN4 )" . SPARSER::COLLECTION)
    ("VCL" . SPARSER::PROTEIN) ("TLN1 and TLN2" . SPARSER::COLLECTION)
    ("integrins and actin" . SPARSER::COLLECTION)
    ("vinculin and α-actinin" . SPARSER::COLLECTION)
    ("COL2A1, COL5A3, COL7A1 , COL13A1 and LAMA2" . SPARSER::COLLECTION)
    ("LAMA5, LAMB1, LAMB2 and LAMC1" . SPARSER::COLLECTION)
    ("COL4A1, COL4A2, COL4A4, COL6A3, COL8A1, COL12A1, COL18A1, LAMA1, FN1 and VTN"
     . SPARSER::COLLECTION)
    ("ITGA10 and ITGB6" . SPARSER::COLLECTION) ("ITGAV" . SPARSER::PROTEIN)
    ("eight of the eleven expressed desmosome genes and six"
     . SPARSER::COLLECTION)
    ("DSG4 , DSC2 , JUP , GJA5 , GJB2 and GJB4" . SPARSER::COLLECTION)
    ("JUP" . SPARSER::PROTEIN)
    ("Two further tight junction genes" . SPARSER::GENE)
    ("CLDN1, CLDN4 , CLDN7 , OCLN and CGN" . SPARSER::COLLECTION)
    ("CGN" . SPARSER::PROTEIN) ("OCLN" . SPARSER::PROTEIN)
    ("adherens junction-associated proteins" . SPARSER::PROTEIN)
    ("nectin" . SPARSER::PROTEIN) ("CDH2 and CDH4" . SPARSER::COLLECTION)
    ("CDH3 and CDH16" . SPARSER::COLLECTION) ("b" . SPARSER::PROTEIN)
    ("α-tubulin and F-actin" . SPARSER::COLLECTION) ("t " . SPARSER::PROTEIN)
    ("b-c" . SPARSER::PROTEIN-PAIR) ("Aldrich" . SPARSER::PROTEIN)
    ("The multifocal SRCC foci" . SPARSER::PROTEIN) ("comm" . SPARSER::PROTEIN)
    ("gastric foci" . SPARSER::PROTEIN)
    ("highly penetrant DGC" . SPARSER::PROTEIN)
    ("Hereditary Diffuse Gastric Cancer (HDGC) families"
     . SPARSER::PROTEIN-FAMILY)
    ("HDGC" . SPARSER::PROTEIN) ("LBC and DGC" . SPARSER::COLLECTION)
    ("both the sporadic and familial forms" . SPARSER::FORM)
    ("LBC" . SPARSER::PROTEIN) ("DGC" . SPARSER::PROTEIN)
    ("WNT and EGFR" . SPARSER::COLLECTION)
    ("both cortical actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("a homophilic cell-to-cell adhesion protein" . SPARSER::PROTEIN)
    ("CDH2, FN1, VIM and VTN" . SPARSER::COLLECTION)
    ("metalloprotease and kallikrein" . SPARSER::COLLECTION)
    ("VTN" . SPARSER::PROTEIN) ("VIM" . SPARSER::PROTEIN)
    ("ITGA1, COL8A1 , COL4A2 and COL12A1" . SPARSER::COLLECTION)
    ("S100A9" . SPARSER::PROTEIN)
    ("calcium-binding protein" . SPARSER::PROTEIN) ("MMP28" . SPARSER::PROTEIN)
    ("MMP17" . SPARSER::PROTEIN) ("α1β1" . SPARSER::PROTEIN)
    ("P130Cas" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("KIFC3" . SPARSER::PROTEIN)
    ("P-cadherin" . SPARSER::PROTEIN) ("TIMP2" . SPARSER::PROTEIN)
    ("TWIST2" . SPARSER::PROTEIN) ("S100A7" . SPARSER::PROTEIN)
    ("S100A8" . SPARSER::PROTEIN) ("S100A" . SPARSER::PROTEIN)
    ("S100A4" . SPARSER::PROTEIN) ("CDH11" . SPARSER::PROTEIN)
    ("TJP3" . SPARSER::PROTEIN) ("DLC1" . SPARSER::PROTEIN)
    ("PTK2" . SPARSER::PROTEIN) ("TUBB2A" . SPARSER::PROTEIN)
    ("ACTG1" . SPARSER::PROTEIN) ("TNS2" . SPARSER::PROTEIN)
    ("TNS1" . SPARSER::PROTEIN) ("ACTN4" . SPARSER::PROTEIN)
    ("TLN2" . SPARSER::PROTEIN) ("LAMA2" . SPARSER::PROTEIN)
    ("COL13A1" . SPARSER::PROTEIN) ("COL7A1" . SPARSER::PROTEIN)
    ("COL5A3" . SPARSER::PROTEIN) ("COL2A1" . SPARSER::PROTEIN)
    ("LAMC1" . SPARSER::PROTEIN) ("LAMB2" . SPARSER::PROTEIN)
    ("LAMB1" . SPARSER::PROTEIN) ("LAMA1" . SPARSER::PROTEIN)
    ("COL18A1" . SPARSER::PROTEIN) ("COL6A3" . SPARSER::PROTEIN)
    ("COL4A4" . SPARSER::PROTEIN) ("COL4A1" . SPARSER::PROTEIN)
    ("ITGB6" . SPARSER::PROTEIN) ("ITGA10" . SPARSER::PROTEIN)
    ("ITGB2" . SPARSER::PROTEIN) ("ITGA5" . SPARSER::PROTEIN)
    ("ITGA4" . SPARSER::PROTEIN) ("GJB4" . SPARSER::PROTEIN)
    ("GJB2" . SPARSER::PROTEIN) ("GJA5" . SPARSER::PROTEIN)
    ("DSG4" . SPARSER::PROTEIN) ("CLDN22" . SPARSER::PROTEIN)
    ("TJP2" . SPARSER::PROTEIN) ("TJP1" . SPARSER::PROTEIN)
    ("CLDN15" . SPARSER::PROTEIN) ("JAM3" . SPARSER::PROTEIN)
    ("CLDN7" . SPARSER::PROTEIN) ("CLDN4" . SPARSER::PROTEIN)
    ("PVRL4" . SPARSER::PROTEIN) ("CDH16" . SPARSER::PROTEIN)
    ("CDH3" . SPARSER::PROTEIN) ("CDH4" . SPARSER::PROTEIN)
    ("and cytoplasmic domain" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("FN1" . SPARSER::PROTEIN)
    ("COL12A1" . SPARSER::PROTEIN) ("COL4A2" . SPARSER::PROTEIN)
    ("COL8A1" . SPARSER::PROTEIN) ("ITGA1" . SPARSER::PROTEIN)
    ("hypoxia and/or HIF1-α" . SPARSER::COLLECTION)
    ("Hypoxia, TAZ, and YAP" . SPARSER::COLLECTION)
    ("Hypoxia and HIF1-α" . SPARSER::COLLECTION) ("HIF1-" . SPARSER::PROTEIN)
    ("p-TAZ" . SPARSER::COLLECTION) ("TEAD" . SPARSER::PROTEIN)
    ("Lats1 and Akt" . SPARSER::COLLECTION) ("ATK" . SPARSER::PROTEIN)
    ("YAP/TAZ" . SPARSER::COLLECTION)
    ("DMOG-treatment (  xref  )" . SPARSER::DRUG)
    ("DMOG-treatment" . SPARSER::DRUG) ("PC3 and SW480" . SPARSER::COLLECTION)
    ("DMOG, and DFO" . SPARSER::COLLECTION) ("-TAZ" . SPARSER::COLLECTION)
    ("TAZ and YAZ" . SPARSER::COLLECTION) ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("DMOG" . SPARSER::DRUG) ("DFO" . SPARSER::MOLECULE)
    ("deferoxamine" . SPARSER::MOLECULE) ("chelators" . SPARSER::MOLECULE)
    ("a tumor-promoting micro-environmental factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heat shock protein 90 and HIF-1α" . SPARSER::COLLECTION)
    ("HEY" . SPARSER::PROTEIN)
    ("the key transcription factor" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor-1alpha" . SPARSER::COLLECTION)
    ("an important micro-environmental factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("YAP or TAZ" . SPARSER::COLLECTION)
    ("Yes-associated protein (YAP  xref  ) and its paralog transcriptional coactivator"
     . SPARSER::COLLECTION)
    ("Yes-associated protein" . SPARSER::PROTEIN)
    ("kinases, Lats1 and Akt" . SPARSER::COLLECTION)
    ("YAP (Yes-associated protein) and TAZ (transcriptional co-activator with PDZ-binding motif)"
     . SPARSER::COLLECTION)
    ("the two most important Hippo-YAP effectors, YAP (Yes-associated protein) and TAZ (transcriptional co-activator with PDZ-binding motif)"
     . SPARSER::COLLECTION)
    ("an important microenvironmental factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p89" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("HIF1" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("prolyl 4-hydroxylase" . SPARSER::PROTEIN)
    ("inducible factor-1alpha" . SPARSER::PROTEIN) ("Lats1" . SPARSER::PROTEIN)
    ("a beautiful example" . SPARSER::EXAMPLE)
    ("a predominant vasodilator" . SPARSER::PROTEIN)
    ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("vasodilator" . SPARSER::PROTEIN) ("prostanoids" . SPARSER::MOLECULE)
    ("cyclooxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("namely two ESR1 and three NOS3 polymorphisms" . SPARSER::COLLECTION)
    ("namely two ESR1" . SPARSER::PROTEIN) ("FSS" . SPARSER::DRUG)
    ("Vasculature" . SPARSER::PROTEIN)
    ("pre- and post-shear" . SPARSER::COLLECTION)
    ("Variant" . SPARSER::VARIANT)
    ("had at least one C allele" . SPARSER::ALLELE)
    ("had at least one variant allele" . SPARSER::ALLELE)
    ("HOMA" . SPARSER::PROTEIN) ("at least one G allele" . SPARSER::ALLELE)
    ("AG or GG" . SPARSER::COLLECTION)
    ("had at least one variant (C) allele" . SPARSER::ALLELE)
    ("ESR1 ( PvuII and XbaI ) and NOS3 ( VNTR , T-786C and G894T ) polymorphisms"
     . SPARSER::COLLECTION)
    ("ESR1 and NOS3" . SPARSER::COLLECTION)
    ("nitrite, and nitrate" . SPARSER::COLLECTION)
    ("nitrate" . SPARSER::MOLECULE) ("nitrite" . SPARSER::MOLECULE)
    ("ESR1 and ESR2" . SPARSER::COLLECTION)
    ("endothelin and angiotensin II" . SPARSER::COLLECTION)
    ("endothelin" . SPARSER::PROTEIN) ("prostacyclin" . SPARSER::MOLECULE)
    ("Estradiol" . SPARSER::PROTEIN) ("citrulline" . SPARSER::MOLECULE)
    ("HOMA-IR" . SPARSER::COLLECTION) ("ERS1" . SPARSER::PROTEIN)
    ("COX-1" . SPARSER::PROTEIN) ("superoxide anions" . SPARSER::MOLECULE)
    ("TCA3" . SPARSER::PROTEIN) ("AC3" . SPARSER::PROTEIN)
    ("TGA3" . SPARSER::PROTEIN) ("β-blockers" . SPARSER::DRUG)
    ("G-protein coupled" . SPARSER::PROTEIN) ("NOS3" . SPARSER::PROTEIN)
    ("ERK1/2 and JNK1" . SPARSER::COLLECTION)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("jun- and fos-related genes" . SPARSER::COLLECTION)
    ("this heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("hepatic AP-1-associated genes and proteins" . SPARSER::COLLECTION)
    ("jun-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CFOS or FRA-1" . SPARSER::COLLECTION) ("GRP78/BiP" . SPARSER::COLLECTION)
    ("total and phosphorylated CJUN protein" . SPARSER::PROTEIN)
    ("CFOS and FRA-1" . SPARSER::COLLECTION)
    ("both total and phosphorylated CFOS" . SPARSER::PROTEIN)
    ("Total and phosphorylated CFOS" . SPARSER::PROTEIN)
    ("both fos- and jun-related genes" . SPARSER::COLLECTION)
    ("fos-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The AP-1-associated genes" . SPARSER::GENE)
    ("cFos , Fra-1 , cJun , and JunD" . SPARSER::COLLECTION)
    ("Tunicamycin" . SPARSER::MOLECULE)
    ("CFOS and fos-related antigen 1" . SPARSER::COLLECTION)
    ("JUND" . SPARSER::PROTEIN) ("CFOS" . SPARSER::PROTEIN)
    ("GRP78/BIP" . SPARSER::COLLECTION) ("BIP" . SPARSER::PROTEIN)
    ("tunicamycin, thapsigargin, and homocysteine" . SPARSER::COLLECTION)
    ("homocysteine" . SPARSER::MOLECULE)
    ("AP-1-associated genes" . SPARSER::GENE)
    ("cJun , JunD , and JunB" . SPARSER::COLLECTION)
    ("cFos , FosB , Fra-1 , and Fra-2" . SPARSER::COLLECTION)
    ("FosB" . SPARSER::PROTEIN) ("cFos" . SPARSER::PROTEIN)
    ("JunD" . SPARSER::PROTEIN)
    ("a molecular chaperone and master regulator" . SPARSER::COLLECTION)
    ("BiP" . SPARSER::PROTEIN) ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K and adaptor protein" . SPARSER::COLLECTION)
    ("Nck" . SPARSER::PROTEIN) ("cJun" . SPARSER::PROTEIN)
    ("Cirrhosis" . SPARSER::PROTEIN) ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both Jun- and Fos-related genes" . SPARSER::COLLECTION)
    ("Jun-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JNK-" . SPARSER::PROTEIN)
    ("AP-1-associated genes and proteins" . SPARSER::COLLECTION)
    ("FRA-1" . SPARSER::PROTEIN) ("fos-related antigen 1" . SPARSER::PROTEIN)
    ("GRP78" . SPARSER::PROTEIN) ("PD184352" . SPARSER::DRUG)
    ("Fra-1" . SPARSER::PROTEIN) ("IRE1α" . SPARSER::PROTEIN)
    ("Mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP90/EGFR-TKI" . SPARSER::COLLECTION)
    ("erlotinib and afatinib" . SPARSER::COLLECTION)
    ("the dual EGFR/HER inhibitor afatinib" . SPARSER::DRUG)
    ("irreversible TKIs" . SPARSER::PROTEIN) ("EGFR/HER" . SPARSER::COLLECTION)
    ("ganetespib " . SPARSER::DRUG)
    ("STAT, ERK, and AKT" . SPARSER::COLLECTION)
    ("kinase and HSP90" . SPARSER::COLLECTION) ("E746_A750" . SPARSER::PROTEIN)
    ("EGFR Del E746_A750" . SPARSER::PROTEIN)
    ("erlotinib, gefitinib, and afatinib" . SPARSER::COLLECTION)
    ("ganetespib or erlotinib" . SPARSER::COLLECTION)
    ("modest impact" . SPARSER::PROTEIN)
    ("MEK, ERK, and AKT" . SPARSER::COLLECTION) ("Afatinib" . SPARSER::DRUG)
    ("ganetespib (50 mg/kg) and afatinib (5 mg/kg)" . SPARSER::COLLECTION)
    ("MTD" . SPARSER::PROTEIN)
    ("ganetespib and erlotinib" . SPARSER::COLLECTION)
    ("resorcinol" . SPARSER::DRUG)
    ("a singular molecular target" . SPARSER::TARGET-PROTEIN)
    ("EGFR and anaplastic lymphoma kinase" . SPARSER::COLLECTION)
    ("RAF and AKT" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("RAS/RAF/extracellular-signal-regulated kinase" . SPARSER::COLLECTION)
    ("transmembrane receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER4/ErbB4" . SPARSER::COLLECTION) ("HER3/ErbB3" . SPARSER::COLLECTION)
    ("/ErbB2" . SPARSER::COLLECTION) ("EGFR/ErbB1" . SPARSER::COLLECTION)
    ("completely abrogated extracellular-signal-regulated kinase (ERK)"
     . SPARSER::PROTEIN)
    ("afatinib" . SPARSER::DRUG)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("AUY922" . SPARSER::DRUG) ("heat shock protein 90" . SPARSER::PROTEIN)
    ("ErbB3" . SPARSER::PROTEIN) ("tBID" . SPARSER::PROTEIN)
    ("cardiolipin" . SPARSER::MOLECULE) ("Fas-receptor" . SPARSER::COLLECTION)
    ("pro-apoptotic Bad" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-XL or Mcl-1" . SPARSER::COLLECTION)
    ("pro-apoptotic Bcl-2 proteins" . SPARSER::PROTEIN)
    ("the two kinases prevented this process" . SPARSER::KINASE)
    ("JNK1 or JNK2" . SPARSER::COLLECTION)
    ("the canonical JNK target c-Jun or the less common target p53"
     . SPARSER::COLLECTION)
    ("a cell-permeable caspase-8 inhibitor" . SPARSER::INHIBITOR)
    ("cathepsin" . SPARSER::PROTEIN) ("Pro-apoptotic Bid" . SPARSER::PROTEIN)
    ("Tsu-Pr" . SPARSER::COLLECTION) ("Tsu" . SPARSER::PROTEIN)
    ("Both wild-type Bid and the T59A mutant" . SPARSER::COLLECTION)
    ("GFP-Bid" . SPARSER::COLLECTION)
    ("protein and tBid" . SPARSER::COLLECTION) ("ANP" . SPARSER::PROTEIN)
    ("wild-type Bid and its T59A and T59D mutants" . SPARSER::COLLECTION)
    ("LC/MS-MS" . SPARSER::COLLECTION)
    ("‘empty' vector Bid" . SPARSER::PROTEIN)
    ("-phosphatase" . SPARSER::PHOSPHATASE)
    ("c-Jun or JNKs" . SPARSER::COLLECTION) ("JNK/c-Jun" . SPARSER::COLLECTION)
    ("JNK and Bid" . SPARSER::COLLECTION)
    ("pro-apoptotic Bax and Bak" . SPARSER::COLLECTION)
    ("JNKs" . SPARSER::PROTEIN) ("JNK1/2 or Bid" . SPARSER::COLLECTION)
    ("JNK1 and JNK2" . SPARSER::COLLECTION) ("Core 2" . SPARSER::PROTEIN)
    ("pH 3" . SPARSER::PROTEIN) ("COX IV" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("C2H2" . SPARSER::MOLECULE) ("Smac/DIABLO" . SPARSER::PROTEIN)
    ("JNK3" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JNK2" . SPARSER::PROTEIN)
    ("formyltetrahydrofolate dehydrogenase" . SPARSER::PROTEIN)
    ("dual inhibitors" . SPARSER::INHIBITOR) ("p-" . SPARSER::PROTEIN)
    ("anti-Mcl-1/Bim" . SPARSER::COLLECTION) ("VT" . SPARSER::PROTEIN)
    ("Peroxidase" . SPARSER::PROTEIN) ("TX" . SPARSER::PROTEIN)
    ("GST-protein" . SPARSER::PROTEIN-PAIR)
    ("GST-Bcl-xL" . SPARSER::COLLECTION) ("GST-Mcl-1" . SPARSER::COLLECTION)
    ("is run" . SPARSER::PROTEIN) ("Prism" . SPARSER::PROTEIN)
    ("THF" . SPARSER::MOLECULE) ("NaO" . SPARSER::PROTEIN)
    ("mL/min" . SPARSER::COLLECTION) ("MeOH" . SPARSER::MOLECULE)
    ("HRMS" . SPARSER::PROTEIN-FAMILY) ("flash" . SPARSER::PROTEIN)
    ("anhydrous sodium sulfate" . SPARSER::MOLECULE)
    ("-Pr" . SPARSER::COLLECTION) ("dioxane" . SPARSER::MOLECULE)
    ("NEt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("thiophenyl" . SPARSER::MOLECULE)
    ("ESI-TOF" . SPARSER::COLLECTION) ("TOF" . SPARSER::PROTEIN)
    ("Flash" . SPARSER::PROTEIN) ("acetonitrile" . SPARSER::MOLECULE)
    ("benzophenone" . SPARSER::DRUG) ("–SO 2" . SPARSER::COLLECTION)
    ("racemic marinopyrrole A" . SPARSER::DRUG) ("the RO5" . SPARSER::PROTEIN)
    ("RO" . SPARSER::PROTEIN) ("LiOH" . SPARSER::MOLECULE)
    ("sulphones" . SPARSER::MOLECULE) ("methanethiol" . SPARSER::MOLECULE)
    ("mercaptoacetate" . SPARSER::MOLECULE) ("palladium" . SPARSER::MOLECULE)
    ("acceptors" . SPARSER::MOLECULE)
    ("a series ofsymmetrical derivatives" . SPARSER::DERIVATIVE)
    ("symmetrical, nonsymmetrical and cyclic marinopyrrole derivatives"
     . SPARSER::DERIVATIVE)
    ("para-" . SPARSER::PROTEIN-FAMILY)
    ("dual Mcl-1 and Bcl-xL antagonists" . SPARSER::MOLECULE)
    ("Mcl-1 and Bcl-xL" . SPARSER::COLLECTION)
    ("ABT-737 and ABT-263" . SPARSER::COLLECTION)
    ("ABT-737 or its orally-available ABT-263" . SPARSER::COLLECTION)
    ("its orally-available ABT-263" . SPARSER::DRUG)
    ("Bcl-2 and/or Mcl-1" . SPARSER::COLLECTION)
    ("expressing Bcl-xL, Bcl-2 and/or Mcl-1" . SPARSER::COLLECTION)
    ("proteins, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("-marinopyrrole A" . SPARSER::DRUG) ("Bcl-xL/Bim" . SPARSER::COLLECTION)
    ("Mcl-1/Bim" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN)
    ("proteins, Mcl-1 and Bcl-xL" . SPARSER::COLLECTION)
    ("sulphone" . SPARSER::MOLECULE) ("O 12" . SPARSER::PROTEIN)
    ("Cl 2" . SPARSER::PROTEIN) ("S 2" . SPARSER::MOLECULE)
    ("sodium sulfate" . SPARSER::MOLECULE) ("Pd 2" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("ABT-737" . SPARSER::DRUG)
    ("marinopyrrole A" . SPARSER::DRUG)
    ("a crystalline
HDAC8-substrate-activator complex"
     . SPARSER::BIO-COMPLEX)
    ("A188T HDAC8 and I243N
HDAC8"
     . SPARSER::COLLECTION)
    ("HDAC8 and its mutants" . SPARSER::COLLECTION)
    ("Mutants" . SPARSER::MUTANT) ("guanidinium" . SPARSER::MOLECULE)
    ("I243N/Y306F HDAC8 and Y306F HDAC8 (Figure xref b and xref )"
     . SPARSER::COLLECTION)
    ("HDAC8-TSA" . SPARSER::COLLECTION)
    ("nearly fully active enzymes" . SPARSER::ENZYME)
    ("Roberts Syndrome, and Warsaw" . SPARSER::COLLECTION)
    ("proteins
or mediators"
     . SPARSER::COLLECTION)
    ("Cohesin and
its effectors"
     . SPARSER::COLLECTION)
    ("SMC1A and SMC3" . SPARSER::COLLECTION) ("Cohesin" . SPARSER::PROTEIN)
    ("benzamide" . SPARSER::DRUG)
    ("SMC1A, SMC3, and RAD21" . SPARSER::COLLECTION)
    ("proteins, NIPBL and HDAC8" . SPARSER::COLLECTION)
    ("NIPBL" . SPARSER::PROTEIN) ("cohesin" . SPARSER::PROTEIN)
    ("CdLS" . SPARSER::PROTEIN) ("His-Lys" . SPARSER::MOLECULE)
    ("Hos1" . SPARSER::PROTEIN) ("ESCO1" . SPARSER::PROTEIN)
    ("Roberts Syndrome" . SPARSER::PROTEIN) ("RAD21" . SPARSER::PROTEIN)
    ("SMC1A" . SPARSER::PROTEIN) ("gene and sunlight" . SPARSER::COLLECTION)
    ("fgr" . SPARSER::PROTEIN)
    ("PRKCA, another member of the PKC family, and a gene"
     . SPARSER::COLLECTION)
    ("PRKCA" . SPARSER::PROTEIN) ("Prkcz" . SPARSER::PROTEIN)
    ("FGR" . SPARSER::PROTEIN)
    ("Drugs and Diet Network (GOLDN)" . SPARSER::COLLECTION)
    ("ultraviolet B (UVB) light" . SPARSER::PROTEIN)
    ("Sunlight-induced vitamin D3" . SPARSER::MOLECULE)
    ("zeta ( PRKCZ )" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN) ("CCL27" . SPARSER::PROTEIN)
    ("vitamin D3" . SPARSER::MOLECULE) ("AKT1 and MDM2" . SPARSER::COLLECTION)
    ("either wild-type SIRT6 or the phosphorylation-mimic SIRT6-S338D mutant ( xref )"
     . SPARSER::COLLECTION)
    ("total and phosphorylated SIRT6" . SPARSER::PROTEIN)
    ("AKT1 , AKT3 , IGF-1R , PDK1 , MTOR , and LDHA" . SPARSER::COLLECTION)
    ("GSK3B and PFKM" . SPARSER::COLLECTION) ("PFKM" . SPARSER::PROTEIN)
    ("MTOR" . SPARSER::PROTEIN)
    ("wild-type SIRT6 or the phosphorylation-mimic SIRT6-S338D mutant"
     . SPARSER::COLLECTION)
    ("the nonphosphorylatable SIRT6-S338A mutant" . SPARSER::MUTANT)
    ("tumori-genesis" . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("the nonphosphorylatable SIRT6 mutant" . SPARSER::MUTANT)
    ("Nonphosphorylatable SIRT6" . SPARSER::PROTEIN)
    ("MDM2 and SIRT6" . SPARSER::COLLECTION)
    ("MDM2 and MG-132" . SPARSER::COLLECTION)
    ("a nonphosphorylatable mutant" . SPARSER::MUTANT)
    ("exogenous Flag-SIRT6" . SPARSER::COLLECTION)
    ("Flag-SIRT6" . SPARSER::COLLECTION) ("MDM2-" . SPARSER::PROTEIN)
    ("PI3K-AKT" . SPARSER::COLLECTION)
    ("the nonphosphorylatable S338A mutant SIRT6" . SPARSER::PROTEIN)
    ("a commercially available antibody" . SPARSER::ANTIBODY)
    ("EGF or IGF" . SPARSER::COLLECTION)
    ("Both endogenous SIRT6 ( xref ) and exogenous Flag-tagged SIRT6 ( xref )"
     . SPARSER::COLLECTION)
    ("exogenous Flag-tagged SIRT6" . SPARSER::PROTEIN)
    ("MK2206 or wortmannin" . SPARSER::COLLECTION)
    ("the proteasome inhibitor MG-132 or the AKT inhibitor MK2206"
     . SPARSER::COLLECTION)
    ("hemagglutinin (HA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor (EGF) and IGF" . SPARSER::COLLECTION)
    ("IGF-AKT" . SPARSER::COLLECTION) ("–AKT" . SPARSER::COLLECTION)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("peptidase" . SPARSER::PROTEIN)
    ("deacetylase and mono–ADP" . SPARSER::COLLECTION)
    ("subcutaneous fat, and hypoglycemia" . SPARSER::COLLECTION)
    ("fat, and hypoglycemia" . SPARSER::COLLECTION)
    ("a chromatin-associated factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a nonphosphorylatable SIRT6 mutant" . SPARSER::MUTANT)
    ("an E3 ligase–deficient MDM2 or knocking down endogenous MDM2"
     . SPARSER::COLLECTION)
    ("Hsc70-interacting protein" . SPARSER::PROTEIN)
    ("Lys 9" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("Sirtuin 6" . SPARSER::PROTEIN)
    ("Coro1C or RCC2-depleted MEFs" . SPARSER::COLLECTION)
    ("Rac1, RCC2 and Coro1C" . SPARSER::COLLECTION)
    ("SILAC" . SPARSER::AMINO-ACID)
    ("a soluble syndecan-4 ligand" . SPARSER::MOLECULE)
    ("adhesion-receptor-associated GEFs" . SPARSER::PROTEIN)
    ("coronin and Coro1C" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID) ("CRIB" . SPARSER::DRUG)
    ("trimeric Coro1C" . SPARSER::PROTEIN) ("crest" . SPARSER::PROTEIN)
    ("hpf" . SPARSER::PROTEIN)
    ("Fli1:eGFP or Sox10:eGFP" . SPARSER::COLLECTION)
    ("Sox10:eGFP" . SPARSER::BIO-COMPLEX) ("Fli1:eGFP" . SPARSER::BIO-COMPLEX)
    ("both RCC2- and Coro1C-knockdown MEFs" . SPARSER::COLLECTION)
    ("β1-integrin–GFP" . SPARSER::COLLECTION)
    ("RCC2- and Coro1C-depleted MEFs" . SPARSER::COLLECTION)
    ("RCC2- and Coro1C-knockdown MEFs" . SPARSER::COLLECTION)
    ("RCC2-" . SPARSER::PROTEIN)
    ("RCC2, Coro1C or Sdc4-" . SPARSER::COLLECTION)
    ("Sdc4-" . SPARSER::PROTEIN) ("Sdc4" . SPARSER::PROTEIN)
    ("Sdc" . SPARSER::PROTEIN) ("RCC2 or Coro1C" . SPARSER::COLLECTION)
    ("matrix (CDM)" . SPARSER::PROTEIN-FAMILY)
    ("a fibrous matrix" . SPARSER::PROTEIN-FAMILY) ("CDM" . SPARSER::PROTEIN)
    ("RCC2, Coro1C and GEFs" . SPARSER::COLLECTION)
    ("RCC2 and GEF" . SPARSER::COLLECTION) ("Rac1-" . SPARSER::PROTEIN)
    ("Rac1–RCC2" . SPARSER::COLLECTION)
    ("RCC2 and Coro1C" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("RCC2, Coro1C and Rac1" . SPARSER::COLLECTION)
    ("Coro1C–RCC2" . SPARSER::COLLECTION) ("Coro1C–Rac1" . SPARSER::COLLECTION)
    ("GFP–Coro1C" . SPARSER::COLLECTION)
    ("Coro1C and GDP-Rac1" . SPARSER::COLLECTION)
    ("GST–Coro1C" . SPARSER::COLLECTION)
    ("Coro1C and Rac1" . SPARSER::COLLECTION)
    ("PAGFP–Coro1C" . SPARSER::COLLECTION)
    ("Lateral PAGFP–Rac1" . SPARSER::PROTEIN-PAIR)
    ("PAGFP–Rac1" . SPARSER::PROTEIN-PAIR) ("PAGFP" . SPARSER::PROTEIN)
    ("photoactivatable GFP (PAGFP)-tagged Rac1" . SPARSER::PROTEIN)
    ("the insoluble and soluble fractions" . SPARSER::COMPONENT)
    ("detergent-insoluble (including flotillin microdomains) fractions"
     . SPARSER::COMPONENT)
    ("flotillin" . SPARSER::PROTEIN) ("Rac1 or RCC2" . SPARSER::COLLECTION)
    ("nuclear and cytoskeletal fractions" . SPARSER::COLLECTION)
    ("the cytoskeletal fraction" . SPARSER::COMPONENT)
    ("cytoskeletal fractions" . SPARSER::COMPONENT)
    ("Rac1 and Coro1C" . SPARSER::COLLECTION)
    ("Raichu-Rac1" . SPARSER::COLLECTION)
    ("Coro1C and RCC2" . SPARSER::COLLECTION)
    ("Coro1C and Coro1A" . SPARSER::COLLECTION)
    ("RCC2 and the 1C isoform ( xref )" . SPARSER::COLLECTION)
    ("Coronins" . SPARSER::DRUG) ("RhoGDI and Rac1" . SPARSER::COLLECTION)
    ("Coro1B" . SPARSER::PROTEIN) ("GDI" . SPARSER::PROTEIN)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("regulators and effectors" . SPARSER::COLLECTION)
    ("GFP–Rac1" . SPARSER::COLLECTION)
    ("Rac1, RhoA, Cdc42 or Ras" . SPARSER::COLLECTION)
    ("GFP-trap" . SPARSER::COLLECTION)
    ("RCC2 (green) and hydrogen bonds form" . SPARSER::COLLECTION)
    ("RCC2–Rac1" . SPARSER::COLLECTION) ("DsRed–Rac1" . SPARSER::COLLECTION)
    ("DsRed" . SPARSER::PROTEIN) ("soluble fractions" . SPARSER::COMPONENT)
    ("RCC2 and RhoGDI" . SPARSER::COLLECTION) ("ARHGDIA" . SPARSER::PROTEIN)
    ("RhoGDI" . SPARSER::PROTEIN) ("GST–Rac1" . SPARSER::COLLECTION)
    ("GFP–RCC2" . SPARSER::COLLECTION)
    ("integrin and syndecan-4" . SPARSER::COLLECTION)
    ("RCC2–Coro1C" . SPARSER::COLLECTION)
    ("RCC2 and coronins" . SPARSER::COLLECTION)
    ("GEFs, GAPs or GDIs" . SPARSER::COLLECTION) ("coronins" . SPARSER::DRUG)
    ("the Arp2/3 complex and stimulation" . SPARSER::COLLECTION)
    ("a seven-bladed propeller" . SPARSER::PROTEIN-FAMILY)
    ("RCC1 and RCC2" . SPARSER::COLLECTION)
    ("Rac1, and guanine-nucleotide-dissociation" . SPARSER::COLLECTION)
    ("GDIs" . SPARSER::PROTEIN) ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GEFs" . SPARSER::GEF) ("Rac1–RCC2–Coro1C" . SPARSER::COLLECTION)
    ("Coro1C or RCC2" . SPARSER::COLLECTION)
    ("the protrusive tip" . SPARSER::PROTEIN) ("GEF" . SPARSER::PROTEIN)
    ("a protrusive tip" . SPARSER::PROTEIN)
    ("RCC2 and Rac1" . SPARSER::COLLECTION) ("Coro1C" . SPARSER::PROTEIN)
    ("coronin" . SPARSER::DRUG) ("col2a1" . SPARSER::PROTEIN)
    ("Lamin A/C" . SPARSER::PROTEIN) ("flotillin-2" . SPARSER::PROTEIN)
    ("Arp3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Scd4" . SPARSER::PROTEIN)
    ("Col2a1" . SPARSER::PROTEIN) ("Sox10" . SPARSER::PROTEIN)
    ("Fli1" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("ARHGAP1" . SPARSER::PROTEIN)
    ("p50RhoGAP" . SPARSER::PROTEIN) ("GTPγS" . SPARSER::PROTEIN)
    ("Coro1A" . SPARSER::PROTEIN) ("Coronin-1A" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN) ("GTPase-activating" . SPARSER::PROTEIN)
    ("syndecan-4" . SPARSER::PROTEIN) ("RCC2" . SPARSER::PROTEIN)
    ("filament" . SPARSER::PROTEIN-FAMILY) ("merlin" . SPARSER::PROTEIN)
    ("MET and its associated effectors" . SPARSER::COLLECTION)
    ("its associated effectors" . SPARSER::EFFECTOR)
    ("the extreme pain" . SPARSER::PROTEIN)
    ("the invasive component" . SPARSER::COMPONENT)
    ("PAK1 and class I" . SPARSER::COLLECTION)
    ("DPC4/SMAD4" . SPARSER::COLLECTION) ("only four genes" . SPARSER::GENE)
    ("MET and p53" . SPARSER::COLLECTION)
    ("two distinct cohorts" . SPARSER::MOLECULE)
    ("1 mg/ml DOX and 5% sucrose" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE) ("PAK1 or LacZ" . SPARSER::COLLECTION)
    ("LacZ" . SPARSER::PROTEIN) ("doxycycline (DOX)" . SPARSER::MOLECULE)
    ("KPC" . SPARSER::PROTEIN)
    ("onartuzumab and bolster" . SPARSER::COLLECTION)
    ("paxillin and stathmin" . SPARSER::COLLECTION)
    ("HGF, onartuzumab, and PAK1" . SPARSER::COLLECTION)
    ("PAK1 and MET" . SPARSER::COLLECTION)
    ("PAK1 and PI3K" . SPARSER::COLLECTION)
    ("stathmin and paxillin" . SPARSER::COLLECTION)
    ("PAK and PI3K" . SPARSER::COLLECTION)
    ("PAK, PI3K, and MAPK" . SPARSER::COLLECTION)
    ("GDC-0973 (cobimetinib) and GDC-0941 (pictilisib)" . SPARSER::COLLECTION)
    ("MAPK/ERK kinase (MEK) and class I PI3Ks" . SPARSER::COLLECTION)
    ("kinase (MEK)" . SPARSER::KINASE) ("cobimetinib" . SPARSER::DRUG)
    ("receptor and IGF-1" . SPARSER::COLLECTION)
    ("proximal effectors and cytoskeletal regulators" . SPARSER::COLLECTION)
    ("cytoskeletal regulators" . SPARSER::REGULATOR)
    ("proximal effectors" . SPARSER::EFFECTOR) ("onartuzumab-" . SPARSER::DRUG)
    ("either exogenous HGF or other growth factors ( xref )"
     . SPARSER::COLLECTION)
    ("either exogenous HGF" . SPARSER::PROTEIN)
    ("Neither exogenous HGF" . SPARSER::PROTEIN)
    ("The monovalent anti-MET antibody onartuzumab" . SPARSER::DRUG)
    ("cyclin D1, p27 Kip1 , cyclin E1, and cyclin B1" . SPARSER::COLLECTION)
    ("cytoskeletal effector proteins" . SPARSER::PROTEIN)
    ("exogenous HGF" . SPARSER::PROTEIN)
    ("HGF and/or crizotinib kinase inhibitor" . SPARSER::COLLECTION)
    ("neuregulin" . SPARSER::PROTEIN) ("BTC" . SPARSER::PROTEIN)
    ("whose cognate ligands" . SPARSER::LIGAND)
    ("MET and PAK1" . SPARSER::COLLECTION)
    ("the E-cadherin-associated protein" . SPARSER::PROTEIN)
    ("RAC/CDC42" . SPARSER::COLLECTION)
    ("RAS-related C3 botulinum toxin substrate 1 (RAC1)/cell division control protein 42 (CDC42) and p21-activated kinases (PAKs)"
     . SPARSER::COLLECTION)
    ("PI3K–AKT" . SPARSER::COLLECTION) ("RAS–MAPK" . SPARSER::COLLECTION)
    ("several adaptor proteins and signalling molecules [ xref ]"
     . SPARSER::COLLECTION)
    ("monovalent monoclonal antibody" . SPARSER::DRUG)
    ("semaphorin" . SPARSER::PROTEIN-FAMILY) ("Onartuzumab" . SPARSER::DRUG)
    ("HGF and MET" . SPARSER::COLLECTION)
    ("a liver mitogen and fibroblast-derived epithelial motility factor"
     . SPARSER::COLLECTION)
    ("HGF/SF" . SPARSER::COLLECTION)
    ("Hepatocyte growth factor/scatter factor" . SPARSER::COLLECTION)
    ("extreme pain" . SPARSER::PROTEIN) ("MET/PAK1" . SPARSER::COLLECTION)
    ("onartuzumab and crizotinib" . SPARSER::COLLECTION)
    ("cytoskeletal effectors" . SPARSER::EFFECTOR)
    ("HGF/MET" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF) and MET receptor tyrosine kinase"
     . SPARSER::COLLECTION)
    ("SMAD4" . SPARSER::PROTEIN) ("DPC4" . SPARSER::PROTEIN)
    ("GDC-0973" . SPARSER::DRUG) ("PF02341066" . SPARSER::DRUG)
    ("SP44" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("secreted growth factor" . SPARSER::PROTEIN)
    ("Group I" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("very few functional substrates" . SPARSER::SUBSTRATE)
    ("monomeric and heterodimeric states" . SPARSER::BIO-STATE)
    ("a monomeric form" . SPARSER::FORM) ("Itch" . SPARSER::PROTEIN)
    ("p73 and its isoforms" . SPARSER::COLLECTION)
    ("full-length and N-terminally" . SPARSER::COLLECTION)
    ("the monomeric state" . SPARSER::BIO-STATE)
    ("the heterodimeric WWP2-WWP1 state" . SPARSER::BIO-STATE)
    ("monomeric and dimeric states" . SPARSER::BIO-STATE)
    ("monomeric and heterodimeric WWP2-WWP1" . SPARSER::COLLECTION)
    ("WWP2, WWP1, or PPM1G" . SPARSER::COLLECTION)
    ("antiapoptotic ΔNp73" . SPARSER::PROTEIN)
    ("the proapoptotic p73" . SPARSER::PROTEIN)
    ("a WWP2-WWP1 heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("WWP1 and WWP2" . SPARSER::COLLECTION)
    ("heterodimeric WWP2" . SPARSER::PROTEIN)
    ("testing various listed WWP2-associated proteins" . SPARSER::PROTEIN)
    ("the monomeric and heterodimeric WWP2 state" . SPARSER::BIO-STATE)
    ("WWP2-WWP1 heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("monomeric form" . SPARSER::FORM)
    ("a WWP2-associated E3 ligase" . SPARSER::LIGASE)
    ("WWP2 or WWP1" . SPARSER::COLLECTION) ("WWP1-WWP2" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("WWP2 and WWP1" . SPARSER::COLLECTION)
    ("WWP2-associated proteins" . SPARSER::PROTEIN)
    ("ΔNp73" . SPARSER::PROTEIN) ("WWP2 and p73" . SPARSER::COLLECTION)
    ("GST-ΔNp73" . SPARSER::PROTEIN-PAIR) ("GST-p73" . SPARSER::COLLECTION)
    ("WWP2 and these two p73 isoforms" . SPARSER::COLLECTION)
    ("an alternate isoform and a known negative regulator"
     . SPARSER::COLLECTION)
    ("an alternate isoform" . SPARSER::PROTEIN)
    ("p73 and WWP2" . SPARSER::COLLECTION)
    ("several WWP2-associated proteins" . SPARSER::PROTEIN)
    ("a novel WWP2-associated protein" . SPARSER::PROTEIN)
    ("PTEN and SMADs" . SPARSER::COLLECTION) ("SMADs" . SPARSER::PROTEIN)
    ("p73 and inactive" . SPARSER::COLLECTION)
    ("alternatively spliced C-terminal isoforms (α, β, γ, δ, ε, ζ, and η) and three alternatively spliced N-terminal isoforms"
     . SPARSER::COLLECTION)
    ("cellular p73 and ΔNp73" . SPARSER::COLLECTION)
    ("p73 and ΔNp73" . SPARSER::COLLECTION) ("WWP2-WWP1" . SPARSER::COLLECTION)
    ("monomeric WWP2 and a WWP2/WWP1 heterodimeric state"
     . SPARSER::COLLECTION)
    ("a WWP2/WWP1 heterodimeric state" . SPARSER::BIO-STATE)
    ("monomeric WWP2" . SPARSER::PROTEIN) ("WWP2/WWP1" . SPARSER::COLLECTION)
    ("a novel p73-associated protein" . SPARSER::PROTEIN)
    ("transcription factor p73 and its functionally opposing N-terminally"
     . SPARSER::COLLECTION)
    ("FBXO45" . SPARSER::PROTEIN) ("UFD2a" . SPARSER::PROTEIN)
    ("PIR2" . SPARSER::PROTEIN) ("PP2Cγ" . SPARSER::PROTEIN)
    ("2b" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UbcH5b" . SPARSER::PROTEIN)
    ("UBE1" . SPARSER::PROTEIN) ("S-protein" . SPARSER::PROTEIN)
    ("E6AP" . SPARSER::PROTEIN) ("HACE1" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TP73" . SPARSER::PROTEIN)
    ("PPM1G" . SPARSER::PROTEIN) ("WWP2" . SPARSER::PROTEIN)
    ("kRas" . SPARSER::PROTEIN)
    ("HER2, progesterone, and estrogen receptor" . SPARSER::COLLECTION)
    ("Src and p210" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("K-ras and Isg15" . SPARSER::COLLECTION)
    ("frequently mutated Ras allele" . SPARSER::ALLELE)
    ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("Src-transformed MEFs" . SPARSER::PROTEIN)
    ("p21/Waf1" . SPARSER::COLLECTION)
    ("wild-type p53 [ xref ] and Ab240" . SPARSER::COLLECTION)
    ("p53 and Herc5" . SPARSER::COLLECTION)
    ("Ras and myc" . SPARSER::COLLECTION)
    ("p53 and the E3 ligase HERC5 (Figure xref )" . SPARSER::COLLECTION)
    ("Src, Ras, and Myc" . SPARSER::COLLECTION)
    ("Oncogenes" . SPARSER::ONCOGENE)
    ("dominant-negative p53" . SPARSER::PROTEIN) ("Isg15" . SPARSER::PROTEIN)
    ("Herc5" . SPARSER::PROTEIN) ("Herc" . SPARSER::PROTEIN)
    ("V-Src" . SPARSER::PROTEIN) ("MnCl2" . SPARSER::DRUG)
    ("ISG15" . SPARSER::PROTEIN) ("UbcH8" . SPARSER::PROTEIN)
    ("Ube1" . SPARSER::PROTEIN) ("Dok-1" . SPARSER::PROTEIN)
    ("bcr-abl" . SPARSER::PROTEIN) ("p210" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("HERC5" . SPARSER::PROTEIN)
    ("UBCH8" . SPARSER::PROTEIN) ("UBE1L" . SPARSER::PROTEIN)
    ("a relatively small historic cohort" . SPARSER::MOLECULE)
    ("p53 inhibitor Mdm2 and the tumour suppressor PTEN" . SPARSER::COLLECTION)
    ("p53 and mTOR" . SPARSER::COLLECTION) ("Luminal" . SPARSER::DRUG)
    ("a systemic biomarker" . SPARSER::MOLECULE)
    ("Arginine-Cysteine" . SPARSER::COLLECTION)
    ("Arginina-Serine" . SPARSER::COLLECTION)
    ("Cysteine" . SPARSER::AMINO-ACID)
    ("whose fasting glucose" . SPARSER::MOLECULE) ("erbB" . SPARSER::PROTEIN)
    ("dl" . SPARSER::MOLECULE) ("Chromosome 17" . SPARSER::PROTEIN)
    ("p-Nrf-2" . SPARSER::COLLECTION)
    ("its functional E2F1" . SPARSER::PROTEIN)
    ("the extrinsic P1 promoter and intrinsic P2 promoter"
     . SPARSER::COLLECTION)
    ("DNMTs" . SPARSER::PROTEIN) ("Nrf-2 and promoter" . SPARSER::COLLECTION)
    ("sh-Nrf-2" . SPARSER::COLLECTION) ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("DNA Methyltransferase" . SPARSER::PROTEIN) ("Nrf-2" . SPARSER::PROTEIN)
    ("the single worst prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAK and RhoA" . SPARSER::COLLECTION) ("LIM2-LIM3" . SPARSER::COLLECTION)
    ("larger FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLA, apFRET, and co-IP" . SPARSER::COLLECTION)
    ("HDAC6 and paxillin" . SPARSER::COLLECTION)
    ("soluble α-tubulin" . SPARSER::PROTEIN)
    ("a positive prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paxillin and GM130" . SPARSER::COLLECTION)
    ("other migration-relevant substrates" . SPARSER::SUBSTRATE)
    ("cortactin and Hsp90" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("GFP–α-tubulin" . SPARSER::COLLECTION)
    ("a nonacetylatable K40R mutant" . SPARSER::MUTANT)
    ("giantin" . SPARSER::PROTEIN) ("tubacin or HDAC6" . SPARSER::COLLECTION)
    ("a 3D collagen and fibronectin-rich ECM ( xref )" . SPARSER::COLLECTION)
    ("LD1, LD2, or LD4" . SPARSER::COLLECTION)
    ("GFP-paxillin" . SPARSER::COLLECTION)
    ("LD1, LD2, and LD4" . SPARSER::COLLECTION)
    ("around FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("talin-GFP" . SPARSER::COLLECTION) ("paxillin-FAK" . SPARSER::COLLECTION)
    ("paxillin–HDAC6" . SPARSER::COLLECTION) ("talin" . SPARSER::PROTEIN)
    ("paxillin and HDAC6" . SPARSER::COLLECTION)
    ("the predominant α-tubulin deacetylase" . SPARSER::PROTEIN)
    ("the only other identified MT deacetylase" . SPARSER::PROTEIN)
    ("dysfunctional acetyltransferases" . SPARSER::PROTEIN)
    ("tubacin" . SPARSER::DRUG)
    ("the predominant tubulin deacetylase" . SPARSER::PROTEIN)
    ("polymerized α-tubulin" . SPARSER::PROTEIN)
    ("paxillin and α-tubulin" . SPARSER::COLLECTION)
    ("PKC-α, GRK2, and GSK3-β" . SPARSER::COLLECTION)
    ("aurora" . SPARSER::PROTEIN)
    ("dynein and the protein phosphatase PP1 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("dynein" . SPARSER::PROTEIN) ("HDAC6 and sirtuin-2" . SPARSER::COLLECTION)
    ("TAT1" . SPARSER::PROTEIN)
    ("active Cdc42 and its effector β-PIX" . SPARSER::COLLECTION)
    ("promigratory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vinculin and actopaxin" . SPARSER::COLLECTION)
    ("3D-ECM" . SPARSER::COLLECTION) ("actopaxin" . SPARSER::PROTEIN)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("latrunculin A" . SPARSER::DRUG)
    ("cytochalasin D" . SPARSER::DRUG) ("α-actinin" . SPARSER::PROTEIN)
    ("11B" . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("LIM3" . SPARSER::PROTEIN) ("LIM2" . SPARSER::PROTEIN)
    ("GM130" . SPARSER::PROTEIN) ("LD4" . SPARSER::PROTEIN)
    ("Hic-5" . SPARSER::PROTEIN) ("GSK3-β" . SPARSER::PROTEIN)
    ("GRK2" . SPARSER::PROTEIN) ("PKC-α" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("N -acetyltransferase 1" . SPARSER::PROTEIN)
    ("kinesin-1" . SPARSER::PROTEIN) ("β-PIX" . SPARSER::PROTEIN)
    ("α-parvin" . SPARSER::PROTEIN) ("Mena" . SPARSER::PROTEIN)
    ("the heterozygous state" . SPARSER::BIO-STATE) ("GHK" . SPARSER::MOLECULE)
    ("group (CBE)" . SPARSER::MOLECULE)
    ("an interdisciplinary working group" . SPARSER::MOLECULE)
    ("the more aggressive type" . TYPE)
    ("an immediate impact" . SPARSER::PROTEIN)
    ("bovine growth hormone" . SPARSER::PROTEIN) ("Ding" . SPARSER::PROTEIN)
    ("Ning" . SPARSER::PROTEIN-FAMILY)
    ("hypomorphic mdm2 alleles" . SPARSER::ALLELE)
    ("p16 INK4A as well as ARF" . SPARSER::COLLECTION)
    ("viral oncogenes" . SPARSER::ONCOGENE)
    ("c-myc, Ras , STAT5A, and E2F1" . SPARSER::COLLECTION)
    ("Courtois-Cox" . SPARSER::COLLECTION)
    ("Insulin and insulin-like" . SPARSER::COLLECTION)
    ("SIRT1–DBC1" . SPARSER::COLLECTION) ("SIRT1-DBC1" . SPARSER::COLLECTION)
    ("DBC1" . SPARSER::PROTEIN) ("trichostatin" . SPARSER::MOLECULE)
    ("HATs and HDACs" . SPARSER::COLLECTION)
    ("exogenous IGF-1" . SPARSER::PROTEIN)
    ("IGF/insulin" . SPARSER::COLLECTION) ("SIRT1-p53" . SPARSER::COLLECTION)
    ("p53 and Rb" . SPARSER::COLLECTION)
    ("IGF-1-SIRT1-p53" . SPARSER::COLLECTION) ("sir2" . SPARSER::PROTEIN)
    ("mL −1" . SPARSER::PROTEIN) ("age-1" . SPARSER::PROTEIN)
    ("PAPP-A" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nutlin-3a" . SPARSER::DRUG)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IGFR1" . SPARSER::PROTEIN)
    ("STAT3 and c-Jun" . SPARSER::COLLECTION)
    ("c-Jun or c-Myc" . SPARSER::COLLECTION)
    ("JNK-JAK/STAT" . SPARSER::COLLECTION)
    ("JNK or STAT3" . SPARSER::COLLECTION)
    ("siRNA or STAT3" . SPARSER::COLLECTION)
    ("p-c-Jun and p-STAT3 in these cells" . SPARSER::COLLECTION)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("The c-Jun N-terminal kinase (JNK)
[ xref , xref , xref ] and Janus kinase/signal transducer"
     . SPARSER::COLLECTION)
    ("driving oncogene" . SPARSER::ONCOGENE)
    ("c-Myc and CyclinD1" . SPARSER::COLLECTION)
    ("The aggressive NHL" . SPARSER::PROTEIN)
    ("complex and co-localized" . SPARSER::COLLECTION)
    ("the presumptive complex" . SPARSER::BIO-COMPLEX)
    ("c-Jun and STAT3" . SPARSER::COLLECTION)
    ("ISL-1-luc" . SPARSER::COLLECTION)
    ("JNK and JAK/STAT signaling inhibitors" . SPARSER::COLLECTION)
    ("c-Jun or STAT3" . SPARSER::COLLECTION)
    ("SP600125 and STATTIC" . SPARSER::COLLECTION)
    ("JNK and JAK/STAT inhibitors" . SPARSER::COLLECTION)
    ("both JNK and JAK/STAT signaling inhibitors" . SPARSER::COLLECTION)
    ("JNK or JAK/STAT inhibitor (SP600125 or STATTIC)" . SPARSER::COLLECTION)
    ("SP600125 or STATTIC" . SPARSER::COLLECTION)
    ("JNK or JAK/STAT activator (Anisomycin or IL-6)" . SPARSER::COLLECTION)
    ("Anisomycin or IL-6" . SPARSER::COLLECTION) ("Anisomycin" . SPARSER::DRUG)
    ("ISL-1 and c-Myc" . SPARSER::COLLECTION)
    ("ISL-1 and the prominent oncogenic protein c-Myc" . SPARSER::COLLECTION)
    ("both JNK signaling inhibitor SP600125 and JAK/STAT signaling inhibitor STATTIC"
     . SPARSER::COLLECTION)
    ("STATTIC" . SPARSER::DRUG)
    ("inhibitors or activators" . SPARSER::COLLECTION)
    ("TA" . SPARSER::PROTEIN) ("c-Myc-luc" . SPARSER::COLLECTION)
    ("CyclinD1 and BCL-6" . SPARSER::COLLECTION)
    ("CyclinD1, BCL-6 and c-Myc" . SPARSER::COLLECTION)
    ("-ISL1" . SPARSER::COLLECTION) ("Aberrant ISL-1" . SPARSER::PROTEIN)
    ("LIM-homeodomain" . SPARSER::COLLECTION)
    ("NHL and T/NK-cell" . SPARSER::COLLECTION)
    ("ChIP, Co-IP and ChIP-re-IP" . SPARSER::COLLECTION)
    ("p-STAT3/p-c-Jun/ISL-1" . SPARSER::COLLECTION)
    ("p-c-Jun" . SPARSER::COLLECTION) ("p-c-jun" . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION)
    ("CCK-8 and Western blot assays" . SPARSER::COLLECTION)
    ("Both the JNK and JAK/STAT signaling inhibitors" . SPARSER::COLLECTION)
    ("the c-Jun N-terminal kinase (JNK) and the Janus kinase/signal transducer"
     . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("NHL" . SPARSER::PROTEIN) ("IgG2a" . SPARSER::PROTEIN)
    ("ISl-1" . SPARSER::PROTEIN) ("BCL-6" . SPARSER::PROTEIN)
    ("CyclinD1" . SPARSER::PROTEIN) ("ISL1" . SPARSER::PROTEIN)
    ("ISL-1" . SPARSER::PROTEIN)
    ("RASSF1, CDH1 and HIC1" . SPARSER::COLLECTION)
    ("SFN, KRT8, SRC or PTGS2" . SPARSER::COLLECTION)
    ("molecules and signaling pathways" . SPARSER::COLLECTION)
    ("prognostic molecules" . SPARSER::MOLECULE)
    ("receptors (PR)" . SPARSER::PROTEIN)
    ("receptors (ER)" . SPARSER::RECEPTOR) ("transducers" . SPARSER::PROTEIN)
    ("ERBB2, RASSF1, CDH1, MKI67, GATA3, GLI1, SFN, PTGS2, JUN, NOTCH1, CTNNB1, KRT8, SRC, and HIC1"
     . SPARSER::COLLECTION)
    ("JUN" . SPARSER::PROTEIN) ("CK-19" . SPARSER::PROTEIN)
    ("Cyclin A1" . SPARSER::PROTEIN) ("A 15" . SPARSER::PROTEIN)
    ("HIC1" . SPARSER::PROTEIN) ("KRT8" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN) ("Annual screening CBC’s" . SPARSER::PROTEIN)
    ("Annual screening CBC" . SPARSER::PROTEIN)
    ("fludarabine, melphalan, and alemtuzumab" . SPARSER::COLLECTION)
    ("alemtuzumab" . SPARSER::DRUG)
    ("glycine (G) instead of aspartic acid (D)" . SPARSER::COLLECTION)
    ("the mature telomerase protein" . SPARSER::PROTEIN)
    ("TCAB1/WRAP53" . SPARSER::COLLECTION)
    ("NOLA3/NOP10" . SPARSER::COLLECTION) ("NOLA2/NHP2" . SPARSER::COLLECTION)
    ("Fanconi anemia and paroxysmal nocturnal hemoglobinuria"
     . SPARSER::COLLECTION)
    ("mildly increased fetal hemoglobin" . SPARSER::PROTEIN)
    ("CASE" . SPARSER::PROTEIN) ("nail" . SPARSER::PROTEIN)
    ("at least eight genes" . SPARSER::GENE) ("NOLA3" . SPARSER::PROTEIN)
    ("NOLA2" . SPARSER::PROTEIN)
    ("paroxysmal nocturnal hemoglobinuria" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("B 12" . SPARSER::PROTEIN)
    ("MUNC13" . SPARSER::PROTEIN) ("WRAP53" . SPARSER::PROTEIN)
    ("NOP10" . SPARSER::PROTEIN) ("DKC1" . SPARSER::PROTEIN)
    ("TINF2" . SPARSER::PROTEIN)
    ("even non-tumorigenic mutant KRAS alleles" . SPARSER::ALLELE)
    ("KRAS , HRAS and NRAS" . SPARSER::COLLECTION)
    ("melanoma and myeloid" . SPARSER::COLLECTION)
    ("inactive RAS:GDP" . SPARSER::BIO-COMPLEX)
    ("active RAS:GTP" . SPARSER::BIO-COMPLEX)
    ("RAS:GDP" . SPARSER::BIO-COMPLEX) ("RAS:GTP" . SPARSER::BIO-COMPLEX)
    ("widespread nuclear" . SPARSER::PROTEIN)
    ("PCNA and phospho-ERK" . SPARSER::COLLECTION)
    ("witheGFP-KRAS" . SPARSER::COLLECTION)
    ("expressingUAS:eGFP-KRAS" . SPARSER::BIO-COMPLEX)
    ("eGFP-KRAS" . SPARSER::COLLECTION) ("aneGFP-KRAS" . SPARSER::COLLECTION)
    ("JH" . SPARSER::PROTEIN) ("transgenes" . SPARSER::PROTEIN)
    ("ofeGFP-KRAS" . SPARSER::COLLECTION) ("Gal4" . SPARSER::PROTEIN)
    ("Gal" . SPARSER::PROTEIN) ("ptf1a" . SPARSER::PROTEIN)
    ("the triple negative BC group" . SPARSER::MOLECULE)
    ("p-cMET" . SPARSER::COLLECTION) ("cMET" . SPARSER::PROTEIN)
    ("c-MET and HER2" . SPARSER::COLLECTION)
    ("hHGF/scatter factor" . SPARSER::COLLECTION)
    ("a shorter median TTF" . SPARSER::PROTEIN)
    ("bevacizumab, temsirolimus, and carboplatin" . SPARSER::COLLECTION)
    ("TTF" . SPARSER::PROTEIN)
    ("progesterone receptor and estrogen receptor" . SPARSER::COLLECTION)
    ("Investigational Cancer Therapeutics" . SPARSER::THERAPEUTICS)
    ("Therapeutics" . SPARSER::THERAPEUTICS)
    ("scatter factor" . SPARSER::PROTEIN) ("c-met" . SPARSER::PROTEIN)
    ("different soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-6, GM-CSF, IL-10 and IL-1β" . SPARSER::COLLECTION)
    ("IFNs" . SPARSER::DRUG) ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("STAT3/IDO" . SPARSER::COLLECTION)
    ("development innovative drugs" . SPARSER::DRUG)
    ("STAT3 and NF-κ B" . SPARSER::COLLECTION)
    ("cytokines, IL-1β, GM-CSF, IL-6 and IL-10" . SPARSER::COLLECTION)
    ("GM-CSF, IL-6, and IL-10" . SPARSER::COLLECTION)
    ("GM-CSF, IL-6, IFN-γ, IL-1β, TGF-β and IL-10" . SPARSER::COLLECTION)
    ("GM-CSF, IL-6, IL-10 and IL-1β" . SPARSER::COLLECTION)
    ("NIK and CD33" . SPARSER::COLLECTION)
    ("IDO and CD33" . SPARSER::COLLECTION) ("p52/RelB" . SPARSER::COLLECTION)
    ("RelB and p52" . SPARSER::COLLECTION)
    ("both noncanonical NF-κB subunits p52 and RelB" . SPARSER::COLLECTION)
    ("p52-RelB" . SPARSER::COLLECTION) ("IDO and NIK" . SPARSER::COLLECTION)
    ("p52 and RelB" . SPARSER::COLLECTION)
    ("noncanonical NF-κB subunits, p52 and RelB" . SPARSER::COLLECTION)
    ("subunits, p52 and RelB" . SPARSER::COLLECTION)
    ("subunits, p50 and RelA" . SPARSER::COLLECTION)
    ("p50, p52, RelA and RelB" . SPARSER::COLLECTION)
    ("RelB/p52" . SPARSER::COLLECTION)
    ("STAT3 and NF-κB" . SPARSER::COLLECTION)
    ("STAT3 and C/EBPβ" . SPARSER::COLLECTION)
    ("activating protein (LAP)" . SPARSER::PROTEIN)
    ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCAAT" . SPARSER::PROTEIN)
    ("AKAP12 and HIC2" . SPARSER::COLLECTION) ("STATs" . SPARSER::PROTEIN)
    ("macrophages and DCs" . SPARSER::COLLECTION) ("DCs" . SPARSER::PROTEIN)
    ("tolerogenic kynurenine metabolites" . SPARSER::MOLECULE)
    ("intracellular enzyme" . SPARSER::ENZYME)
    ("kynurenine" . SPARSER::MOLECULE)
    ("suppressive cytokines" . SPARSER::PROTEIN)
    ("IL-10 and TGF-β" . SPARSER::COLLECTION) ("ARG" . SPARSER::PROTEIN)
    ("two distinct subtypes" . SPARSER::PROTEIN)
    ("CD14 and CD15" . SPARSER::COLLECTION) ("Myeloid" . SPARSER::PROTEIN)
    ("STAT3-NF-κB-IDO" . SPARSER::COLLECTION)
    ("NIK and IDO" . SPARSER::COLLECTION)
    ("IKKα and p100" . SPARSER::COLLECTION) ("RelB-p52" . SPARSER::COLLECTION)
    ("RelB" . SPARSER::PROTEIN) ("NF-κB and IDO" . SPARSER::COLLECTION)
    ("IDO" . SPARSER::PROTEIN)
    ("competent immune effectors" . SPARSER::EFFECTOR)
    ("NF-κ B" . SPARSER::PROTEIN) ("SP2" . SPARSER::PROTEIN)
    ("TGF-β 1" . SPARSER::PROTEIN) ("HIC2" . SPARSER::PROTEIN)
    ("AKAP12" . SPARSER::PROTEIN) ("skp2" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("Cucurbitacin I" . SPARSER::DRUG)
    ("JSI-124" . SPARSER::DRUG) ("IRF-1" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("CD13" . SPARSER::PROTEIN) ("CD3ζ" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("GCN2" . SPARSER::PROTEIN)
    ("indoleamine 2,3-dioxygenase" . SPARSER::PROTEIN)
    ("CD62L" . SPARSER::PROTEIN) ("GR-1" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("element binding protein and early growth response protein"
     . SPARSER::COLLECTION)
    ("IL-8 and cyclin D1" . SPARSER::COLLECTION)
    ("phosphodiesterases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("plasmalemmal (and hence eNOS-associated) β-catenin" . SPARSER::PROTEIN)
    ("associated eNOS" . SPARSER::PROTEIN)
    ("histamine or thrombin" . SPARSER::COLLECTION)
    ("adenosine or salbutamol" . SPARSER::COLLECTION)
    ("VE-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("sGC or PKG" . SPARSER::COLLECTION)
    ("cGMP or sildenafil" . SPARSER::COLLECTION)
    ("β-catenin and TCF-4" . SPARSER::COLLECTION)
    ("adenosine and histamine" . SPARSER::COLLECTION)
    ("VEGF or bFGF" . SPARSER::COLLECTION) ("Tube" . SPARSER::PROTEIN)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("either ODQ or Rp (Figure  xref C)" . SPARSER::COLLECTION)
    ("either ODQ or Rp" . SPARSER::COLLECTION)
    ("Adenosine and spermine" . SPARSER::COLLECTION)
    ("protein kinase (PKG)" . SPARSER::PROTEIN) ("ODQ" . SPARSER::MOLECULE)
    ("soluble guanylyl cyclase" . SPARSER::PROTEIN) ("sGC" . SPARSER::PROTEIN)
    ("LiCl" . SPARSER::DRUG) ("ionomycin" . SPARSER::DRUG)
    ("ionophore" . SPARSER::MOLECULE)
    ("adenosine and salbutamol" . SPARSER::COLLECTION)
    ("histamine and thrombin" . SPARSER::COLLECTION)
    ("minimal nuclear" . SPARSER::PROTEIN)
    ("eNOS and NO-cGMP" . SPARSER::COLLECTION) ("IU/mL" . SPARSER::COLLECTION)
    ("adenosine or histamine" . SPARSER::COLLECTION)
    ("eNOS and β-catenin" . SPARSER::COLLECTION) ("sox" . SPARSER::PROTEIN)
    ("an essential part" . SPARSER::COMPONENT)
    ("caveolin-1, and dynamin-2" . SPARSER::COLLECTION)
    ("subcutaneous VEGF-supplemented Matrigel" . SPARSER::PROTEIN)
    ("bFGF" . SPARSER::PROTEIN) ("IL-8, and cyclin D1" . SPARSER::COLLECTION)
    ("sildenafil" . SPARSER::DRUG)
    ("adenosine, salbutamol, thrombin, or histamine" . SPARSER::COLLECTION)
    ("bromo" . SPARSER::MOLECULE) ("spermine" . SPARSER::PROTEIN)
    ("histamine" . SPARSER::PROTEIN) ("thrombin" . SPARSER::PROTEIN)
    ("salbutamol" . SPARSER::DRUG) ("adenosine" . SPARSER::MOLECULE)
    ("cGMP" . SPARSER::PROTEIN) ("β-catenin and eNOS" . SPARSER::COLLECTION)
    ("nitric oxide synthase (NOS)" . SPARSER::PROTEIN)
    ("p45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("erythroid 2" . SPARSER::PROTEIN)
    ("early growth response protein" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN) ("TCF-4" . SPARSER::PROTEIN)
    ("cGMP-dependent" . SPARSER::PROTEIN)
    ("1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one" . SPARSER::MOLECULE)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("lamin A/C" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("TX-100" . SPARSER::DRUG) ("NOR-1" . SPARSER::PROTEIN)
    ("sox-9" . SPARSER::PROTEIN) ("axin-2" . SPARSER::PROTEIN)
    ("inducible NOS" . SPARSER::PROTEIN) ("dynamin-2" . SPARSER::PROTEIN)
    ("heat shock protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ca 2+ -calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("type 5" . SPARSER::PROTEIN) ("endothelial NOS" . SPARSER::PROTEIN)
    ("c-SRC" . SPARSER::COLLECTION)
    ("other proteins or membrane lipids" . SPARSER::COLLECTION)
    ("EGFR and PTPD1" . SPARSER::COLLECTION)
    ("Immobile fractions" . SPARSER::COMPONENT) ("FLIM" . SPARSER::PROTEIN)
    ("a fluorescent fusion protein" . SPARSER::PROTEIN)
    ("GFP and mCherry" . SPARSER::COLLECTION)
    ("each fluorescent fusion protein" . SPARSER::PROTEIN)
    ("PTPD1-mCherry  " . SPARSER::COLLECTION)
    ("PTPD1-GFP  " . SPARSER::COLLECTION) ("mCherry  " . SPARSER::PROTEIN)
    ("GFP  " . SPARSER::PROTEIN)
    ("sub membranous filamentous actin" . SPARSER::BIO-COMPLEX)
    ("PTPD1-GFP" . SPARSER::COLLECTION) ("cortical actin" . SPARSER::PROTEIN)
    ("PTPD1-mCherry" . SPARSER::COLLECTION) ("clear-cut" . SPARSER::PROTEIN)
    ("PTPD1 and a PTPD1(ΔFERM) mutant" . SPARSER::COLLECTION)
    ("the fluorescent protein mCherry" . SPARSER::PROTEIN)
    ("EGFR-GFP" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("MCF7-EG" . SPARSER::COLLECTION) ("EG" . SPARSER::PROTEIN)
    ("An immobile fraction" . SPARSER::COMPONENT)
    ("fluorescent protein" . SPARSER::PROTEIN) ("FRAP" . SPARSER::PROTEIN)
    ("EGFR-CFP" . SPARSER::COLLECTION) ("CFP" . SPARSER::PROTEIN)
    ("Moesin" . SPARSER::PROTEIN) ("Radixin" . SPARSER::PROTEIN)
    ("Ezrin" . SPARSER::PROTEIN) ("PTPD1/EGFR" . SPARSER::COLLECTION)
    ("PTPD1 and EGFR" . SPARSER::COLLECTION) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("PTPN21" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("PTPD1" . SPARSER::PROTEIN)
    ("multiple and different genes" . SPARSER::GENE) ("GA" . SPARSER::PROTEIN)
    ("neurotoxins" . SPARSER::PROTEIN) ("AD" . SPARSER::PROTEIN)
    ("ESR2" . SPARSER::PROTEIN) ("Estrogen-receptor" . SPARSER::PROTEIN)
    ("OR 1" . SPARSER::PROTEIN)
    ("the ultimate electron acceptor" . SPARSER::MOLECULE)
    ("the proximal acceptor and coenzyme" . SPARSER::COLLECTION)
    ("acceptor and coenzyme" . SPARSER::COLLECTION)
    ("orotate" . SPARSER::MOLECULE) ("Bax/Bak" . SPARSER::COLLECTION)
    ("pCAD" . SPARSER::PROTEIN) ("their own glucose" . SPARSER::PROTEIN)
    ("exogeneous glucose" . SPARSER::PROTEIN)
    ("exogenous glucose" . SPARSER::PROTEIN)
    ("CAD and p70S6K" . SPARSER::COLLECTION)
    ("dihydroorotate dehydrogenase (DHODH)" . SPARSER::PROTEIN)
    ("dihydroorotase" . SPARSER::PROTEIN)
    ("significantly more sensitive to 2-DG" . SPARSER::PROTEIN)
    ("the higher basal OCR" . SPARSER::PROTEIN)
    ("the basal OCR" . SPARSER::PROTEIN) ("the maximal OCR" . SPARSER::PROTEIN)
    ("rotenone and antimycin" . SPARSER::COLLECTION)
    ("antimycin" . SPARSER::DRUG) ("rotenone" . SPARSER::PROTEIN)
    ("FCCP" . SPARSER::MOLECULE) ("basal OCR" . SPARSER::PROTEIN)
    ("bendamustine" . SPARSER::DRUG) ("DG" . SPARSER::PROTEIN)
    ("Seahorse" . SPARSER::PROTEIN)
    ("ATP and substrates" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("rapamycin (Rap) and everolimus (Ev)" . SPARSER::COLLECTION)
    ("hyper-mTORC1" . SPARSER::COLLECTION) ("Mec" . SPARSER::PROTEIN)
    ("glutamine ( xref ) and pyrimidine metabolism" . SPARSER::COLLECTION)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("the ATP-competitive" . SPARSER::ATP)
    ("rapamycin and its analogs (rapalogs)" . SPARSER::COLLECTION)
    ("in turn phophorylates p70S6 kinase (p70S6K) and the eukaryotic-initiation-factor 4E-binding protein-1 (4EBP1)"
     . SPARSER::COLLECTION)
    ("in turn phophorylates p70S6 kinase" . SPARSER::KINASE)
    ("Fludarabine" . SPARSER::DRUG) ("leflunomide" . SPARSER::DRUG)
    ("phospho-CAD" . SPARSER::PROTEIN) ("DHODH" . SPARSER::PROTEIN)
    ("isogenic Flu-resistant (FluR) derivatives" . SPARSER::DERIVATIVE)
    ("analog and anti-metabolite" . SPARSER::COLLECTION)
    ("NAD+" . SPARSER::MOLECULE) ("ATG1" . SPARSER::PROTEIN)
    ("ULK-1" . SPARSER::PROTEIN) ("inhibitor of CAD" . SPARSER::PROTEIN)
    ("As 2" . SPARSER::PROTEIN) ("lactic acid" . SPARSER::MOLECULE)
    ("dihydroorotate dehydrogenase" . SPARSER::PROTEIN)
    ("dystrophic" . SPARSER::PROTEIN)
    ("receptors and adhesion molecule" . SPARSER::COLLECTION)
    ("Gpr" . SPARSER::PROTEIN) ("fetuses" . SPARSER::PROTEIN)
    ("TUBA1A or TUBB2B" . SPARSER::COLLECTION)
    ("a defective glia" . SPARSER::PROTEIN)
    ("the atypical forms" . SPARSER::FORM) ("pia" . SPARSER::PROTEIN)
    ("TUBA1A, TUBB2B or TUBB3" . SPARSER::COLLECTION)
    ("the classical lissencephaly group" . SPARSER::MOLECULE)
    ("TUBB2 and TUBB3" . SPARSER::COLLECTION)
    ("our foetal cohort" . SPARSER::MOLECULE)
    ("Norman-Roberts syndrome" . SPARSER::PROTEIN-PAIR)
    ("previously called Norman Roberts syndrome [ xref , xref ] and type B"
     . SPARSER::COLLECTION)
    ("previously called Norman Roberts syndrome" . SPARSER::PROTEIN)
    ("the neonatal period" . SPARSER::PROTEIN)
    ("severe congenital microcephaly" . SPARSER::PROTEIN)
    ("variant (thick four-layered cortex with a cell-sparse zone, normal pons and cerebellum, or with either a three or a two-layered cortical plate) and polymicrogyria-like cortical dysplasia"
     . SPARSER::COLLECTION)
    ("severe complex cortical malformations" . SPARSER::PROTEIN)
    ("the seminal foetal case" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN)
    ("fronto-centrally predominant malformations" . SPARSER::PROTEIN)
    ("the ventral part" . SPARSER::COMPONENT)
    ("foetal brain MRI" . SPARSER::PROTEIN)
    ("hypoplasic and disorganized striatum and thalami" . SPARSER::COLLECTION)
    ("severe microcephaly" . SPARSER::PROTEIN)
    ("striatum and thalami" . SPARSER::COLLECTION)
    ("striatum and pallidum" . SPARSER::COLLECTION)
    ("neuroglial overmigration foci" . SPARSER::PROTEIN)
    ("TUB" . SPARSER::PROTEIN) ("LIS" . SPARSER::PROTEIN)
    ("extreme microcephaly" . SPARSER::PROTEIN)
    ("TUBA1A, TUBB2B and TUBB3" . SPARSER::COLLECTION)
    ("TUBB2B and TUBB3" . SPARSER::COLLECTION)
    ("these complex cortical developmental malformations" . SPARSER::PROTEIN)
    ("Only few foetal case" . SPARSER::PROTEIN)
    ("ARX, LIS1, DCX, or RELN" . SPARSER::COLLECTION)
    ("RELN" . SPARSER::PROTEIN) ("DCX" . SPARSER::PROTEIN)
    ("ARX" . SPARSER::PROTEIN) ("LIS1" . SPARSER::PROTEIN)
    ("TUBA1A , TUBA8 and TUBB2B" . SPARSER::COLLECTION)
    ("seizures and microcephaly" . SPARSER::COLLECTION)
    ("tubulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cortical malformations" . SPARSER::PROTEIN)
    ("microcephaly" . SPARSER::PROTEIN)
    ("neuronal migration, and post-migrational" . SPARSER::COLLECTION)
    ("TUBA1A (3 cases) or TUBB2B (1 case)" . SPARSER::COLLECTION)
    ("TUBB2B (6 cases) and TUBB3 (one case)" . SPARSER::COLLECTION)
    ("Complex cortical malformations" . SPARSER::PROTEIN)
    ("Tubb3" . SPARSER::PROTEIN) ("adhesion molecule" . SPARSER::PROTEIN)
    ("G protein–coupled" . SPARSER::PROTEIN) ("GPR56" . SPARSER::PROTEIN)
    ("TUBB2" . SPARSER::PROTEIN) ("type B" . SPARSER::PROTEIN)
    ("Roberts syndrome" . SPARSER::PROTEIN)
    ("P72S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TUBG1" . SPARSER::PROTEIN)
    ("TUBB5" . SPARSER::PROTEIN) ("TUBA8" . SPARSER::PROTEIN)
    ("TUBB3" . SPARSER::PROTEIN) ("TUBB2B" . SPARSER::PROTEIN)
    ("TUBA1A" . SPARSER::PROTEIN) ("ZEB1 and miR-200c" . SPARSER::COLLECTION)
    ("miR-200c and EGFR" . SPARSER::COLLECTION) ("TIC" . SPARSER::PROTEIN)
    ("ZEB1 and other activators" . SPARSER::COLLECTION)
    ("CDH1 and miR-200c" . SPARSER::COLLECTION)
    ("miR-200c and CDH1" . SPARSER::COLLECTION)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anaplastic thyroid cancers EGFR" . SPARSER::PROTEIN)
    ("ligand (EGF)" . SPARSER::MOLECULE)
    ("possible targets" . SPARSER::TARGET-PROTEIN)
    ("CDH1 and ZEB1" . SPARSER::COLLECTION) ("HCA" . SPARSER::PROTEIN)
    ("-ampH" . SPARSER::COLLECTION) ("ampH" . SPARSER::PROTEIN)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("approximately 20–30 nucleotides" . SPARSER::NUCLEOTIDE)
    ("accurate prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("ZEB-1" . SPARSER::PROTEIN) ("mir-200c" . SPARSER::MOLECULE)
    ("H11" . SPARSER::PROTEIN)
    ("dexamethasone or doxorubicin" . SPARSER::COLLECTION)
    ("Redd1" . SPARSER::PROTEIN) ("dexamethasone" . SPARSER::PROTEIN)
    ("TRAIL and staurosporine" . SPARSER::COLLECTION)
    ("p70S6K and RPS6" . SPARSER::COLLECTION)
    ("TM, and ΔNter1" . SPARSER::COLLECTION)
    ("the triple mutant" . SPARSER::MUTANT) ("alanines" . SPARSER::AMINO-ACID)
    ("procaspase 3 and caspase 3" . SPARSER::COLLECTION)
    ("around 17 kDa" . SPARSER::PROTEIN)
    ("Pro-apoptotic inducers Fas receptor activator" . SPARSER::ACTIVATOR)
    ("a 232 amino-acid TSC2 activator and mTORC1-dependent signaling pathway inhibitor"
     . SPARSER::COLLECTION)
    ("a 232 amino-acid TSC2 activator" . SPARSER::ACTIVATOR)
    ("JA" . SPARSER::PROTEIN) ("zVAD-fmk" . SPARSER::DRUG)
    ("procaspase 3" . SPARSER::PROTEIN)
    ("the complete stress-inducible human HSP70-SBD" . SPARSER::COLLECTION)
    ("small molecule inhibitors or inhibitory peptides that preferentially interact with one"
     . SPARSER::COLLECTION)
    ("NBD, SBDβ and SBDα" . SPARSER::COLLECTION) ("YK" . SPARSER::MOLECULE)
    ("DnaK and other HSP70 proteins" . SPARSER::COLLECTION)
    ("DnaK, Met and Phe" . SPARSER::COLLECTION)
    ("HscA and Ser and Ala" . SPARSER::COLLECTION)
    ("Ser and Ala" . SPARSER::COLLECTION)
    ("DnaK and other HSP70 proteins ( xref )" . SPARSER::COLLECTION)
    ("residues Leu4 p and Thr6 p (methyl group)" . SPARSER::COLLECTION)
    ("β5, β4 and β1" . SPARSER::COLLECTION)
    ("NRLLLTG-DnaK-SBD" . SPARSER::COLLECTION)
    ("HSP70/DnaK" . SPARSER::COLLECTION) ("Substrate" . SPARSER::SUBSTRATE)
    ("fix" . SPARSER::PROTEIN) ("valine or isoleucine" . SPARSER::COLLECTION)
    ("the eukaryotic and bacterial HSP70 proteins" . SPARSER::PROTEIN)
    ("eukaryotic HSP70" . SPARSER::PROTEIN) ("SBDα" . SPARSER::PROTEIN)
    ("HSP70-SBDα" . SPARSER::PROTEIN-PAIR) ("NRLLLTG" . SPARSER::PROTEIN)
    ("both human HSP70 and bacterial DnaK" . SPARSER::COLLECTION)
    ("bacterial DnaK" . SPARSER::PROTEIN) ("par" . SPARSER::PROTEIN)
    ("HSP70 and DnaK" . SPARSER::COLLECTION)
    ("structural homology" . SPARSER::PROTEIN)
    ("HSP70-NRLLLTG" . SPARSER::COLLECTION)
    ("arginine and asparagine" . SPARSER::COLLECTION)
    ("HTA" . SPARSER::PROTEIN) ("his" . SPARSER::AMINO-ACID)
    ("DnaK" . SPARSER::PROTEIN) ("DnaK-SBD" . SPARSER::PROTEIN-PAIR)
    ("an intact eukaryotic HSP70 SBD" . SPARSER::PROTEIN)
    ("apo" . SPARSER::PROTEIN)
    ("the stress-inducible human HSP70" . SPARSER::PROTEIN)
    ("ADP or ATP" . SPARSER::COLLECTION)
    ("modest ATPase activity" . SPARSER::PROTEIN)
    ("HSPA8, Hsp70-8 and HSP73" . SPARSER::COLLECTION)
    ("HSP70-1 and HSP72" . SPARSER::COLLECTION)
    ("HSPA1A/A1B" . SPARSER::COLLECTION)
    ("HscA(Hsc66) and HscC(Hsc62)" . SPARSER::COLLECTION)
    ("HscA" . SPARSER::PROTEIN) ("only one HSP70 gene" . SPARSER::PROTEIN)
    ("their respective substrates" . SPARSER::SUBSTRATE)
    ("SBD and NBD" . SPARSER::COLLECTION) ("HSP70-SBD" . SPARSER::COLLECTION)
    ("eukaryotic HSP70 proteins" . SPARSER::PROTEIN)
    ("NBD and SBD" . SPARSER::COLLECTION)
    ("NBD and SBDα" . SPARSER::COLLECTION) ("SBD" . SPARSER::PROTEIN)
    ("The major stress-induced form" . SPARSER::FORM)
    ("HSP72 or HSPA1A" . SPARSER::COLLECTION) ("site 2" . SPARSER::PROTEIN)
    ("Leu5" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P32" . SPARSER::PROTEIN)
    ("oxygen atom" . SPARSER::MOLECULE) ("SO4" . SPARSER::PROTEIN)
    ("HSP73" . SPARSER::PROTEIN) ("HSPA8" . SPARSER::PROTEIN)
    ("HSC70" . SPARSER::PROTEIN) ("HSP70-1" . SPARSER::PROTEIN)
    ("A1B" . SPARSER::PROTEIN) ("Hsc66" . SPARSER::PROTEIN)
    ("70 kD" . SPARSER::PROTEIN) ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt or Ras" . SPARSER::COLLECTION) ("Ras/Erk" . SPARSER::COLLECTION)
    ("a carcinogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gao" . SPARSER::PROTEIN)
    ("the most commonly studied predictive biomarkers" . SPARSER::MOLECULE)
    ("Gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("both Western blot and IHC" . SPARSER::COLLECTION)
    ("PC9/GR" . SPARSER::COLLECTION) ("PR and SD" . SPARSER::COLLECTION)
    ("PTEN/AKT" . SPARSER::COLLECTION) ("pten" . SPARSER::PROTEIN)
    ("shorter DSF" . SPARSER::PROTEIN) ("DSF" . SPARSER::PROTEIN)
    ("GR" . SPARSER::PROTEIN) ("Pten" . SPARSER::PROTEIN)
    ("PC9" . SPARSER::PROTEIN) ("Green fluorescent protein" . SPARSER::PROTEIN)
    ("vandetanib [ xref ] and other VEGFR signaling inhibitors"
     . SPARSER::COLLECTION)
    ("MUT" . SPARSER::PROTEIN)
    ("erlotinib and bevacizumab" . SPARSER::COLLECTION)
    ("VEGF and EGFR" . SPARSER::COLLECTION) ("BETA" . SPARSER::PROTEIN)
    ("EGFR and VEGFR2" . SPARSER::COLLECTION)
    ("vandetanib and EGFR" . SPARSER::COLLECTION)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("PFS and ORR" . SPARSER::COLLECTION) ("FISH−" . SPARSER::PROTEIN)
    ("the prospective biomarker" . SPARSER::MOLECULE)
    ("Vandetanib" . SPARSER::DRUG)
    ("prospective biomarker" . SPARSER::MOLECULE) ("CI 1" . SPARSER::PROTEIN)
    ("REDD1 and TSC2" . SPARSER::COLLECTION)
    ("the active TSC complex" . SPARSER::BIO-COMPLEX)
    ("Akt and TSC2" . SPARSER::COLLECTION)
    ("the active TSC1•TSC2 complex" . SPARSER::BIO-COMPLEX)
    ("RagB and RagC" . SPARSER::COLLECTION) ("PP2A-B55" . SPARSER::COLLECTION)
    ("approximately 15 different PP2AB subunits" . SPARSER::FRAGMENT)
    ("a trimeric form" . SPARSER::FORM) ("both a dimeric form" . SPARSER::FORM)
    ("holoenzyme" . SPARSER::PROTEIN)
    ("at least three Akt substrates" . SPARSER::SUBSTRATE)
    ("TSC2, GSK-3, and FOXO1/3" . SPARSER::COLLECTION)
    ("TSC2, PRAS40, and TBC1D4" . SPARSER::COLLECTION)
    ("factors, TSC2, PRAS40, and Bad" . SPARSER::COLLECTION)
    ("REDD1, Akt, and PP2A" . SPARSER::COLLECTION)
    ("both Akt and the catalytic subunit" . SPARSER::COLLECTION)
    ("ERK or PP1" . SPARSER::COLLECTION)
    ("GSK3 and FOXO1/3" . SPARSER::COLLECTION)
    ("serum-starved REDD1 −/− and REDD1 +/+ MEFs" . SPARSER::COLLECTION)
    ("TSC2 and 14-3-3" . SPARSER::COLLECTION)
    ("a configuration-specific monoclonal antibody" . SPARSER::DRUG)
    ("GTP/GDP" . SPARSER::PROTEIN-PAIR)
    ("Rheb, and Rheb-GTP" . SPARSER::COLLECTION)
    ("GTP and a variant of RagC that preferentially binds GDP (caRags) which dimerize"
     . SPARSER::COLLECTION)
    ("a constitutively active RagBC complex" . SPARSER::BIO-COMPLEX)
    ("RagB" . SPARSER::PROTEIN)
    ("The most proximal activators" . SPARSER::ACTIVATOR)
    ("Rheb and Rags" . SPARSER::COLLECTION) ("Rags" . SPARSER::PROTEIN)
    ("p70S6K1 and 4E-BP1" . SPARSER::COLLECTION)
    ("HA-REDD1" . SPARSER::COLLECTION)
    ("protein phosphatase (PP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("promoter and mouse" . SPARSER::COLLECTION)
    ("a ubiquitous protein" . SPARSER::PROTEIN)
    ("both REDD1 and its homolog REDD2 ( xref )" . SPARSER::COLLECTION)
    ("nutrient ( xref ) and serum deprivation ( xref )" . SPARSER::COLLECTION)
    ("amino acids or leucine" . SPARSER::COLLECTION)
    ("RagC" . SPARSER::PROTEIN) ("RagA" . SPARSER::PROTEIN)
    ("TSC1 and Tre2-Bub2-Cdc16 domain family member 7 (TBC1D7)"
     . SPARSER::COLLECTION)
    ("GTPase activating protein (GAP)" . SPARSER::PROTEIN)
    ("Tre2-Bub2-Cdc16" . SPARSER::COLLECTION)
    ("Insulin and amino acids" . SPARSER::COLLECTION)
    ("two interdependent complexes" . SPARSER::BIO-COMPLEX)
    ("growth factor and nutrient" . SPARSER::COLLECTION)
    ("Akt and PP2A" . SPARSER::COLLECTION)
    ("REDD1 and PP2A" . SPARSER::COLLECTION) ("l Protein" . SPARSER::PROTEIN)
    ("S16" . SPARSER::PROTEIN) ("pRK5" . SPARSER::PROTEIN)
    ("GAG -3" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("PPP1CA" . SPARSER::PROTEIN) ("B55" . SPARSER::PROTEIN)
    ("TBC1D4" . SPARSER::PROTEIN)
    ("activating transcription factor 4" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("PP2Ac" . SPARSER::PROTEIN)
    ("REDD2" . SPARSER::PROTEIN) ("DDIT4" . SPARSER::PROTEIN)
    ("Rag C" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("member 7" . SPARSER::PROTEIN) ("Cdc16" . SPARSER::PROTEIN)
    ("Bub2" . SPARSER::PROTEIN) ("Tre2" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("protein phosphatase 2A" . SPARSER::PROTEIN) ("REDD1" . SPARSER::PROTEIN)
    ("lapatinib and paclitaxel" . SPARSER::COLLECTION)
    ("three-arm" . SPARSER::PROTEIN)
    ("PFS, ORR, and CBR" . SPARSER::COLLECTION) ("CBR" . SPARSER::PROTEIN)
    ("PTEN and PIK3CA" . SPARSER::COLLECTION) ("ITT" . SPARSER::MOLECULE)
    ("lapatinib and
trastuzumab"
     . SPARSER::COLLECTION)
    ("PIK3CA and
PTEN"
     . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("PTEN and
PIK3CA"
     . SPARSER::COLLECTION)
    ("catalytic
subunit"
     . SPARSER::PROTEIN)
    ("lysine/arginine" . SPARSER::COLLECTION)
    ("The dramatic impact" . SPARSER::PROTEIN) ("ES2" . SPARSER::PROTEIN)
    ("BRCA1-PP1" . SPARSER::COLLECTION) ("VC and BRCA1" . SPARSER::COLLECTION)
    ("post-IR" . SPARSER::COLLECTION) ("VC" . SPARSER::MOLECULE)
    ("the largest exon" . SPARSER::PROTEIN)
    ("dysfunctional BRCA1" . SPARSER::PROTEIN)
    ("GFP and full-length" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("BF4" . SPARSER::PROTEIN) ("GST-BF4" . SPARSER::COLLECTION)
    ("BF" . SPARSER::PROTEIN) ("a serious impact" . SPARSER::PROTEIN)
    ("lysine and glutamic acid" . SPARSER::COLLECTION)
    ("PP1-non-binding BRCA1 mutants F901A and DEL (deletion of the 898 KVTF 901 motif)"
     . SPARSER::COLLECTION)
    ("DEL" . SPARSER::PROTEIN)
    ("valine or phenylalanine" . SPARSER::COLLECTION)
    ("subunits and PP1" . SPARSER::COLLECTION)
    ("catalytic subunits (PP1c) and regulatory (R) subunits"
     . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION) ("hCds1/Chk2" . SPARSER::COLLECTION)
    ("BRCA1 and PP1" . SPARSER::COLLECTION)
    ("BRCA1 and PP1α" . SPARSER::COLLECTION) ("1K" . SPARSER::PROTEIN)
    ("polycystin-1" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN) ("1 K" . SPARSER::PROTEIN)
    ("PP1c" . SPARSER::PROTEIN) ("hCds1" . SPARSER::PROTEIN)
    ("PP1α" . SPARSER::PROTEIN) ("protein phosphatase 1" . SPARSER::PROTEIN)
    ("PI3K-PTEN-AKT" . SPARSER::COLLECTION)
    ("a preclinical RAF inhibitor" . SPARSER::INHIBITOR)
    ("DOX" . SPARSER::DRUG) ("GFP and RAC1" . SPARSER::COLLECTION)
    ("CP" . SPARSER::PROTEIN)
    ("vemurafenib, dabrafenib, trametinib and
PD325901"
     . SPARSER::COLLECTION)
    ("both RAF inhibitors (vemurafenib and dabrafenib) and MEK inhibitors
(trametinib and PD325901)"
     . SPARSER::COLLECTION)
    ("trametinib and PD325901" . SPARSER::COLLECTION)
    ("RAF, MEK, PI3K, and mTOR" . SPARSER::COLLECTION)
    ("p21-activated protein
kinase (PAK)"
     . SPARSER::COLLECTION)
    ("p21-activated protein
kinase"
     . SPARSER::COLLECTION)
    ("variant (DNV)" . SPARSER::VARIANT) ("dinucleotide" . SPARSER::MOLECULE)
    ("vemurafenib or
dabrafenib"
     . SPARSER::COLLECTION)
    ("SNV" . SPARSER::VARIANT) ("RAF and MEK" . SPARSER::COLLECTION)
    ("MAPK kinases (MEK) and BRAF" . SPARSER::COLLECTION)
    ("kinases (MEK)" . SPARSER::KINASE) ("RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("vemurafenib and
dabrafenib"
     . SPARSER::COLLECTION)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("variant (SNV)" . SPARSER::VARIANT) ("MAPK3" . SPARSER::PROTEIN)
    ("MEK1/2 S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAP2K2" . SPARSER::PROTEIN)
    ("MAP2K1" . SPARSER::PROTEIN)
    ("activated protein
kinase"
     . SPARSER::PROTEIN)
    ("S29" . SPARSER::PROTEIN) ("PLX-4720" . SPARSER::DRUG)
    ("PLX4720" . SPARSER::DRUG) ("PD325901" . SPARSER::DRUG)
    ("GSK1120212" . SPARSER::DRUG) ("PLX4032" . SPARSER::DRUG)
    ("GSK21118436" . SPARSER::DRUG) ("EF1α" . SPARSER::PROTEIN)
    ("RAS family" . SPARSER::PROTEIN)
    ("amino
acid"
     . SPARSER::AMINO-ACID)
    ("P29S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RAC1" . SPARSER::PROTEIN)
    ("therapeutics, and point" . SPARSER::COLLECTION)
    ("RPS" . SPARSER::PROTEIN) ("CD19 and CD20" . SPARSER::COLLECTION)
    ("glia" . SPARSER::PROTEIN)
    ("CACNA1C , CACNB2 , and CACNA1I" . SPARSER::COLLECTION)
    ("DRD2 (the target of all effective antipsychotic drugs) and multiple genes (e.g. GRM3 , GRIN2A , SRR , GRIA1 )"
     . SPARSER::COLLECTION)
    ("SRR" . SPARSER::PROTEIN) ("trio" . SPARSER::PROTEIN)
    ("the schizophrenia-associated allele" . SPARSER::ALLELE)
    ("PCs" . SPARSER::PROTEIN)
    ("DRD2 and multiple genes" . SPARSER::COLLECTION)
    ("glutamatergic neurotransmission highlight molecules" . SPARSER::MOLECULE)
    ("calcium channel" . SPARSER::PROTEIN) ("CACNA1I" . SPARSER::PROTEIN)
    ("CACNB2" . SPARSER::PROTEIN) ("CACNA1C" . SPARSER::PROTEIN)
    ("GRIA1" . SPARSER::PROTEIN) ("GRIN2A" . SPARSER::PROTEIN)
    ("GRM3" . SPARSER::PROTEIN) ("DRD2" . SPARSER::PROTEIN)
    ("other possible targets" . SPARSER::TARGET-PROTEIN)
    ("Snail or JAK2" . SPARSER::COLLECTION)
    ("non-invasive gastric epithelial cell line GES-1" . SPARSER::PROTEIN)
    ("pri" . SPARSER::PROTEIN) ("MiR-375-regulated JAK2" . SPARSER::PROTEIN)
    ("precursor-negative control oligonucleotides" . SPARSER::MOLECULE)
    ("specific dysregulated miRNA and specific metastasis step"
     . SPARSER::COLLECTION)
    ("activators or suppressors" . SPARSER::COLLECTION)
    ("Snail, Twist and ZEB1" . SPARSER::COLLECTION)
    ("zinc finger protein" . SPARSER::PROTEIN) ("GES-1" . SPARSER::PROTEIN)
    ("PI3K and estrogen" . SPARSER::COLLECTION)
    ("could constitutively active" . SPARSER::ACTIVE)
    ("pT1 and pT2" . SPARSER::COLLECTION)
    ("alcohol and tobacco" . SPARSER::COLLECTION)
    ("the predominant histological subtype" . SPARSER::PROTEIN)
    ("HR  " . SPARSER::PROTEIN) ("pT1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pT2" . SPARSER::PROTEIN) ("POP7" . SPARSER::PROTEIN)
    ("Exonuclease I" . SPARSER::PROTEIN)
    ("nuclear/cytoplasmic" . SPARSER::PROTEIN)
    ("the miR-221-targeted p27Kip1 mRNAs" . SPARSER::PROTEIN)
    ("β-catenin-nuclear/cytoplasmic" . SPARSER::PROTEIN-PAIR)
    ("the miR-221 targets Rad51 and ERa mRNAs" . SPARSER::COLLECTION)
    ("the intermediate and fleshy types" . TYPE)
    ("inhibitor and tumor" . SPARSER::COLLECTION) ("the atrophic type" . TYPE)
    ("the fleshy and intermediate types" . TYPE)
    ("protein and miR-221expression" . SPARSER::COLLECTION)
    ("ß-catenin" . SPARSER::COLLECTION)
    ("protein and miR-221" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1 (Gene ID: 595 OMIM) and c-myc (Gene ID: 4609; OMIM)"
     . SPARSER::COLLECTION)
    ("factor/lymphoid" . SPARSER::COLLECTION) ("ID" . SPARSER::PROTEIN)
    ("β-catenin, miR-221, and p27Kip1" . SPARSER::COLLECTION)
    ("PECs" . SPARSER::PROTEIN)
    ("β-catenin-associated miRNA" . SPARSER::MICRO-RNA)
    ("P27Kip1" . SPARSER::PROTEIN) ("Rad 51" . SPARSER::PROTEIN)
    ("p73 and the estrogen receptor [ xref - xref ]" . SPARSER::COLLECTION)
    ("sh-c" . SPARSER::COLLECTION) ("HMGB1 and p21" . SPARSER::COLLECTION)
    ("p21 and p53" . SPARSER::COLLECTION) ("Mithramycin" . SPARSER::DRUG)
    ("HMGB1 and Sp1" . SPARSER::COLLECTION) ("ester (PMA)" . SPARSER::MOLECULE)
    ("PMA" . SPARSER::PROTEIN)
    ("another essential factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("CDK2, CDK3, CDK4, and CDK6" . SPARSER::COLLECTION)
    ("a universal cyclin-dependent kinase inhibitor (CDKI)"
     . SPARSER::INHIBITOR)
    ("inhibitor (CDKI)" . SPARSER::INHIBITOR)
    ("p21/WAF1/CIP1" . SPARSER::COLLECTION)
    ("HMGB1-RAGE" . SPARSER::COLLECTION)
    ("extracellular ligand" . SPARSER::LIGAND)
    ("β-Galactosidase" . SPARSER::PROTEIN) ("si-RNA" . SPARSER::RNA)
    ("CDK3" . SPARSER::PROTEIN) ("three domains" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN)
    ("high mobility group box 1" . SPARSER::PROTEIN)
    ("Cdk-cyclins" . SPARSER::COLLECTION)
    ("Myc-Skp2-p27" . SPARSER::COLLECTION)
    ("high Myc and low p27" . SPARSER::COLLECTION)
    ("exogenous Cdk2" . SPARSER::PROTEIN)
    ("cyclins and Cdks" . SPARSER::COLLECTION)
    ("p27-Cdk-Cyclin" . SPARSER::COLLECTION)
    ("Cdk-cyclin" . SPARSER::COLLECTION)
    ("Myc and cyclin" . SPARSER::COLLECTION)
    ("Cyclins and Skp2" . SPARSER::COLLECTION)
    ("Bcl2 and p27" . SPARSER::COLLECTION)
    ("p27 and Bcl2" . SPARSER::COLLECTION) ("fludarabine" . SPARSER::DRUG)
    ("p27-YFP" . SPARSER::COLLECTION) ("bad" . SPARSER::PROTEIN)
    ("Myc-p27" . SPARSER::COLLECTION) ("Rai" . SPARSER::PROTEIN)
    ("p27 mRNA (by RT-qPCR) and p27 protein (by immunoblot) levels"
     . SPARSER::COLLECTION)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("CDK-Cyclin" . SPARSER::COLLECTION) ("Myc and p27" . SPARSER::COLLECTION)
    ("Myc-Max" . SPARSER::COLLECTION)
    ("an oncogenic transcription factor or the helix-loop-helix/leucine zipper protein family"
     . SPARSER::COLLECTION)
    ("genes (IGH)" . SPARSER::GENE) ("CD38 or ZAP70" . SPARSER::COLLECTION)
    ("IGH" . SPARSER::PROTEIN) ("high p27 and low Myc" . SPARSER::COLLECTION)
    ("cyclin-Cdk" . SPARSER::COLLECTION) ("p27 and Myc" . SPARSER::COLLECTION)
    ("triton X-100" . SPARSER::MOLECULE) ("HE12" . SPARSER::PROTEIN)
    ("TCA-3" . SPARSER::PROTEIN) ("RPS14" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("E 7" . SPARSER::PROTEIN-FAMILY)
    ("CD20" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("MEC1" . SPARSER::PROTEIN)
    ("protein Max" . SPARSER::PROTEIN) ("p27 KIP1" . SPARSER::PROTEIN)
    ("ZAP70" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN) ("HER2 and PIK3CA" . SPARSER::COLLECTION)
    ("metformin and AIs" . SPARSER::COLLECTION)
    ("mTOR inhibitors and mTORC1 blockers (Everolimus, Temsirolimus, Rapamycin)"
     . SPARSER::COLLECTION)
    ("SLUG and SNAIL2" . SPARSER::COLLECTION)
    ("SLUG/SNAIL2" . SPARSER::COLLECTION) ("LBL" . SPARSER::PROTEIN)
    ("Pgp" . SPARSER::PROTEIN) ("transporters" . SPARSER::PROTEIN)
    ("Stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("components of the PI3K/Akt/mTORC1 and GSK-3 pathways"
     . SPARSER::COLLECTION)
    ("PI3K/Akt/mTORC1" . SPARSER::COLLECTION)
    ("TGF-beta and Smads" . SPARSER::COLLECTION)
    ("Smads" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("doxorubicin, daunorubicin, and epirubicin" . SPARSER::COLLECTION)
    ("epirubicin" . SPARSER::DRUG) ("PARP and HDAC" . SPARSER::COLLECTION)
    ("Jak2 and Src and receptor" . SPARSER::COLLECTION)
    ("Src and receptor" . SPARSER::COLLECTION)
    ("HER2/PI3K/FOXO/survivin" . SPARSER::COLLECTION)
    ("pertuzumab, or T-DM1 and mTOR" . SPARSER::COLLECTION)
    ("IGF-1R or PDGFR" . SPARSER::COLLECTION)
    ("lapatinib and Src" . SPARSER::COLLECTION)
    ("PI3K and Src" . SPARSER::COLLECTION)
    ("vitamin D and retinoid" . SPARSER::COLLECTION)
    ("a small molecule HER2/EGFR1 dual kinase inhibitor" . SPARSER::INHIBITOR)
    ("raloxifene, and lasofoxifene" . SPARSER::COLLECTION)
    ("anastrozole, letrozole, and exemestane" . SPARSER::COLLECTION)
    ("AIs" . SPARSER::PROTEIN) ("lasofoxifene" . SPARSER::DRUG)
    ("raloxifene" . SPARSER::PROTEIN)
    ("EGFR, PI3K, and mTORC1" . SPARSER::COLLECTION)
    ("Herceptin and the EGFR2 kinase inhibitor lapatinib"
     . SPARSER::COLLECTION)
    ("RESA" . SPARSER::PROTEIN)
    ("docetaxel or paclitaxel" . SPARSER::COLLECTION)
    ("herceptin and taxanes" . SPARSER::COLLECTION) ("Tykerb" . SPARSER::DRUG)
    ("Mertansine" . SPARSER::MOLECULE)
    ("emtansine and PRO132365" . SPARSER::COLLECTION)
    ("ado" . SPARSER::PROTEIN) ("Kadcyla" . SPARSER::DRUG)
    ("mertansine" . SPARSER::MOLECULE) ("emtansine" . SPARSER::DRUG)
    ("herceptin and a taxol" . SPARSER::COLLECTION) ("taxol" . SPARSER::DRUG)
    ("herceptin and docetaxel" . SPARSER::COLLECTION)
    ("just pertuzumab" . SPARSER::DRUG)
    ("PI3K/PTEN/Akt/mTOR" . SPARSER::COLLECTION)
    ("Pertuzumab and herceptin" . SPARSER::COLLECTION)
    ("pertuzumab and herceptin" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("Perjeta" . SPARSER::DRUG)
    ("Pertuzumab" . SPARSER::DRUG)
    ("HER2 and other signaling molecules and sites" . SPARSER::COLLECTION)
    ("molecules and sites" . SPARSER::COLLECTION)
    ("herceptin and mTORC1" . SPARSER::COLLECTION)
    ("hormonal receptors (ER, PR) and HER2" . SPARSER::COLLECTION)
    ("hormonal receptors" . SPARSER::PROTEIN)
    ("exemestane and Herceptin" . SPARSER::COLLECTION)
    ("Navelbine" . SPARSER::DRUG) ("Vinorelbine" . SPARSER::DRUG)
    ("everolimus, herceptin and vinorelbine" . SPARSER::COLLECTION)
    ("herceptin and vinorelbine" . SPARSER::COLLECTION)
    ("exemestane and the mTORC1 blocker everolimus" . SPARSER::COLLECTION)
    ("Exemestane" . SPARSER::DRUG) ("receptor, and HER2" . SPARSER::COLLECTION)
    ("docetaxel, doxorubicin, and cyclophosphamide" . SPARSER::COLLECTION)
    ("fluorouracil, doxorubicin, and cyclophosphamide" . SPARSER::COLLECTION)
    ("FAC" . SPARSER::PROTEIN) ("ACT" . SPARSER::PROTEIN)
    ("docetaxel" . SPARSER::DRUG)
    ("antibiotic chemotherapeutic drugs" . SPARSER::DRUG)
    ("adriamycin" . SPARSER::DRUG)
    ("Common chemotherapeutic drugs" . SPARSER::DRUG)
    ("anthracyclines, taxanes, 5-fluorouracil, cyclophosphamide, and methotrexate"
     . SPARSER::COLLECTION)
    ("Alisertib" . SPARSER::DRUG) ("cyclin-A/Cdk2" . SPARSER::COLLECTION)
    ("DNp" . SPARSER::DRUG) ("Raf-1/p53/Aurora" . SPARSER::COLLECTION)
    ("ERalpha-" . SPARSER::PROTEIN) ("Aurora-A/SMAD5" . SPARSER::COLLECTION)
    ("The Aurora-A mitotic kinase" . SPARSER::KINASE)
    ("the mitotic kinase Aurora-A" . SPARSER::PROTEIN)
    ("Aurora-A and SMAD5" . SPARSER::COLLECTION)
    ("CD24 and ERalpha" . SPARSER::COLLECTION)
    ("HER2 and CD44" . SPARSER::COLLECTION)
    ("EMT and stemness" . SPARSER::COLLECTION)
    ("Aurora-A mitotic kinase" . SPARSER::KINASE)
    ("Raf/MEK/MAPK" . SPARSER::COLLECTION)
    ("TGFB2 , TWIST1 and FOXC1" . SPARSER::COLLECTION)
    ("EMT-inducer" . SPARSER::COLLECTION) ("BMB" . SPARSER::PROTEIN)
    ("Raf-1 and Aurora-1" . SPARSER::COLLECTION)
    ("EMT and MET" . SPARSER::COLLECTION)
    ("Raf-1 and Aurora" . SPARSER::COLLECTION) ("histological type" . TYPE)
    ("metronomic cyclophosphamide" . SPARSER::DRUG) ("LTF" . SPARSER::PROTEIN)
    ("lactotransferrin" . SPARSER::PROTEIN) ("NRIP" . SPARSER::PROTEIN)
    ("SEC" . SPARSER::PROTEIN) ("TNFRSF" . SPARSER::PROTEIN)
    ("Akt and GSK-3beta" . SPARSER::COLLECTION)
    ("Wnt and Akt" . SPARSER::COLLECTION)
    ("the chemotherapeutic drug" . SPARSER::DRUG)
    ("doxorubicin or 4HT" . SPARSER::COLLECTION)
    ("doxorubicin and 4HT" . SPARSER::COLLECTION) ("Micro RNAs" . SPARSER::RNA)
    ("breast cancer resistance protein (BCRP)" . SPARSER::PROTEIN)
    ("BCRP" . SPARSER::PROTEIN)
    ("GSK-3beta and beta-catenin" . SPARSER::COLLECTION)
    ("GSK-" . SPARSER::PROTEIN)
    ("eEF2K, rpS6, and p4E-BP" . SPARSER::COLLECTION)
    ("pdcd4, eEF2 and eEF2K" . SPARSER::COLLECTION)
    ("eEF2 and eEF2K" . SPARSER::COLLECTION) ("phenocopy" . SPARSER::PROTEIN)
    ("PIK3R1 and PIK3R2" . SPARSER::COLLECTION)
    ("PI3K-p110-beta" . SPARSER::COLLECTION)
    ("PI3K-p110-alpha" . SPARSER::COLLECTION)
    ("PI3K-p110 alpha" . SPARSER::COLLECTION) ("Subunits" . SPARSER::FRAGMENT)
    ("GSK2636771 and AZD6482" . SPARSER::COLLECTION)
    ("ECC" . SPARSER::MOLECULE)
    ("the pan-class I PI3K inhibitor GDC-0941 and the mTORC1 inhibitor temsirolimus"
     . SPARSER::COLLECTION)
    ("pan-class I" . SPARSER::COLLECTION)
    ("PTEN , PIK3CA , PIK3R1 and KRAS" . SPARSER::COLLECTION)
    ("AR and PIK3CA" . SPARSER::COLLECTION) ("AR and ER" . SPARSER::COLLECTION)
    ("IGF-1R or EGFR-3" . SPARSER::COLLECTION) ("EGFR-3" . SPARSER::COLLECTION)
    ("Fulvestrant" . SPARSER::DRUG) ("fulvestrant" . SPARSER::DRUG)
    ("ER and PI3K" . SPARSER::COLLECTION)
    ("p70S6K, p85S6K and Akt" . SPARSER::COLLECTION)
    ("PI3K inhibitors and 4HT" . SPARSER::COLLECTION)
    ("the less aggressive luminal A subtype" . SPARSER::PROTEIN)
    ("the more aggressive luminal B subtype" . SPARSER::PROTEIN)
    ("PI3K or mTORC1" . SPARSER::COLLECTION) ("letrozole-" . SPARSER::DRUG)
    ("the letrozole and cyclophosphamide-treated patients"
     . SPARSER::COLLECTION)
    ("PI3K and P-mTOR" . SPARSER::COLLECTION)
    ("letrozole or letrozole" . SPARSER::COLLECTION) ("AI" . SPARSER::PROTEIN)
    ("the interleukin-8 receptor (IL-8R) and HER2" . SPARSER::COLLECTION)
    ("immune-regulator" . SPARSER::PROTEIN) ("perifosine" . SPARSER::PROTEIN)
    ("PTEN and Cytokines" . SPARSER::COLLECTION) ("Adriamycin" . SPARSER::DRUG)
    ("the particular kinase or other type" . SPARSER::COLLECTION)
    ("GSK-3beta and TSC-2" . SPARSER::COLLECTION)
    ("cyclin E and target" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY) ("SKP" . SPARSER::PROTEIN)
    ("AKT1 and CTNNB1" . SPARSER::COLLECTION)
    ("KIT and KRAS" . SPARSER::COLLECTION) ("-catenin" . SPARSER::COLLECTION)
    ("PIK3CA or polymorphism" . SPARSER::COLLECTION)
    ("Side" . SPARSER::PROTEIN) ("-ligand" . SPARSER::LIGAND)
    ("RANK" . SPARSER::PROTEIN) ("↑/CD24" . SPARSER::COLLECTION)
    ("CIC" . SPARSER::PROTEIN)
    ("the chemotherapeutic drug mitoxantrone" . SPARSER::DRUG)
    ("mitoxantrone" . SPARSER::DRUG) ("glycosyltransferase" . SPARSER::PROTEIN)
    ("ITR/GPR180" . SPARSER::COLLECTION) ("coenzyme" . SPARSER::MOLECULE)
    ("hydroxyacyl" . SPARSER::PROTEIN)
    ("fatty acid and branched chain" . SPARSER::COLLECTION)
    ("RECK , SFRP2 , UAP1L1 , ACADL , ITR , and UGT3A1" . SPARSER::COLLECTION)
    ("UGT" . SPARSER::PROTEIN) ("ITR" . SPARSER::PROTEIN)
    ("ACADL" . SPARSER::PROTEIN) ("RECK" . SPARSER::PROTEIN)
    ("PI3K and PTEN" . SPARSER::COLLECTION)
    ("PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("PI3K and EGFR" . SPARSER::COLLECTION)
    ("activated receptor tyrosine kinases (RTK) or adaptor molecules"
     . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hormonal based therapeutics" . SPARSER::THERAPEUTICS)
    ("HER2 and PI3K" . SPARSER::COLLECTION)
    ("BEZ235 and lapatinib" . SPARSER::COLLECTION)
    ("HRG and P-AKT" . SPARSER::COLLECTION)
    ("the HER2 inhibitors herceptin (trastuzumab) and lapatinib"
     . SPARSER::COLLECTION)
    ("HER2/PIK3CA" . SPARSER::COLLECTION)
    ("heregulin (HRG)" . SPARSER::PROTEIN) ("HRG" . SPARSER::PROTEIN)
    ("PI3K-p110" . SPARSER::COLLECTION) ("ERalpha" . SPARSER::PROTEIN)
    ("PIK3CA , AKT and PTEN" . SPARSER::COLLECTION)
    ("claudin" . SPARSER::PROTEIN) ("PI3K/PTEN/Akt" . SPARSER::COLLECTION)
    ("Bmi-1/H-Ras" . SPARSER::COLLECTION)
    ("p16Ink4A/ARF" . SPARSER::COLLECTION)
    ("Ras and Bmi-1" . SPARSER::COLLECTION) ("RCP" . SPARSER::PROTEIN)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the proliferation markers MIB1 (a monoclonal antibody which is directed to a different epitope on the Ki67 protein than the original Ki67 antibody) and TP53"
     . SPARSER::COLLECTION)
    ("Waf-1 and p27" . SPARSER::COLLECTION)
    ("-triphosphatase" . SPARSER::COLLECTION) ("Bis" . SPARSER::PROTEIN)
    ("FHIT" . SPARSER::PROTEIN)
    ("the cytokeratins (CK7/8, CK18 and CK19) and FOXOA1"
     . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN)
    ("luminal and ER-" . SPARSER::COLLECTION) ("RERG" . SPARSER::PROTEIN)
    ("HER2 and mouse double minute 2 homolog ( MDM2 )" . SPARSER::COLLECTION)
    ("tumor suppressors p16 ( CDKN2A ) and p14ARF" . SPARSER::COLLECTION)
    ("BRCA1 , RB1 , RAS and BRAF" . SPARSER::COLLECTION)
    ("E-cadherin ( CDH1 ) and mitogen-activated protein kinase kinase 4"
     . SPARSER::COLLECTION)
    ("TP53, RB and PI3K" . SPARSER::COLLECTION)
    ("Ras and PI3K" . SPARSER::COLLECTION)
    ("KRAS , HRAS , NRAS , and BRAF" . SPARSER::COLLECTION)
    ("histological types" . TYPE) ("MEK and PI3K" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("NF1 and CELF3-6" . SPARSER::COLLECTION) ("CELF" . SPARSER::PROTEIN)
    ("NF1 and Ras" . SPARSER::COLLECTION) ("Proteins (GAP)" . SPARSER::PROTEIN)
    ("Neurofibromin 1 and GTPase Activating" . SPARSER::COLLECTION)
    ("NRG1-beta" . SPARSER::COLLECTION)
    ("PI3K/PTEN/Akt/mTORC" . SPARSER::COLLECTION)
    ("HER2 or EGFR3" . SPARSER::COLLECTION) ("neratinib" . SPARSER::DRUG)
    ("Akt and p38 MAPK" . SPARSER::COLLECTION)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION)
    ("EGFRvIII and HER2 and CXCR4" . SPARSER::COLLECTION)
    ("HER2 and CXCR4" . SPARSER::COLLECTION)
    ("HER2 [ xref ] and chemokine (C-X-C motif) receptor"
     . SPARSER::COLLECTION)
    ("PI3K/PTEN/Akt/mTORC1" . SPARSER::COLLECTION)
    ("phospho-EGFR or EGFRvIII" . SPARSER::COLLECTION)
    ("ER- or HER2+" . SPARSER::COLLECTION)
    ("EGFRvIII and EGFR" . SPARSER::COLLECTION)
    ("LCM" . SPARSER::PROTEIN-FAMILY) ("herstatin" . SPARSER::PROTEIN)
    ("Neu differentiation factor (NDF) or neuregulins, and heregulin"
     . SPARSER::COLLECTION)
    ("EGF, schwannoma-derived growth factor (SDGF), vaccinia growth factor (VGF), Neu differentiation factor (NDF) or neuregulins, and heregulin"
     . SPARSER::COLLECTION)
    ("neuregulins, and heregulin" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN) ("neuregulins" . SPARSER::PROTEIN)
    ("NDF" . SPARSER::PROTEIN) ("VGF" . SPARSER::PROTEIN)
    ("SDGF" . SPARSER::PROTEIN)
    ("both HER2 inhibitors and PI3K inhibitors" . SPARSER::COLLECTION)
    ("BKM120 and XL147" . SPARSER::COLLECTION)
    ("Akt and ERK1/2" . SPARSER::COLLECTION)
    ("ER-alpha and EGFR4" . SPARSER::COLLECTION)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("ER-beta-" . SPARSER::PROTEIN)
    ("ER-alpha- and 49 ER-alpha+" . SPARSER::COLLECTION)
    ("ER-alpha- and PR-" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-alpha-" . SPARSER::PROTEIN)
    ("the ER and other genes" . SPARSER::COLLECTION)
    ("environmental mutagens" . SPARSER::MOLECULE)
    ("mutagens" . SPARSER::MOLECULE) ("ER-" . SPARSER::PROTEIN)
    ("lymph node positive and overexpressed c-Myc" . SPARSER::PROTEIN)
    ("the CHK2 gene and a germ line variant (T59K)" . SPARSER::COLLECTION)
    ("CISH" . SPARSER::PROTEIN)
    ("TP53 , BRCA1 , ATM , and PIK3CA" . SPARSER::COLLECTION)
    ("PALB2 ( FANCN ) and RAD51C ( FANCO )" . SPARSER::COLLECTION)
    ("CHEK2 , ATM , BRIP1 ( FANCJ ), PALB2 ( FANCN ) and RAD51C ( FANCO )"
     . SPARSER::COLLECTION)
    ("FANCO" . SPARSER::PROTEIN) ("FANCN" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 , PTEN and TP53" . SPARSER::COLLECTION)
    ("progesterone receptor ( PR ) and other genes" . SPARSER::COLLECTION)
    ("the BRCA1 , estrogen receptor ( ER ), progesterone receptor ( PR ) and other genes"
     . SPARSER::COLLECTION)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("the cAMP-responsive element-binding protein (CREB) complex"
     . SPARSER::BIO-COMPLEX)
    ("TNRC9 and BRCA1" . SPARSER::COLLECTION)
    ("acrylamide [ xref ] and other toxins" . SPARSER::COLLECTION)
    ("acrylamide" . SPARSER::MOLECULE) ("Pesticides" . SPARSER::MOLECULE)
    ("the tumor suppressor genes ( TP53 , Serine/threonine kinase 11 [ STK11 ] also known as liver kinase B1[ LKB1 ], phosphatase and tensin homolog [ PTEN ]) and protein phosphatase 6 ( PP6 )"
     . SPARSER::COLLECTION)
    ("mismatch repair endonuclease PMS2 [ PMS2 ] and DNA repair genes"
     . SPARSER::COLLECTION)
    ("FANCD2 , FANCA and FANCC" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia and Rad3" . SPARSER::COLLECTION)
    ("MutL" . SPARSER::PROTEIN) ("FANCC" . SPARSER::PROTEIN)
    ("certain cancer-associated BRCA1/BRCA2 alleles" . SPARSER::ALLELE)
    ("BRCA1/BRCA2" . SPARSER::COLLECTION) ("/BRCA2" . SPARSER::COLLECTION)
    ("BRCA1/partner and localizer of BRCA2" . SPARSER::COLLECTION)
    ("the BRCA1-associated genome surveillance complex (BASC)"
     . SPARSER::BIO-COMPLEX)
    ("complex (BASC)" . SPARSER::BIO-COMPLEX)
    ("BRCA Genes and Other Genes" . SPARSER::COLLECTION)
    ("TP53 , MDM2 and RB" . SPARSER::COLLECTION)
    ("receptor, HER2 and EGFR1" . SPARSER::COLLECTION)
    ("relevant examples" . SPARSER::EXAMPLE) ("herceptin" . SPARSER::DRUG)
    ("RB as well as other oncogenes" . SPARSER::COLLECTION)
    ("EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3" . SPARSER::COLLECTION)
    ("SNAIL2" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("MRP1" . SPARSER::PROTEIN) ("multidrug resistance" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("XL 147" . SPARSER::DRUG) ("vitamin D" . SPARSER::MOLECULE)
    ("anti-mitotic" . SPARSER::MOLECULE) ("SU9516" . SPARSER::DRUG)
    ("cyclin-A" . SPARSER::PROTEIN) ("SMAD5" . SPARSER::PROTEIN)
    ("FOXC1" . SPARSER::PROTEIN) ("TGFB2" . SPARSER::PROTEIN)
    ("LIMCH1" . SPARSER::PROTEIN)
    ("LIM and calponin homology domains 1" . SPARSER::PROTEIN)
    ("SLC40A1" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("solute carrier family 40 (iron-regulated transporter)"
     . SPARSER::PROTEIN)
    ("CYP4Z2P" . SPARSER::PROTEIN) ("polypeptide 2" . SPARSER::PROTEIN)
    ("CYP4Z1" . SPARSER::PROTEIN) ("subfamily Z" . SPARSER::PROTEIN)
    ("family 4" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY) ("beta)" . SPARSER::PROTEIN)
    ("enhancer binding protein" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor superfamily" . SPARSER::PROTEIN)
    ("GSK-3alpha" . SPARSER::PROTEIN)
    ("breast cancer resistance protein" . SPARSER::PROTEIN)
    ("prolactin receptor" . SPARSER::PROTEIN) ("c-Myb" . SPARSER::PROTEIN)
    ("cadherin-11" . SPARSER::PROTEIN) ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("eEF2K" . SPARSER::PROTEIN) ("eEF2" . SPARSER::PROTEIN)
    ("pdcd4" . SPARSER::PROTEIN)
    ("programmed cell death protein 4" . SPARSER::PROTEIN)
    ("p85beta" . SPARSER::PROTEIN) ("PIK3R2" . SPARSER::PROTEIN)
    ("p85alpha" . SPARSER::PROTEIN) ("p110-alpha" . SPARSER::PROTEIN)
    ("p110 alpha" . SPARSER::PROTEIN) ("AZD6482" . SPARSER::DRUG)
    ("GSK2636771" . SPARSER::DRUG) ("p110beta" . SPARSER::PROTEIN)
    ("p110alpha" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("p85S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BEZ-235" . SPARSER::DRUG)
    ("insulin like growth factor-1" . SPARSER::PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN) ("TSC-2" . SPARSER::PROTEIN)
    ("GSK-3beta" . SPARSER::PROTEIN) ("SGK3" . SPARSER::PROTEIN)
    ("member 3" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN)
    ("ubiquitin protein ligase" . SPARSER::PROTEIN)
    ("F-box and WD repeat domain containing 7" . SPARSER::PROTEIN)
    ("PHLPP2" . SPARSER::PROTEIN)
    ("PH domain and leucine rich repeat protein phosphatase 2"
     . SPARSER::PROTEIN)
    ("transporter activity" . SPARSER::PROTEIN) ("BCRP1" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("GPR180" . SPARSER::PROTEIN)
    ("branched chain" . SPARSER::PROTEIN) ("UDP-" . SPARSER::PROTEIN)
    ("Secreted frizzled-related protein 2" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN) ("3A1" . SPARSER::PROTEIN)
    ("UAP1" . SPARSER::PROTEIN) ("SFRP2" . SPARSER::PROTEIN)
    ("PI3K-alpha" . SPARSER::PROTEIN) ("p16Ink4A" . SPARSER::PROTEIN)
    ("Bmi-1" . SPARSER::PROTEIN) ("Rab family" . SPARSER::PROTEIN)
    ("RAB11FIP1" . SPARSER::PROTEIN) ("Kip-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Waf-1" . SPARSER::PROTEIN) ("fragile histidine triad" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN) ("MEK4" . SPARSER::PROTEIN)
    ("MAP2K4" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 4" . SPARSER::PROTEIN)
    ("RASAL2" . SPARSER::PROTEIN) ("GTPase Activating" . SPARSER::PROTEIN)
    ("Neurofibromin 1" . SPARSER::PROTEIN) ("neuregulin-2" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN)
    ("Neu differentiation factor" . SPARSER::PROTEIN)
    ("vaccinia growth factor" . SPARSER::PROTEIN) ("HB-EGF" . SPARSER::PROTEIN)
    ("TGF-alpha" . SPARSER::PROTEIN) ("CI-1040" . SPARSER::DRUG)
    ("mitogen-activated protein kinase kinase1" . SPARSER::PROTEIN)
    ("XL147" . SPARSER::DRUG) ("BKM120" . SPARSER::DRUG)
    ("beta-estradiol" . SPARSER::MOLECULE) ("cathepsin-D" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("erbB4" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN) ("c-erbB2" . SPARSER::PROTEIN)
    ("erbB1" . SPARSER::PROTEIN) ("ER- beta" . SPARSER::PROTEIN)
    ("ER-beta" . SPARSER::PROTEIN) ("ER -beta" . SPARSER::PROTEIN)
    ("ER-alpha" . SPARSER::PROTEIN) ("ER -alpha" . SPARSER::PROTEIN)
    ("PIN3" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("TNRC9" . SPARSER::PROTEIN) ("PP6" . SPARSER::PROTEIN)
    ("protein phosphatase 6" . SPARSER::PROTEIN)
    ("Serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("Ataxia telangiectasia" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("mismatch repair endonuclease PMS2" . SPARSER::PROTEIN)
    ("mutS homolog 6" . SPARSER::PROTEIN) ("PMS1" . SPARSER::PROTEIN)
    ("PMS1 protein homolog 1" . SPARSER::PROTEIN)
    ("homolog 2" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("partner and localizer of BRCA2" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN)
    ("breast cancer type 1 susceptibility protein" . SPARSER::PROTEIN)
    ("COT" . SPARSER::PROTEIN) ("lower limb" . SPARSER::PROTEIN)
    ("NM (10.1%, 8/79) and LMM (6.3%, 5/79)" . SPARSER::COLLECTION)
    ("SSM, LMM and NM" . SPARSER::COLLECTION)
    ("the histological subtypes" . SPARSER::PROTEIN)
    ("SSM and NM" . SPARSER::COLLECTION)
    ("the Food and Drug Administration" . SPARSER::COLLECTION)
    ("Vemurafenib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("dacarbazine" . SPARSER::DRUG) ("trametinib" . SPARSER::DRUG)
    ("dabrafenib" . SPARSER::DRUG) ("MAP3K8" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase 8" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE) ("MAPK kinase" . SPARSER::PROTEIN)
    ("CTLA-4" . SPARSER::PROTEIN) ("B-Raf" . SPARSER::PROTEIN)
    ("Bright" . SPARSER::PROTEIN) ("Pak1 and Pak2" . SPARSER::COLLECTION)
    ("Cdc42, Rac and Rho" . SPARSER::COLLECTION)
    ("possible mediators" . SPARSER::PROTEIN) ("HPFs" . SPARSER::PROTEIN)
    ("metallopeptidase" . SPARSER::PROTEIN) ("soluble FN" . SPARSER::PROTEIN)
    ("collagen and Burleson" . SPARSER::COLLECTION)
    ("the submesothelial ECM" . SPARSER::PROTEIN)
    ("the interstitial matrix" . SPARSER::PROTEIN-FAMILY)
    ("haptotactic attractant" . SPARSER::PROTEIN)
    ("attractant" . SPARSER::PROTEIN) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("Glass" . SPARSER::MOLECULE) ("relevant genes" . SPARSER::GENE)
    ("glass or fibronectin" . SPARSER::COLLECTION)
    ("fibronectin-" . SPARSER::PROTEIN) ("PAK1 and PAK2" . SPARSER::COLLECTION)
    ("protein, or myosin light chain" . SPARSER::COLLECTION)
    ("MLC" . SPARSER::PROTEIN) ("cofilin" . SPARSER::PROTEIN)
    ("Paks" . SPARSER::PROTEIN-FAMILY) ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("PAKS" . SPARSER::PROTEIN-FAMILY) ("PID" . SPARSER::PROTEIN)
    ("Rac and Rho" . SPARSER::COLLECTION)
    ("focal adhesion kinase (FAK) and Src ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("cytoskeletal adaptor proteins" . SPARSER::PROTEIN)
    ("fibrillar collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("αvβ3, αvβ1 and α5β1" . SPARSER::COLLECTION)
    ("Specifically ECM proteins" . SPARSER::PROTEIN) ("OSE" . SPARSER::PROTEIN)
    ("FN and COLL" . SPARSER::COLLECTION)
    ("COLL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type I (COLL)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glass" . SPARSER::MOLECULE) ("transwell" . SPARSER::PROTEIN)
    ("TLN1" . SPARSER::PROTEIN) ("talin-1" . SPARSER::PROTEIN)
    ("PAK3" . SPARSER::PROTEIN) ("chemo-attractant" . SPARSER::PROTEIN)
    ("RNase H" . SPARSER::PROTEIN) ("Sodium bicarbonate" . SPARSER::DRUG)
    ("sodium bicarbonate" . SPARSER::DRUG)
    ("myosin light chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LIM domain kinase 1" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("group I" . SPARSER::PROTEIN) ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α5β1" . SPARSER::PROTEIN) ("αvβ3" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("IPA-3" . SPARSER::MOLECULE)
    ("Pak2" . SPARSER::PROTEIN) ("p21-activated kinase 2" . SPARSER::PROTEIN)
    ("nick" . SPARSER::PROTEIN) ("TP53, KAP1, and SMC1" . SPARSER::COLLECTION)
    ("TP53, KAP1 or SMC1" . SPARSER::COLLECTION)
    ("TP53 and KAP" . SPARSER::COLLECTION)
    ("TP53, KAP1, SMC1, and γH2AX" . SPARSER::COLLECTION)
    ("Ppo" . SPARSER::PROTEIN) ("DNases" . SPARSER::PROTEIN)
    ("strong nuclear or mitochondrial" . SPARSER::COLLECTION)
    ("nuclear and mitochondrial" . SPARSER::COLLECTION)
    ("nuc" . SPARSER::PROTEIN)
    ("both mitochondrial and nuclear" . SPARSER::COLLECTION)
    ("Cytochrome c oxidase (or Complex IV) subunit 1 (Cox1) and nuclear histone H3 antibodies ( xref )"
     . SPARSER::COLLECTION)
    ("sub-cellular fractions" . SPARSER::COMPONENT)
    ("SMC1-pS957" . SPARSER::COLLECTION) ("KAP1-pS824" . SPARSER::COLLECTION)
    ("TP53-pS15" . SPARSER::COLLECTION)
    ("TP53 and other substrates" . SPARSER::COLLECTION)
    ("pSer" . SPARSER::PROTEIN) ("Annexin V and 7AAD" . SPARSER::COLLECTION)
    ("mitoSOX" . SPARSER::DRUG) ("ester (TMRE)" . SPARSER::MOLECULE)
    ("TMRE" . SPARSER::MOLECULE) ("tetramethylrhodamine" . SPARSER::MOLECULE)
    ("OCR" . SPARSER::PROTEIN)
    ("respiratory chain subunits" . SPARSER::FRAGMENT)
    ("the respective proteins" . SPARSER::PROTEIN) ("RV" . SPARSER::PROTEIN)
    ("Eco" . SPARSER::PROTEIN) ("Sac" . SPARSER::PROTEIN)
    ("Southern blot" . SPARSER::PROTEIN)
    ("mitochondrial and nuclear fractions" . SPARSER::COLLECTION)
    ("IRES-EGFP sequence" . SPARSER::PROTEIN-PAIR)
    ("IRES-EGFP" . SPARSER::PROTEIN-PAIR) ("EGFP" . SPARSER::PROTEIN)
    ("PstI" . SPARSER::PROTEIN) ("subunit I and complex" . SPARSER::COLLECTION)
    ("subunit F6" . SPARSER::PROTEIN)
    ("antigen (HA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATM and mitochondrial" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("ETC, or drugs" . SPARSER::COLLECTION)
    ("ETC and ATP synthase" . SPARSER::COLLECTION) ("ETC" . SPARSER::PROTEIN)
    ("the activated form of ATM and some" . SPARSER::COLLECTION)
    ("both mitochondrial and nuclear fractions" . SPARSER::COLLECTION)
    ("ATM and SMC1" . SPARSER::COLLECTION)
    ("TP53 and KAP1" . SPARSER::COLLECTION) ("NTS-" . SPARSER::PROTEIN)
    ("SMC" . SPARSER::PROTEIN) ("KAP" . SPARSER::PROTEIN)
    ("KRAB" . SPARSER::PROTEIN-FAMILY)
    ("mitochondrial and nuclear DNA DSBs" . SPARSER::COLLECTION)
    ("a mitochondrial (MTS) or nuclear (NTS)" . SPARSER::COLLECTION)
    ("mitochondrial (MTS)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NTS" . SPARSER::PROTEIN) ("Pst" . SPARSER::PROTEIN)
    ("nuclear and/or mitochondrial DNA DSBs" . SPARSER::COLLECTION)
    ("nuclear or mitochondrial" . SPARSER::COLLECTION)
    ("Cox1" . SPARSER::PROTEIN) ("subunit 1" . SPARSER::PROTEIN)
    ("cytochrome oxidase" . SPARSER::PROTEIN)
    ("cytochrome c oxidase subunit VIII" . SPARSER::PROTEIN)
    ("subunit F" . SPARSER::PROTEIN) ("subunit I" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN)
    ("ataxia telangiectasia" . SPARSER::PROTEIN)
    ("77.5% superficial spreading melanoma" . SPARSER::PROTEIN)
    ("SSM" . SPARSER::PROTEIN)
    ("the most common somatic BRAF" . SPARSER::PROTEIN)
    ("RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("both constitutional and environmental factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("factors, and Kaplan-Meier" . SPARSER::COLLECTION)
    ("NHS" . SPARSER::PROTEIN) ("sun" . SPARSER::PROTEIN)
    ("Biomarker" . SPARSER::MOLECULE)
    ("DNA, RNA, and protein" . SPARSER::COLLECTION)
    ("p63/p73" . SPARSER::COLLECTION) ("pCR" . SPARSER::PROTEIN)
    ("taxane" . SPARSER::DRUG) ("anthracycline" . SPARSER::MOLECULE)
    ("a predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p  " . SPARSER::PROTEIN)
    ("the basal-like intrinsic subtype" . SPARSER::PROTEIN)
    ("RNAs, and proteins" . SPARSER::COLLECTION)
    ("the intrinsic subtype" . SPARSER::PROTEIN)
    ("predictive biomarker" . SPARSER::MOLECULE)
    ("other associated molecular traits" . SPARSER::PROTEIN)
    ("four main intrinsic subtypes" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("gene, protein, and miRNA" . SPARSER::COLLECTION)
    ("protein and phospho-protein" . SPARSER::COLLECTION)
    ("TP53 and PIK3CA" . SPARSER::COLLECTION)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("ID4" . SPARSER::PROTEIN)
    ("pharmacologic AMPK activators" . SPARSER::ACTIVATOR)
    ("dietary factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methotrexate, and metformin" . SPARSER::COLLECTION)
    ("AMPK and PGC-1 α and FoxO3A" . SPARSER::COLLECTION)
    ("AMPK/PGC-1 α" . SPARSER::COLLECTION)
    ("AMPK and FoxO3A" . SPARSER::COLLECTION)
    ("Bcl-2/adenovirus E1B 19-kd protein-interacting protein 3 and autophagy protein"
     . SPARSER::COLLECTION)
    ("growth arrest and DNA damage–inducible protein" . SPARSER::PROTEIN)
    ("AMPK/FoxO3A" . SPARSER::COLLECTION)
    ("PGC-1 α , and PGC-1 α" . SPARSER::COLLECTION)
    ("catalase ( xref ) and SOD2 ( xref )" . SPARSER::COLLECTION)
    ("the major chondroprotective targets" . SPARSER::TARGET-PROTEIN)
    ("p65 and PGC-1 α" . SPARSER::COLLECTION)
    ("AMPK α 1 or AMPK α 2" . SPARSER::COLLECTION)
    ("AMPK, PGC-1 α , and FoxO3A" . SPARSER::COLLECTION)
    ("Chondrocytes" . SPARSER::PROTEIN) ("Superoxide" . SPARSER::MOLECULE)
    ("MMP-3 and MMP-13" . SPARSER::COLLECTION)
    ("cytosolic I κ B α and nuclear p65 NF- κ B" . SPARSER::COLLECTION)
    ("AMPK α , PGC-1 α , and FoxO3A" . SPARSER::COLLECTION)
    ("chondrocytes and AMPK α 2-knockout" . SPARSER::COLLECTION)
    ("manganese superoxide dismutase (MnSOD; or SOD2) and catalase ( xref , xref )"
     . SPARSER::COLLECTION)
    ("MnSOD" . SPARSER::PROTEIN)
    ("collagen and aggrecan" . SPARSER::COLLECTION)
    ("the peroxisome proliferator-activated receptor γ coactivator 1 α (PGC-1 α ) transcription factor and the FoxO family transcription factor FoxO3A"
     . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN)
    ("sodium salicylate and high-dose aspirin (by allosteric effects on AMPK)"
     . SPARSER::COLLECTION)
    ("salicylate" . SPARSER::MOLECULE)
    ("Several pharmacologic AMPK activators" . SPARSER::ACTIVATOR)
    ("IL-1 β and TNF α" . SPARSER::COLLECTION)
    ("normal chondrocytes" . SPARSER::PROTEIN) ("TNFa" . SPARSER::PROTEIN)
    ("-subunit" . SPARSER::FRAGMENT) ("-subunits" . SPARSER::COLLECTION)
    ("AMPK pharmacologic activators" . SPARSER::ACTIVATOR)
    ("PGC-1 α or FoxO3A" . SPARSER::COLLECTION) ("menadione" . SPARSER::DRUG)
    ("SOD2 and catalase" . SPARSER::COLLECTION)
    ("pharmacologic AMPK activator A-769662" . SPARSER::DRUG)
    ("MitoSOX" . SPARSER::DRUG) ("RNA or plasmid" . SPARSER::COLLECTION)
    ("PGC-1 α and FoxO3A" . SPARSER::COLLECTION)
    ("AMPK α 1- or AMPK α 2-knockout" . SPARSER::COLLECTION)
    ("AMPK α 1-" . SPARSER::PROTEIN)
    ("peroxisome proliferator–activated receptor γ coactivator 1 α (PGC-1 α ) and FoxO3A"
     . SPARSER::COLLECTION)
    ("E1B" . SPARSER::PROTEIN) ("GATA-4" . SPARSER::PROTEIN)
    ("cAMP response element binding protein" . SPARSER::PROTEIN)
    ("PGC-1" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor γ coactivator 1 α"
     . SPARSER::PROTEIN)
    ("TNF α" . SPARSER::PROTEIN) ("interleukin-1 β" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("A-769662" . SPARSER::DRUG)
    ("AMPK α" . SPARSER::PROTEIN-FAMILY) ("FoxO3A" . SPARSER::PROTEIN)
    ("PGC-1 α" . SPARSER::PROTEIN)
    ("peroxisome proliferator–activated receptor γ coactivator 1 α"
     . SPARSER::PROTEIN)
    ("PARP-1 and ADP-ribose" . SPARSER::COLLECTION)
    ("kinases and acetylases" . SPARSER::COLLECTION)
    ("acetylases and deacetylases" . SPARSER::COLLECTION)
    ("probably more complex" . SPARSER::BIO-COMPLEX)
    ("pERK2" . SPARSER::PROTEIN)
    ("acetylases and kinases" . SPARSER::COLLECTION)
    ("acetylases" . SPARSER::PROTEIN) ("c-fos and c-jun" . SPARSER::COLLECTION)
    ("ERK and/or p38" . SPARSER::COLLECTION)
    ("PARP-1 and SP1" . SPARSER::COLLECTION)
    ("SP1 and CTCF" . SPARSER::COLLECTION)
    ("the dual c-MYC P1/P2 promoter" . SPARSER::PROMOTER)
    ("the GQ-element, a sequence able to adopt a four-stranded secondary structure"
     . SPARSER::DRUG)
    ("the GQ-element, a sequence" . SPARSER::DRUG)
    ("the GQ-element" . SPARSER::DRUG) ("GQ-element" . SPARSER::DRUG)
    ("a strong activator" . SPARSER::ACTIVATOR)
    ("deacetylases, or anisomycin" . SPARSER::COLLECTION)
    ("anisomycin" . SPARSER::DRUG) ("c-FOS and c-JUN" . SPARSER::COLLECTION)
    ("histones and chromatin-associated proteins" . SPARSER::COLLECTION)
    ("chromatin-associated proteins" . SPARSER::PROTEIN)
    ("a positive regulator of c-MYC expression and whose consensus sequences lie"
     . SPARSER::COLLECTION)
    ("CTCF and SP1" . SPARSER::COLLECTION) ("CTCF" . SPARSER::PROTEIN)
    ("the previously silent c-MYC promoter" . SPARSER::PROMOTER)
    ("inhibitor or serum" . SPARSER::COLLECTION) ("DNAse" . SPARSER::PROTEIN)
    ("an accessible chromatin conformation" . SPARSER::BIO-CONFORMATION)
    ("antibodies recognizing poly(ADP-ribose) or normal mouse IgG"
     . SPARSER::COLLECTION)
    ("IEG" . SPARSER::GENE)
    ("the permanently inactive rhodopsin promoter (RHO)" . SPARSER::PROMOTER)
    ("promoter (RHO)" . SPARSER::PROMOTER)
    ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("rhodopsin" . SPARSER::PROTEIN)
    ("GQ" . SPARSER::DRUG) ("FB" . SPARSER::PROTEIN)
    ("c-FOS and c-MYC" . SPARSER::COLLECTION) ("Gene (IEG)" . SPARSER::PROTEIN)
    ("factors and co-regulatory" . SPARSER::COLLECTION)
    ("c-MYC, c-FOS, JUNB and EGR-1" . SPARSER::COLLECTION)
    ("c-jun" . SPARSER::PROTEIN) ("MSK1" . SPARSER::PROTEIN)
    ("acetyl-transferase" . SPARSER::PROTEIN) ("Elk-1" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN) ("ME1" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("PJ-34" . SPARSER::DRUG)
    ("Immediate Early" . SPARSER::PROTEIN)
    ("histone lysine demethylase" . SPARSER::PROTEIN)
    ("KDM5B" . SPARSER::PROTEIN) ("diphtheria toxin" . SPARSER::PROTEIN)
    ("c- MYC" . SPARSER::PROTEIN) ("EGR-1" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN)
    ("Immediate Early Response" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("CH, GZ and YQL" . SPARSER::COLLECTION)
    ("MCM 2, MCM 3 and MCM7" . SPARSER::COLLECTION)
    ("Scott" . SPARSER::PROTEIN) ("primase" . SPARSER::PROTEIN)
    ("The hexameric MCM component" . SPARSER::COMPONENT)
    ("MCM2 and MCM3" . SPARSER::COLLECTION)
    ("MCM2 and MCM7" . SPARSER::COLLECTION)
    ("a strongly positive prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCM3(II 2.4, III 3.1, and IV 5.3) and MCM7 (II 1.6, III 4.6, and IV 6.1)"
     . SPARSER::COLLECTION)
    ("MCM3 and MCM7" . SPARSER::COLLECTION) ("Genes" . SPARSER::GENE)
    ("MCM2 and MCM6" . SPARSER::COLLECTION)
    ("MCM7 and MCM10" . SPARSER::COLLECTION)
    ("MCM3-MCM5" . SPARSER::COLLECTION) ("MCM2-MCM7" . SPARSER::COLLECTION)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("the major mutational targets" . SPARSER::TARGET-PROTEIN)
    ("MCM 2, MCM3 and MCM7" . SPARSER::COLLECTION)
    ("MCM2, MCM3 and MCM7" . SPARSER::COLLECTION)
    ("novel glioma prognosis-associated candidate genes" . SPARSER::GENE)
    ("MCM 3" . SPARSER::PROTEIN) ("Cdc7" . SPARSER::PROTEIN)
    ("Cdc6" . SPARSER::PROTEIN)
    ("pre-replicative complex" . SPARSER::BIO-COMPLEX)
    ("MCM6" . SPARSER::PROTEIN) ("MCM5" . SPARSER::PROTEIN)
    ("brain)" . SPARSER::PROTEIN) ("MCM 2" . SPARSER::PROTEIN)
    ("MCM7" . SPARSER::PROTEIN) ("MCM10" . SPARSER::PROTEIN)
    ("MCM2" . SPARSER::PROTEIN) ("protein and ligand" . SPARSER::COLLECTION)
    ("proteins and ligands" . SPARSER::COLLECTION)
    ("mTOR proteins and each ligand" . SPARSER::COLLECTION)
    ("Swiss-Prot" . SPARSER::COLLECTION) ("Prot" . SPARSER::PROTEIN)
    ("acerosin" . SPARSER::MOLECULE) ("ligand and mTOR" . SPARSER::COLLECTION)
    ("PONDR-Fit" . SPARSER::COLLECTION) ("Fit" . SPARSER::PROTEIN-FAMILY)
    ("PLP1" . SPARSER::PROTEIN) ("Torin2" . SPARSER::DRUG)
    ("P42345" . SPARSER::PROTEIN) ("ID 4" . SPARSER::PROTEIN)
    ("the more precise MRI" . SPARSER::PROTEIN)
    ("Visceral fat" . SPARSER::PROTEIN)
    ("factors, and nitric oxide" . SPARSER::COLLECTION)
    ("SIRT4 and CAD" . SPARSER::COLLECTION)
    ("SIRT4 and HOMA" . SPARSER::COLLECTION) ("FFAs" . SPARSER::PROTEIN)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SAT" . SPARSER::PROTEIN)
    ("age, cIMT, SAP, and DAP" . SPARSER::COLLECTION)
    ("DAP" . SPARSER::PROTEIN) ("SAP" . SPARSER::PROTEIN)
    ("Ferritin" . SPARSER::PROTEIN) ("CRP and SLD" . SPARSER::COLLECTION)
    ("HDL" . SPARSER::PROTEIN) ("SLD and RMR/FFM" . SPARSER::COLLECTION)
    ("-GT" . SPARSER::COLLECTION) ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FFM" . SPARSER::PROTEIN) ("VAT" . SPARSER::PROTEIN)
    ("DBP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fibrinogen" . SPARSER::PROTEIN)
    ("SLD" . SPARSER::PROTEIN) ("IMTG" . SPARSER::PROTEIN)
    ("intima-media" . SPARSER::COLLECTION)
    ("Intramuscular fat" . SPARSER::PROTEIN)
    ("triglyceride (TG)" . SPARSER::MOLECULE) ("CAD" . SPARSER::PROTEIN)
    ("gamma-glutamyl" . SPARSER::MOLECULE)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN) ("SIRT4" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38 and proapoptotic molecules" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin or AKT" . SPARSER::COLLECTION)
    ("liver kinase B1 and calcium/calmodulin-dependent protein kinase"
     . SPARSER::COLLECTION)
    ("hypoxia, and ischemia" . SPARSER::COLLECTION)
    ("immunotoxin" . SPARSER::DRUG) ("JNK and p38 MAPK" . SPARSER::COLLECTION)
    ("AMPK and MAPKs" . SPARSER::COLLECTION)
    ("p38, p21, and caspase-3" . SPARSER::COLLECTION)
    ("AICAR and BRAF" . SPARSER::COLLECTION)
    ("p21 and caspase-3" . SPARSER::COLLECTION)
    ("AMPK-α1-siRNAs" . SPARSER::COLLECTION)
    ("random oligomers" . SPARSER::PROTEIN) ("oligomer" . SPARSER::MOLECULE)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("p38 and caspase-3" . SPARSER::COLLECTION)
    ("ERK or JNK" . SPARSER::COLLECTION)
    ("ERK, p38, and JNK" . SPARSER::COLLECTION)
    ("AMPK and proapoptotic molecules" . SPARSER::COLLECTION)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 MAPK"
     . SPARSER::COLLECTION)
    ("AMPK and MAPK" . SPARSER::COLLECTION)
    ("MAPK and AMPK" . SPARSER::COLLECTION)
    ("a strong AMPK activator" . SPARSER::ACTIVATOR)
    ("-adenosine monophosphate" . SPARSER::MOLECULE)
    ("AMPK and p38 MAPK" . SPARSER::COLLECTION)
    ("-activated protein kinase (AMPK)" . SPARSER::COLLECTION)
    ("-Adenosine monophosphate" . SPARSER::MOLECULE)
    ("Compound C" . SPARSER::MOLECULE)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AMPK-α1" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("vascular malformations" . SPARSER::PROTEIN)
    ("non-invasively sampled cell-free fetal DNA" . SPARSER::DNA)
    ("PORCN" . SPARSER::PROTEIN)
    ("the underlying lymphovascular malformations" . SPARSER::PROTEIN)
    ("these lymphovascular malformations" . SPARSER::PROTEIN)
    ("the subcutaneous fat" . SPARSER::PROTEIN)
    ("life number five showed bilateral multicystic venous lymphatic malformations"
     . SPARSER::PROTEIN)
    ("a sandal gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bilateral multicystic malformations" . SPARSER::PROTEIN)
    ("the fetal MRI" . SPARSER::PROTEIN)
    ("vascular or lymphatic malformations" . SPARSER::PROTEIN)
    ("fetal MRI" . SPARSER::PROTEIN) ("leg" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::COLLECTION)
    ("severe lymphovascular malformations" . SPARSER::PROTEIN)
    ("lymphovascular malformations" . SPARSER::PROTEIN)
    ("combined-type vascular malformations" . SPARSER::PROTEIN)
    ("-AKT" . SPARSER::COLLECTION) ("malformations" . SPARSER::PROTEIN)
    ("incontinentia pigmenti" . SPARSER::PROTEIN) ("Kit 2" . SPARSER::PROTEIN)
    ("FISH or ERG" . SPARSER::COLLECTION)
    ("essential AR transcriptional cofactors" . SPARSER::PROTEIN)
    ("UTX/KDM6A" . SPARSER::COLLECTION) ("UTX" . SPARSER::PROTEIN)
    ("ERG and AR" . SPARSER::COLLECTION)
    ("a unique cohort" . SPARSER::MOLECULE)
    ("ERG, AR, and PSA" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION)
    ("this unique cohort" . SPARSER::MOLECULE)
    ("ERG and AR or PSA" . SPARSER::COLLECTION)
    ("AR or PSA" . SPARSER::COLLECTION) ("anti- androgen" . SPARSER::DRUG)
    ("KDM6A" . SPARSER::PROTEIN) ("MLL2" . SPARSER::PROTEIN)
    ("CRISPR-associated nuclease" . SPARSER::PROTEIN)
    ("Concurrent PVT1 RNA" . SPARSER::RNA)
    ("CCDC26 or GSDMC" . SPARSER::COLLECTION)
    ("essentially no MYC" . SPARSER::PROTEIN)
    ("MYC and PVT1" . SPARSER::COLLECTION) ("Pvt1/PVT1" . SPARSER::COLLECTION)
    ("Myc/MYC" . SPARSER::COLLECTION)
    ("CCDC26 and GSDMC" . SPARSER::COLLECTION)
    ("MYC/PVT1" . SPARSER::COLLECTION) ("FBW7 and AXIN1" . SPARSER::COLLECTION)
    ("PVT1 and MYC" . SPARSER::COLLECTION)
    ("approximately 3.5-fold more Myc mRNA" . SPARSER::RNA)
    ("Myc or Pvt1" . SPARSER::COLLECTION)
    ("Myc and Pvt1" . SPARSER::COLLECTION)
    ("Myc/Pvt1/Ccdc26/Gsdmc" . SPARSER::COLLECTION)
    ("p53 (a key mediator of cellular stress response) and phospho-ERK1/2 (a pro-survival signaling molecule; xref )"
     . SPARSER::COLLECTION)
    ("γ-H2AX (a marker of DNA damage; xref ), p53 (a key mediator of cellular stress response) and phospho-ERK1/2 (a pro-survival signaling molecule; xref )"
     . SPARSER::COLLECTION)
    ("Pvt1/Ccdc26/Gsdmc" . SPARSER::COLLECTION)
    ("PVT1 , CCDC26 and GSDMC" . SPARSER::COLLECTION)
    ("Pvt1, Ccdc26 and Gsdmc" . SPARSER::COLLECTION)
    ("Pvt1 , Ccdc26 and Gsdmc" . SPARSER::COLLECTION)
    ("Ccdc26" . SPARSER::PROTEIN) ("Gsdmc" . SPARSER::PROTEIN)
    ("GSDMC" . SPARSER::PROTEIN) ("pT3" . SPARSER::PROTEIN)
    ("guide RNA" . SPARSER::RNA) ("MYC 1" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pERK1/2" . SPARSER::PROTEIN) ("NBP1" . SPARSER::PROTEIN)
    ("cytokeratin 14" . SPARSER::PROTEIN) ("cytokeratin 8" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("Myc protein" . SPARSER::PROTEIN)
    ("keratin-8" . SPARSER::PROTEIN) ("keratin-14" . SPARSER::PROTEIN)
    ("Cdc26" . SPARSER::PROTEIN) ("Pvt1" . SPARSER::PROTEIN)
    ("CCDC26" . SPARSER::PROTEIN) ("PVT1" . SPARSER::PROTEIN)
    ("lower exogenous amino acids" . SPARSER::AMINO-ACID)
    ("two distinct siRNAs" . SPARSER::PROTEIN)
    ("rapamycin or cycloheximide" . SPARSER::COLLECTION)
    ("c-del3/c-del3" . SPARSER::COLLECTION)
    ("a conditional hypomorphic allele" . SPARSER::ALLELE)
    ("c-del3" . SPARSER::PROTEIN-PAIR) ("NRF2/NFE2L2" . SPARSER::COLLECTION)
    ("SCD" . SPARSER::PROTEIN) ("mature SREBP1c" . SPARSER::PROTEIN)
    ("sterol" . SPARSER::PROTEIN) ("NFE2L1/NRF1" . SPARSER::COLLECTION)
    ("Nrf1" . SPARSER::PROTEIN) ("an exogenous promoter" . SPARSER::PROMOTER)
    ("NRF1 and proteasomes" . SPARSER::COLLECTION)
    ("classical chemical inducers" . SPARSER::MOLECULE)
    ("tunicamycin and thapsigargin" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE) ("tunicamycin" . SPARSER::MOLECULE)
    ("inducers" . SPARSER::MOLECULE) ("PERK" . SPARSER::PROTEIN)
    ("growth factors or TSC2" . SPARSER::COLLECTION)
    ("growth factors, and NRF1" . SPARSER::COLLECTION)
    ("EGF, or insulin" . SPARSER::COLLECTION)
    ("PSM genes and increase in intact proteasome levels in multiple TSC2-deficient cell lines ( xref and xref )"
     . SPARSER::COLLECTION)
    ("Tsc2 null MEFs" . SPARSER::PROTEIN) ("PSM" . SPARSER::PROTEIN)
    ("bortezomib and MG132" . SPARSER::COLLECTION)
    ("bortezomib" . SPARSER::DRUG)
    ("Both TSC1- and TSC2-deficient MEFs" . SPARSER::COLLECTION)
    ("TSC1-" . SPARSER::PROTEIN) ("Tsc2" . SPARSER::PROTEIN)
    ("TSC1, TSC2, and TBC1D7" . SPARSER::COLLECTION)
    ("amino acid and protein" . SPARSER::COLLECTION)
    ("the transcription factor nuclear factor erythroid-derived 2-related factor 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFE2L1 or NRF1" . SPARSER::COLLECTION) ("erythroid" . SPARSER::PROTEIN)
    ("proteasomes" . SPARSER::PROTEIN) ("RPLP0" . SPARSER::PROTEIN)
    ("chymotrypsin-like" . SPARSER::PROTEIN) ("del3" . SPARSER::PROTEIN)
    ("SREBP2" . SPARSER::PROTEIN) ("SREBP1" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN) ("PP242" . SPARSER::DRUG)
    ("TBC1D7" . SPARSER::PROTEIN) ("NRF1" . SPARSER::PROTEIN)
    ("NFE2L1" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("FAK/SRC" . SPARSER::COLLECTION) ("FAK or paxillin" . SPARSER::COLLECTION)
    ("Nudel and Dvl" . SPARSER::COLLECTION)
    ("FAK and paxillin" . SPARSER::COLLECTION)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nudel" . SPARSER::PROTEIN)
    ("DIXDC1 and zyxin" . SPARSER::COLLECTION) ("Mise" . SPARSER::PROTEIN)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("FAK-ERK-Snail1" . SPARSER::COLLECTION)
    ("the only previously noted biomarkers" . SPARSER::MOLECULE)
    ("only 97 genes" . SPARSER::GENE) ("Kras and p53" . SPARSER::COLLECTION)
    ("FAK/Src" . SPARSER::COLLECTION)
    ("lack appreciable Dixdc1" . SPARSER::PROTEIN)
    ("FAK-Snail" . SPARSER::COLLECTION)
    ("Mark1 or Dixdc1" . SPARSER::COLLECTION) ("Mark1" . SPARSER::PROTEIN)
    ("Lkb1, Mark1, and Mark4" . SPARSER::COLLECTION)
    ("Mark4" . SPARSER::PROTEIN) ("Mark" . SPARSER::PROTEIN)
    ("Snail and FAK" . SPARSER::COLLECTION) ("Dixdc1" . SPARSER::PROTEIN)
    ("LKB1, MARK1, or DIXDC1" . SPARSER::COLLECTION)
    ("MEK, PI3K, Akt, or mTOR" . SPARSER::COLLECTION)
    ("FAK and Src" . SPARSER::COLLECTION) ("Ras-MEK-ERK" . SPARSER::COLLECTION)
    ("DIXDC1 or LKB1" . SPARSER::COLLECTION)
    ("LKB1 or DIXDC1" . SPARSER::COLLECTION)
    ("FLAG-DIXDC1" . SPARSER::COLLECTION) ("FLAG-" . SPARSER::PROTEIN-FAMILY)
    ("LKB1 or MARK1" . SPARSER::COLLECTION)
    ("zyxin and paxillin" . SPARSER::COLLECTION)
    ("paxillin and zyxin" . SPARSER::COLLECTION) ("zyxin" . SPARSER::PROTEIN)
    ("LKB1, MARK1, or MARK4" . SPARSER::COLLECTION)
    ("AMPK or MARK2 or MARK3" . SPARSER::COLLECTION)
    ("MARK2 or MARK3" . SPARSER::COLLECTION)
    ("LKB1-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MARK1, or LKB1" . SPARSER::COLLECTION)
    ("a poorly-studied scaffolding protein" . SPARSER::PROTEIN)
    ("DIX" . SPARSER::PROTEIN-FAMILY) ("axin" . SPARSER::PROTEIN)
    ("MARK1 or LKB1" . SPARSER::COLLECTION)
    ("previously reported MARK substrates" . SPARSER::SUBSTRATE)
    ("MARK/Par1" . SPARSER::COLLECTION) ("AMPK and MARK" . SPARSER::COLLECTION)
    ("MARK1 and MARK" . SPARSER::COLLECTION)
    ("LKB1 and MARK1" . SPARSER::COLLECTION)
    ("MARK1 (also known as Par1c) and MARK4 (Par1d)" . SPARSER::COLLECTION)
    ("MARK2 and MARK3" . SPARSER::COLLECTION)
    ("MARK/Par-1" . SPARSER::COLLECTION) ("MARK" . SPARSER::PROTEIN)
    ("AMPKa" . SPARSER::PROTEIN) ("G12D" . SPARSER::PROTEIN)
    ("LSL-G12D" . SPARSER::PROTEIN-PAIR) ("LSL" . SPARSER::PROTEIN)
    ("Wnt5a/Wnt5b" . SPARSER::COLLECTION)
    ("the noncanonical Wnt ligands" . SPARSER::LIGAND)
    ("Wnt5a and Wnt5b" . SPARSER::COLLECTION)
    ("ZEB1, ZEB2, or Twist" . SPARSER::COLLECTION)
    ("LKB1 or its downstream kinases MARK1 and MARK4" . SPARSER::COLLECTION)
    ("regulators, and transcriptional regulators" . SPARSER::COLLECTION)
    ("AMPK and its related kinases" . SPARSER::COLLECTION)
    ("the Microtubule Affinity-Regulating Kinase (MARKs) (or Partitioning-defective 1 /Par1) genes"
     . SPARSER::GENE)
    ("/Par1" . SPARSER::COLLECTION) ("MARKs" . SPARSER::PROTEIN)
    ("Protein Kinase (AMPK)" . SPARSER::PROTEIN) ("Cdkn2a" . SPARSER::PROTEIN)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LKB1/STK11" . SPARSER::COLLECTION)
    ("MARK1 and MARK4" . SPARSER::COLLECTION) ("FAK1" . SPARSER::PROTEIN)
    ("p90" . SPARSER::PROTEIN) ("P-MEK1" . SPARSER::PROTEIN)
    ("P-S6K" . SPARSER::PROTEIN) ("P-ERK1/2" . SPARSER::PROTEIN)
    ("P-Src" . SPARSER::PROTEIN) ("SIK2" . SPARSER::PROTEIN)
    ("Nuak1" . SPARSER::PROTEIN) ("P-ULK" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("P-ACC" . SPARSER::PROTEIN)
    ("N-term" . SPARSER::PROTEIN) ("LYK5" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("PF-573228" . SPARSER::DRUG)
    ("STRADα" . SPARSER::PROTEIN) ("CCD1" . SPARSER::PROTEIN)
    ("CLASP2" . SPARSER::PROTEIN) ("CLASP1" . SPARSER::PROTEIN)
    ("IRSp53" . SPARSER::PROTEIN) ("KIF13B" . SPARSER::PROTEIN)
    ("MARK3" . SPARSER::PROTEIN) ("MARK2" . SPARSER::PROTEIN)
    ("Par1d" . SPARSER::PROTEIN) ("Par1c" . SPARSER::PROTEIN)
    ("Par-1" . SPARSER::PROTEIN) ("AMPKa2" . SPARSER::PROTEIN)
    ("1  L" . SPARSER::PROTEIN) ("Wnt5b" . SPARSER::PROTEIN)
    ("Wnt5a" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("Snail2" . SPARSER::PROTEIN) ("Par1" . SPARSER::PROTEIN)
    ("par-4" . SPARSER::PROTEIN) ("Protein Kinase" . SPARSER::PROTEIN)
    ("Cdkn2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DIXDC1" . SPARSER::PROTEIN)
    ("MARK4" . SPARSER::PROTEIN) ("MARK1" . SPARSER::PROTEIN)
    ("DLAT and/or ACAT2" . SPARSER::COLLECTION)
    ("complex (PDC)" . SPARSER::BIO-COMPLEX) ("PDC" . SPARSER::PROTEIN)
    ("ACAT2 and DLAT" . SPARSER::COLLECTION)
    ("acetyltransferases and HDAC4" . SPARSER::COLLECTION)
    ("the acetyl-mimetic K76/294Q mutant" . SPARSER::MUTANT)
    ("acetyl-mimetic 6PGD K76/294Q mutant" . SPARSER::MUTANT)
    ("the 6PGD upstream acetyltransferases (DLAT and ACAT2) and deacetylase (HDAC4)"
     . SPARSER::COLLECTION)
    ("lipid and RNA" . SPARSER::COLLECTION)
    ("distinct acetyl-mimetic K→Q mutants" . SPARSER::MUTANT)
    ("phosphofructokinase (PFK)" . SPARSER::PROTEIN)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("active LKB1 complex" . SPARSER::BIO-COMPLEX)
    ("LKB-AMPK" . SPARSER::COLLECTION)
    ("acetyl-mimetic mutant K76/294Q" . SPARSER::PROTEIN)
    ("K76/294Q" . SPARSER::PROTEIN)
    ("increased LKB1 active complex" . SPARSER::BIO-COMPLEX)
    ("monophosphate-activated protein kinase (AMPK)" . SPARSER::COLLECTION)
    ("monophosphate-activated protein kinase" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("ACAT2 and HDAC4" . SPARSER::COLLECTION)
    ("DLAT, ACAT2 and HDAC4" . SPARSER::COLLECTION)
    ("K76/294R or K76/294Q" . SPARSER::COLLECTION)
    ("FLAG-HDAC4" . SPARSER::COLLECTION)
    ("HDAC4 or HDAC7" . SPARSER::COLLECTION)
    ("HDAC7 or HDAC4" . SPARSER::COLLECTION)
    ("catalytically less active forms" . SPARSER::FORM)
    ("FLAG-DLAT" . SPARSER::COLLECTION) ("ACAT2 or DLAT" . SPARSER::COLLECTION)
    ("dihydrolipoamide S-acetyltransferase (DLAT) and P300/CBP-associated factor (PCAF)"
     . SPARSER::COLLECTION)
    ("acetyltransferases, and histone deacetylase (HDAC)"
     . SPARSER::COLLECTION)
    ("acetyltransferases, and histone deacetylase" . SPARSER::COLLECTION)
    ("acetyltransferase or deacetylase" . SPARSER::COLLECTION)
    ("particular acetyltransferases or deacetylases" . SPARSER::COLLECTION)
    ("acetyltransferases or deacetylases" . SPARSER::COLLECTION)
    ("upstream acetyltransferase(s) and deacetylase(s)" . SPARSER::COLLECTION)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("Acetyltransferases" . SPARSER::PROTEIN)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("6PGD and NADP +" . SPARSER::COLLECTION) ("Agarose" . SPARSER::MOLECULE)
    ("Sigma-Aldrich" . SPARSER::COLLECTION) ("dimeric 6PGD" . SPARSER::PROTEIN)
    ("Monomeric 6PGD" . SPARSER::PROTEIN)
    ("6PGD and active" . SPARSER::COLLECTION)
    ("acetylation-mimetic K76/294Q mutant" . SPARSER::MUTANT)
    ("catalytically more active" . SPARSER::ACTIVE)
    ("K76/294R and K76/294Q" . SPARSER::COLLECTION)
    ("TSA and NAM" . SPARSER::COLLECTION)
    ("HDAC and SIRT" . SPARSER::COLLECTION) ("K76/294R" . SPARSER::PROTEIN)
    ("FLAG-6PGD" . SPARSER::COLLECTION) ("rFLAG-6PGD" . SPARSER::COLLECTION)
    ("nicotinamide (NAM)" . SPARSER::MOLECULE)
    ("NAM" . SPARSER::PROTEIN-FAMILY) ("CST" . SPARSER::PROTEIN)
    ("a reliable prognostic biomarker" . SPARSER::MOLECULE)
    ("both 6PGD and the first enzyme" . SPARSER::COLLECTION)
    ("the most crucial metabolite" . SPARSER::MOLECULE)
    ("a crucial antioxidant" . SPARSER::PROTEIN)
    ("amino acids and fatty acids" . SPARSER::COLLECTION)
    ("proteins and lipids" . SPARSER::COLLECTION) ("ATPs" . SPARSER::ATP)
    ("RNA and lipid" . SPARSER::COLLECTION) ("ribulose" . SPARSER::MOLECULE)
    ("DLAT and ACAT2" . SPARSER::COLLECTION) ("DLAT" . SPARSER::PROTEIN)
    ("NADP + -binding to 6PGD and formation of active 6PGD dimers"
     . SPARSER::COLLECTION)
    ("active 6PGD dimers" . SPARSER::DIMER)
    ("protein acetyltransferase" . SPARSER::PROTEIN) ("EL1" . SPARSER::PROTEIN)
    ("ACC1" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("dihydrolipoamide S-acetyltransferase" . SPARSER::PROTEIN)
    ("acetyltransferase 2" . SPARSER::PROTEIN) ("CL-6" . SPARSER::PROTEIN)
    ("NADP+" . SPARSER::MOLECULE) ("PGAM1" . SPARSER::PROTEIN)
    ("phosphoglycerate mutase 1" . SPARSER::PROTEIN)
    ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("glucose-6-phosphate" . SPARSER::MOLECULE) ("ACAT2" . SPARSER::PROTEIN)
    ("NADP +" . SPARSER::MOLECULE) ("6PGD" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("hypercalcemic type" . TYPE) ("alu" . SPARSER::PROTEIN)
    ("other histologic subtype" . SPARSER::PROTEIN) ("usual type" . TYPE)
    ("the concurrent acinar foci" . SPARSER::PROTEIN)
    ("PSA, p501s and PSMA" . SPARSER::COLLECTION)
    ("AR and NKX3-1" . SPARSER::COLLECTION) ("PSMA" . SPARSER::PROTEIN)
    ("at least part" . SPARSER::COMPONENT) ("usual types" . TYPE)
    ("SCCs" . SPARSER::PROTEIN)
    ("an unusual and aggressive subtype" . SPARSER::PROTEIN)
    ("other histologic variants" . SPARSER::VARIANT)
    ("the urinary bladder bear TERT promoter mutation C228T"
     . SPARSER::PROTEIN)
    ("a rare subtype" . SPARSER::PROTEIN) ("SMARCA4" . SPARSER::PROTEIN)
    ("NKX3-1" . SPARSER::PROTEIN) ("GATA-3" . SPARSER::PROTEIN)
    ("chr5" . SPARSER::PROTEIN)
    ("LKB1 and phospho-AMPKα" . SPARSER::COLLECTION)
    ("AMPK/mTOR" . SPARSER::COLLECTION) ("LKB" . SPARSER::PROTEIN)
    ("p53 and LKB1" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("TESS" . SPARSER::PROTEIN) ("synonymous mutation p" . SPARSER::PROTEIN)
    ("strong LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hyper" . SPARSER::PROTEIN)
    ("AMP-dependent kinase (AMPK) and other substrates" . SPARSER::COLLECTION)
    ("a multifunctional serine/threonine kinase" . SPARSER::KINASE)
    ("mRNA, and protein" . SPARSER::COLLECTION) ("A 20" . SPARSER::PROTEIN)
    ("CCAAT/Enhancer Binding Protein" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Liver kinase B1" . SPARSER::PROTEIN)
    ("Akt, and protein kinase" . SPARSER::COLLECTION)
    ("the membrane-associated fraction" . SPARSER::COMPONENT)
    ("β-catenin and GSK-3β" . SPARSER::COLLECTION)
    ("GSK-3β, pGSK-3beta-ser-9, and β-catenin" . SPARSER::COLLECTION)
    ("Valproate and antipsychotic" . SPARSER::COLLECTION)
    ("stabilizers and antipsychotics" . SPARSER::COLLECTION)
    ("antipsychotic" . SPARSER::DRUG) ("Valproate" . SPARSER::DRUG)
    ("major components and regulators of this pathway" . SPARSER::REGULATOR)
    ("components and regulators" . SPARSER::COLLECTION)
    ("the DLPFC (p = 0.006) and TEMP (p = 0.003)" . SPARSER::COLLECTION)
    ("hoc" . SPARSER::PROTEIN)
    ("the DLPFC (p = 0.025) and TEMP (p = 0.042)" . SPARSER::COLLECTION)
    ("either GSK-3β or the pGSK-3β-ser-9" . SPARSER::COLLECTION)
    ("GSK-3β (p = 0.003) and pGSK-3beta-ser-9 (p = 0.003)"
     . SPARSER::COLLECTION)
    ("GSK-3β (p = 0.15) or pGSK-3β-ser-9 (p = 0.30)" . SPARSER::COLLECTION)
    ("post-hoc" . SPARSER::COLLECTION)
    ("GSK-3β or pGSK-3β-ser-9" . SPARSER::COLLECTION)
    ("GSK-3β, pGSK-3β-ser-9, and β-catenin, and gene" . SPARSER::COLLECTION)
    ("β-catenin, and gene" . SPARSER::COLLECTION)
    ("protein and gene" . SPARSER::COLLECTION)
    ("GSK-3β and pGSK-3β-ser-9" . SPARSER::COLLECTION)
    ("tyr" . SPARSER::PROTEIN)
    ("GSK-3β and/or β-catenin" . SPARSER::COLLECTION)
    ("BP and NC" . SPARSER::COLLECTION)
    ("GSK-3β or β-catenin" . SPARSER::COLLECTION)
    ("GSK-3α and GSK-3β" . SPARSER::COLLECTION)
    ("platelets" . SPARSER::PROTEIN) ("valproate" . SPARSER::DRUG)
    ("an anticonvulsant and a mood-stabilizing drug" . SPARSER::COLLECTION)
    ("anticonvulsant" . SPARSER::DRUG)
    ("factor and Lymphoid" . SPARSER::COLLECTION)
    ("Lymphoid" . SPARSER::PROTEIN) ("DVL" . SPARSER::PROTEIN)
    ("frizzled" . SPARSER::PROTEIN)
    ("GSK-3β, pGSK-3β-ser-9, or β-catenin" . SPARSER::COLLECTION)
    ("DLPFC and TEMP" . SPARSER::COLLECTION) ("gyrus (CG)" . SPARSER::PROTEIN)
    ("GSK-3β, pGSK-3β-ser-9, and β-catenin" . SPARSER::COLLECTION)
    ("TEMP" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN) ("DLPFC" . SPARSER::PROTEIN)
    ("GSK-3β and β-catenin" . SPARSER::COLLECTION)
    ("ribonuclease inhibitor" . SPARSER::PROTEIN) ("GSK-3α" . SPARSER::PROTEIN)
    ("promoter, and H4K16Ac" . SPARSER::COLLECTION) ("Sun" . SPARSER::PROTEIN)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY)
    ("p53(Mercer et al ., xref ) or p21(Khanna, xref )" . SPARSER::COLLECTION)
    ("SIRT1, H3K9Ac and H4K16Ac" . SPARSER::COLLECTION)
    ("the –844 A alleles" . SPARSER::ALLELE)
    ("an exogenous stable form" . SPARSER::FORM) ("PAI" . SPARSER::PROTEIN)
    ("RR" . SPARSER::PROTEIN) ("HPAI" . SPARSER::DRUG)
    ("phenylephrine" . SPARSER::DRUG) ("Ach" . SPARSER::PROTEIN)
    ("Tg" . SPARSER::PROTEIN) ("SIRT1-Tg" . SPARSER::COLLECTION)
    ("sirtinol or another SIRT1-specific inhibitor" . SPARSER::COLLECTION)
    ("sirtinol, nicotinamide, and suramin" . SPARSER::COLLECTION)
    ("suramin" . SPARSER::DRUG) ("sirtinol" . SPARSER::DRUG)
    ("PAI-1 and p21 protein" . SPARSER::COLLECTION)
    ("senescence-associated molecules" . SPARSER::MOLECULE)
    ("the established senescence-associated marker p21" . SPARSER::PROTEIN)
    ("Chen" . SPARSER::PROTEIN) ("Ota" . SPARSER::MOLECULE)
    ("proteins, or sirtuins" . SPARSER::COLLECTION) ("AS" . SPARSER::PROTEIN)
    ("tissue-type (t-PA) and urokinase-type (u-PA) plasminogen activators"
     . SPARSER::COLLECTION)
    ("Van" . SPARSER::PROTEIN)
    ("histone deacetylase, and PAI-1" . SPARSER::COLLECTION)
    ("SIRT1 and PAI-1" . SPARSER::COLLECTION) ("mL -1" . SPARSER::PROTEIN)
    ("P14" . SPARSER::PROTEIN) ("CDK5" . SPARSER::PROTEIN)
    ("Pol II" . SPARSER::PROTEIN) ("p66Shc" . SPARSER::PROTEIN)
    ("PAI-039" . SPARSER::DRUG) ("SRT1720" . SPARSER::DRUG)
    ("EX527" . SPARSER::DRUG)
    ("silent information regulator 2" . SPARSER::PROTEIN)
    ("u-PA" . SPARSER::PROTEIN) ("t-PA" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN) ("K16" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("Hyper-IgE" . SPARSER::PROTEIN-PAIR) ("Activator" . SPARSER::ACTIVATOR)
    ("Both showed reduced regulatory T-cell" . SPARSER::PROTEIN)
    ("IFN-γ and TNF" . SPARSER::COLLECTION) ("LGL" . SPARSER::PROTEIN)
    ("parental DNA" . SPARSER::DNA) ("synonymous variants" . SPARSER::VARIANT)
    ("Heterozygous variants" . SPARSER::VARIANT) ("yrs" . SPARSER::PROTEIN)
    ("AIRE" . SPARSER::PROTEIN) ("IPEX" . SPARSER::PROTEIN)
    ("IgE" . SPARSER::PROTEIN) ("CD49d" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("18h" . SPARSER::PROTEIN)
    ("X-linked" . SPARSER::PROTEIN)
    ("methylated and unmethylated RASSF1A promoter" . SPARSER::PROMOTER)
    ("mitogen-activated protein kinase and phosphatidylinositol-3"
     . SPARSER::COLLECTION)
    ("neurofibromin" . SPARSER::PROTEIN)
    ("TP53 , CDKN2A , and RB1" . SPARSER::COLLECTION)
    ("ERRB2, EGFR , KIT , and MET" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT)
    ("an adverse prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras association domain family member 1" . SPARSER::PROTEIN)
    ("ERRB2" . SPARSER::PROTEIN)
    ("respective client protein" . SPARSER::PROTEIN)
    ("a larger fraction" . SPARSER::COMPONENT)
    ("NUDCD3 and SGT1" . SPARSER::COLLECTION)
    ("propellers" . SPARSER::PROTEIN-FAMILY) ("TRiC/CCT" . SPARSER::COLLECTION)
    ("CCT" . SPARSER::PROTEIN) ("TRiC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hsp90, Hsp70, and prefoldins" . SPARSER::COLLECTION)
    ("conformational states" . SPARSER::BIO-STATE)
    ("the associated proteins" . SPARSER::PROTEIN)
    ("BAG5 and MAD" . SPARSER::COLLECTION)
    ("prefoldins and G protein" . SPARSER::COLLECTION)
    ("MAD" . SPARSER::PROTEIN) ("NUDC and NUDCD2" . SPARSER::COLLECTION)
    ("NUDCD3 or SGT1" . SPARSER::COLLECTION)
    ("subunits and NUDCD1" . SPARSER::COLLECTION) ("COP-" . SPARSER::PROTEIN)
    ("COP" . SPARSER::PROTEIN)
    ("multiple DEAH/DEAD box RNA helicases and several subunits"
     . SPARSER::COLLECTION)
    ("AP-MS and LUMIER" . SPARSER::COLLECTION)
    ("DEAH/DEAD" . SPARSER::COLLECTION)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARAF and SGT1" . SPARSER::COLLECTION)
    ("kinase, β-propeller, or LRR" . SPARSER::COLLECTION)
    ("NUDC and NUDCD3" . SPARSER::COLLECTION)
    ("Hsp90 and Cdc37" . SPARSER::COLLECTION)
    ("four evolutionary related proteins" . SPARSER::PROTEIN)
    ("PP5 and p23" . SPARSER::COLLECTION)
    ("proteins and Argonaute" . SPARSER::COLLECTION) ("LRR" . SPARSER::PROTEIN)
    ("actin and tubulin" . SPARSER::COLLECTION)
    ("RPAP3 and Hsp90" . SPARSER::COLLECTION)
    ("prefoldins" . SPARSER::PROTEIN-FAMILY)
    ("VBP1, UXT, and PDRG1" . SPARSER::COLLECTION) ("UXT" . SPARSER::PROTEIN)
    ("TP" . SPARSER::PROTEIN)
    ("chaperones or co-chaperones" . SPARSER::COLLECTION)
    ("RPN1 and Hsc70" . SPARSER::COLLECTION)
    ("diverse proteasome-associated factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPN1/PSMD2" . SPARSER::COLLECTION)
    ("BAG2 and RPN1" . SPARSER::COLLECTION)
    ("UNC45A and FKBP38" . SPARSER::COLLECTION) ("held" . SPARSER::PROTEIN)
    ("Hsp70 or Hsc70" . SPARSER::COLLECTION)
    ("Hsp70, Hsc70, and Hsp70B" . SPARSER::COLLECTION)
    ("Hsp70B" . SPARSER::PROTEIN) ("p53 and HSF1" . SPARSER::COLLECTION)
    ("Hsp90 (  xref  , red circles) or Hsp70 (  xref  , ochre circles)"
     . SPARSER::COLLECTION)
    ("Paralogous chaperones" . SPARSER::PROTEIN)
    ("biologically coherent chaperone" . SPARSER::PROTEIN)
    ("PSMD4, PSMC1 and ADRM1" . SPARSER::COLLECTION)
    ("PFDN2 and PFDN5" . SPARSER::COLLECTION)
    ("This recovered well-known biological complexes" . SPARSER::BIO-COMPLEX)
    ("Hsp90β and Hsc70" . SPARSER::COLLECTION)
    ("the 630 unique proteins" . SPARSER::PROTEIN)
    ("Ganetespib" . SPARSER::DRUG) ("Hsp90β or Hsc70" . SPARSER::COLLECTION)
    ("ganetespib" . SPARSER::DRUG)
    ("interactors and LUMIER" . SPARSER::COLLECTION)
    ("EYFP" . SPARSER::PROTEIN) ("EYFP-BAG4" . SPARSER::COLLECTION)
    ("DCP1A, EDC3 and DDX6" . SPARSER::COLLECTION) ("Mad" . SPARSER::PROTEIN)
    ("BAG5 and BAG4" . SPARSER::COLLECTION)
    ("Hsp27/HSPB1" . SPARSER::COLLECTION) ("Hsp22/HSPB8" . SPARSER::COLLECTION)
    ("Hsp70 and Hsp90" . SPARSER::COLLECTION) ("Listerin" . SPARSER::PROTEIN)
    ("BAG" . SPARSER::PROTEIN)
    ("chaperones and co-chaperones" . SPARSER::COLLECTION)
    ("OSBP and FKBP36" . SPARSER::COLLECTION) ("OSBP" . SPARSER::PROTEIN)
    ("oxysterol" . SPARSER::PROTEIN) ("PDCL" . SPARSER::PROTEIN)
    ("FKBP51 and genome" . SPARSER::COLLECTION)
    ("Hsp90 and MCMBP" . SPARSER::COLLECTION)
    ("MCM4 and MCMBP" . SPARSER::COLLECTION) ("MCM" . SPARSER::PROTEIN)
    ("MCMBP" . SPARSER::PROTEIN) ("AGO1 and AGO2" . SPARSER::COLLECTION)
    ("aka" . SPARSER::PROTEIN) ("FKBP" . SPARSER::PROTEIN)
    ("its divergent N-terminus CDC37L1" . SPARSER::PROTEIN)
    ("CDC37L1/Harc" . SPARSER::COLLECTION) ("Harc" . SPARSER::PROTEIN)
    ("the TPR domain protein EDRF1" . SPARSER::PROTEIN)
    ("NRDP1/RNF41" . SPARSER::COLLECTION) ("EDRF" . SPARSER::PROTEIN)
    ("CHIP/STUB1" . SPARSER::COLLECTION) ("TPR2/DNAJC7" . SPARSER::COLLECTION)
    ("HOP/STIP1" . SPARSER::COLLECTION) ("HOP" . SPARSER::PROTEIN)
    ("Hsp90 and Hsp70" . SPARSER::COLLECTION) ("Chaperone" . SPARSER::PROTEIN)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSF" . SPARSER::PROTEIN)
    ("prefoldin" . SPARSER::PROTEIN-FAMILY)
    ("almost all surveyed proteins" . SPARSER::PROTEIN)
    ("cochaperones" . SPARSER::PROTEIN)
    ("the canonical chaperones" . SPARSER::PROTEIN)
    ("cofactors, or co-chaperones" . SPARSER::COLLECTION)
    ("a salient example" . SPARSER::EXAMPLE) ("NUDC" . SPARSER::PROTEIN)
    ("protein/protein" . SPARSER::COLLECTION) ("chaperones" . SPARSER::PROTEIN)
    ("Chaperones" . SPARSER::PROTEIN) ("KLHL38" . SPARSER::PROTEIN)
    ("FBXL2" . SPARSER::PROTEIN) ("FBXW2" . SPARSER::PROTEIN)
    ("NUDCD1" . SPARSER::PROTEIN) ("Cdc37" . SPARSER::PROTEIN)
    ("RCC1" . SPARSER::PROTEIN) ("NUDCD2" . SPARSER::PROTEIN)
    ("NUDCD3" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("PP5" . SPARSER::PROTEIN) ("SGT1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Leucine-rich repeat" . SPARSER::PROTEIN) ("POLR3A" . SPARSER::PROTEIN)
    ("PDRG1" . SPARSER::PROTEIN) ("VBP1" . SPARSER::PROTEIN)
    ("RPT2" . SPARSER::PROTEIN) ("RPN13" . SPARSER::PROTEIN)
    ("RPN10" . SPARSER::PROTEIN) ("PSMD2" . SPARSER::PROTEIN)
    ("DCP1B" . SPARSER::PROTEIN) ("RPN1" . SPARSER::PROTEIN)
    ("UNC45A" . SPARSER::PROTEIN) ("RPAP3" . SPARSER::PROTEIN)
    ("PFDN5" . SPARSER::PROTEIN) ("PFDN2" . SPARSER::PROTEIN)
    ("ADRM1" . SPARSER::PROTEIN) ("PSMC1" . SPARSER::PROTEIN)
    ("PSMD4" . SPARSER::PROTEIN) ("BAG2" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("Hsp90β" . SPARSER::PROTEIN) ("EDC3" . SPARSER::PROTEIN)
    ("DCP1A" . SPARSER::PROTEIN) ("MAD2L1" . SPARSER::PROTEIN)
    ("MAD1L1" . SPARSER::PROTEIN) ("BAG4" . SPARSER::PROTEIN)
    ("BAG5" . SPARSER::PROTEIN) ("HSF1" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN) ("Hsp27" . SPARSER::PROTEIN)
    ("HSPB8" . SPARSER::PROTEIN) ("Hsp22" . SPARSER::PROTEIN)
    ("heat shock proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BAG3" . SPARSER::PROTEIN) ("LTN1" . SPARSER::PROTEIN)
    ("protein it" . SPARSER::PROTEIN) ("FKBP8" . SPARSER::PROTEIN)
    ("FKBP38" . SPARSER::PROTEIN) ("MCM4" . SPARSER::PROTEIN)
    ("PDCD2" . SPARSER::PROTEIN) ("EGLN1" . SPARSER::PROTEIN)
    ("AGO2" . SPARSER::PROTEIN) ("AGO1" . SPARSER::PROTEIN)
    ("FKBP51" . SPARSER::PROTEIN) ("AHA1" . SPARSER::PROTEIN)
    ("CDC37L1" . SPARSER::PROTEIN) ("CDC37" . SPARSER::PROTEIN)
    ("RNF41" . SPARSER::PROTEIN) ("NRDP1" . SPARSER::PROTEIN)
    ("HSPBP1" . SPARSER::PROTEIN) ("DNAJB6" . SPARSER::PROTEIN)
    ("DNAJB1" . SPARSER::PROTEIN) ("Hsp40" . SPARSER::PROTEIN)
    ("STUB1" . SPARSER::PROTEIN) ("DNAJC7" . SPARSER::PROTEIN)
    ("TPR2" . SPARSER::PROTEIN) ("STIP1" . SPARSER::PROTEIN)
    ("Sgt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("AP-MS" . SPARSER::PROTEIN) ("Hsp70" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE)
    ("this epigenetic mark" . SPARSER::PROTEIN)
    ("the temporal and spatial cues" . SPARSER::PROTEIN-FAMILY)
    ("HJURP or MgcRacGAP" . SPARSER::COLLECTION)
    ("kinase (DDK)" . SPARSER::KINASE) ("Plk4" . SPARSER::PROTEIN)
    ("DDK" . SPARSER::BIO-COMPLEX) ("CDK and Plk1" . SPARSER::COLLECTION)
    ("CENP-C-Mis18α" . SPARSER::COLLECTION)
    ("mitotic centromeres" . SPARSER::PROTEIN)
    ("Mis18α and Mis18β" . SPARSER::COLLECTION)
    ("non-functional" . SPARSER::PROTEIN) ("Plk" . SPARSER::PROTEIN)
    ("mCherry-Mis18α" . SPARSER::COLLECTION)
    ("M18BP1, Mis18α, or Mis18β" . SPARSER::COLLECTION)
    ("CDK ( xref ) and Plk1" . SPARSER::COLLECTION)
    ("the Mis18 complex and the Plk1 PBD" . SPARSER::COLLECTION)
    ("Polo" . SPARSER::PROTEIN) ("CENP-C-M18BP1" . SPARSER::COLLECTION)
    ("GFP-HJURP" . SPARSER::COLLECTION) ("mCherry-" . SPARSER::PROTEIN)
    ("GFP-M18BP1" . SPARSER::COLLECTION)
    ("The Mis18 complex and HJURP" . SPARSER::COLLECTION)
    ("MgcRacGAP" . SPARSER::PROTEIN) ("geminin-GFP" . SPARSER::COLLECTION)
    ("Cdt1-RFP" . SPARSER::COLLECTION) ("geminin" . SPARSER::PROTEIN)
    ("an analogue-sensitive allele" . SPARSER::ALLELE)
    ("new CENP-A" . SPARSER::PROTEIN) ("CENP-A-SNAP" . SPARSER::COLLECTION)
    ("SNAP" . SPARSER::PROTEIN) ("Mis18α or M18BP1" . SPARSER::COLLECTION)
    ("kinases, Plk2 and Plk3" . SPARSER::COLLECTION)
    ("Plk1-YFP" . SPARSER::COLLECTION) ("YFP-Plk1" . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN)
    ("Mis18α, Mis18β, and M18BP1" . SPARSER::COLLECTION)
    ("Mis18α" . SPARSER::PROTEIN) ("GFP-Mis18α" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("M18BP1/KNL2" . SPARSER::COLLECTION) ("HJURP" . SPARSER::PROTEIN)
    ("this crucial epigenetic mark" . SPARSER::PROTEIN)
    ("Plk1 and CDK" . SPARSER::COLLECTION)
    ("Plk1 and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("cyclin-B" . SPARSER::PROTEIN-FAMILY) ("Cas9" . SPARSER::PROTEIN)
    ("AZ3146" . SPARSER::DRUG) ("Dbf4" . SPARSER::PROTEIN)
    ("CDK-A" . SPARSER::PROTEIN) ("CENP-T" . SPARSER::PROTEIN)
    ("Mps1" . SPARSER::PROTEIN) ("CENP-C" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RPE1" . SPARSER::PROTEIN)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BI2536" . SPARSER::DRUG)
    ("Plk3" . SPARSER::PROTEIN) ("Plk2" . SPARSER::PROTEIN)
    ("Polo-like" . SPARSER::PROTEIN) ("KNL2" . SPARSER::PROTEIN)
    ("M18BP1" . SPARSER::PROTEIN) ("Mis18" . SPARSER::PROTEIN)
    ("Polo-like kinase 1" . SPARSER::PROTEIN) ("CENP-A" . SPARSER::PROTEIN)
    ("BRCA and FMR1" . SPARSER::COLLECTION) ("insC" . SPARSER::PROTEIN)
    ("homozygous ( hom ) alleles" . SPARSER::ALLELE)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Satisfactory FMR1" . SPARSER::PROTEIN)
    ("low FMR1 alleles or the Austrian data" . SPARSER::COLLECTION)
    ("p-53" . SPARSER::PROTEIN)
    ("fragile X mental retardation1" . SPARSER::PROTEIN)
    ("FMR1" . SPARSER::PROTEIN)
    ("fragile X mental retardation 1" . SPARSER::PROTEIN)
    ("p21 and PL" . SPARSER::COLLECTION)
    ("FEN1, p15, and DNA" . SPARSER::COLLECTION)
    ("Alanine" . SPARSER::AMINO-ACID) ("Protein-Protein" . SPARSER::COLLECTION)
    ("the competitive ligands" . SPARSER::LIGAND)
    ("peptide and T3" . SPARSER::COLLECTION)
    ("PCNA conformation and the overall ligand occupancy"
     . SPARSER::COLLECTION)
    ("the incomplete competitive binding model fit" . SPARSER::PROTEIN-FAMILY)
    ("trimeric PCNA" . SPARSER::PROTEIN) ("FEN1 and p21" . SPARSER::COLLECTION)
    ("DNA and protein" . SPARSER::COLLECTION) ("trimers" . SPARSER::TRIMER)
    ("oligomers and the trimer" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION)
    ("structure-based drug" . SPARSER::DRUG)
    ("the competitive ligand" . SPARSER::LIGAND)
    ("PCNA-p21" . SPARSER::COLLECTION) ("a 20-mer" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 and PCNA" . SPARSER::COLLECTION) ("iodine" . SPARSER::MOLECULE)
    ("Molecule" . SPARSER::MOLECULE) ("Akt- and PI3K" . SPARSER::COLLECTION)
    ("carboxamide" . SPARSER::MOLECULE) ("PL and p21" . SPARSER::COLLECTION)
    ("PCNA-PL" . SPARSER::COLLECTION) ("Anchor" . SPARSER::ANCHOR)
    ("ANCHOR" . SPARSER::ANCHOR)
    ("specific PCNA conformations and ligand interactions"
     . SPARSER::COLLECTION)
    ("a robust fit" . SPARSER::PROTEIN-FAMILY)
    ("Akt and p85α" . SPARSER::COLLECTION)
    ("PI3-kinase (p85α regulatory domain) and Akt" . SPARSER::COLLECTION)
    ("two proteins, PI3-kinase (p85α regulatory domain) and Akt"
     . SPARSER::COLLECTION)
    ("mers" . SPARSER::PROTEIN) ("p21-PCNA" . SPARSER::COLLECTION)
    ("PL, p66 or Abl" . SPARSER::COLLECTION)
    ("the trimeric state" . SPARSER::BIO-STATE) ("trimer" . SPARSER::TRIMER)
    ("p66 and Abl" . SPARSER::COLLECTION)
    ("50 nM FITC-PL peptide and 1 µM PCNA (monomer concentration) and fraction"
     . SPARSER::COLLECTION)
    ("the 12-mer competitive peptide ligand" . SPARSER::MOLECULE)
    ("the previously identified Mcl-1 PIP Box-like peptide" . SPARSER::PEPTIDE)
    ("PCNA-PIP" . SPARSER::COLLECTION)
    ("shorter (12-mer) peptide" . SPARSER::PEPTIDE)
    ("fluorescein isothiocyanate (FITC)" . SPARSER::MOLECULE)
    ("DNA ligase and POGO" . SPARSER::COLLECTION)
    ("PL-PCNA" . SPARSER::COLLECTION) ("PL" . SPARSER::PROTEIN)
    ("potentially new PCNA" . SPARSER::PROTEIN)
    ("p21 and FEN1" . SPARSER::COLLECTION)
    ("accessory proteins" . SPARSER::PROTEIN)
    ("an essential protein" . SPARSER::PROTEIN)
    ("PCNA-protein" . SPARSER::COLLECTION)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("Srs2" . SPARSER::PROTEIN)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA glycosylase" . SPARSER::PROTEIN)
    ("p66" . SPARSER::HUMAN-PROTEIN-FAMILY) ("3d" . SPARSER::PROTEIN-FAMILY)
    ("PDB 1" . SPARSER::PROTEIN) ("6-aminohexanoic acid" . SPARSER::DRUG)
    ("1 L" . SPARSER::PROTEIN) ("Ssp1" . SPARSER::PROTEIN)
    ("FEN1" . SPARSER::PROTEIN) ("IDH1 and 2HG" . SPARSER::PROTEIN)
    ("HR and TMZ" . SPARSER::COLLECTION)
    ("exogenous mutant IDH1" . SPARSER::PROTEIN)
    ("RAD51-driven HR" . SPARSER::PROTEIN)
    ("IDH1, and mutant" . SPARSER::COLLECTION)
    ("HR and TMZ-resistance" . SPARSER::COLLECTION)
    ("TMZ-resistance" . SPARSER::DRUG)
    ("mutant IDH1-driven transformation increases HR" . SPARSER::PROTEIN)
    ("Mutant IDH1-driven transformation increases HR" . SPARSER::PROTEIN)
    ("IDH1, or mutant" . SPARSER::COLLECTION) ("V12H-Ras" . SPARSER::PROTEIN)
    ("E6, E7, and hTERT" . SPARSER::COLLECTION)
    ("virally-encoded E6, E7 and hTERT" . SPARSER::COLLECTION)
    ("E6, E7 and hTERT" . SPARSER::COLLECTION)
    ("indirectly causes DNA" . SPARSER::DNA)
    ("temozolomide (TMZ)" . SPARSER::DRUG)
    ("α-KG-dependent enzymes" . SPARSER::ENZYME)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("the homologous recombination DNA repair protein RAD51"
     . SPARSER::PROTEIN)
    ("WT IDH1 or an oncogenic form (V12H)" . SPARSER::COLLECTION)
    ("gamma-H2AX" . SPARSER::COLLECTION) ("Isocitrate" . SPARSER::DRUG)
    ("RasV12" . SPARSER::DRUG)
    ("p63, Trim29 and keratin 5" . SPARSER::COLLECTION)
    ("Trim29" . SPARSER::PROTEIN) ("Trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("recombinase" . SPARSER::PROTEIN) ("FGF3 and FGF7" . SPARSER::COLLECTION)
    ("FGF9 or FGF10" . SPARSER::COLLECTION)
    ("FRS2α, AKT and ERK" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("FRS2α, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("inhibitor or vehicle" . SPARSER::COLLECTION)
    ("both the kinase domain mutant ( xref ) and the extracellular domain mutant ( xref )"
     . SPARSER::COLLECTION)
    ("AKT, ERK1/2 and FRS2α" . SPARSER::COLLECTION)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION) ("SFTPC" . SPARSER::PROTEIN)
    ("bi-allelic FGFR2 K660N" . SPARSER::PROTEIN) ("Sick" . SPARSER::PROTEIN)
    ("FGFR2 or p53" . SPARSER::COLLECTION) ("cre-lox" . SPARSER::COLLECTION)
    ("lox" . SPARSER::PROTEIN) ("cre" . SPARSER::PROTEIN)
    ("extracellular or kinase" . SPARSER::COLLECTION)
    ("extracellular and kinase" . SPARSER::COLLECTION)
    ("both major subtypes" . SPARSER::PROTEIN)
    ("Fibroblast growth factors (FGFs) and their cognate cell surface receptors"
     . SPARSER::COLLECTION)
    ("therapeutic biomarkers" . SPARSER::MOLECULE)
    ("pan-FGFR" . SPARSER::COLLECTION) ("STK11" . SPARSER::PROTEIN)
    ("keratin 5" . SPARSER::PROTEIN) ("FGF10" . SPARSER::PROTEIN)
    ("FRS2α" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor substrate 2" . SPARSER::PROTEIN)
    ("CC10" . SPARSER::PROTEIN) ("surfactant protein C" . SPARSER::PROTEIN)
    ("thyroid transcription factor 1" . SPARSER::PROTEIN)
    ("FGFR2-IIIb" . SPARSER::PROTEIN) ("FGF3" . SPARSER::PROTEIN)
    ("Fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("Fibroblast Growth Factor Receptor 2" . SPARSER::PROTEIN)
    ("AGR, ZY, and X-FM" . SPARSER::COLLECTION)
    ("AGR" . SPARSER::PROTEIN-FAMILY) ("YY" . SPARSER::MOLECULE)
    ("Ester" . SPARSER::MOLECULE) ("Arginase" . SPARSER::PROTEIN)
    ("arginase activity and Arg-II" . SPARSER::COLLECTION)
    ("dysfunctional eNOS" . SPARSER::PROTEIN) ("DHE" . SPARSER::DRUG)
    ("nitroprusside (SNP)" . SPARSER::DRUG) ("nitroprusside" . SPARSER::DRUG)
    ("ACh" . SPARSER::PROTEIN) ("ApoE" . SPARSER::PROTEIN)
    ("endothelial NO synthase" . SPARSER::PROTEIN)
    ("L-NAME-inhibitable superoxide" . SPARSER::MOLECULE)
    ("eNOS, Arg-II and p38mapk" . SPARSER::COLLECTION)
    ("Diacetate" . SPARSER::MOLECULE) ("face" . SPARSER::PROTEIN)
    ("mapk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("arginase" . SPARSER::PROTEIN)
    ("Endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("Apolipoprotein E" . SPARSER::PROTEIN)
    ("angiotensin-II" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("Arginase activity" . SPARSER::PROTEIN)
    ("Superoxide anion" . SPARSER::MOLECULE) ("DAF-2" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN) ("NO synthase" . SPARSER::PROTEIN)
    ("L-NAME" . SPARSER::MOLECULE) ("arginase activity" . SPARSER::PROTEIN)
    ("L-arginine" . SPARSER::MOLECULE)
    ("these neurons equally repair SSBs" . SPARSER::PROTEIN)
    ("CPT and Trabectedin" . SPARSER::COLLECTION)
    ("Trabectedin" . SPARSER::DRUG)
    ("the respective protein components" . SPARSER::COMPONENT)
    ("the synaptic vesicle proteins VAMP2 and Synapsin-1"
     . SPARSER::COLLECTION)
    ("VAMP2 and Synapsin-1" . SPARSER::COLLECTION)
    ("SCG10 and KChip" . SPARSER::COLLECTION) ("cc" . SPARSER::PROTEIN)
    ("CPT and trabectedin" . SPARSER::COLLECTION)
    ("H 2 O 2 and Paraquat" . SPARSER::COLLECTION)
    ("Paraquat" . SPARSER::MOLECULE)
    ("γ -H2AX and 5.6±2.1" . SPARSER::COLLECTION)
    ("γ -H2AX and 53BP1" . SPARSER::COLLECTION)
    ("a defective DDR" . SPARSER::PROTEIN) ("Pol-" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN)
    ("the MRN complex (RAD50-MRE11-NBS1) and X-ray repair"
     . SPARSER::COLLECTION)
    ("RAD50-MRE11-NBS1" . SPARSER::COLLECTION)
    ("CDC25A and p21" . SPARSER::COLLECTION) ("p53-pS15" . SPARSER::COLLECTION)
    ("pF" . SPARSER::PROTEIN) ("Cdc2 and cyclin B1" . SPARSER::COLLECTION)
    ("SYP and PSD95" . SPARSER::COLLECTION)
    ("SCG10 and KChIP" . SPARSER::COLLECTION)
    ("Synaptophysin (SYP)" . SPARSER::PROTEIN)
    ("Synaptophysin" . SPARSER::PROTEIN)
    ("the neuronal growth-associated protein SCG10 and the potassium channel-interacting proteins (KChIPs)"
     . SPARSER::COLLECTION)
    ("the neuronal growth-associated protein SCG10" . SPARSER::PROTEIN)
    ("the inhibitory synapse marker vesicular GABA transporter (VGAT)"
     . SPARSER::PROTEIN)
    ("transporter (VGAT)" . SPARSER::PROTEIN)
    ("the postsynaptic marker PSD95 postsynaptic density protein 95"
     . SPARSER::PROTEIN)
    ("VGAT" . SPARSER::PROTEIN)
    ("ATM and checkpoint kinase 2" . SPARSER::COLLECTION)
    ("Sox2 and Nestin" . SPARSER::COLLECTION)
    ("the neural precursor markers Sox2, Nestin and Vimentin"
     . SPARSER::COLLECTION)
    ("Sox2, Nestin and Vimentin" . SPARSER::COLLECTION)
    ("EB" . SPARSER::PROTEIN)
    ("Sox17 and alpha-smooth muscle" . SPARSER::COLLECTION)
    ("stage-specific embryonic antigen 4 (SSEA4) and Tra-1-81 ( xref )"
     . SPARSER::COLLECTION)
    ("stage-specific embryonic antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tra" . SPARSER::PROTEIN) ("SSEA" . SPARSER::PROTEIN)
    ("Ctrl and A-T" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("Oct4/Klf4/Sox2/cMyc" . SPARSER::COLLECTION) ("cMyc" . SPARSER::PROTEIN)
    ("multiple neuronal genes" . SPARSER::GENE)
    ("-methyltransferase" . SPARSER::COLLECTION)
    ("the synaptic proteins VAMP2 and synapsin-1" . SPARSER::COLLECTION)
    ("VAMP2 and synapsin-1" . SPARSER::COLLECTION)
    ("Top1-cc" . SPARSER::COLLECTION) ("Top1-ccs" . SPARSER::COLLECTION)
    ("ccs" . SPARSER::PROTEIN)
    ("the genotoxic agents camptothecin and trabectedin" . SPARSER::COLLECTION)
    ("camptothecin and trabectedin" . SPARSER::COLLECTION)
    ("trabectedin" . SPARSER::DRUG) ("p53-S15" . SPARSER::COLLECTION)
    ("patch" . SPARSER::PROTEIN)
    ("synaptic markers SCG10, SYP and PSD95" . SPARSER::COLLECTION)
    ("SCG10, SYP and PSD95" . SPARSER::COLLECTION) ("SYP" . SPARSER::PROTEIN)
    ("DNA ligase" . SPARSER::PROTEIN)
    ("single-stranded DNA-binding protein" . SPARSER::PROTEIN)
    ("ATP 5" . SPARSER::PROTEIN) ("32P" . SPARSER::|32P|)
    ("P40" . SPARSER::PROTEIN) ("Oct 3" . SPARSER::PROTEIN)
    ("Fen1" . SPARSER::PROTEIN) ("TIF1 β" . SPARSER::PROTEIN)
    ("OCT3" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("B27" . SPARSER::PROTEIN) ("Synapsin-1" . SPARSER::PROTEIN)
    ("Topoisomerase I" . SPARSER::PROTEIN) ("γ -H2AX" . SPARSER::PROTEIN)
    ("SMC1" . SPARSER::PROTEIN) ("Flap endonuclease 1" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN) ("endonuclease 1" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("pS15" . SPARSER::PROTEIN)
    ("D53" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN)
    ("growth-associated protein" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN) ("MAP2" . SPARSER::PROTEIN)
    ("α -SMA" . SPARSER::PROTEIN) ("Sox17" . SPARSER::PROTEIN)
    ("Oct3" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("synapsin-1" . SPARSER::PROTEIN) ("VAMP2" . SPARSER::PROTEIN)
    ("Top1" . SPARSER::PROTEIN) ("topoisomerase 1" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("Kap1" . SPARSER::PROTEIN)
    ("Smc1" . SPARSER::PROTEIN) ("γ H2AX" . SPARSER::PROTEIN)
    ("postsynaptic density protein 95" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN) ("SCG10" . SPARSER::PROTEIN)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("β -tubulin" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("PML or NLS-K487R" . SPARSER::COLLECTION)
    ("nonmitochondrial substrates" . SPARSER::SUBSTRATE)
    ("NCOA2/GRIP1" . SPARSER::COLLECTION)
    ("PML, SIRT1, and SIRT5" . SPARSER::COLLECTION)
    ("SIRT1 and PML" . SPARSER::COLLECTION) ("Myc-SIRT1" . SPARSER::COLLECTION)
    ("FLAG-SUMO1" . SPARSER::COLLECTION)
    ("PML1 (K487R) and PML6 (K487R)" . SPARSER::COLLECTION)
    ("PML4 (K487R), PML1 (K487R) and PML6 (K487R)" . SPARSER::COLLECTION)
    ("PML1 and PML6" . SPARSER::COLLECTION)
    ("wild-type SIRT1 or the catalytically impaired mutant SIRT1"
     . SPARSER::COLLECTION)
    ("PML4" . SPARSER::PROTEIN) ("SIRT1 or SIRT5" . SPARSER::COLLECTION)
    ("HA-PML4 and wild-type SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 (H363Y) or SIRT5 (H158Y)" . SPARSER::COLLECTION)
    ("HA-PML4" . SPARSER::PROTEIN-PAIR) ("SIRT1/SIRT5" . SPARSER::COLLECTION)
    ("SIRT1, and SIRT5" . SPARSER::COLLECTION)
    ("carbamoyl" . SPARSER::MOLECULE) ("XPC" . SPARSER::PROTEIN)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY) ("prolyl" . SPARSER::PROTEIN)
    ("RBCC" . SPARSER::PROTEIN)
    ("the essential component" . SPARSER::COMPONENT)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIRT1 and SIRT5" . SPARSER::COLLECTION)
    ("promyelocytic leukemia protein (PML)" . SPARSER::PROTEIN)
    ("PML 1" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("GRIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NCOA2" . SPARSER::PROTEIN)
    ("nuclear receptor coactivator 2" . SPARSER::PROTEIN)
    ("peptidase activity" . SPARSER::PROTEIN)
    ("N -ethylmaleimide" . SPARSER::MOLECULE) ("K65" . SPARSER::PROTEIN)
    ("PML1" . SPARSER::PROTEIN) ("CPS1" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("xeroderma pigmentosum" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1 α" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("Pin1" . SPARSER::PROTEIN) ("trans isomerase" . SPARSER::PROTEIN)
    ("PHD and RING finger domains 1" . SPARSER::PROTEIN)
    ("UHRF1" . SPARSER::PROTEIN) ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("SIRT5" . SPARSER::PROTEIN) ("SUMO1" . SPARSER::PROTEIN)
    ("promyelocytic leukemia protein" . SPARSER::PROTEIN)
    ("ATG5 or ATG7" . SPARSER::COLLECTION)
    ("DOX-treated cells not expressing ATG5" . SPARSER::PROTEIN)
    ("mEF" . SPARSER::PROTEIN) ("further increased LC3-II" . SPARSER::PROTEIN)
    ("BIRC5/survivin" . SPARSER::COLLECTION) ("ATG7" . SPARSER::PROTEIN)
    ("ATG12" . SPARSER::PROTEIN) ("ATG5" . SPARSER::PROTEIN)
    ("Akt and Src" . SPARSER::COLLECTION) ("ER or PR" . SPARSER::COLLECTION)
    ("IGF or EGF" . SPARSER::COLLECTION)
    ("effectors, Akt and Src kinase" . SPARSER::COLLECTION)
    ("estradiol and progesterone" . SPARSER::COLLECTION)
    ("uterine myocyte contractile proteins" . SPARSER::PROTEIN)
    ("caspase 8 and downstream executioner caspases" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins, Bax and BAK" . SPARSER::COLLECTION)
    ("proteins, Bax and BAK" . SPARSER::COLLECTION)
    ("Src/STAT3" . SPARSER::COLLECTION) ("Src-STAT3" . SPARSER::COLLECTION)
    ("Src kinase and STAT3" . SPARSER::COLLECTION)
    ("Src kinase and the transcription factor STAT3" . SPARSER::COLLECTION)
    ("EGF, RASA, GRB2 and SHC" . SPARSER::COLLECTION)
    ("Src-STAT3-Mcl-1" . SPARSER::COLLECTION)
    ("Src and STAT3" . SPARSER::COLLECTION)
    ("Bcl2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Src and its downstream effector STAT3" . SPARSER::COLLECTION)
    ("EGF-Akt-Mcl-1" . SPARSER::COLLECTION)
    ("Mcl-1 or MIM1" . SPARSER::COLLECTION) ("EGF-Akt" . SPARSER::COLLECTION)
    ("EGF/Akt" . SPARSER::COLLECTION)
    ("increased phospho-SHC (p-SHC) and phospho-Akt (p-Akt)"
     . SPARSER::COLLECTION)
    ("p-SHC" . SPARSER::COLLECTION) ("first treated hTERT" . SPARSER::PROTEIN)
    ("factors (SRSF1, SRSF2, SRSF4, hnRNPM and hnRNPU) and proteins"
     . SPARSER::COLLECTION)
    ("EGF, SHC, PKC, GRB2 and RASA" . SPARSER::COLLECTION)
    ("SRSF1, SRSF2, SRSF4, hnRNPM and hnRNPU" . SPARSER::COLLECTION)
    ("NONO" . SPARSER::PROTEIN) ("hnRNPU" . SPARSER::PROTEIN)
    ("hnRNPM" . SPARSER::PROTEIN) ("RASA" . SPARSER::PROTEIN)
    ("UV light and the anti-Fas antibody ( xref )" . SPARSER::COLLECTION)
    ("CPT, UV light and the anti-Fas antibody ( xref )" . SPARSER::COLLECTION)
    ("CPT and UV" . SPARSER::COLLECTION)
    ("light or anti-Fas" . SPARSER::COLLECTION)
    ("c-CASP3" . SPARSER::COLLECTION) ("c-PARP1" . SPARSER::COLLECTION)
    ("CPT" . SPARSER::PROTEIN) ("Camptothecin" . SPARSER::DRUG)
    ("receptors and growth factors" . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("receptors and trigger" . SPARSER::COLLECTION)
    ("Akt and Ras" . SPARSER::COLLECTION)
    ("proteins, Bcl2 and Bcl2L1" . SPARSER::COLLECTION)
    ("PCNA and BrdU" . SPARSER::COLLECTION) ("caspases 3" . SPARSER::PROTEIN)
    ("WP1066" . SPARSER::DRUG) ("MIM1" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::DRUG) ("XRCC6" . SPARSER::PROTEIN)
    ("XRCC5" . SPARSER::PROTEIN) ("SRSF4" . SPARSER::PROTEIN)
    ("SRSF1" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("MDV3100" . SPARSER::DRUG) ("CASP3" . SPARSER::PROTEIN)
    ("Bcl2L" . SPARSER::PROTEIN) ("PFKFB3 and F26BP" . SPARSER::COLLECTION)
    ("Cdks and p27" . SPARSER::COLLECTION) ("APC/C" . SPARSER::PROTEIN)
    ("APC/C-Cdh1" . SPARSER::COLLECTION)
    ("Cdks and PFKFB3" . SPARSER::COLLECTION)
    ("oxygen- and glucose-poor microenvironments" . SPARSER::COLLECTION)
    ("oxygen-" . SPARSER::MOLECULE) ("Cdk1 and Cdk2" . SPARSER::COLLECTION)
    ("Cdk1 and p27" . SPARSER::COLLECTION) ("PO" . SPARSER::PROTEIN)
    ("p27 siRNA or both the PFKFB3 and p27 siRNA molecules"
     . SPARSER::COLLECTION)
    ("PFKFB3 and p27" . SPARSER::COLLECTION)
    ("our group and other laboratories" . SPARSER::COLLECTION)
    ("p57 and p21" . SPARSER::COLLECTION) ("p57 or p21" . SPARSER::COLLECTION)
    ("Cdh1" . SPARSER::PROTEIN) ("PFKFB3 and cyclin B1" . SPARSER::COLLECTION)
    ("Cdh" . SPARSER::PROTEIN) ("PX" . SPARSER::PROTEIN)
    ("enolase" . SPARSER::PROTEIN) ("Cdk1-" . SPARSER::PROTEIN)
    ("PFKFB" . SPARSER::PROTEIN) ("PFKFB3 and F2,6BP" . SPARSER::COLLECTION)
    ("HIF-1 α , Akt and PTEN" . SPARSER::COLLECTION)
    ("Pfk-1" . SPARSER::PROTEIN)
    ("guarantee sufficient ATP and anabolic substrates" . SPARSER::COLLECTION)
    ("anabolic substrates" . SPARSER::SUBSTRATE)
    ("triosephosphate isomerase" . SPARSER::PROTEIN)
    ("α -tubulin" . SPARSER::PROTEIN) ("CDKN1" . SPARSER::PROTEIN)
    ("fructose-2,6-bisphosphatase" . SPARSER::PROTEIN)
    ("phosphoglucose isomerase" . SPARSER::PROTEIN) ("Cdk1" . SPARSER::PROTEIN)
    ("HIF-1 α" . SPARSER::PROTEIN) ("PFKFB1" . SPARSER::PROTEIN)
    ("especially metastatic CRC" . SPARSER::PROTEIN)
    ("this mature miRNA" . SPARSER::MICRO-RNA)
    ("a tumor-suppressive miRNA" . SPARSER::MICRO-RNA)
    ("DNMT3A/DNMT3B" . SPARSER::COLLECTION)
    ("ERK or AKT" . SPARSER::COLLECTION) ("ERK and PI3K" . SPARSER::COLLECTION)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("DNMT" . SPARSER::PROTEIN) ("mesenchymal components" . SPARSER::COMPONENT)
    ("GC and inhibitor" . SPARSER::COLLECTION)
    ("simultaneously co-transfected SW480" . SPARSER::PROTEIN)
    ("pcDNA" . SPARSER::PROTEIN) ("miR-29b and Tiam1" . SPARSER::COLLECTION)
    ("miR-29b directly targets tumor metastasis-related gene Tiam1"
     . SPARSER::PROTEIN)
    ("mesenchymal marker Vimentin" . SPARSER::PROTEIN)
    ("E-cadherin and β -catenin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("ELL" . SPARSER::PROTEIN)
    ("pcDNA-GW" . SPARSER::PROTEIN-PAIR) ("GW" . SPARSER::PROTEIN)
    ("Transwell" . SPARSER::PROTEIN) ("Exogenous miR-29b" . SPARSER::MOLECULE)
    ("HAG" . SPARSER::PROTEIN) ("Hexane" . SPARSER::MOLECULE)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT"
     . SPARSER::COLLECTION)
    ("Texas Red" . SPARSER::DRUG)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNMT3B" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("TIAM1" . SPARSER::PROTEIN) ("KRT1" . SPARSER::PROTEIN)
    ("KIF5B" . SPARSER::PROTEIN) ("EIF3H" . SPARSER::PROTEIN)
    ("PDIA3" . SPARSER::PROTEIN) ("PSMD11" . SPARSER::PROTEIN)
    ("CCT2" . SPARSER::PROTEIN) ("polypeptide 1" . SPARSER::PROTEIN)
    ("LIM and SH3 protein 1" . SPARSER::PROTEIN)
    ("miR-339-5p" . SPARSER::MOLECULE) ("Tiam1" . SPARSER::PROTEIN)
    ("miR-29b" . SPARSER::MOLECULE) ("nonfunctional PTEN" . SPARSER::PROTEIN)
    ("NRAS, or PIK3CA" . SPARSER::COLLECTION)
    ("PTEN or AKT" . SPARSER::COLLECTION) ("EWG" . SPARSER::PROTEIN)
    ("Canadian Expert group" . SPARSER::MOLECULE)
    ("BRAF , NRAS , PIK3CA , PTEN, or AKT" . SPARSER::COLLECTION)
    ("showed longer PFS" . SPARSER::PROTEIN)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("EGFR, HER2, HER3, and c-MET" . SPARSER::COLLECTION)
    ("HER2 and HER3" . SPARSER::COLLECTION)
    ("KRAS , BRAF , and PI3KCA" . SPARSER::COLLECTION)
    ("a key tumor suppressor gene" . SPARSER::PROTEIN)
    ("PI3 K/PTEN/AKT" . SPARSER::COLLECTION) ("UFT" . SPARSER::DRUG)
    ("ftorafur" . SPARSER::DRUG) ("NCCN" . SPARSER::PROTEIN)
    ("ARAF" . SPARSER::PROTEIN)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("RAS/MAPK" . SPARSER::COLLECTION)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("PI3 K-PTEN-AKT" . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION)
    ("KRAS , NRAS , or BRAF" . SPARSER::COLLECTION)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION)
    ("BRAF , NRAS , PIK3CA , and PTEN" . SPARSER::COLLECTION)
    ("prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("anti- EGFR" . SPARSER::PROTEIN) ("miR-181a" . SPARSER::MOLECULE)
    ("miR-200a" . SPARSER::MOLECULE) ("Let-7" . SPARSER::RNA)
    ("single-stranded RNAs" . SPARSER::RNA) ("c-MET" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("nSH2" . SPARSER::PROTEIN)
    ("IMC-C225" . SPARSER::DRUG) ("SL" . SPARSER::PROTEIN)
    ("negative prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nuclear and membranous β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin-catenin" . SPARSER::COLLECTION) ("sentinel" . SPARSER::DRUG)
    ("abnormal expression membranous β-catenin" . SPARSER::PROTEIN)
    ("β-catenin or TAZ" . SPARSER::COLLECTION)
    ("β-catenin and downstream effectors" . SPARSER::COLLECTION)
    ("β-catenin and TAZ" . SPARSER::COLLECTION)
    ("the APC gene or the β-catenin gene" . SPARSER::COLLECTION)
    ("AXIN1 or AXIN2" . SPARSER::COLLECTION)
    ("Runx2, PPAR, TBX5, TEADs, TTF-1, and PAX3" . SPARSER::COLLECTION)
    ("TAZ and YAP" . SPARSER::COLLECTION) ("MOB" . SPARSER::PROTEIN)
    ("Salvador" . SPARSER::PROTEIN) ("TAZ and TAZ" . SPARSER::COLLECTION)
    ("TAZ or β-catenin" . SPARSER::COLLECTION)
    ("membranous β-catenin" . SPARSER::PROTEIN)
    ("TAZ and β-catenin" . SPARSER::COLLECTION)
    ("Transcriptional coactivator" . SPARSER::PROTEIN)
    ("WWP1" . SPARSER::PROTEIN) ("KLF5" . SPARSER::PROTEIN)
    ("Casein Kinase1" . SPARSER::PROTEIN) ("Dvl2" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("AXIN2" . SPARSER::PROTEIN)
    ("AXIN1" . SPARSER::PROTEIN) ("membrane component" . SPARSER::PROTEIN)
    ("PAX3" . SPARSER::PROTEIN) ("TTF-1" . SPARSER::PROTEIN)
    ("TBX5" . SPARSER::PROTEIN) ("protein kinase 1" . SPARSER::PROTEIN)
    ("STE20" . SPARSER::PROTEIN) ("WWTR1" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("K-ras and p38 MAPK" . SPARSER::COLLECTION)
    ("HBP1 and p16" . SPARSER::COLLECTION)
    ("ERK1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("ERK1/2, JNK1-3 and p38" . SPARSER::COLLECTION)
    ("invasive or metastatic PDAC" . SPARSER::PROTEIN)
    ("mutant K-ras and knockdown p16" . SPARSER::COLLECTION)
    ("these viral genes" . SPARSER::GENE) ("These viral genes" . SPARSER::GENE)
    ("small t antigens and HPV E6E7 genes" . SPARSER::COLLECTION)
    ("DNA tumor viral oncogenes" . SPARSER::ONCOGENE)
    ("TGFα and K-ras" . SPARSER::COLLECTION)
    ("K-Ras, EGFR, and EGFR" . SPARSER::COLLECTION)
    ("Erk1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("HER-2 and EGFR" . SPARSER::COLLECTION)
    ("p15, p21, and p27" . SPARSER::COLLECTION)
    ("inhibitors-" . SPARSER::INHIBITOR) ("CKIs" . SPARSER::PROTEIN)
    ("Oncogene" . SPARSER::ONCOGENE)
    ("N-cadherin, MMP2, and uPA" . SPARSER::COLLECTION)
    ("N-cadherin, MMP2 and uPA" . SPARSER::COLLECTION)
    ("cytokeratin-19, E-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("transwell-matrigel" . SPARSER::PROTEIN-PAIR)
    ("cyclins and c-Myc" . SPARSER::COLLECTION)
    ("nearly all the E2F" . SPARSER::PROTEIN)
    ("cyclin D1, cyclin E, cyclin B1, and c-Myc" . SPARSER::COLLECTION)
    ("K-ras and p16" . SPARSER::COLLECTION)
    ("the mutant K-ras and inactivated p16" . SPARSER::COLLECTION)
    ("p16 and p14ARF" . SPARSER::COLLECTION)
    ("p16 and p14" . SPARSER::COLLECTION) ("-Rb" . SPARSER::COLLECTION)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mutated K-ras (K-ras G12V ) and p16 shRNA" . SPARSER::COLLECTION)
    ("antibiotic" . SPARSER::DRUG) ("K-ras and p16shRNA" . SPARSER::COLLECTION)
    ("/p16shRNA" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("unrelated viral oncogenes" . SPARSER::ONCOGENE)
    ("PDCA" . SPARSER::PROTEIN) ("the viral oncogenes" . SPARSER::ONCOGENE)
    ("p16/INK4A/p14ARF" . SPARSER::COLLECTION)
    ("p16INK4A/p14ARF" . SPARSER::COLLECTION)
    ("mutated K-ras and inactivated p16" . SPARSER::COLLECTION)
    ("p38/MAPK" . SPARSER::COLLECTION) ("metastatic PDAC" . SPARSER::PROTEIN)
    ("rasV12" . SPARSER::DRUG) ("G 2 /M" . SPARSER::PROTEIN)
    ("p-Rb" . SPARSER::PROTEIN) ("X-Gal" . SPARSER::MOLECULE)
    ("X-gal" . SPARSER::MOLECULE) ("β-gal" . SPARSER::PROTEIN)
    ("MCM3" . SPARSER::PROTEIN) ("RFC1" . SPARSER::PROTEIN)
    ("HBP1" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("cytokeratin-19" . SPARSER::PROTEIN) ("c-K-ras" . SPARSER::PROTEIN)
    ("small t antigen" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("p16INK4A" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("histologic type" . TYPE)
    ("identifying predominant subtypes" . SPARSER::PROTEIN)
    ("a smaller cohort" . SPARSER::MOLECULE)
    ("MIA, and KRAS" . SPARSER::COLLECTION) ("FISH-" . SPARSER::PROTEIN)
    ("mucin, and cribriform" . SPARSER::COLLECTION)
    ("mucin and KRAS" . SPARSER::COLLECTION)
    ("the other mucinous subtypes" . SPARSER::PROTEIN)
    ("specific histologic subtypes" . SPARSER::PROTEIN)
    ("nonmucinous subtype" . SPARSER::PROTEIN)
    ("subtypes and EGFR" . SPARSER::COLLECTION)
    ("the other predominant subtypes" . SPARSER::PROTEIN)
    ("nonmucinous MIA" . SPARSER::PROTEIN)
    ("One mucinous MIA" . SPARSER::PROTEIN)
    ("Mucinous subtype" . SPARSER::PROTEIN)
    ("subtypes and EGFR and KRAS" . SPARSER::COLLECTION)
    ("2 nonmucinous MIA" . SPARSER::PROTEIN)
    ("31 nonmucinous MIA" . SPARSER::PROTEIN)
    ("nonmucinous subtypes" . SPARSER::PROTEIN)
    ("1 mucinous MIA" . SPARSER::PROTEIN)
    ("mucinous subtypes" . SPARSER::PROTEIN)
    ("Histologic Subtypes" . SPARSER::PROTEIN)
    ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("EGFR or KRAS" . SPARSER::COLLECTION) ("Extracellular" . SPARSER::PROTEIN)
    ("predominant histologic subtype" . SPARSER::PROTEIN)
    ("EGFR and KRAS" . SPARSER::COLLECTION) ("PL2" . SPARSER::PROTEIN)
    ("PL1" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("receptors, FLT1 and KDR" . SPARSER::COLLECTION)
    ("DNA methyltransferase, and Polycomb proteins as well as chromatin-remodeling"
     . SPARSER::COLLECTION)
    ("histone deacetylase 1 (HDAC1), DNA methyltransferase, and Polycomb proteins as well as chromatin-remodeling"
     . SPARSER::COLLECTION)
    ("DNA methyltransferase, and Polycomb" . SPARSER::COLLECTION)
    ("Brm" . SPARSER::PROTEIN) ("Polycomb" . SPARSER::PROTEIN)
    ("the salient promoters" . SPARSER::PROMOTER)
    ("14-3-3-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("maspin" . SPARSER::PROTEIN)
    ("sigma" . SPARSER::PROTEIN-FAMILY)
    ("many invasive breast carcinomas essentially lack MEPCs" . SPARSER::DRUG)
    ("KDR and FLT-1" . SPARSER::COLLECTION)
    ("receptors, KDR and FLT-1" . SPARSER::COLLECTION)
    ("Rb-LP" . SPARSER::COLLECTION) ("LP" . SPARSER::PROTEIN)
    ("MMP2, MMP9, MMP14, and MMP15" . SPARSER::COLLECTION)
    ("E2F1 and KDM2A" . SPARSER::COLLECTION)
    ("MMP9, MMP14 and MMP15" . SPARSER::COLLECTION)
    ("MM9, MMP15 and MMP15" . SPARSER::COLLECTION)
    ("MMPs and VEGF" . SPARSER::COLLECTION)
    ("an anti-KDM2A antibody and the DNA" . SPARSER::COLLECTION)
    ("CDC25A (cell cycle division homolog 25A) or TS (Thymidylate Synthase)"
     . SPARSER::COLLECTION)
    ("E2F1 and Rb" . SPARSER::COLLECTION) ("sharp" . SPARSER::PROTEIN)
    ("a secondary anti-Rabbit IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Actin" . SPARSER::PROTEIN) ("GST-E2F1" . SPARSER::COLLECTION)
    ("GST-Rb" . SPARSER::COLLECTION) ("sepharose" . SPARSER::MOLECULE)
    ("Rb or E2F1" . SPARSER::COLLECTION) ("DAPI" . SPARSER::DRUG)
    ("KDM2A and E2F1" . SPARSER::COLLECTION) ("Rb-E2F1" . SPARSER::COLLECTION)
    ("many vital genes" . SPARSER::GENE)
    ("VEGF receptors and certain MMPs" . SPARSER::COLLECTION)
    ("FLT-1 and KDR" . SPARSER::COLLECTION)
    ("a control siRNA or two independent siRNAs" . SPARSER::COLLECTION)
    ("the heterochromatic state" . SPARSER::BIO-STATE)
    ("higher eukaryotic genes" . SPARSER::GENE) ("LSD" . SPARSER::PROTEIN)
    ("Demethylase" . SPARSER::PROTEIN) ("FLT1 and KDR" . SPARSER::COLLECTION)
    ("CDC25A and TS" . SPARSER::COLLECTION)
    ("Rb and E2F1" . SPARSER::COLLECTION)
    ("receptors, FLT-1 and KDR" . SPARSER::COLLECTION)
    ("MEPCs" . SPARSER::DRUG) ("demethylase" . SPARSER::PROTEIN)
    ("demethylases" . SPARSER::PROTEIN) ("PHF8" . SPARSER::PROTEIN)
    ("KDM7B" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("KMT6" . SPARSER::PROTEIN) ("DNA methyltransferase" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN) ("DUSP3" . SPARSER::PROTEIN)
    ("Thymidylate Synthase" . SPARSER::PROTEIN) ("- 3 " . SPARSER::PROTEIN)
    ("and 1 " . SPARSER::PROTEIN) ("MMP15" . SPARSER::PROTEIN)
    ("MMP14" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("KDM2" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KIAA0601" . SPARSER::PROTEIN)
    ("AOF2" . SPARSER::PROTEIN) ("BHC110" . SPARSER::PROTEIN)
    ("KDM1" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("FLT-1" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("JHDM1A" . SPARSER::PROTEIN)
    ("KDM2A" . SPARSER::PROTEIN) ("a valuable molecule" . SPARSER::MOLECULE)
    ("SAPK/JNK" . SPARSER::COLLECTION)
    ("kinase, and extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("JNK and C-jun" . SPARSER::COLLECTION)
    ("kinase or ERK" . SPARSER::COLLECTION)
    ("RAS-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S26 or SUNE-1" . SPARSER::COLLECTION) ("cisplatin-" . SPARSER::DRUG)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("cleaved-PARP or caspase 3" . SPARSER::COLLECTION)
    ("AAD" . SPARSER::PROTEIN) ("low metastatic S26" . SPARSER::PROTEIN)
    ("S18 or 5-8F" . SPARSER::COLLECTION)
    ("cisplatin or radiation treatment" . SPARSER::COLLECTION)
    ("S18 and 5-8F" . SPARSER::COLLECTION)
    ("cisplatin and radiation treatment" . SPARSER::COLLECTION)
    ("NPCs" . SPARSER::MOLECULE) ("S18 and S26" . SPARSER::COLLECTION)
    ("RASSF" . SPARSER::PROTEIN-FAMILY) ("RASSFs" . SPARSER::PROTEIN-FAMILY)
    ("synthetase, matrix metalloproteinase 19, and eIF3a"
     . SPARSER::COLLECTION)
    ("synthetase" . SPARSER::PROTEIN) ("asparagine" . SPARSER::AMINO-ACID)
    ("cisplatin-base" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VP-16" . SPARSER::DRUG) ("C-jun" . SPARSER::PROTEIN)
    ("sh-RNAs" . SPARSER::RNA) ("RASSF7" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("RASSF5" . SPARSER::PROTEIN)
    ("RASSF4" . SPARSER::PROTEIN) ("RASSF2" . SPARSER::PROTEIN)
    ("S26" . SPARSER::PROTEIN) ("S18" . SPARSER::PROTEIN)
    ("matrix metalloproteinase 19" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("RASSF6" . SPARSER::PROTEIN)
    ("Ras association domain family member 6" . SPARSER::PROTEIN)
    ("MYOCD, SRF, BAD and SRC" . SPARSER::COLLECTION)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("ACTC1 , ACTA2 , ACTN1 , CALD1 , CNN1 , MYLK , MYL9 , DMD , SGCA , TAGLN , TPM1 , TPM2 and SMTN"
     . SPARSER::COLLECTION)
    ("SMTN" . SPARSER::PROTEIN) ("SGCA" . SPARSER::PROTEIN)
    ("ACTG2 , CALD1 , DMD , MYOCD , MYLK , SRF and TAGLN"
     . SPARSER::COLLECTION)
    ("TAGLN" . SPARSER::PROTEIN) ("DMD" . SPARSER::PROTEIN)
    ("Almost all genes" . SPARSER::GENE)
    ("22 UPS and 22 LMS" . SPARSER::COLLECTION)
    ("the same histological subtype" . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("30 LMS and 36 UPS" . SPARSER::COLLECTION)
    ("22 LMS and two UPS ( P <0.001)" . SPARSER::COLLECTION)
    ("LMS-NR" . SPARSER::COLLECTION) ("NR" . SPARSER::PROTEIN)
    ("SRF , SRC and BAD" . SPARSER::COLLECTION)
    ("BAD , SRC , SRF and MYOCD" . SPARSER::COLLECTION)
    ("BAD, SRC, SRF , and MYOCD" . SPARSER::COLLECTION)
    ("ACTN1, AR, FLNA and MUC1" . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION)
    ("FLNA , MEF2C , CHEK1 and BAD" . SPARSER::COLLECTION)
    ("FLNA" . SPARSER::PROTEIN)
    ("ILK , CXCL1 , LAMA5 and SRC" . SPARSER::COLLECTION)
    ("ILK" . SPARSER::PROTEIN)
    ("ACTA2 , MYLK , MYOCD and SRF" . SPARSER::COLLECTION)
    ("MYLK" . SPARSER::PROTEIN) ("Only two LMS" . SPARSER::PROTEIN)
    ("the retroperitoneal LMS" . SPARSER::PROTEIN)
    ("UPS and LMS" . SPARSER::COLLECTION)
    ("well-differentiated LMS" . SPARSER::PROTEIN)
    ("transgelin and sirtuin" . SPARSER::COLLECTION)
    ("h-caldesmon" . SPARSER::COLLECTION) ("transgelin" . SPARSER::PROTEIN)
    ("caldesmon" . SPARSER::PROTEIN) ("MFH" . SPARSER::PROTEIN)
    ("STS" . SPARSER::PROTEIN) ("Retroperitoneal LMS" . SPARSER::PROTEIN)
    ("BAD , SRC , SRF , and MYOCD" . SPARSER::COLLECTION)
    ("retroperitoneal LMS" . SPARSER::PROTEIN)
    ("LMS and UPS" . SPARSER::COLLECTION)
    ("38 UPS and 52 LMS" . SPARSER::COLLECTION)
    ("BAD , MYOCD , SRF and SRC" . SPARSER::COLLECTION)
    ("SRF" . SPARSER::PROTEIN) ("MYOCD" . SPARSER::PROTEIN)
    ("22 LMS and 22 UPS" . SPARSER::COLLECTION) ("LMS" . SPARSER::PROTEIN)
    ("UPS" . SPARSER::PROTEIN) ("TPM2" . SPARSER::PROTEIN)
    ("TPM1" . SPARSER::PROTEIN) ("MYL9" . SPARSER::PROTEIN)
    ("CNN1" . SPARSER::PROTEIN) ("ACTC1" . SPARSER::PROTEIN)
    ("CALD1" . SPARSER::PROTEIN) ("ACTG2" . SPARSER::PROTEIN)
    ("ACTN1" . SPARSER::PROTEIN) ("CHEK1" . SPARSER::PROTEIN)
    ("MEF2C" . SPARSER::PROTEIN) ("LAMA5" . SPARSER::PROTEIN)
    ("ACTA2" . SPARSER::PROTEIN)
    ("a prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prostaglandin" . SPARSER::PROTEIN)
    ("the crucial prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NSAIDs" . SPARSER::DRUG) ("complex (SABC)" . SPARSER::BIO-COMPLEX)
    ("streptavidin-peroxidase" . SPARSER::COLLECTION)
    ("COX2-positive group ( n = 157) and COX2-negative group ( n = 254)"
     . SPARSER::COLLECTION)
    ("prostaglandin E2 and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("COX" . SPARSER::PROTEIN)
    ("a complex and multifactorial disease which may be induced by the interaction of genetic and environmental factors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Stata" . SPARSER::PROTEIN) ("STATA" . SPARSER::PROTEIN)
    ("synthase 2" . SPARSER::PROTEIN) ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("PTGS-2" . SPARSER::PROTEIN) ("Cyclo-Oxygenase" . SPARSER::PROTEIN)
    ("Cyclooxygenase 2" . SPARSER::PROTEIN)
    ("pre-treatment predictive pharmacodynamics biomarkers"
     . SPARSER::MOLECULE)
    ("pre- and post-treatment" . SPARSER::COLLECTION)
    ("erlotinib or crizotinib" . SPARSER::COLLECTION)
    ("EML4-ALK" . SPARSER::COLLECTION)
    ("a broadly acting DNA intercalator" . SPARSER::MOLECULE)
    ("intercalator" . SPARSER::MOLECULE)
    ("treatment response pharmacodynamic biomarkers" . SPARSER::MOLECULE)
    ("SSRP1 and SPT16" . SPARSER::COLLECTION)
    ("MYC (MYC, MYCN) and SP/KLF (SP1, KLF4) families ( xref )"
     . SPARSER::COLLECTION)
    ("the EGR (EGR1), ETS (ELK1, ELK4, GABPA, SPI1), MYC (MYC, MYCN) and SP/KLF (SP1, KLF4) families ( xref )"
     . SPARSER::COLLECTION)
    ("SP/KLF" . SPARSER::COLLECTION) ("KLF" . SPARSER::PROTEIN)
    ("MYCN" . SPARSER::PROTEIN) ("GABPA" . SPARSER::PROTEIN)
    ("EGR" . SPARSER::PROTEIN)
    ("1 µM erlotinib and 5 or 3 µM quinacrine" . SPARSER::COLLECTION)
    ("SSRP1-regulated genes and cell cycle genes" . SPARSER::COLLECTION)
    ("quinacrine and erlotinib" . SPARSER::COLLECTION)
    ("Quinacrine and chloroquine" . SPARSER::COLLECTION)
    ("the insoluble chromatin fraction" . SPARSER::COMPONENT)
    ("the soluble cytoplasmic fraction" . SPARSER::COMPONENT)
    ("Luciferase" . SPARSER::PROTEIN)
    ("quinacrine or chloroquine" . SPARSER::COLLECTION)
    ("NF-κB-luciferase" . SPARSER::COLLECTION)
    ("chloroquine and quinacrine" . SPARSER::COLLECTION)
    ("erlotinib or quinacrine" . SPARSER::COLLECTION)
    ("Annexin V-PI" . SPARSER::COLLECTION)
    ("1 µM erlotinib and either 5 µM" . SPARSER::COLLECTION)
    ("a major EGFR-TKI" . SPARSER::PROTEIN) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("erlotinib and quinacrine" . SPARSER::COLLECTION) ("IIIB" . SPARSER::DRUG)
    ("the FACT-associated kinase CK2" . SPARSER::PROTEIN)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("the structure-specific recognition protein (SSRP1) and suppressor"
     . SPARSER::COLLECTION)
    ("the structure-specific recognition protein" . SPARSER::PROTEIN)
    ("p53 and inhibitors" . SPARSER::COLLECTION)
    ("aminoacridines" . SPARSER::DRUG)
    ("alternative receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mut" . SPARSER::PROTEIN) ("a reversible TKI" . SPARSER::PROTEIN)
    ("Cytotoxic" . SPARSER::PROTEIN) ("Quinacrine" . SPARSER::DRUG)
    ("FACT" . SPARSER::PROTEIN) ("quinacrine" . SPARSER::DRUG)
    ("Erlotinib" . SPARSER::DRUG) ("EML4" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN) ("SPI1" . SPARSER::PROTEIN)
    ("ELK4" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("EGR1" . SPARSER::PROTEIN) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("Gene 2" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("SPT16" . SPARSER::PROTEIN)
    ("SSRP1" . SPARSER::PROTEIN)
    ("platinum and gemcitabine" . SPARSER::COLLECTION)
    ("negative predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smit" . SPARSER::PROTEIN)
    ("TS (both 5′-UTR VNTR and G>C polymorphism within the third VNTR) and MTHFR genes"
     . SPARSER::COLLECTION)
    ("carboplatin or pemetrexed" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG)
    ("significantly longer PFS" . SPARSER::PROTEIN)
    ("2R and 3R alleles as well as alleles" . SPARSER::COLLECTION)
    ("gene and deletion/insertion" . SPARSER::COLLECTION)
    ("MTHFR as well as ERCC1 enzymes" . SPARSER::COLLECTION)
    ("had statistically significant prognostic impact" . SPARSER::PROTEIN)
    ("gemcitabine ( n  = 862) or cisplatin" . SPARSER::COLLECTION)
    ("n  " . SPARSER::PROTEIN)
    ("clinical prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TS gene and two C alleles" . SPARSER::COLLECTION)
    ("PSF" . SPARSER::PROTEIN)
    ("TS gene ( TSER ) and a single nucleotide polymorphism (G>C)"
     . SPARSER::COLLECTION)
    ("TSER" . SPARSER::GENE)
    ("Several polymorphic variants" . SPARSER::VARIANT)
    ("TS and MTHFR" . SPARSER::COLLECTION) ("good PS" . SPARSER::PROTEIN)
    ("only one allele" . SPARSER::ALLELE) ("Guanine" . SPARSER::PROTEIN)
    ("heterozygotes" . SPARSER::PROTEIN) ("gene ( TSER )" . SPARSER::PROTEIN)
    ("methyltetrahydrofolate" . SPARSER::MOLECULE)
    ("methylenetetrahydrofolate" . SPARSER::MOLECULE)
    ("purine and pyrimidine" . SPARSER::COLLECTION)
    ("Enzyme" . SPARSER::ENZYME) ("folates" . SPARSER::MOLECULE)
    ("folate" . SPARSER::MOLECULE)
    ("this histologic subtype" . SPARSER::PROTEIN)
    ("TS, DHFR and GARFT" . SPARSER::COLLECTION)
    ("pemetrexed, and pemetrexed" . SPARSER::COLLECTION)
    ("DHFR" . SPARSER::PROTEIN) ("pyrimidine and purine" . SPARSER::COLLECTION)
    ("a novel cytostatic drug" . SPARSER::DRUG) ("Pemetrexed" . SPARSER::DRUG)
    ("predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERCC1 and other NER enzymes" . SPARSER::COLLECTION)
    ("Platinum" . SPARSER::MOLECULE)
    ("new 3rd generation drugs" . SPARSER::DRUG)
    ("gemcitabine or vinorelbine" . SPARSER::COLLECTION)
    ("vinorelbine" . SPARSER::DRUG) ("pemetrexed-" . SPARSER::DRUG)
    ("poor PS" . SPARSER::PROTEIN)
    ("TS and two C alleles" . SPARSER::COLLECTION)
    ("synchronous 3R allele" . SPARSER::ALLELE)
    ("platinum and pemetrexed" . SPARSER::COLLECTION)
    ("TS , MTHFR and ERCC1" . SPARSER::COLLECTION)
    ("pemetrexed and platinum" . SPARSER::COLLECTION)
    ("front-line" . SPARSER::PROTEIN) ("MTHFR" . SPARSER::PROTEIN)
    ("Thymidylate synthase" . SPARSER::PROTEIN)
    ("methylenetetrahydrofolate reductase" . SPARSER::PROTEIN)
    ("dihydrofolate reductase" . SPARSER::PROTEIN) ("MH" . SPARSER::PROTEIN)
    ("CYS" . SPARSER::PROTEIN) ("KCL" . SPARSER::MOLECULE)
    ("MLK" . SPARSER::PROTEIN)
    ("This study not only sheds light" . SPARSER::PROTEIN)
    ("ERK-TSC-mTOR" . SPARSER::COLLECTION) ("Threonine" . SPARSER::AMINO-ACID)
    ("TSC" . SPARSER::PROTEIN) ("RAS-RAF-MEK-ERK-MAPK" . SPARSER::COLLECTION)
    ("a dual serine-threonine/tyrosine phosphatase" . SPARSER::PROTEIN)
    ("JNK, p38, and ERK" . SPARSER::COLLECTION)
    ("serine-threonine/tyrosine" . SPARSER::COLLECTION)
    ("the G9a-associated transcriptional complex" . SPARSER::BIO-COMPLEX)
    ("serine-glycine biosynthetic genes PHGDH and SHMT" . SPARSER::COLLECTION)
    ("PHGDH and SHMT" . SPARSER::COLLECTION)
    ("serine-glycine" . SPARSER::COLLECTION) ("SHMT" . SPARSER::PROTEIN)
    ("PHGDH" . SPARSER::PROTEIN) ("AMPK and TSC1/2" . SPARSER::COLLECTION)
    ("G9a-GLP" . SPARSER::COLLECTION)
    ("valuable epigenetic targets" . SPARSER::TARGET-PROTEIN)
    ("romidepsin" . SPARSER::DRUG)
    ("insulin-like growth factor binding protein (IGFBP)" . SPARSER::PROTEIN)
    ("LC3-II and DUSP4" . SPARSER::COLLECTION)
    ("DUSP4 and G9a" . SPARSER::COLLECTION)
    ("G9a and DUSP4" . SPARSER::COLLECTION) ("genes " . SPARSER::GENE)
    ("ERK-mTOR" . SPARSER::COLLECTION) ("p-S6K" . SPARSER::PROTEIN)
    ("chloroquine (CQ)" . SPARSER::PROTEIN) ("DN-G9a" . SPARSER::COLLECTION)
    ("the poly ADP-ribose polymerase (PARP) and caspase-3"
     . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("Annexin V and PI" . SPARSER::COLLECTION)
    ("a heteromeric complex" . SPARSER::BIO-COMPLEX) ("GLP" . SPARSER::PROTEIN)
    ("SAS" . SPARSER::PROTEIN) ("whose G9a" . SPARSER::PROTEIN)
    ("G9a and Ki-67" . SPARSER::COLLECTION)
    ("proteins or organelles" . SPARSER::COLLECTION)
    ("an abnormal H3K9" . SPARSER::PROTEIN)
    ("euchromatin" . SPARSER::BIO-COMPLEX) ("anti-S" . SPARSER::ANTIBODY)
    ("ki67" . SPARSER::PROTEIN) ("MKP-2" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase phosphatase-2" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("BNIP3" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("BIX-01294" . SPARSER::DRUG)
    ("DUSP4" . SPARSER::PROTEIN) ("G9a" . SPARSER::PROTEIN)
    ("present heterozygous genotype Arg/Pro" . SPARSER::COLLECTION)
    ("Arg/Pro" . SPARSER::COLLECTION) ("BRCA2 and p53" . SPARSER::COLLECTION)
    ("Pro heterozygous variant" . SPARSER::VARIANT)
    ("heterozygous Arg" . SPARSER::AMINO-ACID)
    ("the heterozygous Arg" . SPARSER::AMINO-ACID)
    ("any possible p53 gene isoform" . SPARSER::ISOFORM)
    ("UI" . SPARSER::PROTEIN)
    ("arginine (Arg) and proline (Pro)" . SPARSER::COLLECTION)
    ("two distinct functional allelic forms" . SPARSER::FORM)
    ("Pro and Arg" . SPARSER::COLLECTION) ("CpGs" . SPARSER::PROTEIN)
    ("potential auxiliary biomarker" . SPARSER::MOLECULE)
    ("at least 13 different proteins" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("shorter CAG alleles" . SPARSER::ALLELE) ("glycine" . SPARSER::AMINO-ACID)
    ("AR (CAG)" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Afro" . SPARSER::PROTEIN)
    ("shorter alleles and ≤ 22.5" . SPARSER::COLLECTION)
    ("the shorter alleles" . SPARSER::ALLELE)
    ("longer AR CAG alleles" . SPARSER::ALLELE)
    ("The total AR CAG alleles (≤22 repeats) and shorter AR CAG alleles (≤22 repeats)"
     . SPARSER::COLLECTION)
    ("shorter GGN" . SPARSER::PROTEIN) ("GGC" . SPARSER::PROTEIN)
    ("GGG" . SPARSER::MOLECULE) ("polyglycine" . SPARSER::MOLECULE)
    ("polyglutamine" . SPARSER::MOLECULE)
    ("lipoprotein, the vascular endothelium and smooth muscle, and blood coagulation"
     . SPARSER::COLLECTION)
    ("Androgens" . SPARSER::DRUG) ("PCOS" . SPARSER::PROTEIN)
    ("Hormonal factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nutritional, and environmental factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immunologic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Some known aetiologic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the RSA group and the control" . SPARSER::COLLECTION)
    ("longer alleles" . SPARSER::ALLELE) ("shorter alleles" . SPARSER::ALLELE)
    ("shorter AR CAG alleles" . SPARSER::ALLELE) ("GGN" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN) ("CM" . SPARSER::PROTEIN)
    ("Prolactin" . SPARSER::PROTEIN) ("Dopamine" . SPARSER::DRUG)
    ("VEGF and MGMT" . SPARSER::COLLECTION)
    ("MGMT and VEGF" . SPARSER::COLLECTION) ("Octreotide" . SPARSER::DRUG)
    ("prolactin" . SPARSER::PROTEIN) ("almost all subtypes" . SPARSER::PROTEIN)
    ("cabergoline and bromocriptine" . SPARSER::COLLECTION)
    ("cabergoline" . SPARSER::DRUG) ("recurrent PA" . SPARSER::PROTEIN)
    ("bromocriptine" . SPARSER::MOLECULE)
    ("PRL, GH, ACTH, TSH and FSH" . SPARSER::COLLECTION)
    ("TSH" . SPARSER::PROTEIN)
    ("DAs, TMZ and Bevacizumab" . SPARSER::COLLECTION)
    ("Temozolomide (TMZ) and Bevacizumab" . SPARSER::COLLECTION)
    ("Bevacizumab" . SPARSER::DRUG) ("Temozolomide" . SPARSER::DRUG)
    ("somatostatin analogs (SSAs) or combinations" . SPARSER::COLLECTION)
    ("SSAs" . SPARSER::PROTEIN) ("DAs" . SPARSER::MOLECULE)
    ("VEGF, TMZ or bevacizumab" . SPARSER::COLLECTION) ("TMZ" . SPARSER::DRUG)
    ("FSH" . SPARSER::PROTEIN) ("ACTH" . SPARSER::PROTEIN)
    ("PRL- and GH-" . SPARSER::COLLECTION) ("GH-" . SPARSER::PROTEIN)
    ("PRL-" . SPARSER::PROTEIN) ("GH" . SPARSER::PROTEIN)
    ("PRL" . SPARSER::PROTEIN)
    ("197 different histological subtypes" . SPARSER::PROTEIN)
    ("temozolomide and bevacizumab" . SPARSER::COLLECTION)
    ("Thyroid stimulating hormone" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Adrenocorticotropic hormone" . SPARSER::PROTEIN)
    ("Growth hormone" . SPARSER::PROTEIN)
    ("Dopamine D2 receptor" . SPARSER::PROTEIN) ("A–F" . SPARSER::PROTEIN)
    ("O6-methylguanine DNA methyltransferase" . SPARSER::PROTEIN)
    ("a very strong predicting factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a novel promising prognostic biomarker" . SPARSER::MOLECULE)
    ("ETP-" . SPARSER::PROTEIN)
    ("other prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("other traditional factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the most relevant prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a relevant prognostic biomarker" . SPARSER::MOLECULE)
    ("this larger cohort" . SPARSER::MOLECULE)
    ("a dominant-negative PKCα" . SPARSER::PROTEIN)
    ("its prognostic impact" . SPARSER::PROTEIN)
    ("new prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the most powerful independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HG" . SPARSER::MOLECULE)
    ("no other prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HR and IR" . SPARSER::COLLECTION)
    ("Prognostic impact" . SPARSER::PROTEIN) ("PPR" . SPARSER::PROTEIN)
    ("T-ALL prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SE" . SPARSER::PROTEIN) ("mRNA and patient" . SPARSER::COLLECTION)
    ("EFS and CIR" . SPARSER::COLLECTION) ("CIR" . SPARSER::PROTEIN)
    ("EFS" . SPARSER::PROTEIN)
    ("early T-cell precursor acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("ETP" . SPARSER::PROTEIN) ("RQ" . SPARSER::MOLECULE)
    ("anti - β" . SPARSER::PROTEIN) ("anti –" . SPARSER::ANTIBODY)
    ("PKC α" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("IGF-IR/PI3K" . SPARSER::COLLECTION)
    ("sirolimus, temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("IGF-1R/mTOR" . SPARSER::COLLECTION)
    ("UVRAG and other ATG genes" . SPARSER::COLLECTION) ("ATG" . SPARSER::DRUG)
    ("UVRAG" . SPARSER::PROTEIN)
    ("MitoTracker Deep Red FM (MTRed) and MitoTracker Green FM (MTGreen)"
     . SPARSER::COLLECTION)
    ("FM" . SPARSER::PROTEIN) ("iodide (PI)" . SPARSER::PROTEIN)
    ("CQ" . SPARSER::PROTEIN)
    ("sequence-specific inhibitor" . SPARSER::INHIBITOR)
    ("anti-miR-NC" . SPARSER::COLLECTION)
    ("NC-transfectants" . SPARSER::COLLECTION)
    ("Beclin-1 and Atg7" . SPARSER::COLLECTION)
    ("PLK1, mTOR, IGF-1R, FKBP5 and RBSP3" . SPARSER::COLLECTION)
    ("PI3K, Akt and mTOR" . SPARSER::COLLECTION)
    ("IGF-1R/EGFR" . SPARSER::COLLECTION) ("Atg" . SPARSER::DRUG)
    ("mTOR or IGF-1R" . SPARSER::COLLECTION)
    ("mTOR and IGF-1R" . SPARSER::COLLECTION) ("SP5" . SPARSER::PROTEIN)
    ("EF1" . SPARSER::PROTEIN) ("S6K1" . SPARSER::PROTEIN)
    ("OSU-03012" . SPARSER::DRUG) ("concanavalin A" . SPARSER::DRUG)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("RBSP3" . SPARSER::PROTEIN)
    ("FKBP5" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("Atg7" . SPARSER::PROTEIN)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("a vital effector" . SPARSER::EFFECTOR)
    ("SHP2 and KIT" . SPARSER::COLLECTION)
    ("SHP2 and PI3K" . SPARSER::COLLECTION)
    ("kinase and Stat5" . SPARSER::COLLECTION)
    ("mature MCs" . SPARSER::PROTEIN) ("Ras/ERK" . SPARSER::COLLECTION)
    ("SHP2 and tyrosine kinase" . SPARSER::COLLECTION)
    ("KIT and FLT3" . SPARSER::COLLECTION)
    ("ERK, Stat5, Lyn and Btk" . SPARSER::COLLECTION)
    ("ponatinib and Dasatinib" . SPARSER::COLLECTION)
    ("Lyn, Stat5 and Btk" . SPARSER::COLLECTION)
    ("Tec/Btk" . SPARSER::COLLECTION) ("Tec" . SPARSER::PROTEIN)
    ("neoplastic MCs" . SPARSER::PROTEIN) ("MCs" . SPARSER::PROTEIN)
    ("Erk and Stat5" . SPARSER::COLLECTION)
    ("semisolid methyl cellulose media" . SPARSER::PROTEIN)
    ("DMSO or SHP2" . SPARSER::COLLECTION)
    ("P815-KD or sham" . SPARSER::COLLECTION)
    ("P815-NT and P815-KD" . SPARSER::COLLECTION)
    ("P815-NT or P815-KD" . SPARSER::COLLECTION)
    ("exogenous cytokines or colony-stimulating factors" . SPARSER::COLLECTION)
    ("colony-stimulating factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous cytokines" . SPARSER::PROTEIN)
    ("methylcellulose" . SPARSER::DRUG) ("EL" . SPARSER::PROTEIN)
    ("Lyn and Btk" . SPARSER::COLLECTION) ("Puromycin" . SPARSER::DRUG)
    ("ERK, Btk, Lyn and STAT5" . SPARSER::COLLECTION)
    ("Ras/MEK/ERK" . SPARSER::COLLECTION) ("spi-1" . SPARSER::PROTEIN)
    ("SH2" . SPARSER::PROTEIN)
    ("Ras, Lyn, Btk and Stat5" . SPARSER::COLLECTION)
    ("MPD" . SPARSER::PROTEIN) ("Stem Cell Factor (SCF)" . SPARSER::PROTEIN)
    ("ASM" . SPARSER::PROTEIN) ("ISM" . SPARSER::PROTEIN)
    ("Subtypes" . SPARSER::PROTEIN)
    ("oncogenic KIT and a therapeutic target" . SPARSER::COLLECTION)
    ("mast cell" . SPARSER::PROTEIN)
    ("Btk, Lyn, and Stat5" . SPARSER::COLLECTION)
    ("ERK/Bim" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("Btk" . SPARSER::PROTEIN) ("SHP2/PTPN11" . SPARSER::COLLECTION)
    ("K23" . SPARSER::PROTEIN) ("BMS-354825" . SPARSER::DRUG)
    ("SU11652" . SPARSER::MOLECULE) ("FLT3" . SPARSER::PROTEIN)
    ("G-CSF receptor" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("Gab2" . SPARSER::PROTEIN) ("Stem Cell Factor" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("combinational drugs" . SPARSER::DRUG)
    ("TRAIL, FasL, and TNF" . SPARSER::COLLECTION)
    ("killer" . SPARSER::PROTEIN) ("FasL" . SPARSER::PROTEIN)
    ("K-Ras and other isoforms" . SPARSER::COLLECTION)
    ("EGFR/Ras" . SPARSER::COLLECTION)
    ("an active K-Ras (residues 12 or 13) and/or B-RafV600E mutant"
     . SPARSER::COLLECTION)
    ("oncogenic Ras (e.g. H-Ras12V or K-Ras12V) or B-RafV600E mutant"
     . SPARSER::COLLECTION)
    ("H-Ras12V or K-Ras12V" . SPARSER::COLLECTION)
    ("cetuximab (an anti-EGFR monoclonal antibody) or sorafenib (a multi-kinase inhibitor that acts on Raf kinases, MEK, and ERK signaling)"
     . SPARSER::COLLECTION)
    ("kinases, MEK, and ERK" . SPARSER::COLLECTION)
    ("K-Ras and H-Ras" . SPARSER::COLLECTION)
    ("surface DR4 and/or DR5" . SPARSER::COLLECTION)
    ("Raf, PI3K and RalGDS" . SPARSER::COLLECTION)
    ("RalGDS" . SPARSER::PROTEIN) ("TRAIL and anti-DR5" . SPARSER::COLLECTION)
    ("rationally designing combinational drugs" . SPARSER::DRUG)
    ("antiapoptotic proteins (c-IAP1, FLIP, Bcl-2, Bcl-XL, and Mcl-1) and proapoptotic proteins (BAX and BID)"
     . SPARSER::COLLECTION)
    ("FLIP, Bcl-2, Bcl-XL, and Mcl-1" . SPARSER::COLLECTION)
    ("BAX and BID" . SPARSER::COLLECTION) ("c-IAP1" . SPARSER::COLLECTION)
    ("c" . SPARSER::PROTEIN) ("respective siRNA" . SPARSER::PROTEIN)
    ("a monoclonal anti-DR5 antibody" . SPARSER::ANTIBODY)
    ("DR5 agnostic antibodies" . SPARSER::ANTIBODY)
    ("H-Ras and K-Ras" . SPARSER::COLLECTION)
    ("H-Ras or K-Ras" . SPARSER::COLLECTION)
    ("K-Ras and N-Ras" . SPARSER::COLLECTION)
    ("pro-enzymes and the caspase substrate PARP (Fig. xref )"
     . SPARSER::COLLECTION)
    ("caspase-3 and caspase-8" . SPARSER::COLLECTION)
    ("FTS and TRAIL" . SPARSER::COLLECTION) ("-Ras" . SPARSER::COLLECTION)
    ("FTS" . SPARSER::PROTEIN) ("K-Ras or H-Ras" . SPARSER::COLLECTION)
    ("K-Ras or N-Ras" . SPARSER::COLLECTION)
    ("H-Ras and its closely related isoforms" . SPARSER::COLLECTION)
    ("DR4/DR5" . SPARSER::COLLECTION)
    ("c-FLIP, c-IAPs and Bcl-2" . SPARSER::COLLECTION)
    ("c-IAPs" . SPARSER::PROTEIN-PAIR)
    ("TRAIL or anti-DR5" . SPARSER::COLLECTION)
    ("the relevant molecules" . SPARSER::MOLECULE)
    ("c-FLIP, IAPs and Bcl2" . SPARSER::COLLECTION) ("IAPs" . SPARSER::PROTEIN)
    ("protein FADD and caspase 8" . SPARSER::COLLECTION)
    ("recombinant human TRAIL ( e.g. dulanermin) and agonistic antibodies"
     . SPARSER::COLLECTION)
    ("DR4 ( e.g. mapatumumab) or DR5 (e.g. lexatumumab, AMG 655, PRO95780, LBY135, and CS-1008)"
     . SPARSER::COLLECTION)
    ("PRO" . SPARSER::PROTEIN) ("lexatumumab" . SPARSER::DRUG)
    ("mapatumumab" . SPARSER::DRUG) ("DR4 and/or DR5" . SPARSER::COLLECTION)
    ("their respective cognate ligands" . SPARSER::LIGAND)
    ("Fas, DR4 and DR5" . SPARSER::COLLECTION)
    ("VEGF receptors [ xref , xref ] or ErbB family" . SPARSER::COLLECTION)
    ("humanized monoclonal antibodies" . SPARSER::ANTIBODY)
    ("both TRAIL and agonistic DR5 antibody" . SPARSER::COLLECTION)
    ("agonistic DR5 antibody" . SPARSER::ANTIBODY)
    ("recombinant human TRAIL and agonistic antibodies" . SPARSER::COLLECTION)
    ("agonistic antibodies" . SPARSER::ANTIBODY)
    ("DR4 or DR5" . SPARSER::COLLECTION) ("DRs" . SPARSER::PROTEIN)
    ("Ras-GTP" . SPARSER::PROTEIN) ("Monoclonal antibody" . SPARSER::DRUG)
    ("caco-2" . SPARSER::PROTEIN) ("Bcl-XL" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("decoy receptor 1" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("c-FLIP" . SPARSER::PROTEIN)
    ("protein FADD" . SPARSER::PROTEIN) ("receptor 1" . SPARSER::PROTEIN)
    ("TNFR1" . SPARSER::PROTEIN) ("H-Ras" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("a key basic helix-loop-helix leucine zipper transcription factor"
     . SPARSER::PROTEIN)
    ("sequence-specific base" . SPARSER::PROTEIN)
    ("Mitomycin C" . SPARSER::DRUG)
    ("topical targeting both molecules" . SPARSER::MOLECULE)
    ("the two secretory molecules" . SPARSER::MOLECULE)
    ("the pentameric CRP post" . SPARSER::PROTEIN)
    ("a soluble pattern recognition receptor" . SPARSER::RECEPTOR)
    ("CRP and APC" . SPARSER::COLLECTION)
    ("mutated p53 (n = 35; xref and xref ) or K-ras (n = 35; xref and xref )"
     . SPARSER::COLLECTION)
    ("CRP-" . SPARSER::PROTEIN) ("p53 , K-ras and APC" . SPARSER::COLLECTION)
    ("IL-1β and IL-8" . SPARSER::COLLECTION)
    ("gene-associated SNP" . SPARSER::PROTEIN)
    ("associated genes" . SPARSER::GENE)
    ("CRP and other frequently mutated genes" . SPARSER::COLLECTION)
    ("the mutated allele" . SPARSER::ALLELE)
    ("CRP and Wnt" . SPARSER::COLLECTION)
    ("CRP and p53 or K-ras" . SPARSER::COLLECTION)
    ("p53 or K-ras" . SPARSER::COLLECTION)
    ("IPM sheds new light" . SPARSER::PROTEIN) ("enigma" . SPARSER::PROTEIN)
    ("TCF/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("bipartite" . SPARSER::PROTEIN) ("Wingless/Wnt" . SPARSER::COLLECTION)
    ("Wingless" . SPARSER::PROTEIN)
    ("perivascular collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD10, CD35 and CD21" . SPARSER::COLLECTION)
    ("CD117, and CD23" . SPARSER::COLLECTION) ("keratin" . SPARSER::PROTEIN)
    ("KP1" . SPARSER::PROTEIN) ("DER" . SPARSER::PROTEIN)
    ("desmin" . SPARSER::PROTEIN) ("calponin" . SPARSER::PROTEIN)
    ("“tram-track" . SPARSER::COLLECTION)
    ("tram" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smooth muscle" . SPARSER::PROTEIN)
    ("Microscopic foci" . SPARSER::PROTEIN)
    ("fibrillary eosinophilic collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("18 classic examples" . SPARSER::EXAMPLE)
    ("myosin, and vimentin" . SPARSER::COLLECTION)
    ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("smooth-muscle actin and/or muscle-specific actin (n=5, each)"
     . SPARSER::COLLECTION)
    ("muscle-specific actin" . SPARSER::PROTEIN)
    ("beta-catenin and cyclin D1" . SPARSER::COLLECTION)
    ("hyaline" . SPARSER::PROTEIN)
    ("myxocollagenous(n=7) matrix" . SPARSER::PROTEIN-FAMILY)
    ("S33" . SPARSER::PROTEIN) ("CD23" . SPARSER::PROTEIN)
    ("CD21" . SPARSER::PROTEIN) ("CD35" . SPARSER::PROTEIN)
    ("S-100" . SPARSER::HUMAN-PROTEIN-FAMILY) ("(beta" . SPARSER::PROTEIN)
    ("SP4" . SPARSER::PROTEIN) ("actin, muscle" . SPARSER::PROTEIN)
    ("muscle specific" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3 beta" . SPARSER::PROTEIN)
    ("XRCC1 or ERCC1" . SPARSER::COLLECTION)
    ("a contributory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least one 8092Ala allele" . SPARSER::ALLELE)
    ("DNA ligase III, PARP, and POL" . SPARSER::COLLECTION)
    ("POL" . SPARSER::PROTEIN) ("nitrosamine" . SPARSER::MOLECULE)
    ("Cigarette" . SPARSER::DRUG) ("poor PFS" . SPARSER::PROTEIN)
    ("Cys/Cys" . SPARSER::COLLECTION) ("Log-rank" . SPARSER::COLLECTION)
    ("Log" . SPARSER::PROTEIN) ("XRCC1/ERCC1" . SPARSER::COLLECTION)
    ("ERCC1 and XRCC1" . SPARSER::COLLECTION) ("Cys/Ala" . SPARSER::COLLECTION)
    ("rays" . SPARSER::PROTEIN) ("a strong impact" . SPARSER::PROTEIN)
    ("type and duration" . SPARSER::COLLECTION)
    ("the XRCC1 Gln allele (HR 7.057; 95% CI 2.073–24.021; P  = 0.002) or the ERCC1 Cys allele (HR 2.568; 95% CI 1.056–6.248; P  = 0.038)"
     . SPARSER::COLLECTION)
    ("Ala/Ala" . SPARSER::COLLECTION) ("PFS" . SPARSER::PROTEIN)
    ("p53 and pAkt" . SPARSER::COLLECTION)
    ("XRCC1 Arg399Glu and ERCC1 Cys8092Ala SNPs" . SPARSER::COLLECTION)
    ("the XRCC1 Arg399Gln and ERCC1 Cys8092Ala SNPs" . SPARSER::COLLECTION)
    ("Ala" . SPARSER::AMINO-ACID) ("DNA ligase III" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN)
    ("HR 2" . SPARSER::PROTEIN) ("ERCC1" . SPARSER::PROTEIN)
    ("c-KIT, VEGFR2 or PDGFRα" . SPARSER::COLLECTION)
    ("PDGFR and VEGF" . SPARSER::COLLECTION)
    ("PDGFRβ and their ligand PDGF-C" . SPARSER::COLLECTION)
    ("PDGFRα, PDGFRβ and their ligand PDGF-C" . SPARSER::COLLECTION)
    ("the three RTKs and potential drug" . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-KIT and PDGFRα" . SPARSER::COLLECTION)
    ("VEGFR2 ( xref ) and PDGFRα ( xref )" . SPARSER::COLLECTION)
    ("c-KIT, PDGFRα and VEGFR2" . SPARSER::COLLECTION)
    ("normal FISH" . SPARSER::PROTEIN) ("Cut" . SPARSER::PROTEIN)
    ("VEGFR2 and PDGFRα" . SPARSER::COLLECTION)
    ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("Patient cohort and TNBC patient characteristics" . SPARSER::COLLECTION)
    ("c-KIT and VEGFR2" . SPARSER::COLLECTION)
    ("c-KIT , VEGFR2 and PDGFRα" . SPARSER::COLLECTION)
    ("c-KIT, vascular endothelial growth factor receptor-2 (VEGFR2) and PDGFRα"
     . SPARSER::COLLECTION)
    ("sunitinib and sorafenib" . SPARSER::COLLECTION)
    ("c-KIT and platelet-derived growth factor receptor alpha"
     . SPARSER::COLLECTION)
    ("HER2-type (ER−, PR− and HER2+) and triple-negative (ER−, PR− and HER2−) xref"
     . SPARSER::COLLECTION)
    ("Ki67 and HER2+" . SPARSER::COLLECTION)
    ("ER−, PR− and HER2+" . SPARSER::COLLECTION)
    ("ER−, PR− and HER2−" . SPARSER::COLLECTION)
    ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER−" . SPARSER::PROTEIN)
    ("HER2−" . SPARSER::PROTEIN)
    ("the progesterone receptor (PR) and Ki67, and ISH-analysis"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("Ki67, and ISH-analysis" . SPARSER::COLLECTION)
    ("c-KIT, PDGFRα or VEGFR2" . SPARSER::COLLECTION)
    ("BCM" . SPARSER::PROTEIN)
    ("c-KIT, VEGFR2 and PDGFRα" . SPARSER::COLLECTION)
    ("PDGF-C" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF- κ B, IKK, and microglia" . SPARSER::COLLECTION)
    ("a pivotal target" . SPARSER::TARGET-PROTEIN)
    ("focal cerebral ischemia" . SPARSER::PROTEIN)
    ("AS602868 and BAY 11-7082" . SPARSER::COLLECTION)
    ("NAD and a reduction in the level of p65 subunit" . SPARSER::COLLECTION)
    ("IL-1 β , IL-6, TNF- α , and iNOS" . SPARSER::COLLECTION)
    ("TNF- α and IL-6" . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE) ("NF- κ B-I κ B" . SPARSER::COLLECTION)
    ("several proinflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF- α , IL-1 β , IL-6, COX-2, and iNOS" . SPARSER::COLLECTION)
    ("the increased proinflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF- α , IL-1 β , and IL-6" . SPARSER::COLLECTION)
    ("enhanced the production of NO" . SPARSER::PROTEIN)
    ("interferon- γ" . SPARSER::PROTEIN)
    ("a variety of proinflammatory cytokines or other cytotoxic factors"
     . SPARSER::COLLECTION)
    ("toxin" . SPARSER::MOLECULE) ("Microglia" . SPARSER::PROTEIN)
    ("an important etiological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nitric oxide (NO) and prostaglandin E2 (PGE2)" . SPARSER::COLLECTION)
    ("inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2)"
     . SPARSER::COLLECTION)
    ("iNOS" . SPARSER::PROTEIN) ("IL-6 and TNF- α" . SPARSER::COLLECTION)
    ("microglia" . SPARSER::PROTEIN)
    ("glucose, lipid, and protein" . SPARSER::COLLECTION)
    ("-monophosphate-activated protein kinase" . SPARSER::COLLECTION)
    ("Adenosine" . SPARSER::PROTEIN) ("BAY 11-7082" . SPARSER::DRUG)
    ("AS602868" . SPARSER::DRUG) ("P65" . SPARSER::PROTEIN)
    ("Prostaglandin E2" . SPARSER::MOLECULE) ("AMPK α 1" . SPARSER::PROTEIN)
    ("IL-1 β" . SPARSER::PROTEIN) ("cyclooxygenase 2" . SPARSER::PROTEIN)
    ("PGE2" . SPARSER::DRUG) ("prostaglandin E2" . SPARSER::MOLECULE)
    ("RH" . SPARSER::MOLECULE)
    ("camptothecin or fluorouracil" . SPARSER::COLLECTION)
    ("quinolone" . SPARSER::MOLECULE) ("Chk" . SPARSER::PROTEIN)
    ("DDB1/Chk1" . SPARSER::COLLECTION) ("DDB1 and Chk1" . SPARSER::COLLECTION)
    ("Cul4a" . SPARSER::PROTEIN) ("hydroxyurea" . SPARSER::DRUG)
    ("which was run" . SPARSER::WH-QUESTION)
    ("likely represented total and phosphorylated Chk1" . SPARSER::PROTEIN)
    ("was run" . SPARSER::PROTEIN)
    ("either wt or S495A Metnase" . SPARSER::COLLECTION)
    ("total and phosphorylated Chk1 protein" . SPARSER::PROTEIN)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methylase and nuclease" . SPARSER::COLLECTION)
    ("complex (PEC)" . SPARSER::BIO-COMPLEX) ("TIR" . SPARSER::PROTEIN)
    ("methylase and transposase" . SPARSER::COLLECTION)
    ("nuclease" . SPARSER::PROTEIN) ("transposase" . SPARSER::PROTEIN)
    ("SET" . SPARSER::PROTEIN) ("SETMAR" . SPARSER::PROTEIN)
    ("Metnase" . SPARSER::PROTEIN) ("anti-neoplastic" . SPARSER::DRUG)
    ("Cul4" . SPARSER::PROTEIN) ("DNA Ligase IV" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN) ("Cul4A" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("GM" . SPARSER::PROTEIN)
    ("MX" . SPARSER::PROTEIN) ("LW" . SPARSER::PROTEIN)
    ("KZ" . SPARSER::PROTEIN) ("XX" . SPARSER::PROTEIN)
    ("Chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("hemoglobin" . SPARSER::PROTEIN)
    ("JAK2, CALR, TET2, DNMT3A, and ASXL1" . SPARSER::COLLECTION)
    ("a moderately-sized patient cohort" . SPARSER::MOLECULE)
    ("the preliminary HRMA and Sanger" . SPARSER::COLLECTION)
    ("HRMA and Sanger" . SPARSER::COLLECTION)
    ("the protein’s" . SPARSER::PROTEIN) ("the 9th exon" . SPARSER::PROTEIN)
    ("JAK2 and MPL" . SPARSER::COLLECTION) ("calreticulin" . SPARSER::PROTEIN)
    ("the wild-type JAK2 exon 12 and exon 14" . SPARSER::COLLECTION)
    ("CBC" . SPARSER::PROTEIN) ("Melting" . SPARSER::DRUG)
    ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JAK2-" . SPARSER::PROTEIN)
    ("the 10th exon" . SPARSER::PROTEIN)
    ("vitamin B12 and serum urate" . SPARSER::COLLECTION)
    ("urate" . SPARSER::MOLECULE)
    ("the classical Ph-negative MPNs" . SPARSER::PROTEIN)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("JAK2, MPL and CALR" . SPARSER::COLLECTION) ("CALR" . SPARSER::PROTEIN)
    ("MPL" . SPARSER::PROTEIN) ("ASXL1" . SPARSER::PROTEIN)
    ("DNMT3A" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("/c-Src" . SPARSER::COLLECTION)
    ("dasatinib and mTOR" . SPARSER::COLLECTION)
    ("Src and p-Src" . SPARSER::COLLECTION)
    ("the combination-treated animals displayed PRs or CRs"
     . SPARSER::COLLECTION)
    ("rapamycin or the combined drugs" . SPARSER::COLLECTION)
    ("dasatinib, rapamycin or the combined drugs" . SPARSER::COLLECTION)
    ("rapamycin and dasatinib" . SPARSER::COLLECTION)
    ("rapamycin or the combination" . SPARSER::COLLECTION)
    ("PRs or CRs" . SPARSER::COLLECTION) ("PRs" . SPARSER::PROTEIN)
    ("dasatinib-" . SPARSER::DRUG) ("PyMT" . SPARSER::PROTEIN)
    ("MMTV-PyMT" . SPARSER::COLLECTION)
    ("wild-type Src (Src wt) or a dasatininb-resistant Src (Src DR)"
     . SPARSER::COLLECTION)
    ("saracatinib" . SPARSER::DRUG)
    ("dimethyl sulfoxide (DMSO)" . SPARSER::MOLECULE)
    ("triple-negative (MDA-MB-231) subtypes" . SPARSER::PROTEIN)
    ("p-Src and p-S6" . SPARSER::COLLECTION) ("TN" . SPARSER::PROTEIN)
    ("CML and Ph+" . SPARSER::COLLECTION) ("Src/c-Abl" . SPARSER::COLLECTION)
    ("CML" . SPARSER::PROTEIN) ("Dasatinib" . SPARSER::DRUG)
    ("IGF-1R and the EGFR family" . SPARSER::COLLECTION)
    ("mTOR/PI3K" . SPARSER::COLLECTION)
    ("dual mTORC1/2 inhibitors" . SPARSER::INHIBITOR)
    ("phosphatidyl" . SPARSER::MOLECULE) ("mTOR and Src" . SPARSER::COLLECTION)
    ("dasatinib and rapamycin" . SPARSER::COLLECTION)
    ("Src and mTOR" . SPARSER::COLLECTION) ("Src/c-abl" . SPARSER::COLLECTION)
    ("Src or mTOR" . SPARSER::COLLECTION)
    ("Src and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("p-S6" . SPARSER::PROTEIN) ("p-Src" . SPARSER::PROTEIN)
    ("De-" . SPARSER::MOLECULE) ("NK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T Antigen" . SPARSER::MOLECULE) ("FoxO1" . SPARSER::PROTEIN)
    ("mTORC-1" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-abl" . SPARSER::PROTEIN) ("TIGAR" . SPARSER::PROTEIN)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("these same pro–apoptotic promoters" . SPARSER::PROMOTER)
    ("3 complex and enrichment" . SPARSER::COLLECTION)
    ("CBP and p300" . SPARSER::COLLECTION)
    ("p21 and mdm2" . SPARSER::COLLECTION)
    ("P53 and Ash2L" . SPARSER::COLLECTION)
    ("typical housekeeping genes" . SPARSER::GENE)
    ("active genes" . SPARSER::GENE)
    ("hypo–phosphorylated CTD" . SPARSER::PROTEIN)
    ("TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH" . SPARSER::COLLECTION)
    ("TFIIE" . SPARSER::PROTEIN-FAMILY) ("TFIID" . SPARSER::PROTEIN)
    ("active promoters" . SPARSER::PROMOTER)
    ("P53 target pro-apoptotic promoters" . SPARSER::PROMOTER)
    ("these same P53 pro–apoptotic target promoters" . SPARSER::PROMOTER)
    ("its pro-apoptotic promoters" . SPARSER::PROMOTER)
    ("P53 pro-apoptotic targets" . SPARSER::TARGET-PROTEIN)
    ("the repressive chromatin conformation" . SPARSER::BIO-CONFORMATION)
    ("the P53 pro-apoptotic promoters" . SPARSER::PROMOTER)
    ("pro–apoptotic target genes" . SPARSER::GENE)
    ("3 repressive histone conformation" . SPARSER::BIO-CONFORMATION)
    ("pro-apoptotic target promoters" . SPARSER::PROMOTER)
    ("inactive and active" . SPARSER::COLLECTION)
    ("P53 pro–apoptotic promoters" . SPARSER::PROMOTER)
    ("TFIIB and TFIIF" . SPARSER::COLLECTION)
    ("TFIIF, TFIIB or TAF1" . SPARSER::COLLECTION)
    ("promoters and employs" . SPARSER::COLLECTION) ("GTFs" . SPARSER::PROTEIN)
    ("P53 pro–apoptotic target genes" . SPARSER::GENE)
    ("its pro–apoptotic targets" . SPARSER::TARGET-PROTEIN)
    ("serine, tyrosine and threonine" . SPARSER::COLLECTION)
    ("cis–trans" . SPARSER::COLLECTION)
    ("the largest subunit" . SPARSER::FRAGMENT)
    ("these P53 pro–apoptotic target promoters" . SPARSER::PROMOTER)
    ("PIG3, PUMA, PIDD and FAS" . SPARSER::COLLECTION)
    ("CD95/APO–1" . SPARSER::COLLECTION) ("PIDD" . SPARSER::PROTEIN)
    ("P21 and MDM2" . SPARSER::COLLECTION)
    ("all mRNA (messenger RNA) as well as some snRNA (small nuclear RNA) and snoRNA (small nucleolar RNA)"
     . SPARSER::COLLECTION)
    ("some snRNA (small nuclear RNA) and snoRNA (small nucleolar RNA)"
     . SPARSER::COLLECTION)
    ("snoRNA" . SPARSER::RNA) ("MI–219 or Nutlin3a" . SPARSER::COLLECTION)
    ("P53 or its pro–apoptotic target genes" . SPARSER::COLLECTION)
    ("its pro–apoptotic target genes" . SPARSER::GENE)
    ("sh-GFP" . SPARSER::COLLECTION) ("sh-Ash2L" . SPARSER::COLLECTION)
    ("Doxycycline" . SPARSER::DRUG)
    ("these same P53 pro-apoptotic target promoters" . SPARSER::PROMOTER)
    ("etoposide and Nutlin3a" . SPARSER::COLLECTION)
    ("its pro-apoptotic target genes and induction of apoptosis"
     . SPARSER::COLLECTION)
    ("its pro-apoptotic target genes" . SPARSER::GENE)
    ("an intrinsic methyltransferase activity" . SPARSER::PROTEIN)
    ("Wdr5 and RbBP5" . SPARSER::COLLECTION)
    ("Setd1A, Setd1B, and MLL" . SPARSER::COLLECTION)
    ("Setd1B" . SPARSER::PROTEIN) ("Setd1A" . SPARSER::PROTEIN)
    ("Wdr5, RbBP5 or Ash2L" . SPARSER::COLLECTION)
    ("RbBP5 ( xref ; xref , xref ) as well as Ash2L ( xref ; xref , xref )"
     . SPARSER::COLLECTION)
    ("Wdr5, RbBP5, DPY30 or Ash2L" . SPARSER::COLLECTION)
    ("EJ-P53 or B5/589" . SPARSER::COLLECTION)
    ("at least four common structural components" . SPARSER::COMPONENT)
    ("Wdr5, RbBP5, DPY30 and Ash2L" . SPARSER::COLLECTION)
    ("required functional P53" . SPARSER::PROTEIN)
    ("the P53 pro–apoptotic target promoters" . SPARSER::PROMOTER)
    ("sh–SUV39H1" . SPARSER::COLLECTION) ("tet" . SPARSER::PROTEIN)
    ("enhancers" . SPARSER::PROTEIN)
    ("its pro–apoptotic target promoters" . SPARSER::PROMOTER)
    ("P53 pro–apoptotic target promoters" . SPARSER::PROMOTER)
    ("absent, small, or homeotic – like Drosophila)" . SPARSER::PROTEIN)
    ("P53–dependent pro–apoptotic target promoters" . SPARSER::PROMOTER)
    ("proteins, Wdr5, RbBP5 and Ash2L" . SPARSER::COLLECTION)
    ("TFIIH as well as TBP and its associated factors" . SPARSER::COLLECTION)
    ("TBP and its associated factors" . SPARSER::COLLECTION)
    ("its associated factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBP" . SPARSER::PROTEIN) ("TFIIA" . SPARSER::PROTEIN)
    ("general transcriptional cofactors" . SPARSER::PROTEIN)
    ("TAF6, TAF9, TRAP80 and TFIIH" . SPARSER::COLLECTION)
    ("TFIIH" . SPARSER::PROTEIN)
    ("P53 pro-apoptotic promoters" . SPARSER::PROMOTER)
    ("SET1/MLL" . SPARSER::COLLECTION) ("HMTs" . SPARSER::PROTEIN)
    ("this repressive mark" . SPARSER::PROTEIN)
    ("Complex (PIC)" . SPARSER::BIO-COMPLEX) ("PIC" . SPARSER::PROTEIN)
    ("a transcriptionally repressive chromatin conformation"
     . SPARSER::BIO-CONFORMATION)
    ("TSS" . SPARSER::PROTEIN) ("lys" . SPARSER::AMINO-ACID)
    ("TFIIB as well as TFIIF (RAP74)" . SPARSER::COLLECTION)
    ("these same pro-apoptotic target promoters" . SPARSER::PROMOTER)
    ("TFIIF" . SPARSER::PROTEIN) ("TFIIB" . SPARSER::PROTEIN)
    ("CTD" . SPARSER::PROTEIN) ("P53 or RNAP" . SPARSER::COLLECTION)
    ("RNAP" . SPARSER::PROTEIN) ("3 epigenetic mark" . SPARSER::PROTEIN)
    ("its pro-apoptotic target promoters" . SPARSER::PROMOTER)
    ("Wdr5, RbBP5 and Ash2L" . SPARSER::COLLECTION)
    ("Ash2L" . SPARSER::PROTEIN) ("Wdr5" . SPARSER::PROTEIN)
    ("this repressive chromatin conformation" . SPARSER::BIO-CONFORMATION)
    ("P53 pro-apoptotic target promoters" . SPARSER::PROMOTER)
    ("APAF1" . SPARSER::PROTEIN) ("ml –1" . SPARSER::PROTEIN)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TRIM22" . SPARSER::PROTEIN)
    ("GLS2" . SPARSER::PROTEIN) ("TAF3" . SPARSER::PROTEIN)
    ("T 4 S" . SPARSER::MOLECULE) ("S 2 P" . SPARSER::PROTEIN)
    ("Rpb1" . SPARSER::PROTEIN) ("APO–1" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("small nucleolar RNA" . SPARSER::RNA) ("small nuclear RNA" . SPARSER::RNA)
    ("messenger RNA" . SPARSER::RNA) ("topoisomerase II" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("nutlin3a" . SPARSER::DRUG) ("Nutlin3a" . SPARSER::DRUG)
    ("MI–219" . SPARSER::DRUG) ("K4" . SPARSER::PROTEIN)
    ("Drosophila)" . SPARSER::PROTEIN) ("TRAP80" . SPARSER::PROTEIN)
    ("TAF9" . SPARSER::PROTEIN) ("TAF6" . SPARSER::PROTEIN)
    ("ASH2L" . SPARSER::PROTEIN) ("DPY30" . SPARSER::PROTEIN)
    ("WDR5" . SPARSER::PROTEIN) ("Set1" . SPARSER::PROTEIN)
    ("SET1" . SPARSER::PROTEIN) ("lys9" . SPARSER::PROTEIN)
    ("RAP74" . SPARSER::PROTEIN) ("Ash2" . SPARSER::PROTEIN)
    ("RbBP5" . SPARSER::PROTEIN) ("SUV39H1" . SPARSER::PROTEIN)
    ("synthetic MTH1 inhibitors and support" . SPARSER::COLLECTION)
    ("concurrent downstream traits" . SPARSER::PROTEIN)
    ("directly target oncogenic RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both positive prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nonfunctional p53" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("UNG" . SPARSER::PROTEIN)
    ("the predominant inhibitor" . SPARSER::INHIBITOR)
    ("NSCLC shGFP/shMTH1" . SPARSER::PROTEIN)
    ("KRAS and pAkt" . SPARSER::COLLECTION)
    ("significantly higher
baseline KRAS"
     . SPARSER::PROTEIN)
    ("subsequently either overexpressed or suppressed MTH1" . SPARSER::PROTEIN)
    ("hygromycin" . SPARSER::MOLECULE) ("KRAS and MTH1" . SPARSER::COLLECTION)
    ("MTH1 and KRAS" . SPARSER::COLLECTION)
    ("p53/p21 cip1/waf1" . SPARSER::COLLECTION)
    ("pERK and pAkt" . SPARSER::COLLECTION)
    ("protein and
mRNA"
     . SPARSER::COLLECTION)
    ("pERK" . SPARSER::PROTEIN) ("pBp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and wildtype" . SPARSER::COLLECTION) ("wt-p53" . SPARSER::COLLECTION)
    ("neo" . SPARSER::PROTEIN) ("Myr" . SPARSER::MOLECULE)
    ("p21 cip1/waf1" . SPARSER::COLLECTION)
    ("PI/Annexin V" . SPARSER::COLLECTION)
    ("the
accompanying elevated senescence-associated beta-galactosidase"
     . SPARSER::PROTEIN)
    ("gamma-H2AX/53BP1" . SPARSER::COLLECTION) ("wt" . SPARSER::PROTEIN)
    ("KRAS or p53" . SPARSER::COLLECTION)
    ("this aggressive
tumor type"
     . TYPE)
    ("the first tumor suppressive step" . SPARSER::PROTEIN)
    ("Many such malignant traits" . SPARSER::PROTEIN)
    ("multiple
malignant traits"
     . SPARSER::PROTEIN)
    ("several KRAS-driven pro-malignant traits" . SPARSER::PROTEIN)
    ("MutT" . SPARSER::PROTEIN) ("Beta-gal" . SPARSER::PROTEIN)
    ("hOGG1" . SPARSER::PROTEIN) ("B-F" . SPARSER::PROTEIN)
    ("pErk1/2" . SPARSER::PROTEIN) ("p27 kip1" . SPARSER::PROTEIN)
    ("waf1" . SPARSER::PROTEIN) ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SA-beta-gal" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("MTH1" . SPARSER::PROTEIN)
    ("Homolog 1" . SPARSER::PROTEIN)
    ("paclitaxel and capecitabine" . SPARSER::COLLECTION)
    ("an unusual UBE2L3-KRas fusion protein" . SPARSER::PROTEIN)
    ("UBE2L3-KRas" . SPARSER::COLLECTION) ("KRas" . SPARSER::PROTEIN)
    ("ERK and mTOR" . SPARSER::COLLECTION)
    ("K-Ras or K-Ras" . SPARSER::COLLECTION) ("BJ" . SPARSER::PROTEIN)
    ("cell cycle phase-specific cytotoxic drugs" . SPARSER::DRUG)
    ("malate" . SPARSER::MOLECULE)
    ("aspartate as well as α-ketoglutarate" . SPARSER::COLLECTION)
    ("α-ketoglutarate and aspartate" . SPARSER::COLLECTION)
    ("pan-transaminase" . SPARSER::COLLECTION)
    ("dehydrogenase or transaminase" . SPARSER::COLLECTION)
    ("transaminase" . SPARSER::PROTEIN) ("Glutaminase" . SPARSER::PROTEIN)
    ("MCF7 and BJ-K-Ras" . SPARSER::COLLECTION)
    ("BJ-K-Ras" . SPARSER::PROTEIN-PAIR)
    ("capecitabine and paclitaxel" . SPARSER::COLLECTION)
    ("capecitabine or paclitaxel" . SPARSER::COLLECTION)
    ("phase-specific cytotoxic drugs" . SPARSER::DRUG)
    ("K-Ras and TPA" . SPARSER::COLLECTION) ("BJ-hTERT" . SPARSER::COLLECTION)
    ("12-O-tetradecanoylphorbol-13-acetate (TPA)" . SPARSER::DRUG)
    ("Raf/Mek/ERK" . SPARSER::COLLECTION) ("TPA" . SPARSER::PROTEIN)
    ("Panc" . SPARSER::PROTEIN)
    ("Neither U0126 nor Torin1" . SPARSER::COLLECTION)
    ("U0126 and Torin1" . SPARSER::COLLECTION)
    ("Mek and mTOR" . SPARSER::COLLECTION)
    ("ERK and S6 kinase" . SPARSER::COLLECTION)
    ("U0126 (Mek inhibitor) and Torin1 (mTOR inhibitor)" . SPARSER::COLLECTION)
    ("cyclin D and ERK" . SPARSER::COLLECTION)
    ("cyclin E and mTOR" . SPARSER::COLLECTION)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-Rb, and p27" . SPARSER::COLLECTION)
    ("Rb, and p27" . SPARSER::COLLECTION) ("Glutamine" . SPARSER::AMINO-ACID)
    ("oxaloacetate and acetyl-CoA" . SPARSER::COLLECTION)
    ("oxaloacetate" . SPARSER::MOLECULE)
    ("the cell cycle phase-specific cytotoxic drugs, capecitabine and paclitaxel"
     . SPARSER::COLLECTION)
    ("drugs, capecitabine and paclitaxel" . SPARSER::COLLECTION)
    ("capecitabine" . SPARSER::DRUG)
    ("biological molecules" . SPARSER::MOLECULE) ("UBE2L3" . SPARSER::PROTEIN)
    ("malic enzyme" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("Panc1" . SPARSER::PROTEIN) ("Torin1" . SPARSER::DRUG)
    ("U0126" . SPARSER::DRUG) ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("K-Ras" . SPARSER::PROTEIN) ("WX" . SPARSER::PROTEIN)
    ("ZW" . SPARSER::PROTEIN) ("hematoxylin and eosin" . SPARSER::COLLECTION)
    ("tumor necrosis factor receptor-associated factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kappa-light polypeptide" . SPARSER::COLLECTION)
    ("hematoxylin" . SPARSER::MOLECULE)
    ("a proto-oncogene and a therapeutic target" . SPARSER::COLLECTION)
    ("Ubc13-Uev1" . SPARSER::COLLECTION)
    ("Uev1 and Mms2" . SPARSER::COLLECTION)
    ("MMP9 and possibly other genes" . SPARSER::COLLECTION)
    ("possibly other genes" . SPARSER::GENE)
    ("NF-κB and metastasis-related genes" . SPARSER::COLLECTION)
    ("TRAF2 and/or TRAF6 [ xref , xref ]" . SPARSER::COLLECTION)
    ("NEMO [ xref ] and TAB2/3 [ xref , xref ]" . SPARSER::COLLECTION)
    ("TAB2/3" . SPARSER::PROTEIN) ("polyUb" . SPARSER::PROTEIN)
    ("Tet" . SPARSER::PROTEIN) ("UEV1A , UEV1C and MMS2" . SPARSER::COLLECTION)
    ("the previously reported two UEV1" . SPARSER::PROTEIN)
    ("Mms2 or Uev1" . SPARSER::COLLECTION)
    ("Uev1A and Mms2" . SPARSER::COLLECTION) ("UEV" . SPARSER::PROTEIN)
    ("Luc" . SPARSER::PROTEIN) ("UevA-Ubc13" . SPARSER::COLLECTION)
    ("MMP1 and/or MMP9" . SPARSER::COLLECTION)
    ("MMP1 or MMP9" . SPARSER::COLLECTION)
    ("VEGF [ xref ] and MMP family genes" . SPARSER::COLLECTION)
    ("MMP1 and MMP9" . SPARSER::COLLECTION) ("ecotopic genes" . SPARSER::GENE)
    ("Uev1 (LN2B, Additional file xref : Figure S2D) or Uev1"
     . SPARSER::COLLECTION)
    ("UEV1A , UEV1C or MMS2" . SPARSER::COLLECTION)
    ("UEV1A and UEV1C" . SPARSER::COLLECTION)
    ("UEV1A and UEV1B" . SPARSER::COLLECTION) ("кB" . SPARSER::PROTEIN)
    ("RelA" . SPARSER::PROTEIN) ("NEMO/IKKγ" . SPARSER::COLLECTION)
    ("Uev1A-Ubc13" . SPARSER::COLLECTION) ("NEMO" . SPARSER::PROTEIN)
    ("polyubiquitinate" . SPARSER::PROTEIN) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("Ubc" . SPARSER::PROTEIN)
    ("T- and B-cell mitogens and bacterial lipopolysaccharides (LPS) [ xref ]"
     . SPARSER::COLLECTION)
    ("the matrix metalloproteinase ( MMP ) family [ xref , xref ] and chemokine (C-X-C motif) ligand ( CXCL ) family genes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("ligand ( CXCL )" . SPARSER::MOLECULE) ("NF-кB" . SPARSER::COLLECTION)
    ("Mms2 and Uev1A" . SPARSER::COLLECTION)
    ("Ubc13-Uev1A" . SPARSER::COLLECTION) ("DNA-damage" . SPARSER::DNA)
    ("Ubc13-Mms2" . SPARSER::COLLECTION)
    ("Uev1A or Mms2" . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("also known as CROC1 [ xref ] or CIR1 [ xref ]" . SPARSER::COLLECTION)
    ("UEV1 , also known as CROC1 [ xref ] or CIR1 [ xref ]"
     . SPARSER::COLLECTION)
    ("Uev" . SPARSER::PROTEIN-FAMILY) ("functional Ubc13" . SPARSER::PROTEIN)
    ("UEV1 and MMS2" . SPARSER::COLLECTION)
    ("a ubiquitin-conjugating enzyme variant (Ubc13), which is required for Ubc13-catalyzed Lys63-linked polyubiquitination of target proteins and nuclear factor κB (NF-кB) activation"
     . SPARSER::COLLECTION)
    ("Ubc13-catalyzed Lys63-linked polyubiquitination" . SPARSER::PROTEIN)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("tumor necrosis factor receptor" . SPARSER::PROTEIN)
    ("light polypeptide" . SPARSER::PROTEIN) ("MMP1 " . SPARSER::PROTEIN)
    ("NF-κB " . SPARSER::PROTEIN) ("Uev1A " . SPARSER::PROTEIN)
    ("TAB2" . SPARSER::PROTEIN) ("S6E" . SPARSER::PROTEIN-FAMILY)
    ("S6B" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("K63" . SPARSER::PROTEIN) ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("Uev1" . SPARSER::PROTEIN)
    ("Rieske iron-sulfur polypeptide 1" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 6" . SPARSER::PROTEIN)
    ("IL-1b" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("Mms2" . SPARSER::PROTEIN) ("Uev1A" . SPARSER::PROTEIN)
    ("CIR1" . SPARSER::PROTEIN) ("CROC1" . SPARSER::PROTEIN)
    ("MMS2" . SPARSER::PROTEIN) ("UEV1" . SPARSER::PROTEIN)
    ("Ubc13" . SPARSER::PROTEIN) ("UEV1A" . SPARSER::PROTEIN)
    ("MAFbx or MURF1" . SPARSER::COLLECTION) ("tracer" . SPARSER::MOLECULE)
    ("MAFbx and/or MURF1" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION)
    ("mTORC1 and protein" . SPARSER::COLLECTION)
    ("4EBP1 and ULK1" . SPARSER::COLLECTION) ("limb" . SPARSER::PROTEIN)
    ("Fast" . SPARSER::PROTEIN) ("eIF2α" . SPARSER::PROTEIN)
    ("/β-actin" . SPARSER::COLLECTION)
    ("phenylalanine-, tyrosine- and urea" . SPARSER::COLLECTION)
    ("tyrosine-" . SPARSER::AMINO-ACID)
    ("phenylalanine-" . SPARSER::AMINO-ACID) ("phe" . SPARSER::AMINO-ACID)
    ("Tracer" . SPARSER::MOLECULE)
    ("the hyperinsulinemic euglycemic clamp" . SPARSER::PROTEIN)
    ("insulin and glucose" . SPARSER::COLLECTION)
    ("glucagon and FFA" . SPARSER::COLLECTION) ("clamp" . SPARSER::PROTEIN)
    ("insulin, c-peptide and triiodothyronine" . SPARSER::COLLECTION)
    ("glucagon" . SPARSER::PROTEIN) ("triiodothyronine" . SPARSER::DRUG)
    ("FFA" . SPARSER::PROTEIN) ("Skeletal muscle" . SPARSER::PROTEIN)
    ("MAFbx and MURF1" . SPARSER::COLLECTION) ("MAFbx" . SPARSER::PROTEIN)
    ("mTOR and rpS6" . SPARSER::COLLECTION) ("rpS6" . SPARSER::PROTEIN)
    ("4EBP1, ULK1 and rpS6" . SPARSER::COLLECTION) ("rpS" . SPARSER::PROTEIN)
    ("tracers" . SPARSER::MOLECULE)
    ("the postabsorptive state" . SPARSER::BIO-STATE)
    ("Forkhead box O3" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("Tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E binding protein 1"
     . SPARSER::PROTEIN)
    ("c-peptide" . SPARSER::MOLECULE) ("sequestosome-1" . SPARSER::PROTEIN)
    ("p-ULK" . SPARSER::PROTEIN) ("C-peptide" . SPARSER::MOLECULE)
    ("growth hormone" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("MURF1" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("Smo-Ampk" . SPARSER::COLLECTION)
    ("the less aggressive HCC group" . SPARSER::MOLECULE)
    ("the highly aggressive (including histological differentiation, portal vein tumorous thrombogenesis, lymph node invasion and TNM stage) HCC group"
     . SPARSER::MOLECULE)
    ("Shh and Gli1" . SPARSER::COLLECTION)
    ("factors, Gli1, Gli2 and Gli3" . SPARSER::COLLECTION)
    ("tip" . SPARSER::PROTEIN) ("Gli1, Gli2 and Gli3" . SPARSER::COLLECTION)
    ("Gli2" . SPARSER::PROTEIN) ("Gli" . SPARSER::PROTEIN)
    ("Ptch" . SPARSER::PROTEIN) ("Ihh" . SPARSER::PROTEIN)
    ("functional AMPK" . SPARSER::PROTEIN) ("GST-AMPK" . SPARSER::COLLECTION)
    ("HA-Gli1" . SPARSER::COLLECTION)
    ("cyclopamine or SAG" . SPARSER::COLLECTION)
    ("Gli1 and AMPK" . SPARSER::COLLECTION)
    ("AMPK and Shh" . SPARSER::COLLECTION)
    ("Gli1, Shh and AMPK" . SPARSER::COLLECTION)
    ("agonist (SAG)" . SPARSER::AGONIST) ("cyclopamine" . SPARSER::DRUG)
    ("SAG" . SPARSER::PROTEIN) ("smoothened" . SPARSER::PROTEIN)
    ("both Sonic hedgehog (Shh) and Gli1" . SPARSER::COLLECTION)
    ("Shh" . SPARSER::PROTEIN)
    ("forkhead box O3 (FOXO3) and tuberous sclerosis complex"
     . SPARSER::COLLECTION)
    ("CaMKK" . SPARSER::PROTEIN)
    ("a scaffolding subunit (β) and an AMP-sensing subunit (γ)"
     . SPARSER::COLLECTION)
    ("a catalytic subunit (α), a scaffolding subunit (β) and an AMP-sensing subunit (γ)"
     . SPARSER::COLLECTION)
    ("a heterotrimeric serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("-activated protein kinase(AMPK)" . SPARSER::COLLECTION)
    ("-activated protein kinase" . SPARSER::COLLECTION)
    ("-Ampk" . SPARSER::COLLECTION) ("Ampk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smo" . SPARSER::PROTEIN) ("Suh" . SPARSER::PROTEIN)
    ("AMPK and Gli1" . SPARSER::COLLECTION) ("zinc finger" . SPARSER::PROTEIN)
    ("Gli3" . SPARSER::PROTEIN)
    ("smoothened, frizzled class receptor" . SPARSER::PROTEIN)
    ("patched 1" . SPARSER::PROTEIN) ("Indian hedgehog" . SPARSER::PROTEIN)
    ("Desert hedgehog" . SPARSER::PROTEIN)
    ("alpha fetoprotein" . SPARSER::PROTEIN)
    ("Sonic hedgehog" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TSC2" . SPARSER::PROTEIN)
    ("forkhead box O3" . SPARSER::PROTEIN)
    ("protein kinase kinase" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Adenosine monophosphate" . SPARSER::MOLECULE)
    ("Glioma-associated oncogene" . SPARSER::PROTEIN)
    ("Gli1" . SPARSER::PROTEIN)
    ("glioma-associated oncogene" . SPARSER::PROTEIN)
    ("IR and IR" . SPARSER::COLLECTION) ("IR/IGF1R" . SPARSER::COLLECTION)
    ("available antibodies" . SPARSER::ANTIBODY)
    ("insulin and IR" . SPARSER::COLLECTION)
    ("mRNAs, and IR-A:IR-B" . SPARSER::COLLECTION) ("Igf1r" . SPARSER::PROTEIN)
    ("mRNA and presence" . SPARSER::COLLECTION)
    ("insulin and IGF1R, IR and IR-A:IR-B" . SPARSER::COLLECTION)
    ("insulin and IR-A:IR-B" . SPARSER::COLLECTION)
    ("IGF1R, IR and IR-A:IR-B" . SPARSER::COLLECTION)
    ("Ovt" . SPARSER::PROTEIN) ("IGF1R, IR and IR" . SPARSER::COLLECTION)
    ("insulin, and overweight/obese" . SPARSER::COLLECTION)
    ("IGF1R or IR" . SPARSER::COLLECTION)
    ("the predominant IR isoform" . SPARSER::ISOFORM)
    ("insulin or the IGFs ( xref , xref )" . SPARSER::COLLECTION)
    ("IGFs" . SPARSER::PROTEIN) ("alternate pre-mRNA" . SPARSER::RNA)
    ("dual IGF1R/IR inhibitors" . SPARSER::INHIBITOR)
    ("IGF1R/IR" . SPARSER::COLLECTION)
    ("insulin receptor (IR) or IGF1 receptor (IGF1R)" . SPARSER::COLLECTION)
    ("insulin/IGF" . SPARSER::COLLECTION) ("Impact" . SPARSER::PROTEIN)
    ("mRNA or IR-A:IR-B" . SPARSER::COLLECTION)
    ("IGF1R and IR" . SPARSER::COLLECTION) ("UNC" . SPARSER::PROTEIN)
    ("Hydroxymethylbilane synthase" . SPARSER::PROTEIN)
    ("terminal deoxynucleotidyltransferase" . SPARSER::PROTEIN)
    ("IGFBP1" . SPARSER::PROTEIN) ("IGF binding protein 1" . SPARSER::PROTEIN)
    ("MDM2-p53" . SPARSER::COLLECTION)
    ("p53 mutant and p53 null pancreatic cancer cells" . SPARSER::COLLECTION)
    ("oligonucleotides and siRNAs" . SPARSER::COLLECTION)
    ("SP141" . SPARSER::PROTEIN) ("SP141-MDM2" . SPARSER::PROTEIN-PAIR)
    ("MDM2, Cyclin E, and Bcl2" . SPARSER::COLLECTION)
    ("p21 and Bax" . SPARSER::COLLECTION)
    ("the available drug" . SPARSER::DRUG)
    ("siRNA and MDM2" . SPARSER::COLLECTION)
    ("MDM2 and ubiquitin" . SPARSER::COLLECTION)
    ("Cyclin E and Bcl2" . SPARSER::COLLECTION)
    ("Waf1/CIP1" . SPARSER::COLLECTION) ("HPAC/p53" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION) ("naphthalen" . SPARSER::MOLECULE)
    ("indole" . SPARSER::DRUG) ("aryl" . SPARSER::PROTEIN)
    ("an essential negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("p53 and p16" . SPARSER::COLLECTION)
    ("MDM2 , KRAS , and BCL2" . SPARSER::COLLECTION)
    ("gemcitabine, oxaliplatin, tarceva, and 5-fluorouracil"
     . SPARSER::COLLECTION)
    ("tarceva" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("gemcitabine" . SPARSER::DRUG) ("functional P53" . SPARSER::PROTEIN)
    ("called SP141" . SPARSER::PROTEIN) ("HPAC" . SPARSER::PROTEIN)
    ("MDM2 and P53" . SPARSER::COLLECTION) ("AIMS" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("MI219" . SPARSER::DRUG)
    ("abundant Alcian blue–positive mucinous matrix" . SPARSER::PROTEIN-FAMILY)
    ("melanoma or GG" . SPARSER::COLLECTION)
    ("CK7 (1:300; DAKO) or BRST-2 (predilute; Ventana Medical Systems)"
     . SPARSER::COLLECTION)
    ("adrenals" . SPARSER::DRUG) ("chromogranin" . SPARSER::PROTEIN)
    ("discrete foci" . SPARSER::PROTEIN) ("subpial foci" . SPARSER::PROTEIN)
    ("an abundant Alcian blue–positive matrix" . SPARSER::PROTEIN-FAMILY)
    ("prednisone" . SPARSER::DRUG) ("VP" . SPARSER::PROTEIN)
    ("thoracic pain" . SPARSER::PROTEIN) ("Electron" . SPARSER::MOLECULE)
    ("synaptophysin or neurofilament protein (clone 2F11, predilute; Ventana Medical Systems)"
     . SPARSER::COLLECTION)
    ("IDH" . SPARSER::PROTEIN) ("GFAP" . SPARSER::PROTEIN)
    ("grid" . SPARSER::PROTEIN)
    ("The copious mucin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mucin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an abundant mucinous matrix" . SPARSER::PROTEIN-FAMILY)
    ("the temporal lobe" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("S100" . SPARSER::PROTEIN) ("F11" . SPARSER::PROTEIN)
    ("Glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("KIT receptor and its variants" . SPARSER::COLLECTION)
    ("SCF and KIT" . SPARSER::COLLECTION) ("MCC" . SPARSER::PROTEIN)
    ("heterozygous state" . SPARSER::BIO-STATE)
    ("a polymorphic variant" . SPARSER::VARIANT)
    ("Stem cell Factor (SCF)" . SPARSER::PROTEIN)
    ("FIP1L1-PDGFRalpha" . SPARSER::COLLECTION) ("ARMS" . SPARSER::PROTEIN)
    ("tryptase" . SPARSER::PROTEIN) ("BCR/ABL1" . SPARSER::COLLECTION)
    ("whose gene" . SPARSER::GENE) ("TEL/PDGFRbeta" . SPARSER::COLLECTION)
    ("FIP1L1/PDGFRalpha" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("PDGFRalpha, PDGFRbeta, or FGFR1" . SPARSER::COLLECTION)
    ("PDGFRalpha and PDGFRbeta" . SPARSER::COLLECTION)
    ("PDGFRalpha" . SPARSER::PROTEIN)
    ("chronic eosinophilic leukemia" . SPARSER::PROTEIN)
    ("PDGFRbeta" . SPARSER::PROTEIN) ("CEL" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN) ("Stem cell Factor" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("FIP1L1" . SPARSER::PROTEIN)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("BAX, NOXA, and PUMA" . SPARSER::COLLECTION)
    ("TFF1 or pcDNA" . SPARSER::COLLECTION)
    ("p53-caspases" . SPARSER::COLLECTION)
    ("Annexin V and propidium" . SPARSER::COLLECTION)
    ("p53 and its target" . SPARSER::COLLECTION)
    ("PG13-Luc" . SPARSER::PROTEIN) ("TFF1 or PTT5" . SPARSER::COLLECTION)
    ("PTT" . SPARSER::MOLECULE)
    ("stably overexpressing TFF1 or control empty vector pcDNA"
     . SPARSER::COLLECTION)
    ("The classical tumor suppressor gene" . SPARSER::PROTEIN)
    ("Tff1" . SPARSER::PROTEIN) ("a small-secreted protein" . SPARSER::PROTEIN)
    ("mm 3" . SPARSER::PROTEIN) ("pS2" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("quantitative clinical traits" . SPARSER::PROTEIN)
    ("TC" . SPARSER::PROTEIN)
    ("1742 unrelated ethnic Chinese Han" . SPARSER::PROTEIN)
    ("UK and male European" . SPARSER::COLLECTION) ("UK" . SPARSER::PROTEIN)
    ("the substitutive guanine" . SPARSER::PROTEIN)
    ("the exact causal variant" . SPARSER::VARIANT)
    ("the former SNP" . SPARSER::PROTEIN)
    ("the wild-type A allele" . SPARSER::ALLELE)
    ("adenine" . SPARSER::NUCLEOBASE) ("lipogenic genes" . SPARSER::GENE)
    ("GT and GC" . SPARSER::COLLECTION) ("AT" . SPARSER::PROTEIN)
    ("high density lipoprotein and low density lipoprotein"
     . SPARSER::COLLECTION)
    ("BAT" . SPARSER::PROTEIN) ("gluconeogenic genes" . SPARSER::GENE)
    ("neural STAT3" . SPARSER::PROTEIN)
    ("leptin receptor–STAT3" . SPARSER::COLLECTION)
    ("leptin" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("STAT" . SPARSER::PROTEIN)
    ("plasma triglyceride and other metabolic diseases related parameters"
     . SPARSER::COLLECTION)
    ("triglyceride" . SPARSER::MOLECULE) ("FOXD1" . SPARSER::PROTEIN)
    ("micro-RNA" . SPARSER::MICRO-RNA) ("SREBP1c" . SPARSER::PROTEIN)
    ("sterol regulatory element binding protein 1" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("leptin receptor" . SPARSER::PROTEIN) ("long form" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("multiple recurrence sinonasal IPs" . SPARSER::PROTEIN)
    ("PCNA and Ki67" . SPARSER::COLLECTION) ("CADD" . SPARSER::PROTEIN)
    ("PCNA and Ki-67" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("p53, p21, and p27" . SPARSER::COLLECTION)
    ("p21, p27, and CDKs" . SPARSER::COLLECTION)
    ("p53, p63, p21, and p27" . SPARSER::COLLECTION)
    ("sinonasal IP" . SPARSER::PROTEIN)
    ("CDK1 and target proteins" . SPARSER::COLLECTION)
    ("Ki67, P27, and PCNA" . SPARSER::COLLECTION)
    ("PCNA-CDK1" . SPARSER::COLLECTION) ("p27-CDK1" . SPARSER::COLLECTION)
    ("Ki67-CDK1" . SPARSER::COLLECTION) ("PCNA and CDK1" . SPARSER::COLLECTION)
    ("CDK1-Ki67" . SPARSER::COLLECTION) ("ps" . SPARSER::PROTEIN)
    ("CDK1 and Ki-67, CDK1-p27, and CDK1-PCNA" . SPARSER::COLLECTION)
    ("CDK1-PCNA" . SPARSER::COLLECTION) ("CDK1-p27" . SPARSER::COLLECTION)
    ("PCNA and CDK1, Ki-67 and CDK1, and p27 and CDK1" . SPARSER::COLLECTION)
    ("CDK1, Ki-67 and CDK1, and p27 and CDK1" . SPARSER::COLLECTION)
    ("CDK1, and p27 and CDK1" . SPARSER::COLLECTION)
    ("p27 and CDK1" . SPARSER::COLLECTION)
    ("both sinonasal IPs" . SPARSER::PROTEIN)
    ("The preoperative MRI" . SPARSER::PROTEIN)
    ("PCNA, Ki-67, p27, and PLUNC" . SPARSER::COLLECTION)
    ("PCNA, Ki-67, and p27" . SPARSER::COLLECTION)
    ("PCNA, p53, p21, p27, and Ki-67" . SPARSER::COLLECTION)
    ("sinonasal IPs" . SPARSER::PROTEIN)
    ("p16, p53, Ki-67, and PLUNC" . SPARSER::COLLECTION)
    ("cyclin D1-CDK4" . SPARSER::COLLECTION)
    ("cyclin E-CDK2" . SPARSER::COLLECTION) ("CDKI" . SPARSER::DRUG)
    ("p21, P27, and CDK" . SPARSER::COLLECTION) ("CDKs" . SPARSER::PROTEIN)
    ("Cyclin and cyclin dependent kinase" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("facial pain" . SPARSER::PROTEIN) ("the sinonasal IPs" . SPARSER::PROTEIN)
    ("IPs" . SPARSER::PROTEIN) ("PLUNC" . SPARSER::PROTEIN)
    ("p53, p16, p21, and p27" . SPARSER::COLLECTION)
    ("TIP3" . SPARSER::PROTEIN) ("P27" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("Bax/Bcl-2" . SPARSER::COLLECTION) ("more toxic ROS" . SPARSER::PROTEIN)
    ("several chemotherapeutic drugs" . SPARSER::DRUG)
    ("ROS and JNK" . SPARSER::COLLECTION)
    ("Bcl-2, procaspase-3, and PARP-1" . SPARSER::COLLECTION)
    ("caspase-3 and PARP-1" . SPARSER::COLLECTION)
    ("tris-base" . SPARSER::COLLECTION) ("MTT and SRB" . SPARSER::COLLECTION)
    ("SRB" . SPARSER::PROTEIN)
    ("-GGGTGTCGCTGTTGAAGTCA-3" . SPARSER::COLLECTION)
    ("-TGGGCTACACTGAGCACCAG-3" . SPARSER::COLLECTION)
    ("CAGGTCCACATGGTCTTCC-3" . SPARSER::COLLECTION)
    ("-AGGCACCGAGGCACTCAGAG-3" . SPARSER::COLLECTION)
    ("-GTGGAGTCTTCCAGTGTGAT-3" . SPARSER::COLLECTION)
    ("-AATTTGCGTGTGGAGTATTT-3" . SPARSER::COLLECTION)
    ("TRIzol" . SPARSER::DRUG) ("methanol" . SPARSER::MOLECULE)
    ("a peroxidase-conjugated secondary antibody" . SPARSER::ANTIBODY)
    ("ice" . SPARSER::PROTEIN)
    ("osthole or hydrogen peroxide" . SPARSER::COLLECTION)
    ("VA" . SPARSER::PROTEIN) ("Type" . TYPE)
    ("The dominant-negative (DN) mutant" . SPARSER::MUTANT)
    ("Dr" . SPARSER::MOLECULE) ("p-JNK" . SPARSER::COLLECTION)
    ("Bax, Bcl2, procaspase-3, PARP, JNK, and β -actin" . SPARSER::COLLECTION)
    ("Santa" . SPARSER::PROTEIN) ("LF" . SPARSER::PROTEIN)
    ("coumarin" . SPARSER::DRUG) ("DN-JNK" . SPARSER::COLLECTION)
    ("extracellular-signal-regulated kinase (ERK)" . SPARSER::PROTEIN)
    ("p38, and c-Jun" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("the most commonly mutated genes found in human malignancies [ xref ]"
     . SPARSER::GENE)
    ("p-p53" . SPARSER::COLLECTION) ("osthole" . SPARSER::MOLECULE)
    ("Osthole" . SPARSER::MOLECULE) ("n-acetylcysteine" . SPARSER::DRUG)
    ("DCF-DA" . SPARSER::DRUG) ("SP600125" . SPARSER::PROTEIN)
    ("H 2 DCFDA" . SPARSER::DRUG) ("JNK1" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("AGP-" . SPARSER::PROTEIN) ("lipoprotein (LDL)" . SPARSER::PROTEIN)
    ("LDL" . SPARSER::PROTEIN) ("lipoprotein" . SPARSER::PROTEIN)
    ("HDAC2 and its downstream target genes" . SPARSER::COLLECTION)
    ("agonists" . SPARSER::AGONIST) ("lysophospholipids" . SPARSER::MOLECULE)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION) ("oxLDL" . SPARSER::PROTEIN)
    ("HDAC1 , HDAC3 , and HDAC8" . SPARSER::COLLECTION)
    ("SMRT and nuclear receptor corepressor" . SPARSER::COLLECTION)
    ("NcoR" . SPARSER::PROTEIN)
    ("a naturally occurring phospholipid" . SPARSER::PHOSPHOLIPID)
    ("receptors (SMRT)" . SPARSER::RECEPTOR) ("-PPARγ" . SPARSER::COLLECTION)
    ("retinoid" . SPARSER::PROTEIN)
    ("lysophosphatidic acid (LPA)" . SPARSER::LPA)
    ("LPA 1 and LPA 2" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LPA" . SPARSER::PROTEIN)
    ("fatty substances" . SPARSER::SUBSTANCE)
    ("substances" . SPARSER::SUBSTANCE)
    ("interleukin (IL)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL" . SPARSER::PROTEIN) ("interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC2 and low levels HDAC1, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("HDAC1, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("AGP" . SPARSER::PROTEIN) ("acyl-CoA" . SPARSER::MOLECULE)
    ("PLD2" . SPARSER::PROTEIN) ("phospholipase D2" . SPARSER::PROTEIN)
    ("LPA receptor" . SPARSER::PROTEIN) ("LPA 2" . SPARSER::PROTEIN)
    ("LPA 1" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("receptor gamma" . SPARSER::PROTEIN) ("proteoglycans" . SPARSER::PROTEIN)
    ("heparan" . SPARSER::MOLECULE) ("glycoproteins" . SPARSER::PROTEIN)
    ("factors and EGFR" . SPARSER::COLLECTION) ("oro" . SPARSER::MOLECULE)
    ("NOS" . SPARSER::PROTEIN) ("CDKN2A, TP53 and EGFR" . SPARSER::COLLECTION)
    ("RB1–E2F1" . SPARSER::COLLECTION)
    ("tumour protein p53 (TP53/p53) and epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("cyclin-dependent kinase inhibitor 2A (CDKN2A/p16), tumour protein p53 (TP53/p53) and epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("TP53/p53" . SPARSER::COLLECTION)
    ("EGFR, CDKN2A and TP53" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase inhibitor 2A (CDKN2A/p16) and tumour protein p53 (TP53)"
     . SPARSER::COLLECTION)
    ("annexin A2" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN) ("G 1 –S" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AA" . SPARSER::MOLECULE) ("Chk1 and PP2A" . SPARSER::COLLECTION)
    ("checkpoint kinase Chk1 and pro-apoptotic protein BAK"
     . SPARSER::COLLECTION)
    ("pro-apoptotic protein BAK" . SPARSER::PROTEIN)
    ("BAK and PUMA" . SPARSER::COLLECTION)
    ("PUMA and Chk1" . SPARSER::COLLECTION)
    ("Chk1 and anti-apopototic Bcl-xL and pro-apoptotic BH3-only protein PUMA"
     . SPARSER::COLLECTION)
    ("pro-apoptotic BH3-only protein PUMA" . SPARSER::PROTEIN)
    ("Chk1 and anti-apopototic" . SPARSER::COLLECTION)
    ("BAK and Chk1" . SPARSER::COLLECTION)
    ("BAK and pro-apoptotic BH3-only proteins PUMA and BIM"
     . SPARSER::COLLECTION)
    ("pro-apoptotic BH3-only proteins PUMA and BIM" . SPARSER::COLLECTION)
    ("PUMA and BIM" . SPARSER::COLLECTION)
    ("BAK and anti" . SPARSER::COLLECTION) ("HT1080" . SPARSER::PROTEIN)
    ("BAK Y108A and S117A/S117E" . SPARSER::COLLECTION)
    ("monomeric BAK" . SPARSER::PROTEIN) ("crosslinker" . SPARSER::PROTEIN)
    ("BMH" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mitochondria" . SPARSER::PROTEIN)
    ("apoptogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The resulting symmetric homodimers" . SPARSER::HOMODIMER)
    ("BAX, the anti-apoptotic Bcl-xL and MCL1, and the BH3-only proteins such as Bid"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins BAK and BAX" . SPARSER::COLLECTION)
    ("Bcl-xL and MCL1" . SPARSER::COLLECTION)
    ("BAK and BAX" . SPARSER::COLLECTION)
    ("BH3- only protein PUMA" . SPARSER::PROTEIN)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("proteins or p53" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN) ("MCL-1" . SPARSER::PROTEIN)
    ("caspase3" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("SLS" . SPARSER::PROTEIN) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("its accessory protein Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("newly synthesized viral DNA" . SPARSER::DNA)
    ("these highly adaptive immunity genes" . SPARSER::GENE)
    ("arms" . SPARSER::PROTEIN) ("new allelic variants" . SPARSER::VARIANT)
    ("PDB" . SPARSER::MOLECULE) ("BRC" . SPARSER::PROTEIN)
    ("a significantly better fit" . SPARSER::PROTEIN-FAMILY)
    ("the entire BRCA2 protein" . SPARSER::PROTEIN) ("Exon" . SPARSER::PROTEIN)
    ("the largest BRCA1 exon" . SPARSER::PROTEIN)
    ("a unique amino acid" . SPARSER::AMINO-ACID)
    ("often encoding very dissimilar amino acids" . SPARSER::AMINO-ACID)
    ("coiled-coil" . SPARSER::PROTEIN)
    ("specifically ones encoding BRCA1-interacting proteins"
     . SPARSER::PROTEIN)
    ("our simian primate dataset fit" . SPARSER::PROTEIN-FAMILY)
    ("an otherwise highly conserved protein" . SPARSER::PROTEIN)
    ("alleles and polymorphisms" . SPARSER::COLLECTION)
    ("BRCA1 [ xref - xref ] and BRCA2 [ xref ]" . SPARSER::COLLECTION)
    ("most hereditary forms" . SPARSER::FORM) ("Pan" . SPARSER::PROTEIN)
    ("an essential gene" . SPARSER::GENE)
    ("an essential task" . SPARSER::PROTEIN)
    ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("a beta" . SPARSER::PROTEIN)
    ("BRCA2 protein" . SPARSER::PROTEIN) ("M1a" . SPARSER::MOLECULE)
    ("provided crucial reagents" . SPARSER::MOLECULE)
    ("WAS and GN" . SPARSER::COLLECTION) ("GN" . SPARSER::PROTEIN)
    ("WAS" . SPARSER::PROTEIN) ("AK" . SPARSER::PROTEIN)
    ("thymidylate synthase and p21" . SPARSER::COLLECTION)
    ("α-tubulin and other cytoskeleton proteins" . SPARSER::COLLECTION)
    ("SAHA" . SPARSER::DRUG) ("further class I HDACs" . SPARSER::PROTEIN)
    ("SiRNA" . SPARSER::PROTEIN) ("HDAC1 and HDAC2/3" . SPARSER::COLLECTION)
    ("HDAC1 or HDAC2" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2 and HDAC3" . SPARSER::COLLECTION)
    ("class I-HDACs" . SPARSER::COLLECTION)
    ("HDAC8 specific hydroxamic acid inhibitors" . SPARSER::INHIBITOR)
    ("thymidylate synthase (TS)" . SPARSER::PROTEIN)
    ("transiently transfecting HDAC8 siRNA and irrelevant siRNA"
     . SPARSER::COLLECTION)
    ("irrelevant siRNA" . SPARSER::PROTEIN)
    ("HDAC2 and HDAC8" . SPARSER::COLLECTION)
    ("HDAC4, HDAC5, and HDAC7" . SPARSER::COLLECTION)
    ("HDAC1, HDAC6 or HDAC8" . SPARSER::COLLECTION)
    ("protein kinase A (PKA)" . SPARSER::PROTEIN)
    ("Substrates" . SPARSER::SUBSTRATE)
    ("a considerable part" . SPARSER::COMPONENT)
    ("The classical HDACs" . SPARSER::PROTEIN)
    ("HDAC11 (class IV) and seven sirtuins (class III)" . SPARSER::COLLECTION)
    ("Rpd3, HdaI and Sir2" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, HDAC3 and HDAC8" . SPARSER::COLLECTION)
    ("HDAC4, HDAC5, HDAC7 and HDAC9" . SPARSER::COLLECTION)
    ("HDAC6 and HDAC10" . SPARSER::COLLECTION)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY) ("deacetylases" . SPARSER::PROTEIN)
    ("HDAC and marker proteins" . SPARSER::COLLECTION)
    ("Histone H4" . SPARSER::PROTEIN) ("SiRNA-mediated" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN) ("D11" . SPARSER::PROTEIN)
    ("TATA-box binding protein" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::MOLECULE)
    ("SMC3" . SPARSER::PROTEIN) ("Zn 2+" . SPARSER::MOLECULE)
    ("HDAC11" . SPARSER::PROTEIN) ("HDAC10" . SPARSER::PROTEIN)
    ("HDAC9" . SPARSER::PROTEIN) ("HDAC7" . SPARSER::PROTEIN)
    ("HDAC5" . SPARSER::PROTEIN) ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rpd3" . SPARSER::PROTEIN) ("thymidylate synthase" . SPARSER::PROTEIN)
    ("HDAC8" . SPARSER::PROTEIN) ("RZ and WMG" . SPARSER::COLLECTION)
    ("AZ" . SPARSER::PROTEIN) ("PG" . SPARSER::PROTEIN)
    ("FP and MU" . SPARSER::COLLECTION) ("MU" . SPARSER::PROTEIN)
    ("KC" . SPARSER::PROTEIN) ("AMG" . SPARSER::PROTEIN)
    ("BTH" . SPARSER::PROTEIN) ("RZ" . SPARSER::PROTEIN)
    ("TMA and cohort" . SPARSER::COLLECTION) ("tris" . SPARSER::PROTEIN)
    ("sulfate" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("RIPA" . SPARSER::PROTEIN) ("-azino-bis" . SPARSER::COLLECTION)
    ("peroxidase" . SPARSER::PROTEIN) ("HRP" . SPARSER::PROTEIN)
    ("HPA" . SPARSER::PROTEIN) ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("BCA" . SPARSER::PROTEIN) ("ABTS" . SPARSER::PROTEIN)
    ("peroxiredoxins" . SPARSER::PROTEIN)
    ("decameric PRDX1" . SPARSER::PROTEIN)
    ("cellular PRDX1" . SPARSER::PROTEIN)
    ("the oligomeric state" . SPARSER::BIO-STATE)
    ("PRDX1 and these proteins" . SPARSER::COLLECTION)
    ("pro-EMT" . SPARSER::COLLECTION) ("peroxiredoxin" . SPARSER::PROTEIN)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("PRDX1 and ERα" . SPARSER::COLLECTION)
    ("RPPA and TMA" . SPARSER::COLLECTION)
    ("significantly more PRDX2 protein" . SPARSER::PROTEIN)
    ("PRDX1 or PRDX2" . SPARSER::COLLECTION)
    ("PRDX1 and PRDX2" . SPARSER::COLLECTION) ("estradiol" . SPARSER::MOLECULE)
    ("-luciferase" . SPARSER::COLLECTION)
    ("PRDX1 and ER" . SPARSER::COLLECTION) ("NTC" . SPARSER::PROTEIN)
    ("exogenous H 2 O 2 or peroxynitrite" . SPARSER::COLLECTION)
    ("H 2 O 2 or peroxynitrite" . SPARSER::COLLECTION)
    ("pThr" . SPARSER::PROTEIN) ("VI" . SPARSER::PROTEIN)
    ("Collagen" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FC " . SPARSER::PROTEIN)
    ("protein and ERα" . SPARSER::COLLECTION)
    ("PRDX1 and cancer-related signaling proteins" . SPARSER::COLLECTION)
    ("lobular subtype" . SPARSER::PROTEIN)
    ("improved RFS ( P  = 0.010) and BCSS ( P  = 0.013)" . SPARSER::COLLECTION)
    ("RFS" . SPARSER::PROTEIN) ("DAB" . SPARSER::MOLECULE)
    ("V5-tagged PRDX1" . SPARSER::PROTEIN)
    ("Peroxiredoxins" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("H 2 O 2 , peroxynitrite, or adenanthin" . SPARSER::COLLECTION)
    ("adenanthin" . SPARSER::DRUG) ("peroxynitrite" . SPARSER::MOLECULE)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("HSP-70" . SPARSER::PROTEIN) ("tight junction" . SPARSER::PROTEIN)
    ("S3B" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("17β-estradiol" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("Claudin-7" . SPARSER::PROTEIN)
    ("PRDX2" . SPARSER::PROTEIN) ("β-estradiol" . SPARSER::MOLECULE)
    ("Prdx1" . SPARSER::PROTEIN) ("peroxiredoxin 1" . SPARSER::PROTEIN)
    ("PRDX1" . SPARSER::PROTEIN) ("Peroxiredoxin-1" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("numerous biological functions—including tumor suppressor"
     . SPARSER::SUPPRESSOR)
    ("basic leucine zipper transcription factor 2" . SPARSER::PROTEIN)
    ("Menin" . SPARSER::PROTEIN)
    ("CREBBP , FBX11 , and DNMT1" . SPARSER::COLLECTION)
    ("FBX" . SPARSER::PROTEIN) ("Jurkat" . SPARSER::PROTEIN)
    ("the unique genes" . SPARSER::GENE) ("suppressive ART" . SPARSER::PROTEIN)
    ("specific viral variants" . SPARSER::VARIANT) ("env" . SPARSER::PROTEIN)
    ("ART" . SPARSER::PROTEIN)
    ("mediator of DNA damage checkpoint 1" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("transcription factor 2" . SPARSER::PROTEIN)
    ("TRAPPC10" . SPARSER::PROTEIN) ("ST8SIA4" . SPARSER::PROTEIN)
    ("OXCT1" . SPARSER::PROTEIN) ("KCTD13" . SPARSER::PROTEIN)
    ("IKZF3" . SPARSER::PROTEIN) ("HNRNPUL1" . SPARSER::PROTEIN)
    ("C2CD3" . SPARSER::PROTEIN) ("ANKRD13" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("nef -3" . SPARSER::PROTEIN)
    ("SOX2 and FGFR1" . SPARSER::COLLECTION) ("BRAF/MEK" . SPARSER::COLLECTION)
    ("BRAF and SOX2" . SPARSER::COLLECTION)
    ("RAS/RAF/MAP kinase" . SPARSER::COLLECTION)
    ("fits" . SPARSER::PROTEIN-FAMILY)
    ("possible regulator" . SPARSER::PROTEIN)
    ("FGFR2, FGFR3 or FGFR4" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION)
    ("either BRAF V600E or KRAS G12V" . SPARSER::COLLECTION)
    ("mutant BRAF (Caco2-BRAF V600E , xref ) or mutant KRAS (Caco2-KRAS G12V , xref )"
     . SPARSER::COLLECTION)
    ("the prognostic impact" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("parts" . SPARSER::COMPONENT) ("SOX" . SPARSER::PROTEIN)
    ("SRY" . SPARSER::PROTEIN) ("the sporadic CRC" . SPARSER::PROTEIN)
    ("a SOX2 positive primary CRC" . SPARSER::PROTEIN)
    ("CRABP1" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("RUNX3" . SPARSER::PROTEIN) ("NEUROG1" . SPARSER::PROTEIN)
    ("CACNA1G" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("sex determining region Y" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("active full-length receptor dimers" . SPARSER::DIMER)
    ("Calcium" . SPARSER::CALCIUM) ("calmodulin" . SPARSER::PROTEIN)
    ("calcium" . SPARSER::CALCIUM) ("the dimeric state" . SPARSER::BIO-STATE)
    ("ErbB2 or Neu" . SPARSER::COLLECTION) ("Leucine" . SPARSER::AMINO-ACID)
    ("Deuterium" . SPARSER::MOLECULE) ("coil" . SPARSER::PROTEIN)
    ("POPC and
POPS"
     . SPARSER::COLLECTION)
    ("100 mM monovalent salt" . SPARSER::MOLECULE)
    ("polylysine" . SPARSER::MOLECULE) ("deuterium" . SPARSER::MOLECULE)
    ("triple resonance MAS" . SPARSER::PROTEIN) ("MAS" . SPARSER::PROTEIN)
    ("State" . SPARSER::BIO-STATE) ("KCl" . SPARSER::MOLECULE)
    ("MOPS" . SPARSER::MOLECULE) ("tryptophan" . SPARSER::AMINO-ACID)
    ("POPC and POPS" . SPARSER::COLLECTION) ("gas" . SPARSER::PROTEIN)
    ("solvents" . SPARSER::MOLECULE) ("-Trp" . SPARSER::COLLECTION)
    ("-glucoside" . SPARSER::MOLECULE) ("methoxyamine" . SPARSER::DRUG)
    ("-thioester and FGFR3" . SPARSER::COLLECTION)
    ("t-Boc" . SPARSER::COLLECTION) ("-thioester" . SPARSER::MOLECULE)
    ("Fmoc" . SPARSER::MOLECULE) ("Boc" . SPARSER::PROTEIN)
    ("thioester" . SPARSER::MOLECULE) ("FIL" . SPARSER::PROTEIN)
    ("-maleimide" . SPARSER::DRUG) ("Avanti Polar Lipids" . SPARSER::LIPID)
    ("Lipids" . SPARSER::LIPID) ("POPS" . SPARSER::MOLECULE)
    ("POPC" . SPARSER::PROTEIN) ("glucoside" . SPARSER::MOLECULE)
    ("Solvents and
other agents"
     . SPARSER::COLLECTION)
    ("Chemicals" . SPARSER::MOLECULE) ("Solvents" . SPARSER::MOLECULE)
    ("leucines" . SPARSER::AMINO-ACID) ("FT-IR" . SPARSER::COLLECTION)
    ("FT" . SPARSER::PROTEIN) ("EGFR and FGFR" . SPARSER::COLLECTION)
    ("Neu" . SPARSER::PROTEIN)
    ("a symmetric
dimer"
     . SPARSER::DIMER)
    ("FGFR1, FGFR2, FGFR3, and FGFR4" . SPARSER::COLLECTION)
    ("tilt" . SPARSER::DRUG) ("thrombopoietin receptor" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PROTEIN) ("NCMs and MCMs" . SPARSER::COLLECTION)
    ("cyclobutyl" . SPARSER::MOLECULE) ("SHD" . SPARSER::PROTEIN)
    ("group and the residue Arg141 of GSK3β (it is indicated in the xref )"
     . SPARSER::COLLECTION)
    ("group and a high log(10 3 /IC 50 ) value" . SPARSER::COLLECTION)
    ("the catalytic lysine (Lys85) or DFG aspartate (Asp200)"
     . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::MOLECULE) ("ah" . SPARSER::MOLECULE)
    ("HBs" . SPARSER::PROTEIN) ("pdb" . SPARSER::MOLECULE)
    ("maleimides" . SPARSER::DRUG) ("Asn" . SPARSER::AMINO-ACID)
    ("benzofuran" . SPARSER::DRUG) ("ray" . SPARSER::PROTEIN)
    ("NCMs" . SPARSER::PROTEIN)
    ("Many small organic chemical" . SPARSER::MOLECULE)
    ("GSK3α/GSK3β" . SPARSER::COLLECTION)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION) ("NCM" . SPARSER::PROTEIN)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("propeller" . SPARSER::PROTEIN-FAMILY) ("CH 2" . SPARSER::PROTEIN)
    ("NH 2" . SPARSER::MOLECULE) ("sp 3" . SPARSER::PROTEIN)
    ("GSK3α" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("glycogen synthase kinase 3 beta" . SPARSER::PROTEIN)
    ("ICP4 and ICP22" . SPARSER::COLLECTION)
    ("the viral tegument protein" . SPARSER::PROTEIN)
    ("the viral transactivator VP16" . SPARSER::DRUG)
    ("ICP0 , ICP4 , ICP22 , ICP27 , and ICP47" . SPARSER::COLLECTION)
    ("Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the possible impact" . SPARSER::PROTEIN)
    ("colorectal carcinoma lines SW480" . SPARSER::PROTEIN)
    ("critical viral regulatory proteins" . SPARSER::PROTEIN)
    ("UL29 , UL30 , ICP4 , ICP22 or ICP47" . SPARSER::COLLECTION)
    ("the actual targets" . SPARSER::TARGET-PROTEIN)
    ("UL30 and ICP4" . SPARSER::COLLECTION)
    ("significantly more active" . SPARSER::ACTIVE)
    ("target viral proteins" . SPARSER::PROTEIN) ("Tax" . SPARSER::PROTEIN)
    ("the simian virus 40 early promoter" . SPARSER::PROMOTER)
    ("TTG" . SPARSER::PROTEIN) ("promoters and introns" . SPARSER::COLLECTION)
    ("both ICP4 (both at 6 and 24 h post infection) and ICP8 (at 24 h post infection)"
     . SPARSER::COLLECTION)
    ("p53RE proximal viral genes" . SPARSER::GENE)
    ("C(A/T)(T/A)G -3" . SPARSER::PROTEIN) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("such ternary complexes" . SPARSER::BIO-COMPLEX)
    ("No apparent ternary antibody-p53-DNA complex" . SPARSER::BIO-COMPLEX)
    ("p53-specific monoclonal antibodies" . SPARSER::ANTIBODY)
    ("PAb" . SPARSER::PROTEIN) ("DO" . SPARSER::PROTEIN)
    ("any possible cofactors" . SPARSER::PROTEIN)
    ("GADD45A and p53RE-L" . SPARSER::COLLECTION)
    ("GADD45A , p53RE-L and p53RE-S" . SPARSER::COLLECTION)
    ("32 P-labeled duplex oligonucleotides" . SPARSER::MOLECULE)
    ("the DNA polymerase ( UL30 ) and ICP8 ( UL29 )" . SPARSER::COLLECTION)
    ("the essential early genes" . SPARSER::GENE)
    ("important viral genes" . SPARSER::GENE)
    ("ICP4 , and ICP22 or ICP47" . SPARSER::COLLECTION)
    ("VDR" . SPARSER::PROTEIN) ("TK" . SPARSER::PROTEIN)
    ("CTAG" . SPARSER::PROTEIN) ("GAA" . SPARSER::PROTEIN)
    ("C(A/T)(T/A)G-3" . SPARSER::PROTEIN) ("CCG" . SPARSER::PROTEIN)
    ("CATG" . SPARSER::PROTEIN) ("AAA" . SPARSER::PROTEIN)
    ("tetramer" . SPARSER::TETRAMER) ("purine and Y" . SPARSER::COLLECTION)
    ("RRR" . SPARSER::PROTEIN)
    ("two essential viral proteins" . SPARSER::PROTEIN)
    ("ICP4 and ICP8" . SPARSER::COLLECTION)
    ("ICP27 and ICP0" . SPARSER::COLLECTION)
    ("p68, lamin B, nucleophosmin, and Ki67" . SPARSER::COLLECTION)
    ("nucleophosmin" . SPARSER::PROTEIN)
    ("other essential nuclear proteins" . SPARSER::PROTEIN)
    ("tetramers" . SPARSER::TETRAMER)
    ("ICP4 and ICP22 or ICP47" . SPARSER::COLLECTION)
    ("ICP22 or ICP47" . SPARSER::COLLECTION) ("IE" . SPARSER::PROTEIN)
    ("UL29 and UL30" . SPARSER::COLLECTION)
    ("the essential immediate early viral transactivator ICP4 and the essential DNA replication protein ICP8"
     . SPARSER::COLLECTION)
    ("the essential DNA replication protein ICP8" . SPARSER::PROTEIN)
    ("the essential immediate early viral transactivator ICP4"
     . SPARSER::PROTEIN)
    ("ICP" . SPARSER::PROTEIN)
    ("a heterologous reporter gene" . SPARSER::PROTEIN)
    ("or 2 µ" . SPARSER::MOLECULE) ("Oct-1" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("thymidine kinase" . SPARSER::PROTEIN)
    ("G -3" . SPARSER::PROTEIN) ("Cdc25C" . SPARSER::PROTEIN)
    ("CASP10" . SPARSER::PROTEIN) ("CASP6" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("ABCA1" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("ICP0" . SPARSER::PROTEIN)
    ("ICP27" . SPARSER::PROTEIN) ("p68" . SPARSER::PROTEIN)
    ("ICP22" . SPARSER::PROTEIN)
    ("single-strand DNA binding protein" . SPARSER::PROTEIN)
    ("UL30" . SPARSER::PROTEIN) ("UL29" . SPARSER::PROTEIN)
    ("ICP4" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("CD133 and EpCAM" . SPARSER::COLLECTION)
    ("beta-catenin and gene" . SPARSER::COLLECTION)
    ("CD133 and HDAC6" . SPARSER::COLLECTION)
    ("snail/slug" . SPARSER::COLLECTION)
    ("Wnt and TGF-beta" . SPARSER::COLLECTION)
    ("Snail or Slug" . SPARSER::COLLECTION) ("Eda/Edar" . SPARSER::COLLECTION)
    ("EpCAM and E-cadherin" . SPARSER::COLLECTION)
    ("Anti-CD133 antibody or an isotype control antibody"
     . SPARSER::COLLECTION)
    ("CD133, E-cadherin and beta-catenin" . SPARSER::COLLECTION)
    ("pink" . SPARSER::PROTEIN)
    ("beta-catenin or HDAC6 and CD133" . SPARSER::COLLECTION)
    ("HDAC6 and CD133" . SPARSER::COLLECTION)
    ("CD133:HDAC6" . SPARSER::BIO-COMPLEX)
    ("EpCAM, beta-catenin and HDAC6" . SPARSER::COLLECTION)
    ("protein:protein" . SPARSER::BIO-COMPLEX)
    ("HDAC6 and beta-catenin" . SPARSER::COLLECTION)
    ("TGF-beta2, Wif1 and Slug" . SPARSER::COLLECTION)
    ("CDH1, CDH2, vimentin and fibronectin" . SPARSER::COLLECTION)
    ("Lef1" . SPARSER::PROTEIN)
    ("Key morphogenetic regulators" . SPARSER::REGULATOR)
    ("TGF-beta and Wif1" . SPARSER::COLLECTION) ("Wif1" . SPARSER::PROTEIN)
    ("EpCAM and CD133" . SPARSER::COLLECTION)
    ("AC133 and 293C3" . SPARSER::COLLECTION)
    ("alpha6-integrin" . SPARSER::COLLECTION)
    ("several adhesion proteins and planar polarity proteins"
     . SPARSER::COLLECTION)
    ("planar polarity proteins" . SPARSER::PROTEIN)
    ("EpCAM" . SPARSER::PROTEIN) ("Snail/Slug" . SPARSER::COLLECTION)
    ("particular E-cadherin and beta-catenin" . SPARSER::COLLECTION)
    ("E-cadherin and beta-catenin" . SPARSER::COLLECTION)
    ("Eda:Edar, TGF-beta, Sonic Hedgehog and other signaling pathways"
     . SPARSER::COLLECTION)
    ("Eda:Edar" . SPARSER::BIO-COMPLEX) ("Edar" . SPARSER::PROTEIN)
    ("spacial and temporal activation cues" . SPARSER::PROTEIN-FAMILY)
    ("beta-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta galactosidase" . SPARSER::PROTEIN) ("Prominin 1" . SPARSER::PROTEIN)
    ("ZO1" . SPARSER::PROTEIN) ("CLDN1" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("TGF-beta2" . SPARSER::PROTEIN)
    ("CDH2" . SPARSER::PROTEIN) ("e-cadherin" . SPARSER::PROTEIN)
    ("p-Cadherin" . SPARSER::PROTEIN) ("LEF1" . SPARSER::PROTEIN)
    ("AC133" . SPARSER::PROTEIN) ("alpha6" . SPARSER::PROTEIN)
    ("prominin 1" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("Sonic Hedgehog" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("batimastat" . SPARSER::DRUG) ("pain" . SPARSER::PROTEIN)
    ("FN and its fragments" . SPARSER::COLLECTION)
    ("the soluble protein fraction" . SPARSER::COMPONENT)
    ("surgically-obtained discs" . SPARSER::BIO-COMPLEX)
    ("collagen, aggrecan and MMP-9 and MMP-13" . SPARSER::COLLECTION)
    ("MMP-9 and MMP-13" . SPARSER::COLLECTION) ("aggrecan" . SPARSER::PROTEIN)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("human cadaveric NP" . SPARSER::PROTEIN)
    ("The largest molecule" . SPARSER::MOLECULE) ("NPs" . SPARSER::PROTEIN)
    ("each subsequent blot" . SPARSER::PROTEIN) ("III IVDs" . SPARSER::PROTEIN)
    ("LI-COR" . SPARSER::COLLECTION) ("COR" . SPARSER::PROTEIN)
    ("the two FN monoclonal antibodies" . SPARSER::ANTIBODY)
    ("one Western blot" . SPARSER::PROTEIN)
    ("only 2 amino acids" . SPARSER::AMINO-ACID)
    ("the 29-kDa tryptic fragment" . SPARSER::FRAGMENT)
    ("AC" . SPARSER::PROTEIN) ("around 25-29 kDa" . SPARSER::PROTEIN)
    ("polypeptides" . SPARSER::PEPTIDE) ("NP and AF" . SPARSER::COLLECTION)
    ("AF" . SPARSER::PROTEIN)
    ("a goat anti-rabbit secondary antibody" . SPARSER::ANTIBODY)
    ("goat anti-mouse secondary antibody" . SPARSER::ANTIBODY)
    ("a Western blot" . SPARSER::PROTEIN) ("goat" . SPARSER::PROTEIN)
    ("The fibronectin (FN) antibody (to the neoepitope VRAA 271 ) and the N-terminal antibody (mAB 1936)"
     . SPARSER::COLLECTION)
    ("full-length FN and its fragments (FN-fs)" . SPARSER::COLLECTION)
    ("fibronectin (FN)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mAB" . SPARSER::DRUG)
    ("focal adhesion kinase (FAK) and mitogen-activated protein kinases (MAPKs)"
     . SPARSER::COLLECTION)
    ("diverse biologic" . SPARSER::DRUG) ("EDA or EDB" . SPARSER::COLLECTION)
    ("EDB" . SPARSER::PROTEIN) ("EDA" . SPARSER::PROTEIN)
    ("Fibronectin" . SPARSER::PROTEIN)
    ("Moderately degenerative discs" . SPARSER::BIO-COMPLEX)
    ("discs" . SPARSER::BIO-COMPLEX) ("Soluble proteins" . SPARSER::PROTEIN)
    ("FN" . SPARSER::PROTEIN) ("IVDs" . SPARSER::PROTEIN)
    ("protein (ADAM)" . SPARSER::PROTEIN) ("IVD" . SPARSER::PROTEIN)
    ("disc" . SPARSER::BIO-COMPLEX) ("ADAM" . SPARSER::PROTEIN)
    ("ADAM8" . SPARSER::PROTEIN) ("MMP-13" . SPARSER::PROTEIN)
    ("HTRA1" . SPARSER::PROTEIN) ("1-L" . SPARSER::PROTEIN)
    ("α 5 β 1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IDH1, and glutathione" . SPARSER::COLLECTION) ("GSSG" . SPARSER::DRUG)
    ("fatty acid and ketone" . SPARSER::COLLECTION)
    ("an essential metabolite" . SPARSER::MOLECULE)
    ("cobalt" . SPARSER::MOLECULE) ("nearly all the genes" . SPARSER::GENE)
    ("SDH" . SPARSER::PROTEIN) ("This major oncoprotein" . SPARSER::PROTEIN)
    ("HK2 and PFKFB3" . SPARSER::COLLECTION)
    ("pyruvate and lactate" . SPARSER::COLLECTION)
    ("ACCA and FASN" . SPARSER::COLLECTION)
    ("FASN and ACCA" . SPARSER::COLLECTION)
    ("the key lipogenic enzymes" . SPARSER::ENZYME)
    ("LCAT, PTDSS1 and PCYT1A" . SPARSER::COLLECTION)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("PTDSS1, PCYT1A and FASN" . SPARSER::COLLECTION)
    ("Ketone" . SPARSER::MOLECULE)
    ("propionate and acetone" . SPARSER::COLLECTION)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("reactive oxygen" . SPARSER::MOLECULE)
    ("taurine and glutathione" . SPARSER::COLLECTION)
    ("taurine" . SPARSER::MOLECULE)
    ("ligase, or gamma-glutamylcysteine synthetase" . SPARSER::COLLECTION)
    ("the hypoxia mimetic CoCl 2" . SPARSER::MOLECULE)
    ("glucose and lactate" . SPARSER::COLLECTION)
    ("Western Blot" . SPARSER::PROTEIN) ("HK2 and IDH1" . SPARSER::COLLECTION)
    ("IDH1 in the cytosol and IDH2" . SPARSER::COLLECTION)
    ("Pyruvate and lactate" . SPARSER::COLLECTION)
    ("lactate and p " . SPARSER::COLLECTION) ("Pyruvate" . SPARSER::PROTEIN)
    ("HK1 and HK2" . SPARSER::COLLECTION) ("BP" . SPARSER::PROTEIN)
    ("Fru" . SPARSER::PROTEIN) ("fructose" . SPARSER::PROTEIN)
    ("SLC2A1 , HK1 , HK2, PFKFB3 and LDHA" . SPARSER::COLLECTION)
    ("nucleic acid derivatives (ADP, p<0.01) and an unexpected sugar"
     . SPARSER::COLLECTION)
    ("nucleic acid derivatives" . SPARSER::DERIVATIVE)
    ("sugar" . SPARSER::MOLECULE) ("pyruvate" . SPARSER::PROTEIN)
    ("propionate" . SPARSER::MOLECULE) ("acetone" . SPARSER::MOLECULE)
    ("LCMS" . SPARSER::PROTEIN-FAMILY) ("NMR" . SPARSER::PROTEIN)
    ("Metabolites" . SPARSER::PROTEIN) ("SDHC" . SPARSER::PROTEIN)
    ("FASN" . SPARSER::PROTEIN) ("GSR" . SPARSER::PROTEIN)
    ("LCAT" . SPARSER::PROTEIN) ("LDHA" . SPARSER::PROTEIN)
    ("HK1" . SPARSER::PROTEIN)
    ("fatty acid and inositol" . SPARSER::COLLECTION)
    ("major traits" . SPARSER::PROTEIN) ("isocitrate" . SPARSER::PROTEIN)
    ("sdha" . SPARSER::PROTEIN) ("citrate" . SPARSER::MOLECULE)
    ("HIF1α, Akt, Myc, and p53" . SPARSER::COLLECTION)
    ("ACCA" . SPARSER::PROTEIN)
    ("a major breast cancer suppressor gene and the most frequently mutated gene"
     . SPARSER::COLLECTION)
    ("ketone" . SPARSER::MOLECULE) ("anti-oxidant" . SPARSER::DRUG)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("acetyl-coA" . SPARSER::MOLECULE) ("glycine)" . SPARSER::PROTEIN)
    ("gamma-glutamylcysteine synthetase" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE) ("PFK-1" . SPARSER::PROTEIN)
    ("Glut1" . SPARSER::PROTEIN) ("PTDSS1" . SPARSER::PROTEIN)
    ("PCYT1A" . SPARSER::PROTEIN) ("ARG2" . SPARSER::PROTEIN)
    ("ODC1" . SPARSER::PROTEIN) ("GOT2" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("PFKFB3" . SPARSER::PROTEIN)
    ("SLC2A1" . SPARSER::PROTEIN) ("HK2" . SPARSER::PROTEIN)
    ("N2" . SPARSER::PROTEIN) ("Fatty acid" . SPARSER::MOLECULE)
    ("1D" . SPARSER::PROTEIN) ("3- 2" . SPARSER::PROTEIN)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("HIF1α" . SPARSER::PROTEIN)
    ("Acetyl-CoA" . SPARSER::MOLECULE) ("ETS2 and EDN2" . SPARSER::COLLECTION)
    ("a gene’s" . SPARSER::PROTEIN)
    ("the AR’s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SPDEF" . SPARSER::PROTEIN)
    ("Androgen" . SPARSER::PROTEIN) ("PDEF" . SPARSER::PROTEIN)
    ("AR-V7 and AR-FL" . SPARSER::COLLECTION)
    ("FOXA1 and AR" . SPARSER::COLLECTION)
    ("EXTL2 and ETS2" . SPARSER::COLLECTION)
    ("EDN2 and ETS" . SPARSER::COLLECTION)
    ("EDN2 and ETS2" . SPARSER::COLLECTION)
    ("EDN2 or ETS2" . SPARSER::COLLECTION)
    ("RASSF3 and EXTL2" . SPARSER::COLLECTION)
    ("AR and its variants" . SPARSER::COLLECTION)
    ("PSA and PCDH11" . SPARSER::COLLECTION)
    ("TMPRSS2 and PCDH11" . SPARSER::COLLECTION)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION)
    ("PCDH11 and AR-FL" . SPARSER::COLLECTION)
    ("full-length and variant" . SPARSER::COLLECTION)
    ("approximately 80 kDa" . SPARSER::PROTEIN)
    ("pan-AR" . SPARSER::COLLECTION)
    ("The artificial AR-NTD isoform" . SPARSER::ISOFORM)
    ("FOXA1 or HNF3A" . SPARSER::COLLECTION)
    ("the apparently unique targets" . SPARSER::TARGET-PROTEIN)
    ("protocadherin" . SPARSER::PROTEIN)
    ("testosterone or DHT" . SPARSER::COLLECTION) ("DHT" . SPARSER::PROTEIN)
    ("AR or AR-V7" . SPARSER::COLLECTION)
    ("AR and AR-V7" . SPARSER::COLLECTION) ("AR-NTD" . SPARSER::COLLECTION)
    ("NTD" . SPARSER::PROTEIN) ("cryptic" . SPARSER::PROTEIN)
    ("castration-resistant PCa" . SPARSER::PROTEIN) ("PCa" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("LRIG1" . SPARSER::PROTEIN)
    ("ETS2" . SPARSER::PROTEIN) ("EDN2" . SPARSER::PROTEIN)
    ("EXTL2" . SPARSER::PROTEIN) ("RASSF3" . SPARSER::PROTEIN)
    ("GRE 2" . SPARSER::PROTEIN) ("PSA 1" . SPARSER::PROTEIN)
    ("HNF3A" . SPARSER::PROTEIN) ("forkhead box" . SPARSER::PROTEIN)
    ("PCDH11" . SPARSER::PROTEIN) ("serine 2" . SPARSER::PROTEIN)
    ("transmembrane protease" . SPARSER::PROTEIN)
    ("Prostate specific antigen" . SPARSER::PROTEIN)
    ("p160" . SPARSER::PROTEIN) ("FOXA1" . SPARSER::PROTEIN)
    ("AR-V7" . SPARSER::PROTEIN) ("a pivotal enzyme" . SPARSER::ENZYME)
    ("cis-" . SPARSER::PROTEIN)
    ("two interdependent components" . SPARSER::COMPONENT)
    ("EZH2, and lncRNA-EBIC" . SPARSER::COLLECTION)
    ("matrigel" . SPARSER::PROTEIN)
    ("an EZH2 antibody and nuclear" . SPARSER::COLLECTION)
    ("LncRNA" . SPARSER::RNA)
    ("Eleven mRNAs and nine lncRNAs" . SPARSER::COLLECTION)
    ("ASK" . SPARSER::PROTEIN) ("hub" . SPARSER::PROTEIN)
    ("could active" . SPARSER::ACTIVE)
    ("APOD, ESR1, MMP1, PCNA, and EZH2" . SPARSER::COLLECTION)
    ("APOD" . SPARSER::PROTEIN) ("CCDB" . SPARSER::PROTEIN)
    ("lncRNA and mRNA" . SPARSER::COLLECTION) ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("HOTAIR" . SPARSER::PROTEIN) ("EZH2, SUZ12 and EED" . SPARSER::COLLECTION)
    ("EED" . SPARSER::PROTEIN) ("methylase" . SPARSER::PROTEIN)
    ("PCR2" . SPARSER::PROTEIN)
    ("Enhancer of Zeste Homolog 2" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog2" . SPARSER::PROTEIN)
    ("strong LD" . SPARSER::PROTEIN)
    ("a more stringent barrier" . SPARSER::PROTEIN) ("Nan" . SPARSER::PROTEIN)
    ("Variants" . SPARSER::VARIANT) ("PS" . SPARSER::PROTEIN)
    ("Minor" . SPARSER::PROTEIN)
    ("the hTERT and TERT-CLPTM1L genes" . SPARSER::COLLECTION)
    ("reactive metabolites" . SPARSER::PROTEIN)
    ("CLPTM1L and TERT" . SPARSER::COLLECTION)
    ("the TERT gene and the CLPTM1L gene" . SPARSER::COLLECTION)
    ("Telomerase reverse transcriptase-cleft lip and palate transmembrane 1 like"
     . SPARSER::COLLECTION)
    ("palate transmembrane 1 like" . SPARSER::PROTEIN)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TT" . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN) ("TERT-CLPTM1L" . SPARSER::COLLECTION)
    ("carboxy-fluorescein" . SPARSER::DRUG) ("1 like" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("CLPTM1L" . SPARSER::PROTEIN)
    ("IGFBP-5, RASSF1C, and PIWIL1" . SPARSER::COLLECTION)
    ("MST2 and LATS" . SPARSER::COLLECTION) ("Metformin" . SPARSER::DRUG)
    ("waf/cip" . SPARSER::COLLECTION) ("ATM-AMPK-p21" . SPARSER::COLLECTION)
    ("cip" . SPARSER::PROTEIN) ("waf" . SPARSER::PROTEIN)
    ("IGFBP-5/RASSF1C" . SPARSER::COLLECTION)
    ("RASSF1C and PIWIL1" . SPARSER::COLLECTION)
    ("Dorsomorphin and Trichostatin" . SPARSER::COLLECTION)
    ("Dorsomorphin" . SPARSER::MOLECULE)
    ("The most notable reagents" . SPARSER::MOLECULE)
    ("negatively impacts RASSF1C" . SPARSER::PROTEIN)
    ("RASSF1C and IGFBP-5" . SPARSER::COLLECTION)
    ("RASSF1C-IGFBP-5" . SPARSER::COLLECTION) ("RASSF1C" . SPARSER::PROTEIN)
    ("RASSF1A-RASSF1C" . SPARSER::PROTEIN-PAIR) ("AGS" . SPARSER::PROTEIN)
    ("bax" . SPARSER::PROTEIN) ("BB-SP-CD133" . SPARSER::COLLECTION)
    ("EFG and FGF" . SPARSER::COLLECTION) ("EFG" . SPARSER::PROTEIN)
    ("BB" . SPARSER::PROTEIN) ("IGFBP-5 and PIWIL1" . SPARSER::COLLECTION)
    ("mitogens" . SPARSER::MITOGEN)
    ("The PIWIL proteins and their interacting small RNAs (piRNAs)"
     . SPARSER::COLLECTION)
    ("piRNAs" . SPARSER::RNA) ("Piwil1 and Piwil 2" . SPARSER::COLLECTION)
    ("Piwi" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Piwil 2" . SPARSER::PROTEIN)
    ("Piwil1" . SPARSER::PROTEIN) ("Piwil2, and Piwil3" . SPARSER::COLLECTION)
    ("Piwil2" . SPARSER::PROTEIN) ("Piwil 1" . SPARSER::PROTEIN)
    ("PIWI" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MID" . SPARSER::PROTEIN)
    ("argonaute" . SPARSER::PROTEIN-FAMILY)
    ("RASSF1A and RASSF1C" . SPARSER::COLLECTION)
    ("ATM-AMPK" . SPARSER::COLLECTION)
    ("a stem cell self-renewal gene" . SPARSER::GENE)
    ("piwil1" . SPARSER::PROTEIN) ("sh-RNA" . SPARSER::RNA)
    ("KU60019" . SPARSER::DRUG) ("bcl2" . SPARSER::PROTEIN)
    ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("compound C" . SPARSER::MOLECULE) ("CD133" . SPARSER::PROTEIN)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN) ("IGF I" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("Piwil3" . SPARSER::PROTEIN) ("PIWIL1" . SPARSER::PROTEIN)
    ("IGFBP-5" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("KSA" . SPARSER::PROTEIN) ("HAM" . SPARSER::PROTEIN)
    ("NAS" . SPARSER::PROTEIN) ("KAO" . SPARSER::PROTEIN)
    ("SP" . SPARSER::PROTEIN)
    ("EGFR inhibitors and BRAF inhibitors" . SPARSER::COLLECTION)
    ("CRCs" . SPARSER::PROTEIN)
    ("almost all sporadic MSI-H CRC" . SPARSER::PROTEIN)
    ("HNPCC or MSI-H" . SPARSER::COLLECTION)
    ("sporadic MSI" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("KRAS gene and the BRAF gene" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("right-sided CRC" . SPARSER::PROTEIN) ("MSS" . SPARSER::PROTEIN)
    ("sporadic CRC" . SPARSER::PROTEIN)
    ("v-Raf murine sarcoma viral oncogene homolog B1 ( BRAF)"
     . SPARSER::PROTEIN)
    ("PIK3CA/BRAF/NRAS/PTEN/TP53" . SPARSER::COLLECTION)
    ("panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("KRAS , BRAF and PI3K" . SPARSER::COLLECTION) ("LS" . SPARSER::PROTEIN)
    ("HNPCC" . SPARSER::PROTEIN) ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("MgCl2" . SPARSER::MOLECULE) ("D5S346" . SPARSER::PROTEIN)
    ("v-Raf murine sarcoma viral oncogene homolog B1" . SPARSER::PROTEIN)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("meta" . SPARSER::PROTEIN) ("giving anti-EGFR drugs" . SPARSER::DRUG)
    ("the currently known clinically relevant genes" . SPARSER::GENE)
    ("rest" . SPARSER::PROTEIN)
    ("fluorouracil, leucovorin and irinotecan" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("leucovorin" . SPARSER::DRUG)
    ("mCRC" . SPARSER::PROTEIN) ("NRAS and HRAS" . SPARSER::COLLECTION)
    ("HRAS" . SPARSER::PROTEIN) ("Erbitux" . SPARSER::DRUG)
    ("a negative predictive biomarker" . SPARSER::MOLECULE)
    ("Anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("low tumour fraction and a third" . SPARSER::COLLECTION)
    ("Aims" . SPARSER::PROTEIN) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("its proximal downstream effectors" . SPARSER::EFFECTOR)
    ("paralogs" . SPARSER::PROTEIN)
    ("a unique miR-203 target" . SPARSER::TARGET-PROTEIN)
    ("either anti-apoptotic proteins (e.g. API5, BIRC2, and TRIAP1 ) or the novel oncogenic molecule"
     . SPARSER::COLLECTION)
    ("SOCS3, BCL2 , and BIRC5" . SPARSER::COLLECTION)
    ("Snail/PRCs" . SPARSER::COLLECTION) ("PRCs" . SPARSER::PROTEIN)
    ("the associated Snail/Suz12" . SPARSER::COLLECTION)
    ("Snail/Suz12" . SPARSER::COLLECTION)
    ("The polycomb repressive complexes PRC1 and PRC2" . SPARSER::COLLECTION)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("EGFR and ERK1/2" . SPARSER::COLLECTION)
    ("SRC and EGFR" . SPARSER::COLLECTION) ("RAF-ERK" . SPARSER::COLLECTION)
    ("RAS, AKT, and MAPK" . SPARSER::COLLECTION)
    ("anti-apoptotic proteins as well as an oncogenic molecule"
     . SPARSER::COLLECTION)
    ("proteins, API5, BIRC2 , and TRIAP1" . SPARSER::COLLECTION)
    ("proteins, API5, BIRC2, and TRIAP1" . SPARSER::COLLECTION)
    ("EGFR/RAS" . SPARSER::COLLECTION)
    ("the control anti-miR" . SPARSER::ANTIBODY)
    ("CI1033 or AG1478" . SPARSER::COLLECTION)
    ("autocrine AREG, EREG, and TGFA" . SPARSER::COLLECTION)
    ("AREG, EREG, and TGFA" . SPARSER::COLLECTION)
    ("AREG, EREG , and TGFA" . SPARSER::COLLECTION)
    ("LNCap" . SPARSER::PROTEIN) ("WB" . SPARSER::PROTEIN)
    ("p-EGFR" . SPARSER::COLLECTION) ("Blot" . SPARSER::PROTEIN)
    ("DU145/RasB1" . SPARSER::COLLECTION) ("RasG" . SPARSER::PROTEIN)
    ("API5, BIRC2 , and TRIAP1" . SPARSER::COLLECTION)
    ("SRC" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a tumor-suppressive microRNA" . SPARSER::MICRO-RNA)
    ("Ras and EGFR" . SPARSER::COLLECTION) ("miRs" . SPARSER::MICRO-RNA)
    ("an essential step" . SPARSER::PROTEIN) ("-mutant" . SPARSER::MUTANT)
    ("epiregulin" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("EREG and TGFA" . SPARSER::COLLECTION)
    ("API5, BIRC2, and TRIAP1" . SPARSER::COLLECTION)
    ("EREG" . SPARSER::PROTEIN) ("Glo 3" . SPARSER::PROTEIN)
    ("N-Ras" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("Bmi1" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN) ("Suz12" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("TNFAIP8" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("CI1033" . SPARSER::DRUG) ("RasB1" . SPARSER::PROTEIN)
    ("DAB2IP" . SPARSER::PROTEIN) ("activator protein 1" . SPARSER::PROTEIN)
    ("TRIAP1" . SPARSER::PROTEIN) ("BIRC2" . SPARSER::PROTEIN)
    ("API5" . SPARSER::PROTEIN)
    ("nutlin-3 and actinomycin D" . SPARSER::COLLECTION)
    ("PTEN or PTEN" . SPARSER::COLLECTION)
    ("PTEN and HER2" . SPARSER::COLLECTION) ("dL" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK" . SPARSER::COLLECTION)
    ("serum albumin and lactate" . SPARSER::COLLECTION)
    ("p63 and p73" . SPARSER::COLLECTION) ("hot" . SPARSER::PROTEIN)
    ("nutlin-3" . SPARSER::DRUG)
    ("a fairly new prognostic biomarker" . SPARSER::MOLECULE)
    ("ER, PGR and Ki-67" . SPARSER::COLLECTION) ("PGR" . SPARSER::PROTEIN)
    ("Both a retrospective cohort (data not shown) and the described prospective cohort"
     . SPARSER::COLLECTION)
    ("the described prospective cohort" . SPARSER::MOLECULE)
    ("Both a retrospective cohort" . SPARSER::MOLECULE)
    ("the prospective cohort" . SPARSER::MOLECULE)
    ("ER/PgR" . SPARSER::COLLECTION) ("the economic impact" . SPARSER::PROTEIN)
    ("/HER2" . SPARSER::COLLECTION)
    ("colorectal study group" . SPARSER::MOLECULE) ("CHT" . SPARSER::PROTEIN)
    ("the quantitative and qualitative impact" . SPARSER::PROTEIN)
    ("MGS" . SPARSER::PROTEIN) ("retinoids" . SPARSER::DRUG)
    ("ATRA, and promyelocytes" . SPARSER::COLLECTION)
    ("RAR α and Nrf2" . SPARSER::COLLECTION)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("daunorubicin and Ara-C" . SPARSER::COLLECTION)
    ("standard chemotherapeutic drugs" . SPARSER::DRUG)
    ("iron" . SPARSER::MOLECULE) ("catabolism" . SPARSER::PROTEIN)
    ("proteins or other thiol-rich molecules ( xref )" . SPARSER::COLLECTION)
    ("fluorescein" . SPARSER::MOLECULE)
    ("mannitol and tiron" . SPARSER::COLLECTION)
    ("superoxide and hydroxyl radical" . SPARSER::COLLECTION)
    ("Ara-C, daunorubicin and ATO" . SPARSER::COLLECTION)
    ("RAR α and ATRA" . SPARSER::COLLECTION)
    ("a cellular subline" . SPARSER::PROTEIN) ("subline" . SPARSER::PROTEIN)
    ("pSFFV-HO-1" . SPARSER::COLLECTION) ("ATRA and ATO" . SPARSER::COLLECTION)
    ("HL60 and NB4" . SPARSER::COLLECTION) ("BSO" . SPARSER::DRUG)
    ("methotrexate, daunorubicin or Ara-C" . SPARSER::COLLECTION)
    ("ATO or t" . SPARSER::COLLECTION) ("/RAR α" . SPARSER::COLLECTION)
    ("HO-1 and GSH" . SPARSER::COLLECTION)
    ("HO-1 or GSH" . SPARSER::COLLECTION) ("AML and APL" . SPARSER::COLLECTION)
    ("the fluorescent dye DCFH-DA" . SPARSER::DRUG) ("dye" . SPARSER::MOLECULE)
    ("mannitol or tiron" . SPARSER::COLLECTION) ("tiron" . SPARSER::MOLECULE)
    ("mannitol" . SPARSER::PROTEIN)
    ("both ATO (6.25  μ  M ) and t -BHQ (25  μ  M )" . SPARSER::COLLECTION)
    ("NQO1 or HO-1" . SPARSER::COLLECTION)
    ("Ara-C or daunorubicin" . SPARSER::COLLECTION)
    ("Ara-C (1–5  μ  M ) or daunorubicin (0.25–1  μ  M )"
     . SPARSER::COLLECTION)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("a well-known electrophilic Nrf2 activator" . SPARSER::ACTIVATOR)
    ("HO-1, NQO1, GCLM and ferritin" . SPARSER::COLLECTION)
    ("NQO1 and HO-1" . SPARSER::COLLECTION) ("haem" . SPARSER::MOLECULE)
    ("PML–RAR" . SPARSER::COLLECTION)
    ("ATRA and chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("daunorubicin or idarubicin" . SPARSER::COLLECTION)
    ("idarubicin" . SPARSER::DRUG) ("daunorubicin" . SPARSER::DRUG)
    ("PML–RAR α" . SPARSER::COLLECTION) ("receptor-" . SPARSER::PROTEIN)
    ("ferritin" . SPARSER::PROTEIN) ("GCLM" . SPARSER::PROTEIN)
    ("Gene and protein" . SPARSER::COLLECTION) ("HL60" . SPARSER::PROTEIN)
    ("ATO" . SPARSER::PROTEIN) ("retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("ATRA" . SPARSER::DRUG) ("APL" . SPARSER::PROTEIN)
    ("promyelocytic" . SPARSER::PROTEIN)
    ("carbon monoxide" . SPARSER::MOLECULE) ("pro-oxidant" . SPARSER::MOLECULE)
    ("sodium arsenite" . SPARSER::DRUG) ("N -acetyl-cysteine" . SPARSER::DRUG)
    ("superoxide anion" . SPARSER::MOLECULE) ("Q-VD-OPh" . SPARSER::DRUG)
    ("Asp-Glu" . SPARSER::MOLECULE) ("ferritin heavy chain" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TBP1" . SPARSER::PROTEIN)
    ("tert -butylhydroquinone" . SPARSER::DRUG)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("Retinoic acid" . SPARSER::MOLECULE) ("Ara-C" . SPARSER::DRUG)
    ("RAR α" . SPARSER::PROTEIN) ("NB4" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE)
    ("Myc and CDKN1B" . SPARSER::COLLECTION)
    ("Brachyury/p27  Kip1" . SPARSER::COLLECTION)
    ("p27 Kip1 and cMYC" . SPARSER::COLLECTION)
    ("Brachyury and p27  Kip1" . SPARSER::COLLECTION)
    ("Brachyury and p27 Kip1" . SPARSER::COLLECTION)
    ("Brachyury-" . SPARSER::PROTEIN) ("-siRNA" . SPARSER::COLLECTION)
    ("cMYC/p27  Kip1" . SPARSER::COLLECTION) ("cMYC/p27" . SPARSER::COLLECTION)
    ("Brachyury" . SPARSER::PROTEIN)
    ("siRNA-Brachyury" . SPARSER::PROTEIN-PAIR)
    ("phospho-Rb or unphosphorylated-Rb" . SPARSER::COLLECTION)
    ("adherent monolayers" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN)
    ("cMYC and p27 Kip1" . SPARSER::COLLECTION) ("cMYC" . SPARSER::PROTEIN)
    ("cyclin-CDK" . SPARSER::COLLECTION) ("KIP" . SPARSER::PROTEIN)
    ("well-described nuclear-associated tumour suppressor"
     . SPARSER::SUPPRESSOR)
    ("inhibitors (CKI)" . SPARSER::INHIBITOR) ("CKI" . SPARSER::PROTEIN)
    ("p27Kip1" . SPARSER::PROTEIN) ("POLR2L" . SPARSER::PROTEIN)
    ("POLR3B" . SPARSER::PROTEIN) ("TNFRSF12A" . SPARSER::PROTEIN)
    ("CDC27" . SPARSER::PROTEIN) ("p27  Kip1" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("Cyclin D2" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("Brachyury protein" . SPARSER::PROTEIN)
    ("p53, PARP-1 and β-catenin" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("peroxisome proliferator-activated receptors and glucocorticoid receptor"
     . SPARSER::COLLECTION)
    ("receptors and glucocorticoid receptor" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTor" . SPARSER::COLLECTION)
    ("potentially more specific activators" . SPARSER::ACTIVATOR)
    ("ATP/AMP" . SPARSER::PROTEIN-PAIR)
    ("several tumour-relevant genes" . SPARSER::GENE)
    ("dominant-negative AMPK" . SPARSER::PROTEIN) ("androgens" . SPARSER::DRUG)
    ("NKX3.1 and CAMKK2" . SPARSER::COLLECTION)
    ("CAMKK2 and another established AR target gene" . SPARSER::COLLECTION)
    ("CAMKK2 , KLK2 , KLK3 and TMPRSS2" . SPARSER::COLLECTION)
    ("AMPKα1 ( PRKAA1 ) and AMPKα2 ( PRKAA2 )" . SPARSER::COLLECTION)
    ("CAMKK2 , KLK2 , and TMPRSS2" . SPARSER::COLLECTION)
    ("bicalutamide" . SPARSER::DRUG) ("MMTV-" . SPARSER::PROTEIN)
    ("kallikrein" . SPARSER::PROTEIN)
    ("AMPK- and AR-regulated genes (Figure xref )" . SPARSER::COLLECTION)
    ("AMPK-" . SPARSER::PROTEIN)
    ("metformin- and androgen receptor" . SPARSER::COLLECTION)
    ("metformin-" . SPARSER::DRUG)
    ("transcriptional regulator, and NKX3.1" . SPARSER::COLLECTION)
    ("p53 [ xref ] and NR3C1 [ xref ]" . SPARSER::COLLECTION)
    ("glucocorticoid receptor ( NR3C1 ) and MYC" . SPARSER::COLLECTION)
    ("AR, p53, glucocorticoid receptor ( NR3C1 ) and MYC"
     . SPARSER::COLLECTION)
    ("the AICAR- and metformin-regulated genes" . SPARSER::COLLECTION)
    ("MANEA" . SPARSER::PROTEIN) ("NES" . SPARSER::PROTEIN)
    ("thioridazine, wortmannin and LY-294002" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN) ("thioridazine" . SPARSER::DRUG)
    ("Map" . SPARSER::PROTEIN) ("AICAR-" . SPARSER::PROTEIN)
    ("AICAR or metformin" . SPARSER::COLLECTION)
    ("5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and metformin [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("ribonucleotide (AICAR)" . SPARSER::MOLECULE)
    ("differentially expressed genes" . SPARSER::GENE)
    ("AMPK and AR" . SPARSER::COLLECTION)
    ("multi-tyrosine kinase" . SPARSER::COLLECTION)
    ("dasatinib" . SPARSER::DRUG) ("hypoxia or glucose" . SPARSER::COLLECTION)
    ("a highly conserved heterotrimeric serine/threonine kinase"
     . SPARSER::KINASE)
    ("beta and gamma" . SPARSER::COLLECTION)
    ("fatty acid synthase and alpha-methylacyl-CoA" . SPARSER::COLLECTION)
    ("CoA" . SPARSER::MOLECULE) ("AMPK and AMPK" . SPARSER::COLLECTION)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("protein kinase (AMPK)" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("log2" . SPARSER::PROTEIN)
    ("PRKAA2" . SPARSER::PROTEIN) ("PRKAA1" . SPARSER::PROTEIN)
    ("AMPKα1" . SPARSER::PROTEIN) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("TMPRSS2" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("COL4A3BP" . SPARSER::PROTEIN) ("PPAP2A" . SPARSER::PROTEIN)
    ("DEGS1" . SPARSER::PROTEIN) ("KLK3" . SPARSER::PROTEIN)
    ("KLK2" . SPARSER::PROTEIN) ("NKX3.1" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("NR3C1" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("PRR15" . SPARSER::PROTEIN) ("OR51E1" . SPARSER::PROTEIN)
    ("FBXO9" . SPARSER::PROTEIN) ("DSC2" . SPARSER::PROTEIN)
    ("HNRNPH1" . SPARSER::PROTEIN) ("LY-294002" . SPARSER::PROTEIN)
    ("anti-diabetic" . SPARSER::DRUG) ("CAMKK2" . SPARSER::PROTEIN)
    ("Calcium/Calmodulin-Dependent Protein Kinase Kinase 2" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN)
    ("AMP-activated" . SPARSER::PROTEIN)
    ("centrosomal Aurora A" . SPARSER::PROTEIN) ("PAK" . SPARSER::PROTEIN)
    ("CLASP" . SPARSER::PROTEIN) ("stabilizer" . SPARSER::MOLECULE)
    ("MCAK and the active (pT288)–Aurora A" . SPARSER::COLLECTION)
    ("–Aurora A" . SPARSER::COLLECTION)
    ("a mitotic molecular motor protein" . SPARSER::PROTEIN)
    ("CA-Rac1 and GFP-MCAK" . SPARSER::COLLECTION)
    ("CA-Rac1 and MCAK" . SPARSER::COLLECTION)
    ("CA-Rac1 or MCAK" . SPARSER::COLLECTION)
    ("mApple-tubulin" . SPARSER::COLLECTION) ("Aurora A–" . SPARSER::PROTEIN)
    ("pT288" . SPARSER::PROTEIN) ("DN-Rac1" . SPARSER::COLLECTION)
    ("pT288–Aurora A" . SPARSER::COLLECTION) ("active (CA)" . SPARSER::ACTIVE)
    ("dominant-negative (DN) mutants" . SPARSER::MUTANT)
    ("Rac1 and Aurora A" . SPARSER::COLLECTION)
    ("the phosphomimic EEEEE MCAK or S196E MCAK mutants" . SPARSER::COLLECTION)
    ("the phosphomimic EEEEE MCAK" . SPARSER::PROTEIN)
    ("the AAAAA MCAK or S196A MCAK nonphosphorylatable mutants"
     . SPARSER::COLLECTION)
    ("S196A MCAK nonphosphorylatable mutants" . SPARSER::MUTANT)
    ("phosphomimic (serine to glutamic acid) MCAK" . SPARSER::PROTEIN)
    ("MCAK and EEEEE" . SPARSER::COLLECTION) ("serines" . SPARSER::AMINO-ACID)
    ("fluorescent EB3" . SPARSER::PROTEIN)
    ("Aurora A and MCAK" . SPARSER::COLLECTION)
    ("Aurora A or MCAK" . SPARSER::COLLECTION)
    ("GFP-Zyxin" . SPARSER::COLLECTION) ("GFP–Aurora A" . SPARSER::COLLECTION)
    ("Zyxin" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("Em" . SPARSER::PROTEIN) ("Aurora A–MCAK" . SPARSER::COLLECTION)
    ("EB3 or tubulin" . SPARSER::COLLECTION)
    ("mCherry-MCAK" . SPARSER::COLLECTION)
    ("mEmerald (Em) fluorescent protein fused" . SPARSER::PROTEIN)
    ("Em–Aurora A" . SPARSER::COLLECTION)
    ("all available anti-MCAK antibodies" . SPARSER::ANTIBODY)
    ("MCAK-shRNA" . SPARSER::COLLECTION) ("BFP" . SPARSER::PROTEIN)
    ("soft (0.7 kPa) polyacrylamide substrates" . SPARSER::SUBSTRATE)
    ("mApple" . SPARSER::PROTEIN)
    ("mApple fluorescent protein fused" . SPARSER::PROTEIN)
    ("mApple-EB3" . SPARSER::COLLECTION) ("GFP-MCAK" . SPARSER::COLLECTION)
    ("Op18/stathmin" . SPARSER::COLLECTION) ("stathmin" . SPARSER::PROTEIN)
    ("triphosphatase" . SPARSER::PROTEIN) ("MTs" . SPARSER::PROTEIN)
    ("Mitotic centromere-associated kinesin (MCAK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPs" . SPARSER::PROTEIN) ("Rac1–Aurora A–MCAK" . SPARSER::COLLECTION)
    ("anti–" . SPARSER::ANTIBODY) ("Ca 2" . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("aurora kinase A" . SPARSER::PROTEIN)
    ("Aurora kinase A" . SPARSER::PROTEIN)
    ("Pak-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pak1" . SPARSER::PROTEIN)
    ("Kinesin-13" . SPARSER::PROTEIN) ("Op18" . SPARSER::PROTEIN)
    ("Myosin II" . SPARSER::PROTEIN) ("Aurora A" . SPARSER::PROTEIN)
    ("mm3" . SPARSER::PROTEIN) ("Glo" . SPARSER::PROTEIN)
    ("Drugs" . SPARSER::DRUG) ("LSR" . SPARSER::PROTEIN)
    ("RNAse" . SPARSER::PROTEIN) ("SNP or STR" . SPARSER::COLLECTION)
    ("STR" . SPARSER::PROTEIN) ("hyperglycemia" . SPARSER::PROTEIN)
    ("CDK 4/6 and PI3K" . SPARSER::COLLECTION)
    ("mTORC-PI3K" . SPARSER::COLLECTION) ("PI3K/CDK 4/6" . SPARSER::COLLECTION)
    ("Akt and mTORC" . SPARSER::COLLECTION)
    ("PRAS40 and mTORC" . SPARSER::COLLECTION)
    ("mTORC and its downstream effectors" . SPARSER::COLLECTION)
    ("BYL719 and LEE011" . SPARSER::COLLECTION)
    ("BYL719 or LEE011" . SPARSER::COLLECTION)
    ("LEE011 and GDC-0941" . SPARSER::COLLECTION)
    ("Akt and Cyclin D/" . SPARSER::COLLECTION)
    ("mTORC1 and Akt" . SPARSER::COLLECTION)
    ("Akt and mTORC1" . SPARSER::COLLECTION)
    ("parental MCF7" . SPARSER::PROTEIN)
    ("CCND1 or CDK4 and CDK6" . SPARSER::COLLECTION)
    ("pAkt and pRB" . SPARSER::COLLECTION)
    ("pRB or mTORC1" . SPARSER::COLLECTION)
    ("CDK 4/6-Cyclin D1" . SPARSER::COLLECTION)
    ("PI3K and TORC1" . SPARSER::COLLECTION)
    ("mTORC or CDK 4/6" . SPARSER::COLLECTION)
    ("twelve PIK3CA mutant and ten PIK3CA wild-type lines ( xref )"
     . SPARSER::COLLECTION)
    ("CCND1 (which encodes for Cyclin D1) or CDK4 and CDK6 ( xref )"
     . SPARSER::COLLECTION)
    ("LEE011 and PI3Ki" . SPARSER::COLLECTION)
    ("CDK 4/6 and PI3Ki" . SPARSER::COLLECTION)
    ("PI3Ki and LEE011" . SPARSER::COLLECTION)
    ("the parental line" . SPARSER::PROTEIN)
    ("pAkt and PIP 3" . SPARSER::COLLECTION)
    ("PIP 3 , pAkt and AKT" . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("pAkt and its substrates" . SPARSER::COLLECTION)
    ("substrate and S6" . SPARSER::COLLECTION)
    ("PIP 3 , pAkt, and phosphorylation of Akt substrates in the MCF7R cells ( xref )"
     . SPARSER::COLLECTION)
    ("GDC-0941 or BYL719" . SPARSER::COLLECTION)
    ("the respective PI3Ki" . SPARSER::PROTEIN)
    ("ATP citrate lyase and PRAS40" . SPARSER::COLLECTION)
    ("phosphorylated Akt (pAkt) and Akt substrates" . SPARSER::COLLECTION)
    ("Phosphatidylinositol" . SPARSER::MOLECULE)
    ("CDK 4/6, mTORC, and Akt" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent paclitaxel" . SPARSER::DRUG)
    ("the dual PI3K/mTORC inhibitor BEZ235" . SPARSER::DRUG)
    ("PI3K/mTORC" . SPARSER::COLLECTION) ("DR" . SPARSER::PROTEIN)
    ("BYL719 or GDC-0941" . SPARSER::COLLECTION)
    ("pan-isoform" . SPARSER::COLLECTION)
    ("p110α-isoform" . SPARSER::COLLECTION)
    ("dual PI3K and mTOR inhibitors" . SPARSER::INHIBITOR)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("BEZ235 and GDC-0980" . SPARSER::COLLECTION)
    ("PI3K and mTORC" . SPARSER::COLLECTION) ("mTORC" . SPARSER::PROTEIN)
    ("PI3K and CDK 4/6" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("RSK 3" . SPARSER::PROTEIN) ("matrix associated" . SPARSER::PROTEIN)
    ("Cyclin D" . SPARSER::PROTEIN) ("PD-0332991" . SPARSER::DRUG)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("ATP citrate lyase" . SPARSER::PROTEIN) ("AZD8055" . SPARSER::DRUG)
    ("Rad001" . SPARSER::DRUG) ("LEE011" . SPARSER::DRUG)
    ("GDC-0941" . SPARSER::DRUG) ("BYL719" . SPARSER::DRUG)
    ("GDC-0980" . SPARSER::DRUG) ("BEZ235" . SPARSER::DRUG)
    ("PI3Ki" . SPARSER::PROTEIN) ("PI3K inhibitor BYL719" . SPARSER::DRUG)
    ("CDK 4/6" . SPARSER::PROTEIN) ("DM, and c-MYCp" . SPARSER::COLLECTION)
    ("GAL4-c-MYC" . SPARSER::COLLECTION) ("aTM" . SPARSER::PROTEIN)
    ("pGL3-DBE" . SPARSER::COLLECTION)
    ("SIRT1 and FOXO3" . SPARSER::COLLECTION)
    ("SIRT1 and FOXO" . SPARSER::COLLECTION)
    ("a multifunctional NAD + dependent protein deacetylase"
     . SPARSER::PROTEIN)
    ("SIRT1 and FOXO3a" . SPARSER::COLLECTION)
    ("tel2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tel1" . SPARSER::PROTEIN)
    ("GAL4" . SPARSER::PROTEIN) ("DAF-16" . SPARSER::PROTEIN)
    ("β-Gal" . SPARSER::PROTEIN) ("TAK1" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE)
    ("inhibitors and agents" . SPARSER::COLLECTION) ("FAT" . SPARSER::PROTEIN)
    ("focal adhesion kinase (FAK) and EGFR" . SPARSER::COLLECTION)
    ("proteins and EGFR" . SPARSER::COLLECTION)
    ("EGFR and its downstream effectors" . SPARSER::COLLECTION)
    ("punctate vinculin-positive focal complexes" . SPARSER::BIO-COMPLEX)
    ("punctate" . SPARSER::PROTEIN)
    ("EGFR and focal adhesion proteins ( xref )" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("focal adhesion kinase (FAK) and PI3K" . SPARSER::COLLECTION)
    ("EGFR and PI3K" . SPARSER::COLLECTION)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("DMSO-only" . SPARSER::MOLECULE) ("Wortmannin" . SPARSER::PROTEIN)
    ("Triciribine" . SPARSER::MOLECULE)
    ("Tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous EGF" . SPARSER::PROTEIN) ("EGFR and Akt" . SPARSER::COLLECTION)
    ("phosphorylated Akt (pAkt) and total PI3K" . SPARSER::COLLECTION)
    ("EGFR or its downstream effectors Akt and PI3K ( xref )"
     . SPARSER::COLLECTION)
    ("pAkt" . SPARSER::PROTEIN-FAMILY) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE) ("polyacrylamide" . SPARSER::DRUG)
    ("BrdU" . SPARSER::DRUG) ("bromodeoxyuridine" . SPARSER::DRUG)
    ("highly compliant substrates" . SPARSER::SUBSTRATE)
    ("Akt and PI3K" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("MAPK, RAF1, and Src" . SPARSER::COLLECTION)
    ("protein and phosphoprotein" . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("a single biotin-tagged secondary antibody" . SPARSER::ANTIBODY)
    ("proteins and phosphoproteins" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN) ("RPPA" . SPARSER::PROTEIN)
    ("EGFR and focal adhesion markers co-localize" . SPARSER::COLLECTION)
    ("soft substrates" . SPARSER::SUBSTRATE)
    ("EGFR, Akt, and PI3K" . SPARSER::COLLECTION)
    ("microenvironmental stiffness cues" . SPARSER::PROTEIN-FAMILY)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION) ("EGFRvIII" . SPARSER::PROTEIN)
    ("downstream signaling molecules phosphoinositide 3-kinase (PI3K) and protein kinase B (PKB or Akt)"
     . SPARSER::COLLECTION)
    ("PKB or Akt" . SPARSER::COLLECTION)
    ("ErbB1 or HER1" . SPARSER::COLLECTION)
    ("cell-intrinsic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, Akt, or PI3 kinase" . SPARSER::COLLECTION)
    ("EGFR and its downstream effector Akt" . SPARSER::COLLECTION)
    ("PD153035" . SPARSER::DRUG)
    ("growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF1" . SPARSER::PROTEIN) ("Tyrphostin AG1478" . SPARSER::DRUG)
    ("HER1" . SPARSER::PROTEIN) ("myosin II" . SPARSER::PROTEIN)
    ("DQ" . SPARSER::MOLECULE) ("CYCL" . SPARSER::PROTEIN)
    ("DH" . SPARSER::PROTEIN) ("at least one SNP" . SPARSER::PROTEIN)
    ("gene, and 6q25" . SPARSER::COLLECTION) ("TAGAP" . SPARSER::PROTEIN)
    ("KIAA1109 , ADAD1 , IL2 and IL21" . SPARSER::COLLECTION)
    ("CCR3 and CCR2" . SPARSER::COLLECTION) ("Quad" . SPARSER::DRUG)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("HLA-DQ2" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("FYCO1" . SPARSER::PROTEIN) ("CXCR6" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("IL21" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("KIAA1109" . SPARSER::PROTEIN) ("CCR3" . SPARSER::PROTEIN)
    ("or 2" . SPARSER::MOLECULE) ("DQ2" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("p14" . SPARSER::PROTEIN) ("IGF-mTOR" . SPARSER::COLLECTION)
    ("Fli-1
and RNA helicase A"
     . SPARSER::COLLECTION)
    ("midostaurin" . SPARSER::DRUG) ("mithramycin" . SPARSER::DRUG)
    ("luciferase–EWS-Fli-1" . SPARSER::COLLECTION)
    ("cytosine arabinoside, doxorubicin,
and rapamycin"
     . SPARSER::COLLECTION)
    ("refs" . SPARSER::PROTEIN)
    ("c-Myc [half-life = ∼30 min  xref  ] and cyclin D1 [half-life <30 min  xref  ]"
     . SPARSER::COLLECTION)
    ("a translational
inhibitor"
     . SPARSER::INHIBITOR)
    ("p62/SQSTM1" . SPARSER::COLLECTION) ("glycoprotein" . SPARSER::PROTEIN)
    ("chloroquine or a
cathepsin D inhibitor"
     . SPARSER::COLLECTION)
    ("pepstatin" . SPARSER::DRUG) ("CIMPR and retromer" . SPARSER::COLLECTION)
    ("CIMPR or VPS26A" . SPARSER::COLLECTION)
    ("insoluble proteins" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION)
    ("FLAG-EWS-Fli-1" . SPARSER::COLLECTION) ("lamin" . SPARSER::PROTEIN)
    ("insoluble protein" . SPARSER::PROTEIN)
    ("The biotinylated vicinal proteins" . SPARSER::PROTEIN)
    ("streptavidin" . SPARSER::PROTEIN) ("BirA" . SPARSER::PROTEIN)
    ("p21 (CDKN1A)
and histone macroH2A"
     . SPARSER::COLLECTION)
    ("obtained using two unrelated nuclear proteins, p21 (CDKN1A)
and histone macroH2A"
     . SPARSER::COLLECTION)
    ("macroH2A" . SPARSER::PROTEIN)
    ("FLAG-His-tagged EWS-Fli-1" . SPARSER::COLLECTION)
    ("ESI" . SPARSER::PROTEIN) ("nickel" . SPARSER::MOLECULE)
    ("hydrolase" . SPARSER::PROTEIN)
    ("EWS and an Ets family transcription factor" . SPARSER::COLLECTION)
    ("TFEB" . SPARSER::PROTEIN) ("hydrolases" . SPARSER::PROTEIN)
    ("CIMPR" . SPARSER::PROTEIN) ("mannose" . SPARSER::MOLECULE)
    ("cation" . SPARSER::MOLECULE) ("EWS-Fli-1" . SPARSER::COLLECTION)
    ("EWS and
an Ets family transcription factor"
     . SPARSER::COLLECTION)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("torin
1"
     . SPARSER::DRUG)
    ("cathepsin D" . SPARSER::PROTEIN)
    ("cathepsin
D"
     . SPARSER::PROTEIN)
    ("phosphate receptor" . SPARSER::PROTEIN) ("K-X" . SPARSER::PROTEIN)
    ("U2AF1" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("p62" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LAMP2" . SPARSER::PROTEIN)
    ("B12" . SPARSER::PROTEIN) ("HCO 3" . SPARSER::MOLECULE)
    ("Cathepsin D" . SPARSER::PROTEIN) ("VPS26A" . SPARSER::PROTEIN)
    ("Cytosine arabinoside" . SPARSER::DRUG) ("torin 1" . SPARSER::DRUG)
    ("phosphate
receptor"
     . SPARSER::PROTEIN)
    ("Fli-1" . SPARSER::PROTEIN) ("a Canadian cohort" . SPARSER::MOLECULE)
    ("uPA and PAI-1" . SPARSER::COLLECTION)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("both uPAR (using the #3936 anti-uPAR antibody) and PAI-1 (using the MAI-11 anti-PAI-1 antibody)"
     . SPARSER::COLLECTION)
    ("MAI" . SPARSER::PROTEIN) ("stromal macrophages" . SPARSER::PROTEIN)
    ("laminin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("uPAR, PAI-1 and uPA" . SPARSER::COLLECTION)
    ("reliable prognostic biomarkers" . SPARSER::MOLECULE)
    ("gingival rim" . SPARSER::PROTEIN) ("rim" . SPARSER::PROTEIN)
    ("uPAR or PAI-1" . SPARSER::COLLECTION)
    ("typical examples" . SPARSER::EXAMPLE)
    ("PAI-1 and uPA" . SPARSER::COLLECTION) ("vitronectin" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1 (PAI-1) and PAI-2"
     . SPARSER::COLLECTION)
    ("uPA and tPA" . SPARSER::COLLECTION)
    ("either urokinase plasminogen activator (uPA) or tissue type plasminogen activator (tPA)"
     . SPARSER::COLLECTION)
    ("tPA" . SPARSER::PROTEIN) ("uPA" . SPARSER::PROTEIN)
    ("plasminogen" . SPARSER::PROTEIN) ("plasmin" . SPARSER::PROTEIN)
    ("p53 and matrix" . SPARSER::COLLECTION) ("TNM-groups" . SPARSER::MOLECULE)
    ("TNM" . SPARSER::MOLECULE)
    ("potential predictive biomarkers" . SPARSER::MOLECULE)
    ("uPAR and PAI-1" . SPARSER::COLLECTION)
    ("uPAR (p = 0.031) and PAI-1 (p = 0.021)" . SPARSER::COLLECTION)
    ("uPAR" . SPARSER::PROTEIN) ("Norwegian cohort" . SPARSER::MOLECULE)
    ("PA" . SPARSER::PROTEIN) ("predictive biomarkers" . SPARSER::MOLECULE)
    ("phospholipase C" . SPARSER::PROTEIN) ("PAI-2" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("PAI-1" . SPARSER::PROTEIN) ("a larger part" . SPARSER::COMPONENT)
    ("phenocopies" . SPARSER::PROTEIN) ("p53 or p53" . SPARSER::COLLECTION)
    ("HSCs" . SPARSER::PROTEIN) ("Fbw7" . SPARSER::PROTEIN)
    ("tumor-associated MYC alleles" . SPARSER::ALLELE)
    ("Recent BL" . SPARSER::PROTEIN) ("BL" . SPARSER::PROTEIN)
    ("a pristine form" . SPARSER::FORM) ("Gr1" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN) ("Melanoma" . SPARSER::PROTEIN)
    ("G3BP2 or PABP" . SPARSER::COLLECTION)
    ("G3BP2 and PABP" . SPARSER::COLLECTION)
    ("the cytoplasmic poly (A) binding protein (PABP) and NTF2"
     . SPARSER::COLLECTION)
    ("G3BP2, the cytoplasmic poly (A) binding protein (PABP) and NTF2"
     . SPARSER::COLLECTION)
    ("poly (A) binding protein (PABP)" . SPARSER::PROTEIN)
    ("leukotriene A4 hydrolase and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("USP10 and 4 molecules" . SPARSER::COLLECTION)
    ("TAT-RasGAP" . SPARSER::COLLECTION) ("TAT" . SPARSER::PROTEIN)
    ("G3BP1 and RasGAP" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RasGAP" . SPARSER::PROTEIN)
    ("resveratrol directly targets G3BP1" . SPARSER::PROTEIN)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("p21 and PUMA" . SPARSER::COLLECTION)
    ("G3BP1 and p53" . SPARSER::COLLECTION)
    ("p53 and USP10" . SPARSER::COLLECTION)
    ("USP10 and p53" . SPARSER::COLLECTION) ("USP10/p53" . SPARSER::COLLECTION)
    ("G3BP1 and USP10" . SPARSER::COLLECTION)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("ubiquitin-protein" . SPARSER::COLLECTION)
    ("USP10 and G3BP1" . SPARSER::COLLECTION)
    ("p53 and its target genes" . SPARSER::COLLECTION)
    ("p21 and the p53" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("RRM" . SPARSER::PROTEIN)
    ("recombinant full-length G3BP1 (rG3BP1) and endogenous G3BP1"
     . SPARSER::COLLECTION)
    ("a natural phytoalexin" . SPARSER::MOLECULE)
    ("trans-3" . SPARSER::COLLECTION) ("phytoalexin" . SPARSER::MOLECULE)
    ("RSVL" . SPARSER::PROTEIN)
    ("a desirable target" . SPARSER::TARGET-PROTEIN)
    ("G3BP1/USP10" . SPARSER::COLLECTION) ("Sepharose" . SPARSER::MOLECULE)
    ("resveratrol" . SPARSER::PROTEIN) ("Resveratrol" . SPARSER::PROTEIN)
    ("B12)" . SPARSER::PROTEIN) ("s 5a" . SPARSER::PROTEIN)
    ("poly (A) binding protein" . SPARSER::PROTEIN)
    ("leukotriene A4 hydrolase" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN) ("G3BP2" . SPARSER::PROTEIN)
    ("NTF2" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("Ras-GAP" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("USP10" . SPARSER::PROTEIN) ("G3BP1" . SPARSER::PROTEIN)
    ("SH3 domain binding protein 1" . SPARSER::PROTEIN)
    ("Ras-GTPase activating protein" . SPARSER::PROTEIN)
    ("both p120 3A and p120" . SPARSER::COLLECTION)
    ("the principal mediators" . SPARSER::PROTEIN) ("BLM" . SPARSER::PROTEIN)
    ("Bleomycin" . SPARSER::DRUG) ("NF- κ B and RhoA" . SPARSER::COLLECTION)
    ("exogenous p120 3A and p120" . SPARSER::COLLECTION)
    ("exogenous p120 3A" . SPARSER::PROTEIN)
    ("p120 3A and p120" . SPARSER::COLLECTION)
    ("exogenous p120" . SPARSER::PROTEIN)
    ("1A and LZRS-mp120" . SPARSER::COLLECTION)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("isoform 1 (120 kD) and isoform 3 (100 kD)" . SPARSER::COLLECTION)
    ("alveolar septa" . SPARSER::PROTEIN) ("septa" . SPARSER::PROTEIN)
    ("p120 and NF- κ B" . SPARSER::COLLECTION)
    ("Rho GTPase-activating protein" . SPARSER::COLLECTION)
    ("p120 and RhoA" . SPARSER::COLLECTION)
    ("VE-cadherin" . SPARSER::COLLECTION)
    ("RhoA and NF- κ B" . SPARSER::COLLECTION)
    ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("total RhoA and p120-bound RhoA" . SPARSER::COLLECTION)
    ("p120-Catenin" . SPARSER::COLLECTION)
    ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("100 kD" . SPARSER::PROTEIN)
    ("isoform 3" . SPARSER::PROTEIN) ("120 kD" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("activating protein" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("p190A" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN) ("I κ B α" . SPARSER::PROTEIN)
    ("factor- κ B" . SPARSER::PROTEIN)
    ("Cyclin D1 and cyclin E1" . SPARSER::COLLECTION)
    ("the miRNAs and downstream target genes regulatory networks"
     . SPARSER::COLLECTION)
    ("the crucial mitogen cell cycle regulators, which play"
     . SPARSER::REGULATOR)
    ("antioncogenes" . SPARSER::PROTEIN)
    ("essentially posttranscriptional regulators" . SPARSER::REGULATOR)
    ("miR-15b and Cyclin D1" . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("VCR" . SPARSER::DRUG)
    ("their simultaneous target genes" . SPARSER::GENE)
    ("CDC42, CDK6, KIT, and AEG-1" . SPARSER::COLLECTION)
    ("simultaneous multiple upstream miRNAs" . SPARSER::MICRO-RNA)
    ("glioma biological targets" . SPARSER::TARGET-PROTEIN)
    ("cyclin dependent kinase 4" . SPARSER::PROTEIN)
    ("single-stranded RNA" . SPARSER::RNA) ("U87" . SPARSER::PROTEIN)
    ("FUT2" . SPARSER::PROTEIN) ("MiR-15b" . SPARSER::MOLECULE)
    ("MiR-34a" . SPARSER::MOLECULE) ("AEG-1" . SPARSER::PROTEIN)
    ("CDC42" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("miR-15b" . SPARSER::MOLECULE)
    ("relevant prognostic biomarkers" . SPARSER::MOLECULE)
    ("IGF-1R and mTOR" . SPARSER::COLLECTION) ("IGF-1R-" . SPARSER::PROTEIN)
    ("relevant biomarkers" . SPARSER::MOLECULE)
    ("chloroquine and temsirolimus" . SPARSER::COLLECTION)
    ("lysosomal" . SPARSER::PROTEIN)
    ("temsirolimus and autophagy" . SPARSER::COLLECTION)
    ("BII" . SPARSER::PROTEIN)
    ("NVP-AEW541 ( xref ) and OSI-906 ( xref )" . SPARSER::COLLECTION)
    ("pAKT" . SPARSER::PROTEIN-FAMILY) ("PTEN and CD99" . SPARSER::COLLECTION)
    ("CD99 as well as PTEN" . SPARSER::COLLECTION)
    ("arm or centromere" . SPARSER::COLLECTION) ("SK" . SPARSER::PROTEIN)
    ("Formaldehyde" . SPARSER::MOLECULE) ("IGF and mTOR" . SPARSER::COLLECTION)
    ("PIP 3 and AKT activation" . SPARSER::COLLECTION)
    ("IGF-1 and IGF-1R" . SPARSER::COLLECTION)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("EWS-FLI" . SPARSER::COLLECTION) ("FLI" . SPARSER::PROTEIN)
    ("IGF-1 and its receptor" . SPARSER::COLLECTION)
    ("EWS-FLI1" . SPARSER::COLLECTION) ("EWS" . SPARSER::PROTEIN)
    ("ETS" . SPARSER::PROTEIN) ("TET" . SPARSER::PROTEIN)
    ("LC3" . SPARSER::PROTEIN) ("IGF-1-" . SPARSER::PROTEIN)
    ("NVP-AEW541" . SPARSER::DRUG) ("LC3B" . SPARSER::PROTEIN)
    ("CD99" . SPARSER::PROTEIN) ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G17" . SPARSER::PROTEIN) ("FLI1" . SPARSER::PROTEIN)
    ("EWSR1" . SPARSER::PROTEIN)
    ("epigallocatechin-3-gallate and berberine" . SPARSER::COLLECTION)
    ("berberine" . SPARSER::MOLECULE)
    ("Snail and other transcriptional repressors" . SPARSER::COLLECTION)
    ("Foxo3a and YB-1" . SPARSER::COLLECTION)
    ("E-cadherin, YB-1, Snail, and Twist" . SPARSER::COLLECTION)
    ("AMPK and Foxo3a" . SPARSER::COLLECTION)
    ("mesenchymal markers vimentin, YB-1, Snail, and Twist"
     . SPARSER::COLLECTION)
    ("vimentin, YB-1, Snail, and Twist" . SPARSER::COLLECTION)
    ("MDA" . SPARSER::DRUG) ("FITC" . SPARSER::MOLECULE)
    ("Foxo3a and MDM2" . SPARSER::COLLECTION)
    ("Akt and IKKβ" . SPARSER::COLLECTION) ("FBE" . SPARSER::PROTEIN)
    ("Foxo" . SPARSER::PROTEIN-FAMILY)
    ("the mesenchymal markers YB-1 and Snail" . SPARSER::COLLECTION)
    ("YB-1 and Snail" . SPARSER::COLLECTION)
    ("various EMT-associated effectors" . SPARSER::EFFECTOR)
    ("AICAR and metformin" . SPARSER::COLLECTION)
    ("the aforementioned biomarkers" . SPARSER::MOLECULE)
    ("mesenchymal traits" . SPARSER::PROTEIN)
    ("AMPK and ACC" . SPARSER::COLLECTION)
    ("Foxo3a, E-cadherin, claudin-1, vimentin, YB-1, and Snail"
     . SPARSER::COLLECTION)
    ("MECs" . SPARSER::PROTEIN) ("Foxo3a and E-cadherin" . SPARSER::COLLECTION)
    ("vimentin, YB-1 and Snail" . SPARSER::COLLECTION)
    ("AMPK and EMT" . SPARSER::COLLECTION)
    ("the EMT regulator Foxo3a and the epithelial marker E-cadherin"
     . SPARSER::COLLECTION)
    ("ACC" . SPARSER::PROTEIN) ("Akt-MDM2" . SPARSER::COLLECTION)
    ("ribonucleotide" . SPARSER::MOLECULE)
    ("Akt-MDM2-Foxo3a" . SPARSER::COLLECTION) ("vis" . SPARSER::DRUG)
    ("the peroxisome proliferator-activated receptor (PPAR)γ agonist ciglitazone"
     . SPARSER::DRUG)
    ("ciglitazone" . SPARSER::DRUG) ("PPAR" . SPARSER::PROTEIN)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR) ("AMP" . SPARSER::AMP)
    ("deoxyglucose" . SPARSER::MOLECULE) ("Akt and ERKs" . SPARSER::COLLECTION)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mRNA encoding Snail and other EMT-inducing transcription factors in noninvasive breast epithelial cells ( xref )"
     . SPARSER::COLLECTION)
    ("YB-1 and E-cadherin" . SPARSER::COLLECTION)
    ("Snail and/or other transcriptional repressors" . SPARSER::COLLECTION)
    ("Zeb-1, Twist, and Slug" . SPARSER::COLLECTION)
    ("Twist" . SPARSER::PROTEIN)
    ("mesenchymal-associated genes" . SPARSER::GENE)
    ("vimentin, N-cadherin, fibronectin, integrins, and α-smooth muscle"
     . SPARSER::COLLECTION)
    ("integrins" . SPARSER::PROTEIN) ("smooth muscle" . SPARSER::PROTEIN)
    ("metformin and AICAR" . SPARSER::COLLECTION) ("AICAR" . SPARSER::PROTEIN)
    ("Akt-MDM2-Foxo3" . SPARSER::COLLECTION) ("ERα" . SPARSER::PROTEIN)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("LKB1-AMPK" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("claudin-1" . SPARSER::PROTEIN)
    ("C-T" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("liver kinase B1" . SPARSER::PROTEIN) ("AMPK α1" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN) ("protein-1" . SPARSER::PROTEIN)
    ("Zeb-1" . SPARSER::PROTEIN) ("GSK3β" . SPARSER::PROTEIN)
    ("IGF-IR" . SPARSER::PROTEIN)
    ("epithelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("Foxo3a" . SPARSER::PROTEIN)
    ("OSU-53" . SPARSER::DRUG) ("Foxo3" . SPARSER::PROTEIN)
    ("senescence-associated heterochromatin foci (SAHF)" . SPARSER::PROTEIN)
    ("foci (SAHF)" . SPARSER::PROTEIN) ("SAHF" . SPARSER::BIO-COMPLEX)
    ("constitutively active oncogenes" . SPARSER::ONCOGENE)
    ("BRG1 and/or UCA1" . SPARSER::COLLECTION)
    ("helicase/ATPase activity" . SPARSER::COLLECTION)
    ("BRG1, BRG1 and UCA1" . SPARSER::COLLECTION)
    ("BRG1-shRNA" . SPARSER::COLLECTION)
    ("BRG1 and UCA1" . SPARSER::COLLECTION)
    ("UCA1 and BRG1" . SPARSER::COLLECTION) ("RIP" . SPARSER::PROTEIN)
    ("any associated proteins" . SPARSER::PROTEIN)
    ("Avidin" . SPARSER::PROTEIN)
    ("Biotin-labeled sense UCA1 RNA and antisense UCA1 RNA"
     . SPARSER::COLLECTION)
    ("antisense" . SPARSER::PROTEIN) ("UCA1-shRNA" . SPARSER::COLLECTION)
    ("CYP1A1 ( xref ) and AURKC ( xref )" . SPARSER::COLLECTION)
    ("WNT6 ( xref ), CYP1A1 ( xref ) and AURKC ( xref )" . SPARSER::COLLECTION)
    ("AURKC" . SPARSER::PROTEIN) ("very few lncRNAs" . SPARSER::RNA)
    ("factors and other proteins" . SPARSER::COLLECTION)
    ("together multiple proteins" . SPARSER::PROTEIN)
    ("subdomains" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("lncRNAs" . SPARSER::RNA)
    ("overexpressed UCA1 reduced p21 protein" . SPARSER::PROTEIN)
    ("UCA1" . SPARSER::PROTEIN) ("UCA1-BRG" . SPARSER::COLLECTION)
    ("BRG" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("micrococcal nuclease" . SPARSER::PROTEIN) ("K 2" . SPARSER::PROTEIN)
    ("Micrococcal nuclease" . SPARSER::PROTEIN)
    ("ATPase activity" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("H3K4" . SPARSER::PROTEIN) ("H3K9" . SPARSER::PROTEIN)
    ("BRG1 protein" . SPARSER::PROTEIN) ("CYP1A1" . SPARSER::PROTEIN)
    ("WNT6" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("chromatin remodeling factor" . SPARSER::PROTEIN)
    ("confirmatory FISH" . SPARSER::PROTEIN)
    ("prospective cohorts" . SPARSER::MOLECULE)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("TLL and AMD" . SPARSER::COLLECTION) ("TLL" . SPARSER::PROTEIN)
    ("normal acini" . SPARSER::PROTEIN) ("acini" . SPARSER::PROTEIN)
    ("AMD and Bruce" . SPARSER::COLLECTION) ("Bruce" . SPARSER::PROTEIN)
    ("intact PTEN protein and evaluable PTEN FISH" . SPARSER::COLLECTION)
    ("evaluable PTEN FISH" . SPARSER::PROTEIN)
    ("FAS and WAPAL" . SPARSER::COLLECTION) ("WAPAL" . SPARSER::PROTEIN)
    ("heterogeneous PTEN" . SPARSER::PROTEIN)
    ("contemporary surgical cohorts" . SPARSER::MOLECULE)
    ("higher preoperative PSA" . SPARSER::PROTEIN)
    ("preoperative PSA" . SPARSER::PROTEIN)
    ("AIF and STK3" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("AIF and H2AX" . SPARSER::COLLECTION)
    ("Endonuclease G, Cyclophilin A, and H2AX" . SPARSER::COLLECTION)
    ("the methylated cytosines" . SPARSER::NUCLEOBASE)
    ("peroxisome" . SPARSER::PROTEIN)
    ("the mitochondrial respiratory complex I" . SPARSER::PROTEIN)
    ("STK3-FLAG" . SPARSER::COLLECTION) ("GST-AIF" . SPARSER::COLLECTION)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("Bisulfite" . SPARSER::MOLECULE) ("CCRCC" . SPARSER::PROTEIN)
    ("strong AIF" . SPARSER::PROTEIN) ("RCC (CCRCC)" . SPARSER::PROTEIN)
    ("RCC and AIF" . SPARSER::COLLECTION)
    ("STK3 or STK4" . SPARSER::COLLECTION) ("MST2/MST1" . SPARSER::COLLECTION)
    ("STK3/STK4" . SPARSER::COLLECTION) ("MST" . SPARSER::PROTEIN)
    ("YAP and TAZ" . SPARSER::COLLECTION)
    ("both Yes-Associated Protein (YAP) and Tafazzin (TAZ)"
     . SPARSER::COLLECTION)
    ("both Yes-Associated Protein (YAP)" . SPARSER::PROTEIN)
    ("Kinase (LATS)" . SPARSER::KINASE) ("TAZ" . SPARSER::PROTEIN)
    ("Tafazzin" . SPARSER::PROTEIN) ("LATS" . SPARSER::PROTEIN)
    ("STK3 and its family member STK4 (MST1)" . SPARSER::COLLECTION)
    ("a pro-apoptotic cytoplasmic kinase" . SPARSER::KINASE)
    ("the transformed state" . SPARSER::BIO-STATE)
    ("incomplete complex I" . SPARSER::PROTEIN)
    ("H2AX and form" . SPARSER::COLLECTION)
    ("calpains or cathepsins" . SPARSER::COLLECTION)
    ("EndoG" . SPARSER::PROTEIN) ("cathepsins" . SPARSER::PROTEIN)
    ("calpains" . SPARSER::PROTEIN) ("anchors" . SPARSER::ANCHOR)
    ("a 62 kDa mature AIF" . SPARSER::PROTEIN) ("oxidase" . SPARSER::PROTEIN)
    ("NADH" . SPARSER::MOLECULE) ("condensation and DNA" . SPARSER::COLLECTION)
    ("Cyclophilin A" . SPARSER::PROTEIN) ("Endonuclease G" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    ("NF1" . SPARSER::PROTEIN) ("p32" . SPARSER::PROTEIN)
    ("forkhead box protein O3" . SPARSER::PROTEIN) ("Raf1" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN)
    ("Large Tumor Suppressor" . SPARSER::PROTEIN) ("WW45" . SPARSER::PROTEIN)
    ("Salvador Homolog 1" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("STK4" . SPARSER::PROTEIN) ("Ste-20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MST2" . SPARSER::PROTEIN)
    ("Serine/threonine-protein kinase 3" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("cyclophilin A" . SPARSER::PROTEIN)
    ("endonuclease G" . SPARSER::PROTEIN) ("STK3" . SPARSER::PROTEIN)
    ("Apoptosis-inducing" . SPARSER::PROTEIN)
    ("GSK-3β and τ protein" . SPARSER::COLLECTION)
    ("the N-terminal serine of GSK3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK" . SPARSER::PROTEIN) ("antidepressant" . SPARSER::DRUG)
    ("antidepressants" . SPARSER::DRUG) ("stabilizers" . SPARSER::MOLECULE)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("neurotrophic factor" . SPARSER::PROTEIN)
    ("glycogen synthase kinase–3" . SPARSER::PROTEIN)
    ("T-A" . SPARSER::PROTEIN) ("valproic acid" . SPARSER::MOLECULE)
    ("almost all pro-Nrgs isoforms" . SPARSER::ISOFORM)
    ("pro-Nrgs" . SPARSER::PROTEIN-PAIR) ("axon-glia" . SPARSER::PROTEIN-PAIR)
    ("NRG1/ERBB" . SPARSER::COLLECTION)
    ("both Nrg1 heterogyzous mouse mutants and transgenic overexpressors"
     . SPARSER::COLLECTION)
    ("both Nrg1 heterogyzous mouse mutants" . SPARSER::MUTANT)
    ("PI3KCD/p110δ" . SPARSER::COLLECTION) ("amphetamine" . SPARSER::DRUG)
    ("a major endocannabinoid" . SPARSER::MOLECULE)
    ("endocannabinoid" . SPARSER::MOLECULE) ("Limk1" . SPARSER::PROTEIN)
    ("LIM" . SPARSER::PROTEIN) ("NRG1 or ERBB4" . SPARSER::COLLECTION)
    ("ramp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Dlx6" . SPARSER::PROTEIN)
    ("NRG1/ERBB4" . SPARSER::COLLECTION)
    ("neuronal Nrg1 Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BACE1 or neuropsin" . SPARSER::COLLECTION)
    ("neuropsin" . SPARSER::PROTEIN)
    ("Nrg1 , Erbb2 , Erbb3 , or Erbb4" . SPARSER::COLLECTION)
    ("NRG or ERBB" . SPARSER::COLLECTION)
    ("impaired hippocampal LTP" . SPARSER::PROTEIN)
    ("NRG1 and NRG3" . SPARSER::COLLECTION) ("enteric" . SPARSER::PROTEIN)
    ("ADHD" . SPARSER::PROTEIN) ("NRG1 and ERBB4" . SPARSER::COLLECTION)
    ("NRG-ERBB" . SPARSER::COLLECTION)
    ("DISC1 and a7 ACHR ( xref ; xref ; xref )" . SPARSER::COLLECTION)
    ("NRG1 and NRG2, NRG3, NRG6 or ERBB4" . SPARSER::COLLECTION)
    ("NRG2, NRG3, NRG6 or ERBB4" . SPARSER::COLLECTION)
    ("NRG2 and EGFR" . SPARSER::COLLECTION)
    ("PIK3CD/p110δ" . SPARSER::COLLECTION) ("CSF" . SPARSER::PROTEIN)
    ("the postmortem dorsal lateral PFC (DLPFC)" . SPARSER::PROTEIN)
    ("NRG3 and ERBB4" . SPARSER::COLLECTION)
    ("NRG2, NRG3 and NRG6" . SPARSER::COLLECTION)
    ("EGFR, ERBB2, ERBB3 and ERBB4" . SPARSER::COLLECTION) ("Types" . TYPE)
    ("antipsychotics" . SPARSER::DRUG)
    ("peripheral leukocytes" . SPARSER::PROTEIN)
    ("an Australian cohort" . SPARSER::MOLECULE)
    ("Type I and IV mRNA" . SPARSER::COLLECTION)
    ("the frontal lobe ( xref ) and SNP8NRG243177" . SPARSER::COLLECTION)
    ("the frontal lobe" . SPARSER::PROTEIN)
    ("frontal and temporal lobes" . SPARSER::PROTEIN)
    ("p22" . SPARSER::PROTEIN) ("‘complex’" . SPARSER::BIO-COMPLEX)
    ("Erbbs" . SPARSER::PROTEIN) ("Erbb4-ECD" . SPARSER::COLLECTION)
    ("ECD" . SPARSER::PROTEIN)
    ("Here Nrg1 Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nicotine" . SPARSER::DRUG)
    ("dopamine and D4 dopamine receptor (D4R)" . SPARSER::COLLECTION)
    ("Fyn" . SPARSER::PROTEIN) ("Src or Src-like" . SPARSER::COLLECTION)
    ("The acute LTP" . SPARSER::PROTEIN) ("axon" . SPARSER::PROTEIN)
    ("seizures" . SPARSER::PROTEIN) ("Nrg1-Erbb4" . SPARSER::COLLECTION)
    ("dopamine" . SPARSER::PROTEIN)
    ("two major inotropic receptors a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) and N-methyl-D-aspartate receptor (NMDAR)"
     . SPARSER::COLLECTION)
    ("receptor (NMDAR)" . SPARSER::RECEPTOR)
    ("two major inotropic receptors a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)"
     . SPARSER::RECEPTOR)
    ("receptor (AMPAR)" . SPARSER::RECEPTOR)
    ("hippocampal LTP" . SPARSER::PROTEIN) ("LTP" . SPARSER::PROTEIN)
    ("CA1" . SPARSER::PROTEIN) ("Nrg1 and Erbb" . SPARSER::COLLECTION)
    ("a ubiquitously active promoter" . SPARSER::PROMOTER)
    ("NMDAR" . SPARSER::PROTEIN) ("cortisol" . SPARSER::PROTEIN)
    ("Erbb" . SPARSER::PROTEIN) ("conditional mouse mutants" . SPARSER::MUTANT)
    ("Nrg1-Erbb" . SPARSER::COLLECTION)
    ("conditional mutants" . SPARSER::MUTANT)
    ("mere" . SPARSER::PROTEIN-FAMILY)
    ("Erbb3 and Erbb4" . SPARSER::COLLECTION)
    ("Erbb3/Erbb4" . SPARSER::COLLECTION)
    ("The responsible growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("completely lack Nrg1" . SPARSER::PROTEIN)
    ("this axonal growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("these conditional mutants" . SPARSER::MUTANT)
    ("axonal Nrg1 Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors and MAPK" . SPARSER::COLLECTION)
    ("Type II or Type III" . SPARSER::COLLECTION)
    ("similar neuronal proteases" . SPARSER::PROTEIN)
    ("neurotrophins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/NRDc" . SPARSER::COLLECTION) ("NRDc" . SPARSER::PROTEIN)
    ("Nardilysin" . SPARSER::PROTEIN) ("/ADAM17" . SPARSER::COLLECTION)
    ("TACE" . SPARSER::PROTEIN) ("metalloprotease" . SPARSER::PROTEIN)
    ("pro-Nrg1" . SPARSER::COLLECTION)
    ("the only relevant protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bace1" . SPARSER::PROTEIN)
    ("neuronal metalloproteases" . SPARSER::PROTEIN)
    ("a larger membrane-bound precursor protein" . SPARSER::PROTEIN)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("the same PTEN-deficient conditional mouse mutants" . SPARSER::MUTANT)
    ("Erk/MAPK" . SPARSER::COLLECTION) ("Schwann" . SPARSER::PROTEIN)
    ("‘myelin’" . SPARSER::PROTEIN)
    ("phosphatidylinositol-" . SPARSER::PROTEIN) ("axons" . SPARSER::PROTEIN)
    ("focal adhesion kinase (FAK) and the small GTPases Cdc42 and Rac1"
     . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("axon-glial" . SPARSER::PROTEIN-PAIR) ("FAK" . SPARSER::PROTEIN)
    ("PLC/Calcineurin/NFAT" . SPARSER::COLLECTION)
    ("Shp2/Erk/MAPK" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("NFAT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Calcineurin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PLC" . SPARSER::PROTEIN)
    ("Another ErbB-associated scaffolding protein" . SPARSER::PROTEIN)
    ("Erbin" . SPARSER::PROTEIN) ("phosphoinositide-3" . SPARSER::COLLECTION)
    ("Erbb2/Erbb3" . SPARSER::COLLECTION)
    ("PNS development neuronal Nrg1 TypeIII molecules" . SPARSER::MOLECULE)
    ("considerably more complex" . SPARSER::BIO-COMPLEX)
    ("neurotrophin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either Type I or Type III cDNA transgenes (both under control of the Thy1 promoter in DRG and motoneurons) only Nrg1 Type III"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type I or Type III" . SPARSER::COLLECTION)
    ("a soluble factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble Nrg1" . SPARSER::PROTEIN)
    ("this membrane-associated isoform" . SPARSER::PROTEIN)
    ("regulating functional TRPV1" . SPARSER::PROTEIN)
    ("cue" . SPARSER::PROTEIN-FAMILY) ("TrkA" . SPARSER::PROTEIN)
    ("Cnp-Cre" . SPARSER::COLLECTION) ("Krox20-Cre" . SPARSER::COLLECTION)
    ("weak kinase" . SPARSER::KINASE) ("Erbb2 and Erbb3" . SPARSER::COLLECTION)
    ("DRG" . SPARSER::PROTEIN) ("anchor" . SPARSER::ANCHOR)
    ("The responsible factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor or Nrg1" . SPARSER::COLLECTION)
    ("axonal Nrg1" . SPARSER::PROTEIN) ("myelin" . SPARSER::PROTEIN)
    ("Myelin" . SPARSER::PROTEIN) ("Nrg1/ErbB" . SPARSER::COLLECTION)
    ("receptors or GABA-A" . SPARSER::COLLECTION) ("BACa" . SPARSER::PROTEIN)
    ("metabotropic glutamate receptors" . SPARSER::RECEPTOR)
    ("NMDA" . SPARSER::MOLECULE) ("ARIA" . SPARSER::PROTEIN)
    ("neurotransmitter" . SPARSER::MOLECULE)
    ("CaMKII-Cre" . SPARSER::COLLECTION) ("CaMKII" . SPARSER::PROTEIN)
    ("ICD" . SPARSER::PROTEIN) ("conditional Erbb2" . SPARSER::PROTEIN)
    ("Erbb2 or Erbb4" . SPARSER::COLLECTION)
    ("radial glial and astrocytes" . SPARSER::COLLECTION)
    ("glial and astrocytes" . SPARSER::COLLECTION)
    ("Erbb2 and Erbb4" . SPARSER::COLLECTION)
    ("hGFAP-Cre" . SPARSER::COLLECTION) ("EMX1-Cre" . SPARSER::COLLECTION)
    ("hGFAP" . SPARSER::PROTEIN) ("Nestin" . SPARSER::PROTEIN)
    ("nestin-Cre" . SPARSER::COLLECTION) ("NEX-Cre" . SPARSER::COLLECTION)
    ("Emx-Cre" . SPARSER::COLLECTION) ("nestin" . SPARSER::PROTEIN)
    ("cortical neuronal migration" . SPARSER::PROTEIN)
    ("radial neuronal migration" . SPARSER::PROTEIN)
    ("Soluble Nrg1 Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("medial PFC" . SPARSER::PROTEIN) ("PFC" . SPARSER::PROTEIN)
    ("puncta or Syn" . SPARSER::COLLECTION) ("Syn" . SPARSER::PROTEIN)
    ("a postsynaptic scaffold protein" . SPARSER::PROTEIN)
    ("gephyrin" . SPARSER::PROTEIN) ("GABA" . SPARSER::MOLECULE)
    ("presynaptic Erbb4" . SPARSER::PROTEIN)
    ("transmembrane Nrg1" . SPARSER::PROTEIN)
    ("postsynaptic Erbb4" . SPARSER::PROTEIN)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("Lhx6-Cre" . SPARSER::COLLECTION)
    ("PV-Cre" . SPARSER::COLLECTION) ("Cre" . SPARSER::PROTEIN)
    ("synaptophysin and vGlut1" . SPARSER::COLLECTION)
    ("synaptophysin" . SPARSER::PROTEIN)
    ("puncta and mEPSC" . SPARSER::COLLECTION) ("puncta" . SPARSER::PROTEIN)
    ("a dendritic Rac-GEF" . SPARSER::PROTEIN)
    ("interneuronal Erbb4" . SPARSER::PROTEIN) ("kalirin" . SPARSER::PROTEIN)
    ("Erbb4 and downstream PI3 kinase ( xref )" . SPARSER::COLLECTION)
    ("Gad65-GFP" . SPARSER::COLLECTION) ("Nrg1/Erbb4" . SPARSER::COLLECTION)
    ("genesis" . SPARSER::PROTEIN) ("Nrg1 and Nrg3" . SPARSER::COLLECTION)
    ("Nrg3" . SPARSER::PROTEIN)
    ("soluble Nrg1 Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("striatum" . SPARSER::PROTEIN)
    ("parvalbumin (PV) and somatostatin ( xref ; xref ; xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("parvalbumin" . SPARSER::PROTEIN) ("GAD" . SPARSER::PROTEIN)
    ("particular Erbb4" . SPARSER::PROTEIN)
    ("NRG and ERBB" . SPARSER::COLLECTION) ("ErbB" . SPARSER::PROTEIN)
    ("NRG/ERBB" . SPARSER::COLLECTION) ("ERBBs" . SPARSER::PROTEIN)
    ("NRG" . SPARSER::PROTEIN) ("Neuregulins" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("Angelman syndrome" . SPARSER::PROTEIN)
    ("p25" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p110δ" . SPARSER::PROTEIN)
    ("PIK3CD" . SPARSER::PROTEIN) ("GAD1" . SPARSER::PROTEIN)
    ("GAD67" . SPARSER::PROTEIN) ("CYT-1" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("NRG 1" . SPARSER::PROTEIN)
    ("DISC1" . SPARSER::PROTEIN) ("CA3" . SPARSER::PROTEIN)
    ("Src-like kinase" . SPARSER::PROTEIN) ("Src-like" . SPARSER::PROTEIN)
    ("sodium channel" . SPARSER::PROTEIN) ("voltage-gated" . SPARSER::PROTEIN)
    ("Kv1.1" . SPARSER::PROTEIN) ("N-methyl-D-aspartate" . SPARSER::MOLECULE)
    ("a polypeptide" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("ADAM17" . SPARSER::PROTEIN) ("converting enzyme" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("BACE1" . SPARSER::PROTEIN) ("precursor protein" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Par3" . SPARSER::PROTEIN)
    ("Thy1" . SPARSER::PROTEIN) ("TRPV1" . SPARSER::PROTEIN)
    ("Sema3A" . SPARSER::PROTEIN) ("Krox20" . SPARSER::PROTEIN)
    ("EMX1" . SPARSER::PROTEIN) ("neuronal migration" . SPARSER::PROTEIN)
    ("glial growth factor" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("vGlut-1" . SPARSER::PROTEIN)
    ("Lhx6" . SPARSER::PROTEIN) ("Dlx5" . SPARSER::PROTEIN)
    ("vGlut1" . SPARSER::PROTEIN) ("GAD65" . SPARSER::PROTEIN)
    ("GluA1" . SPARSER::PROTEIN) ("PSD-95" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("Rac-GEF" . SPARSER::PROTEIN)
    ("PI3 kinase" . SPARSER::PROTEIN) ("ErbB4" . SPARSER::PROTEIN)
    ("Gad65" . SPARSER::PROTEIN) ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nrg1" . SPARSER::PROTEIN)
    ("Erbb4" . SPARSER::PROTEIN) ("NRG3" . SPARSER::PROTEIN)
    ("NRG2" . SPARSER::PROTEIN) ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN)
    ("Nix, PUMA, Bak and Bim" . SPARSER::COLLECTION)
    ("MPTP" . SPARSER::PROTEIN) ("HEK and CHO" . SPARSER::COLLECTION)
    ("Bax and mito" . SPARSER::COLLECTION)
    ("the lysine-null Bax" . SPARSER::PROTEIN)
    ("a lysine-null Bax" . SPARSER::PROTEIN)
    ("CHO and CHO" . SPARSER::COLLECTION) ("ØK-Bax" . SPARSER::COLLECTION)
    ("mito-mCherry" . SPARSER::COLLECTION) ("mito" . SPARSER::PROTEIN)
    ("arginines" . SPARSER::AMINO-ACID) ("solvent" . SPARSER::MOLECULE)
    ("parkin and Bax" . SPARSER::COLLECTION)
    ("either Flag-tagged WT Bax or Bax-BH3 sw and the two proteins"
     . SPARSER::COLLECTION)
    ("Nix" . SPARSER::PROTEIN)
    ("immunoprecipitation (IP)–Western blot" . SPARSER::PROTEIN)
    ("the proteasomal inhibitor MG-132" . SPARSER::DRUG)
    ("Bax and mitochondrial" . SPARSER::COLLECTION)
    ("CHO-Parkin" . SPARSER::COLLECTION)
    ("Mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TOM20 and VDAC" . SPARSER::COLLECTION)
    ("MES, HEK and Chinese hamster ovary (CHO) cells" . SPARSER::COLLECTION)
    ("HEK-Parkin" . SPARSER::COLLECTION) ("Parkin" . SPARSER::PROTEIN)
    ("HEK" . SPARSER::PROTEIN)
    ("outer mitochondrial proteins (VDAC, TOM20) or the inner mitochondrial membrane proteins"
     . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX) ("MES" . SPARSER::MOLECULE)
    ("ADP" . SPARSER::PROTEIN) ("Staurosporine" . SPARSER::DRUG)
    ("VDAC" . SPARSER::PROTEIN) ("anion" . SPARSER::MOLECULE)
    ("staurosporine" . SPARSER::DRUG)
    ("two specific lysines of Bax that are critical" . SPARSER::PROTEIN)
    ("CCCP" . SPARSER::MOLECULE) ("parkin-Bax" . SPARSER::COLLECTION)
    ("parkin" . SPARSER::PROTEIN) ("Protein-G" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NdufS4" . SPARSER::PROTEIN) ("subunit A" . SPARSER::PROTEIN)
    ("succinate dehydrogenase complex" . SPARSER::PROTEIN)
    ("PA1" . SPARSER::PROTEIN) ("PINK1" . SPARSER::PROTEIN)
    ("RING1" . SPARSER::PROTEIN) ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP5A" . SPARSER::PROTEIN) ("TOM20" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN)
    ("CXCR4 small-molecule inhibitor and temsirolimus" . SPARSER::COLLECTION)
    ("AMD" . SPARSER::PROTEIN) ("kinases and PDK" . SPARSER::COLLECTION)
    ("CXCL12 and PI3K" . SPARSER::COLLECTION)
    ("mTOR and CXCL12" . SPARSER::COLLECTION) ("PIM" . SPARSER::PROTEIN)
    ("phosphatase and tension homolog" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("p27 or 4EBP1" . SPARSER::COLLECTION)
    ("the CXCL11- or CXCL12-induced p-ERK suggesting that p-ERK induction is independent of p38"
     . SPARSER::COLLECTION)
    ("CXCL11-" . SPARSER::PROTEIN)
    ("a newly developed CXCR4 antagonist" . SPARSER::MOLECULE)
    ("a fully signaling receptor" . SPARSER::RECEPTOR)
    ("ERK1/2, p38 MAPK and SAPK" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("CXCR4/CXCL12/CXCR7" . SPARSER::COLLECTION)
    ("AMD3100 and Peptide R" . SPARSER::COLLECTION)
    ("AMD3100 or Peptide R (10  μ M; Table1)" . SPARSER::COLLECTION)
    ("CXCL12 and AMD3100 or anti-CXCR7" . SPARSER::COLLECTION)
    ("AMD3100 or anti-CXCR7" . SPARSER::COLLECTION) ("RAD" . SPARSER::PROTEIN)
    ("CXCL11 and CXCL12" . SPARSER::COLLECTION)
    ("CXCL11 and the relative inhibitors" . SPARSER::COLLECTION)
    ("CXCL12, CXCL11 and the relative inhibitors" . SPARSER::COLLECTION)
    ("ester (CFSE)" . SPARSER::MOLECULE)
    ("the relative inhibitors" . SPARSER::INHIBITOR) ("CFSE" . SPARSER::DRUG)
    ("diacetate" . SPARSER::MOLECULE)
    ("anti-CXCR7 ( xref ) or CXC771 ( xref )" . SPARSER::COLLECTION)
    ("CXCL12 or CXCL11" . SPARSER::COLLECTION)
    ("CXCL11 or CXCL12" . SPARSER::COLLECTION) ("CXCL12-" . SPARSER::PROTEIN)
    ("CXCL11 or CXCL12, AMD3100 and anti-CXCR7" . SPARSER::COLLECTION)
    ("CXCL12, AMD3100 and anti-CXCR7" . SPARSER::COLLECTION)
    ("CXCL12 and CXCL11 and actin" . SPARSER::COLLECTION)
    ("CXCL11 and actin" . SPARSER::COLLECTION)
    ("anti-CXCR7 (11G8) or CXC771 ( xref )" . SPARSER::COLLECTION)
    ("CXCR4/CXCR7" . SPARSER::COLLECTION)
    ("the CXCR4–CXCR7-unrelated chemokine" . SPARSER::PROTEIN)
    ("anti-CXCR4 and Peptide" . SPARSER::COLLECTION)
    ("P38 and ERK1/2" . SPARSER::COLLECTION)
    ("CXCR4 and low CXCR7" . SPARSER::COLLECTION)
    ("4EBP1and p-P70S6K" . SPARSER::COLLECTION)
    ("the anti-CXCR4" . SPARSER::ANTIBODY)
    ("p-ERK1/2 and p-P38" . SPARSER::COLLECTION)
    ("ERK1/2 and P38MAPK" . SPARSER::COLLECTION)
    ("AMD3100 and CCX771" . SPARSER::COLLECTION)
    ("CXCL12–CXCR7" . SPARSER::COLLECTION)
    ("a possible CXCR7 agonist" . SPARSER::AGONIST)
    ("ERK1/2 and P38" . SPARSER::COLLECTION)
    ("ERK and P38" . SPARSER::COLLECTION) ("p-ERK1/2" . SPARSER::PROTEIN)
    ("p-4EBP1" . SPARSER::COLLECTION) ("CXCL12–CXCR4" . SPARSER::COLLECTION)
    ("CXCL12–CXCR4–CXCR7" . SPARSER::COLLECTION)
    ("Chemokines and their receptors" . SPARSER::COLLECTION)
    ("RhoA, Cdc42 and Rac1" . SPARSER::COLLECTION) ("RhoA" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::PROTEIN) ("HIF" . SPARSER::PROTEIN)
    ("VHL" . SPARSER::PROTEIN) ("sunitinib or sorafenib" . SPARSER::COLLECTION)
    ("second-line" . SPARSER::PROTEIN) ("first-line" . SPARSER::PROTEIN)
    ("Temsirolimus" . SPARSER::DRUG) ("ridaforolimus" . SPARSER::DRUG)
    ("analogs" . SPARSER::ANALOG) ("sirolimus" . SPARSER::DRUG)
    ("the vascular endothelial growth factor receptor (VEGF) and the mammalian target of rapamycin (mTOR)"
     . SPARSER::COLLECTION)
    ("receptor (VEGF)" . SPARSER::RECEPTOR)
    ("metastatic RCC" . SPARSER::PROTEIN) ("protor" . SPARSER::PROTEIN-FAMILY)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Food" . SPARSER::MOLECULE)
    ("RCC" . SPARSER::PROTEIN)
    ("CXCL12, CXCL11 and mTOR" . SPARSER::COLLECTION)
    ("antagonists and RAD001" . SPARSER::COLLECTION)
    ("AMD3100 and anti-CXCR7" . SPARSER::COLLECTION)
    ("spikes" . SPARSER::PROTEIN) ("CXCR7 and RAD001" . SPARSER::COLLECTION)
    ("CXCL12 and CXCL11" . SPARSER::COLLECTION)
    ("CXCR4, CXCR7 and mTOR" . SPARSER::COLLECTION)
    ("CXCR4 antagonists (AMD3100, anti-CXCR4-12G5 and Peptide R, a newly developed CXCR4 antagonist) and CXCR7 antagonists (anti-CXCR7-12G8 and CCX771, CXCR7 inhibitor)"
     . SPARSER::COLLECTION)
    ("P70S6K and 4EBP1" . SPARSER::COLLECTION)
    ("CXCR4–CXCR7" . SPARSER::COLLECTION)
    ("CXCR4–CXCL12–CXCR7" . SPARSER::COLLECTION)
    ("temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("Na3VO4" . SPARSER::MOLECULE) ("p70S6K1" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("P-ERK" . SPARSER::PROTEIN)
    ("RAD 10 " . SPARSER::PROTEIN) ("CXCL1" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SB203580" . SPARSER::DRUG)
    ("p-P38" . SPARSER::PROTEIN) ("p-ERK1" . SPARSER::PROTEIN)
    ("Cdc42" . SPARSER::PROTEIN) ("β -arrestin" . SPARSER::PROTEIN)
    ("Ca2+" . SPARSER::CALCIUM-ION) ("I-TAC" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN) ("RDC1" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("FK506" . SPARSER::DRUG)
    ("AP23573" . SPARSER::DRUG) ("CCI-779" . SPARSER::DRUG)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("proline-rich protein 5" . SPARSER::PROTEIN) ("PRR5" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("mSin1" . SPARSER::PROTEIN)
    ("regulatory associated protein of mTOR" . SPARSER::PROTEIN)
    ("LST8" . SPARSER::PROTEIN) ("yeast homolog" . SPARSER::PROTEIN)
    ("G β L" . SPARSER::PROTEIN) ("G-protein" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN) ("RAD001" . SPARSER::DRUG)
    ("P70S6K" . SPARSER::PROTEIN) ("CXCL11" . SPARSER::PROTEIN)
    ("promoter and nonpromoter" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("the associated genes" . SPARSER::GENE)
    ("a profound impact" . SPARSER::PROTEIN) ("Partial" . SPARSER::PROTEIN)
    ("ECAD and COX-2" . SPARSER::COLLECTION) ("ECAD" . SPARSER::PROTEIN)
    ("von" . SPARSER::PROTEIN)
    ("tobacco, bidi, alcohol, and pan" . SPARSER::COLLECTION)
    ("uracils" . SPARSER::NUCLEOBASE) ("bisulfite" . SPARSER::MOLECULE)
    ("BstU1, and FNU4H1 restriction enzymes cut only templates containing methylated cytosines"
     . SPARSER::NUCLEOBASE)
    ("cytosines" . SPARSER::NUCLEOBASE) ("MSP" . SPARSER::PROTEIN)
    ("AGE" . SPARSER::PROTEIN)
    ("tobacco, alcohol, bidi, and pan" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("DNA-repair" . SPARSER::DNA) ("AGT" . SPARSER::PROTEIN)
    ("SMF" . SPARSER::PROTEIN) ("nitrosamines" . SPARSER::MOLECULE)
    ("bidi" . SPARSER::DRUG) ("MGMT and p16" . SPARSER::COLLECTION)
    ("MGMT" . SPARSER::PROTEIN) ("CDK6" . SPARSER::PROTEIN)
    ("p16 protein" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("Green fluorescent" . SPARSER::PROTEIN) ("CdK-4" . SPARSER::PROTEIN)
    ("PKCζ or PKMζ" . SPARSER::COLLECTION)
    ("PRKCZ and/or PRKMZ" . SPARSER::COLLECTION)
    ("The chimeric transcription factor" . SPARSER::PROTEIN)
    ("TCF3-PBX1" . SPARSER::COLLECTION)
    ("a currently used drug" . SPARSER::DRUG)
    ("different genetic subtypes" . SPARSER::PROTEIN)
    ("ETV6-RUNX1" . SPARSER::COLLECTION) ("REH" . SPARSER::PROTEIN)
    ("MHH-CALL-3" . SPARSER::COLLECTION) ("CALL" . SPARSER::PROTEIN)
    ("genetic subtype" . SPARSER::PROTEIN)
    ("the western blot" . SPARSER::PROTEIN)
    ("PRKCZ and PRKMZ" . SPARSER::COLLECTION) ("PRKCZ" . SPARSER::PROTEIN)
    ("TCF3 and PBX1" . SPARSER::COLLECTION) ("a shorter form" . SPARSER::FORM)
    ("MP" . SPARSER::PROTEIN)
    ("PKCζ (PKCzeta) and PKCι (PKCiota)" . SPARSER::COLLECTION)
    ("diacylglycerol" . SPARSER::PROTEIN)
    ("novel PKCs and atypical PKCs" . SPARSER::COLLECTION)
    ("the classic or conventional PKCs, novel PKCs and atypical PKCs"
     . SPARSER::COLLECTION)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the classic or conventional PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("thiopurine" . SPARSER::MOLECULE)
    ("thiopurines" . SPARSER::MOLECULE) ("mercaptopurine" . SPARSER::DRUG)
    ("thioguanine" . SPARSER::DRUG) ("PKCζ and PKMζ" . SPARSER::COLLECTION)
    ("Both tumour suppressor and oncogenic functions" . SPARSER::COLLECTION)
    ("the atypical zeta isoform" . SPARSER::ISOFORM) ("PKM" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TCF-3" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("PKC ζ" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("RPS20" . SPARSER::PROTEIN) ("Ribosomal Protein" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("ETV6" . SPARSER::PROTEIN) ("PBX1" . SPARSER::PROTEIN)
    ("PKCι" . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("PKCζ" . SPARSER::PROTEIN) ("NAR" . SPARSER::PROTEIN)
    ("an inefficient enzyme" . SPARSER::ENZYME)
    ("a very efficient polymerase" . SPARSER::PROTEIN)
    ("other nucleic acid polymerases" . SPARSER::PROTEIN)
    ("telomerase and super-telomerase" . SPARSER::COLLECTION)
    ("more hTR and (in HeLa) hTERT subunits" . SPARSER::COLLECTION)
    ("other small Cajal body-specific RNPs" . SPARSER::PROTEIN)
    ("tRNA and rRNA" . SPARSER::COLLECTION)
    ("RNP and RNase" . SPARSER::COLLECTION) ("RNase" . SPARSER::PROTEIN)
    ("snRNPs" . SPARSER::BIO-COMPLEX) ("telomerases" . SPARSER::PROTEIN)
    ("the monoclonal anti-hTERT antibody" . SPARSER::ANTIBODY)
    ("hTR and telomerase activity" . SPARSER::COLLECTION)
    ("hTERT protein and the assembled telomerase RNP" . SPARSER::COLLECTION)
    ("hTR, hTERT protein and the assembled telomerase RNP"
     . SPARSER::COLLECTION)
    ("subunits and RNP" . SPARSER::COLLECTION)
    ("hTERT or hTR" . SPARSER::COLLECTION)
    ("other macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("more purified telomerase" . SPARSER::PROTEIN) ("S5b" . SPARSER::PROTEIN)
    ("-dGMP" . SPARSER::DGMP) ("dGMP" . SPARSER::DGMP)
    ("mer" . SPARSER::PROTEIN) ("hTR–hTERT" . SPARSER::COLLECTION)
    ("Northern and western blot" . SPARSER::PROTEIN)
    ("hTR, hTERT and active" . SPARSER::COLLECTION)
    ("either hTR or hTERT alone increases total telomerase activity"
     . SPARSER::PROTEIN)
    ("hTR or hTERT" . SPARSER::COLLECTION) ("snRNA" . SPARSER::RNA)
    ("TR and TERT" . SPARSER::COLLECTION) ("S3a" . SPARSER::PROTEIN)
    ("∼240 active telomerase monomers" . SPARSER::MONOMER)
    ("hTERT and telomerase" . SPARSER::COLLECTION) ("-dGTP" . SPARSER::DGTP)
    ("TRAP" . SPARSER::PROTEIN) ("two-step" . SPARSER::PROTEIN)
    ("pg" . SPARSER::MOLECULE) ("northern blot" . SPARSER::PROTEIN)
    ("Std hTR and endogenous hTR" . SPARSER::COLLECTION)
    ("Std hTR and total cellular RNA" . SPARSER::COLLECTION)
    ("the Std hTR and endogenous hTR" . SPARSER::COLLECTION)
    ("quantitative northern blot" . SPARSER::PROTEIN)
    ("dGTP of telomerase and address" . SPARSER::COLLECTION)
    ("the hTERT protein as well as hTR" . SPARSER::COLLECTION)
    ("haploid and diploid" . SPARSER::COLLECTION)
    ("enough telomeric repeat-binding factor 1 (TRF1) and telomeric repeat-binding factor 2 (TRF2)"
     . SPARSER::COLLECTION)
    ("enough protection of telomeres 1 (POT1) and TPP1" . SPARSER::COLLECTION)
    ("telomere-associated shelterin complex subunits" . SPARSER::FRAGMENT)
    ("the most clearly established accessory proteins" . SPARSER::PROTEIN)
    ("Cajal" . SPARSER::PROTEIN) ("Accessory proteins" . SPARSER::PROTEIN)
    ("RNA (TR)" . SPARSER::RNA)
    ("specific telomere-associated proteins" . SPARSER::PROTEIN)
    ("dGTP" . SPARSER::DGTP) ("hTR and hTERT" . SPARSER::COLLECTION)
    ("monomers" . SPARSER::MONOMER)
    ("human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT)"
     . SPARSER::COLLECTION)
    ("the human telomerase RNP and its two key components"
     . SPARSER::COLLECTION)
    ("hTERT" . SPARSER::PROTEIN) ("hTR" . SPARSER::PROTEIN)
    ("Telomerase" . SPARSER::PROTEIN) ("7SK" . SPARSER::RNA)
    ("3b" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HD2" . SPARSER::PROTEIN)
    ("1 A" . SPARSER::PROTEIN) ("l 35" . SPARSER::PROTEIN)
    ("RNA polymerase" . SPARSER::PROTEIN)
    ("protection of telomeres 1" . SPARSER::PROTEIN)
    ("telomeric repeat-binding factor 2" . SPARSER::PROTEIN)
    ("TCAB1" . SPARSER::PROTEIN)
    ("telomerase Cajal body protein 1" . SPARSER::PROTEIN)
    ("Src and Aurora" . SPARSER::COLLECTION)
    ("PI 3-kinase/AKT" . SPARSER::COLLECTION) ("Aurora" . SPARSER::PROTEIN)
    ("Crk" . SPARSER::PROTEIN)
    ("the C-terminal 8 aa (SDPEEDDE) and a polar region of 2 aa"
     . SPARSER::COLLECTION)
    ("aa (SDPEEDDE)" . SPARSER::MOLECULE) ("BAF" . SPARSER::PROTEIN)
    ("hBRM and p53" . SPARSER::COLLECTION) ("hBRM" . SPARSER::PROTEIN)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("miR-17 directly targets p21-3" . SPARSER::COLLECTION)
    ("E2F1 , E2F3 and p21" . SPARSER::COLLECTION)
    ("MiR-17 directly targets p21-3" . SPARSER::COLLECTION)
    ("p21-3" . SPARSER::COLLECTION)
    ("SS18-SSX1 and SS18-SSX2-harboring" . SPARSER::COLLECTION)
    ("six mature microRNA" . SPARSER::MICRO-RNA)
    ("the miR-19 family (miR-19a and miR-19b-1) and the miR-92 family (miR-92a-1)"
     . SPARSER::COLLECTION)
    ("the miR-17 family (miR-17 and miR-20a), the miR-18 family (miR-18a), the miR-19 family (miR-19a and miR-19b-1) and the miR-92 family (miR-92a-1)"
     . SPARSER::COLLECTION)
    ("six mature micro RNA" . SPARSER::RNA)
    ("BIM , Tsp1 , CTGF , AIB1 and Cyclin D1" . SPARSER::COLLECTION)
    ("CDK2 or cyclin" . SPARSER::COLLECTION)
    ("genes or oncogenes" . SPARSER::COLLECTION)
    ("p and miR" . SPARSER::COLLECTION) ("MiRNA" . SPARSER::MICRO-RNA)
    ("SS18-SSX2" . SPARSER::COLLECTION) ("para" . SPARSER::PROTEIN-FAMILY)
    ("SS18-SSX" . SPARSER::COLLECTION) ("SSX" . SPARSER::PROTEIN)
    ("oncoprotein" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("DOCK180" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("SSX1" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::MOLECULE)
    ("BAF47" . SPARSER::PROTEIN) ("G1-S" . SPARSER::PROTEIN)
    ("p21CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E2F3" . SPARSER::PROTEIN)
    ("Jc1" . SPARSER::MOLECULE) ("6B" . SPARSER::PROTEIN)
    ("Doxorubicin hydrochloride" . SPARSER::DRUG) ("MIB1" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("AIB1" . SPARSER::PROTEIN) ("Tsp1" . SPARSER::PROTEIN)
    ("miR-92a" . SPARSER::MOLECULE) ("let-7" . SPARSER::RNA)
    ("SSX2" . SPARSER::PROTEIN) ("SS18-SSX1" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("SS18" . SPARSER::PROTEIN)
    ("other biological targets" . SPARSER::TARGET-PROTEIN)
    ("Nrf2 and NQO1" . SPARSER::COLLECTION)
    ("subsequent enzymes" . SPARSER::ENZYME)
    ("many cytoprotective proteins" . SPARSER::PROTEIN)
    ("an indirect antioxidant" . SPARSER::PROTEIN)
    ("the electrophilic molecules" . SPARSER::MOLECULE)
    ("toxins" . SPARSER::MOLECULE) ("electrophiles" . SPARSER::MOLECULE)
    ("oxygen and water" . SPARSER::COLLECTION)
    ("ROS and antioxidant" . SPARSER::COLLECTION)
    ("ALP and LDH" . SPARSER::COLLECTION)
    ("cardiac ischemia" . SPARSER::PROTEIN)
    ("a natural dietary isothiocyanate" . SPARSER::MOLECULE)
    ("glucosinolate" . SPARSER::MOLECULE) ("myrosinase" . SPARSER::PROTEIN)
    ("isothiocyanate" . SPARSER::MOLECULE) ("siRNA" . SPARSER::PROTEIN)
    ("acetaminophen" . SPARSER::DRUG)
    ("oltipraz and the natural triterpenoid oleanolic acid"
     . SPARSER::COLLECTION)
    ("triterpenoid" . SPARSER::MOLECULE) ("oltipraz" . SPARSER::DRUG)
    ("NQO1, HO-1 and GCLC" . SPARSER::COLLECTION) ("GCLC" . SPARSER::PROTEIN)
    ("GPx" . SPARSER::PROTEIN) ("SOD" . SPARSER::PROTEIN)
    ("ALT and LDH" . SPARSER::COLLECTION) ("AST" . SPARSER::PROTEIN)
    ("GSH and ROS" . SPARSER::COLLECTION)
    ("siRNA-Nrf2" . SPARSER::PROTEIN-PAIR)
    ("A typical Nrf2 agonist" . SPARSER::AGONIST)
    ("xenobiotic-metabolizing enzymes [e.g., glutathione-S-transferases and NAD(P)H:quinine oxidoreductase 1 (NQO1)] and antioxidant-related enzymes [e.g., heme oxygenase-1 (HO-1) and glutamate cysteine ligase (GCL)]"
     . SPARSER::COLLECTION)
    ("Typical Nrf2-target genes" . SPARSER::GENE) ("GCL" . SPARSER::PROTEIN)
    ("oxygenase" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("oxidoreductase" . SPARSER::PROTEIN) ("quinine" . SPARSER::DRUG)
    ("xenobiotic" . SPARSER::MOLECULE)
    ("multiple cytoprotective genes" . SPARSER::GENE)
    ("Response Element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("cis" . SPARSER::PROTEIN) ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Antioxidant" . SPARSER::PROTEIN) ("diterpenoid" . SPARSER::MOLECULE)
    ("Nrf2 and its downstream targets" . SPARSER::COLLECTION)
    ("sulforaphane (SFN)" . SPARSER::DRUG)
    ("a typical Nrf2 agonist" . SPARSER::AGONIST) ("SFN" . SPARSER::PROTEIN)
    ("sulforaphane" . SPARSER::PROTEIN) ("triptolide" . SPARSER::DRUG)
    ("Hook" . SPARSER::PROTEIN-FAMILY) ("Triptolide" . SPARSER::DRUG)
    ("hydroxyl radical" . SPARSER::MOLECULE)
    ("oleanolic acid" . SPARSER::MOLECULE)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("Anti-Histone" . SPARSER::PROTEIN) ("HO-1" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Keap1" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("p27 and c-Abl" . SPARSER::COLLECTION) ("Rb" . SPARSER::PROTEIN)
    ("Rb-E2F" . SPARSER::PROTEIN-PAIR) ("c-Abl and p27" . SPARSER::COLLECTION)
    ("abl" . SPARSER::PROTEIN) ("E2F2, p27 and p53" . SPARSER::COLLECTION)
    ("caspases" . SPARSER::PROTEIN)
    ("c-Abl and the related pro-apoptotic factors caspase 3, caspase 9 and PARP"
     . SPARSER::COLLECTION)
    ("the related pro-apoptotic factors caspase 3, caspase 9 and PARP"
     . SPARSER::COLLECTION)
    ("caspase 3, caspase 9 and PARP" . SPARSER::COLLECTION)
    ("Abl-tyrosine kinase" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("protein and erufosine" . SPARSER::COLLECTION)
    ("p16 Ink4A and p27 Kip1" . SPARSER::COLLECTION)
    ("p16 Ink4A , p27 Kip1 , p53, or Cdk4" . SPARSER::COLLECTION)
    ("p27 Kip1 , p16 Ink4A and p53" . SPARSER::COLLECTION)
    ("Cyclin D3 and Cdk4" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor suppressor protein and repressor" . SPARSER::COLLECTION)
    ("certain Rb/E2F target genes and the G 1 checkpoint mechanism xref"
     . SPARSER::COLLECTION)
    ("p107 and Rb" . SPARSER::COLLECTION) ("p53-p21" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("cytosine arabinoside and doxorubicin" . SPARSER::COLLECTION)
    ("functional p53" . SPARSER::PROTEIN) ("synthase (TS)" . SPARSER::PROTEIN)
    ("synthase" . SPARSER::PROTEIN) ("metabolite" . SPARSER::MOLECULE)
    ("doxorubicin and cisplatin" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE) ("cytarabine" . SPARSER::MOLECULE)
    ("/shRNA" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("the INK4 and the Cip/Kip protein families" . SPARSER::COLLECTION)
    ("cyclin/cyclin dependent kinase (CDK)" . SPARSER::COLLECTION)
    ("cyclin/cyclin dependent kinase" . SPARSER::COLLECTION)
    ("family and cyclin D1" . SPARSER::COLLECTION)
    ("ether" . SPARSER::MOLECULE) ("alkylphosphocholine" . SPARSER::DRUG)
    ("retinoblastoma" . SPARSER::PROTEIN)
    ("a new antineoplastic agent" . SPARSER::DRUG)
    ("alkylphosphocholines" . SPARSER::DRUG) ("TNF-α" . SPARSER::PROTEIN)
    ("Mdm-2" . SPARSER::PROTEIN) ("caspase 9" . SPARSER::PROTEIN)
    ("transcription factor E2F2" . SPARSER::PROTEIN)
    ("cyclin E2" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Caspase 9" . SPARSER::PROTEIN) ("Cyclin D3" . SPARSER::PROTEIN)
    ("Cdk 4" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("E2F2" . SPARSER::PROTEIN) ("L-Glutamine" . SPARSER::MOLECULE)
    ("cytosine arabinoside" . SPARSER::DRUG) ("Cdk4" . SPARSER::PROTEIN)
    ("p16 Ink4A" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27 Kip1" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("antineoplastic agent" . SPARSER::DRUG)
    ("TLR9 and NF-κB" . SPARSER::COLLECTION)
    ("AP -1 or NF -IL-6" . SPARSER::COLLECTION) ("AP -1" . SPARSER::PROTEIN)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAP" . SPARSER::PROTEIN)
    ("available DNA" . SPARSER::DNA) ("IL-6 and IL-12" . SPARSER::COLLECTION)
    ("bacterial DNA" . SPARSER::DNA) ("PRRs" . SPARSER::PROTEIN)
    ("nitrogen" . SPARSER::MOLECULE) ("functional TLR9" . SPARSER::PROTEIN)
    ("PDTC" . SPARSER::DRUG) ("neutrophil" . SPARSER::PROTEIN)
    ("anti-TLR9 or chloroquine" . SPARSER::COLLECTION)
    ("chloroquine or inhibitory ODN" . SPARSER::COLLECTION)
    ("the Hp-DNA and increase IL-8 production" . SPARSER::COLLECTION)
    ("probably other receptors" . SPARSER::RECEPTOR)
    ("RAGE" . SPARSER::PROTEIN) ("IgG and anti-TLR9" . SPARSER::COLLECTION)
    ("chloroquine or inhibitory oligonucleotide" . SPARSER::COLLECTION)
    ("ODN" . SPARSER::PROTEIN) ("oligonucleotide" . SPARSER::MOLECULE)
    ("chloroquine" . SPARSER::PROTEIN)
    ("Hp-DNA and H. pylori" . SPARSER::COLLECTION)
    ("DNA and LPS" . SPARSER::COLLECTION)
    ("neutrophils and monocytes" . SPARSER::COLLECTION)
    ("DNase" . SPARSER::PROTEIN) ("polymyxin" . SPARSER::MOLECULE)
    ("an essential component" . SPARSER::COMPONENT)
    ("microbial DNA" . SPARSER::DNA)
    ("IL-6, IL-1β, IL-12 and IL-10" . SPARSER::COLLECTION)
    ("TLR2 and TLR4" . SPARSER::COLLECTION) ("TLR2" . SPARSER::PROTEIN)
    ("flagellin" . SPARSER::PROTEIN) ("lipopeptides" . SPARSER::PROTEIN)
    ("receptors (PRR)" . SPARSER::RECEPTOR) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("PRR" . SPARSER::PROTEIN) ("Neutrophils" . SPARSER::PROTEIN)
    ("neutrophils" . SPARSER::PROTEIN) ("NF -IL-6" . SPARSER::PROTEIN)
    ("NOD1" . SPARSER::PROTEIN) ("TLR-9" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("IL-12" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("TLR9" . SPARSER::PROTEIN)
    ("SD, skewness, and kurtosis" . SPARSER::COLLECTION)
    ("SD" . SPARSER::PROTEIN) ("IA, IB, IIA, and IIB" . SPARSER::COLLECTION)
    ("PET" . SPARSER::PROTEIN) ("track" . SPARSER::PROTEIN)
    ("wildtype" . SPARSER::PROTEIN) ("pan-wildtype" . SPARSER::COLLECTION)
    ("K-ras" . SPARSER::PROTEIN) ("amine" . SPARSER::MOLECULE)
    ("CAM, and tube" . SPARSER::COLLECTION) ("-VEGFR-2" . SPARSER::COLLECTION)
    ("VEGFR-2/PI3K/Akt" . SPARSER::COLLECTION)
    ("VEGF/VEGFR-2" . SPARSER::COLLECTION) ("Flk" . SPARSER::PROTEIN)
    ("Rq" . SPARSER::MOLECULE) ("AuNP-treated VEGF" . SPARSER::PROTEIN)
    ("active and had" . SPARSER::COLLECTION) ("wine" . SPARSER::MOLECULE)
    ("Vis" . SPARSER::DRUG)
    ("the recombinant humanized monoclonal antibodies" . SPARSER::ANTIBODY)
    ("bevacizumab" . SPARSER::DRUG)
    ("the heparin-binding growth factor VEGF 165 and the non-heparin-binding growth factor VEGF 121"
     . SPARSER::COLLECTION)
    ("heparin" . SPARSER::PROTEIN)
    ("VEGFR-2/PI3K/Akt/eNOS" . SPARSER::COLLECTION) ("eNOS" . SPARSER::PROTEIN)
    ("VEGFR-2/PI3K" . SPARSER::COLLECTION) ("AFM" . SPARSER::PROTEIN)
    ("CAM" . SPARSER::PROTEIN) ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("Ly294002" . SPARSER::MOLECULE) ("anti-phospho" . SPARSER::PROTEIN)
    ("IP 2" . SPARSER::PROTEIN) ("VEGF 121" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN) ("PD-1 or PD-L1" . SPARSER::COLLECTION)
    ("PDL" . SPARSER::MOLECULE) ("TILs" . SPARSER::PROTEIN)
    ("immunodominant viral antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIL" . SPARSER::PROTEIN)
    ("IL-2 or immunological adjuvants" . SPARSER::COLLECTION)
    ("immunological adjuvants" . SPARSER::DRUG) ("adjuvants" . SPARSER::DRUG)
    ("fell" . SPARSER::PROTEIN) ("pre- and post-vaccine" . SPARSER::COLLECTION)
    ("Peptides" . SPARSER::PEPTIDE)
    ("a larger patient cohort" . SPARSER::MOLECULE)
    ("HLADR" . SPARSER::PROTEIN) ("LIN" . SPARSER::PROTEIN)
    ("pre and post-vaccine" . SPARSER::COLLECTION)
    ("CD4 and CD8" . SPARSER::COLLECTION)
    ("an irrelevant peptide" . SPARSER::PEPTIDE) ("ipilimumab" . SPARSER::DRUG)
    ("IL-2 and MUC1" . SPARSER::COLLECTION) ("HLA" . SPARSER::PROTEIN)
    ("normal p53" . SPARSER::PROTEIN)
    ("pre- and post-immunization" . SPARSER::COLLECTION)
    ("PD-L1" . SPARSER::PROTEIN) ("CD15" . SPARSER::DRUG)
    ("CD14" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("CD57" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("CD27" . SPARSER::PROTEIN)
    ("CD4" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("CD33" . SPARSER::PROTEIN) ("LIN1" . SPARSER::PROTEIN)
    ("CD127" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("CD137" . SPARSER::PROTEIN) ("VP1" . SPARSER::PROTEIN)
    ("pp65" . SPARSER::PROTEIN) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("GM-CSF" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("5T4" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("PD-1" . SPARSER::PROTEIN) ("p53MVA" . SPARSER::DRUG)
    ("DA and FF" . SPARSER::COLLECTION) ("DA" . SPARSER::MOLECULE)
    ("LB" . SPARSER::PROTEIN) ("MT" . SPARSER::PROTEIN)
    ("RD" . SPARSER::PROTEIN) ("GT" . SPARSER::PROTEIN)
    ("Serine-glutamine/treonine-glutamine" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID) ("Aa" . SPARSER::MOLECULE)
    ("the legal age" . SPARSER::PROTEIN)
    ("prostate and breast cancer and undergoes annual PSA" . SPARSER::PROTEIN)
    ("NC" . SPARSER::PROTEIN) ("XT" . SPARSER::PROTEIN)
    ("San" . SPARSER::PROTEIN) ("ethidium" . SPARSER::MOLECULE)
    ("agarose" . SPARSER::MOLECULE) ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MRC" . SPARSER::PROTEIN) ("IRCCS-AVR" . SPARSER::COLLECTION)
    ("AVR" . SPARSER::PROTEIN) ("cytosine" . SPARSER::NUCLEOBASE)
    ("delC" . SPARSER::PROTEIN) ("PML" . SPARSER::PROTEIN)
    ("gamma" . SPARSER::PROTEIN) ("Ser/Thr" . SPARSER::COLLECTION)
    ("forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY) ("aa" . SPARSER::MOLECULE)
    ("TQ" . SPARSER::DRUG) ("SQ" . SPARSER::MOLECULE)
    ("the human homolog of RAD53 ( Saccharomyces cerevisiae ) and CDS1 ( Schizosaccharomyces pombe )"
     . SPARSER::COLLECTION)
    ("MIM" . SPARSER::PROTEIN)
    ("ATM , BRIP1 , CDH1 , PALB2 and CHEK2" . SPARSER::COLLECTION)
    ("The principal genes" . SPARSER::GENE)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 and CHEK2" . SPARSER::COLLECTION)
    ("MLPA" . SPARSER::PROTEIN) ("Case" . SPARSER::PROTEIN)
    ("P190-B" . SPARSER::PROTEIN) ("I-1" . SPARSER::PROTEIN)
    ("CDC25C" . SPARSER::PROTEIN) ("CDS1" . SPARSER::PROTEIN)
    ("RAD53" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("checkpoint kinase 2" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("QC and LZ" . SPARSER::COLLECTION)
    ("QC" . SPARSER::PROTEIN) ("WL and QP" . SPARSER::COLLECTION)
    ("WL, TG and LZ" . SPARSER::COLLECTION) ("LZ" . SPARSER::PROTEIN)
    ("TG" . SPARSER::PROTEIN) ("SHH" . SPARSER::PROTEIN)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FISH and IHC" . SPARSER::COLLECTION)
    ("ERBB-2 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Herceptin" . SPARSER::DRUG) ("aggressive forms" . SPARSER::FORM)
    ("ERBB-2 and ERBB-4" . SPARSER::COLLECTION)
    ("ERBB-2 and ERBB-3" . SPARSER::COLLECTION)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("a key etiologic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HH" . SPARSER::PROTEIN) ("Hedgehog" . SPARSER::PROTEIN)
    ("CDKN2A, EGFR, CDK4, and MDM2" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION) ("Iressa" . SPARSER::DRUG)
    ("the negative prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the statistically significant poor prognostic factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FISH and EGFR" . SPARSER::COLLECTION)
    ("temporal lobe" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("task" . SPARSER::PROTEIN) ("astrocytes" . SPARSER::PROTEIN)
    ("a histological subtype" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("MYCC" . SPARSER::PROTEIN)
    ("ERBB-2, ERBB-3 and ERBB-4" . SPARSER::COLLECTION)
    ("MBs" . SPARSER::PROTEIN) ("EGFR and ERBB-2" . SPARSER::COLLECTION)
    ("EGFR, ERBB-2, ERBB-3 and ERBB-4" . SPARSER::COLLECTION)
    ("age " . SPARSER::PROTEIN) ("MB" . SPARSER::PROTEIN)
    ("ErbB-4" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("IDH1" . SPARSER::PROTEIN) ("ERBB-2" . SPARSER::PROTEIN)
    ("FX" . SPARSER::PROTEIN) ("HL" . SPARSER::PROTEIN)
    ("RhoC and final effectors" . SPARSER::COLLECTION)
    ("snail and slug" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("ß-Smad" . SPARSER::COLLECTION) ("Snail and Slug" . SPARSER::COLLECTION)
    ("N-cadherin and α-SMA" . SPARSER::COLLECTION)
    ("VEGF and TGF-β" . SPARSER::COLLECTION)
    ("MMP-9 and VEGF" . SPARSER::COLLECTION) ("Lovastatin" . SPARSER::DRUG)
    ("E-cadherin, N-cadherin and α-SMA" . SPARSER::COLLECTION)
    ("N-cadherin, α-SMA, Slug and Notch1" . SPARSER::COLLECTION)
    ("N-cadherin, α-SMA and Slug" . SPARSER::COLLECTION)
    ("N-cadherin , α-SMA , snail and Notch1" . SPARSER::COLLECTION)
    ("RhoC-" . SPARSER::PROTEIN) ("TGF-β1 or VEGF" . SPARSER::COLLECTION)
    ("EMT and related molecules" . SPARSER::COLLECTION)
    ("VEGF and TGF-β1" . SPARSER::COLLECTION)
    ("N-cadherin and a-SMA" . SPARSER::COLLECTION)
    ("Akt , stat-3 , bcl-xL and survivin" . SPARSER::COLLECTION)
    ("Bax and Caspase-3" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("post-EMT" . SPARSER::COLLECTION)
    ("Notch1 and RhoC" . SPARSER::COLLECTION)
    ("EMT, and Notch1" . SPARSER::COLLECTION) ("GDP" . SPARSER::NUCLEOTIDE)
    ("E-cadherin, desmoplakin and plakoglobin" . SPARSER::COLLECTION)
    ("N-cadherin, fibronectin and α-SMA" . SPARSER::COLLECTION)
    ("plakoglobin" . SPARSER::PROTEIN)
    ("Akt, glycogen synthase kinase-3, Rho-GTPases and Smad"
     . SPARSER::COLLECTION)
    ("Snai1, Slug, Zeb1, Zeb2, Goosecoid, and forkhead box protein C2"
     . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epithelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagen, hyaluronic acid and integrin" . SPARSER::COLLECTION)
    ("proteins and matrix" . SPARSER::COLLECTION)
    ("TGF-β1 and VEGF" . SPARSER::COLLECTION)
    ("VEGFR or TGF-β1R" . SPARSER::COLLECTION)
    ("VEGF or TGF-β1" . SPARSER::COLLECTION)
    ("N-cadherin, α-SMA, snail and Notch1" . SPARSER::COLLECTION)
    ("vascular epithelial growth factor (VEGF)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF" . SPARSER::PROTEIN) ("GTPase" . SPARSER::GTPASE)
    ("RhoC" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("for 3 " . SPARSER::PROTEIN)
    ("SB431542" . SPARSER::DRUG) ("BIBF1120" . SPARSER::DRUG)
    ("Caspase-3" . SPARSER::PROTEIN) ("bcl-xL" . SPARSER::PROTEIN)
    ("stat-3" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN)
    ("forkhead box protein C2" . SPARSER::PROTEIN) ("Snai1" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("hyaluronic acid" . SPARSER::MOLECULE) ("Notch1" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("small G protein" . SPARSER::PROTEIN)
    ("a weak inducer" . SPARSER::PROTEIN) ("p53 and ROS" . SPARSER::COLLECTION)
    ("p53-GFP" . SPARSER::COLLECTION) ("UVB or UVC" . SPARSER::COLLECTION)
    ("IR and UVC" . SPARSER::COLLECTION)
    ("GCAGGCAAATGTGCA-3" . SPARSER::COLLECTION)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UVC" . SPARSER::PROTEIN)
    ("ultraviolet C light (UVC)" . SPARSER::PROTEIN)
    ("light (UVC)" . SPARSER::PROTEIN) ("alt1" . SPARSER::PROTEIN)
    ("ROS and p53" . SPARSER::COLLECTION) ("a good inducer" . SPARSER::PROTEIN)
    ("UVB" . SPARSER::PROTEIN) ("cm 2" . SPARSER::PROTEIN)
    ("ultraviolet B light (UVB)" . SPARSER::PROTEIN)
    ("light (UVB)" . SPARSER::PROTEIN) ("2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1 µL" . SPARSER::PROTEIN) ("a 20 µ" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("L-NAC" . SPARSER::DRUG) ("hdm2" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("Hdm2" . SPARSER::PROTEIN)
    ("PTEN and PTEN-L and aid" . SPARSER::COLLECTION)
    ("a natural longer protein" . SPARSER::PROTEIN)
    ("PTEN and PTEN-L" . SPARSER::COLLECTION) ("acceptor" . SPARSER::MOLECULE)
    ("the shorter 403-amino-acid form" . SPARSER::FORM)
    ("less abundant longer PTEN protein" . SPARSER::PROTEIN)
    ("relatively few genes" . SPARSER::GENE) ("ASD" . SPARSER::PROTEIN)
    ("a major tumor suppressor gene" . SPARSER::PROTEIN)
    ("MMAC1, or TEP1" . SPARSER::COLLECTION)
    ("this longer form" . SPARSER::FORM)
    ("a previously uncharacterized form" . SPARSER::FORM)
    ("the 403-residue-long PTEN protein" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION)
    ("signal peptide" . SPARSER::PROTEIN) ("TEP1" . SPARSER::PROTEIN)
    ("MMAC1" . SPARSER::PROTEIN) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pivotal apoptosis regulators" . SPARSER::REGULATOR)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PARP1-" . SPARSER::PROTEIN)
    ("tBid" . SPARSER::PROTEIN) ("Fluorouracil" . SPARSER::DRUG)
    ("GSK3A or GSK3B" . SPARSER::COLLECTION) ("MLL" . SPARSER::PROTEIN)
    ("Myc and cyclin D1" . SPARSER::COLLECTION) ("KO" . SPARSER::PROTEIN)
    ("glucose and insulin" . SPARSER::COLLECTION) ("NFkB" . SPARSER::PROTEIN)
    ("GSK3A and GSK3B" . SPARSER::COLLECTION)
    ("only one isoform" . SPARSER::ISOFORM) ("AIF" . SPARSER::PROTEIN)
    ("Glycogen Synthase Kinase-3 alpha (GSK3A) and beta (GSK3B) isoforms"
     . SPARSER::COLLECTION)
    ("NP40" . SPARSER::MOLECULE) ("pGL4" . SPARSER::PROTEIN)
    ("Glo3" . SPARSER::PROTEIN) ("GL2" . SPARSER::PROTEIN)
    ("TWS119" . SPARSER::DRUG) ("necrostatin-1" . SPARSER::MOLECULE)
    ("SB415286" . SPARSER::DRUG) ("PARP1" . SPARSER::PROTEIN)
    ("RPA70" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("GSK3B protein" . SPARSER::PROTEIN) ("and 1 µ" . SPARSER::PROTEIN)
    ("SB216763" . SPARSER::DRUG) ("S21" . SPARSER::PROTEIN)
    ("beta isoform" . SPARSER::PROTEIN) ("beta-amyloid" . SPARSER::MOLECULE)
    ("alpha isoform" . SPARSER::PROTEIN) ("TNF-alpha" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RIP1" . SPARSER::PROTEIN)
    ("GSK3B" . SPARSER::PROTEIN) ("GSK3A" . SPARSER::PROTEIN)
    ("Glycogen Synthase Kinase-3 alpha" . SPARSER::PROTEIN)
    ("AKT kinase inhibitors or antagonists" . SPARSER::COLLECTION)
    ("FOXO4/RUNX2" . SPARSER::COLLECTION)
    ("PIP, PGC and SNAI1" . SPARSER::COLLECTION)
    ("synergizes" . SPARSER::PROTEIN)
    ("CaP and osteoblasts/osteoclasts" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN)
    ("RUNX2 and FOXO4" . SPARSER::COLLECTION)
    ("genes and promoters" . SPARSER::COLLECTION)
    ("only two gene promoters" . SPARSER::PROMOTER)
    ("FOXO4 and pro-metastasis" . SPARSER::COLLECTION)
    ("repressor" . SPARSER::REPRESSOR) ("RUNX2 and gene" . SPARSER::COLLECTION)
    ("PIP, PGC, MMP9, MMP13 and OP" . SPARSER::COLLECTION)
    ("constitutively-activated AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myr-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("myr" . SPARSER::MOLECULE)
    ("HA-RUNX2" . SPARSER::COLLECTION) ("PIP and PGC" . SPARSER::COLLECTION)
    ("GGT" . SPARSER::PROTEIN) ("FOXO4-TM" . SPARSER::COLLECTION)
    ("PIP and PLA2G16" . SPARSER::COLLECTION)
    ("PGC and CAMK2N1" . SPARSER::COLLECTION) ("DBE" . SPARSER::PROTEIN)
    ("PIP or PGC" . SPARSER::COLLECTION) ("PIP-" . SPARSER::PROTEIN)
    ("PIP, CAMK2N1, PLA2G16, ALDH1L1, VCX, VCX3A, APP , and PGC"
     . SPARSER::COLLECTION)
    ("APP" . SPARSER::PROTEIN) ("repressors" . SPARSER::REPRESSOR)
    ("LNCaP[vector] or LNCaP[shFOXO4]" . SPARSER::COLLECTION)
    ("their dorsal lobes" . SPARSER::PROTEIN) ("lobes" . SPARSER::PROTEIN)
    ("testosterone" . SPARSER::MOLECULE)
    ("the more invasive variants" . SPARSER::VARIANT)
    ("FOXO4, FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("Myc-FOXO4" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("Green" . SPARSER::PROTEIN) ("shRNA or siRNA" . SPARSER::COLLECTION)
    ("either wt-FOXO4 or a constitutively-active FOXO4 mutant (TM, for “triple mutant”, i.e.- loss of all three AKT phosphorylation sites)"
     . SPARSER::COLLECTION)
    ("wt-FOXO4" . SPARSER::PROTEIN-PAIR) ("Rv" . SPARSER::MOLECULE)
    ("sh- or siFOXO4" . SPARSER::COLLECTION) ("sh-" . SPARSER::PROTEIN-FAMILY)
    ("scr" . SPARSER::PROTEIN) ("metastatic CaP" . SPARSER::PROTEIN)
    ("STAM" . SPARSER::PROTEIN) ("bar" . SPARSER::PROTEIN)
    ("were run" . SPARSER::PROTEIN) ("run" . SPARSER::PROTEIN)
    ("human genomic shRNAs" . SPARSER::PROTEIN) ("puromycin" . SPARSER::DRUG)
    ("PIP, PGC, CAMK2N1 and PLA2G16" . SPARSER::COLLECTION)
    ("FOXO1, FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3a" . SPARSER::COLLECTION)
    ("OP, IL8, VEGF and MMP13" . SPARSER::COLLECTION) ("OP" . SPARSER::PROTEIN)
    ("TRAMP" . SPARSER::PROTEIN) ("androgen-" . SPARSER::PROTEIN)
    ("FOXO1, FOXO3a and FOXO4" . SPARSER::COLLECTION)
    ("PI3K, AKT or TORC1" . SPARSER::COLLECTION) ("taxanes" . SPARSER::DRUG)
    ("/AKT" . SPARSER::COLLECTION)
    ("AR mutants or overexpression xref" . SPARSER::COLLECTION)
    ("anti-androgens or AR" . SPARSER::COLLECTION)
    ("FOXO1 or FOXO3" . SPARSER::COLLECTION)
    ("PIP, CAMK2N1, PLA2G16 and PGC" . SPARSER::COLLECTION)
    ("PLA2G16" . SPARSER::PROTEIN) ("FOXO4-KD" . SPARSER::COLLECTION)
    ("PGC" . SPARSER::PROTEIN) ("PIP" . SPARSER::PROTEIN)
    ("KD" . SPARSER::PROTEIN) ("CR-CaP" . SPARSER::COLLECTION)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SNAI1" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("ALDH1L1" . SPARSER::PROTEIN)
    ("tissue-type" . SPARSER::PROTEIN) ("ANXA8" . SPARSER::PROTEIN)
    ("SLC17A4" . SPARSER::PROTEIN) ("solute carrier family" . SPARSER::PROTEIN)
    ("KIF3B" . SPARSER::PROTEIN)
    ("kinesin family member 3B" . SPARSER::PROTEIN)
    ("forkhead box O4" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("ddH 2" . SPARSER::PROTEIN) ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("Na 3 VO4" . SPARSER::MOLECULE) ("MMP13" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXO3a" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG) ("RUNX2" . SPARSER::PROTEIN)
    ("G16" . SPARSER::PROTEIN) ("PLA2" . SPARSER::PROTEIN)
    ("CAMK2" . SPARSER::PROTEIN) ("FOXO3" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("the companion diagnostic SRM" . SPARSER::PROTEIN)
    ("many actionable biomarkers" . SPARSER::MOLECULE)
    ("no antibodies or other types" . SPARSER::COLLECTION)
    ("FISH, IHC, and SRM" . SPARSER::COLLECTION)
    ("SRM and IHC" . SPARSER::COLLECTION)
    ("SRM and FISH" . SPARSER::COLLECTION)
    ("other relevant proteins" . SPARSER::PROTEIN)
    ("affinity reagents or subjective interpretation" . SPARSER::COLLECTION)
    ("trypsinization" . SPARSER::PROTEIN)
    ("a linear tryptic peptide" . SPARSER::PEPTIDE)
    ("PR, and Ki-67" . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("relevant protein biomarkers" . SPARSER::MOLECULE)
    ("gold" . SPARSER::MOLECULE) ("SRM and MET:CEP7" . SPARSER::COLLECTION)
    ("FISH, and Met" . SPARSER::COLLECTION)
    ("SRM and MET" . SPARSER::COLLECTION)
    ("the Gastroesophageal Cancer (GEC) Patient Cohort" . SPARSER::MOLECULE)
    ("Cohort" . SPARSER::MOLECULE) ("ischemia" . SPARSER::PROTEIN)
    ("the light and heavy peptides" . SPARSER::COLLECTION)
    ("spiked" . SPARSER::PROTEIN) ("spiking" . SPARSER::PROTEIN)
    ("tryptic peptides" . SPARSER::PEPTIDE) ("ions" . SPARSER::MOLECULE)
    ("SRM-MS" . SPARSER::COLLECTION) ("-MS" . SPARSER::COLLECTION)
    ("arm" . SPARSER::PROTEIN)
    ("ATP competitive tyrosine kinase inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("Met−" . SPARSER::AMINO-ACID)
    ("rilotumumab" . SPARSER::DRUG) ("onartuzumab" . SPARSER::DRUG)
    ("HGF or Met" . SPARSER::COLLECTION) ("EA" . SPARSER::PROTEIN)
    ("MAPKK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CREB" . SPARSER::PROTEIN)
    ("HGFR" . SPARSER::PROTEIN)
    ("SRM (n = 44; R 2  = 0.537) nor FISH GCN (n = 31; R 2  = 0.509)"
     . SPARSER::COLLECTION)
    ("n " . SPARSER::PROTEIN) ("the optimal SRM peptide" . SPARSER::PEPTIDE)
    ("LT-SRM-MS" . SPARSER::COLLECTION) ("SRM" . SPARSER::PROTEIN)
    ("LT" . SPARSER::PROTEIN) ("Alpha-" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("P08581" . SPARSER::PROTEIN)
    ("Mg 2+" . SPARSER::MOLECULE) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("CAT-2" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("Bortezomib" . SPARSER::DRUG)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("digestive protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Generally blood serum proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pure p38α" . SPARSER::PROTEIN)
    ("Asp (168) and Ser" . SPARSER::COLLECTION)
    ("p38γ and p38δ" . SPARSER::COLLECTION)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("active or inactive" . SPARSER::COLLECTION)
    ("almost all kinases" . SPARSER::KINASE)
    ("“Asp-Phe-Gly" . SPARSER::COLLECTION)
    ("Thr and Tyr" . SPARSER::COLLECTION)
    ("ATP and substrate" . SPARSER::COLLECTION) ("tri" . SPARSER::PROTEIN)
    ("Tyr" . SPARSER::AMINO-ACID)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("anti-phospho-ATF-2" . SPARSER::PROTEIN-PAIR)
    ("western-blot" . SPARSER::PROTEIN)
    ("the resultant casein fragments" . SPARSER::FRAGMENT)
    ("trypsin" . SPARSER::PROTEIN) ("casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RBC" . SPARSER::PROTEIN)
    ("the pure p38α and the serum-p38α" . SPARSER::COLLECTION)
    ("the pure p38α" . SPARSER::PROTEIN) ("mixture" . SPARSER::MOLECULE)
    ("commercial inhibitor" . SPARSER::INHIBITOR) ("RU" . SPARSER::PROTEIN)
    ("Leu" . SPARSER::AMINO-ACID)
    ("Asp (168) and Glu (71)" . SPARSER::COLLECTION)
    ("c-ABL and b-RAF" . SPARSER::COLLECTION) ("FWCS" . SPARSER::MOLECULE)
    ("tetra" . SPARSER::MOLECULE) ("MSA" . SPARSER::PROTEIN)
    ("trypsinized" . SPARSER::PROTEIN) ("DEAE-sephadex" . SPARSER::DRUG)
    ("sephadex" . SPARSER::DRUG) ("DEAE" . SPARSER::DRUG)
    ("NaCl" . SPARSER::PROTEIN) ("phenylalanine" . SPARSER::AMINO-ACID)
    ("Asp-Phe-Gly" . SPARSER::COLLECTION) ("DFG-" . SPARSER::PROTEIN)
    ("Asp" . SPARSER::AMINO-ACID)
    ("a specific competitive peptide inhibitor" . SPARSER::INHIBITOR)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("Cytokines" . SPARSER::PROTEIN)
    ("TNFα, IL6 and IL12" . SPARSER::COLLECTION)
    ("an attractive target" . SPARSER::TARGET-PROTEIN)
    ("anti" . SPARSER::PROTEIN)
    ("faulty genes and proteins" . SPARSER::COLLECTION)
    ("a proficient small peptide" . SPARSER::PEPTIDE)
    ("SPR" . SPARSER::PROTEIN) ("tetrapeptide (FWCS)" . SPARSER::MOLECULE)
    ("tetrapeptide" . SPARSER::MOLECULE)
    ("mitogen activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DFG" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("two domains" . SPARSER::PROTEIN) ("MS-MS" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN) ("p38 µ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PS3" . SPARSER::PROTEIN) ("b-RAF" . SPARSER::PROTEIN)
    ("c-ABL" . SPARSER::PROTEIN) ("p38δ" . SPARSER::PROTEIN)
    ("p38γ" . SPARSER::PROTEIN) ("id 3" . SPARSER::PROTEIN)
    ("BIRB 796" . SPARSER::DRUG) ("id 1" . SPARSER::PROTEIN)
    ("O15264" . SPARSER::PROTEIN) ("Q15759" . SPARSER::PROTEIN)
    ("Q16539" . SPARSER::PROTEIN)
    ("4-nitrophenyl phosphate" . SPARSER::MOLECULE)
    ("ATF-2" . SPARSER::PROTEIN) ("transcription factor-2" . SPARSER::PROTEIN)
    ("BIRB-796" . SPARSER::DRUG) ("TNFα" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("4 esophageal cancer samples expressing A279T" . SPARSER::PROTEIN)
    ("genes-" . SPARSER::GENE) ("BRG-1 and nucleostemin" . SPARSER::COLLECTION)
    ("nucleostemin" . SPARSER::PROTEIN) ("heterochromatin" . SPARSER::PROTEIN)
    ("leukocytes" . SPARSER::PROTEIN)
    ("TERT-immortalized human fetal hepatocytes" . SPARSER::PROTEIN)
    ("endoribonuclease" . SPARSER::PROTEIN)
    ("BRG1-TERT-β-catenin" . SPARSER::COLLECTION) ("ALT" . SPARSER::PROTEIN)
    ("Zeocin-treated A279T- MEFs" . SPARSER::PROTEIN)
    ("A279T-" . SPARSER::PROTEIN) ("A279T-MEFs" . SPARSER::COLLECTION)
    ("A279T-MEF" . SPARSER::COLLECTION) ("centromeres" . SPARSER::PROTEIN)
    ("SKY" . SPARSER::PROTEIN) ("normal media" . SPARSER::PROTEIN)
    ("MEF" . SPARSER::PROTEIN) ("MAF" . SPARSER::PROTEIN)
    ("bright" . SPARSER::PROTEIN) ("intense red" . SPARSER::PROTEIN)
    ("FBS" . SPARSER::PROTEIN) ("EsC1- and EsC2-" . SPARSER::COLLECTION)
    ("EsC2-" . SPARSER::PROTEIN) ("EsC1-" . SPARSER::PROTEIN)
    ("actin and actin-associated proteins" . SPARSER::COLLECTION)
    ("actin-associated proteins" . SPARSER::PROTEIN)
    ("β-catenin, α-catenin and p120" . SPARSER::COLLECTION)
    ("vinculin, and formin-1" . SPARSER::COLLECTION)
    ("cadherin-catenin" . SPARSER::COLLECTION) ("formin" . SPARSER::PROTEIN)
    ("vinculin" . SPARSER::PROTEIN) ("catenin" . SPARSER::PROTEIN-FAMILY)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chemotaxis" . SPARSER::PROTEIN)
    ("cisplatin as well as paclitaxel" . SPARSER::COLLECTION)
    ("cisplatin and paclitaxel" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("paclitaxel" . SPARSER::DRUG)
    ("BRCA1, BRCA2, p57, caspase 8, TNF, FAS, IL-6 and IL-8"
     . SPARSER::COLLECTION)
    ("JunB" . SPARSER::PROTEIN) ("FAS" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("A279T-EsC2" . SPARSER::COLLECTION)
    ("A279T-EsC1" . SPARSER::COLLECTION) ("TCF" . SPARSER::PROTEIN)
    ("FOP-FLASH" . SPARSER::COLLECTION) ("TOP-FLASH" . SPARSER::COLLECTION)
    ("FOP" . SPARSER::PROTEIN) ("FLASH" . SPARSER::PROTEIN)
    ("TOP" . SPARSER::PROTEIN) ("BRG-1-TERT-β-catenin" . SPARSER::COLLECTION)
    ("APC/Axin" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("β-catenin and TERT" . SPARSER::COLLECTION)
    ("TERT and BRG-1" . SPARSER::COLLECTION)
    ("EsC1 or EsC2" . SPARSER::COLLECTION) ("elongation" . SPARSER::PROTEIN)
    ("A279T-TERT" . SPARSER::COLLECTION)
    ("Parental EsC1 and EsC2" . SPARSER::COLLECTION)
    ("EsC1 and EsC2" . SPARSER::COLLECTION)
    ("A279T or wtTERT" . SPARSER::COLLECTION)
    ("EsC2-A279T" . SPARSER::COLLECTION) ("A279T" . SPARSER::PROTEIN)
    ("EsC1-A279T and ESC2-A279T" . SPARSER::COLLECTION)
    ("ESC2-A279T" . SPARSER::PROTEIN-PAIR) ("EsC1-A279T" . SPARSER::COLLECTION)
    ("ESC2" . SPARSER::PROTEIN) ("EsC2" . SPARSER::PROTEIN)
    ("EsC1" . SPARSER::PROTEIN)
    ("EsC1-TERT, and EsC2-TERT" . SPARSER::COLLECTION)
    ("EsC2-TERT" . SPARSER::COLLECTION) ("EsC1-TERT" . SPARSER::COLLECTION)
    ("mAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The previous homozygous A279T variant" . SPARSER::VARIANT)
    ("one heterozygous A1062T variant" . SPARSER::VARIANT)
    ("4 heterozygous A279T variants" . SPARSER::VARIANT)
    ("TERC and TERT" . SPARSER::COLLECTION) ("germ-line" . SPARSER::PROTEIN)
    ("son" . SPARSER::PROTEIN) ("Post" . SPARSER::PROTEIN)
    ("IIB" . SPARSER::PROTEIN) ("biliary cirrhosis" . SPARSER::PROTEIN)
    ("cirrhosis" . SPARSER::PROTEIN) ("dyskerin" . SPARSER::PROTEIN)
    ("shelterin" . SPARSER::PROTEIN)
    ("additional cytoskeletal proteins" . SPARSER::PROTEIN)
    ("TERT-BRG-1-β-catenin" . SPARSER::COLLECTION)
    ("TERT and several TERT variants" . SPARSER::COLLECTION)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("BRG-1 and β-catenin" . SPARSER::COLLECTION)
    ("telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC)"
     . SPARSER::COLLECTION)
    ("TERC" . SPARSER::PROTEIN) ("TERT" . SPARSER::PROTEIN)
    ("telomerase" . SPARSER::PROTEIN) ("mitochondrial RNA" . SPARSER::RNA)
    ("RNA polymerase activity" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("p120" . SPARSER::PROTEIN) ("α-catenin" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("TRP1" . SPARSER::PROTEIN)
    ("Telomerase Activity" . SPARSER::PROTEIN) ("CENP-B" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX)
    ("Telomerase activity" . SPARSER::PROTEIN) ("NHP2" . SPARSER::PROTEIN)
    ("P10" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("TIN2" . SPARSER::PROTEIN) ("POT1" . SPARSER::PROTEIN)
    ("TPP1" . SPARSER::PROTEIN) ("RAP1" . SPARSER::PROTEIN)
    ("TRF2" . SPARSER::PROTEIN) ("TRF1" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN) ("BRG-1" . SPARSER::PROTEIN)
    ("telomerase RNA component" . SPARSER::RNA)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("the predictive biomarkers KRAS , BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS , BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("the primary CRC" . SPARSER::PROTEIN) ("EGFR/PI3K" . SPARSER::COLLECTION)
    ("specifically target EGFR (for example, cetuximab, panitumumab) or PTGS2 (for example, celecoxib)"
     . SPARSER::COLLECTION)
    ("specifically target EGFR" . SPARSER::PROTEIN)
    ("celecoxib" . SPARSER::DRUG) ("panitumumab" . SPARSER::DRUG)
    ("cetuximab" . SPARSER::DRUG) ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("EGFR and PTGS" . SPARSER::COLLECTION) ("primary CRC" . SPARSER::PROTEIN)
    ("EGFR or PTGS2" . SPARSER::COLLECTION) ("pre-" . SPARSER::PROTEIN)
    ("both EGFR (HRR 1.91, 95% CI 1.31–2.81, P <0.01) and PTGS2 (HRR 1.50, 95% CI 1.00–2.26, P =0.05)"
     . SPARSER::COLLECTION)
    ("CEA" . SPARSER::PROTEIN) ("av" . SPARSER::MOLECULE)
    ("metastatic CRC" . SPARSER::PROTEIN)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("EGFR and PGE 2" . SPARSER::COLLECTION)
    ("RAS/RAF/MAPK" . SPARSER::COLLECTION)
    ("better prognostic biomarkers" . SPARSER::MOLECULE)
    ("TMAs" . SPARSER::MOLECULE) ("Formalin" . SPARSER::MOLECULE)
    ("EGFR and PTGS2" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2; also known as cyclooxygenase-2)"
     . SPARSER::COLLECTION)
    ("Prognostic biomarkers" . SPARSER::MOLECULE) ("5FU" . SPARSER::DRUG)
    ("ml −1" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EP2 receptor" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("HRR 1" . SPARSER::PROTEIN) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN)
    ("prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("sorafenib, vandetanib and sunitinib" . SPARSER::COLLECTION)
    ("sunitinib" . SPARSER::DRUG) ("vandetanib" . SPARSER::DRUG)
    ("sorafenib" . SPARSER::DRUG) ("multi" . SPARSER::PROTEIN)
    ("vascular-specific receptor tyrosine kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIE1, KDR and FLT1" . SPARSER::COLLECTION)
    ("MYC, RET and FLT4" . SPARSER::COLLECTION)
    ("RET and protein" . SPARSER::COLLECTION)
    ("UNC5A, CTLA4, ISLR2, ICOS, RAB17 and RASGRP3" . SPARSER::COLLECTION)
    ("MYC, RET and CDKN2C" . SPARSER::COLLECTION)
    ("MYC and KIT" . SPARSER::COLLECTION)
    ("MYC , KIT, RET and CDKN2C" . SPARSER::COLLECTION)
    ("only 29 genes" . SPARSER::GENE) ("RET and CDKN2C" . SPARSER::COLLECTION)
    ("protein or gene" . SPARSER::COLLECTION)
    ("MYC and RET" . SPARSER::COLLECTION)
    ("RET , KIT and FLT4" . SPARSER::COLLECTION) ("EC" . SPARSER::PROTEIN)
    ("UNC5A, CTLA4, ISLR2, ICOS, RAB17, FLT4 and RASGRP3"
     . SPARSER::COLLECTION)
    ("ICOS" . SPARSER::PROTEIN) ("ISLR" . SPARSER::PROTEIN)
    ("genes and key pathways" . SPARSER::COLLECTION)
    ("Target" . SPARSER::TARGET-PROTEIN) ("MYC and KDR" . SPARSER::COLLECTION)
    ("KDR" . SPARSER::PROTEIN)
    ("highly aggressive soft tissue sarcoma subtype" . SPARSER::PROTEIN)
    ("MYC , KIT and RET" . SPARSER::COLLECTION)
    ("MYC, KIT and RET" . SPARSER::COLLECTION) ("KIT" . SPARSER::PROTEIN)
    ("FLT1" . SPARSER::PROTEIN) ("TIE1" . SPARSER::PROTEIN)
    ("N-MYC" . SPARSER::PROTEIN) ("cytokine receptor" . SPARSER::PROTEIN)
    ("ANKRD1" . SPARSER::PROTEIN) ("2.7.10.1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RASGRP3" . SPARSER::PROTEIN) ("FLT4" . SPARSER::PROTEIN)
    ("RAB17" . SPARSER::PROTEIN) ("CTLA4" . SPARSER::PROTEIN)
    ("UNC5A" . SPARSER::PROTEIN) ("RPS17" . SPARSER::PROTEIN)
    ("log 2" . SPARSER::PROTEIN) ("AE3" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN)
    ("commercially available inhibitors" . SPARSER::INHIBITOR)
    ("ALK, PIK3CA, and CTNNB1" . SPARSER::COLLECTION)
    ("XALKORI" . SPARSER::DRUG) ("SWI/SNF" . SPARSER::COLLECTION)
    ("methyltransferase" . SPARSER::PROTEIN) ("SNF" . SPARSER::PROTEIN)
    ("SWI" . SPARSER::PROTEIN)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("CDKN2A and 10q23.3" . SPARSER::COLLECTION)
    ("PTEN and CDKN2A" . SPARSER::COLLECTION)
    ("SMARCB1 and CDKN2A" . SPARSER::COLLECTION) ("CGH" . SPARSER::PROTEIN)
    ("DOS" . SPARSER::PROTEIN) ("cancer-associated genes" . SPARSER::GENE)
    ("CDKN2A (located in 9p21) and PTEN (located in 10q23.3)"
     . SPARSER::COLLECTION)
    ("SMARCB1/INI1" . SPARSER::COLLECTION)
    ("CDKN2A and PTEN" . SPARSER::COLLECTION) ("NRAS" . SPARSER::PROTEIN)
    ("hME" . SPARSER::PROTEIN) ("seven" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN) ("INI1" . SPARSER::PROTEIN)
    ("SMARCB1" . SPARSER::PROTEIN)
    ("ITGA6, ITGAL, ITGB1, ITGAX, CCL3, PIK3R3 , and CDKN2A"
     . SPARSER::COLLECTION)
    ("ITGA6, ITGAL, ITGB1 , and PIK3R3" . SPARSER::COLLECTION)
    ("transmembrane receptor integrin or cell adhesion molecule"
     . SPARSER::COLLECTION)
    ("ITGB1 and ITGA6" . SPARSER::COLLECTION)
    ("PRAME and CYP26B1" . SPARSER::COLLECTION)
    ("ACTA1, ASPN, C4orf7, CYP26B1 , and PRAME" . SPARSER::COLLECTION)
    ("molecules or pathways" . SPARSER::COLLECTION)
    ("PIK3R3, ITGB1, ITGA6 , and ITGAL" . SPARSER::COLLECTION)
    ("PIK3R3, ITGB1 , ITGA6 , and ITGAL" . SPARSER::COLLECTION)
    ("CDKN2A and PIK3R3" . SPARSER::COLLECTION) ("HGF" . SPARSER::PROTEIN)
    ("MIA, PIK3R3, AR, CCR7, CDKN2A, EN1, PITX2 , and TFPI"
     . SPARSER::COLLECTION)
    ("TFPI" . SPARSER::PROTEIN) ("MIA" . SPARSER::PROTEIN)
    ("ITGB1, ITGA6 , and ITGAL" . SPARSER::COLLECTION)
    ("integrin" . SPARSER::PROTEIN)
    ("CCL3, ITGAX, ITGA6, ITGB1, ITGAL, CCL21 , and CD226"
     . SPARSER::COLLECTION)
    ("CDKN2A, EN1 , and PITX2" . SPARSER::COLLECTION)
    ("ITGA6, CCL3 , and ITGAX" . SPARSER::COLLECTION)
    ("ITGB1 , ITGAL , and CD226" . SPARSER::COLLECTION)
    ("ITGAX" . SPARSER::PROTEIN)
    ("the cell migration-related genes and the networks" . SPARSER::COLLECTION)
    ("ACTA1, C4orf7, CYP26B1 , and PRAME" . SPARSER::COLLECTION)
    ("ASPN" . SPARSER::PROTEIN) ("PRAME" . SPARSER::PROTEIN)
    ("orf" . SPARSER::PROTEIN)
    ("48 upregulated genes and 77 downregulated genes" . SPARSER::COLLECTION)
    ("433 upregulated genes and 241 downregulated genes" . SPARSER::COLLECTION)
    ("IPA" . SPARSER::MOLECULE) ("SAM" . SPARSER::PROTEIN)
    ("odd" . SPARSER::PROTEIN) ("a highly aggressive type" . TYPE)
    ("PIK3R3, ITGB1, ITGAL , and ITGA6" . SPARSER::COLLECTION)
    ("ITGAL" . SPARSER::PROTEIN)
    ("molecules and mechanisms" . SPARSER::COLLECTION)
    ("an aggressive type" . TYPE) ("miR-200c" . SPARSER::MOLECULE)
    ("miR-7" . SPARSER::PROTEIN) ("IL12" . SPARSER::PROTEIN-FAMILY)
    ("focal adhesion-associated protein" . SPARSER::PROTEIN)
    ("retinoic acid" . SPARSER::MOLECULE) ("CCR7" . SPARSER::PROTEIN)
    ("CCL21" . SPARSER::PROTEIN) ("PITX2" . SPARSER::PROTEIN)
    ("EN1" . SPARSER::PROTEIN) ("CD226" . SPARSER::PROTEIN)
    ("CYP26B1" . SPARSER::PROTEIN) ("ACTA1" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("hormone-sensitive" . SPARSER::PROTEIN)
    ("ITGA6" . SPARSER::PROTEIN) ("ITGB1" . SPARSER::PROTEIN)
    ("PIK3R3" . SPARSER::PROTEIN) ("much larger cohorts" . SPARSER::MOLECULE)
    ("CDK4 and its regulator" . SPARSER::COLLECTION)
    ("the healthy control group and SCCHN group" . SPARSER::MOLECULE)
    ("group and SCCHN" . SPARSER::COLLECTION)
    ("CDK4, cyclin D1, cyclin E, gankyrin, SEI1 , and BMI1"
     . SPARSER::COLLECTION)
    ("INK4-ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("CDK4 and its selected five regulators" . SPARSER::COLLECTION)
    ("cyclin D1:gankyrin, cyclin D1:SEI1, and cyclin E:SEI1"
     . SPARSER::COLLECTION)
    ("CDK4 and its regulators (except cyclin E1 )" . SPARSER::COLLECTION)
    ("CDK4 and gankyrin" . SPARSER::COLLECTION)
    ("CDK4 and four regulators ( cyclin D1, cyclin E, gankyrin, and SEI1 )"
     . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, gankyrin, and SEI1" . SPARSER::COLLECTION)
    ("p16 or transcriptionally silencing p16" . SPARSER::COLLECTION)
    ("CDK4 and p16" . SPARSER::COLLECTION)
    ("CDK4, cyclin D1, and gankyrin" . SPARSER::COLLECTION)
    ("CDK4, cyclin D1, gankyrin, SEI1, and BMI1" . SPARSER::COLLECTION)
    ("CDK4, cyclin D1, gankyrin, SEI1 , and BMI1" . SPARSER::COLLECTION)
    ("gankyrin , SEI1 , and BMI1" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION)
    ("CDK4-inhibiting tumor suppressor genes or both" . SPARSER::COLLECTION)
    ("CDK4 gene as well as CDK4-promoting oncogenes" . SPARSER::COLLECTION)
    ("CDK4-pRb" . SPARSER::COLLECTION)
    ("CDK4 , cyclin E, and SEI1" . SPARSER::COLLECTION)
    ("CDK4:gankyrin and SEI1:gankyrin" . SPARSER::COLLECTION)
    ("SEI1:gankyrin" . SPARSER::BIO-COMPLEX)
    ("gankyrin:BMI1" . SPARSER::BIO-COMPLEX)
    ("CDK4:BMI1" . SPARSER::BIO-COMPLEX)
    ("cyclin E:SEI1" . SPARSER::BIO-COMPLEX)
    ("cyclin D1:cyclin E" . SPARSER::BIO-COMPLEX)
    ("CDK4:cyclin E" . SPARSER::BIO-COMPLEX)
    ("CDK4:cyclin D1" . SPARSER::BIO-COMPLEX)
    ("CDK4, cyclin D1, gankyrin, and SEI1" . SPARSER::COLLECTION)
    ("CDK4:gankyrin, CDK4:SEI1, cyclin D1:gankyrin, cyclin D1:SEI1, and gankyrin:SEI1"
     . SPARSER::COLLECTION)
    ("gankyrin:SEI1" . SPARSER::BIO-COMPLEX)
    ("cyclin D1:SEI1" . SPARSER::BIO-COMPLEX)
    ("cyclin D1:gankyrin" . SPARSER::BIO-COMPLEX)
    ("CDK4:SEI1" . SPARSER::BIO-COMPLEX)
    ("CDK4:gankyrin" . SPARSER::BIO-COMPLEX)
    ("clinico-pathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK4, cyclin D1, cyclin E, gankyrin, SEI1, and BMI1"
     . SPARSER::COLLECTION)
    ("the SCCHN group and the healthy-volunteer group" . SPARSER::COLLECTION)
    ("the healthy control group" . SPARSER::MOLECULE)
    ("Further studies using principal component" . SPARSER::COMPONENT)
    ("CDK4, cyclin D, cyclin E, gankyrin, SEI1 , and BMI1"
     . SPARSER::COLLECTION)
    ("CCND1/cyclin D1 (hereafter, cyclin D1) CCNE1/cyclin E ( cyclin E ) PSMD10/gankyrin"
     . SPARSER::COLLECTION)
    ("SERTAD1/p34SEI1" . SPARSER::COLLECTION)
    ("PSMD10/gankyrin" . SPARSER::COLLECTION)
    ("CCNE1/cyclin E" . SPARSER::COLLECTION)
    ("CCND1/cyclin D1" . SPARSER::COLLECTION)
    ("p16 mRNA and up-regulation of BMI1" . SPARSER::COLLECTION)
    ("CDKN2A/p16" . SPARSER::COLLECTION)
    ("CDK4 and CDK2" . SPARSER::COLLECTION)
    ("p16 ( CDKN2A ) and p15 ( CDKN2B ) genes" . SPARSER::COLLECTION)
    ("CDK4-cyclin D1" . SPARSER::COLLECTION) ("polycomb" . SPARSER::PROTEIN)
    ("its hypophosphorylated E2F-associated state" . SPARSER::BIO-STATE)
    ("p15 INK4B , p16, p18 INK4C , and p19 INK4D" . SPARSER::COLLECTION)
    ("cyclin B1 ( CCNB1 ) and jun B proto-oncogene ( JUNB ) ( xref )"
     . SPARSER::COLLECTION)
    ("proto-oncogene ( JUNB )" . SPARSER::PROTO-ONCOGENE)
    ("JUNB" . SPARSER::PROTEIN) ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proto-oncogenes and inactivation of tumor suppressor genes"
     . SPARSER::COLLECTION)
    ("p53 (the TP53 gene product) and pRb (the RB1 gene product)"
     . SPARSER::COLLECTION)
    ("multi-step" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("CDK4-pRB" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("CDK4 and its regulators" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, gankyrin, SEI1, and BMI1" . SPARSER::COLLECTION)
    ("gankyrin" . SPARSER::PROTEIN) ("Aim" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("PSMD10" . SPARSER::PROTEIN) ("CCNE1" . SPARSER::PROTEIN)
    ("G 1 -S" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("CDKN2B" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("ring finger protein" . SPARSER::PROTEIN) ("SERTAD1" . SPARSER::PROTEIN)
    ("p34" . SPARSER::PROTEIN) ("p19 INK4D" . SPARSER::PROTEIN)
    ("p18 INK4C" . SPARSER::PROTEIN) ("p15 INK4B" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCNB1" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("E2F" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("BMI1" . SPARSER::PROTEIN) ("SEI1" . SPARSER::PROTEIN)
    ("PPARγ activator and an insulin sensitizer" . SPARSER::COLLECTION)
    ("pioglitazone (Actos by Takeda Pharmaceuticals) and rosiglitazone (Avandia by GlaxoSmithKline)"
     . SPARSER::COLLECTION)
    ("rosiglitazone" . SPARSER::DRUG) ("DM" . SPARSER::PROTEIN)
    ("p300/CBP" . SPARSER::COLLECTION) ("HATs" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("an exogenous ligand" . SPARSER::LIGAND)
    ("HDAC1/HDAC3" . SPARSER::COLLECTION) ("CEBPD" . SPARSER::PROTEIN)
    ("brown adipocytes" . SPARSER::PROTEIN) ("food" . SPARSER::MOLECULE)
    ("HDAC3 inhibitor and pioglitazone both significantly reduced glucose levels"
     . SPARSER::COLLECTION)
    ("IRS-2 and Glut4" . SPARSER::COLLECTION)
    ("exogenous ligands and the potency" . SPARSER::COLLECTION)
    ("Adiponectin" . SPARSER::PROTEIN) ("inhibitor-" . SPARSER::INHIBITOR)
    ("intracellular lipids" . SPARSER::LIPID) ("Pioglitazone" . SPARSER::DRUG)
    ("HDAC3/NCOR1" . SPARSER::COLLECTION) ("Lys" . SPARSER::AMINO-ACID)
    ("Fluor" . SPARSER::MOLECULE) ("cat" . SPARSER::PROTEIN)
    ("enzyme and substrate" . SPARSER::COLLECTION)
    ("GFP and HA" . SPARSER::COLLECTION) ("Antibodies" . SPARSER::ANTIBODY)
    ("HDAC3–PPARγ" . SPARSER::COLLECTION)
    ("HDAC3 and SMRT or NCoR" . SPARSER::COLLECTION)
    ("SMRT or NCoR" . SPARSER::COLLECTION)
    ("PPARγ, PPARγ1 and PPARγ2" . SPARSER::COLLECTION)
    ("classical ligands" . SPARSER::LIGAND)
    ("butyrate and TSA" . SPARSER::COLLECTION) ("butyrate" . SPARSER::PROTEIN)
    ("class I and class II HDACs" . SPARSER::COLLECTION)
    ("pan-HDAC" . SPARSER::COLLECTION) ("class I" . SPARSER::PROTEIN)
    ("HDAC3 and PPARγ" . SPARSER::COLLECTION) ("Ligand" . SPARSER::LIGAND)
    ("SMRT/NCoR" . SPARSER::COLLECTION) ("NCoR" . SPARSER::PROTEIN)
    ("SMRT" . SPARSER::PROTEIN)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN)
    ("retinoid X receptor (RXR)" . SPARSER::PROTEIN) ("RXR" . SPARSER::PROTEIN)
    ("mature adipocytes" . SPARSER::PROTEIN)
    ("a well-documented transcription factor" . SPARSER::PROTEIN)
    ("glucose and fatty acid" . SPARSER::COLLECTION)
    ("Dio" . SPARSER::MOLECULE) ("pioglitazone" . SPARSER::DRUG)
    ("adiponectin and aP2" . SPARSER::COLLECTION) ("aP2" . SPARSER::PROTEIN)
    ("adiponectin" . SPARSER::PROTEIN) ("an external ligand" . SPARSER::LIGAND)
    ("exogenous ligands" . SPARSER::LIGAND)
    ("thiazolidinediones" . SPARSER::PROTEIN) ("MEF2" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("Prdm16" . SPARSER::PROTEIN) ("FABP4" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN) ("RXRα" . SPARSER::PROTEIN)
    ("NCOR1" . SPARSER::PROTEIN) ("Histone deacetylase" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("HDAC1" . SPARSER::PROTEIN)
    ("nuclear receptor corepressor" . SPARSER::PROTEIN)
    ("AF2" . SPARSER::PROTEIN) ("AF1" . SPARSER::PROTEIN)
    ("retinoid X receptor" . SPARSER::PROTEIN) ("HDAC3" . SPARSER::PROTEIN)
    ("histone deacetylase 3" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN)
    ("The lymphatic vasculature" . SPARSER::PROTEIN)
    ("PDGF-BB/PDGFRβ" . SPARSER::COLLECTION)
    ("lymphangiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGF-A and VEGF-C" . SPARSER::COLLECTION)
    ("venous BECs" . SPARSER::MOLECULE)
    ("PECAM1 and LYVE-1" . SPARSER::COLLECTION)
    ("PDGFRβ and Fc" . SPARSER::COLLECTION)
    ("c-Kit and v-Abl" . SPARSER::COLLECTION) ("Imatinib" . SPARSER::DRUG)
    ("PBS" . SPARSER::PROTEIN) ("VEGF-C and PDGF-BB" . SPARSER::COLLECTION)
    ("chemotaxis" . SPARSER::PROTEIN)
    ("VEGFR3 and podoplanin" . SPARSER::COLLECTION)
    ("fibronectin or collagen" . SPARSER::COLLECTION)
    ("PDGFRβ and Prox1" . SPARSER::COLLECTION) ("tube" . SPARSER::PROTEIN)
    ("Prox1 and podoplanin" . SPARSER::COLLECTION)
    ("Cao and colleagues" . SPARSER::COLLECTION)
    ("Prox1, VEGFR3, and podoplanin" . SPARSER::COLLECTION)
    ("podoplanin" . SPARSER::PROTEIN)
    ("PDGFRα and PDGFRβ" . SPARSER::COLLECTION)
    ("Platelet-derived growth factor-B and PDGFRβ" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN)
    ("homodimer or heterodimer" . SPARSER::COLLECTION)
    ("PDGF-AA, PDGF-BB, and PDGF-AB" . SPARSER::COLLECTION)
    ("homodimers" . SPARSER::HOMODIMER) ("homodimer" . SPARSER::HOMODIMER)
    ("embryonic BECs" . SPARSER::MOLECULE)
    ("BECs and LECs" . SPARSER::COLLECTION)
    ("VEGFR3 and FGFR3" . SPARSER::COLLECTION) ("LEC" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN) ("sacs" . SPARSER::PROTEIN)
    ("BECs" . SPARSER::MOLECULE) ("homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thioglycollate" . SPARSER::MOLECULE) ("imatinib" . SPARSER::DRUG)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR) ("VEGFR" . SPARSER::PROTEIN)
    ("Ets2" . SPARSER::PROTEIN) ("v-Abl" . SPARSER::PROTEIN)
    ("c-Kit" . SPARSER::PROTEIN) ("decoy receptor" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN)
    ("Platelet-derived growth factor-BB" . SPARSER::PROTEIN)
    ("TOTO-3" . SPARSER::MOLECULE) ("LYVE-1" . SPARSER::PROTEIN)
    ("PECAM1" . SPARSER::PROTEIN) ("NG2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STI571" . SPARSER::DRUG) ("PDGFRα" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGF-B" . SPARSER::PROTEIN)
    ("derived growth factor-B" . SPARSER::PROTEIN)
    ("PDGF receptor" . SPARSER::PROTEIN) ("PDGF-AB" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN) ("PDGF-A" . SPARSER::PROTEIN)
    ("angiopoietin-1" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN) ("Tie2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 3" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN) ("VEGF-D" . SPARSER::PROTEIN)
    ("VEGF-C" . SPARSER::PROTEIN) ("VEGFR3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vascular endothelial growth factor receptor 3" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("Prox1" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("LAM" . SPARSER::PROTEIN)
    ("ELK" . SPARSER::PROTEIN) ("PAG" . SPARSER::PROTEIN)
    ("Mutant" . SPARSER::MUTANT) ("HER" . SPARSER::PROTEIN)
    ("exemestane or tamoxifen" . SPARSER::COLLECTION)
    ("everolimus and letrozole" . SPARSER::COLLECTION)
    ("letrozole" . SPARSER::DRUG)
    ("homogeneously treated cohort" . SPARSER::MOLECULE)
    ("a larger sample cohort" . SPARSER::MOLECULE)
    ("smaller cohorts" . SPARSER::MOLECULE)
    ("the steroidal aromatase inhibitor exemestane" . SPARSER::DRUG)
    ("third-line" . SPARSER::PROTEIN) ("exemestane" . SPARSER::DRUG)
    ("our smaller cohort" . SPARSER::MOLECULE)
    ("pre-Ki67" . SPARSER::PROTEIN-PAIR) ("cut" . SPARSER::PROTEIN)
    ("PIK3CA-" . SPARSER::PROTEIN) ("-GS" . SPARSER::COLLECTION)
    ("GS" . SPARSER::PROTEIN)
    ("the PIK3CA-GS (Loi) and PTEN -loss-GS (Saal)" . SPARSER::COLLECTION)
    ("PIK3CA-GS" . SPARSER::PROTEIN-PAIR) ("PI3K-" . SPARSER::PROTEIN)
    ("PAM" . SPARSER::PROTEIN) ("QR " . SPARSER::PROTEIN)
    ("ER and PgR" . SPARSER::COLLECTION) ("VIC " . SPARSER::PROTEIN)
    ("n  " . SPARSER::PROTEIN) ("the drug’s" . SPARSER::DRUG)
    ("other key biomarkers" . SPARSER::MOLECULE)
    ("trastuzumab" . SPARSER::DRUG) ("HER2-" . SPARSER::PROTEIN)
    ("HSs" . SPARSER::PROTEIN) ("Raptor" . SPARSER::PROTEIN)
    ("TOR" . SPARSER::PROTEIN) ("type I and type II" . SPARSER::COLLECTION)
    ("HER2 and insulin-like growth factor" . SPARSER::COLLECTION)
    ("tamoxifen" . SPARSER::MOLECULE) ("luminal A subtype" . SPARSER::PROTEIN)
    ("PgR" . SPARSER::PROTEIN) ("anastrozole" . SPARSER::DRUG)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Proliferation-associated" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ESR1" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("6-carboxyfluorescein" . SPARSER::DRUG) ("PIK3" . SPARSER::PROTEIN)
    ("GS4" . SPARSER::PROTEIN) ("ZD1839" . SPARSER::DRUG)
    ("p110α" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LNCaP and p53" . SPARSER::COLLECTION) ("curcumin" . SPARSER::DRUG)
    ("IκB or MAP3K14" . SPARSER::COLLECTION)
    ("protein and NFκB" . SPARSER::COLLECTION)
    ("-GGGRNWYYCC-3" . SPARSER::COLLECTION) ("IKK/NF-κB" . SPARSER::COLLECTION)
    ("c-PARP" . SPARSER::COLLECTION) ("LNCaP and PC-3" . SPARSER::COLLECTION)
    ("p53, p73, ATR and MAPK" . SPARSER::COLLECTION)
    ("kinase (NIK)" . SPARSER::KINASE) ("NIK" . SPARSER::PROTEIN)
    ("PSA and AR" . SPARSER::COLLECTION)
    ("further verity BTG2's" . SPARSER::PROTEIN)
    ("further verity BTG2" . SPARSER::PROTEIN)
    ("LN-BTG2si" . SPARSER::COLLECTION) ("LN" . SPARSER::PROTEIN)
    ("MG132 and 80 μM cisplatin" . SPARSER::COLLECTION)
    ("RT" . SPARSER::PROTEIN) ("BTG2 and p53" . SPARSER::COLLECTION)
    ("thymidine" . SPARSER::MOLECULE) ("topoisomerase" . SPARSER::PROTEIN)
    ("BTG" . SPARSER::PROTEIN) ("planar complex" . SPARSER::BIO-COMPLEX)
    ("prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("LNCaP or PC-3" . SPARSER::COLLECTION)
    ("p53 and BTG2" . SPARSER::COLLECTION) ("AR and PSA" . SPARSER::COLLECTION)
    ("androgen receptor (AR) and prostate specific antigen (PSA)"
     . SPARSER::COLLECTION)
    ("LNCaP or p53-null" . SPARSER::COLLECTION) ("PC-3" . SPARSER::COLLECTION)
    ("PC" . SPARSER::PROTEIN) ("PSA" . SPARSER::PROTEIN)
    ("βgal" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("early growth response" . SPARSER::PROTEIN) ("MAP3K14" . SPARSER::PROTEIN)
    ("PKC-δ" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("prostate specific antigen" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("gene 2" . SPARSER::PROTEIN)
    ("glucose and amino acids" . SPARSER::COLLECTION)
    ("PFK and TKT" . SPARSER::COLLECTION)
    ("hexokinase and 6-phosphofructo-2-kinase" . SPARSER::COLLECTION)
    ("PFK" . SPARSER::PROTEIN) ("hexokinase" . SPARSER::PROTEIN)
    ("Max" . SPARSER::PROTEIN) ("Peptide" . SPARSER::PEPTIDE)
    ("pS" . SPARSER::PROTEIN)
    ("the cofactor and substrate binding channels ( xref )"
     . SPARSER::COLLECTION)
    ("TPP and substrates" . SPARSER::COLLECTION)
    ("Pyr-PP" . SPARSER::PROTEIN-PAIR) ("PP" . SPARSER::PROTEIN)
    ("aminopyrimidine" . SPARSER::MOLECULE) ("mixtures" . SPARSER::MOLECULE)
    ("salt" . SPARSER::MOLECULE) ("carbohydrate" . SPARSER::MOLECULE)
    ("pyrimidine" . SPARSER::DRUG) ("TKT or Akt" . SPARSER::COLLECTION)
    ("the essential co-factor thiamine pyrophosphate (TPP)"
     . SPARSER::MOLECULE)
    ("pyrophosphate (TPP)" . SPARSER::MOLECULE) ("TPP" . SPARSER::PROTEIN)
    ("pyrophosphate" . SPARSER::MOLECULE)
    ("the bacterially-produced enzyme" . SPARSER::ENZYME)
    ("Akt and ATP" . SPARSER::COLLECTION)
    ("both CA-Akt and wild type Akt" . SPARSER::COLLECTION)
    ("wild type TKT or the S387A mutant" . SPARSER::COLLECTION)
    ("the residual TKT protein" . SPARSER::PROTEIN) ("fish" . SPARSER::PROTEIN)
    ("zebra" . SPARSER::PROTEIN) ("the enzyme’s" . SPARSER::PROTEIN)
    ("CA-Akt and/or alkaline phosphatase" . SPARSER::COLLECTION)
    ("exogenous Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TKT and CA-Akt" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("xylulose" . SPARSER::MOLECULE)
    ("lysine or other essential amino acids" . SPARSER::COLLECTION)
    ("other essential amino acids" . SPARSER::AMINO-ACID)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypoxanthine, guanosine, and inosine" . SPARSER::COLLECTION)
    ("uracil, uridine, and xanthine" . SPARSER::COLLECTION)
    ("xanthine" . SPARSER::MOLECULE) ("uridine" . SPARSER::PROTEIN)
    ("uracil" . SPARSER::NUCLEOBASE) ("pyrimidines" . SPARSER::DRUG)
    ("inosine" . SPARSER::MOLECULE) ("guanosine" . SPARSER::MOLECULE)
    ("hypoxanthine" . SPARSER::DRUG) ("purines" . SPARSER::DRUG)
    ("metabolites" . SPARSER::MOLECULE) ("DNA and RNA" . SPARSER::COLLECTION)
    ("MEFs, and lysine" . SPARSER::COLLECTION)
    ("an essential amino acid" . SPARSER::AMINO-ACID)
    ("NBD" . SPARSER::PROTEIN) ("Rheb and mTORC1" . SPARSER::COLLECTION)
    ("raptor" . SPARSER::PROTEIN)
    ("S6 kinase and 4E-BP1" . SPARSER::COLLECTION)
    ("Akt and purine" . SPARSER::COLLECTION)
    ("S6 kinase, 4E–BP1, and Akt" . SPARSER::COLLECTION)
    ("Akt and Purine" . SPARSER::COLLECTION) ("Kinase" . SPARSER::KINASE)
    ("amino acids and growth factors" . SPARSER::COLLECTION)
    ("Akt, GSK-3β, S6 kinase, and 4E–BP1" . SPARSER::COLLECTION)
    ("a kinase-dead dominant-negative (DN) Akt"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DN-Akt" . SPARSER::COLLECTION) ("DN" . SPARSER::PROTEIN)
    ("myristoylated" . SPARSER::PROTEIN)
    ("all essential amino acids" . SPARSER::AMINO-ACID)
    ("valine" . SPARSER::AMINO-ACID) ("isoleucine" . SPARSER::AMINO-ACID)
    ("formate" . SPARSER::MOLECULE) ("Purine" . SPARSER::DRUG)
    ("Akt and TKT" . SPARSER::COLLECTION) ("Akt/TKT" . SPARSER::COLLECTION)
    ("a ubiquitous enzyme" . SPARSER::ENZYME)
    ("transketolase (TKT)" . SPARSER::PROTEIN)
    ("transaldolase, and triose" . SPARSER::COLLECTION)
    ("isomerase" . SPARSER::PROTEIN) ("transaldolase" . SPARSER::PROTEIN)
    ("almost all PRPP" . SPARSER::MOLECULE) ("PRPP" . SPARSER::MOLECULE)
    ("phosphoribosylpyrophosphate" . SPARSER::MOLECULE)
    ("a single essential amino acid" . SPARSER::AMINO-ACID)
    ("PDK-1 and mTORC2" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rag" . SPARSER::PROTEIN)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("RNA and DNA" . SPARSER::COLLECTION)
    ("mTORC2 and IκB" . SPARSER::COLLECTION) ("pentose" . SPARSER::MOLECULE)
    ("TKT" . SPARSER::PROTEIN) ("transketolase" . SPARSER::PROTEIN)
    ("purine" . SPARSER::DRUG) ("Amino Acid" . SPARSER::AMINO-ACID)
    ("Akt-1" . SPARSER::PROTEIN) ("Akt3" . SPARSER::PROTEIN)
    ("6-phosphofructo-2-kinase" . SPARSER::PROTEIN)
    ("TKTL1" . SPARSER::PROTEIN) ("PO 4" . SPARSER::PROTEIN)
    ("Torin 1" . SPARSER::DRUG) ("4E–BP1" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("MK2206" . SPARSER::DRUG)
    ("Akt1" . SPARSER::PROTEIN) ("GSK-3β" . SPARSER::PROTEIN)
    ("Amino Acids" . SPARSER::AMINO-ACID) ("Amino acid" . SPARSER::AMINO-ACID)
    ("PDK-1" . SPARSER::PROTEIN) ("protein kinase" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("CR" . SPARSER::PROTEIN)
    ("LO" . SPARSER::PROTEIN) ("IH" . SPARSER::MOLECULE)
    ("BS" . SPARSER::PROTEIN) ("CB" . SPARSER::PROTEIN)
    ("MM and RS" . SPARSER::COLLECTION) ("MM" . SPARSER::PROTEIN)
    ("these MMPs and the CRP" . SPARSER::COLLECTION)
    ("CRP and MMP-9" . SPARSER::COLLECTION)
    ("interstitial and basal membranes molecules" . SPARSER::MOLECULE)
    ("EM" . SPARSER::PROTEIN) ("MMP-1 and MMP-7" . SPARSER::COLLECTION)
    ("almost all extracellular matrix molecules" . SPARSER::MOLECULE)
    ("MMP-9 and the MMP-9/TIMP-1 complex (Figure  xref )"
     . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN)
    ("Both FEV 1 (% predicted) and FVC (% predicted)" . SPARSER::COLLECTION)
    ("GOLD" . SPARSER::MOLECULE) ("CRQ" . SPARSER::PROTEIN)
    ("smoke (TS)" . SPARSER::MOLECULE)
    ("matrix metalloproteinase-" . SPARSER::PROTEIN)
    ("plasma and sputum matrix metalloproteinases (MMPs) and the tissue inhibitor"
     . SPARSER::COLLECTION)
    ("metalloproteinase-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMP" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("supplemental oxygen" . SPARSER::MOLECULE)
    ("its prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mainly wood smoke and COPD" . SPARSER::COLLECTION)
    ("smoke and COPD" . SPARSER::COLLECTION) ("smoke (BE)" . SPARSER::MOLECULE)
    ("smoke" . SPARSER::MOLECULE) ("FEV" . SPARSER::PROTEIN)
    ("MMP-9/TIMP-1" . SPARSER::COLLECTION) ("NS" . SPARSER::PROTEIN)
    ("MMPs and CRP" . SPARSER::COLLECTION) ("TS" . SPARSER::PROTEIN)
    ("tobacco" . SPARSER::DRUG)
    ("Matrix metalloproteinases (MMPs) and C-reactive protein (CRP)"
     . SPARSER::COLLECTION)
    ("COPD" . SPARSER::PROTEIN) ("CRP" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase-7" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN) ("TW" . SPARSER::PROTEIN)
    ("FY" . SPARSER::PROTEIN) ("HY" . SPARSER::PROTEIN)
    ("LC" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN) ("Glucose" . SPARSER::PROTEIN)
    ("FDG" . SPARSER::PROTEIN) ("a larger cohort" . SPARSER::MOLECULE)
    ("cohort" . SPARSER::MOLECULE)
    ("HIF-1α/GLUT-1/PI3K/Akt" . SPARSER::COLLECTION)
    ("a significant poor prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Endocrine" . SPARSER::PROTEIN)
    ("contrast-enhanced T1-weighted MRI" . SPARSER::PROTEIN)
    ("DWI and ADC" . SPARSER::COLLECTION) ("cigarettes" . SPARSER::DRUG)
    ("specific etiological factors and prognostic factors"
     . SPARSER::COLLECTION)
    ("prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("specific etiological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DWI" . SPARSER::PROTEIN) ("MRI (DWI)" . SPARSER::PROTEIN)
    ("Contrast-enhanced T1-weighted MRI" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN) ("GLUT-1 and HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α and GLUT-1" . SPARSER::COLLECTION)
    ("/protein kinase B" . SPARSER::COLLECTION) ("hypoxia" . SPARSER::PROTEIN)
    ("Hypoxia" . SPARSER::PROTEIN)
    ("the prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Conclusive prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Unfavorable prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("n " . SPARSER::PROTEIN) ("wax" . SPARSER::MOLECULE)
    ("p-Akt" . SPARSER::COLLECTION)
    ("Vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("d-glucose" . SPARSER::MOLECULE)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-3  " . SPARSER::PROTEIN) ("MIB 1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypoxia-inducible factor-1α" . SPARSER::PROTEIN)
    ("GLUT-1" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("EPR" . SPARSER::PROTEIN)
    ("EGF and transforming growth factor alpha" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("heteropolymers" . SPARSER::MOLECULE)
    ("dense EGFR" . SPARSER::PROTEIN)
    ("viral genome fragments" . SPARSER::FRAGMENT)
    ("E6 and E7" . SPARSER::COLLECTION)
    ("Dox-loaded Dextran or Pluronic F127 (routinely used to improve water dispersibility of carbon nanotube and graphene nanoparticles)-coated O-GNRs"
     . SPARSER::COLLECTION)
    ("nanotubes and graphene" . SPARSER::COLLECTION)
    ("nanotube and graphene" . SPARSER::COLLECTION)
    ("nanotube" . SPARSER::MOLECULE) ("Dextran" . SPARSER::DEXTRAN)
    ("Filipin" . SPARSER::MOLECULE) ("Dynasore" . SPARSER::MOLECULE)
    ("nanoparticle" . SPARSER::MOLECULE) ("DSPE" . SPARSER::PROTEIN)
    ("LDH" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("multidrug" . SPARSER::PROTEIN) ("simple" . SPARSER::PROTEIN)
    ("FDA" . SPARSER::PROTEIN) ("Gefitinib" . SPARSER::DRUG)
    ("showed no observable nanoparticles" . SPARSER::MOLECULE)
    ("nanoparticles" . SPARSER::MOLECULE) ("CDR" . SPARSER::PROTEIN)
    ("amiloride (EIPA)" . SPARSER::DRUG) ("EIPA" . SPARSER::DRUG)
    ("amiloride" . SPARSER::DRUG) ("filipin" . SPARSER::MOLECULE)
    ("clathrin" . SPARSER::PROTEIN) ("dynasore" . SPARSER::MOLECULE)
    ("TEM" . SPARSER::PROTEIN)
    ("a supramolecular complex" . SPARSER::BIO-COMPLEX)
    ("the amphiphilic polymer PEG-DSPE" . SPARSER::PROTEIN-PAIR)
    ("PEG-DSPE" . SPARSER::COLLECTION) ("polymer" . SPARSER::MOLECULE)
    ("water" . SPARSER::MOLECULE) ("oxide" . SPARSER::MOLECULE)
    ("These systems typically target specific antigens"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffolds" . SPARSER::SCAFFOLD) ("Antibody" . SPARSER::ANTIBODY)
    ("antibodies or peptides" . SPARSER::COLLECTION)
    ("API-" . SPARSER::PROTEIN) ("API" . SPARSER::PROTEIN)
    ("scaffold" . SPARSER::SCAFFOLD)
    ("lipids, or metals" . SPARSER::COLLECTION)
    ("nanotubes" . SPARSER::MOLECULE) ("fullerenes" . SPARSER::MOLECULE)
    ("EGFRs" . SPARSER::PROTEIN) ("PEG" . SPARSER::PROTEIN)
    ("graphene" . SPARSER::MOLECULE) ("Ligands" . SPARSER::LIGAND)
    ("TGF-α" . SPARSER::PROTEIN)
    ("transforming growth factor alpha" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribonucleic acid" . SPARSER::RNA) ("–3 µ" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("p-glycoprotein" . SPARSER::PROTEIN) ("membrane-bound" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN) ("EGFR antibody" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("other histologic types" . TYPE)
    ("three different histologic types" . TYPE)
    ("histological subtype" . SPARSER::PROTEIN) ("aims" . SPARSER::PROTEIN)
    ("EGFR , KRAS , PI3KCA , HER2 or ALK" . SPARSER::COLLECTION)
    ("BRAF or BRAF" . SPARSER::COLLECTION)
    ("ADCs and non-ADCs" . SPARSER::COLLECTION) ("ADC" . SPARSER::PROTEIN)
    ("MS or HRMA" . SPARSER::COLLECTION) ("HRMA" . SPARSER::PROTEIN)
    ("melting" . SPARSER::DRUG) ("MS" . SPARSER::PROTEIN)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CI " . SPARSER::PROTEIN) ("ADCs" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("C-RAF" . SPARSER::PROTEIN)
    ("A-RAF" . SPARSER::PROTEIN) ("p15 and p21" . SPARSER::COLLECTION)
    ("cell cycle inhibitor p16 and epithelial to mesenchymal transition (EMT) marker E-Cadherin"
     . SPARSER::COLLECTION)
    ("C-Jun and positive cell cycle regulators" . SPARSER::COLLECTION)
    ("C-Myc, CCND1 and E2F1" . SPARSER::COLLECTION)
    ("p21, p27, p15 and p16" . SPARSER::COLLECTION) ("CDS" . SPARSER::PROTEIN)
    ("C-Myc and CCND1" . SPARSER::COLLECTION)
    ("p21 and p15" . SPARSER::COLLECTION)
    ("p21, p15 and p27" . SPARSER::COLLECTION)
    ("C-Myc, CCND1, E2F1 and C-Jun" . SPARSER::COLLECTION)
    ("p21, p15, p16 and p27" . SPARSER::COLLECTION)
    ("factors and transcription factor" . SPARSER::COLLECTION)
    ("phos-AKT" . SPARSER::COLLECTION) ("phos-PI3K" . SPARSER::COLLECTION)
    ("phos" . SPARSER::PROTEIN) ("si-CCDC19" . SPARSER::COLLECTION)
    ("si" . SPARSER::PROTEIN) ("si-Ctr" . SPARSER::PROTEIN-PAIR)
    ("Ctr" . SPARSER::PROTEIN) ("SPCA1" . SPARSER::PROTEIN)
    ("CCDC19-GFP" . SPARSER::COLLECTION) ("NPC" . SPARSER::MOLECULE)
    ("ORF" . SPARSER::PROTEIN) ("NM" . SPARSER::PROTEIN)
    ("the predominant types" . TYPE)
    ("an unfavourable factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/AKT/C-Jun" . SPARSER::COLLECTION)
    ("the nasopharyngeal epithelium specific protein CCDC19"
     . SPARSER::PROTEIN)
    ("CDC6" . SPARSER::PROTEIN) ("cell division cycle 6" . SPARSER::PROTEIN)
    ("CCNA1" . SPARSER::PROTEIN) ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("MT2" . SPARSER::PROTEIN) ("MT1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("pPI3K" . SPARSER::PROTEIN-FAMILY) ("E-Cadherin" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN) ("C-Jun" . SPARSER::PROTEIN)
    ("C-Myc" . SPARSER::PROTEIN) ("CCDC19" . SPARSER::PROTEIN)
    ("TACC3 and CH-TOG" . SPARSER::COLLECTION)
    ("the erroneous state" . SPARSER::BIO-STATE)
    ("a key trigger" . SPARSER::PROTEIN)
    ("mitotic centrosomes" . SPARSER::PROTEIN)
    ("Aurora-A and Chk2" . SPARSER::COLLECTION)
    ("AURKA and CHK2" . SPARSER::COLLECTION)
    ("CHK2-BRCA1" . SPARSER::COLLECTION) ("MCAK or APC" . SPARSER::COLLECTION)
    ("MCAK" . SPARSER::PROTEIN) ("monastrol" . SPARSER::DRUG)
    ("GFP-centrin" . SPARSER::COLLECTION) ("centrin" . SPARSER::PROTEIN)
    ("nocodazole" . SPARSER::DRUG) ("Taxol" . SPARSER::DRUG)
    ("CH" . SPARSER::PROTEIN) ("EB3-GFP" . SPARSER::COLLECTION)
    ("the mitotic kinesin Eg5/Kif11" . SPARSER::COLLECTION)
    ("Eg5/Kif11" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DME" . SPARSER::PROTEIN)
    ("MIN/MSI" . SPARSER::COLLECTION) ("MSI" . SPARSER::PROTEIN)
    ("MIN" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("EB3" . SPARSER::PROTEIN) ("CHK2 and BRCA1" . SPARSER::COLLECTION)
    ("Plk1 and Aurora-A" . SPARSER::COLLECTION)
    ("supernumerary centrosomes" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN) ("mal" . SPARSER::PROTEIN)
    ("AURKA" . SPARSER::PROTEIN) ("a fundamental trigger" . SPARSER::PROTEIN)
    ("Foxn1" . SPARSER::PROTEIN) ("protein-G" . SPARSER::PROTEIN)
    ("H10" . SPARSER::PROTEIN) ("Axin-2" . SPARSER::PROTEIN)
    ("γ-Tubulin" . SPARSER::PROTEIN) ("k 2" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("k 1" . SPARSER::PROTEIN)
    ("centrin-2" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("MgSO 4" . SPARSER::DRUG) ("H2B" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("MLN8054" . SPARSER::DRUG) ("TPX2" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE) ("TACC3" . SPARSER::PROTEIN)
    ("CKAP5" . SPARSER::PROTEIN) ("Kif11" . SPARSER::PROTEIN)
    ("Eg5" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("CHK2" . SPARSER::PROTEIN)
    ("the catalytic cysteines of both proteins" . SPARSER::PROTEIN)
    ("the active site cysteine of TRX1" . SPARSER::PROTEIN)
    ("TRX-PTP1B" . SPARSER::COLLECTION) ("PTP1B or PTEN" . SPARSER::COLLECTION)
    ("incomplete thiol" . SPARSER::MOLECULE)
    ("non-covalent dimers [ xref ] and several" . SPARSER::COLLECTION)
    ("dimers" . SPARSER::DIMER) ("dimer" . SPARSER::DIMER)
    ("PTP1B-Trx1(CS)" . SPARSER::COLLECTION)
    ("PTP1B-Trx1" . SPARSER::COLLECTION) ("monomer" . SPARSER::MONOMER)
    ("CS" . SPARSER::PROTEIN) ("lab" . SPARSER::PROTEIN)
    ("the classical PTPs SHP1 and CD45" . SPARSER::COLLECTION)
    ("SHP1 and CD45" . SPARSER::COLLECTION) ("sulphoxide" . SPARSER::DRUG)
    ("methionine" . SPARSER::MOLECULE)
    ("the active site Cys of TRX1" . SPARSER::PROTEIN)
    ("PTEN and TRX" . SPARSER::COLLECTION)
    ("PRL2 [ xref ] and PTEN [ xref ]" . SPARSER::COLLECTION)
    ("cdc25 [ xref ], PRL2 [ xref ] and PTEN [ xref ]" . SPARSER::COLLECTION)
    ("PTP1B [ xref , xref ] and the Low Mr PTP [ xref ]" . SPARSER::COLLECTION)
    ("pKa" . SPARSER::PROTEIN)
    ("cdc25 [ xref , xref ] and PRL2 [ xref ]" . SPARSER::COLLECTION)
    ("the sulphenic acid form" . SPARSER::FORM)
    ("the classical PTP SHP2" . SPARSER::PROTEIN)
    ("Several dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("PTP1B [ xref ] and PTPα [ xref ]" . SPARSER::COLLECTION)
    ("the classical pTyr-specific PTPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("the major ROS" . SPARSER::PROTEIN)
    ("an essential reactive cysteine" . SPARSER::AMINO-ACID)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the catalytic cysteine of PTP1B ( xref )" . SPARSER::PROTEIN)
    ("-PTP1B" . SPARSER::COLLECTION)
    ("the catalytic cysteine of PTP1B" . SPARSER::PROTEIN)
    ("PTP1B-CASA" . SPARSER::COLLECTION) ("CASA" . SPARSER::PROTEIN)
    ("PTP1B and the TRX1" . SPARSER::COLLECTION) ("TRX1-" . SPARSER::PROTEIN)
    ("FLAG-tagged wild type PTP1B and His 6 -tagged TRX1 (TRX1-C35S, TRX1-WT, TRX1-C32S)"
     . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN) ("co-precipitated" . SPARSER::PROTEIN)
    ("PTEN and PTP1B" . SPARSER::COLLECTION)
    ("both PTP1B ( xref ) and PTEN ( xref )" . SPARSER::COLLECTION)
    ("SDS" . SPARSER::PROTEIN)
    ("expressed either TRX1 shRNA or control shRNA" . SPARSER::COLLECTION)
    ("doxycycline" . SPARSER::MOLECULE) ("tetracycline" . SPARSER::DRUG)
    ("a formidable barrier" . SPARSER::PROTEIN)
    ("PTEN and the TRX1 ( xref )" . SPARSER::COLLECTION)
    ("PTP1B-TRX1" . SPARSER::COLLECTION)
    ("TRX1 and PTP1B" . SPARSER::COLLECTION)
    ("thioredoxins" . SPARSER::PROTEIN) ("SBP" . SPARSER::PROTEIN)
    ("maleimide (NEM)" . SPARSER::DRUG) ("maleimide" . SPARSER::DRUG)
    ("exogenous H 2 O 2" . SPARSER::DRUG) ("cysteines" . SPARSER::AMINO-ACID)
    ("TRX1 and the phosphatases" . SPARSER::COLLECTION)
    ("dithiol" . SPARSER::MOLECULE) ("mV" . SPARSER::PROTEIN)
    ("redox potential and quantified free thiols" . SPARSER::MOLECULE)
    ("thiols" . SPARSER::MOLECULE)
    ("the active site cysteine of the two phosphatases" . SPARSER::PHOSPHATASE)
    ("PTEN or PTP1B" . SPARSER::COLLECTION) ("TRX" . SPARSER::PROTEIN)
    ("reductant" . SPARSER::MOLECULE)
    ("dithiothreitol (DTT)" . SPARSER::PROTEIN)
    ("glutathione (GSH)" . SPARSER::DRUG) ("TRX1/TR" . SPARSER::COLLECTION)
    ("GRX" . SPARSER::PROTEIN) ("glutaredoxin" . SPARSER::PROTEIN)
    ("GSH" . SPARSER::DRUG) ("DTT" . SPARSER::MOLECULE)
    ("dithiothreitol" . SPARSER::PROTEIN)
    ("PTP1B and PTEN" . SPARSER::COLLECTION)
    ("EGF [ xref , xref ] and insulin [ xref ]" . SPARSER::COLLECTION)
    ("LPS [ xref ], PDGF, EGF [ xref , xref ] and insulin [ xref ]"
     . SPARSER::COLLECTION)
    ("PDGF" . SPARSER::PROTEIN)
    ("EGF [ xref ] and insulin [ xref , xref , xref ]" . SPARSER::COLLECTION)
    ("both the classical and dual-specificity phosphatases"
     . SPARSER::PHOSPHATASE)
    ("antigens and ECM" . SPARSER::COLLECTION)
    ("the dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("disulphide" . SPARSER::MOLECULE)
    ("cellular reductants" . SPARSER::MOLECULE)
    ("reductants" . SPARSER::MOLECULE) ("sulphur" . SPARSER::MOLECULE)
    ("the classical PTPs" . SPARSER::PROTEIN) ("sulphenamide" . SPARSER::DRUG)
    ("thiolate" . SPARSER::MOLECULE) ("PTPs" . SPARSER::PROTEIN)
    ("nucleophile" . SPARSER::MOLECULE) ("pH" . SPARSER::PROTEIN)
    ("amide" . SPARSER::MOLECULE)
    ("platelet-derived growth factor [ xref ] and insulin [ xref ]"
     . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("EGF" . SPARSER::PROTEIN) ("the phagocytic enzyme" . SPARSER::ENZYME)
    ("NOX and DUOX" . SPARSER::COLLECTION)
    ("families" . SPARSER::PROTEIN-FAMILY) ("DUOX" . SPARSER::PROTEIN)
    ("NOX" . SPARSER::PROTEIN) ("superoxide" . SPARSER::MOLECULE)
    ("electrons" . SPARSER::MOLECULE) ("PTP" . SPARSER::PROTEIN)
    ("thioredoxin and either phosphatase" . SPARSER::COLLECTION)
    ("disulfide" . SPARSER::MOLECULE)
    ("the protein tyrosine phosphatase PTP1B and the dual-specificity phosphatase PTEN"
     . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PROTEIN) ("thioredoxin" . SPARSER::PROTEIN)
    ("particular H 2 O 2" . SPARSER::DRUG) ("NADPH" . SPARSER::PROTEIN)
    ("thiol" . SPARSER::MOLECULE) ("glutathione reductase" . SPARSER::PROTEIN)
    ("6,8-Difluoro-4-Methylumbelliferyl Phosphate" . SPARSER::DRUG)
    ("phenol red" . SPARSER::DRUG) ("de-" . SPARSER::MOLECULE)
    ("TRX-1" . SPARSER::PROTEIN) ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY)
    ("Thioredoxin Reductase" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("120kD" . SPARSER::PROTEIN) ("Trx1" . SPARSER::PROTEIN)
    ("SOCS-1" . SPARSER::PROTEIN) ("SHP1" . SPARSER::PROTEIN)
    ("reducing agent" . SPARSER::MOLECULE) ("SHP2" . SPARSER::PROTEIN)
    ("PRL2" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("PTB1" . SPARSER::PROTEIN) ("thioredoxin reductase" . SPARSER::PROTEIN)
    ("thioredoxin 1" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("SO 3" . SPARSER::PROTEIN) ("SO 2" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("TRX1" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("protein phosphatases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cables1 and other p21-like CDK regulatory proteins"
     . SPARSER::COLLECTION)
    ("p15, p16, p18, and p19" . SPARSER::COLLECTION)
    ("p21, p27, and p57" . SPARSER::COLLECTION)
    ("p16 and p27" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cables1, and Cables1" . SPARSER::COLLECTION)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous Cables1" . SPARSER::PROTEIN)
    ("Venus and Venus" . SPARSER::COLLECTION)
    ("Venus-PSMA3" . SPARSER::COLLECTION)
    ("Cables1 and PSMA3" . SPARSER::COLLECTION)
    ("exogenous PSMA3" . SPARSER::PROTEIN)
    ("Venus or Venus-Cables1" . SPARSER::COLLECTION)
    ("The Western blot" . SPARSER::PROTEIN)
    ("exogenous Venus" . SPARSER::PROTEIN) ("CHX" . SPARSER::PROTEIN)
    ("map" . SPARSER::PROTEIN) ("Cables1 and p21" . SPARSER::COLLECTION)
    ("GST-Cables1" . SPARSER::COLLECTION) ("Venus-p21" . SPARSER::COLLECTION)
    ("GST-p21" . SPARSER::COLLECTION)
    ("whose endogenous Cables1" . SPARSER::PROTEIN)
    ("Venus and Venus-Cables1 in p53-null H1299 cells" . SPARSER::COLLECTION)
    ("Venus" . SPARSER::PROTEIN) ("Venus-Cables1" . SPARSER::COLLECTION)
    ("Cdk2 and Wee1" . SPARSER::COLLECTION)
    ("p53, p63 and p73" . SPARSER::COLLECTION) ("Apc" . SPARSER::PROTEIN)
    ("Cdk5 and Abl" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDM2 and MDM4" . SPARSER::COLLECTION) ("Ubiquitin" . SPARSER::PROTEIN)
    ("SCF" . SPARSER::PROTEIN) ("Cables1/p21" . SPARSER::COLLECTION)
    ("Cables1" . SPARSER::PROTEIN) ("Abl" . SPARSER::PROTEIN)
    ("kinases, CDK2 and CDK4" . SPARSER::COLLECTION)
    ("a vital cell cycle regulator" . SPARSER::REGULATOR)
    ("p21/Cip1" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("Protein A" . SPARSER::PROTEIN) ("Nonidet P-40" . SPARSER::DRUG)
    ("Anti-β" . SPARSER::PROTEIN)
    ("p53 families" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p57" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p19" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p18" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p15" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("p63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Wee1" . SPARSER::PROTEIN)
    ("Cdk2" . SPARSER::PROTEIN) ("C-abl" . SPARSER::PROTEIN)
    ("Cdk5" . SPARSER::PROTEIN) ("WISp39" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("proteasome (prosome" . SPARSER::PROTEIN)
    ("Cdc20" . SPARSER::PROTEIN) ("Cdt2" . SPARSER::PROTEIN)
    ("CRL4" . SPARSER::PROTEIN) ("Skp2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PSMA3" . SPARSER::PROTEIN) ("alpha type" . SPARSER::PROTEIN)
    ("Macropain) subunit" . SPARSER::PROTEIN)
    ("proteasome (Prosome" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("at least some PDAC" . SPARSER::PROTEIN)
    ("FGFR-2 mRNA and surface protein expression" . SPARSER::COLLECTION)
    ("factors, epigenetic regulation," . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("factors, epigenetic regulation, or single nucleotide polymorphisms"
     . SPARSER::COLLECTION)
    ("FGFR-2 and its isoforms" . SPARSER::COLLECTION)
    ("FGFR-2-shRNA" . SPARSER::COLLECTION) ("p-ERK" . SPARSER::COLLECTION)
    ("both FGFR-2 IIIb and IIIc isoforms" . SPARSER::COLLECTION)
    ("sham" . SPARSER::DRUG) ("Sh" . SPARSER::PROTEIN-FAMILY)
    ("the FGFR-2-high group and FGFR-2-low group" . SPARSER::COLLECTION)
    ("IIIb and FGFR-2" . SPARSER::COLLECTION)
    ("FGF1 , FGF2 , FGF5 , and FGF7" . SPARSER::COLLECTION)
    ("keratinocyte growth factor and its receptor" . SPARSER::COLLECTION)
    ("IIIb or FGFR-2" . SPARSER::COLLECTION)
    ("the IIIb and IIIc isoforms of FGFR-2" . SPARSER::COLLECTION)
    ("Ig" . SPARSER::MOLECULE) ("FGF/FGFR" . SPARSER::COLLECTION)
    ("PDAC" . SPARSER::PROTEIN)
    ("the IIIb and IIIc isoforms" . SPARSER::COLLECTION)
    ("IIIb" . SPARSER::DRUG) ("surface protein" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor-2" . SPARSER::PROTEIN)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("anti-ERK" . SPARSER::PROTEIN) ("anti-VEGF" . SPARSER::DRUG)
    ("keratinocyte growth factor receptor" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("FGF-7" . SPARSER::PROTEIN) ("FGF7" . SPARSER::PROTEIN)
    ("FGF-1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("FGFR4" . SPARSER::PROTEIN) ("FGF23" . SPARSER::PROTEIN)
    ("FGF1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("FGF-2" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR-2" . SPARSER::PROTEIN)
    ("Growth factors and cytokines" . SPARSER::COLLECTION)
    ("antioxidants" . SPARSER::DRUG) ("aid" . SPARSER::PROTEIN)
    ("PCAF, Ets-1 and AP-1" . SPARSER::COLLECTION)
    ("two closely related transcriptional coactivators" . SPARSER::PROTEIN)
    ("CBP and P300" . SPARSER::COLLECTION) ("coactivators" . SPARSER::PROTEIN)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("CBP/P300" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("ester" . SPARSER::MOLECULE)
    ("Ets-1, c-Jun, c-Fos, and PCAF" . SPARSER::COLLECTION)
    ("example" . SPARSER::EXAMPLE)
    ("the many signaling kinases and their inhibitory phosphatases"
     . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("c-Jun and MMP-1" . SPARSER::COLLECTION)
    ("MMP-1 immunoreactive protein" . SPARSER::PROTEIN)
    ("oligomers" . SPARSER::MOLECULE) ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase (JNK)" . SPARSER::KINASE)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("Ets-1, c-Jun, or c-Fos" . SPARSER::COLLECTION)
    ("Ets-1, c-Jun, and c-Fos" . SPARSER::COLLECTION)
    ("Ets-1, c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("Sod2/catalase" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("Class I and II HDACs" . SPARSER::COLLECTION)
    ("II HDACs" . SPARSER::PROTEIN) ("Trichostatin" . SPARSER::MOLECULE)
    ("HDACs" . SPARSER::PROTEIN)
    ("histone H3 acetylation around both the distal and proximal MMP-1 promoter"
     . SPARSER::PROMOTER)
    ("Histone" . SPARSER::PROTEIN) ("βGlobin and GAPDH" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the distal and proximal MMP-1 promoter" . SPARSER::PROMOTER)
    ("Sod2 or catalase" . SPARSER::COLLECTION) ("Chromatin" . SPARSER::PROTEIN)
    ("HAT/HDAC" . SPARSER::COLLECTION) ("DNA and gene" . SPARSER::COLLECTION)
    ("lysines" . SPARSER::AMINO-ACID) ("inducer" . SPARSER::MOLECULE)
    ("oxidants" . SPARSER::MOLECULE) ("cigarette" . SPARSER::DRUG)
    ("P300 and histone" . SPARSER::COLLECTION) ("acetyl" . SPARSER::MOLECULE)
    ("lysine" . SPARSER::AMINO-ACID)
    ("the distal MMP-1 promoter" . SPARSER::PROMOTER)
    ("Lysine" . SPARSER::AMINO-ACID) ("Jun D and Fra-2" . SPARSER::COLLECTION)
    ("c-Fos/c-Jun" . SPARSER::COLLECTION) ("Jun D/c-Fos" . SPARSER::COLLECTION)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION) ("Ets-1/AP-1" . SPARSER::COLLECTION)
    ("chondrocytes" . SPARSER::PROTEIN) ("MMP" . SPARSER::PROTEIN)
    ("fibronectin" . SPARSER::PROTEIN) ("Ets-1 and AP-1" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("oxidant" . SPARSER::PROTEIN) ("Redox" . SPARSER::PROTEIN)
    ("AP-1" . SPARSER::PROTEIN) ("SS-" . SPARSER::PROTEIN)
    ("SS" . SPARSER::PROTEIN)
    ("MMP-1 or interstitial collagenase" . SPARSER::COLLECTION)
    ("collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endopeptidases" . SPARSER::PROTEIN)
    ("factors and chromatin" . SPARSER::COLLECTION)
    ("catalase" . SPARSER::PROTEIN) ("PCAF" . SPARSER::PROTEIN)
    ("HAT" . SPARSER::PROTEIN) ("HDAC2 and MMP-1" . SPARSER::COLLECTION)
    ("redox" . SPARSER::PROTEIN) ("HDAC" . SPARSER::PROTEIN)
    ("Sod2" . SPARSER::PROTEIN) ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("NRF2" . SPARSER::PROTEIN) ("p300 HAT" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("Nuclear Factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("histone acetyltransferase PCAF" . SPARSER::PROTEIN)
    ("βGlobin" . SPARSER::PROTEIN) ("Mn-SOD" . SPARSER::PROTEIN)
    ("P300/CBP-associated factor" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("P300" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("Fra-2" . SPARSER::PROTEIN) ("Jun D" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("histone acetyltransferase" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN) ("PB" . SPARSER::PROTEIN)
    ("MBC" . SPARSER::PROTEIN) ("ANOVA" . SPARSER::PROTEIN)
    ("CTC-EMT" . SPARSER::COLLECTION) ("CTC-EP" . SPARSER::COLLECTION)
    ("intermediate phenotypic states" . SPARSER::BIO-STATE)
    ("underwent EMT" . SPARSER::PROTEIN)
    ("cell adhesion molecules and chemokines
[ xref , xref ]"
     . SPARSER::COLLECTION)
    ("EP" . SPARSER::PROTEIN) ("Slug and Twist1" . SPARSER::COLLECTION)
    ("Twist1, Slug, and Ck19" . SPARSER::COLLECTION)
    ("Slug" . SPARSER::PROTEIN) ("Snail and Zeb1" . SPARSER::COLLECTION)
    ("Zeb1" . SPARSER::PROTEIN) ("HD" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("Snail" . SPARSER::PROTEIN)
    ("Ck19" . SPARSER::PROTEIN) ("EMT-TF" . SPARSER::COLLECTION)
    ("HDs" . SPARSER::PROTEIN) ("PBC" . SPARSER::PROTEIN)
    ("Ck" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TF" . SPARSER::PROTEIN)
    ("HER-2/neu" . SPARSER::COLLECTION)
    ("collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endopeptidase" . SPARSER::PROTEIN) ("uPa" . SPARSER::PROTEIN)
    ("urokinase" . SPARSER::PROTEIN) ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("mesenchymal molecules" . SPARSER::MOLECULE) ("ECM" . SPARSER::PROTEIN)
    ("MMP1 and CTCs" . SPARSER::COLLECTION)
    ("MMPs and EMT" . SPARSER::COLLECTION) ("CTC" . SPARSER::PROTEIN)
    ("SLUG" . SPARSER::PROTEIN) ("TM" . SPARSER::PROTEIN)
    ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("Tissue factor" . SPARSER::PROTEIN)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN) ("Ki 67" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("m1" . SPARSER::MOLECULE) ("plasminogen activator" . SPARSER::PROTEIN)
    ("CK19" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP1" . SPARSER::PROTEIN) ("around exon" . SPARSER::PROTEIN)
    ("no splicing defects around exon" . SPARSER::PROTEIN)
    ("a physiological alternative splicing around exon" . SPARSER::PROTEIN)
    ("caffeine" . SPARSER::MOLECULE) ("NMD" . SPARSER::PROTEIN)
    ("JAK2V617F-associated MPNs" . SPARSER::PROTEIN)
    ("octamer, and Fas-ESSs" . SPARSER::COLLECTION)
    ("octamer" . SPARSER::PROTEIN)
    ("the serine–arginine-rich (SR) protein SRSF6" . SPARSER::PROTEIN)
    ("SR" . SPARSER::PROTEIN) ("haploid" . SPARSER::PROTEIN)
    ("TF-1" . SPARSER::PROTEIN) ("only eight JAK2 gene" . SPARSER::PROTEIN)
    ("HEL" . SPARSER::PROTEIN) ("appropriate media" . SPARSER::PROTEIN)
    ("JAK2 , INSL4 and INSL6" . SPARSER::COLLECTION)
    ("a 1132 amino-acid protein" . SPARSER::PROTEIN)
    ("vera (PV)" . SPARSER::PROTEIN) ("Phe" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("MPN" . SPARSER::PROTEIN)
    ("PMF" . SPARSER::PROTEIN) ("ET" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN) ("vera" . SPARSER::PROTEIN)
    ("MPNs" . SPARSER::PROTEIN) ("UPF1" . SPARSER::PROTEIN)
    ("SRSF2" . SPARSER::PROTEIN) ("SRSF6" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("INSL6" . SPARSER::PROTEIN)
    ("INSL4" . SPARSER::PROTEIN) ("p24" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAK2" . SPARSER::PROTEIN) ("Janus kinase 2" . SPARSER::PROTEIN)
    ("ATM, ATR, Chk1, Chk2 and p53" . SPARSER::COLLECTION)
    ("ATM and Chk2" . SPARSER::COLLECTION)
    ("the Gynecologic Oncology Group" . SPARSER::MOLECULE)
    ("Group" . SPARSER::MOLECULE)
    ("poor prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GFP-tagged wild-type YAP and GFP-tagged constitutively active S127A mutant YAP"
     . SPARSER::COLLECTION)
    ("YAP and phospho-YAP" . SPARSER::COLLECTION) ("HEC" . SPARSER::PROTEIN)
    ("EMCA or YAP" . SPARSER::COLLECTION) ("log-rank" . SPARSER::COLLECTION)
    ("clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type 1 or type 2" . SPARSER::COLLECTION)
    ("clinicopathological factors and YAP" . SPARSER::COLLECTION)
    ("factors and YAP" . SPARSER::COLLECTION)
    ("type 1 and type 2" . SPARSER::COLLECTION)
    ("YAP/IGF2/Akt" . SPARSER::COLLECTION)
    ("YAP and the WW domain binding protein-2 (WBP-2)" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION) ("alanine" . SPARSER::AMINO-ACID)
    ("CTGF and AREG" . SPARSER::COLLECTION) ("AREG" . SPARSER::PROTEIN)
    ("CTGF" . SPARSER::PROTEIN) ("Adjuvant" . SPARSER::DRUG)
    ("ER/PR" . SPARSER::COLLECTION)
    ("diagnostic biomarkers" . SPARSER::MOLECULE)
    ("PTEN , KRAS , CTNNB1 , PIK3CA and FGFR2" . SPARSER::COLLECTION)
    ("EMCA and favorable prognosis" . SPARSER::COLLECTION)
    ("subsequent impact" . SPARSER::PROTEIN)
    ("an independent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p " . SPARSER::PROTEIN) ("EMCA" . SPARSER::DRUG)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("YAP" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("steroid hormone" . SPARSER::MOLECULE)
    ("LATS1" . SPARSER::PROTEIN) ("Type 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LATS2" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("Anti-" . SPARSER::ANTIBODY) ("IGF2" . SPARSER::PROTEIN)
    ("WBP-2" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPases" . SPARSER::GTPASE)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BDNF" . SPARSER::PROTEIN)
    ("NP" . SPARSER::PROTEIN) ("Matrigel" . SPARSER::PROTEIN)
    ("t" . SPARSER::PROTEIN) ("adjuvant" . SPARSER::DRUG)
    ("Tween20" . SPARSER::MOLECULE) ("brain-specific" . SPARSER::PROTEIN)
    ("Rac 3" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::MOLECULE)
    ("Rac1" . SPARSER::PROTEIN) ("new SUMO" . SPARSER::PROTEIN)
    ("essential regulators" . SPARSER::REGULATOR)
    ("proteins and kinases" . SPARSER::COLLECTION)
    ("SUMO-2 and the Uba2 E1 subunit" . SPARSER::COLLECTION)
    ("Uba2" . SPARSER::PROTEIN) ("Uba" . SPARSER::PROTEIN)
    ("many vital cellular proteins" . SPARSER::PROTEIN)
    ("the relevant components" . SPARSER::COMPONENT)
    ("the exact component" . SPARSER::COMPONENT)
    ("eIF4A (ATP-dependent mRNA helicase) and eIF4G (scaffold protein)"
     . SPARSER::COLLECTION)
    ("SUMO-2/-3" . SPARSER::COLLECTION)
    ("factors or other nuclear proteins that modulate" . SPARSER::COLLECTION)
    ("SUMO-1 and Ubc9" . SPARSER::COLLECTION)
    ("neither SUMO-2 nor 4EGI-1" . SPARSER::COLLECTION)
    ("SUMO-2 or 4EGI-1" . SPARSER::COLLECTION)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("two typical cap-dependent proteins, cyclin D1 and c-myc"
     . SPARSER::COLLECTION)
    ("proteins, cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("active eIF4F complexes" . SPARSER::BIO-COMPLEX)
    ("LUC and EYFP" . SPARSER::COLLECTION)
    ("eIF4G and eIF4E" . SPARSER::COLLECTION)
    ("eIF4E and eIF4A" . SPARSER::COLLECTION)
    ("eIF4G-SUMO-2" . SPARSER::COLLECTION)
    ("eIF4G and eIF4A" . SPARSER::COLLECTION)
    ("eIF4E, eIF4A and eIF4G" . SPARSER::COLLECTION)
    ("SUMO-2 or its non-conjugatable form ( xref )" . SPARSER::COLLECTION)
    ("4EBP1 and eIF4E" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("HA-SUMO-2" . SPARSER::COLLECTION)
    ("eIF4E and eIF4G" . SPARSER::COLLECTION)
    ("SUMO-2 or SUMO-3" . SPARSER::COLLECTION)
    ("poly-SUMO-2 or SUMO-3" . SPARSER::COLLECTION)
    ("covalently conjugation RanGAP1-SUMO-1" . SPARSER::COLLECTION)
    ("SUMO-1 and SUMO-1" . SPARSER::COLLECTION)
    ("RanGAP1-SUMO-1" . SPARSER::COLLECTION) ("Gly-Gly" . SPARSER::COLLECTION)
    ("Gly" . SPARSER::AMINO-ACID) ("LUC" . SPARSER::PROTEIN)
    ("SUMOs" . SPARSER::PROTEIN) ("Ser" . SPARSER::AMINO-ACID)
    ("the eIF4F complex containing eIF4E (cap-binding protein), eIF4A (ATP-dependent mRNA helicase) and eIF4G (scaffold protein) xref"
     . SPARSER::COLLECTION)
    ("SUMO-2 and SUMO-3" . SPARSER::COLLECTION)
    ("modifiers" . SPARSER::MOLECULE)
    ("sheds some new light" . SPARSER::PROTEIN)
    ("eIF4E/eIF4G" . SPARSER::COLLECTION)
    ("Eukaryotic Initiation Factor 4E (eIF4E) and Eukaryotic Initiation Factor 4G (eIF4G)"
     . SPARSER::COLLECTION)
    ("the active eukaryotic initiation factor 4F (eIF4F) complex"
     . SPARSER::BIO-COMPLEX)
    ("cyclinD1 and c-myc" . SPARSER::COLLECTION) ("SUMO" . SPARSER::PROTEIN)
    ("Ulp1" . SPARSER::PROTEIN) ("PIAS3" . SPARSER::PROTEIN)
    ("PHAS-I" . SPARSER::PROTEIN) ("BP1" . SPARSER::PROTEIN)
    ("protein 4" . SPARSER::PROTEIN) ("4EBP-1" . SPARSER::PROTEIN)
    ("m-TOR" . SPARSER::PROTEIN) ("RanGAP1" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("beta-actin" . SPARSER::PROTEIN) ("p70 S6" . SPARSER::PROTEIN)
    ("Mammalian Target of Rapamycin" . SPARSER::PROTEIN)
    ("UBC9" . SPARSER::PROTEIN) ("4E-BP" . SPARSER::PROTEIN)
    ("scaffold protein" . SPARSER::PROTEIN)
    ("cap-binding protein" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("Ubc9" . SPARSER::PROTEIN)
    ("SUMO-3" . SPARSER::PROTEIN) ("SUMO-1" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("cyclinD1" . SPARSER::PROTEIN)
    ("Factor 4" . SPARSER::PROTEIN)
    ("Eukaryotic Initiation Factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("factor 4" . SPARSER::PROTEIN) ("SUMO-2" . SPARSER::PROTEIN)
    ("colorectal cancer family" . SPARSER::PROTEIN-FAMILY)
    ("luminal-HER2 and HER2" . SPARSER::COLLECTION)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER or HER2" . SPARSER::COLLECTION)
    ("ER, HER2 and subtype" . SPARSER::COLLECTION)
    ("ER and HER2" . SPARSER::COLLECTION) ("N1–3" . SPARSER::COLLECTION)
    ("nodal" . SPARSER::PROTEIN) ("loco" . SPARSER::PROTEIN)
    ("Alu or LINE-1" . SPARSER::COLLECTION)
    ("luminal-HER2, and basal-like" . SPARSER::COLLECTION)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BCSC" . SPARSER::PROTEIN)
    ("CD24−" . SPARSER::PROTEIN) ("luminal" . SPARSER::DRUG)
    ("HER2/neu" . SPARSER::COLLECTION) ("neu" . SPARSER::PROTEIN)
    ("promoters" . SPARSER::PROMOTER) ("ADH" . SPARSER::PROTEIN)
    ("Alu and LINE-1" . SPARSER::COLLECTION)
    ("Alu and long interspersed nucleotide element-1 ( LINE-1 )"
     . SPARSER::COLLECTION)
    ("LINE" . SPARSER::PROTEIN) ("Alu" . SPARSER::PROTEIN)
    ("CpG" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("MUC1" . SPARSER::PROTEIN) ("tissue type" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("2-µL" . SPARSER::PROTEIN)
    ("cytokeratin 5" . SPARSER::PROTEIN) ("cytokeratin5" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("gene or pathway" . SPARSER::COLLECTION) ("SP1" . SPARSER::PROTEIN)
    ("MDM2 and Sp1" . SPARSER::COLLECTION)
    ("MDM2 and p53" . SPARSER::COLLECTION)
    ("a Sp1/p53/MDM2 triple protein complex" . SPARSER::BIO-COMPLEX)
    ("Sp1 and MDM2 protein" . SPARSER::COLLECTION)
    ("Sp1/p53/MDM2" . SPARSER::COLLECTION) ("p53/Sp1" . SPARSER::COLLECTION)
    ("MAPK8 , ARNT2 , RAR , DSP , KIAA0513 and LARP1" . SPARSER::COLLECTION)
    ("RAR" . SPARSER::PROTEIN) ("ChIP" . SPARSER::PROTEIN)
    ("DSP, KIAA0513 and LARP1" . SPARSER::COLLECTION)
    ("MAPK8, ARNT2 and RARA" . SPARSER::COLLECTION) ("DSP" . SPARSER::PROTEIN)
    ("MAPK8, RARA, SAMD3, CREBBP, RUNX1, BTRC and NCOA3" . SPARSER::COLLECTION)
    ("BTRC" . SPARSER::PROTEIN) ("CREBBP" . SPARSER::PROTEIN)
    ("RARA" . SPARSER::PROTEIN) ("RITA and nutlin" . SPARSER::COLLECTION)
    ("response elements (RE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("54 unique targets" . SPARSER::TARGET-PROTEIN)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("p53 and Sp1" . SPARSER::COLLECTION) ("cofactor" . SPARSER::MOLECULE)
    ("genes or genes" . SPARSER::COLLECTION)
    ("GADD45a, CDKN1A, SESN1 and BTG2" . SPARSER::COLLECTION)
    ("nutlin and RITA" . SPARSER::COLLECTION)
    ("RITA (triggering apoptosis) and nutlin (inducing cell cycle arrest)"
     . SPARSER::COLLECTION)
    ("these pro-apoptotic p53" . SPARSER::PROTEIN)
    ("these pro-apoptotic genes" . SPARSER::GENE)
    ("some well-known p53 pro-apoptotic targets" . SPARSER::TARGET-PROTEIN)
    ("Fas, Tp53I3, BAX, TNFRSF10A and TNFRSF10B" . SPARSER::COLLECTION)
    ("Fas" . SPARSER::PROTEIN) ("RITA or nutlin" . SPARSER::COLLECTION)
    ("Nutlin and ActD" . SPARSER::COLLECTION)
    ("CDDP or 5-FU" . SPARSER::COLLECTION) ("RN" . SPARSER::PROTEIN)
    ("Sp1, AP1, SAMD2 and RXRA" . SPARSER::COLLECTION)
    ("RXRA" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("AP1" . SPARSER::PROTEIN)
    ("AKR1C1 , TBXAS1 , SULT1A1 , HDP , SCAP , Sp3 , FCER1A , CITED2 and Sp1"
     . SPARSER::COLLECTION)
    ("SCAP" . SPARSER::PROTEIN) ("HDP" . SPARSER::PROTEIN)
    ("a single pro-apoptotic gene" . SPARSER::GENE) ("hsa" . SPARSER::PROTEIN)
    ("DMSO and RITA" . SPARSER::COLLECTION) ("Sigma" . SPARSER::PROTEIN)
    ("FDR" . SPARSER::PROTEIN) ("DMSO" . SPARSER::MOLECULE)
    ("lentiviral shRNA" . SPARSER::PROTEIN) ("shRNAs" . SPARSER::PROTEIN)
    ("Nutlin" . SPARSER::DRUG) ("Bcl-xL and Bcl-2" . SPARSER::COLLECTION)
    ("pifithrin" . SPARSER::DRUG)
    ("cisplatin (CDDP) and 5-FU" . SPARSER::COLLECTION)
    ("an isogenic derivative" . SPARSER::DERIVATIVE)
    ("five well-studied p53-activating chemical" . SPARSER::MOLECULE)
    ("CDDP" . SPARSER::DRUG) ("ActD" . SPARSER::MOLECULE)
    ("chemical" . SPARSER::MOLECULE)
    ("nutlin, RITA and 5-fluorouracil" . SPARSER::COLLECTION)
    ("cofactors" . SPARSER::PROTEIN) ("fluorouracil" . SPARSER::DRUG)
    ("Akt-PI3K" . SPARSER::COLLECTION) ("IGFR" . SPARSER::PROTEIN)
    ("Puma and Noxa" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("fate" . SPARSER::PROTEIN) ("RITA" . SPARSER::PROTEIN)
    ("nutlin" . SPARSER::DRUG) ("which targets Sp1" . SPARSER::PROTEIN)
    ("pro-apoptotic genes" . SPARSER::GENE) ("hSp1" . SPARSER::PROTEIN)
    ("p53 cofactor" . SPARSER::PROTEIN) ("MDM2 protein" . SPARSER::PROTEIN)
    ("ARNT2" . SPARSER::PROTEIN) ("LARP1" . SPARSER::PROTEIN)
    ("KIAA0513" . SPARSER::PROTEIN) ("NCOA3" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("SAMD3" . SPARSER::PROTEIN)
    ("MAPK8" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TGF-beta" . SPARSER::PROTEIN) ("hnRNP K" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("SESN1" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("GADD45a" . SPARSER::PROTEIN) ("TNFRSF10B" . SPARSER::PROTEIN)
    ("TNFRSF10A" . SPARSER::PROTEIN) ("Tp53I3" . SPARSER::PROTEIN)
    ("BBC3" . SPARSER::PROTEIN) ("PMAIP1" . SPARSER::PROTEIN)
    ("SAMD2" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("TAF1" . SPARSER::PROTEIN) ("CITED2" . SPARSER::PROTEIN)
    ("FCER1A" . SPARSER::PROTEIN) ("Sp3" . SPARSER::PROTEIN)
    ("SULT1A1" . SPARSER::PROTEIN) ("TBXAS1" . SPARSER::PROTEIN)
    ("AKR1C1" . SPARSER::PROTEIN) ("actinomycin D" . SPARSER::MOLECULE)
    ("5-FU" . SPARSER::PROTEIN) ("Apr-246" . SPARSER::DRUG)
    ("PRIMA-1" . SPARSER::PROTEIN) ("MDM2" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("MALT1 and NF- κ B" . SPARSER::COLLECTION)
    ("MALT1-A20-NF- κ B" . SPARSER::COLLECTION)
    ("A20 and MALT1" . SPARSER::COLLECTION)
    ("MALT1 and TCR-CD3" . SPARSER::COLLECTION)
    ("MALT1 and A20" . SPARSER::COLLECTION)
    ("TNF- α , IL-6, and IL-2" . SPARSER::COLLECTION)
    ("a pivotal regulator" . SPARSER::PROTEIN)
    ("three strongly associated genetic variants" . SPARSER::VARIANT)
    ("myeloid" . SPARSER::PROTEIN) ("API2-MALT1" . SPARSER::COLLECTION)
    ("A20 and the Bcl-10 adaptor protein" . SPARSER::COLLECTION)
    ("receptor (TCR)" . SPARSER::RECEPTOR) ("/NF- κ B" . SPARSER::COLLECTION)
    ("CARMA1-Bcl-10-MALT1" . SPARSER::COLLECTION)
    ("proximal signaling complexes" . SPARSER::BIO-COMPLEX)
    ("esters, and hydrogen peroxide" . SPARSER::COLLECTION)
    ("esters" . SPARSER::MOLECULE) ("phorbol" . SPARSER::DRUG)
    ("LPS" . SPARSER::PROTEIN) ("tumor necrosis factor-" . SPARSER::PROTEIN)
    ("FLS" . SPARSER::PROTEIN)
    ("MALT1, A20, and NF- κ B" . SPARSER::COLLECTION)
    ("MALT1 and A20 and MALT1-V1 and A20" . SPARSER::COLLECTION)
    ("A20 and MALT1-V1 and A20" . SPARSER::COLLECTION)
    ("MALT1 and NF- κ B, MALT1-V1 and NF- κ B, and A20 and NF- κ B"
     . SPARSER::COLLECTION)
    ("NF- κ B, MALT1-V1 and NF- κ B, and A20 and NF- κ B"
     . SPARSER::COLLECTION)
    ("NF- κ B, and A20 and NF- κ B" . SPARSER::COLLECTION)
    ("A20 and NF- κ B" . SPARSER::COLLECTION)
    ("MALT1 and MALT1-V1" . SPARSER::COLLECTION)
    ("MALT1, MALT-V1, A20, and NF- κ B" . SPARSER::COLLECTION)
    ("MALT" . SPARSER::PROTEIN)
    ("A20, NF- κ B, and A20 regulatory factor mucosa-associated lymphoid tissue lymphoma translocation gene 1"
     . SPARSER::PROTEIN)
    ("A20, NF- κ B, and A20" . SPARSER::COLLECTION)
    ("lymphoid" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("intrinsic factor" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("β 2M" . SPARSER::PROTEIN)
    ("β 2-microglobulin" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN) ("API2" . SPARSER::PROTEIN)
    ("Bcl-10" . SPARSER::PROTEIN) ("CARMA1" . SPARSER::PROTEIN)
    ("TNFAIP3" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("interleukin-1" . SPARSER::PROTEIN) ("interleukin-6" . SPARSER::PROTEIN)
    ("MALT1" . SPARSER::PROTEIN) ("translocation gene 1" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("A20" . SPARSER::PROTEIN) ("RA" . SPARSER::PROTEIN)
    ("allele and malar" . SPARSER::COLLECTION)
    ("Gln/Arg" . SPARSER::COLLECTION) ("Ile" . SPARSER::AMINO-ACID)
    ("Thr" . SPARSER::AMINO-ACID) ("Han" . SPARSER::PROTEIN)
    ("different polymorphic variants" . SPARSER::VARIANT)
    ("internal factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nucleoprotein" . SPARSER::PROTEIN) ("Arg/Arg" . SPARSER::COLLECTION)
    ("Gln/Gln" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION) ("allele" . SPARSER::ALLELE)
    ("APS" . SPARSER::PROTEIN) ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("raised serum creatinine" . SPARSER::PROTEIN)
    ("creatinine" . SPARSER::PROTEIN) ("NER" . SPARSER::PROTEIN)
    ("autoreactive antibodies" . SPARSER::ANTIBODY)
    ("immunogenic antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Abs" . SPARSER::PROTEIN) ("autoantibody" . SPARSER::PROTEIN)
    ("sera" . SPARSER::PROTEIN) ("chemicals" . SPARSER::MOLECULE)
    ("genetic, hormonal, and environmental factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("reproductive age" . SPARSER::PROTEIN)
    ("antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("autoantibodies" . SPARSER::PROTEIN)
    ("Systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("Arg/Gln" . SPARSER::COLLECTION) ("Trp" . SPARSER::AMINO-ACID)
    ("Gln" . SPARSER::AMINO-ACID) ("SLE" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("XRCC4" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN)
    ("KRAS , PI3KCA and TP53" . SPARSER::COLLECTION)
    ("Bak-" . SPARSER::PROTEIN)
    ("Bcl-xL, Mcl1, Birc5 and Cyclin D1" . SPARSER::COLLECTION)
    ("phospho-mTOR and phospho-S6K" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("phospho-S6K and phospho-4E-BP1" . SPARSER::COLLECTION)
    ("p53 +/+ and p53 −/− cells" . SPARSER::COLLECTION)
    ("p53 and p73" . SPARSER::COLLECTION) ("p53-" . SPARSER::PROTEIN)
    ("basal Bak" . SPARSER::PROTEIN)
    ("BAX , PUMA and NOXA" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("MAPK or AKT" . SPARSER::COLLECTION)
    ("KRAS G13D [ xref ] and PIK3CA H1047R [ xref ]" . SPARSER::COLLECTION)
    ("EGFR [ xref , xref ] or ERBB2 [ xref ]" . SPARSER::COLLECTION)
    ("Bak and mitochondrial" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("phospho-AKT and phospho-mTOR" . SPARSER::COLLECTION)
    ("Bcl-xL, Mcl1, Birc5, Cyclin D1 and Cyclin E1" . SPARSER::COLLECTION)
    ("phospho-4E-BP1 and eIF4E" . SPARSER::COLLECTION)
    ("ERBB2, MAPK1/3, and p38" . SPARSER::COLLECTION)
    ("MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-S6K and phospho-S6" . SPARSER::COLLECTION)
    ("phospho-PDK1, phospho-AKT and phospho-mTOR" . SPARSER::COLLECTION)
    ("phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BPs" . SPARSER::PROTEIN)
    ("p53 +/+ and p53 −/− cells (Figure xref )" . SPARSER::COLLECTION)
    ("Bcl-xL, Mcl1 and Birc5" . SPARSER::COLLECTION)
    ("Bak and ERBB3" . SPARSER::COLLECTION)
    ("Bax or Bak" . SPARSER::COLLECTION) ("FACS" . SPARSER::PROTEIN)
    ("Bak and Bax" . SPARSER::COLLECTION)
    ("Bak and Birc5" . SPARSER::COLLECTION)
    ("BCL2L1 and MCL1" . SPARSER::COLLECTION) ("Birc5" . SPARSER::PROTEIN)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pro-apoptotic Bcl-2 family" . SPARSER::PROTEIN-FAMILY)
    ("Bcl-xL or Mcl1" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("Bcl-xL and Mcl1" . SPARSER::COLLECTION) ("Mcl" . SPARSER::PROTEIN)
    ("Bad, Bid, Bim, Noxa and Puma" . SPARSER::COLLECTION)
    ("Noxa" . SPARSER::PROTEIN) ("Bid" . SPARSER::PROTEIN)
    ("Bim or phospho-Bad" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("proteins and Bax" . SPARSER::COLLECTION) ("Parp1" . SPARSER::PROTEIN)
    ("Parp" . SPARSER::PROTEIN)
    ("either EGFR [ xref , xref ] or ERBB2 [ xref ]" . SPARSER::COLLECTION)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("barely detectable ERBB4" . SPARSER::PROTEIN)
    ("EGFR, ERBB2 and ERBB3" . SPARSER::COLLECTION)
    ("Bim and Puma" . SPARSER::COLLECTION)
    ("Bcl-2 or Mcl-1" . SPARSER::COLLECTION)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bim" . SPARSER::PROTEIN)
    ("Bad" . SPARSER::PROTEIN)
    ("pro-apoptotic Bcl-2 family" . SPARSER::PROTEIN-FAMILY)
    ("Bcl-2-homology" . SPARSER::COLLECTION) ("homology" . SPARSER::PROTEIN)
    ("a dual TKI" . SPARSER::PROTEIN) ("lapatinib" . SPARSER::DRUG)
    ("an even more potent target" . SPARSER::TARGET-PROTEIN)
    ("ERBB2/ERBB3" . SPARSER::COLLECTION)
    ("either EGFR [ xref ] or ERBB2 [ xref ]" . SPARSER::COLLECTION)
    ("mAb" . SPARSER::DRUG) ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("EGFR or ERBB2" . SPARSER::COLLECTION) ("mAbs" . SPARSER::DRUG)
    ("a single transmembrane receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERBB2, ERBB3 and ERBB4" . SPARSER::COLLECTION)
    ("ERBB" . SPARSER::PROTEIN) ("EGFR-" . SPARSER::PROTEIN)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("BH3-only pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("EGFR and ERBB2" . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION) ("β-tubulin" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("ErbB2" . SPARSER::PROTEIN) ("LT1" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("Colon cancer" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("p73" . SPARSER::PROTEIN) ("cytochrome C" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("4E-BP1" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("BAK1" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("BCL2L1" . SPARSER::PROTEIN)
    ("Bcl-xL" . SPARSER::PROTEIN) ("Erbb3" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("ERBB4" . SPARSER::PROTEIN) ("ERBB1" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE) ("ERBB2" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("MTA1 and endophilin" . SPARSER::COLLECTION)
    ("endophilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macromolecules" . SPARSER::MOLECULE) ("GO" . SPARSER::PROTEIN)
    ("chip" . SPARSER::PROTEIN) ("rank" . SPARSER::PROTEIN)
    ("MTA1 and α-tubulin" . SPARSER::COLLECTION)
    ("cytoplasmic tubulin-associated proteins" . SPARSER::PROTEIN)
    ("tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MTA1 and TPR" . SPARSER::COLLECTION) ("nucleoporin" . SPARSER::PROTEIN)
    ("IP" . SPARSER::PROTEIN) ("MTA1 and HDAC2" . SPARSER::COLLECTION)
    ("HCT116-M1 and HCT116-M3" . SPARSER::COLLECTION)
    ("con" . SPARSER::PROTEIN) ("kDa" . SPARSER::PROTEIN)
    ("MTA1-GFP" . SPARSER::COLLECTION) ("exogenous MTA1" . SPARSER::PROTEIN)
    ("pEGFP-MTA1" . SPARSER::COLLECTION) ("SF" . SPARSER::PROTEIN)
    ("a monoclonal antibody or GFP-tag" . SPARSER::COLLECTION)
    ("IF" . SPARSER::PROTEIN) ("PLA" . SPARSER::PROTEIN)
    ("deacetylase" . SPARSER::PROTEIN) ("nucleosome" . SPARSER::PROTEIN)
    ("a candidate metastasis-associated gene" . SPARSER::GENE)
    ("Metastasis-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rat" . SPARSER::PROTEIN) ("NF" . SPARSER::PROTEIN)
    ("only nuclear MTA1" . SPARSER::PROTEIN)
    ("microtubules" . SPARSER::PROTEIN) ("TPR" . SPARSER::PROTEIN)
    ("metastasis-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("g protein" . SPARSER::PROTEIN) ("nuclear pores" . SPARSER::BIO-COMPLEX)
    ("2/3" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("Histone deacetylase 2" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("full-length" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN) ("MTA1" . SPARSER::PROTEIN)
    ("metformin and dietary protein restriction" . SPARSER::COLLECTION)
    ("/PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("IR and IGF-R" . SPARSER::COLLECTION) ("metformin" . SPARSER::DRUG)
    ("Cbl or CHIP" . SPARSER::COLLECTION) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("Skp" . SPARSER::PROTEIN)
    ("antibodies or small molecule inhibitors" . SPARSER::COLLECTION)
    ("IGF-1R and EGFR" . SPARSER::COLLECTION) ("biologic" . SPARSER::DRUG)
    ("well-designed engineered ubiquitin ligases" . SPARSER::LIGASE)
    ("oncoproteins" . SPARSER::PROTEIN) ("aberrant RTKs" . SPARSER::PROTEIN)
    ("KRAS [ xref ] and ErbB1-3 [ xref ]" . SPARSER::COLLECTION)
    ("the disease-associated proteins" . SPARSER::PROTEIN)
    ("an artificial E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("dual IGF-1R/IR tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("antibodies and small molecule TKIs" . SPARSER::COLLECTION)
    ("transporter" . SPARSER::PROTEIN) ("mL" . SPARSER::PROTEIN)
    ("PTB and PTB-U-box transfectants" . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN)
    ("PTB (7.2±1.15%) and PTB-U-box (H260Q) transfectants (14.23±3.58%)"
     . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("phospho-Akt or phospho-ERK" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("PTB and PTB-" . SPARSER::COLLECTION) ("PTB-" . SPARSER::PROTEIN)
    ("PTB and the PTB-U-box(HQ) transfectants" . SPARSER::COLLECTION)
    ("PTB and the U-box mutant" . SPARSER::COLLECTION)
    ("IGF-1R or insulin receptor" . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN)
    ("IGF-1 or insulin" . SPARSER::COLLECTION)
    ("EGFR and Met" . SPARSER::COLLECTION) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("two artificial IR/IGF-1R-targeted ubiquitin ligases" . SPARSER::LIGASE)
    ("IR and IGF-1R" . SPARSER::COLLECTION) ("PTK" . SPARSER::PROTEIN)
    ("Cbl" . SPARSER::PROTEIN) ("the client proteins" . SPARSER::PROTEIN)
    ("Hsp90/Hsc70" . SPARSER::COLLECTION) ("Hsc70/Hsp90" . SPARSER::COLLECTION)
    ("TPRs" . SPARSER::PROTEIN) ("chaperone" . SPARSER::PROTEIN)
    ("carboxy" . SPARSER::MOLECULE)
    ("RING-finger proteins [ xref ] and U-box proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("HECT" . SPARSER::PROTEIN) ("E2 or E3" . SPARSER::COLLECTION)
    ("protein (E2) and ubiquitin ligase (E3)" . SPARSER::COLLECTION)
    ("three-step" . SPARSER::PROTEIN) ("enzymes" . SPARSER::ENZYME)
    ("the insulin receptor and the gene" . SPARSER::COLLECTION)
    ("insulin/IR" . SPARSER::COLLECTION) ("IGF/IGF-1R" . SPARSER::COLLECTION)
    ("IGF-1R or hybrid receptor" . SPARSER::COLLECTION)
    ("substrates (IRS)" . SPARSER::SUBSTRATE)
    ("insulin, IGF-1 or IGF-2" . SPARSER::COLLECTION)
    ("Akt and MAPK" . SPARSER::COLLECTION)
    ("IR and a half receptor" . SPARSER::COLLECTION)
    ("IR/IGF-1R" . SPARSER::COLLECTION)
    ("Insulin receptor (IR) and Insulin-like growth factor I receptor (IGF-1R)"
     . SPARSER::COLLECTION)
    ("Insulin and insulin-like growth factor" . SPARSER::COLLECTION)
    ("insulin and IGF-1" . SPARSER::COLLECTION)
    ("Akt and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("mitogen" . SPARSER::MITOGEN) ("IGF" . SPARSER::PROTEIN)
    ("well-designed engineered ubiquitin ligase" . SPARSER::PROTEIN)
    ("IGF-1R/IR" . SPARSER::COLLECTION) ("PTB" . SPARSER::PROTEIN)
    ("IGF-1R and IR" . SPARSER::COLLECTION)
    ("insulin receptor (IR)" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("antibodies and small molecule tyrosine kinase inhibitors (TKIs)"
     . SPARSER::COLLECTION)
    ("G418" . SPARSER::MOLECULE) ("protein A" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("D-glucose" . SPARSER::MOLECULE)
    ("α-tubulin" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("IGF-R" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("IRS-2" . SPARSER::PROTEIN)
    ("subunit E" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN) ("OSI-906" . SPARSER::DRUG)
    ("Glut4" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("ligase activity" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hsc70" . SPARSER::PROTEIN)
    ("Hsc70 interacting protein" . SPARSER::PROTEIN)
    ("E6-AP" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("IGF-2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor I receptor" . SPARSER::PROTEIN)
    ("Insulin receptor" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HCC and a potential therapeutic target" . SPARSER::COLLECTION)
    ("NFκB, FoxD3, miR-137 and AKT2" . SPARSER::COLLECTION)
    ("metastatic HCC" . SPARSER::PROTEIN) ("TGFA" . SPARSER::PROTEIN)
    ("KR" . SPARSER::PROTEIN) ("paxillin and Met" . SPARSER::COLLECTION)
    ("paxillin" . SPARSER::PROTEIN)
    ("EZH2, FMNL2, and Paxillin" . SPARSER::COLLECTION)
    ("Paxillin" . SPARSER::PROTEIN) ("EMT and AKT" . SPARSER::COLLECTION)
    ("P38-HSP27" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("MMTV" . SPARSER::PROTEIN) ("wingless" . SPARSER::PROTEIN)
    ("Ki67 (proliferative marker) and vimentin (mesenchymal marker)"
     . SPARSER::COLLECTION)
    ("AKT2, Ki67 (proliferative marker) and vimentin (mesenchymal marker)"
     . SPARSER::COLLECTION)
    ("FoxD3 and AKT2" . SPARSER::COLLECTION)
    ("FoxD3 and miR-137" . SPARSER::COLLECTION) ("CHIP" . SPARSER::PROTEIN)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("-UTR" . SPARSER::COLLECTION)
    ("PITA" . SPARSER::PROTEIN)
    ("p-AKT, p-mTOR, p-p70S6K, MMP2, and vimentin" . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION) ("p-AKT" . SPARSER::COLLECTION)
    ("Cox" . SPARSER::PROTEIN) ("primary HCC" . SPARSER::PROTEIN)
    ("oncogene or tumour" . SPARSER::COLLECTION)
    ("aflatoxin" . SPARSER::MOLECULE)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("AKT2/mTOR" . SPARSER::COLLECTION)
    ("AKT2 and miR-137" . SPARSER::COLLECTION)
    ("microRNAs" . SPARSER::MICRO-RNA) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("NFκB" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("Twist1" . SPARSER::PROTEIN)
    ("FMNL2" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN) ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ki67" . SPARSER::PROTEIN) ("transcription factor" . SPARSER::PROTEIN)
    ("its 3" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("v-AKT" . SPARSER::PROTEIN) ("HMGA1" . SPARSER::PROTEIN)
    ("FoxD3" . SPARSER::PROTEIN) ("IFN-β and ISG12a" . SPARSER::COLLECTION)
    ("an important antiviral factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BIM" . SPARSER::PROTEIN) ("PTEN and TIMP3" . SPARSER::COLLECTION)
    ("Promoter" . SPARSER::PROMOTER)
    ("CFLAR(FLIP) and Bcl2" . SPARSER::COLLECTION)
    ("mTOR, CFLAR(FLIP) and Bcl2" . SPARSER::COLLECTION)
    ("pro-apoptotic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and p38" . SPARSER::COLLECTION) ("CFLAR" . SPARSER::PROTEIN)
    ("Mut" . SPARSER::PROTEIN) ("CHO" . SPARSER::PROTEIN)
    ("MiRNAs" . SPARSER::MICRO-RNA) ("receptor (IFNR)" . SPARSER::RECEPTOR)
    ("IFNR" . SPARSER::PROTEIN) ("NOD" . SPARSER::PROTEIN)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cohorts" . SPARSER::MOLECULE)
    ("Active" . SPARSER::ACTIVE) ("pan-caspase" . SPARSER::COLLECTION)
    ("pan" . SPARSER::PROTEIN) ("DcR1 and DcR2" . SPARSER::COLLECTION)
    ("DcR1" . SPARSER::PROTEIN) ("DR4 and DR5" . SPARSER::COLLECTION)
    ("soluble TRAIL" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("albumin and α1-antitrypsin" . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN) ("HCC and GC" . SPARSER::COLLECTION)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("MicroRNAs" . SPARSER::MICRO-RNA)
    ("IFN" . SPARSER::PROTEIN) ("agonist" . SPARSER::AGONIST)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("Bax and Bak" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("Bax" . SPARSER::PROTEIN) ("oligomerisation" . SPARSER::PROTEIN-FAMILY)
    ("BID" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("TRAIL, DR4 or DR5" . SPARSER::COLLECTION)
    ("caspase-8, and FLIP" . SPARSER::COLLECTION) ("FLIP" . SPARSER::PROTEIN)
    ("FADD" . SPARSER::PROTEIN) ("DISC" . SPARSER::BIO-COMPLEX)
    ("Sorafenib" . SPARSER::DRUG) ("GC" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::MICRO-RNA) ("miR" . SPARSER::MICRO-RNA)
    ("MicroRNA" . SPARSER::MICRO-RNA)
    ("an attractive death ligand" . SPARSER::MOLECULE)
    ("ligand (TRAIL)" . SPARSER::MOLECULE) ("TRAIL" . SPARSER::PROTEIN)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Annexin V" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TIMP3" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bcl2" . SPARSER::PROTEIN)
    ("a3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pGL3" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("z-VAD-FMK" . SPARSER::DRUG)
    ("DcR2" . SPARSER::PROTEIN) ("α1-antitrypsin" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("death receptor" . SPARSER::PROTEIN) ("Cytochrome c" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("Caspase-8" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("adaptor protein" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("ISG12" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("further experiments using H 2 O 2" . SPARSER::DRUG)
    ("defective p53" . SPARSER::PROTEIN) ("Base" . SPARSER::PROTEIN)
    ("olaparib and veliparib" . SPARSER::COLLECTION)
    ("side" . SPARSER::PROTEIN) ("some extent niraparib's" . SPARSER::DRUG)
    ("niraparib or not" . SPARSER::COLLECTION)
    ("essentially pure SSBs" . SPARSER::PROTEIN)
    ("radiation-induced RAD51 foci" . SPARSER::PROTEIN)
    ("Aphidicolin" . SPARSER::PROTEIN) ("CCD" . SPARSER::PROTEIN)
    ("MCF-10A" . SPARSER::PROTEIN) ("typically lowering PE" . SPARSER::PROTEIN)
    ("PE" . SPARSER::PROTEIN) ("SF2 and SF4" . SPARSER::COLLECTION)
    ("DEF" . SPARSER::PROTEIN) ("pilot" . SPARSER::PROTEIN)
    ("AG" . SPARSER::PROTEIN) ("Olaparib" . SPARSER::DRUG)
    ("veliparib" . SPARSER::DRUG) ("olaparib" . SPARSER::DRUG)
    ("radiation-induced SSBs" . SPARSER::PROTEIN)
    ("alkaline" . SPARSER::PROTEIN) ("derivatives" . SPARSER::DERIVATIVE)
    ("AB" . SPARSER::PROTEIN) ("nicotinamide" . SPARSER::PROTEIN)
    ("cellular NAD" . SPARSER::MOLECULE) ("enzyme" . SPARSER::ENZYME)
    ("NAD" . SPARSER::MOLECULE) ("radiosensitizers" . SPARSER::DRUG)
    ("past unrepaired SSBs" . SPARSER::PROTEIN) ("SSB" . SPARSER::PROTEIN)
    ("MRE11 and NBS" . SPARSER::COLLECTION) ("NBS" . SPARSER::PROTEIN)
    ("camptothecin" . SPARSER::DRUG) ("cyclophosphamide" . SPARSER::DRUG)
    ("histones and other proteins" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("polymers" . SPARSER::MOLECULE)
    ("SSBs and DSBs" . SPARSER::COLLECTION)
    ("DNA and function" . SPARSER::COLLECTION)
    ("sublethal SSBs" . SPARSER::PROTEIN) ("base" . SPARSER::PROTEIN)
    ("SSBs" . SPARSER::PROTEIN) ("Niraparib" . SPARSER::DRUG)
    ("radiation-induced DNA" . SPARSER::DNA)
    ("foci and RAD51" . SPARSER::COLLECTION)
    ("p53 wild-type and p53-defective" . SPARSER::COLLECTION)
    ("MK" . SPARSER::PROTEIN) ("niraparib" . SPARSER::DRUG)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("wee1" . SPARSER::PROTEIN)
    ("AG14361" . SPARSER::DRUG) ("AZD2281" . SPARSER::DRUG)
    ("BRCA2" . SPARSER::PROTEIN) ("H2O2" . SPARSER::DRUG)
    ("SF4" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("AG014699" . SPARSER::DRUG) ("ABT-888" . SPARSER::DRUG)
    ("MRE11" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("PARP-1" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("γ-H 2 AX" . SPARSER::PROTEIN) ("ADP-Ribose" . SPARSER::MOLECULE)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("linking mTOR" . SPARSER::PROTEIN)
    ("GCG" . SPARSER::PROTEIN)
    ("AZD2014 (15 mg/kg) and ibrutinib (12 mg/kg)" . SPARSER::COLLECTION)
    ("AZD2014 and Ibrutinib" . SPARSER::COLLECTION)
    ("mTOR and BTK" . SPARSER::COLLECTION) ("cytokine" . SPARSER::PROTEIN)
    ("exogenous IL10" . SPARSER::PROTEIN)
    ("IL10/JAK/STAT3" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("GTP" . SPARSER::NUCLEOTIDE)
    ("the mTOR substrate 4EBP1 as well as PRAS40" . SPARSER::COLLECTION)
    ("an indirect target" . SPARSER::TARGET-PROTEIN)
    ("IL10 as well as IL6" . SPARSER::COLLECTION)
    ("ibrutinib or AZD2014" . SPARSER::COLLECTION)
    ("Cytokine" . SPARSER::PROTEIN) ("IL6 and IL10" . SPARSER::COLLECTION)
    ("BTK or mTOR" . SPARSER::COLLECTION)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("Ibrutinib and AZD2014" . SPARSER::COLLECTION)
    ("CCL3 and CCL4" . SPARSER::COLLECTION) ("GSEA" . SPARSER::PROTEIN)
    ("BCR/NF-κB" . SPARSER::COLLECTION) ("OCI" . SPARSER::PROTEIN)
    ("MyD88 and CD79B" . SPARSER::COLLECTION)
    ("AZD2014 and ibrutinib" . SPARSER::COLLECTION)
    ("the dual mTORC1/2 inhibitor AZD2014" . SPARSER::DRUG)
    ("NF-κB, STAT3, and mTOR" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("ibrutinib and AZD2014" . SPARSER::COLLECTION)
    ("both the mTORC1 (rapamycin-sensitive) and mTORC2 (rapamycin-insensitive) complexes"
     . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP) ("ATP" . SPARSER::ATP)
    ("Everolimus" . SPARSER::MOLECULE)
    ("Rapamycin and its analogues" . SPARSER::COLLECTION)
    ("everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("MCL" . SPARSER::PROTEIN) ("temsirolimus" . SPARSER::DRUG)
    ("everolimus" . SPARSER::DRUG) ("Rapamycin" . SPARSER::DRUG)
    ("PI3K-Akt" . SPARSER::COLLECTION)
    ("BCL2[ xref ] and mTOR[ xref ]" . SPARSER::COLLECTION)
    ("AML" . SPARSER::PROTEIN) ("Ibrutinib" . SPARSER::DRUG)
    ("NF-κB, MAPK, PKC, and AKT" . SPARSER::COLLECTION)
    ("rituximab" . SPARSER::DRUG) ("CHOP" . SPARSER::PROTEIN)
    ("BCR and NF-κB" . SPARSER::COLLECTION) ("Inhibitors" . SPARSER::INHIBITOR)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("BCR" . SPARSER::PROTEIN)
    ("subtype" . SPARSER::PROTEIN) ("GCB" . SPARSER::PROTEIN)
    ("ABC-subtype" . SPARSER::PROTEIN-PAIR)
    ("NF-κB/IL10/STAT3" . SPARSER::COLLECTION)
    ("BTK and mTOR" . SPARSER::COLLECTION)
    ("BTK, and AZD2014" . SPARSER::COLLECTION) ("ABC" . SPARSER::PROTEIN)
    ("mTOR" . SPARSER::PROTEIN) ("BTK" . SPARSER::PROTEIN)
    ("ibrutinib" . SPARSER::DRUG) ("a 20" . SPARSER::PROTEIN)
    ("IL-10R" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("Reducing Agent" . SPARSER::MOLECULE) ("T-V" . SPARSER::MOLECULE)
    ("LRRK2" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("PIM1" . SPARSER::PROTEIN) ("EBP1" . SPARSER::PROTEIN)
    ("si4" . SPARSER::MOLECULE) ("BRD4" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTO-ONCOGENE) ("CCL4" . SPARSER::PROTEIN)
    ("CCL3" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("CD79B" . SPARSER::PROTEIN) ("MyD88" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("mTORC1" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN) ("AZD2014" . SPARSER::DRUG)
    ("CXCR1/CXCR2" . SPARSER::COLLECTION)
    ("multiple behavioral traits" . SPARSER::PROTEIN)
    ("traits" . SPARSER::PROTEIN)
    ("their respective receptors" . SPARSER::PROTEIN)
    ("a chemotactic CXCL8" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN)
    ("ligand and receptor" . SPARSER::COLLECTION)
    ("CXCR4 and CXCR7" . SPARSER::COLLECTION) ("monocytes" . SPARSER::PROTEIN)
    ("PTEN-" . SPARSER::PROTEIN) ("parental PC3" . SPARSER::PROTEIN)
    ("derivative" . SPARSER::DERIVATIVE) ("pal" . SPARSER::PROTEIN)
    ("peptide" . SPARSER::PEPTIDE) ("isogenic DU145" . SPARSER::PROTEIN)
    ("RS" . SPARSER::PROTEIN) ("CCL2 and CXCL8" . SPARSER::COLLECTION)
    ("antagonist" . SPARSER::MOLECULE)
    ("co-dependent migratory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CXCL8, CXCL12 and CCL2" . SPARSER::COLLECTION)
    ("CXCL8, CCL2 and CXCL12" . SPARSER::COLLECTION)
    ("CCR2 and CXCR12" . SPARSER::COLLECTION)
    ("CCL2 (Fig xref , left panel) and CXCL12 (Fig xref , right panel)"
     . SPARSER::COLLECTION)
    ("CXCL12 and CCL2" . SPARSER::COLLECTION)
    ("functional PTEN" . SPARSER::PROTEIN)
    ("the isogenic DU145" . SPARSER::PROTEIN)
    ("CCR2 and CXCR4" . SPARSER::COLLECTION) ("NT" . SPARSER::PROTEIN)
    ("sh" . SPARSER::PROTEIN-FAMILY) ("CXCR1 or CXCR2" . SPARSER::COLLECTION)
    ("PC3 and LNCaP" . SPARSER::COLLECTION)
    ("PC3 and DU145" . SPARSER::COLLECTION) ("LNCaP" . SPARSER::PROTEIN)
    ("rh" . SPARSER::MOLECULE)
    ("CXCL8 and stromal-derived chemokines" . SPARSER::COLLECTION)
    ("CCL2 or CXCL12" . SPARSER::COLLECTION)
    ("CCL2, CXCL12 and CXCL8" . SPARSER::COLLECTION)
    ("Chemokines" . SPARSER::PROTEIN)
    ("the key biological mediators" . SPARSER::PROTEIN)
    ("PTEN/PI3K/Akt" . SPARSER::COLLECTION) ("radical" . SPARSER::MOLECULE)
    ("Tp53" . SPARSER::PROTEIN) ("ERG" . SPARSER::PROTEIN)
    ("PKB/Akt" . SPARSER::COLLECTION) ("PIN" . SPARSER::PROTEIN)
    ("prostatic" . SPARSER::PROTEIN)
    ("a haplo-insufficient tumor suppressor gene" . SPARSER::PROTEIN)
    ("/Akt" . SPARSER::COLLECTION) ("aggressive CaP" . SPARSER::PROTEIN)
    ("stromal chemokines" . SPARSER::PROTEIN) ("chemokine" . SPARSER::PROTEIN)
    ("CXCL8 and CXCL12" . SPARSER::COLLECTION)
    ("CCL2/CCR2" . SPARSER::COLLECTION) ("CXCL12/CXCR4" . SPARSER::COLLECTION)
    ("CCL2 and CXCL12" . SPARSER::COLLECTION) ("macrophage" . SPARSER::PROTEIN)
    ("CXCR1 and CXCR2" . SPARSER::COLLECTION)
    ("CXCR4 and CCR2" . SPARSER::COLLECTION)
    ("CXCL8 and other disease-promoting chemokines" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN) ("aim" . SPARSER::PROTEIN)
    ("CaP" . SPARSER::PROTEIN) ("phenol-red" . SPARSER::DRUG)
    ("M2" . SPARSER::MOLECULE) ("annexin V" . SPARSER::PROTEIN)
    ("CXCL-8" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("AMD3100" . SPARSER::DRUG) ("3B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("CXCR7" . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("PC3" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("CCR2" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("CXCR2" . SPARSER::PROTEIN) ("CXCR1" . SPARSER::PROTEIN)
    ("CXCL8" . SPARSER::PROTEIN)
    ("caveolin-1 or cavin-1" . SPARSER::COLLECTION)
    ("cAMP/PKA" . SPARSER::COLLECTION) ("PKG" . SPARSER::PROTEIN)
    ("PKA" . SPARSER::PROTEIN)
    ("proteins and caveolin-1" . SPARSER::COLLECTION)
    ("caveolin/cavin" . SPARSER::COLLECTION)
    ("caveolin-1 and cavin-1" . SPARSER::COLLECTION)
    ("state" . SPARSER::BIO-STATE) ("rev" . SPARSER::PROTEIN)
    ("fast" . SPARSER::PROTEIN) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("our findings highlight bidirectional lipid droplet" . SPARSER::PROTEIN)
    ("some caveolar proteins" . SPARSER::PROTEIN)
    ("SDPR/cavin-3" . SPARSER::COLLECTION)
    ("SRBC/cavin-2" . SPARSER::COLLECTION) ("cavin" . SPARSER::PROTEIN)
    ("caveolin-1–RFP" . SPARSER::COLLECTION) ("SRBC-GFP" . SPARSER::COLLECTION)
    ("PTRF-GFP" . SPARSER::COLLECTION) ("SRBC" . SPARSER::PROTEIN)
    ("a constitutive strong promoter" . SPARSER::PROMOTER)
    ("cavins" . SPARSER::PROTEIN) ("cavin-GFP" . SPARSER::PROTEIN-PAIR)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("actin" . SPARSER::PROTEIN)
    ("ATPase" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("SDPR/cavin-2" . SPARSER::COLLECTION) ("SDPR" . SPARSER::PROTEIN)
    ("thin" . SPARSER::PROTEIN)
    ("a fluorescent neutral lipid" . SPARSER::LIPID) ("LD" . SPARSER::PROTEIN)
    ("glycerol" . SPARSER::PROTEIN) ("triacylglycerol" . SPARSER::MOLECULE)
    ("forskolin (FSK)" . SPARSER::PROTEIN)
    ("phosphodiesterase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MIX" . SPARSER::PROTEIN) ("cyclase" . SPARSER::PROTEIN)
    ("forskolin" . SPARSER::PROTEIN) ("analog" . SPARSER::ANALOG)
    ("cAMP/protein kinase A" . SPARSER::COLLECTION) ("cAMP" . SPARSER::PROTEIN)
    ("Protein" . SPARSER::PROTEIN) ("Fat" . SPARSER::PROTEIN)
    ("nutrient" . SPARSER::MOLECULE) ("preadipocytes" . SPARSER::PROTEIN)
    ("transfectants" . SPARSER::PROTEIN) ("transgene" . SPARSER::PROTEIN)
    ("Red" . SPARSER::PROTEIN) ("lipids" . SPARSER::LIPID)
    ("Lipid" . SPARSER::LIPID) ("lactate" . SPARSER::LACTATE)
    ("IRS-1, PKB, and Erk-1/2" . SPARSER::COLLECTION)
    ("Erk-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("substrate (IRS)" . SPARSER::SUBSTRATE)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular" . SPARSER::PROTEIN) ("IRS" . SPARSER::PROTEIN)
    ("substrate" . SPARSER::SUBSTRATE) ("insulin" . SPARSER::PROTEIN)
    ("fractions" . SPARSER::COMPONENT) ("lipogenic mRNAs" . SPARSER::PROTEIN)
    ("caveolin-2 or cavin" . SPARSER::COLLECTION)
    ("exogenous Cav1-RFP" . SPARSER::COLLECTION)
    ("Exogenous Cav1-RFP" . SPARSER::COLLECTION) ("triton" . SPARSER::MOLECULE)
    ("detergent" . SPARSER::MOLECULE)
    ("a strong cytomegalovirus promoter" . SPARSER::PROMOTER)
    ("Cav1-RFP" . SPARSER::COLLECTION) ("Caveolin-RFP" . SPARSER::COLLECTION)
    ("RFP" . SPARSER::PROTEIN) ("Caveolin" . SPARSER::PROTEIN)
    ("promoter" . SPARSER::PROMOTER) ("Insulin" . SPARSER::PROTEIN)
    ("electron" . SPARSER::MOLECULE)
    ("a central unilocular lipid droplet" . SPARSER::PROTEIN)
    ("states" . SPARSER::BIO-STATE) ("PTRF/cavin-1" . SPARSER::COLLECTION)
    ("/cavin-1" . SPARSER::COLLECTION) ("PTRF" . SPARSER::PROTEIN)
    ("oligomeric caveolins" . SPARSER::PROTEIN-FAMILY)
    ("caveolins" . SPARSER::PROTEIN-FAMILY)
    ("cavin/caveolin" . SPARSER::COLLECTION)
    ("cavin-1 and -3 and EHD2" . SPARSER::COLLECTION)
    ("-3 and EHD2" . SPARSER::COLLECTION) ("adipocytes" . SPARSER::PROTEIN)
    ("glucose" . SPARSER::PROTEIN) ("caveolin" . SPARSER::PROTEIN)
    ("fat" . SPARSER::PROTEIN) ("Adipocytes" . SPARSER::PROTEIN)
    ("caveolin-3" . SPARSER::PROTEIN) ("fatty acid" . SPARSER::MOLECULE)
    ("cavin-3" . SPARSER::PROTEIN) ("MG132" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("protein kinase A" . SPARSER::PROTEIN)
    ("Lipid Droplet" . SPARSER::PROTEIN)
    ("Erk-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("cav1" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("m 2" . SPARSER::MOLECULE)
    ("Cav1" . SPARSER::PROTEIN) ("cavin-2" . SPARSER::PROTEIN)
    ("polymerase I and transcript release factor" . SPARSER::PROTEIN)
    ("caveolin-2" . SPARSER::PROTEIN) ("EHD2" . SPARSER::PROTEIN)
    ("cavin-1" . SPARSER::PROTEIN) ("lipid droplet" . SPARSER::PROTEIN)
    ("pre" . SPARSER::PROTEIN) ("Pre" . SPARSER::PROTEIN)
    ("YG" . SPARSER::MOLECULE) ("WL and PLG" . SPARSER::COLLECTION)
    ("PLG" . SPARSER::PROTEIN) ("WL" . SPARSER::MOLECULE)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("fragment" . SPARSER::FRAGMENT) ("PRISMA" . SPARSER::DRUG)
    ("Polymerase" . SPARSER::PROTEIN) ("CI" . SPARSER::PROTEIN)
    ("Arginine" . SPARSER::AMINO-ACID) ("Arg and Pro" . SPARSER::COLLECTION)
    ("alleles" . SPARSER::ALLELE) ("met" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID) ("proline" . SPARSER::AMINO-ACID)
    ("exon" . SPARSER::PROTEIN) ("alcohol" . SPARSER::DRUG)
    ("Tobacco" . SPARSER::DRUG) ("the 11th most common type" . TYPE)
    ("Sri" . SPARSER::PROTEIN) ("ProPro " . SPARSER::MOLECULE)
    ("ProPro" . SPARSER::MOLECULE) ("ArgArg" . SPARSER::MOLECULE)
    ("Pro" . SPARSER::AMINO-ACID) ("Arg" . SPARSER::AMINO-ACID)
    ("CI " . SPARSER::PROTEIN) ("CIs" . SPARSER::PROTEIN)
    ("Tumor protein p53" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID) ("p13" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN)
    ("tumor protein p53" . SPARSER::PROTEIN) ("TP53" . SPARSER::PROTEIN)
    ("factor or factors" . SPARSER::COLLECTION)
    ("antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("viral proteins" . SPARSER::PROTEIN)
    ("no viral protein" . SPARSER::PROTEIN) ("CTL" . SPARSER::PROTEIN)
    ("log" . SPARSER::PROTEIN) ("MKL2 and intron" . SPARSER::COLLECTION)
    ("BACH2 and MKL2" . SPARSER::COLLECTION)
    ("the clonal viral RNA" . SPARSER::RNA)
    ("gag-pro-pol" . SPARSER::COLLECTION) ("pol" . SPARSER::PROTEIN)
    ("gag" . SPARSER::PROTEIN) ("leukemia and Burkitt" . SPARSER::COLLECTION)
    ("leukemia" . SPARSER::PROTEIN) ("MKL2 or BACH2" . SPARSER::COLLECTION)
    ("pre-cART" . SPARSER::PROTEIN-PAIR) ("fragments" . SPARSER::FRAGMENT)
    ("long-term suppressive cART" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("variants" . SPARSER::VARIANT) ("MKL2 and BACH2" . SPARSER::COLLECTION)
    ("MKL2" . SPARSER::PROTEIN) ("cART" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("MKL1" . SPARSER::PROTEIN)
    ("T-cell" . SPARSER::PROTEIN) ("CD34" . SPARSER::PROTEIN)
    ("MAP4" . SPARSER::PROTEIN) ("PKP4" . SPARSER::PROTEIN)
    ("DDX6" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("HORMAD2" . SPARSER::PROTEIN) ("BACH2" . SPARSER::PROTEIN)
    ("a key reagent" . SPARSER::MOLECULE)
    ("NFKB and S6RP" . SPARSER::COLLECTION)
    ("RAS and PI3K" . SPARSER::COLLECTION)
    ("MEK and AKT" . SPARSER::COLLECTION)
    ("PI3K and RAS" . SPARSER::COLLECTION)
    ("BRAF and RAS" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGF5 and FGF9" . SPARSER::COLLECTION) ("ligands" . SPARSER::LIGAND)
    ("serotonin, gastrin and somatostatin" . SPARSER::COLLECTION)
    ("somatostatin" . SPARSER::PROTEIN) ("gastrin" . SPARSER::PROTEIN)
    ("serotonin" . SPARSER::MOLECULE) ("CDH1 and EPCAM" . SPARSER::COLLECTION)
    ("EPCAM and CDH1" . SPARSER::COLLECTION) ("EPCAM" . SPARSER::PROTEIN)
    ("APC, CTNNB1, KRAS, BRAF or PIK3CA" . SPARSER::COLLECTION)
    ("oncogenes" . SPARSER::ONCOGENE) ("endocrine" . SPARSER::PROTEIN)
    ("Examples" . SPARSER::EXAMPLE)
    ("previously described C-terminus antibodies" . SPARSER::ANTIBODY)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("media" . SPARSER::PROTEIN) ("FGFR2 and ERK" . SPARSER::COLLECTION)
    ("FGFR2, ERK, and AKT" . SPARSER::COLLECTION)
    ("partial" . SPARSER::PROTEIN)
    ("PD173074 or 1 uM MK2461" . SPARSER::COLLECTION)
    ("MEK/AKT" . SPARSER::COLLECTION) ("AKT and MEK" . SPARSER::COLLECTION)
    ("AKT inhibitor and MEK inhibitor" . SPARSER::COLLECTION)
    ("AKT and S6RP" . SPARSER::COLLECTION) ("minor" . SPARSER::PROTEIN)
    ("rapamycin" . SPARSER::DRUG) ("ERK, AKT and S6RP" . SPARSER::COLLECTION)
    ("MEK, AKT, and mTor" . SPARSER::COLLECTION) ("mTor" . SPARSER::PROTEIN)
    ("PDK1 and PKC" . SPARSER::COLLECTION) ("Serine" . SPARSER::AMINO-ACID)
    ("RSK" . SPARSER::PROTEIN) ("PKC" . SPARSER::PROTEIN)
    ("AMPK, and PDK" . SPARSER::COLLECTION) ("PDK" . SPARSER::PROTEIN)
    ("AMPK" . SPARSER::PROTEIN) ("P50 and P105" . SPARSER::COLLECTION)
    ("PRAS40 and S235/236" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("MK2461 and PD173074" . SPARSER::COLLECTION) ("SHC" . SPARSER::PROTEIN)
    ("FRS" . SPARSER::DRUG) ("AKT, ERK and NFKB" . SPARSER::COLLECTION)
    ("shRNA and shRNA" . SPARSER::COLLECTION)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("PHA665752 (a Met inhibitor) PD168393 (an irreversible EGFR inhibitor) and an IGF1R inhibitory antibody (Figure S4B in xref )"
     . SPARSER::COLLECTION)
    ("Gleevec" . SPARSER::DRUG) ("Lapatinib" . SPARSER::DRUG)
    ("Tarceva" . SPARSER::DRUG) ("PD173074 and MK2461" . SPARSER::COLLECTION)
    ("Met" . SPARSER::AMINO-ACID) ("DLD1" . SPARSER::PROTEIN)
    ("green" . SPARSER::PROTEIN) ("SNU16" . SPARSER::PROTEIN)
    ("Trastuzumab" . SPARSER::DRUG) ("Cetuximab" . SPARSER::DRUG)
    ("MEK or PI3K" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS, BRAF, p53 , and PIK3CA" . SPARSER::COLLECTION)
    ("BRAF" . SPARSER::PROTEIN) ("KRAS" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("primary colon cancer" . SPARSER::PROTEIN)
    ("AKT or ERK" . SPARSER::COLLECTION) ("AKT and ERK" . SPARSER::COLLECTION)
    ("AKT, ERK, S6RP and NFKB" . SPARSER::COLLECTION)
    ("NFKB" . SPARSER::PROTEIN) ("RP" . SPARSER::PROTEIN)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("line" . SPARSER::PROTEIN)
    ("FGF5" . SPARSER::PROTEIN) ("C20" . SPARSER::PROTEIN)
    ("CDH1" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("FRA1" . SPARSER::PROTEIN) ("PD0325901" . SPARSER::DRUG)
    ("P105" . SPARSER::PROTEIN) ("P50" . SPARSER::PROTEIN)
    ("PHA665752" . SPARSER::MOLECULE) ("FGFR-1" . SPARSER::PROTEIN)
    ("G10" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("FRS2" . SPARSER::PROTEIN) ("GAB1" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("PD168393" . SPARSER::DRUG) ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("L18" . SPARSER::PROTEIN) ("for 3" . SPARSER::PROTEIN)
    ("MK2461" . SPARSER::DRUG) ("PD173074" . SPARSER::DRUG)
    ("Erbb2" . SPARSER::PROTEIN) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatocytes" . SPARSER::PROTEIN) ("EMT and EMT" . SPARSER::COLLECTION)
    ("Cav-1 and EMT" . SPARSER::COLLECTION) ("period" . SPARSER::PROTEIN)
    ("several biological mediators" . SPARSER::PROTEIN)
    ("the antiapoptotic Mcl-1 protein" . SPARSER::PROTEIN)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("cytokines" . SPARSER::PROTEIN) ("protein and EMT" . SPARSER::COLLECTION)
    ("Cav-1 and vimentin" . SPARSER::COLLECTION)
    ("ShRNA-Cav-1" . SPARSER::COLLECTION) ("ShRNA" . SPARSER::PROTEIN)
    ("vimentin and snail" . SPARSER::COLLECTION)
    ("ZO-1, N-cadherin, and β -catenin" . SPARSER::COLLECTION)
    ("E-cadherin, ZO-1, N-cadherin, and β -catenin" . SPARSER::COLLECTION)
    ("TCF8/ZEB1" . SPARSER::COLLECTION) ("rhodamine" . SPARSER::PROTEIN)
    ("phalloidin" . SPARSER::MOLECULE) ("MTT" . SPARSER::MOLECULE)
    ("NONOate" . SPARSER::MOLECULE)
    ("biological substance" . SPARSER::SUBSTANCE)
    ("substance" . SPARSER::SUBSTANCE)
    ("the biological mediators" . SPARSER::PROTEIN)
    ("EMT and Cav-1" . SPARSER::COLLECTION)
    ("N-cadherin, vimentin, and snail" . SPARSER::COLLECTION)
    ("melanoma and colon cancer" . SPARSER::COLLECTION)
    ("Anoikis" . SPARSER::PROTEIN)
    ("vimentin and snail, and caveolin-1" . SPARSER::COLLECTION)
    ("snail, and caveolin-1" . SPARSER::COLLECTION)
    ("snail" . SPARSER::PROTEIN) ("vimentin" . SPARSER::PROTEIN)
    ("EMT" . SPARSER::PROTEIN) ("anoikis" . SPARSER::PROTEIN)
    ("TGF- β 1" . SPARSER::PROTEIN) ("Mcl-1 protein" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("sodium chloride" . SPARSER::DRUG)
    ("sulforhodamine B" . SPARSER::MOLECULE) ("β -catenin" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("TCF8" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("Fas ligand" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN) ("Nitric oxide" . SPARSER::MOLECULE)
    ("AKT3 and PI3KCA-" . SPARSER::COLLECTION)
    ("AKT3 and PIK3CA" . SPARSER::COLLECTION)
    ("BCNU and etoposide" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION)
    ("MAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("melanoma" . SPARSER::PROTEIN)
    ("AKT1 , AKT2 , and AKT3" . SPARSER::COLLECTION)
    ("mitochondria" . SPARSER::PROTEIN)
    ("I κ B kinase (IKK) and HDM2" . SPARSER::COLLECTION)
    ("BCL-2, I κ B kinase (IKK) and HDM2" . SPARSER::COLLECTION)
    ("kinase (IKK)" . SPARSER::KINASE) ("IKK" . SPARSER::PROTEIN)
    ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("Western blot and flow cytometry" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN) ("BCL-2 and BAX" . SPARSER::COLLECTION)
    ("AKT , PI3KCA , and AKT3" . SPARSER::COLLECTION)
    ("resp" . SPARSER::PROTEIN) ("PI" . SPARSER::PROTEIN)
    ("min-max" . SPARSER::COLLECTION) ("max" . SPARSER::PROTEIN)
    ("min" . SPARSER::PROTEIN)
    ("AKT3 , PI3KCA , and AKT3" . SPARSER::COLLECTION)
    ("reagent and trypan" . SPARSER::COLLECTION)
    ("reagent" . SPARSER::MOLECULE) ("cytometry" . SPARSER::PROTEIN)
    ("AKT3 and PIKCA" . SPARSER::COLLECTION)
    ("a potential therapeutic solution" . SPARSER::MOLECULE)
    ("solution" . SPARSER::MOLECULE) ("temozolomide" . SPARSER::DRUG)
    ("etoposide" . SPARSER::PROTEIN) ("carmustine" . SPARSER::DRUG)
    ("bis" . SPARSER::PROTEIN) ("BCNU" . SPARSER::DRUG)
    ("AKT3 (PKB γ ) and PI3KCA (p110 α )" . SPARSER::COLLECTION)
    ("hope" . SPARSER::PROTEIN) ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("AKT2 and AKT3" . SPARSER::COLLECTION)
    ("AKT1, AKT2, and AKT3" . SPARSER::COLLECTION)
    ("Forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BAD" . SPARSER::PROTEIN)
    ("RAC-PK" . SPARSER::COLLECTION) ("PK" . SPARSER::PROTEIN)
    ("RAC" . SPARSER::PROTEIN) ("PKB" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("p110 α and p110 β" . SPARSER::COLLECTION) ("isoform" . SPARSER::PROTEIN)
    ("PI3KC2 α , PI3KC2 β , and PI3KC2 γ" . SPARSER::COLLECTION)
    ("p84 and p87PIKAP" . SPARSER::COLLECTION)
    ("a catalytic subunit p110 γ and a regulatory subunit p101"
     . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("p110 α , p110 β , and p110 γ" . SPARSER::COLLECTION)
    ("isoforms" . SPARSER::ISOFORM)
    ("heterodimers that are composed of a p110 catalytic subunit and a p85 regulatory subunit"
     . SPARSER::COLLECTION)
    ("Class" . CLASS) ("IB" . SPARSER::PROTEIN) ("IA" . SPARSER::MOLECULE)
    ("class" . CLASS) ("classes" . CLASS) ("inositol" . SPARSER::PROTEIN)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("PI3 K/AKT" . SPARSER::COLLECTION)
    ("the most aggressive form" . SPARSER::FORM) ("IV" . SPARSER::PROTEIN)
    ("BAX/BCL-2" . SPARSER::COLLECTION) ("BAX" . SPARSER::PROTEIN)
    ("AKT3 and/or PI3KCA genes" . SPARSER::COLLECTION)
    ("fraction" . SPARSER::COMPONENT) ("AKT3 and PI3KCA" . SPARSER::COLLECTION)
    ("FC" . SPARSER::PROTEIN)
    ("AKT3 and/or PI3KCA siRNAs" . SPARSER::COLLECTION)
    ("AKT3 or PI3KCA" . SPARSER::COLLECTION)
    ("PI3K/AKT/PTEN" . SPARSER::COLLECTION) ("PTEN" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("BAG1" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("I κ B" . SPARSER::PROTEIN)
    ("BCL-X" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("GSK-3" . SPARSER::PROTEIN)
    ("IgG 2A" . SPARSER::PROTEIN) ("PKB γ" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDK1" . SPARSER::PROTEIN) ("PIP 3" . SPARSER::PIP3)
    ("cell membrane" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("Vps34" . SPARSER::PROTEIN) ("PI3KC2 γ" . SPARSER::PROTEIN)
    ("PI3KC2 β" . SPARSER::PROTEIN) ("PI3KC2 α" . SPARSER::PROTEIN)
    ("p87PIKAP" . SPARSER::PROTEIN) ("p84" . SPARSER::PROTEIN)
    ("p101" . SPARSER::PROTEIN) ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("PIP 3    " . SPARSER::PIP3) ("PIP 2" . SPARSER::PROTEIN)
    ("p110 γ" . SPARSER::PROTEIN) ("p110 β" . SPARSER::PROTEIN)
    ("p110 α" . SPARSER::PROTEIN) ("p85" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("catalytic subunit" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("Class I" . SPARSER::PROTEIN) ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("PI3Ks" . SPARSER::PROTEIN) ("PI3 K" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("PI3" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN) ("PI3K" . SPARSER::PROTEIN)
    ("ERR α and its target genes" . SPARSER::COLLECTION)
    ("OPN and OC" . SPARSER::COLLECTION) ("OC" . SPARSER::PROTEIN)
    ("osteopontin (OPN) and osteocalcin (OC)" . SPARSER::COLLECTION)
    ("OPN" . SPARSER::PROTEIN) ("osteopontin" . SPARSER::PROTEIN)
    ("Runx2, and alkaline phosphatase (ALP)" . SPARSER::COLLECTION)
    ("sialoprotein (BSP)" . SPARSER::PROTEIN)
    ("Runx2, and alkaline phosphatase" . SPARSER::COLLECTION)
    ("ALP" . SPARSER::PROTEIN) ("BSP" . SPARSER::PROTEIN)
    ("sialoprotein" . SPARSER::PROTEIN) ("osteocalcin" . SPARSER::PROTEIN)
    ("Drug" . SPARSER::DRUG)
    ("tumor suppressor P53 and its target genes" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("antioxidant" . SPARSER::PROTEIN) ("NAC" . SPARSER::PROTEIN)
    ("CM2" . SPARSER::PROTEIN) ("variety" . SPARSER::VARIETY)
    ("trypan" . SPARSER::DRUG)
    ("chemotherapeutic agent MTX" . SPARSER::PROTEIN) ("Gene" . SPARSER::GENE)
    ("chemotherapeutic drugs" . SPARSER::DRUG) ("drugs" . SPARSER::DRUG)
    ("molecules" . SPARSER::MOLECULE) ("oxygen" . SPARSER::MOLECULE)
    ("skeletal muscle" . SPARSER::PROTEIN) ("Estrogen" . SPARSER::MOLECULE)
    ("chemotherapeutic agent methotrexate (MTX)" . SPARSER::DRUG)
    ("methotrexate (MTX)" . SPARSER::DRUG) ("methotrexate" . SPARSER::DRUG)
    ("antifolate" . SPARSER::MOLECULE)
    ("tumor suppressor P53 and its target genes NOXA and XAF1"
     . SPARSER::COLLECTION)
    ("NOXA and XAF1" . SPARSER::COLLECTION) ("mediators" . SPARSER::PROTEIN)
    ("NOXA" . SPARSER::PROTEIN) ("ROS" . SPARSER::PROTEIN)
    ("Methotrexate (MTX)" . SPARSER::DRUG) ("MTX" . SPARSER::PROTEIN)
    ("Methotrexate" . SPARSER::DRUG) ("Runx2" . SPARSER::PROTEIN)
    ("as 2" . SPARSER::PROTEIN) ("β -Actin" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("and 1 " . SPARSER::PROTEIN)
    ("caspase 7" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("H 2 O 2" . SPARSER::DRUG) ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("N-acetylcysteine" . SPARSER::DRUG) ("P53" . SPARSER::PROTEIN)
    ("XAF1" . SPARSER::PROTEIN) ("tumor suppressor P53" . SPARSER::PROTEIN)
    ("ERR α" . SPARSER::PROTEIN)
    ("estrogen-related receptor alpha" . SPARSER::PROTEIN)
    ("COOH" . SPARSER::PROTEIN)
    ("Src and phosphatidylinositol-3-kinase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN)
    ("c-Src and protein kinase B" . SPARSER::COLLECTION)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER-Src-PELP1-phosphoinositide 3-kinase-ILK1" . SPARSER::COLLECTION)
    ("a viral oncogene" . SPARSER::ONCOGENE) ("ago" . SPARSER::PROTEIN)
    ("receptors, and progesterone" . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN) ("glucocorticoid" . SPARSER::PROTEIN)
    ("ARs" . SPARSER::PROTEIN) ("CRC, and ER α" . SPARSER::COLLECTION)
    ("ER and AR" . SPARSER::COLLECTION) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("estrogen and androgen" . SPARSER::COLLECTION)
    ("androgen" . SPARSER::PROTEIN) ("highly invasive type" . TYPE)
    ("PELP1 or NMAR" . SPARSER::COLLECTION) ("NMAR" . SPARSER::PROTEIN)
    ("Src" . SPARSER::PROTEIN) ("PELP1 and c-Src" . SPARSER::COLLECTION)
    ("shRNA" . SPARSER::PROTEIN) ("PELP1-shRNA" . SPARSER::COLLECTION)
    ("FHC" . SPARSER::PROTEIN) ("HCC" . SPARSER::PROTEIN)
    ("SW" . SPARSER::PROTEIN) ("receptors (NMAR)" . SPARSER::RECEPTOR)
    ("the predominant form" . SPARSER::FORM)
    ("ER α and ER β" . SPARSER::COLLECTION) ("ERs" . SPARSER::PROTEIN)
    ("effector" . SPARSER::EFFECTOR) ("regulators" . SPARSER::REGULATOR)
    ("growth factors and their receptor genes" . SPARSER::COLLECTION)
    ("receptor" . SPARSER::PROTEIN) ("III" . SPARSER::PROTEIN)
    ("age" . SPARSER::PROTEIN) ("CRC" . SPARSER::PROTEIN)
    ("western blot" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("glutamic acid-" . SPARSER::AMINO-ACID) ("Proline-" . SPARSER::AMINO-ACID)
    ("hormone" . SPARSER::PROTEIN) ("estrogen" . SPARSER::MOLECULE)
    ("leucine" . SPARSER::AMINO-ACID) ("Proline" . SPARSER::AMINO-ACID)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("NH2" . SPARSER::MOLECULE)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ILK1" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("v-Src" . SPARSER::PROTEIN) ("nuclear receptor" . SPARSER::PROTEIN)
    ("c - Src" . SPARSER::PROTEIN) ("citric acid" . SPARSER::MOLECULE)
    ("β -Gal" . SPARSER::PROTEIN) ("for 3 " . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("β -actin" . SPARSER::PROTEIN)
    ("anti- β" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("CO 2" . SPARSER::PROTEIN) ("ER β" . SPARSER::PROTEIN)
    ("ER α" . SPARSER::PROTEIN) ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("c-Src" . SPARSER::PROTEIN) ("PELP1" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("drug" . SPARSER::DRUG)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("ALK" . SPARSER::PROTEIN) ("crizotinib" . SPARSER::DRUG)
    ("path" . SPARSER::PROTEIN) ("mRNA and gene" . SPARSER::COLLECTION)
    ("Biomarkers" . SPARSER::MOLECULE) ("Cohorts" . SPARSER::MOLECULE)
    ("Ponatinib" . SPARSER::DRUG) ("II" . SPARSER::PROTEIN)
    ("primary MPM" . SPARSER::MOLECULE) ("FGF-FGFR1" . SPARSER::COLLECTION)
    ("EGFR, VEGFRs, MET and PDGFRs" . SPARSER::COLLECTION)
    ("targets" . SPARSER::TARGET-PROTEIN) ("cytotoxic" . SPARSER::PROTEIN)
    ("luciferase" . SPARSER::PROTEIN)
    ("PDGFRA, PDGFRB and RET" . SPARSER::COLLECTION)
    ("VEGFR1–3" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("PDGFRB" . SPARSER::PROTEIN) ("PDGFRA" . SPARSER::PROTEIN)
    ("tyrosine" . SPARSER::AMINO-ACID)
    ("analyses using commercially-available antibodies" . SPARSER::ANTIBODY)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("basal phospho-ERK" . SPARSER::PROTEIN)
    ("FGFR2 and FGF2" . SPARSER::COLLECTION) ("weaker" . SPARSER::PROTEIN)
    ("GSE" . SPARSER::PROTEIN) ("TMA" . SPARSER::MOLECULE)
    ("n" . SPARSER::PROTEIN) ("formalin" . SPARSER::MOLECULE)
    ("FGFR1 or FGFR2" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION) ("SNP" . SPARSER::PROTEIN)
    ("CEP" . SPARSER::PROTEIN) ("the biphasic variant" . SPARSER::VARIANT)
    ("variant" . SPARSER::VARIANT)
    ("examples of high FGFR1 and either FGF2 or FGF9 expression"
     . SPARSER::COLLECTION)
    ("FGF2 or FGF9" . SPARSER::COLLECTION) ("examples" . SPARSER::EXAMPLE)
    ("Line" . SPARSER::PROTEIN) ("FGFs and FGFRs" . SPARSER::COLLECTION)
    ("FGFRs" . SPARSER::PROTEIN) ("FGF2-FGFR1" . SPARSER::COLLECTION)
    ("therapeutically relevant target" . SPARSER::TARGET-PROTEIN)
    ("the key biomarker" . SPARSER::MOLECULE) ("NCT" . SPARSER::PROTEIN)
    ("FGFR2 and FGFR3" . SPARSER::COLLECTION) ("types" . TYPE)
    ("AXL ( xref , xref ) and insulin-like growth factor receptor (IGF1R)"
     . SPARSER::COLLECTION)
    ("AXL" . SPARSER::PROTEIN) ("VEGFRs" . SPARSER::PROTEIN)
    ("PDGFRs" . SPARSER::PROTEIN) ("receptors" . SPARSER::RECEPTOR)
    ("MET" . SPARSER::PROTEIN) ("RTKs" . SPARSER::PROTEIN)
    ("TKIs, gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("TKIs" . SPARSER::PROTEIN) ("EGFR" . SPARSER::PROTEIN)
    ("oncogene" . SPARSER::ONCOGENE) ("RTK" . SPARSER::PROTEIN)
    ("cisplatin and pemetrexed" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG)
    ("Three histological subtypes" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("States" . SPARSER::BIO-STATE)
    ("mRNA or protein" . SPARSER::COLLECTION) ("biomarker" . SPARSER::MOLECULE)
    ("biomarkers" . SPARSER::MOLECULE) ("FISH" . SPARSER::PROTEIN)
    ("FGFs" . SPARSER::PROTEIN) ("FP" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("ligand" . SPARSER::MOLECULE)
    ("FGF" . SPARSER::PROTEIN) ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("FGFR1 and FGF2" . SPARSER::COLLECTION) ("ponatinib" . SPARSER::DRUG)
    ("TKI" . SPARSER::PROTEIN) ("active" . SPARSER::ACTIVE)
    ("FGFR" . SPARSER::PROTEIN) ("therapeutics" . SPARSER::THERAPEUTICS)
    ("molecule" . SPARSER::MOLECULE) ("asbestos" . SPARSER::MOLECULE)
    ("MPM" . SPARSER::MOLECULE) ("AZD4547" . SPARSER::DRUG)
    ("VEGFR1" . SPARSER::PROTEIN) ("FGF9" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("p11" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RP11" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("phospho-ERK" . SPARSER::PROTEIN) ("serum albumin" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FGFR3" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("FANCA and FANCM" . SPARSER::COLLECTION)
    ("endonucleases" . SPARSER::PROTEIN)
    ("the MLH1-associated endonuclease FAN1" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN)
    ("sufficient residual FANCJ" . SPARSER::PROTEIN)
    ("barrier" . SPARSER::PROTEIN) ("differentially" . SPARSER::PROTEIN)
    ("MSH2 or MSH6" . SPARSER::COLLECTION)
    ("the relevant heterodimer" . SPARSER::HETERODIMER)
    ("MSH2–MSH6" . SPARSER::COLLECTION) ("past" . SPARSER::PROTEIN)
    ("heterodimers" . SPARSER::HETERODIMER) ("MSH2-" . SPARSER::PROTEIN)
    ("step" . SPARSER::PROTEIN) ("foci and chromatin" . SPARSER::COLLECTION)
    ("ATR/ATM" . SPARSER::COLLECTION)
    ("BRCA1, and FANCJ" . SPARSER::COLLECTION)
    ("FANCD2-FAN1" . SPARSER::COLLECTION) ("FANCM" . SPARSER::PROTEIN)
    ("mark" . SPARSER::PROTEIN) ("substrates" . SPARSER::SUBSTRATE)
    ("ATM" . SPARSER::PROTEIN) ("ATR" . SPARSER::PROTEIN)
    ("van" . SPARSER::PROTEIN) ("mutants" . SPARSER::MUTANT)
    ("Fancd2 and Msh2" . SPARSER::COLLECTION) ("impact" . SPARSER::PROTEIN)
    ("the abnormal DDR" . SPARSER::PROTEIN) ("DDR" . SPARSER::PROTEIN)
    ("FANCJ, BRCA1, or FANCD2" . SPARSER::COLLECTION)
    ("BRCA1-" . SPARSER::PROTEIN) ("red" . SPARSER::PROTEIN)
    ("FANCJ, FANCD2, FANCA, or BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 or the central FA pathway protein" . SPARSER::COLLECTION)
    ("FANCJ, FANCD2, or BRCA1" . SPARSER::COLLECTION) ("Edu" . SPARSER::DRUG)
    ("inhibitor" . SPARSER::INHIBITOR) ("aphidicolin" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN)
    ("Rad18 or the TLS polymerase REV1" . SPARSER::COLLECTION)
    ("MCF7 or U20S" . SPARSER::COLLECTION) ("polymerase" . SPARSER::PROTEIN)
    ("MCF7" . SPARSER::PROTEIN) ("MSH2 and Rad18" . SPARSER::COLLECTION)
    ("Rad18 or MSH2" . SPARSER::COLLECTION)
    ("Rad18/Rad6" . SPARSER::COLLECTION) ("ligase" . SPARSER::LIGASE)
    ("ubiquitin" . SPARSER::PROTEIN) ("PCNA" . SPARSER::PROTEIN)
    ("cisplatin" . SPARSER::DRUG) ("RPA and DNA-PKcs" . SPARSER::COLLECTION)
    ("RPA" . SPARSER::PROTEIN) ("post-MMC" . SPARSER::COLLECTION)
    ("chromatin" . SPARSER::PROTEIN) ("MMC or melphalan" . SPARSER::COLLECTION)
    ("melphalan" . SPARSER::DRUG) ("FANCJ–MLH1" . SPARSER::COLLECTION)
    ("DNA-PKcs or 53BP1" . SPARSER::COLLECTION)
    ("factors, DNA-PKcs or 53BP1" . SPARSER::COLLECTION) ("type" . TYPE)
    ("FANCJ and MSH2" . SPARSER::COLLECTION)
    ("FANCJ and MLH1" . SPARSER::COLLECTION) ("MNU" . SPARSER::DRUG)
    ("methylnitrosourea" . SPARSER::DRUG)
    ("FANCJ and MLH1 or MSH2" . SPARSER::COLLECTION)
    ("MLH1 or MSH2" . SPARSER::COLLECTION)
    ("MSH2 or MLH1" . SPARSER::COLLECTION) ("reagents" . SPARSER::MOLECULE)
    ("MLH1 or NHEJ proteins" . SPARSER::COLLECTION)
    ("platinum" . SPARSER::MOLECULE)
    ("MMR proteins binding ICLs or other DNA" . SPARSER::COLLECTION)
    ("MSH2 and MSH3" . SPARSER::COLLECTION)
    ("MSH2 and MSH6" . SPARSER::COLLECTION)
    ("MLH1 and PMS2" . SPARSER::COLLECTION) ("MutS" . SPARSER::PROTEIN)
    ("heterodimer" . SPARSER::HETERODIMER)
    ("ultraviolet light" . SPARSER::PROTEIN)
    ("ICLs and DNA" . SPARSER::COLLECTION) ("light" . SPARSER::PROTEIN)
    ("SLX4/FANCP" . SPARSER::COLLECTION) ("Wang" . SPARSER::PROTEIN)
    ("FANCP" . SPARSER::PROTEIN) ("post" . SPARSER::PROTEIN)
    ("BACH1/BRIP1" . SPARSER::COLLECTION) ("homologue" . SPARSER::PROTEIN)
    ("Fancd2" . SPARSER::PROTEIN) ("Cao" . SPARSER::MOLECULE)
    ("broken DNA" . SPARSER::DNA) ("Aly" . SPARSER::PROTEIN)
    ("BRCA1 and FANCD2" . SPARSER::COLLECTION)
    ("mitomycin C (MMC)" . SPARSER::DRUG) ("MMC" . SPARSER::PROTEIN)
    ("TLS" . SPARSER::PROTEIN) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("HR" . SPARSER::PROTEIN) ("BRCA1 or FANCD2" . SPARSER::COLLECTION)
    ("FANCA" . SPARSER::PROTEIN)
    ("FANCJ and the MMR protein MLH1" . SPARSER::COLLECTION)
    ("MLH1" . SPARSER::PROTEIN) ("ICL" . SPARSER::PROTEIN)
    ("ICLs and other DNA" . SPARSER::COLLECTION)
    ("BRCA-FA" . SPARSER::COLLECTION) ("ICLs" . SPARSER::PROTEIN)
    ("FANCJ, BRCA1, and FANCD2" . SPARSER::COLLECTION)
    ("BRCA-Fanconi anemia" . SPARSER::COLLECTION) ("MMR" . SPARSER::PROTEIN)
    ("mismatch" . SPARSER::PROTEIN) ("FANCJ" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN) ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("-3" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("NaVO 3" . SPARSER::MOLECULE)
    ("and 1 " . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("O6-benzylguanine" . SPARSER::DRUG) ("F12" . SPARSER::PROTEIN)
    ("p53" . SPARSER::PROTEIN) ("MSH2 " . SPARSER::PROTEIN)
    ("S5B" . SPARSER::PROTEIN) ("FAN1" . SPARSER::PROTEIN)
    ("msh2" . SPARSER::PROTEIN) ("FA-D2" . SPARSER::PROTEIN)
    ("8B" . SPARSER::PROTEIN) ("DNA polymerase" . SPARSER::PROTEIN)
    ("U20" . SPARSER::PROTEIN) ("REV1" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("Rad6" . SPARSER::PROTEIN)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("Rad51" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("G2/M" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("chr2" . SPARSER::PROTEIN) ("colon cancer" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("PMS2" . SPARSER::PROTEIN) ("MutLα" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("MSH3" . SPARSER::PROTEIN)
    ("SLX4" . SPARSER::PROTEIN) ("dog-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRIP1" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("Msh2" . SPARSER::PROTEIN) ("Rad18" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("forms" . SPARSER::FORM) ("viral antagonists" . SPARSER::MOLECULE)
    ("antagonists" . SPARSER::MOLECULE) ("PARP" . SPARSER::PROTEIN)
    ("targeting viral RNA" . SPARSER::RNA) ("target" . SPARSER::TARGET-PROTEIN)
    ("70 viral immune modulators" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("kinase" . SPARSER::KINASE) ("viral RNA" . SPARSER::RNA)
    ("UTR" . SPARSER::PROTEIN) ("hnRNP" . SPARSER::PROTEIN)
    ("Nuclear" . SPARSER::PROTEIN)
    ("RHA and La autoantigen" . SPARSER::COLLECTION)
    ("part" . SPARSER::COMPONENT)
    ("the YBX1 macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("IGFBP2, DDX3, ILF2, and RHA" . SPARSER::COLLECTION)
    ("lipid" . SPARSER::LIPID) ("pro-" . SPARSER::PROTEIN)
    ("TIA1 and positive-sense mRNAs form" . SPARSER::COLLECTION)
    ("Some RNA viral proteases" . SPARSER::PROTEIN)
    ("G3BP, PABP, and eIF4G" . SPARSER::COLLECTION)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral protein" . SPARSER::PROTEIN)
    ("ribonucleoproteins and ribosomal proteins" . SPARSER::COLLECTION)
    ("viral RNA or dsRNA" . SPARSER::COLLECTION)
    ("RNA or dsRNA" . SPARSER::COLLECTION)
    ("heterogeneous nuclear ribonucleoproteins" . SPARSER::PROTEIN)
    ("the 40S and 60S ribosomal proteins" . SPARSER::PROTEIN)
    ("other viral proteins" . SPARSER::PROTEIN)
    ("helicases" . SPARSER::PROTEIN) ("DEAD" . SPARSER::PROTEIN)
    ("PKR" . SPARSER::PROTEIN) ("kinases" . SPARSER::KINASE)
    ("a viral suppressor" . SPARSER::SUPPRESSOR)
    ("activator" . SPARSER::ACTIVATOR)
    ("siRNAs and miRNAs" . SPARSER::COLLECTION) ("miRNAs" . SPARSER::MICRO-RNA)
    ("several viral RNAs" . SPARSER::RNA)
    ("RHA, TIA1, and YBX1" . SPARSER::COLLECTION) ("NaA" . SPARSER::MOLECULE)
    ("RHA-GFP" . SPARSER::COLLECTION) ("RHA-HA" . SPARSER::COLLECTION)
    ("GST or GST-N" . SPARSER::COLLECTION)
    ("RHA and N pro" . SPARSER::COLLECTION) ("HA" . SPARSER::PROTEIN)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX) ("miRNA" . SPARSER::MICRO-RNA)
    ("microRNA" . SPARSER::MICRO-RNA) ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("helicase" . SPARSER::PROTEIN) ("DEAH" . SPARSER::PROTEIN)
    ("RHA" . SPARSER::PROTEIN)
    ("important antiviral RNA binding proteins" . SPARSER::PROTEIN)
    ("40S ribosomal subunits" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::FRAGMENT) ("DDX1 and DDX3" . SPARSER::COLLECTION)
    ("TIA1, DDX1, DDX3, and DCP1a" . SPARSER::COLLECTION)
    ("DCP1a" . SPARSER::PROTEIN) ("MEFs" . SPARSER::PROTEIN)
    ("antibodies" . SPARSER::ANTIBODY) ("zinc-binding" . SPARSER::PROTEIN)
    ("antibody" . SPARSER::ANTIBODY) ("Proteins" . SPARSER::PROTEIN)
    ("GST or N pro GST" . SPARSER::COLLECTION) ("foci" . SPARSER::PROTEIN)
    ("pro and YBX1" . SPARSER::COLLECTION)
    ("the other viral proteins" . SPARSER::PROTEIN)
    ("the viral replication complex" . SPARSER::BIO-COMPLEX)
    ("-mCherry" . SPARSER::COLLECTION) ("-GFP" . SPARSER::COLLECTION)
    ("mCherry" . SPARSER::PROTEIN) ("GFP" . SPARSER::PROTEIN)
    ("the single viral protein N pro" . SPARSER::AMINO-ACID)
    ("caspase" . SPARSER::PROTEIN) ("YBX1 or TIA1" . SPARSER::COLLECTION)
    ("YBX1 and TIA1" . SPARSER::COLLECTION) ("DNA" . SPARSER::DNA)
    ("cellular RNPs" . SPARSER::PROTEIN) ("mRNPs" . SPARSER::BIO-COMPLEX)
    ("prion" . SPARSER::PROTEIN-FAMILY) ("arsenate" . SPARSER::MOLECULE)
    ("Arsenate" . SPARSER::MOLECULE) ("mRNAs" . SPARSER::PROTEIN)
    ("trigger" . SPARSER::PROTEIN) ("gene" . SPARSER::GENE)
    ("Heterogeneous ribonucleoproteins hnRNP M" . SPARSER::PROTEIN)
    ("polysomes" . SPARSER::BIO-COMPLEX)
    ("eukaryotic initiation factor eIF3i, and tRNA ligases" . SPARSER::LIGASE)
    ("DDX 5 and DHX 15" . SPARSER::COLLECTION)
    ("eIF3i, and tRNA" . SPARSER::COLLECTION) ("eIF3i" . SPARSER::PROTEIN)
    ("ligases" . SPARSER::LIGASE) ("tRNA" . SPARSER::RNA)
    ("desmoplakin" . SPARSER::PROTEIN) ("TPEN" . SPARSER::DRUG)
    ("chelator" . SPARSER::MOLECULE) ("ion" . SPARSER::MOLECULE)
    ("metalloprotein" . SPARSER::MOLECULE)
    ("IRF3, IRF7, Hax-1, or I-κBα" . SPARSER::COLLECTION)
    ("Hax-1" . SPARSER::PROTEIN) ("modulators" . SPARSER::PROTEIN)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("proteins and dsRNA" . SPARSER::COLLECTION)
    ("peptides" . SPARSER::PEPTIDE) ("glutathione" . SPARSER::DRUG)
    ("genes" . SPARSER::GENE) ("GST" . SPARSER::PROTEIN)
    ("components of ribosomes and ribonucleoprotein particles"
     . SPARSER::COLLECTION)
    ("ribosomes and ribonucleoprotein particles" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("other viral inhibitors" . SPARSER::INHIBITOR)
    ("inhibitors" . SPARSER::INHIBITOR) ("mRNA" . SPARSER::RNA)
    ("RNA helicases and dsRNA" . SPARSER::COLLECTION)
    ("YBX1, DDX3X, and DDX5" . SPARSER::COLLECTION)
    ("40S and 60S ribosomal proteins and initiation factor eIF3a"
     . SPARSER::COLLECTION)
    ("40S and 60S ribosomal proteins" . SPARSER::PROTEIN)
    ("this viral protein" . SPARSER::PROTEIN) ("eIF3a" . SPARSER::PROTEIN)
    ("a single viral protein" . SPARSER::PROTEIN)
    ("a central regulator of interferon transcription and initiator"
     . SPARSER::COLLECTION)
    ("interferon alpha and beta" . SPARSER::COLLECTION)
    ("beta" . SPARSER::PROTEIN) ("regulator" . SPARSER::REGULATOR)
    ("case" . SPARSER::PROTEIN) ("dsRNA" . SPARSER::RNA)
    ("RIG-I and MDA-5" . SPARSER::COLLECTION)
    ("MAVS/IPS-1" . SPARSER::COLLECTION) ("eIF2" . SPARSER::PROTEIN)
    ("MAVS" . SPARSER::PROTEIN) ("factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polypeptide" . SPARSER::PEPTIDE) ("Cys" . SPARSER::AMINO-ACID)
    ("His" . SPARSER::AMINO-ACID) ("Glu" . SPARSER::AMINO-ACID)
    ("cysteine" . SPARSER::AMINO-ACID)
    ("the 40S ribosomal subunit and eIF3" . SPARSER::COLLECTION)
    ("subunit and eIF3" . SPARSER::COLLECTION)
    ("eIF4B and eIF4F" . SPARSER::COLLECTION) ("eIF" . SPARSER::PROTEIN)
    ("factors" . SPARSER::HUMAN-PROTEIN-FAMILY) ("subunit" . SPARSER::FRAGMENT)
    ("ribosome" . SPARSER::BIO-COMPLEX) ("ER" . SPARSER::PROTEIN)
    ("component" . SPARSER::COMPONENT) ("only 12 proteins" . SPARSER::PROTEIN)
    ("NS2, NS3, NS4A, NS4B, NS5A, and NS5B" . SPARSER::COLLECTION)
    ("family" . SPARSER::PROTEIN-FAMILY) ("group" . SPARSER::MOLECULE)
    ("this viral suppressor" . SPARSER::SUPPRESSOR)
    ("suppressor" . SPARSER::SUPPRESSOR) ("complexes" . SPARSER::BIO-COMPLEX)
    ("this unique viral protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex" . SPARSER::BIO-COMPLEX)
    ("glyceraldehyde-3-phosphate dehydrogenase (GAPDH)" . SPARSER::PROTEIN)
    ("other viral suppressors" . SPARSER::SUPPRESSOR)
    ("interferon" . SPARSER::PROTEIN) ("suppressors" . SPARSER::SUPPRESSOR)
    ("siRNAs" . SPARSER::PROTEIN) ("RNAs" . SPARSER::RNA)
    ("GAPDH" . SPARSER::PROTEIN) ("RISC" . SPARSER::PROTEIN)
    ("RNA" . SPARSER::RNA) ("RNP" . SPARSER::PROTEIN)
    ("RNA helicase A and La autoantigen" . SPARSER::COLLECTION)
    ("form" . SPARSER::FORM) ("nuclear" . SPARSER::PROTEIN)
    ("inactive" . SPARSER::INACTIVE) ("mutant" . SPARSER::MUTANT)
    ("RNPs" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("components" . SPARSER::COMPONENT)
    ("mainly ribosomal proteins and ribonucleoproteins" . SPARSER::COLLECTION)
    ("55 associated proteins" . SPARSER::PROTEIN)
    ("proteins and ribonucleoproteins" . SPARSER::COLLECTION)
    ("PABP" . SPARSER::PROTEIN) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("guanine" . SPARSER::PROTEIN) ("protein" . SPARSER::PROTEIN)
    ("ribonucleoproteins" . SPARSER::PROTEIN) ("proteins" . SPARSER::PROTEIN)
    ("The viral N-terminal protease N pro" . SPARSER::AMINO-ACID)
    ("pro" . SPARSER::PROTEIN) ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Argonaute 2" . SPARSER::PROTEIN) ("ADP-ribose" . SPARSER::MOLECULE)
    ("K7" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA) ("ILF2" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN) ("nsP3" . SPARSER::PROTEIN)
    ("G3BP" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("NS1" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("Ago2" . SPARSER::PROTEIN)
    ("RNA helicase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("decapping enzyme" . SPARSER::PROTEIN) (NIL . SPARSER::PROTEIN)
    ("YBX 1" . SPARSER::PROTEIN) ("RNA binding protein" . SPARSER::PROTEIN)
    ("hnRNP M" . SPARSER::PROTEIN) ("DHX 15" . SPARSER::PROTEIN)
    ("DDX 5" . SPARSER::PROTEIN) ("I-κBα" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("monoclonal antibody" . SPARSER::DRUG)
    ("Triton X-100" . SPARSER::MOLECULE) ("Tween 20" . SPARSER::MOLECULE)
    ("MS2" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("and 1" . SPARSER::PROTEIN)
    ("NP-40" . SPARSER::DRUG) ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("Alpha-actin" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("a-V" . SPARSER::MOLECULE) ("amino acids" . SPARSER::AMINO-ACID)
    ("Myc-tagged" . SPARSER::PROTEIN) ("DCP1" . SPARSER::PROTEIN)
    ("DDX1" . SPARSER::PROTEIN) ("YBX-1" . SPARSER::PROTEIN)
    ("TIA1" . SPARSER::PROTEIN) ("DDX3X" . SPARSER::PROTEIN)
    ("zinc atom" . SPARSER::MOLECULE) ("interferon alpha" . SPARSER::PROTEIN)
    ("MDA-5" . SPARSER::PROTEIN) ("RIG-I" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("IPS-1" . SPARSER::PROTEIN)
    ("protein kinase R" . SPARSER::PROTEIN)
    ("RNA helicases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NS5B" . SPARSER::PROTEIN) ("NS5A" . SPARSER::PROTEIN)
    ("NS4B" . SPARSER::PROTEIN) ("NS4A" . SPARSER::PROTEIN)
    ("NS3" . SPARSER::PROTEIN) ("NS2" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("E1" . SPARSER::MOLECULE)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("La autoantigen" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein 3" . SPARSER::PROTEIN)
    ("interleukin enhancer binding factor 3" . SPARSER::PROTEIN)
    ("protein 2" . SPARSER::PROTEIN) ("IGF2BP1" . SPARSER::PROTEIN)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("DDX5" . SPARSER::PROTEIN)
    ("DDX3" . SPARSER::PROTEIN) ("YBX1" . SPARSER::PROTEIN)
    ("DHX9" . SPARSER::PROTEIN) ("RNA helicase A" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN)))